data_2k9x_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k9x _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.5 m-70 . . . . . 0 N--CA 1.465 0.309 0 CA-C-O 120.904 0.383 . . . . 0.0 111.522 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 8.5 mm -104.05 143.18 16.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.648 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 32.1 m -111.09 93.47 4.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.563 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.8 p -114.59 102.65 14.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.15 0.5 . . . . 0.0 110.223 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.424 ' HB2' ' O ' ' A' ' 23' ' ' THR . 0.2 OUTLIER -128.37 175.2 8.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.96 -178.556 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.5 ' CD1' ' HB3' ' A' ' 15' ' ' CYS . 49.8 m-85 -128.39 168.65 15.28 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.112 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.29 136.61 14.02 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.311 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.09 -106.29 3.14 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.216 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -122.98 31.7 4.65 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.727 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.5 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . 69.3 m -106.78 -16.62 14.44 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.422 ' HG2' ' HB2' ' A' ' 11' ' ' PHE . 68.5 mt-10 -58.58 -30.98 67.6 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.523 0.201 . . . . 0.0 111.05 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.8 mp -70.57 -7.8 46.73 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.3 mt -83.57 12.08 6.22 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.418 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 38.5 t80 -147.32 -62.37 0.28 Allowed 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -176.7 36.28 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.067 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.47 35.86 12.1 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.895 0.378 . . . . 0.0 110.663 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -90.2 146.07 24.54 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.913 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.424 ' O ' ' HB2' ' A' ' 10' ' ' GLN . 7.3 p -75.97 -32.64 59.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.098 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.9 p -170.96 157.98 5.53 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.646 0.26 . . . . 0.0 111.145 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.95 154.36 51.13 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.819 0.343 . . . . 0.0 111.547 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.52 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 16.7 mt-30 -132.72 128.15 36.3 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.986 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.5 mt . . . . . 0 C--O 1.235 0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.78 179.851 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.6 m . . . . . 0 C--O 1.233 0.231 0 CA-C-O 120.695 0.283 . . . . 0.0 110.674 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -128.97 -178.59 4.69 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.169 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.2 tt -57.77 -46.65 84.26 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -56.83 -33.76 67.07 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.719 0.295 . . . . 0.0 110.32 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.67 -30.1 49.75 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 121.001 -0.618 . . . . 0.0 111.983 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -70.8 -47.33 60.05 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.674 0.237 . . . . 0.0 111.237 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -53.34 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.866 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -53.41 -33.11 52.64 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.031 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.85 -24.78 62.59 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.302 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.1 -42.18 8.73 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.426 ' HG3' ' H ' ' A' ' 46' ' ' THR . 7.7 pttp -92.36 -60.86 1.73 Allowed 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.426 ' H ' ' HG3' ' A' ' 45' ' ' LYS . 1.5 m -54.57 -27.29 37.85 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 122.176 -0.328 . . . . 0.0 111.244 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -82.71 -26.65 31.82 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.461 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.417 ' O ' HG12 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -135.59 -75.04 0.45 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.77 -0.195 . . . . 0.0 111.323 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.417 HG12 ' O ' ' A' ' 48' ' ' TYR . 13.0 p 40.41 89.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.396 0.678 . . . . 0.0 112.237 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -66.33 -53.7 33.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.228 179.616 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -76.65 -179.47 5.33 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.798 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.12 113.91 6.23 Favored Pre-proline 0 N--CA 1.464 0.246 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.162 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.66 -23.25 75.49 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.546 2.164 . . . . 0.0 112.5 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -90.28 5.55 46.71 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.5 pp -93.38 -21.42 19.54 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 122.379 -0.201 . . . . 0.0 111.484 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.14 -45.28 5.69 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 5.9 m -54.49 150.22 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.214 0.531 . . . . 0.0 111.66 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -66.79 -54.1 26.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.859 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.52 -43.0 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.441 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 71.4 p -87.42 11.06 15.52 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 58.55 23.09 54.02 Favored Glycine 0 C--N 1.338 0.674 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.645 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -110.17 -39.91 4.86 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.903 0.382 . . . . 0.0 110.585 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.493 HG21 ' HB3' ' A' ' 83' ' ' MET . 30.1 p -121.4 -178.05 3.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.022 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.5 mt -110.16 155.93 21.3 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.875 0.369 . . . . 0.0 111.003 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.89 148.98 82.34 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.429 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -50.3 -32.43 33.15 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.249 2.632 . . . . 0.0 113.146 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -47.84 -36.0 13.14 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 121.391 -0.433 . . . . 0.0 113.144 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.1 mt -93.11 138.0 21.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.784 0.292 . . . . 0.0 111.063 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.4 tp -102.87 106.93 17.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.93 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.7 m -84.93 133.34 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.864 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 mt -134.65 141.27 46.53 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.433 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 92' ' ' THR . 38.2 t -119.04 121.92 67.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.591 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 59.52 45.13 13.83 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.075 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.33 39.59 18.62 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.203 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 17.9 t -153.88 153.98 33.06 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.581 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -47.04 121.06 3.42 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.642 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.33 -19.03 43.68 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.684 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -77.53 -29.7 52.48 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.577 0.227 . . . . 0.0 110.838 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 43.7 t -65.24 -50.98 70.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.075 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.7 m -61.3 -36.03 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.521 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -176.78 -44.88 0.06 OUTLIER Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.773 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.41 -51.03 1.84 Allowed Glycine 0 C--N 1.335 0.51 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.213 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.493 ' HB3' HG21 ' A' ' 63' ' ' THR . 3.9 ptt? -142.5 23.74 1.95 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 120.479 0.181 . . . . 0.0 111.217 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -140.35 26.75 2.15 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -84.85 98.15 10.14 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.82 0.343 . . . . 0.0 110.945 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.9 m -61.68 141.56 17.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.584 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.63 160.19 14.52 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.185 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -158.21 31.16 0.25 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.441 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 69.6 120.62 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.89 0.376 . . . . 0.0 110.897 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 97.28 33.66 5.88 Favored Glycine 0 CA--C 1.519 0.302 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.961 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -101.86 167.44 10.07 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.94 0.4 . . . . 0.0 111.476 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 92.9 m -137.47 134.11 35.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.759 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.0 p -141.85 136.61 30.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.823 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -130.49 150.15 51.84 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.616 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -130.51 104.48 7.26 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.098 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.468 HG22 HD11 ' A' ' 96' ' ' ILE . 24.6 mt -118.99 115.4 47.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.035 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 46.6 t -81.24 140.36 34.93 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.284 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 21.3 p . . . . . 0 C--O 1.233 0.2 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.893 179.768 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.414 ' CD2' ' HB3' ' A' ' 26' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.26 0 CA-C-O 120.778 0.323 . . . . 0.0 111.071 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 33.3 mm -115.28 152.23 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.84 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.9 m -115.29 101.72 9.2 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.008 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.8 p -120.43 108.54 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-O 121.007 0.432 . . . . 0.0 111.207 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.36 156.88 44.76 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.571 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -115.05 144.93 42.85 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.859 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.0 151.89 35.34 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.672 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.37 -86.84 1.11 Allowed Glycine 0 C--N 1.336 0.538 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.44 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -143.34 27.73 2.1 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.565 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.29 5.54 21.77 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -93.1 -29.02 15.99 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.53 0.205 . . . . 0.0 111.046 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.0 mp -66.73 -15.56 63.62 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.422 ' CB ' HD12 ' A' ' 55' ' ' LEU . 3.6 pp -83.26 12.71 4.95 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -143.07 -66.5 0.37 Allowed 'General case' 0 CA--C 1.521 -0.135 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -175.78 36.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.31 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 mptt 49.7 34.92 7.95 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.865 0.364 . . . . 0.0 110.694 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -76.27 179.69 5.61 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.708 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.5 p -112.11 -74.55 0.63 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.01 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 87.9 p -135.74 156.81 48.24 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 120.777 0.322 . . . . 0.0 111.181 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.9 tp -150.13 166.56 29.43 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.688 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.482 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 1.0 OUTLIER -126.42 146.59 50.01 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.844 179.665 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.1 mt . . . . . 0 C--O 1.232 0.183 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.09 -179.532 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.2 m . . . . . 0 C--O 1.233 0.223 0 CA-C-O 120.799 0.333 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -111.33 -175.17 2.64 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.885 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.68 -42.85 89.47 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.756 -0.202 . . . . 0.0 111.1 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -55.68 -37.68 68.64 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.953 0.406 . . . . 0.0 109.948 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.75 -32.27 46.37 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.161 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 53.6 tp -62.83 -48.97 76.75 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.714 0.257 . . . . 0.0 110.591 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.16 -57.01 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.847 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -55.82 -28.15 54.84 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 120.498 0.189 . . . . 0.0 111.08 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.423 ' O ' ' HB2' ' A' ' 47' ' ' ASN . 7.1 tt -84.71 -21.86 29.97 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.848 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.2 pp -93.89 -41.08 9.81 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.72 -56.48 6.29 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.77 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.6 m -60.69 -20.33 60.78 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.554 0.216 . . . . 0.0 110.814 178.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.4 OUTLIER -67.45 -44.19 79.27 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.944 179.474 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -146.43 -62.83 0.31 Allowed 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.472 ' O ' HG12 ' A' ' 49' ' ' VAL . 13.2 p 42.91 86.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.469 0.652 . . . . 0.0 112.017 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.78 -48.17 80.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.214 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.61 -156.23 0.44 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.651 -0.249 . . . . 0.0 110.564 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.404 ' HB2' HD21 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -66.88 138.01 95.03 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-O 120.755 0.312 . . . . 0.0 111.583 -179.507 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.77 -29.9 4.16 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.562 2.174 . . . . 0.0 112.468 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.425 ' HA ' ' CG2' ' A' ' 57' ' ' VAL . 4.1 t0 -94.43 10.67 33.5 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.422 HD12 ' CB ' ' A' ' 18' ' ' LEU . 3.4 pp -77.85 -25.96 49.07 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.543 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.418 ' C ' HD21 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -97.4 -50.77 4.4 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.387 179.952 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 64' ' ' LEU . 1.3 m -60.99 149.66 7.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.209 0.528 . . . . 0.0 111.268 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -61.46 -61.3 2.63 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.299 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -171.08 -43.74 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.269 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 38.9 p -85.07 11.43 9.67 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.807 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.404 ' HA2' ' CG1' ' A' ' 57' ' ' VAL . . . 54.08 27.99 39.92 Favored Glycine 0 C--N 1.34 0.779 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.539 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -113.97 -44.66 3.13 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.983 0.42 . . . . 0.0 110.332 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.4 t -122.98 139.89 53.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.948 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 7.2 mt -66.76 154.84 39.74 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.872 0.368 . . . . 0.0 110.911 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.5 156.05 89.04 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.194 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.48 140.54 74.5 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.844 2.362 . . . . 0.0 112.37 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.61 -47.72 1.0 Allowed Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.255 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.4 mt -79.93 149.96 5.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-O 120.867 0.365 . . . . 0.0 110.984 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.3 mt -128.41 104.3 7.63 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.783 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.6 m -77.37 123.62 34.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.833 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.3 mt -124.8 141.46 52.1 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.375 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 92' ' ' THR . 36.6 t -109.34 107.0 21.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.526 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 59.35 55.44 4.23 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.899 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.0 t 57.71 49.2 12.72 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.312 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 52.4 t -162.41 143.63 10.38 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.784 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.3 122.2 9.86 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.913 0.387 . . . . 0.0 111.193 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.29 -19.98 59.37 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.901 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -71.52 -24.99 62.06 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 116.728 -0.215 . . . . 0.0 111.172 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.9 t -56.18 -32.51 34.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.017 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.6 m -105.67 -38.92 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.629 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -154.95 -56.7 0.01 OUTLIER Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.017 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 99.29 -53.16 1.04 Allowed Glycine 0 C--N 1.333 0.4 0 C-N-CA 121.125 -0.56 . . . . 0.0 112.448 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.6 23.74 3.15 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.546 0.213 . . . . 0.0 111.4 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -142.74 27.06 1.69 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.733 0.271 . . . . 0.0 111.733 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -77.74 117.38 19.08 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.77 0.319 . . . . 0.0 110.944 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.7 m -75.28 136.06 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.272 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 mp -86.48 162.19 18.21 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.294 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -146.13 33.5 1.0 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.403 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 60.42 27.34 16.94 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.396 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -169.59 40.01 0.2 Allowed Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.937 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -103.85 166.55 10.35 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.062 0.458 . . . . 0.0 111.253 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 78.9 m -127.81 137.07 52.25 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.434 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.8 p -142.22 134.21 26.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.991 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -133.39 138.81 46.45 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.316 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -110.17 105.64 14.8 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.356 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 10.9 mt -110.85 100.76 11.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.074 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -84.08 110.58 18.58 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.036 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 22.7 p . . . . . 0 C--O 1.233 0.218 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.983 179.888 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.725 0.298 . . . . 0.0 111.316 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 16.1 mm -90.97 157.16 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.562 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 30.3 m -124.91 93.74 3.98 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.807 0.336 . . . . 0.0 111.521 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.6 p -113.23 103.6 15.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.183 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -131.74 166.9 20.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.744 -178.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.493 ' HB2' ' HG2' ' A' ' 16' ' ' GLU . 41.6 m-85 -125.0 163.52 22.16 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.874 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 96' ' ' ILE . . . -175.17 119.51 0.19 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.053 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.67 54.89 0.76 Allowed Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.582 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.26 25.96 72.48 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.199 -0.524 . . . . 0.0 113.478 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -116.44 5.35 13.43 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 117.091 0.445 . . . . 0.0 111.675 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.493 ' HG2' ' HB2' ' A' ' 11' ' ' PHE . 64.1 mt-10 -84.17 -23.29 30.67 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.73 -4.92 21.86 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 24.7 mt -78.88 8.73 5.06 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -149.39 -63.58 0.22 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.788 0.328 . . . . 0.0 110.149 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -174.84 38.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.848 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.93 35.8 20.15 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.241 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -80.48 178.37 8.37 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.963 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 28.1 p -107.69 -74.65 0.65 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.994 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 88.0 p -132.99 160.58 36.71 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.829 0.347 . . . . 0.0 111.355 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.55 152.81 44.42 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.181 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.447 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 1.7 mt-30 -131.06 122.32 26.55 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.6 mt . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.338 179.674 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 58.9 m . . . . . 0 CA--C 1.532 0.285 0 CA-C-O 120.61 0.243 . . . . 0.0 110.984 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -131.81 -179.55 5.46 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.896 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.4 tt -53.47 -48.36 68.94 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 111.514 0.19 . . . . 0.0 111.514 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -52.99 -36.35 60.28 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.812 0.339 . . . . 0.0 110.388 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.3 -31.05 43.33 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.137 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.84 -51.49 54.89 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.633 0.254 . . . . 0.0 110.72 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.452 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -60.7 -57.34 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.915 179.776 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -52.57 -29.33 25.05 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.319 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 30.5 tp -74.53 -27.59 60.6 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 3.5 pp -96.93 -38.61 9.75 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.16 -70.91 0.54 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.411 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.3 m -53.24 -24.32 10.95 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 111.863 0.319 . . . . 0.0 111.863 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -102.45 -23.3 13.94 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -147.84 50.17 1.05 Allowed 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.6 p -99.88 122.72 52.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.871 0.367 . . . . 0.0 110.987 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -100.79 33.05 2.91 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.888 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.439 ' HB3' HD23 ' A' ' 55' ' ' LEU . 1.7 tp10 -160.21 -161.79 0.92 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.111 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 54.5 mtt-85 -88.87 109.88 33.47 Favored Pre-proline 0 CA--C 1.529 0.172 0 CA-C-O 120.418 0.152 . . . . 0.0 110.894 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -48.41 -30.11 14.87 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.724 2.283 . . . . 0.0 112.929 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.19 -17.17 64.56 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.439 HD23 ' HB3' ' A' ' 51' ' ' GLU . 2.5 pp -80.38 -15.19 57.43 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.65 -49.15 3.2 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.712 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.9 m -57.34 148.38 5.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.078 0.466 . . . . 0.0 111.467 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -71.33 -59.72 2.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.913 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -162.96 -56.42 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.229 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.6 p -59.51 -21.2 59.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.2 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.76 21.59 49.97 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 121.149 -0.548 . . . . 0.0 111.862 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -124.45 -46.34 1.9 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.792 0.33 . . . . 0.0 110.974 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.0 t -101.91 130.91 48.52 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.701 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.7 mt -65.91 155.29 36.87 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.806 0.336 . . . . 0.0 111.123 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -53.21 143.76 32.46 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.324 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -51.57 -33.39 47.97 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.181 2.587 . . . . 0.0 112.98 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -49.49 -35.39 21.75 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.348 -0.453 . . . . 0.0 112.914 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.9 mt -82.81 114.4 23.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.83 0.315 . . . . 0.0 110.787 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.61 97.01 8.28 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.198 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.3 t -84.87 136.33 23.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.041 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.6 mt -125.62 126.68 45.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.89 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 92' ' ' THR . 38.4 t -110.23 118.76 57.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.878 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.4 m120 55.29 35.02 24.04 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.363 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.1 t 56.18 33.16 21.56 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.306 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 9.3 t -138.02 31.11 2.46 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.841 0.353 . . . . 0.0 111.01 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 69.05 145.28 0.05 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.371 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -85.08 -22.73 28.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.594 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -82.28 -33.5 29.07 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.755 -0.202 . . . . 0.0 110.993 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 39.5 t -66.16 -41.9 90.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.26 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.476 ' HB ' ' CD1' ' A' ' 85' ' ' TYR . 26.8 m -69.41 -29.13 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 168.3 -34.37 0.2 Allowed Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.339 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 109.25 -55.69 0.5 Allowed Glycine 0 C--N 1.333 0.416 0 N-CA-C 111.823 -0.511 . . . . 0.0 111.823 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.69 27.94 0.28 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.461 0.172 . . . . 0.0 111.289 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -135.42 20.55 3.38 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.476 ' CD1' ' HB ' ' A' ' 80' ' ' VAL . 34.1 t80 -68.56 112.09 5.14 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.787 0.327 . . . . 0.0 110.961 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.2 m -71.04 135.47 27.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.272 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.83 152.99 29.41 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.023 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -155.23 -59.72 0.11 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.055 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -173.03 116.09 0.28 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.137 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 80.26 34.26 29.93 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.826 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -75.39 99.09 4.04 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.84 0.352 . . . . 0.0 110.358 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 16.0 m -81.77 127.84 33.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.56 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.7 p -139.02 113.96 8.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.011 0.434 . . . . 0.0 110.926 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -114.98 149.89 36.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.119 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -123.91 104.71 9.09 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.419 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 12' ' ' ALA . 29.3 mt -114.12 101.97 13.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.323 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.0 m -72.94 97.93 2.38 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.089 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.7 m . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.978 179.985 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 25.0 p-80 . . . . . 0 C--O 1.234 0.251 0 CA-C-O 120.79 0.329 . . . . 0.0 111.515 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.447 HD13 HG23 ' A' ' 7' ' ' ILE . 33.9 mm -95.79 137.84 22.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.692 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.9 m -96.26 98.88 10.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.201 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.1 p -122.47 108.7 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-O 120.92 0.39 . . . . 0.0 110.559 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -135.2 158.91 43.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.396 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.403 ' CB ' ' HA ' ' A' ' 16' ' ' GLU . 31.0 m-85 -126.75 145.47 50.6 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.124 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -92.74 179.99 5.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.303 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.6 97.43 0.12 Allowed Glycine 0 C--N 1.335 0.504 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.6 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 135.16 -40.95 1.49 Allowed Glycine 0 C--N 1.333 0.364 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.807 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.05 -23.95 18.48 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.441 0.162 . . . . 0.0 111.418 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.403 ' HA ' ' CB ' ' A' ' 11' ' ' PHE . 6.9 pt-20 -58.43 -26.92 63.83 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 111.679 0.251 . . . . 0.0 111.679 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 mp -68.59 -8.46 41.98 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 25.3 mt -83.26 13.43 4.26 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -148.46 -59.11 0.24 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.743 0.306 . . . . 0.0 110.253 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -178.67 36.49 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.079 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.54 34.53 9.66 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.952 0.406 . . . . 0.0 110.764 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -78.84 173.25 12.7 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.021 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.2 p -107.97 -45.21 4.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.947 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 94.3 p -159.7 158.87 32.16 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.592 0.234 . . . . 0.0 111.238 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.95 163.6 35.63 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.232 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.24 100.8 5.32 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.855 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.0 mt . . . . . 0 C--O 1.233 0.191 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.663 179.952 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.4 m . . . . . 0 C--O 1.233 0.235 0 CA-C-O 120.641 0.258 . . . . 0.0 111.075 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -136.02 -174.09 3.57 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.05 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.5 tt -56.82 -45.5 82.28 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.731 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -54.69 -38.63 67.22 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.03 -32.96 58.02 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.015 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.6 mt -65.61 -57.03 9.11 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.629 0.252 . . . . 0.0 110.65 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -55.27 -56.89 9.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.994 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -51.02 -29.89 13.8 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.464 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.24 -28.49 57.15 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.0 pp -94.91 -33.03 12.94 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.417 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 4.4 pttt -92.49 -61.05 1.68 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 111.595 0.221 . . . . 0.0 111.595 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.413 ' H ' ' HG3' ' A' ' 45' ' ' LYS . 1.0 OUTLIER -58.29 -20.23 41.02 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 122.126 -0.359 . . . . 0.0 111.306 179.752 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -105.68 -30.14 9.65 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -146.63 48.45 1.17 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.417 ' HB ' ' O ' ' A' ' 45' ' ' LYS . 7.5 p -80.81 -32.81 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.07 20.82 0.65 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 122.544 0.338 . . . . 0.0 111.642 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -158.73 -166.4 1.87 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.242 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.415 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 3.0 ttt180 -70.67 110.91 7.97 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-O 120.601 0.238 . . . . 0.0 110.752 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.32 -22.23 70.16 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.37 2.047 . . . . 0.0 112.347 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.19 8.23 41.03 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 52' ' ' ARG . 2.7 pp -88.85 -7.75 55.56 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 122.239 -0.288 . . . . 0.0 111.534 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.93 -47.68 2.59 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.7 m -53.58 150.35 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-O 121.275 0.56 . . . . 0.0 111.396 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -62.7 -57.15 12.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.598 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.08 -43.16 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.354 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 31.9 p -86.5 10.09 16.35 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.752 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 58.88 21.96 53.23 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.484 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -107.77 -42.05 4.83 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.901 0.382 . . . . 0.0 110.461 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.1 t -118.74 -167.78 1.43 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.097 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.6 mt -111.75 157.58 20.35 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.979 0.418 . . . . 0.0 111.689 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.428 ' HB2' ' HD2' ' A' ' 66' ' ' PRO . 0.5 OUTLIER -78.18 156.93 78.88 Favored Pre-proline 0 C--O 1.233 0.206 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.949 179.859 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.428 ' HD2' ' HB2' ' A' ' 65' ' ' ARG . 10.7 Cg_endo -55.22 134.33 63.21 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.637 2.225 . . . . 0.0 112.472 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 133.73 -47.99 0.97 Allowed Glycine 0 C--N 1.331 0.292 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.185 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.8 mt -86.02 137.03 21.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-O 120.678 0.275 . . . . 0.0 111.092 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -107.74 106.65 17.06 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.674 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.5 m -83.11 128.39 38.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.876 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.5 mt -132.69 136.82 46.67 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.566 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 92' ' ' THR . 38.5 t -108.95 102.86 14.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.374 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 60.36 57.41 2.88 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.764 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.2 m 57.69 49.33 12.55 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.594 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 50.3 t -163.12 137.56 6.25 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.818 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -54.02 124.99 17.16 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.823 0.345 . . . . 0.0 111.276 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.1 -23.38 35.74 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.239 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -70.08 -14.18 62.55 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 111.466 0.173 . . . . 0.0 111.466 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.2 t -74.05 -30.27 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 111.679 0.251 . . . . 0.0 111.679 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 18.8 m -115.73 -43.69 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -176.04 72.61 0.08 OUTLIER Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.409 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -49.93 -28.37 11.94 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 121.525 -0.369 . . . . 0.0 113.352 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.1 ptt? -132.15 29.09 4.38 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.726 0.298 . . . . 0.0 110.56 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -149.52 30.51 0.75 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.491 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -86.83 115.99 24.61 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.827 0.346 . . . . 0.0 111.281 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 29.8 m -66.23 168.61 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.341 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.84 178.74 4.23 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.193 0.521 . . . . 0.0 111.546 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -160.96 -82.77 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.054 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -173.91 33.57 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.877 0.37 . . . . 0.0 111.455 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 178.72 37.55 0.06 OUTLIER Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.429 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -82.52 149.38 27.56 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.779 0.323 . . . . 0.0 110.965 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.442 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 61.8 m -119.43 133.18 55.83 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.401 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.3 p -141.95 127.46 17.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.907 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -128.67 145.08 51.26 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.284 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -123.29 104.59 9.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.233 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 30.0 mt -116.71 109.18 27.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.274 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.5 m -80.24 149.8 30.29 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.137 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 32.0 p . . . . . 0 C--N 1.332 -0.173 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.014 179.913 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 37.3 p-80 . . . . . 0 N--CA 1.463 0.179 0 CA-C-O 120.81 0.338 . . . . 0.0 111.509 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 23.5 mm -99.1 146.11 9.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.847 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.413 ' HB ' ' HA ' ' A' ' 92' ' ' THR . 89.1 m -104.85 118.63 37.02 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.084 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.421 ' CG1' ' HB2' ' A' ' 25' ' ' LEU . 8.4 p -149.47 112.64 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.798 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.431 ' HB3' ' CB ' ' A' ' 24' ' ' SER . 6.2 pm0 -136.35 162.43 33.03 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.953 0.406 . . . . 0.0 111.74 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -120.8 141.75 50.23 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.164 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.32 150.76 46.93 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.387 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.32 -109.57 2.86 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.453 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -115.59 29.63 7.12 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.944 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.73 -8.11 14.19 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.984 0.392 . . . . 0.0 111.692 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -93.69 -25.32 17.51 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.573 0.225 . . . . 0.0 111.008 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.11 -7.13 47.3 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.6 pp -85.74 13.71 6.84 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -145.11 -64.11 0.34 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.922 0.391 . . . . 0.0 109.987 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -175.59 38.8 0.01 OUTLIER 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.561 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.3 mptt 51.2 40.52 26.18 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.362 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -67.23 171.98 5.22 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.918 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 62.3 p -114.09 -80.06 0.59 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.006 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.431 ' CB ' ' HB3' ' A' ' 10' ' ' GLN . 88.5 p -133.08 154.71 50.31 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.85 0.357 . . . . 0.0 111.409 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.421 ' HB2' ' CG1' ' A' ' 9' ' ' VAL . 0.4 OUTLIER -131.62 160.93 33.92 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.178 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 1.1 tt0 -131.17 120.92 23.99 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.032 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.5 mt . . . . . 0 C--O 1.234 0.287 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.739 179.726 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 89.3 m . . . . . 0 C--O 1.235 0.303 0 CA-C-O 120.826 0.346 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 44.9 p30 -116.94 -174.95 2.68 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.967 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.3 tt -57.78 -41.76 82.74 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.004 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -51.68 -43.14 62.62 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.229 178.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.36 -31.11 61.56 Favored Glycine 0 C--N 1.334 0.472 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.549 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -70.7 -56.92 5.31 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.876 0.338 . . . . 0.0 110.955 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.407 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 0.5 OUTLIER -56.98 -56.04 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.361 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.41 ' HA ' ' CG ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -50.93 -29.85 13.24 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.733 179.785 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.414 ' HA ' ' HB2' ' A' ' 47' ' ' ASN . 0.7 OUTLIER -70.18 -34.5 73.05 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.357 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.4 pp -96.99 -25.2 15.47 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.449 0.536 . . . . 0.0 112.449 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.41 ' CG ' ' HA ' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -93.02 -32.88 14.34 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.0 m -108.64 -26.04 10.57 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.414 ' HB2' ' HA ' ' A' ' 43' ' ' LEU . 2.9 m-80 -109.51 -22.38 12.02 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -178.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.69 39.82 3.16 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.4 p -98.38 143.11 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 120.85 0.357 . . . . 0.0 110.866 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.77 27.88 4.59 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.4 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -156.71 -166.98 2.25 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.52 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -57.95 111.03 2.99 Favored Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 116.935 -0.121 . . . . 0.0 110.889 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.51 -25.95 80.41 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.164 1.909 . . . . 0.0 112.209 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -90.66 7.0 41.6 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.7 pp -89.19 -15.76 32.94 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 121.161 -0.216 . . . . 0.0 111.256 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.34 -47.17 2.85 Favored 'General case' 0 C--N 1.339 0.11 0 N-CA-C 111.499 0.185 . . . . 0.0 111.499 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.4 m -58.41 147.05 7.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 121.119 0.485 . . . . 0.0 111.837 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -67.19 -57.23 7.11 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.468 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -171.59 -43.7 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.357 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 46.9 p -81.62 7.28 12.66 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.34 23.99 43.6 Favored Glycine 0 C--N 1.343 0.928 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.334 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -108.79 -39.32 5.38 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 120.753 0.311 . . . . 0.0 110.569 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 11.3 t -132.14 165.02 25.01 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.13 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.0 mt -77.55 157.76 30.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.906 0.384 . . . . 0.0 110.781 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.12 153.21 68.2 Favored Pre-proline 0 N--CA 1.465 0.292 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.254 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -49.02 -32.66 24.12 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.926 2.417 . . . . 0.0 112.591 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -51.27 -34.39 32.95 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.858 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.1 mt -97.19 148.7 5.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 116.855 0.327 . . . . 0.0 110.708 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.29 118.58 32.66 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.017 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.6 m -90.37 129.53 41.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.937 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 mt -125.49 130.43 51.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.166 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.429 HG11 ' CE1' ' A' ' 85' ' ' TYR . 26.3 t -105.0 99.48 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.465 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.1 m120 58.68 55.41 4.74 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.936 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.5 t 61.38 42.08 12.11 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.24 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 53.2 t -160.13 121.94 3.22 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.781 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -48.93 131.59 18.67 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.729 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.48 -26.27 41.69 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.973 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -72.72 -25.55 61.26 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.489 0.185 . . . . 0.0 111.119 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.11 -29.59 46.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.017 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.8 m -112.46 -39.26 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -137.41 -72.96 0.06 OUTLIER Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.858 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 119.92 -42.21 1.8 Allowed Glycine 0 C--N 1.334 0.453 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.386 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -157.42 29.35 0.29 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.743 0.306 . . . . 0.0 110.755 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -145.84 22.11 1.43 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.581 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.429 ' CE1' HG11 ' A' ' 72' ' ' VAL . 4.4 t80 -72.39 120.37 17.91 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 122.348 -0.22 . . . . 0.0 111.275 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.7 m -61.73 125.37 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.206 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.32 169.11 16.87 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.039 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -164.4 165.76 21.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.858 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -57.23 103.08 0.1 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.1 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 106.14 24.65 6.77 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 121.108 -0.568 . . . . 0.0 113.016 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.02 138.88 39.86 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.928 0.364 . . . . 0.0 110.543 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.413 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 86.1 m -113.15 115.24 27.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.117 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.8 p -125.27 111.22 26.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 121.04 0.448 . . . . 0.0 110.633 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -114.92 151.38 34.14 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.176 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -129.57 104.36 7.4 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.531 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.9 mt -106.24 100.44 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.887 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.8 106.64 7.49 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.47 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.5 p . . . . . 0 CA--C 1.536 0.415 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.741 -179.947 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 55.9 m80 . . . . . 0 N--CA 1.464 0.26 0 CA-C-O 120.721 0.296 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 2.0 mp -113.32 135.06 54.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-O 120.931 0.396 . . . . 0.0 111.152 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 83.5 m -88.75 96.63 10.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.983 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.8 p -117.79 113.49 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.206 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.412 ' HB3' ' CB ' ' A' ' 24' ' ' SER . 8.8 pm0 -137.08 166.87 22.69 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.931 0.396 . . . . 0.0 111.899 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -126.67 150.14 49.14 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.24 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -146.55 158.18 43.86 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.559 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 67.96 -100.48 0.64 Allowed Glycine 0 C--N 1.336 0.537 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.459 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -124.04 33.16 3.96 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.586 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.7 m -109.7 -16.23 13.97 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.449 ' HG2' ' N ' ' A' ' 17' ' ' LEU . 12.7 pm0 -81.81 -33.57 30.71 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.702 0.286 . . . . 0.0 111.143 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.449 ' N ' ' HG2' ' A' ' 16' ' ' GLU . 1.4 mp -60.98 -28.19 68.83 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.033 0.382 . . . . 0.0 112.033 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.9 pp -82.87 11.8 5.63 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -133.09 -60.01 0.87 Allowed 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 174.27 36.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.031 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.56 32.16 4.7 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.902 0.382 . . . . 0.0 110.97 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -80.16 168.55 18.96 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.106 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.3 p -101.93 -74.24 0.63 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.852 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.412 ' CB ' ' HB3' ' A' ' 10' ' ' GLN . 89.1 p -137.15 154.98 50.12 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.742 0.306 . . . . 0.0 111.198 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.8 mp -140.43 165.41 27.5 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.391 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.454 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 0.5 OUTLIER -131.27 119.34 21.64 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.827 179.783 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.3 mt . . . . . 0 C--O 1.233 0.188 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.916 -179.903 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 28.7 m . . . . . 0 N--CA 1.463 0.179 0 CA-C-O 120.692 0.282 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -105.26 -172.57 2.12 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.765 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.52 -35.66 65.89 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.335 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.448 ' O ' HG22 ' A' ' 41' ' ' VAL . 24.9 t-20 -54.86 -40.58 69.81 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.88 0.371 . . . . 0.0 110.087 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.15 -30.04 63.59 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.801 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.0 tt -63.37 -49.73 72.69 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.819 0.342 . . . . 0.0 110.692 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.448 HG22 ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -67.35 -52.18 44.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.728 179.767 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -54.72 -23.55 18.18 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.778 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.431 ' O ' ' HB3' ' A' ' 47' ' ' ASN . 4.6 tt -85.4 -22.95 28.14 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.878 0.371 . . . . 0.0 110.577 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -92.48 -50.21 5.74 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.949 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.451 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -89.33 -72.8 0.53 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 111.565 0.209 . . . . 0.0 111.565 -179.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.403 ' H ' ' HG3' ' A' ' 45' ' ' LYS . 5.8 m -49.46 -24.63 2.11 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.431 ' HB3' ' O ' ' A' ' 43' ' ' LEU . 10.1 t30 -106.1 -25.99 11.8 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -138.58 45.52 2.04 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.451 ' HB ' ' O ' ' A' ' 45' ' ' LYS . 10.6 p -104.42 152.41 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.168 0.508 . . . . 0.0 111.478 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.01 -40.48 1.05 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.674 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -79.94 -167.03 1.13 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.313 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.53 111.37 5.03 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.021 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.45 -25.25 80.06 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.275 1.983 . . . . 0.0 112.159 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.446 ' HA ' ' CG2' ' A' ' 57' ' ' VAL . 4.6 m-20 -92.37 8.52 38.12 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.035 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 pp -86.74 -27.4 23.67 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 122.289 -0.257 . . . . 0.0 111.068 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.96 -47.27 5.6 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.446 ' CG2' ' HA ' ' A' ' 54' ' ' ASP . 4.8 m -57.68 149.25 4.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-O 121.243 0.544 . . . . 0.0 111.598 -179.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -65.45 -56.42 12.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.739 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -173.83 -43.91 0.01 OUTLIER 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.402 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 78.0 p -87.5 12.45 12.31 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.406 ' HA2' ' CG1' ' A' ' 57' ' ' VAL . . . 58.21 22.31 49.66 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.673 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -108.86 -41.18 4.82 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.944 0.402 . . . . 0.0 110.582 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.6 p -119.87 -175.94 3.08 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.715 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.0 mt -111.07 157.06 20.41 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.857 0.361 . . . . 0.0 111.148 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.75 155.75 92.5 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.282 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.01 135.13 67.39 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.818 2.345 . . . . 0.0 112.404 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 134.4 -49.29 0.91 Allowed Glycine 0 C--N 1.331 0.284 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.299 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.0 mt -81.46 137.49 21.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-O 120.657 0.265 . . . . 0.0 111.176 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.83 103.69 13.19 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.529 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.4 m -83.25 130.41 35.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.609 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.3 mt -130.15 146.2 51.77 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.45 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 92' ' ' THR . 2.1 m -119.0 121.4 66.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.477 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 57.45 41.87 25.48 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.45 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 65.1 31.75 10.77 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.412 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 6.3 t -142.6 151.87 41.94 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.729 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -50.21 116.75 2.0 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.854 0.359 . . . . 0.0 111.535 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -84.78 -21.54 29.93 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.842 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -75.4 -27.64 59.14 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.602 0.239 . . . . 0.0 110.84 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 24.8 t -71.79 -40.84 69.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.014 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.1 m -74.3 -32.65 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.8 -46.91 0.05 OUTLIER Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.6 -0.809 . . . . 0.0 113.145 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.83 -54.25 1.66 Allowed Glycine 0 C--N 1.334 0.447 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.171 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -136.22 23.92 3.25 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.569 0.223 . . . . 0.0 111.363 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -132.61 17.08 4.35 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -77.99 120.65 23.14 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.668 0.271 . . . . 0.0 111.36 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.1 m -66.39 147.74 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.67 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.23 154.78 17.55 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.267 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -171.01 152.09 3.43 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.864 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -56.73 108.32 0.48 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.159 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 115.58 24.33 4.09 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.408 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -93.25 167.22 11.89 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.683 0.242 . . . . 0.0 110.5 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 94.9 m -141.43 111.67 6.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.817 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 14.3 p -122.78 121.25 62.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.115 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -123.83 155.87 37.21 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.447 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -132.19 104.34 6.72 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.927 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 28.5 mt -121.5 119.46 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.277 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.21 151.43 26.87 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.212 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.533 0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.672 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.465 0.28 0 CA-C-O 120.705 0.288 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.518 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 26.1 mm -127.75 152.83 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.794 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 19.3 m -113.66 95.29 5.26 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.775 0.322 . . . . 0.0 111.293 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.0 p -109.68 104.8 17.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.936 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -130.31 165.3 22.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.578 -179.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -117.51 161.17 20.03 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.17 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.36 155.66 39.12 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.431 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 72.38 -101.17 1.03 Allowed Glycine 0 C--N 1.335 0.51 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.26 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.72 27.35 3.52 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.684 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -95.71 -27.96 15.02 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.707 0.254 . . . . 0.0 111.505 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -58.21 -30.88 66.82 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.648 0.261 . . . . 0.0 111.282 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.9 mp -68.13 -8.56 39.41 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.989 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 60.4 mt -82.76 13.44 3.84 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -147.91 -66.16 0.25 Allowed 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -172.35 38.74 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.828 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.31 37.15 18.04 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.845 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -75.28 155.45 36.66 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.117 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 60.9 p -91.06 -69.54 0.73 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.106 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.7 p -144.59 154.4 42.81 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.95 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.6 mp -141.28 165.15 28.3 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.328 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.518 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 9.5 mt-30 -125.8 119.21 27.28 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.101 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.7 mt . . . . . 0 C--O 1.233 0.205 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.565 179.82 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.8 m . . . . . 0 C--O 1.234 0.238 0 CA-C-O 120.881 0.372 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -135.26 -173.16 3.25 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.694 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.2 tt -57.51 -41.87 81.69 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.278 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -56.19 -36.8 68.79 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.908 0.385 . . . . 0.0 110.18 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.77 -33.6 33.48 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.948 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.455 HD13 HG21 ' A' ' 7' ' ' ILE . 29.6 tp -65.41 -50.73 64.39 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.598 0.199 . . . . 0.0 110.707 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -56.91 -56.57 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.684 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -49.12 -33.22 11.43 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.345 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.34 -27.48 63.4 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.53 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -96.92 -38.42 9.82 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.429 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -81.99 -70.18 0.56 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.496 -179.52 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 m -52.41 -25.14 9.15 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -97.49 -37.29 10.03 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -142.45 58.73 1.45 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.429 ' HB ' ' O ' ' A' ' 45' ' ' LYS . 10.1 p -97.31 -34.92 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.407 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 73.32 -55.95 0.67 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 122.312 0.245 . . . . 0.0 110.644 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -91.72 -177.14 4.68 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.464 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 63.7 mtp85 -58.6 140.84 84.8 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-O 120.718 0.294 . . . . 0.0 111.501 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -81.45 -18.7 8.15 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.818 2.345 . . . . 0.0 113.03 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.72 6.83 29.42 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 52' ' ' ARG . 4.7 pp -90.62 -22.13 21.37 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.544 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.75 -47.44 4.82 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 111.566 0.21 . . . . 0.0 111.566 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.0 m -55.09 150.85 2.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 121.154 0.502 . . . . 0.0 111.489 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -65.64 -56.45 12.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.955 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -174.39 -44.68 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.183 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.9 t -83.47 9.9 10.14 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.688 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.15 23.61 47.85 Favored Glycine 0 C--N 1.34 0.763 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.812 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -110.78 -44.71 3.59 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.055 0.455 . . . . 0.0 110.484 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.2 t -115.1 168.23 10.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.088 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.4 mt -96.58 153.58 17.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.826 0.346 . . . . 0.0 111.232 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.425 ' HD3' ' N ' ' A' ' 67' ' ' GLY . 0.5 OUTLIER -57.01 155.48 15.75 Favored Pre-proline 0 N--CA 1.465 0.306 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.571 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.95 -35.97 91.66 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.142 2.562 . . . . 0.0 112.689 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.425 ' N ' ' HD3' ' A' ' 65' ' ' ARG . . . -45.79 -36.68 6.67 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-N 115.844 -0.616 . . . . 0.0 113.327 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.3 mt -102.03 138.33 26.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 117.032 0.416 . . . . 0.0 110.925 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 mt -105.75 111.13 23.68 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.1 m -80.76 125.63 39.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.208 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.8 mt -123.73 126.79 47.15 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.318 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 92' ' ' THR . 28.2 t -105.11 101.94 13.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.579 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 56.61 55.7 6.19 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.123 0.487 . . . . 0.0 110.867 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.9 m 60.87 41.42 14.47 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.499 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 53.0 t -159.74 119.36 2.92 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.657 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -47.54 126.69 10.25 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.474 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.83 -28.56 67.67 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.965 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -69.96 -25.31 63.57 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.067 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 43.9 t -58.66 -30.51 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.789 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.4 m -110.74 -37.38 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.961 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -148.52 -62.06 0.01 OUTLIER Glycine 0 C--N 1.337 0.601 0 C-N-CA 120.629 -0.796 . . . . 0.0 113.066 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 112.06 -63.34 0.28 Allowed Glycine 0 C--N 1.331 0.277 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.293 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.37 23.2 3.75 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 111.424 0.157 . . . . 0.0 111.424 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -138.02 24.3 2.8 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -70.95 118.8 14.19 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 120.75 0.309 . . . . 0.0 111.396 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.6 m -62.4 165.89 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 116.143 -0.481 . . . . 0.0 112.131 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.46 153.57 31.87 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.571 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -156.85 32.9 0.3 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.678 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 64.66 111.39 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.907 0.384 . . . . 0.0 111.267 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.67 31.63 5.69 Favored Glycine 0 CA--C 1.517 0.217 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.431 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -89.85 112.23 23.5 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.792 0.329 . . . . 0.0 110.577 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.425 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 61.8 m -81.72 130.61 35.12 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.592 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.8 p -139.5 126.73 24.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.875 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -126.75 150.75 48.93 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.194 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -120.55 105.05 10.45 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.333 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.5 mt -112.0 109.47 28.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.346 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.2 p -77.32 150.97 35.16 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.571 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.463 0.216 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.133 179.653 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 46.2 m170 . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.64 0.257 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 2.0 mp -103.71 138.34 28.57 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.002 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 88.5 m -86.55 93.76 9.26 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.891 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.4 p -116.6 106.48 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 120.833 0.349 . . . . 0.0 111.422 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.454 ' HB2' ' O ' ' A' ' 23' ' ' THR . 5.8 pm0 -127.12 170.93 11.85 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.976 0.417 . . . . 0.0 111.872 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.43 ' CB ' ' HA ' ' A' ' 16' ' ' GLU . 89.1 m-85 -134.83 146.74 49.58 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.899 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -167.4 113.18 0.73 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.081 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.17 45.6 0.57 Allowed Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.632 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.99 14.51 82.24 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.562 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -107.23 -25.27 11.58 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 117.523 0.662 . . . . 0.0 111.52 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.43 ' HA ' ' CB ' ' A' ' 11' ' ' PHE . 0.9 OUTLIER -60.53 -22.09 63.22 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.4 mp -68.63 -6.69 27.28 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.2 mt -85.59 12.13 9.31 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -146.98 -63.56 0.29 Allowed 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -175.94 36.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.055 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 50.79 35.36 11.93 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.09 0.471 . . . . 0.0 110.672 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -78.84 167.69 20.8 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.066 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.454 ' O ' ' HB2' ' A' ' 10' ' ' GLN . 38.1 p -100.57 -31.52 11.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.4 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 88.7 p -169.92 146.78 3.2 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.636 0.255 . . . . 0.0 111.302 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 tp -133.13 166.16 23.08 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.436 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.471 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 32.9 mt-30 -132.03 116.19 16.77 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.688 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.0 mt . . . . . 0 C--O 1.232 0.132 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.937 -179.933 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 90.5 m . . . . . 0 C--O 1.233 0.223 0 CA-C-O 120.849 0.357 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -138.85 -168.84 2.5 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.666 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.7 tt -56.69 -40.27 75.31 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.146 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.42 ' O ' HG23 ' A' ' 41' ' ' VAL . 45.7 t30 -58.02 -36.72 73.12 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.74 -32.15 59.54 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.029 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.2 mt -64.0 -49.58 71.91 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.815 0.34 . . . . 0.0 110.713 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -64.6 -53.53 41.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.009 179.793 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -56.18 -27.34 54.14 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.877 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 tp -84.56 -14.6 48.4 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 120.746 0.308 . . . . 0.0 110.914 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.83 -51.73 4.16 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.916 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.4 ' CE ' ' HB ' ' A' ' 41' ' ' VAL . 1.3 pttt -86.16 -69.52 0.66 Allowed 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.9 m -49.16 -31.54 8.52 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.594 0.235 . . . . 0.0 111.395 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -76.2 -33.85 59.28 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.452 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -130.95 -71.56 0.57 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.4 p 34.49 89.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.97 -32.02 64.93 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.038 179.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -97.13 -161.69 0.89 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.533 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.8 mmt180 -66.42 125.23 90.05 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-O 120.599 0.238 . . . . 0.0 111.207 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.53 -28.16 17.95 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.475 2.117 . . . . 0.0 112.535 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.22 7.96 43.45 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.7 pp -82.39 -12.85 57.65 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.61 -45.29 4.46 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 111.636 0.236 . . . . 0.0 111.636 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.425 ' CG1' ' HA2' ' A' ' 61' ' ' GLY . 1.4 m -59.3 149.51 6.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.163 0.506 . . . . 0.0 111.497 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -66.8 -57.99 5.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.764 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -172.44 -44.87 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.315 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.6 p -79.38 4.09 16.38 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.635 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.425 ' HA2' ' CG1' ' A' ' 57' ' ' VAL . . . 60.24 28.18 66.46 Favored Glycine 0 C--N 1.339 0.705 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.574 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.0 tp60 -121.29 -46.1 2.31 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.816 0.341 . . . . 0.0 110.604 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.7 t -114.53 140.61 48.62 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.633 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.8 mt -67.92 154.58 41.29 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.894 0.378 . . . . 0.0 111.315 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.62 158.5 87.25 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.239 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.69 131.92 45.07 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.969 2.446 . . . . 0.0 112.241 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 138.02 -48.49 0.88 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.315 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.413 HG22 ' HB3' ' A' ' 95' ' ' PHE . 5.3 mt -88.29 144.54 8.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 120.794 0.331 . . . . 0.0 111.154 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.8 mt -113.61 99.0 7.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.777 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.5 m -78.67 131.7 33.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.882 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.4 mt -130.16 127.47 39.78 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.209 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 92' ' ' THR . 39.1 t -103.72 119.14 51.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.354 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 59.5 53.29 5.19 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.968 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.9 m 53.34 35.98 21.7 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.576 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 8.2 t -150.8 153.95 36.39 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.139 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -49.23 124.18 8.62 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.681 0.277 . . . . 0.0 111.315 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.38 -20.01 66.2 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.578 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -76.01 -29.77 58.27 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.601 0.238 . . . . 0.0 110.685 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 24.4 t -70.78 -42.6 77.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.056 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.489 ' HB ' ' CD1' ' A' ' 85' ' ' TYR . 17.9 m -68.21 -28.79 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 146.02 36.65 0.06 OUTLIER Glycine 0 C--N 1.337 0.625 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.741 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 53.69 -99.35 0.05 OUTLIER Glycine 0 C--N 1.337 0.593 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.915 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.89 29.16 6.92 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.786 0.327 . . . . 0.0 110.913 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -117.66 19.89 13.68 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.939 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.489 ' CD1' ' HB ' ' A' ' 80' ' ' VAL . 15.1 t80 -81.12 120.66 25.13 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.743 0.306 . . . . 0.0 111.358 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.9 m -75.59 158.69 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.477 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.45 150.28 21.32 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.078 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -147.9 30.52 0.88 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.412 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 59.48 95.99 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.962 0.41 . . . . 0.0 111.653 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 118.75 28.92 1.97 Allowed Glycine 0 CA--C 1.52 0.376 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.694 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -78.19 166.1 23.15 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.769 0.318 . . . . 0.0 110.88 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 98.7 m -141.33 113.2 7.8 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.105 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.8 p -124.94 136.43 60.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.856 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -135.11 153.12 52.12 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.411 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.413 ' HB3' HG22 ' A' ' 68' ' ' ILE . 89.8 m-85 -125.59 104.61 8.49 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.438 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.1 mt -116.95 117.26 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.021 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.12 125.56 34.22 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.751 0.31 . . . . 0.0 111.19 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.9 p . . . . . 0 CA--C 1.531 0.242 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.279 -179.915 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.8 p80 . . . . . 0 N--CA 1.466 0.369 0 CA-C-O 120.814 0.34 . . . . 0.0 111.576 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.6 mm -132.11 136.64 56.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.224 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 89.0 m -86.44 109.23 18.91 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.892 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.0 p -129.08 112.71 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.286 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.417 ' HG2' ' HG2' ' A' ' 94' ' ' GLU . 9.0 pm0 -137.26 166.69 23.17 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.842 0.353 . . . . 0.0 111.643 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.435 ' CB ' ' HA ' ' A' ' 16' ' ' GLU . 89.4 m-85 -134.37 148.88 50.77 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.242 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -164.21 128.91 2.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.967 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.92 40.71 2.25 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.72 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.55 19.55 79.17 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 121.021 -0.609 . . . . 0.0 113.388 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.0 -12.14 14.24 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 117.279 0.539 . . . . 0.0 111.849 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.435 ' HA ' ' CB ' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -69.3 -15.5 63.36 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.701 0.259 . . . . 0.0 111.701 179.867 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 mt -69.03 -5.47 22.09 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.0 mt -81.6 13.65 2.99 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.476 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 2.6 t80 -153.57 -58.49 0.13 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.698 0.285 . . . . 0.0 110.522 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -179.27 36.37 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.136 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.92 33.9 7.2 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.889 0.376 . . . . 0.0 110.889 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -83.73 166.56 17.95 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.014 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 81.6 p -88.14 -70.66 0.62 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.825 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 83.3 p -136.73 156.05 49.03 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.717 0.294 . . . . 0.0 111.306 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.4 mp -140.44 164.57 29.77 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.442 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.23 112.03 17.67 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.523 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.8 mt . . . . . 0 C--N 1.332 -0.183 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.9 -179.882 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 54.4 m . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.922 0.391 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -125.76 -172.35 2.58 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.744 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.3 tt -54.95 -43.59 73.54 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -57.15 -35.33 69.39 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.906 0.384 . . . . 0.0 110.124 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.22 -33.21 36.53 Favored Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.951 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 73.1 mt -63.56 -51.49 65.17 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.756 0.312 . . . . 0.0 110.624 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -57.36 -56.79 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.812 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -49.46 -34.66 17.4 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.329 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.92 -27.62 65.93 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.846 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.1 pp -96.64 -38.14 10.06 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.421 ' CA ' ' HB ' ' A' ' 49' ' ' VAL . 2.8 pttt -85.59 -62.13 1.6 Allowed 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.9 m -58.1 -21.64 47.08 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.118 -0.233 . . . . 0.0 111.61 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -98.75 -36.64 9.76 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -150.23 54.42 0.92 Allowed 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.421 ' HB ' ' CA ' ' A' ' 45' ' ' LYS . 9.4 p -80.91 -43.88 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 121.216 -0.194 . . . . 0.0 111.521 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.476 ' HG3' ' O ' ' A' ' 19' ' ' PHE . 0.6 OUTLIER 67.86 -59.06 0.43 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 122.601 0.36 . . . . 0.0 110.608 -179.126 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.22 -168.55 0.52 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.208 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.429 ' HB3' ' HB3' ' A' ' 55' ' ' LEU . 3.5 ttt180 -69.16 128.33 92.62 Favored Pre-proline 0 CA--C 1.529 0.173 0 CA-C-O 120.625 0.25 . . . . 0.0 111.471 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.72 -23.73 19.06 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.311 2.007 . . . . 0.0 112.492 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -93.08 7.38 44.42 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.429 ' HB3' ' HB3' ' A' ' 52' ' ' ARG . 3.0 pp -85.67 -21.06 28.54 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 121.117 -0.233 . . . . 0.0 111.072 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.03 -48.78 3.95 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 111.477 0.177 . . . . 0.0 111.477 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.457 ' CG1' ' HA2' ' A' ' 61' ' ' GLY . 2.8 m -62.72 144.73 14.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 121.052 0.453 . . . . 0.0 111.14 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.417 ' HA ' ' HB3' ' A' ' 65' ' ' ARG . 10.4 t70 -63.72 -60.23 3.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.596 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.8 tm0? -168.85 -44.66 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.309 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.1 p -79.55 2.71 21.21 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.534 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.457 ' HA2' ' CG1' ' A' ' 57' ' ' VAL . . . 62.16 28.41 70.64 Favored Glycine 0 C--N 1.34 0.761 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.413 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -124.05 -40.46 2.28 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.575 0.226 . . . . 0.0 111.464 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.7 t -114.09 135.8 53.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.636 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.06 132.9 46.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.869 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.417 ' HB3' ' HA ' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -58.89 155.44 31.74 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.419 -179.793 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -58.62 138.07 83.7 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.819 2.346 . . . . 0.0 112.402 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 136.85 -46.74 1.0 Allowed Glycine 0 C--N 1.332 0.336 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.195 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.4 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 5.4 mt -94.93 127.38 46.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 120.697 0.284 . . . . 0.0 111.018 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.9 mp -98.3 102.94 14.83 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.849 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.4 m -76.59 133.98 29.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.744 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.1 mt -129.15 141.98 51.01 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.487 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 92' ' ' THR . 19.6 t -113.68 111.55 36.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.586 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.0 m120 57.67 54.04 6.69 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.989 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.8 t 57.23 49.65 13.03 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.98 0.419 . . . . 0.0 111.186 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 50.6 t -162.17 146.21 12.19 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.671 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -50.83 121.71 6.34 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.46 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.99 -22.8 31.25 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.735 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -74.18 -30.58 62.3 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-O 120.555 0.217 . . . . 0.0 110.888 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 45.2 t -63.69 -40.59 89.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.127 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 26.9 m -79.48 -36.79 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.505 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -166.66 -51.55 0.03 OUTLIER Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.64 -0.791 . . . . 0.0 113.128 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 100.26 -50.97 1.05 Allowed Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.425 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.4 ptt? -144.11 25.51 1.57 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.527 0.203 . . . . 0.0 111.38 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -140.48 23.59 2.31 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -80.78 103.4 10.59 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.771 0.32 . . . . 0.0 110.774 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.6 m -72.63 145.72 11.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.836 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.12 165.39 35.79 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.012 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -134.69 -64.78 0.66 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.084 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -146.59 132.37 18.99 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.749 0.309 . . . . 0.0 111.067 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.96 21.24 36.66 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 121.104 -0.57 . . . . 0.0 112.89 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -86.23 163.98 17.44 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.801 0.334 . . . . 0.0 111.129 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 90.8 m -138.88 130.28 27.14 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.922 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.6 p -140.54 124.07 17.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.696 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.417 ' HG2' ' HG2' ' A' ' 10' ' ' GLN . 14.0 mt-10 -126.7 137.17 53.22 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.4 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.413 ' HB2' ' CD2' ' A' ' 11' ' ' PHE . 3.9 m-85 -107.42 104.81 14.48 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.562 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 28.3 mt -109.04 104.87 17.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.148 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . 41.9 t -85.01 140.13 31.26 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.04 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 34.2 p . . . . . 0 C--N 1.332 -0.182 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.946 179.9 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 14.0 p-80 . . . . . 0 N--CA 1.464 0.269 0 CA-C-O 120.705 0.288 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 27.8 mm -117.49 152.19 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.11 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.1 m -117.15 102.33 9.21 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.05 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.7 p -128.99 112.43 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 120.788 0.328 . . . . 0.0 111.765 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.63 165.2 22.27 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.982 0.42 . . . . 0.0 111.57 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.437 ' CB ' ' HA ' ' A' ' 16' ' ' GLU . 26.0 m-85 -126.41 131.52 51.71 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.199 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.13 151.39 47.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.503 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.19 -94.97 2.03 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.688 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -137.24 28.71 2.77 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.82 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.83 -27.93 9.04 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.736 0.268 . . . . 0.0 111.61 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.437 ' HA ' ' CB ' ' A' ' 11' ' ' PHE . 0.6 OUTLIER -57.35 -30.87 65.19 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.524 0.202 . . . . 0.0 111.226 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.72 -13.86 62.65 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.857 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 32.3 mt -84.9 13.34 6.05 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -143.07 -61.92 0.42 Allowed 'General case' 0 CA--C 1.523 -0.071 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -178.81 36.37 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.103 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 50.37 31.7 5.63 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.962 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.65 173.47 12.41 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.104 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.4 p -102.46 -75.82 0.59 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.764 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 92.5 p -131.46 156.91 44.82 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.783 0.325 . . . . 0.0 111.372 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.19 159.0 43.17 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.259 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.444 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 2.6 mt-30 -129.87 129.75 44.33 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.971 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.9 mt . . . . . 0 C--O 1.233 0.224 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.688 -179.956 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.7 m . . . . . 0 C--O 1.233 0.215 0 CA-C-O 120.695 0.283 . . . . 0.0 110.68 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -104.28 175.76 5.38 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.029 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.2 tt -57.79 -41.93 83.1 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.682 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -54.98 -36.87 65.85 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.943 0.401 . . . . 0.0 110.377 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.13 -31.15 43.7 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.196 178.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 25.1 tp -70.08 -51.87 28.32 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.798 0.299 . . . . 0.0 110.921 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.436 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -57.46 -57.24 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.895 179.787 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -51.39 -28.81 13.64 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.609 -0.268 . . . . 0.0 111.434 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.0 tp -78.12 -27.06 48.22 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 4.6 pp -96.86 -37.15 10.35 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.463 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 0.9 OUTLIER -86.01 -69.24 0.68 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.418 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.9 m -54.66 -23.74 18.65 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -103.97 -20.51 13.85 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -148.06 48.21 1.06 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.463 ' HB ' ' O ' ' A' ' 45' ' ' LYS . 8.1 p -94.06 132.07 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 120.719 0.295 . . . . 0.0 111.222 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -115.4 32.42 6.07 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.276 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -163.17 -171.86 2.79 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.502 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.419 ' HB3' ' HB3' ' A' ' 55' ' ' LEU . 1.4 ttt180 -65.1 110.78 4.66 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.782 -0.19 . . . . 0.0 110.929 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.29 -21.65 67.72 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.345 2.03 . . . . 0.0 112.692 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -91.29 7.66 39.79 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.419 ' HB3' ' HB3' ' A' ' 52' ' ' ARG . 2.5 pp -93.56 -18.97 21.64 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.486 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.53 -48.52 4.12 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.601 0.223 . . . . 0.0 111.601 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.433 ' CG1' ' HA2' ' A' ' 61' ' ' GLY . 3.4 m -57.14 148.32 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 121.101 0.477 . . . . 0.0 111.591 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -69.57 -58.82 3.47 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.712 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -166.91 -48.95 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.517 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.3 p -77.42 6.52 6.79 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.715 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.433 ' HA2' ' CG1' ' A' ' 57' ' ' VAL . . . 57.77 27.92 59.69 Favored Glycine 0 C--N 1.339 0.707 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.637 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -122.18 -42.09 2.39 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.589 0.233 . . . . 0.0 110.943 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 49.9 p -117.21 136.24 53.2 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.426 HD11 HG13 ' A' ' 68' ' ' ILE . 6.3 mt -66.71 155.54 37.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.845 0.355 . . . . 0.0 111.142 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.53 160.14 74.06 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.47 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -51.25 -33.39 44.75 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 123.167 2.578 . . . . 0.0 112.798 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -53.43 -32.13 44.64 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.733 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.426 HG13 HD11 ' A' ' 64' ' ' LEU . 19.5 mm -83.46 151.47 3.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 120.822 0.344 . . . . 0.0 110.793 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.83 99.83 5.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.815 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.9 m -84.55 122.12 37.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.731 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.5 mt -131.3 137.55 48.86 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.174 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.3 m -109.54 118.95 57.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.784 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 24.2 m-20 64.23 -78.57 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.938 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -151.55 32.01 0.57 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.077 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 49.7 t -157.32 146.51 20.02 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.852 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.5 130.6 32.18 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.362 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.3 -23.29 57.34 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.687 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.412 ' HA ' ' CA ' ' A' ' 82' ' ' GLY . 3.2 mt-10 -74.38 -18.69 60.64 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.141 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 38.2 t -63.14 -35.74 73.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 120.661 0.267 . . . . 0.0 110.875 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.9 m -98.88 -37.66 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.789 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -152.61 -60.19 0.01 OUTLIER Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.594 -0.812 . . . . 0.0 113.222 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.412 ' CA ' ' HA ' ' A' ' 78' ' ' GLU . . . 100.72 -51.22 1.0 Allowed Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.253 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.02 4.54 5.91 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -123.7 25.56 8.07 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -74.28 88.72 2.03 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.875 0.369 . . . . 0.0 110.81 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.4 m -61.54 139.6 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.664 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.1 mp -90.52 168.59 11.71 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.073 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 37.1 p30 -168.33 43.58 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.408 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 64.36 96.43 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.151 0.501 . . . . 0.0 110.99 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 112.96 28.25 3.45 Favored Glycine 0 CA--C 1.521 0.433 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.393 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.52 144.12 26.28 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.723 0.297 . . . . 0.0 110.715 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 88.5 m -123.25 133.95 54.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.85 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.14 130.52 18.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.996 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -123.17 155.4 37.15 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.239 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -132.41 108.08 8.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.493 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 33.6 mt -113.94 123.45 69.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.115 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.65 130.88 38.15 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.263 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 71.5 p . . . . . 0 N--CA 1.465 0.288 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.98 179.7 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 . . . . . 0 N--CA 1.463 0.192 0 CA-C-O 120.715 0.293 . . . . 0.0 110.656 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.0 mp -91.27 126.06 43.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.134 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.447 ' HB ' ' CG2' ' A' ' 92' ' ' THR . 0.2 OUTLIER -85.76 96.11 9.62 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.255 179.461 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.7 p -115.72 106.0 19.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.953 0.406 . . . . 0.0 111.272 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.43 ' HB3' ' CB ' ' A' ' 24' ' ' SER . 0.0 OUTLIER -136.38 155.59 49.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.053 0.454 . . . . 0.0 111.375 179.74 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -118.89 138.66 52.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.742 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -92.03 -178.67 5.06 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.185 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.61 97.18 0.08 OUTLIER Glycine 0 C--N 1.335 0.495 0 C-N-CA 121.133 -0.556 . . . . 0.0 112.687 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 138.29 -33.28 2.25 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.733 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.04 9.04 24.25 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -83.92 -37.43 22.35 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.584 0.231 . . . . 0.0 111.426 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.0 mp -69.74 -4.6 20.51 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.7 mt -88.94 13.69 12.21 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -146.73 -61.94 0.3 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.702 0.286 . . . . 0.0 110.326 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -178.07 36.34 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.076 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.51 33.29 7.66 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.927 0.394 . . . . 0.0 110.822 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -80.19 174.47 11.56 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.715 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 79.7 p -110.66 -69.68 0.85 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.06 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.43 ' CB ' ' HB3' ' A' ' 10' ' ' GLN . 59.3 p -141.64 162.99 34.12 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.691 0.281 . . . . 0.0 111.34 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -150.98 165.33 34.05 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.258 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.12 101.02 5.85 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.675 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.4 mt . . . . . 0 C--O 1.233 0.206 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.696 -179.939 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.2 m . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.659 0.266 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -111.83 -176.39 2.92 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.946 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.9 tt -54.32 -37.84 65.3 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.558 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.43 ' O ' HG21 ' A' ' 41' ' ' VAL . 51.5 t30 -57.77 -35.19 70.42 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.904 0.383 . . . . 0.0 110.011 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.55 -32.96 58.98 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.583 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.468 ' HG ' HD13 ' A' ' 87' ' ' LEU . 7.8 mt -64.76 -53.15 51.58 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.718 0.295 . . . . 0.0 110.527 179.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.43 HG21 ' O ' ' A' ' 38' ' ' ASN . 0.2 OUTLIER -57.48 -56.93 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.023 179.667 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -49.23 -30.8 7.58 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.654 0.264 . . . . 0.0 111.489 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.2 tp -70.76 -31.0 67.65 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 2.9 pp -97.13 -42.57 7.79 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.77 -68.46 0.68 Allowed 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -178.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.5 m -50.19 -29.68 9.86 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.422 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -77.31 -36.67 53.87 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.434 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -127.89 -68.26 0.78 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.527 ' O ' HG12 ' A' ' 49' ' ' VAL . 13.8 p 37.77 66.88 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 121.474 0.654 . . . . 0.0 111.766 -179.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.26 -30.81 62.92 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.088 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.404 ' HB3' HD23 ' A' ' 55' ' ' LEU . 0.4 OUTLIER -92.97 -164.84 1.23 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.881 179.271 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.09 135.03 91.58 Favored Pre-proline 0 N--CA 1.462 0.144 0 CA-C-O 120.64 0.257 . . . . 0.0 111.142 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -76.23 -28.45 7.22 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.369 2.046 . . . . 0.0 112.475 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -92.89 9.31 35.95 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.404 HD23 ' HB3' ' A' ' 51' ' ' GLU . 2.6 pp -82.94 -28.2 30.02 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 122.317 -0.239 . . . . 0.0 111.006 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.07 -49.19 4.38 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.445 ' CG1' ' HA2' ' A' ' 61' ' ' GLY . 6.2 m -62.42 146.8 12.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 121.101 0.477 . . . . 0.0 111.451 -179.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -67.21 -57.65 6.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.574 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -169.93 -45.03 0.02 OUTLIER 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.496 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.4 p -77.78 0.63 22.96 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.571 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.445 ' HA2' ' CG1' ' A' ' 57' ' ' VAL . . . 63.43 22.86 66.08 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.388 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -120.27 -38.32 2.93 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.749 0.309 . . . . 0.0 111.1 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.9 t -118.99 132.39 56.06 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.2 mt -67.15 153.81 42.76 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.98 0.419 . . . . 0.0 111.36 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -74.4 161.35 78.47 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.015 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -61.09 123.23 12.48 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.77 2.313 . . . . 0.0 112.188 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 154.01 -45.54 0.56 Allowed Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.4 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.6 mt -96.76 135.35 31.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 120.763 0.316 . . . . 0.0 111.068 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.3 tp -106.05 108.87 20.61 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.518 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.3 m -77.66 129.07 37.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.446 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.5 mt -126.09 128.12 46.86 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.88 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 92' ' ' THR . 4.4 m -117.31 122.4 69.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.073 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 55.24 46.31 23.97 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.52 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.3 m 61.96 30.23 18.0 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.494 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 31.1 t -153.01 130.25 11.23 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.805 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -46.44 130.41 10.91 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.899 0.381 . . . . 0.0 111.536 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.29 -21.12 59.88 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.133 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.408 ' HA ' ' CA ' ' A' ' 82' ' ' GLY . 1.7 mt-10 -73.31 -28.3 62.01 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-O 120.577 0.227 . . . . 0.0 110.918 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 43.5 t -64.93 -33.78 65.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.053 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.4 m -100.92 -37.47 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -140.01 -74.64 0.05 OUTLIER Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.096 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.408 ' CA ' ' HA ' ' A' ' 78' ' ' GLU . . . 107.81 85.11 1.72 Allowed Glycine 0 C--N 1.331 0.302 0 C-N-CA 121.155 -0.545 . . . . 0.0 112.185 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.9 mmt 58.4 23.49 10.64 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.679 0.276 . . . . 0.0 111.394 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -147.1 24.92 1.14 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.336 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -74.94 114.9 13.95 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.693 0.283 . . . . 0.0 110.95 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.7 m -65.12 140.29 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.693 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.468 HD13 ' HG ' ' A' ' 40' ' ' LEU . 2.9 mp -78.61 168.58 19.56 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.433 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -165.3 42.55 0.07 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.232 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 54.35 88.52 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.068 0.461 . . . . 0.0 111.404 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 117.94 26.64 2.71 Favored Glycine 0 CA--C 1.523 0.532 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.895 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -78.58 150.61 32.74 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-O 120.819 0.342 . . . . 0.0 110.846 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.447 ' CG2' ' HB ' ' A' ' 8' ' ' THR . 96.8 m -120.99 129.94 53.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.451 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.15 136.68 25.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.22 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -134.09 151.56 51.44 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.389 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -123.73 104.72 9.16 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.39 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.9 mt -115.14 116.96 54.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.11 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 68.0 m -76.17 82.37 2.98 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.911 0.386 . . . . 0.0 110.739 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.53 0.177 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.244 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.408 ' CD2' ' HG2' ' A' ' 26' ' ' GLN . 1.1 m170 . . . . . 0 N--CA 1.464 0.256 0 CA-C-O 120.434 0.159 . . . . 0.0 110.981 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 25.1 mt -88.97 117.18 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-O 120.858 0.361 . . . . 0.0 111.103 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 37.6 m -82.26 112.4 19.22 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.368 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.7 105.83 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-O 120.907 0.385 . . . . 0.0 111.129 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -130.39 171.62 12.75 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.82 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.456 ' HB2' ' HB3' ' A' ' 16' ' ' GLU . 91.1 m-85 -128.87 151.36 49.71 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.18 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -148.97 130.88 15.21 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.592 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.83 -107.73 3.55 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.287 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -119.34 30.88 5.64 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 121.033 -0.604 . . . . 0.0 112.439 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -108.63 -31.29 7.82 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 111.493 0.183 . . . . 0.0 111.493 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.456 ' HB3' ' HB2' ' A' ' 11' ' ' PHE . 8.6 pm0 -63.68 -30.82 71.88 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.563 0.22 . . . . 0.0 111.206 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 mp -71.57 -7.9 50.63 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.749 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.44 ' HA ' ' HB2' ' A' ' 51' ' ' GLU . 13.3 mt -85.7 13.73 6.75 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -146.74 -61.8 0.3 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.727 0.299 . . . . 0.0 110.228 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -177.31 36.93 0.0 OUTLIER 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.051 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.3 mptt 50.93 33.71 9.27 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.904 0.383 . . . . 0.0 110.997 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -79.18 145.3 33.74 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.833 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.0 p -78.22 -68.69 0.61 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.843 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 99.4 p -137.93 164.53 28.77 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.826 0.346 . . . . 0.0 111.413 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.34 155.59 47.58 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.142 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.408 ' HG2' ' CD2' ' A' ' 6' ' ' HIS . 0.1 OUTLIER -133.36 116.93 16.67 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.028 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.2 mt . . . . . 0 C--N 1.333 -0.138 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.57 179.741 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 51.3 m . . . . . 0 N--CA 1.461 0.12 0 CA-C-O 120.508 0.194 . . . . 0.0 110.591 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -108.21 -177.9 3.46 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.855 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.0 tt -56.47 -44.98 81.1 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.339 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -56.01 -37.97 69.87 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.37 -31.08 59.53 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.166 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 49.3 mt -64.87 -50.87 64.9 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.772 0.32 . . . . 0.0 110.566 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.414 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -64.78 -55.36 21.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.251 179.817 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -52.46 -22.98 5.36 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.6 tt -86.79 -26.33 24.17 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 3.4 pp -93.0 -45.37 7.96 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.243 0.461 . . . . 0.0 112.243 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.89 -55.82 6.82 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 121.014 -0.274 . . . . 0.0 111.513 -179.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 35.1 m -52.06 -28.23 16.67 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.638 0.256 . . . . 0.0 111.117 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.27 -32.96 29.36 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.124 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.88 -75.77 0.6 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.483 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 49' ' ' VAL . 7.9 p 33.52 58.03 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 121.345 0.593 . . . . 0.0 111.821 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.97 -33.5 68.93 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.189 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.44 ' HB2' ' HA ' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -90.33 172.2 8.93 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.399 179.502 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.5 mmm-85 -48.68 106.97 0.68 Allowed Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.61 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.11 -28.96 63.41 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.664 2.243 . . . . 0.0 112.563 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.45 9.78 32.85 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.4 pp -88.25 -28.13 21.31 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 121.148 -0.221 . . . . 0.0 111.1 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.426 HD21 HD11 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -93.77 -54.63 3.55 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.588 -179.871 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 64' ' ' LEU . 2.1 m -53.94 151.53 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 121.068 0.461 . . . . 0.0 111.612 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -65.42 -58.2 6.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.565 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.3 -45.32 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.517 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.8 p -84.09 10.73 9.36 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.617 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.427 ' HA2' ' CG1' ' A' ' 57' ' ' VAL . . . 55.28 27.91 48.36 Favored Glycine 0 C--N 1.338 0.653 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.552 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -118.25 -41.37 2.86 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.755 0.312 . . . . 0.0 110.838 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.7 t -117.97 128.67 55.02 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.979 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 8.3 mt -67.44 156.21 37.14 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.717 0.294 . . . . 0.0 110.989 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -52.44 153.81 4.97 Favored Pre-proline 0 N--CA 1.464 0.275 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.598 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.36 -38.57 73.82 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.048 2.498 . . . . 0.0 112.771 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -48.34 -36.06 16.04 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 121.167 -0.539 . . . . 0.0 112.799 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.6 mt -84.32 126.48 40.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 117.008 0.404 . . . . 0.0 110.951 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 mt -94.63 101.5 13.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.515 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.3 m -79.51 132.3 32.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.899 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.8 mt -137.22 138.77 40.49 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.386 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 92' ' ' THR . 44.0 t -119.06 119.74 61.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.656 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 28.3 m-20 61.27 54.07 3.33 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.079 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.2 m 52.82 38.44 26.63 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.492 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 21.4 t -155.43 155.05 32.87 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.523 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.18 123.91 5.97 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.665 0.269 . . . . 0.0 111.438 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.29 -23.17 63.79 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.693 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -74.86 -28.79 60.81 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.526 0.203 . . . . 0.0 110.653 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 24.1 t -73.52 -41.21 56.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.282 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.8 m -71.4 -34.19 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.663 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.9 -46.31 0.04 OUTLIER Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.74 -0.743 . . . . 0.0 113.055 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.84 73.45 1.27 Allowed Glycine 0 C--N 1.335 0.496 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.192 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 62.2 29.71 17.51 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.586 0.231 . . . . 0.0 111.131 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -150.2 29.86 0.71 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.432 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -90.27 118.91 30.14 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.725 0.297 . . . . 0.0 110.973 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.9 m -66.8 156.25 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.813 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.54 161.12 16.36 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.428 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -158.4 36.84 0.24 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.253 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 47.1 t0 61.17 93.13 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.041 0.448 . . . . 0.0 110.896 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 112.52 31.34 2.6 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.588 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -70.14 166.92 18.89 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.724 0.297 . . . . 0.0 111.049 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 85.1 m -140.05 125.59 19.15 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.08 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.4 p -143.23 140.17 26.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.93 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -138.05 144.72 41.11 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.912 0.387 . . . . 0.0 111.134 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -125.15 104.85 8.74 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.719 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 96' ' ' ILE . 27.6 mt -118.83 112.63 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.22 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 74.3 m -79.98 123.32 27.71 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.394 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.541 0.61 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.944 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.466 0.339 0 CA-C-O 120.982 0.42 . . . . 0.0 111.791 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 29.9 mm -111.23 153.94 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.401 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.3 m -121.19 111.32 17.26 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.664 0.268 . . . . 0.0 111.162 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.3 p -129.99 104.69 10.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-O 120.925 0.393 . . . . 0.0 111.046 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.416 ' HG2' ' HG2' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -130.74 154.94 47.44 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.804 -179.657 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -116.6 142.78 46.44 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.849 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -137.21 167.83 20.81 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.744 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 66.1 -104.74 1.09 Allowed Glycine 0 C--N 1.334 0.434 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.653 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -128.3 32.77 3.32 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.899 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.6 t -105.26 -32.26 8.7 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.865 0.332 . . . . 0.0 111.103 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -59.25 -33.35 70.93 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.32 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.7 mp -68.62 -8.84 45.67 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 68.0 mt -84.11 13.58 5.0 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -147.99 -64.42 0.26 Allowed 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -172.34 37.85 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.18 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.2 mptt 51.38 35.31 13.68 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.989 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -69.24 159.24 33.42 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.129 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 37.6 p -101.49 -71.88 0.7 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.966 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 80.3 p -141.33 162.85 34.49 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.601 0.239 . . . . 0.0 111.254 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -150.64 158.65 44.4 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.24 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.469 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 52.9 mt-30 -133.16 144.84 50.15 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.95 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.4 mt . . . . . 0 C--O 1.233 0.227 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.972 -179.792 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 25.5 m . . . . . 0 CA--C 1.531 0.249 0 CA-C-O 120.749 0.309 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.6 p30 -141.5 -171.82 3.39 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.043 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.1 tt -54.29 -42.71 70.37 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.476 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -55.68 -38.38 69.55 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.98 -32.32 60.9 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.074 178.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 24.2 mt -66.66 -54.57 21.83 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.86 0.33 . . . . 0.0 110.487 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.481 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -59.84 -58.49 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.894 179.895 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -50.26 -30.01 10.84 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.525 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.3 tt -71.43 -31.03 66.76 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 4.6 pp -97.01 -40.75 8.71 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.31 -70.79 0.6 Allowed 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.7 m -55.35 -24.62 30.3 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -96.31 -31.54 12.84 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -152.66 57.9 0.81 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.1 p -91.24 113.67 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 120.868 0.366 . . . . 0.0 110.617 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -94.8 48.74 1.21 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.769 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -177.79 -175.11 0.49 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.284 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.5 mmt-85 -62.11 110.95 3.76 Favored Pre-proline 0 N--CA 1.463 0.188 0 CA-C-O 120.502 0.191 . . . . 0.0 110.991 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.49 -24.95 79.47 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.278 1.986 . . . . 0.0 112.512 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.96 7.96 39.75 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.8 pp -89.62 -21.31 22.87 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.462 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.58 -48.62 4.47 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.402 ' CG1' ' HA2' ' A' ' 61' ' ' GLY . 2.6 m -54.89 151.25 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.063 0.459 . . . . 0.0 111.681 -179.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -69.47 -57.45 5.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.189 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -171.15 -44.6 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.418 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.9 t -82.23 7.78 12.83 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.641 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.402 ' HA2' ' CG1' ' A' ' 57' ' ' VAL . . . 59.34 24.49 59.15 Favored Glycine 0 C--N 1.342 0.885 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.702 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -115.79 -47.36 2.8 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.815 0.34 . . . . 0.0 110.371 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.468 ' HA ' ' HG3' ' A' ' 83' ' ' MET . 45.4 p -105.5 163.93 12.27 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.907 179.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.3 mt -99.06 152.82 19.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.855 0.359 . . . . 0.0 111.073 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.91 147.67 52.97 Favored Pre-proline 0 N--CA 1.467 0.379 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.352 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -49.88 -32.51 30.29 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.344 2.696 . . . . 0.0 113.326 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -45.16 -38.85 6.54 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 121.357 -0.449 . . . . 0.0 113.035 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.0 mt -100.15 135.2 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.951 0.375 . . . . 0.0 111.05 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.7 tp -100.07 101.98 13.19 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.661 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.9 m -83.37 126.12 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.185 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 mt -125.59 161.98 26.0 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.273 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.464 ' HB ' ' CE2' ' A' ' 85' ' ' TYR . 2.7 m -141.17 111.58 3.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.913 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 56.37 53.22 8.99 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.957 0.408 . . . . 0.0 110.888 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.9 m 58.33 30.3 19.36 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.502 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 49.8 t -144.19 130.72 19.98 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.223 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -45.6 128.43 8.34 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.689 0.28 . . . . 0.0 111.137 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.407 ' HA ' HG23 ' A' ' 72' ' ' VAL . . . -62.39 -21.6 65.49 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.768 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -72.52 -24.12 61.1 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.735 -0.212 . . . . 0.0 110.895 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.4 t -71.33 -47.18 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.131 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.46 HG22 HG21 ' A' ' 72' ' ' VAL . 29.8 m -69.36 -42.45 81.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.868 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 165.39 40.16 0.02 OUTLIER Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.517 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 54.3 -104.75 0.26 Allowed Glycine 0 C--N 1.336 0.582 0 C-N-CA 121.236 -0.506 . . . . 0.0 112.919 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.468 ' HG3' ' HA ' ' A' ' 63' ' ' THR . 53.8 mmm -108.89 27.06 9.86 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.682 0.277 . . . . 0.0 111.074 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -122.03 21.19 10.62 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.464 ' CE2' ' HB ' ' A' ' 72' ' ' VAL . 19.4 t80 -73.46 118.92 16.99 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.65 0.262 . . . . 0.0 111.305 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 19.7 m -78.73 159.45 4.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.525 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.7 mp -110.29 175.77 5.3 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.863 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -168.86 -62.18 0.02 OUTLIER 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.04 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -178.91 108.15 0.04 OUTLIER 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.425 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 105.51 24.17 7.21 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.978 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -79.22 143.88 34.92 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 117.02 0.41 . . . . 0.0 110.611 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.407 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 53.5 m -134.22 103.07 5.6 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.003 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.7 p -107.84 134.65 48.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.803 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.416 ' HG2' ' HG2' ' A' ' 10' ' ' GLN . 15.3 mt-10 -136.42 150.47 48.77 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.468 -179.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -124.56 104.48 8.74 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.148 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 24.3 mt -111.87 107.02 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.145 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.52 137.42 34.61 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.953 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.8 p . . . . . 0 CA--C 1.53 0.199 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.941 -179.859 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.4 m170 . . . . . 0 CA--C 1.533 0.31 0 CA-C-O 120.742 0.306 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.546 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 3.2 mp -129.87 145.86 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 120.741 0.305 . . . . 0.0 111.179 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.3 m -96.92 95.93 8.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.959 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.8 p -110.95 105.19 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 121.005 0.431 . . . . 0.0 110.833 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.434 ' HB2' ' O ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -130.51 175.29 9.1 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.725 -179.068 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.494 ' CG ' ' HA ' ' A' ' 16' ' ' GLU . 95.5 m-85 -118.63 161.64 19.73 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.107 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -172.8 157.93 3.82 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.369 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 66.16 45.03 89.73 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.615 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.11 33.2 82.61 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.902 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.7 -17.93 13.58 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.783 0.292 . . . . 0.0 111.613 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.494 ' HA ' ' CG ' ' A' ' 11' ' ' PHE . 2.0 pm0 -59.27 -24.94 63.66 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.7 mp -65.92 -7.7 18.18 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 58.0 mt -72.69 1.27 8.7 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.452 ' CD2' ' HB2' ' A' ' 50' ' ' LYS . 38.8 t80 -144.24 -65.97 0.35 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -172.19 40.0 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.354 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 52.58 46.83 25.97 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.77 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -75.04 -179.66 4.45 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.917 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.434 ' O ' ' HB2' ' A' ' 10' ' ' GLN . 39.9 p -113.74 -47.11 2.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.256 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.5 p -171.21 155.08 4.21 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.673 0.273 . . . . 0.0 110.978 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -141.71 166.58 24.34 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.546 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.546 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 0.8 OUTLIER -132.29 126.47 33.45 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.93 179.791 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.9 mt . . . . . 0 C--O 1.234 0.238 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.846 179.855 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.5 m . . . . . 0 C--O 1.233 0.203 0 CA-C-O 120.694 0.283 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -95.94 -176.05 3.59 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.139 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.6 tt -55.4 -40.26 71.22 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.583 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -51.85 -44.55 63.67 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.63 -32.78 67.24 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.996 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.406 ' HB2' ' CD1' ' A' ' 87' ' ' LEU . 6.3 tt -67.17 -59.2 3.64 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.562 0.22 . . . . 0.0 110.961 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -59.76 -57.77 10.14 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.143 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.288 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -48.73 -33.37 10.08 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.363 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.5 tt -71.81 -29.1 64.08 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.728 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.8 pp -95.83 -32.43 12.68 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.64 -71.07 0.59 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.477 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.9 m -51.53 -26.79 9.15 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -96.73 -36.88 10.52 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -140.62 57.26 1.58 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.5 p -95.79 -34.86 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.452 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 0.2 OUTLIER 66.25 8.46 5.61 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 111.574 0.213 . . . . 0.0 111.574 -179.307 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -144.89 -166.18 2.34 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -75.61 110.74 11.43 Favored Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 116.742 -0.208 . . . . 0.0 110.595 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.6 -21.64 63.35 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.315 2.01 . . . . 0.0 112.537 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.32 5.58 44.4 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pp -95.26 -26.82 15.79 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 121.166 -0.214 . . . . 0.0 111.476 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.7 -44.74 7.31 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.404 ' CG1' ' HA2' ' A' ' 61' ' ' GLY . 5.4 m -54.25 150.49 1.78 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-O 121.119 0.485 . . . . 0.0 111.699 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -63.35 -59.33 4.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.358 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -171.78 -43.92 0.02 OUTLIER 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.371 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 71.3 p -83.63 7.62 16.83 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.805 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.404 ' HA2' ' CG1' ' A' ' 57' ' ' VAL . . . 57.14 25.75 54.65 Favored Glycine 0 C--N 1.341 0.813 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.47 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.4 tm0? -115.08 -37.28 4.16 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.652 0.263 . . . . 0.0 110.977 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.9 t -127.5 142.48 51.38 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.792 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.1 mt -65.88 155.8 35.32 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.877 0.37 . . . . 0.0 111.205 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.26 150.37 72.26 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.075 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -52.32 -32.86 53.24 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.091 2.527 . . . . 0.0 112.819 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -49.88 -35.97 25.75 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.874 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.4 mt -99.93 135.66 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 120.752 0.31 . . . . 0.0 110.789 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.8 mp -105.26 104.91 14.74 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.874 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.5 m -77.25 133.85 29.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.014 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.6 mt -123.98 154.56 39.64 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.551 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 25.8 t -126.53 113.47 33.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.652 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.8 m120 57.9 42.62 22.74 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.965 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.9 m 57.08 50.58 11.74 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.417 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 42.8 t -141.32 -79.38 0.26 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.485 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 177.49 132.29 0.06 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.698 0.285 . . . . 0.0 110.896 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -88.51 -24.91 22.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.562 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -80.81 -38.71 27.93 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.578 0.228 . . . . 0.0 110.842 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 61.8 t -58.58 -37.5 65.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.906 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.9 m -80.83 -32.75 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.531 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.29 -56.49 0.04 OUTLIER Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.77 -0.729 . . . . 0.0 113.13 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 110.63 -57.85 0.41 Allowed Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.253 -0.499 . . . . 0.0 112.266 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -142.92 21.72 1.95 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 111.516 0.191 . . . . 0.0 111.516 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -135.6 20.46 3.33 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -75.1 114.52 13.69 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.927 0.394 . . . . 0.0 111.302 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.8 m -71.7 153.28 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.48 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.406 ' CD1' ' HB2' ' A' ' 40' ' ' LEU . 1.2 mp -104.21 164.28 11.83 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.551 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -161.02 30.33 0.14 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.413 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 58.97 103.93 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.001 0.429 . . . . 0.0 111.604 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 116.73 35.52 1.15 Allowed Glycine 0 C--N 1.332 0.357 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.326 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.15 177.52 4.81 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.863 0.363 . . . . 0.0 111.576 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 74.2 m -140.3 132.66 28.37 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.821 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.1 p -142.46 137.06 28.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.174 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -134.2 158.47 43.6 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.993 0.425 . . . . 0.0 111.532 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -126.55 104.89 8.37 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.298 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 26.5 mt -116.08 118.5 58.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.215 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.81 155.15 39.12 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.108 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.465 0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.563 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 7.7 p80 . . . . . 0 N--CA 1.466 0.344 0 CA-C-O 120.671 0.272 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 29.6 mt -105.35 137.67 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.133 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -92.84 112.43 24.39 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.386 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.6 p -134.23 108.8 11.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.653 179.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -140.04 162.53 35.0 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.499 -179.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.447 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 31.3 m-85 -116.13 148.47 40.28 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.149 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -135.29 143.46 46.23 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.306 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.11 -108.54 2.65 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.138 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -117.16 25.7 8.64 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.564 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.8 m -97.64 -15.53 20.39 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.447 ' HA ' ' CD2' ' A' ' 11' ' ' PHE . 40.0 mt-10 -59.54 -32.97 70.82 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.667 0.27 . . . . 0.0 111.081 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.8 mt -72.54 -5.17 35.23 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.883 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.8 mt -83.1 14.42 3.42 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -153.76 -60.8 0.13 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.61 0.243 . . . . 0.0 110.656 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -177.4 37.49 0.0 OUTLIER 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.149 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.4 mptt 51.19 35.27 12.95 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.966 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -93.06 151.16 20.04 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.876 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.9 p -79.13 -64.29 1.22 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.926 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.8 p -143.22 163.93 31.58 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.792 0.329 . . . . 0.0 111.357 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -148.54 166.58 27.79 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.11 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -132.78 126.5 32.52 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.873 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.2 mt . . . . . 0 C--O 1.233 0.186 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.877 -179.9 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 58.1 m . . . . . 0 CA--C 1.529 0.15 0 CA-C-O 120.646 0.26 . . . . 0.0 110.809 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -113.23 -175.29 2.64 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.704 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.5 tt -55.16 -35.1 64.4 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.404 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.63 -37.39 70.66 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.906 0.384 . . . . 0.0 110.135 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.97 -32.96 56.11 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.93 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 95.2 mt -65.86 -53.29 41.82 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.7 0.286 . . . . 0.0 110.58 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.444 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -56.71 -57.53 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.993 179.884 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.54 -26.65 44.41 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.431 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.9 tp -82.08 -23.81 35.57 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 4.7 pp -96.75 -38.17 10.0 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.425 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -92.37 -59.6 2.05 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -179.627 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.5 m -61.33 -21.85 64.37 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.364 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.38 -34.15 10.77 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -155.58 55.01 0.62 Allowed 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.425 ' HB ' ' O ' ' A' ' 45' ' ' LYS . 7.6 p -70.72 -33.1 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 57.79 13.48 2.07 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -158.37 -170.37 3.08 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.08 112.56 10.19 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-O 120.562 0.22 . . . . 0.0 110.838 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.85 -24.7 76.97 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.272 1.982 . . . . 0.0 112.299 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.36 6.58 42.53 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.6 pp -91.5 -29.34 17.05 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 121.236 -0.186 . . . . 0.0 111.316 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.47 -44.0 7.02 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.5 m -56.5 148.05 4.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.176 0.512 . . . . 0.0 111.696 -179.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -63.18 -55.88 21.38 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.361 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -174.22 -44.65 0.01 OUTLIER 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.481 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.7 t -89.63 15.37 9.63 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.16 23.29 32.21 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.65 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -107.77 -32.77 7.49 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.893 0.377 . . . . 0.0 110.788 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.0 t -132.66 179.48 6.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.092 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.6 mt -103.98 152.92 21.43 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.915 0.388 . . . . 0.0 111.451 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.06 154.18 82.84 Favored Pre-proline 0 N--CA 1.465 0.287 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.389 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -50.31 -32.95 35.13 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.199 2.599 . . . . 0.0 113.036 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -46.51 -37.58 8.71 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 121.392 -0.432 . . . . 0.0 112.993 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.8 mt -104.8 133.28 49.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.861 0.331 . . . . 0.0 111.054 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.0 mt -100.8 100.37 11.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.694 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.5 m -76.57 133.26 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.873 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 mt -132.13 140.62 48.86 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.391 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 92' ' ' THR . 19.5 t -115.73 117.82 56.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.493 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 56.99 49.86 13.16 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.145 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 58.81 47.36 12.75 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.951 0.405 . . . . 0.0 111.275 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 52.0 t -161.37 147.03 14.01 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.628 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -46.01 119.56 2.32 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.781 0.324 . . . . 0.0 111.357 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.2 -17.87 56.2 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.136 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.11 -34.51 49.97 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.379 0.133 . . . . 0.0 111.162 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.2 t -70.11 -45.79 74.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.053 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.9 m -60.62 -35.51 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.691 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 179.0 -35.52 0.08 OUTLIER Glycine 0 CA--C 1.524 0.599 0 C-N-CA 120.785 -0.722 . . . . 0.0 113.251 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.68 -54.13 2.67 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.225 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.52 27.51 0.91 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 120.464 0.173 . . . . 0.0 111.343 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -129.09 15.49 6.24 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -70.38 113.21 7.3 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.755 0.312 . . . . 0.0 110.943 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 26.9 m -69.4 148.21 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.473 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -96.66 157.96 15.66 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.541 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -154.16 36.16 0.43 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.194 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.4 t0 62.96 27.31 15.89 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.963 0.411 . . . . 0.0 111.691 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -168.77 41.08 0.22 Allowed Glycine 0 C--N 1.332 0.35 0 C-N-CA 121.198 -0.525 . . . . 0.0 112.235 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -85.03 166.36 16.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.815 0.34 . . . . 0.0 111.013 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 86.1 m -141.81 127.61 19.28 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.659 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.7 p -141.8 133.63 27.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.111 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -132.96 143.18 49.29 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.327 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -113.19 104.74 12.65 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.275 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 11.0 mt -110.73 110.15 31.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.03 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 60.6 p -76.66 143.64 39.97 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.19 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.532 0.269 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.13 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 14.3 p-80 . . . . . 0 C--O 1.233 0.211 0 CA-C-O 120.787 0.327 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 33.6 mm -87.2 154.32 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.672 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.444 ' HB ' ' HA ' ' A' ' 92' ' ' THR . 48.8 m -121.14 94.12 4.24 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.653 0.263 . . . . 0.0 111.082 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.5 p -118.28 109.2 26.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-O 121.02 0.438 . . . . 0.0 111.426 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.4 pm0 -134.0 162.24 32.6 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.569 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.438 ' CB ' ' HA ' ' A' ' 16' ' ' GLU . 98.1 m-85 -122.04 151.92 40.33 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.102 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -167.23 174.38 8.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.013 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 59.66 32.03 72.8 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.916 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.1 26.91 38.92 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.224 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.6 t -108.07 -22.98 12.18 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 117.129 0.464 . . . . 0.0 111.528 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.438 ' HA ' ' CB ' ' A' ' 11' ' ' PHE . 1.9 pt-20 -57.72 -27.51 63.03 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.512 0.196 . . . . 0.0 111.339 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.1 mp -64.98 -10.66 31.12 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 71.8 mt -83.55 13.57 4.46 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -148.18 -70.83 0.22 Allowed 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -170.98 38.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.969 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.65 34.16 15.31 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.146 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -77.47 178.43 7.21 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.047 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 37.0 p -107.12 -76.89 0.6 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.895 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.6 p -136.77 164.31 28.57 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.688 0.28 . . . . 0.0 111.372 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.53 151.02 34.4 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.267 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.473 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 31.7 mt-30 -132.64 109.57 9.82 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.87 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.3 mt . . . . . 0 C--O 1.233 0.234 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.687 -179.875 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.5 m . . . . . 0 CA--C 1.529 0.172 0 CA-C-O 120.719 0.295 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -100.15 -170.19 1.84 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.6 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.5 tt -55.04 -42.94 73.29 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 111.484 0.179 . . . . 0.0 111.484 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -56.78 -38.14 72.07 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.98 -34.44 47.48 Favored Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.977 178.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.43 ' HB2' ' CD1' ' A' ' 87' ' ' LEU . 23.9 tp -62.32 -52.03 65.3 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.622 0.248 . . . . 0.0 110.634 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -59.11 -57.63 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.929 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.07 -32.42 21.99 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.732 -0.213 . . . . 0.0 111.259 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.5 tt -70.38 -27.84 64.63 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.5 pp -97.02 -41.2 8.49 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.1 pttt -82.21 -65.19 1.04 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 m -56.67 -23.74 43.84 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -94.07 -41.13 9.7 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 111.515 0.191 . . . . 0.0 111.515 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.21 59.74 0.97 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.885 0.374 . . . . 0.0 111.902 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.1 p -78.87 -35.67 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.605 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 64.59 10.76 6.15 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.423 -179.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -154.05 -173.05 4.43 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.479 ' HB2' HD22 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -68.04 135.61 91.77 Favored Pre-proline 0 N--CA 1.464 0.275 0 CA-C-O 120.518 0.199 . . . . 0.0 110.809 179.707 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.39 -23.02 10.43 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.334 2.022 . . . . 0.0 112.834 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -90.69 6.92 42.02 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.479 HD22 ' HB2' ' A' ' 52' ' ' ARG . 3.7 pp -89.87 -17.71 27.55 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 120.987 -0.285 . . . . 0.0 111.312 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.12 -46.0 3.37 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.1 m -56.72 148.36 4.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 121.188 0.518 . . . . 0.0 111.692 -179.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -63.99 -53.9 42.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.496 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -177.15 -43.84 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.436 178.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.3 p -87.45 12.88 11.13 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.01 22.19 41.25 Favored Glycine 0 C--N 1.339 0.747 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.745 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -107.87 -35.54 6.62 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.861 0.363 . . . . 0.0 110.863 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.4 t -129.55 -178.77 4.82 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.006 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.6 mt -102.93 153.68 19.97 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.968 0.414 . . . . 0.0 111.391 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -79.78 155.0 75.85 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.135 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.24 135.21 59.39 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.867 2.378 . . . . 0.0 112.545 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.18 -48.35 0.91 Allowed Glycine 0 C--N 1.332 0.344 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.413 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.2 mt -93.39 143.08 12.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 120.83 0.348 . . . . 0.0 111.21 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -105.1 101.68 11.22 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.8 m -76.84 136.8 23.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.785 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.1 mt -131.4 146.8 52.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.317 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.433 HG12 ' CD2' ' A' ' 85' ' ' TYR . 67.7 t -128.22 133.9 66.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.325 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.2 m120 58.72 26.06 14.16 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.003 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 54.93 31.88 16.82 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.373 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.407 ' SG ' ' N ' ' A' ' 76' ' ' ASP . 16.4 p -130.04 -48.57 1.11 Allowed 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.356 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.407 ' N ' ' SG ' ' A' ' 75' ' ' CYS . 0.2 OUTLIER 172.28 140.6 0.03 OUTLIER 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.491 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.32 -22.58 26.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.65 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -79.19 -32.97 44.28 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.437 0.161 . . . . 0.0 110.609 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 52.7 t -60.62 -46.65 95.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.957 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 18.8 m -65.31 -23.44 33.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 147.43 -23.94 1.53 Allowed Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.766 -0.73 . . . . 0.0 113.344 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 104.04 -57.92 0.52 Allowed Glycine 0 C--N 1.338 0.692 0 C-N-CA 121.126 -0.559 . . . . 0.0 111.705 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 5.6 ptt? -152.89 26.99 0.54 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.497 0.189 . . . . 0.0 110.98 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -135.05 21.72 3.49 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.433 ' CD2' HG12 ' A' ' 72' ' ' VAL . 19.7 t80 -80.44 112.87 18.19 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.846 0.355 . . . . 0.0 110.849 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.1 m -62.72 143.64 15.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.393 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.43 ' CD1' ' HB2' ' A' ' 40' ' ' LEU . 0.6 OUTLIER -82.1 142.34 32.36 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.415 -179.783 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -130.18 43.02 3.19 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.32 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.73 27.3 8.58 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.808 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -173.44 41.2 0.15 Allowed Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.304 -0.474 . . . . 0.0 112.091 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -83.12 114.09 21.08 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.719 0.295 . . . . 0.0 111.222 -179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.444 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 28.4 m -85.01 128.62 34.71 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.56 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.0 p -140.19 133.54 34.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.126 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -129.35 161.31 30.59 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.021 0.439 . . . . 0.0 111.592 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -134.2 104.74 6.32 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.165 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 29.0 mt -114.77 112.91 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.132 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.3 140.38 38.82 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.91 0.386 . . . . 0.0 111.369 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 39.9 p . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.217 179.424 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 . . . . . 0 N--CA 1.468 0.46 0 CA-C-O 120.758 0.313 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.4 mm -88.35 111.54 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.714 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 41.8 m -81.78 102.61 10.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.343 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.9 p -119.93 104.92 16.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.467 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.413 ' HB3' ' CB ' ' A' ' 24' ' ' SER . 0.7 OUTLIER -127.28 161.8 27.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.692 -179.047 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -116.07 159.24 21.97 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.948 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -105.86 176.23 5.23 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.228 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.96 97.38 0.05 OUTLIER Glycine 0 C--N 1.336 0.583 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.53 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.67 -29.31 4.49 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.943 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.7 -27.96 15.02 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.852 0.326 . . . . 0.0 111.558 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.94 -27.87 65.71 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.585 0.231 . . . . 0.0 111.254 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 mp -67.7 -10.16 49.97 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 56.1 mt -81.13 13.3 2.87 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -149.58 -63.73 0.22 Allowed 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -174.37 37.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.114 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.49 34.81 12.94 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.003 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -72.34 -177.36 2.14 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.046 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 49.9 p -115.7 -78.17 0.58 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.919 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.413 ' CB ' ' HB3' ' A' ' 10' ' ' GLN . 83.7 p -136.12 160.24 39.25 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.933 0.397 . . . . 0.0 111.254 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.03 152.06 48.48 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.15 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -133.18 100.61 4.91 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.523 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.1 mt . . . . . 0 C--O 1.234 0.261 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.93 -179.645 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 63.8 m . . . . . 0 CA--C 1.529 0.158 0 CA-C-O 120.718 0.294 . . . . 0.0 110.749 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 53.2 p-10 -108.61 -173.28 2.24 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.891 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 tt -57.66 -39.28 76.69 Favored 'General case' 0 N--CA 1.46 0.071 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.032 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -54.92 -38.19 67.35 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.308 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.05 -32.22 45.12 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.103 179.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 61.7 tp -68.16 -53.08 27.68 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.652 0.226 . . . . 0.0 110.855 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -57.83 -57.4 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.854 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -50.65 -32.09 18.11 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.402 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.4 tp -71.52 -27.56 63.28 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.898 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.3 pp -96.92 -40.58 8.83 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.0 -71.69 0.5 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.4 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 22.5 m -53.04 -22.14 5.51 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.05 -31.35 10.68 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -142.25 51.6 1.48 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -178.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.2 p -100.6 120.07 49.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.873 0.368 . . . . 0.0 110.716 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -101.24 31.91 3.48 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.02 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -155.86 -174.78 5.1 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.252 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.29 110.21 3.08 Favored Pre-proline 0 CA--C 1.53 0.176 0 CA-C-N 116.803 -0.181 . . . . 0.0 111.045 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -60.33 -27.31 84.62 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.405 2.07 . . . . 0.0 112.286 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.423 ' HA ' ' CG2' ' A' ' 57' ' ' VAL . 5.8 t70 -91.38 8.04 38.11 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.994 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 pp -88.58 -26.7 21.82 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 122.306 -0.246 . . . . 0.0 111.472 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.5 -46.82 5.1 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.423 ' CG2' ' HA ' ' A' ' 54' ' ' ASP . 9.0 m -55.59 149.63 2.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 121.164 0.507 . . . . 0.0 111.7 -179.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -63.43 -52.94 59.4 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.736 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.43 -45.5 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.518 179.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.1 p -90.27 16.45 8.62 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.07 21.63 32.39 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.825 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -105.88 -35.35 7.35 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.839 0.352 . . . . 0.0 110.573 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 71.9 p -128.16 -177.07 4.0 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.983 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.4 mt -110.64 154.52 23.69 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.934 0.397 . . . . 0.0 110.997 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -71.67 152.82 93.55 Favored Pre-proline 0 C--O 1.234 0.256 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.068 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -55.77 124.48 16.38 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.764 2.31 . . . . 0.0 112.357 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 147.82 -45.02 0.76 Allowed Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.51 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.0 mt -91.52 120.11 39.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 120.7 0.286 . . . . 0.0 111.155 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.23 100.09 12.95 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.403 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.5 m -77.75 126.35 38.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.276 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.9 mt -125.4 129.67 50.35 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.874 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 92' ' ' THR . 3.6 m -112.82 114.73 47.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.016 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 11.6 m120 54.86 52.22 12.36 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.071 0.462 . . . . 0.0 110.727 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.7 m 59.23 30.1 19.78 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.58 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 46.4 t -145.38 125.31 13.54 Favored 'General case' 0 C--O 1.23 0.048 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.375 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -44.16 127.37 5.51 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.765 0.317 . . . . 0.0 111.254 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.3 -19.48 64.63 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.883 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -73.28 -26.63 61.16 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 120.577 0.227 . . . . 0.0 110.673 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.7 t -70.82 -44.38 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.084 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.4 m -70.39 -39.74 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.507 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.39 42.66 0.02 OUTLIER Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.804 -0.712 . . . . 0.0 113.426 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 53.07 -107.84 0.63 Allowed Glycine 0 C--N 1.334 0.455 0 C-N-CA 121.184 -0.532 . . . . 0.0 113.009 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 60.5 mmm -108.58 27.69 9.14 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.804 0.335 . . . . 0.0 111.073 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -120.29 19.22 12.17 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.828 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -68.83 117.73 10.89 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.827 0.346 . . . . 0.0 111.339 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 15.6 m -70.57 146.53 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.713 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.9 mp -94.88 161.39 14.18 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.18 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 32.8 m-20 -153.54 35.77 0.46 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.616 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 59.93 96.39 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.045 0.45 . . . . 0.0 111.21 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 112.07 36.17 1.7 Allowed Glycine 0 CA--C 1.518 0.237 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.357 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -87.3 170.33 11.52 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.784 0.326 . . . . 0.0 110.902 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 92.6 m -137.91 134.98 35.66 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.8 p -141.41 134.28 29.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.027 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -131.38 149.14 52.66 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.384 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -121.84 104.71 9.75 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.45 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.9 mt -111.89 103.84 16.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.239 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 84.0 p -82.56 132.05 35.2 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.89 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.463 0.207 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.372 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.32 0 CA-C-O 120.742 0.306 . . . . 0.0 111.542 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.474 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 17.3 mm -123.66 153.73 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.86 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 49.5 m -113.12 99.23 7.68 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.914 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.7 p -121.86 115.02 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.573 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.419 ' HG2' ' HG2' ' A' ' 94' ' ' GLU . 3.8 pm0 -128.99 159.14 36.85 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.963 0.411 . . . . 0.0 111.26 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.475 ' HB3' ' N ' ' A' ' 16' ' ' GLU . 12.1 m-85 -115.73 135.12 54.34 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.25 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -142.47 144.61 33.1 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.101 0.476 . . . . 0.0 111.977 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 86.42 -91.48 1.73 Allowed Glycine 0 C--N 1.332 0.355 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.905 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -133.88 28.91 3.16 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.992 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -109.94 -31.06 7.53 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.682 0.241 . . . . 0.0 111.133 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.475 ' N ' ' HB3' ' A' ' 11' ' ' PHE . 0.7 OUTLIER -61.76 -37.08 82.96 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.26 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.461 ' N ' ' HG2' ' A' ' 16' ' ' GLU . 4.5 mt -67.93 -14.4 62.94 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.809 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.414 HD22 HD21 ' A' ' 55' ' ' LEU . 9.0 mt -83.54 13.52 4.48 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -144.28 -64.51 0.36 Allowed 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -174.64 38.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.087 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 49.57 38.79 15.62 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.058 0.456 . . . . 0.0 110.782 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -73.9 175.37 7.39 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.056 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 33.1 p -114.94 -52.25 2.7 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.013 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 94.3 p -155.39 148.83 25.02 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.669 0.271 . . . . 0.0 110.955 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.0 mt -135.72 158.01 45.44 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.931 0.396 . . . . 0.0 111.345 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.474 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 11.8 mt-30 -130.1 106.99 8.99 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.8 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.1 mt . . . . . 0 C--N 1.331 -0.199 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.942 -179.888 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 87.9 m . . . . . 0 C--O 1.234 0.25 0 CA-C-O 120.745 0.307 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.7 p30 -84.43 174.05 10.38 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.975 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.424 ' CD2' ' HA ' ' A' ' 83' ' ' MET . 4.9 tt -57.84 -39.85 78.66 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.246 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -53.64 -41.24 66.56 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.933 0.397 . . . . 0.0 109.986 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.08 -31.86 63.74 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.135 178.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.3 tp -70.13 -57.13 5.29 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.525 0.202 . . . . 0.0 110.964 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -57.54 -57.51 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.203 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -49.67 -32.49 13.33 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.504 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.1 tp -75.63 -24.15 56.41 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -96.35 -37.54 10.44 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.476 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 2.9 pttt -83.95 -71.26 0.52 Allowed 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 121.162 -0.215 . . . . 0.0 111.322 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.9 m -52.25 -24.72 7.77 Favored 'General case' 0 CA--C 1.537 0.442 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -102.08 -27.2 13.06 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -142.42 50.38 1.49 Allowed 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.476 ' HB ' ' O ' ' A' ' 45' ' ' LYS . 10.4 p -96.9 139.66 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 120.684 0.278 . . . . 0.0 111.25 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.91 31.25 5.9 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.46 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -164.15 176.46 9.23 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.153 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.99 106.0 0.58 Allowed Pre-proline 0 N--CA 1.466 0.329 0 CA-C-O 120.508 0.194 . . . . 0.0 111.367 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.07 -28.47 60.47 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.44 2.093 . . . . 0.0 112.676 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.88 9.03 37.13 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.414 HD21 HD22 ' A' ' 18' ' ' LEU . 2.1 pp -83.62 -28.93 28.12 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 121.034 -0.267 . . . . 0.0 111.158 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.414 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 0.2 OUTLIER -94.11 -54.46 3.57 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.765 -0.198 . . . . 0.0 111.335 179.927 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 64' ' ' LEU . 1.4 m -54.55 151.22 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.201 0.524 . . . . 0.0 111.638 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -68.02 -62.91 1.19 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.739 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -165.22 -45.36 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.404 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.1 t -78.89 3.89 15.69 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.595 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.419 ' HA2' ' CG1' ' A' ' 57' ' ' VAL . . . 61.34 22.92 61.68 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.598 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.6 tm0? -121.46 -45.47 2.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.81 0.338 . . . . 0.0 110.407 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.548 ' HA ' ' HG3' ' A' ' 83' ' ' MET . 1.8 t -102.07 123.61 46.25 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.676 178.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 7.8 mt -67.79 156.7 36.44 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.727 0.298 . . . . 0.0 110.917 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.414 ' HG2' ' O ' ' A' ' 56' ' ' LEU . 7.6 ptm180 -57.32 143.26 74.14 Favored Pre-proline 0 C--O 1.234 0.259 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.125 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -50.6 -33.28 38.63 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.091 2.527 . . . . 0.0 112.829 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -50.85 -34.7 30.25 Favored Glycine 0 CA--C 1.523 0.54 0 CA-C-N 116.037 -0.529 . . . . 0.0 113.023 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.2 mt -88.77 120.41 37.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-O 120.76 0.314 . . . . 0.0 111.213 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.9 mt -96.94 97.02 8.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.018 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.9 t -79.46 136.69 23.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.12 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.09 155.73 44.99 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.476 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 39.9 t -124.48 115.04 43.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.8 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 67.03 -77.15 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.2 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.9 t -153.32 33.7 0.46 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.867 0.365 . . . . 0.0 110.942 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 44.4 t -158.46 156.02 29.58 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.682 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -49.14 136.58 14.78 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.611 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.39 -23.13 35.11 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.845 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -71.59 -18.59 62.22 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.432 0.158 . . . . 0.0 111.087 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.6 t -72.53 -41.11 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.316 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.6 m -80.6 -29.14 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.735 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 176.61 -38.32 0.1 OUTLIER Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.035 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 99.06 -72.06 0.54 Allowed Glycine 0 C--N 1.334 0.435 0 C-N-CA 121.003 -0.618 . . . . 0.0 111.968 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.548 ' HG3' ' HA ' ' A' ' 63' ' ' THR . 2.7 mmt -129.0 25.75 5.55 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.725 0.298 . . . . 0.0 111.182 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -136.67 23.99 3.13 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.56 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -82.63 120.17 25.21 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.6 0.238 . . . . 0.0 110.738 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.2 m -69.84 134.06 30.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.426 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.5 mp -98.2 123.57 42.34 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.867 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -108.1 35.19 3.23 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.334 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 63.1 104.83 0.03 OUTLIER 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.209 0.528 . . . . 0.0 111.488 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 113.2 29.34 3.03 Favored Glycine 0 CA--C 1.519 0.322 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.503 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -101.14 152.77 20.23 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.619 0.247 . . . . 0.0 110.837 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 94.9 m -115.18 111.8 21.54 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.962 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.8 p -120.67 125.69 74.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.748 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.419 ' HG2' ' HG2' ' A' ' 10' ' ' GLN . 16.0 mt-10 -126.37 153.68 44.6 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.364 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -120.69 104.53 9.99 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.067 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 25.2 mt -106.11 99.91 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.964 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.97 140.11 29.99 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.301 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.464 0.249 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.405 179.861 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.3 p80 . . . . . 0 N--CA 1.464 0.269 0 CA-C-O 120.634 0.254 . . . . 0.0 110.779 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.5 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 25.2 mm -129.62 152.2 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.611 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.7 m -115.79 122.92 46.87 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.736 0.303 . . . . 0.0 111.474 -179.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.8 p -145.89 110.1 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.201 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -135.62 160.94 36.94 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.961 0.41 . . . . 0.0 111.643 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.418 ' HB2' ' HB3' ' A' ' 16' ' ' GLU . 89.1 m-85 -117.34 147.08 42.94 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.075 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.22 145.82 31.47 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.836 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.04 -95.3 2.06 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.457 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -139.51 30.91 2.37 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.722 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.2 m -108.04 -23.91 11.8 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.418 ' HB3' ' HB2' ' A' ' 11' ' ' PHE . 1.8 pm0 -59.84 -30.65 69.09 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.621 0.248 . . . . 0.0 111.228 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.8 mp -71.26 -7.97 50.53 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.706 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 42.1 mt -87.97 13.58 10.7 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.411 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 42.0 t80 -144.95 -63.63 0.35 Allowed 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -178.22 36.17 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.077 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.74 31.59 6.11 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.965 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -80.6 134.19 35.87 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.976 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -67.76 -66.25 0.59 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.822 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 87.3 p -144.24 161.31 39.22 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.723 0.297 . . . . 0.0 111.062 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.65 148.13 36.89 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.399 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.5 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 4.7 mt-30 -132.16 117.95 18.94 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.883 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.4 mt . . . . . 0 C--O 1.233 0.193 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.877 -179.853 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.0 t . . . . . 0 CA--C 1.536 0.406 0 N-CA-C 110.535 -0.172 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -134.47 -174.24 3.51 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.869 -0.15 . . . . 0.0 110.745 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.3 tt -60.01 -44.3 94.68 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 121.285 -0.166 . . . . 0.0 111.329 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -59.48 -34.33 72.43 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.54 -33.92 46.2 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.601 178.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.0 mt -60.55 -52.17 66.31 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.735 0.302 . . . . 0.0 110.603 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -59.92 -56.66 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.975 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.43 -30.77 13.29 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.51 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.8 tp -73.11 -27.82 61.92 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.8 pp -96.97 -42.55 7.86 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.4 pttt -84.26 -68.79 0.69 Allowed 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.5 m -50.69 -28.82 9.76 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.509 0.195 . . . . 0.0 111.47 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -81.19 -34.31 32.39 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.277 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -130.8 -68.32 0.69 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 111.449 0.166 . . . . 0.0 111.449 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.499 HG13 ' O ' ' A' ' 49' ' ' VAL . 11.5 p 44.72 72.31 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 121.56 0.695 . . . . 0.0 111.491 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -52.55 -50.23 63.33 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.205 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.444 ' HB3' HD21 ' A' ' 55' ' ' LEU . 1.8 tp10 -91.44 -164.06 1.12 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.02 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.3 ttt-85 -66.2 134.39 94.77 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-O 120.675 0.274 . . . . 0.0 111.24 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.24 -25.56 8.39 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.572 2.181 . . . . 0.0 112.529 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -89.84 8.46 31.9 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.444 HD21 ' HB3' ' A' ' 51' ' ' GLU . 2.6 pp -91.41 -26.32 18.92 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 121.287 -0.165 . . . . 0.0 111.323 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.24 -45.1 6.31 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.1 m -55.3 148.52 3.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 121.258 0.551 . . . . 0.0 111.558 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -63.94 -57.0 11.09 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.532 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.76 -44.51 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.515 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 34.6 p -86.07 10.73 13.46 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.735 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 58.31 22.3 50.34 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.688 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -109.69 -34.69 6.4 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.947 0.403 . . . . 0.0 110.886 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.6 t -129.25 175.09 9.0 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.881 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.0 mt -93.75 158.03 15.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.043 0.449 . . . . 0.0 111.402 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.41 ' HB2' ' HD2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -83.17 165.87 38.44 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.191 -179.867 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 65' ' ' ARG . 47.2 Cg_exo -55.72 129.67 36.28 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.741 2.294 . . . . 0.0 112.428 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.49 -49.29 0.86 Allowed Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.196 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.6 mt -94.62 134.61 31.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-O 120.728 0.299 . . . . 0.0 110.859 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.3 mt -111.53 118.65 36.31 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.975 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.9 m -85.77 125.22 40.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.031 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 mt -120.96 131.55 54.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.089 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 92' ' ' THR . 1.5 m -103.99 99.31 8.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.737 179.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 59.58 51.19 6.61 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.685 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.1 t 66.02 35.35 6.42 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.506 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 47.1 t -148.69 123.9 10.18 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.559 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -47.49 114.1 0.82 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.885 0.374 . . . . 0.0 111.32 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.04 -18.99 61.27 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.842 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -73.17 -23.99 60.5 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.87 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.8 t -64.59 -35.76 75.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.813 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.9 m -95.85 -36.72 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.693 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -152.22 -66.15 0.01 OUTLIER Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.061 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 104.39 -40.29 2.51 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.664 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 5.0 ptt? -147.63 25.13 1.08 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.52 0.2 . . . . 0.0 111.318 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -148.74 25.4 0.94 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.663 0.268 . . . . 0.0 111.679 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -81.5 114.32 20.15 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.763 0.316 . . . . 0.0 110.917 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.8 m -63.6 146.1 13.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.487 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.42 168.52 11.8 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.295 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 44.4 p30 -168.45 166.14 12.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.658 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -64.45 96.16 0.16 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.931 0.396 . . . . 0.0 110.343 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 118.77 24.25 3.14 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.529 -179.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -87.41 158.38 19.01 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.751 0.31 . . . . 0.0 111.045 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 53.5 m -138.31 136.93 36.91 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.264 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.4 p -143.26 120.33 5.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.607 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -125.09 147.94 48.77 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.528 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -118.74 104.42 10.58 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.174 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.469 HD12 HG23 ' A' ' 96' ' ' ILE . 30.0 mt -116.59 112.85 41.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.243 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 27.1 t -78.37 86.99 4.41 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.237 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.5 p . . . . . 0 C--N 1.332 -0.182 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.374 -179.493 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . 0.433 ' O ' ' HA2' ' A' ' 90' ' ' GLY . 12.5 m-70 . . . . . 0 N--CA 1.465 0.294 0 CA-C-O 120.814 0.34 . . . . 0.0 111.049 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 6.5 mm -81.25 145.58 8.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.185 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.2 m -102.26 107.51 18.57 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.206 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.6 p -133.07 107.69 11.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.455 178.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.438 ' HB3' ' CB ' ' A' ' 24' ' ' SER . 1.4 pm0 -136.52 164.72 27.51 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.048 0.452 . . . . 0.0 111.75 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.441 ' CD1' ' HB3' ' A' ' 15' ' ' CYS . 15.2 m-85 -112.64 149.36 32.94 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.906 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.68 135.51 31.7 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.028 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.22 -107.03 3.44 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.315 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -121.84 30.5 5.27 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.784 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.441 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . 7.9 m -106.06 -19.96 13.56 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.798 0.299 . . . . 0.0 111.721 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -58.34 -30.45 66.73 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.804 0.335 . . . . 0.0 110.767 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 mp -70.03 -4.46 21.03 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.873 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 91.5 mt -77.09 7.79 4.61 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -149.92 -65.11 0.21 Allowed 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -172.09 39.14 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.772 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 52.18 35.77 17.54 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.892 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -76.13 -176.9 3.71 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.023 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 72.0 p -109.96 -77.42 0.6 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.806 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.438 ' CB ' ' HB3' ' A' ' 10' ' ' GLN . 80.8 p -135.73 162.9 31.47 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.876 0.37 . . . . 0.0 111.406 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -139.08 155.51 47.87 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.779 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.422 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 35.6 mt-30 -132.15 127.78 36.66 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.143 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.5 mt . . . . . 0 CA--C 1.53 0.18 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.018 -179.79 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.461 HG21 HD23 ' A' ' 40' ' ' LEU . 89.4 m . . . . . 0 N--CA 1.464 0.232 0 CA-C-O 120.676 0.274 . . . . 0.0 110.692 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -111.9 -175.11 2.61 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.887 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.7 tt -57.65 -49.47 76.34 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -57.68 -31.95 66.87 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.233 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.42 -32.22 38.98 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 111.414 -0.674 . . . . 0.0 111.414 178.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.461 HD23 HG21 ' A' ' 35' ' ' THR . 0.6 OUTLIER -63.85 -51.68 63.56 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.669 0.271 . . . . 0.0 110.463 179.345 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.434 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -56.99 -56.21 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.835 179.558 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -51.41 -29.82 17.19 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.452 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.65 -28.31 58.69 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 4.4 pp -95.89 -36.6 11.04 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.417 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 2.4 pttt -86.07 -61.39 1.76 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.2 m -58.61 -23.13 58.22 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 122.253 -0.279 . . . . 0.0 111.569 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -96.65 -39.17 9.63 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 111.412 0.152 . . . . 0.0 111.412 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -150.24 59.76 0.97 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.417 ' HB ' ' O ' ' A' ' 45' ' ' LYS . 7.5 p -78.81 -42.27 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.436 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.02 14.12 6.22 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 120.662 0.268 . . . . 0.0 111.501 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -152.34 -160.81 1.19 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.0 mmt85 -87.16 108.15 17.79 Favored Pre-proline 0 C--N 1.331 -0.225 0 N-CA-C 110.412 -0.218 . . . . 0.0 110.412 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.43 -23.21 69.5 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.148 1.898 . . . . 0.0 112.515 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.401 ' HA ' ' CG2' ' A' ' 57' ' ' VAL . 48.8 m-20 -90.43 8.09 35.47 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 pp -92.7 -20.45 20.8 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 121.19 -0.204 . . . . 0.0 111.418 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.63 -45.63 4.18 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.401 ' CG2' ' HA ' ' A' ' 54' ' ' ASP . 5.8 m -52.8 149.88 1.34 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-O 121.135 0.493 . . . . 0.0 111.864 -179.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -65.76 -61.37 2.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.555 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -168.47 -44.47 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.311 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.3 p -80.14 4.68 16.59 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.615 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.54 21.38 60.25 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.433 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -112.63 -41.06 3.9 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.769 0.319 . . . . 0.0 110.594 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.8 p -110.77 -167.12 1.14 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.133 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.4 mt -114.8 154.45 28.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.828 0.347 . . . . 0.0 111.06 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.69 150.46 81.84 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.063 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.79 127.42 24.58 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.875 2.383 . . . . 0.0 112.315 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 142.58 -45.01 0.94 Allowed Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.46 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.6 mt -88.43 141.35 14.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 120.803 0.335 . . . . 0.0 111.228 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 mt -105.48 99.85 9.44 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.79 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.3 m -78.76 135.51 25.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.007 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 mt -126.57 141.2 51.94 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.013 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.9 t -123.74 118.23 53.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.737 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 56.61 31.74 19.7 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.337 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 55.2 35.76 25.54 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.873 0.368 . . . . 0.0 111.113 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 11.2 t -141.89 37.55 1.61 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.922 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 67.37 134.59 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.27 0.557 . . . . 0.0 111.388 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -84.39 -22.81 30.34 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.434 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -77.84 -32.64 52.26 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.61 0.243 . . . . 0.0 110.859 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.2 t -69.21 -42.37 81.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.246 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.447 ' HB ' ' CD1' ' A' ' 85' ' ' TYR . 14.8 m -68.23 -31.22 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.561 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 142.68 42.08 0.06 OUTLIER Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.33 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 47.35 -119.03 4.45 Favored Glycine 0 C--N 1.336 0.574 0 C-N-CA 121.281 -0.485 . . . . 0.0 112.947 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -101.5 26.3 7.43 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.69 0.281 . . . . 0.0 111.134 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -120.2 23.64 10.84 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.369 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.447 ' CD1' ' HB ' ' A' ' 80' ' ' VAL . 28.4 t80 -93.24 130.25 39.0 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.864 0.364 . . . . 0.0 111.074 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.1 m -89.46 142.52 12.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.03 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.8 mp -83.72 174.22 10.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.947 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -135.01 -67.06 0.56 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.98 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -178.52 79.4 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.817 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 6' ' ' HIS . . . 113.48 37.3 1.33 Allowed Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.821 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.91 174.19 6.45 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.774 0.321 . . . . 0.0 110.931 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 58.4 m -132.42 116.08 16.36 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.953 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.9 p -128.81 119.93 50.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.019 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.423 ' HG2' ' HG2' ' A' ' 10' ' ' GLN . 39.9 mt-10 -124.92 146.56 49.29 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.3 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -121.72 104.81 9.86 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.346 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 27.7 mt -116.68 119.52 62.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.293 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.8 t -87.46 134.23 33.63 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.094 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.464 0.228 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.239 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 ttm . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 120.459 0.171 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.6 t -164.65 42.42 0.08 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.889 0.376 . . . . 0.0 110.957 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -89.46 71.29 8.02 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.279 0.561 . . . . 0.0 110.578 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 64.2 m170 -107.98 96.2 6.21 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.394 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.436 ' O ' ' HB2' ' A' ' 6' ' ' HIS . 77.3 m-20 64.54 -85.23 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.949 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.436 ' HB2' ' O ' ' A' ' 5' ' ' ASN . 34.5 m-70 68.19 140.77 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.904 0.383 . . . . 0.0 111.522 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 8.5 mm -104.05 143.18 16.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.648 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 32.1 m -111.09 93.47 4.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.563 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.8 p -114.59 102.65 14.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.15 0.5 . . . . 0.0 110.223 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.424 ' HB2' ' O ' ' A' ' 23' ' ' THR . 0.2 OUTLIER -128.37 175.2 8.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.96 -178.556 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.5 ' CD1' ' HB3' ' A' ' 15' ' ' CYS . 49.8 m-85 -128.39 168.65 15.28 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.112 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.29 136.61 14.02 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.311 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.09 -106.29 3.14 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.216 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -122.98 31.7 4.65 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.727 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.5 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . 69.3 m -106.78 -16.62 14.44 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.422 ' HG2' ' HB2' ' A' ' 11' ' ' PHE . 68.5 mt-10 -58.58 -30.98 67.6 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.523 0.201 . . . . 0.0 111.05 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.8 mp -70.57 -7.8 46.73 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.3 mt -83.57 12.08 6.22 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.418 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 38.5 t80 -147.32 -62.37 0.28 Allowed 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -176.7 36.28 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.067 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.47 35.86 12.1 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.895 0.378 . . . . 0.0 110.663 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -90.2 146.07 24.54 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.913 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.424 ' O ' ' HB2' ' A' ' 10' ' ' GLN . 7.3 p -75.97 -32.64 59.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.098 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.9 p -170.96 157.98 5.53 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.646 0.26 . . . . 0.0 111.145 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.95 154.36 51.13 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.819 0.343 . . . . 0.0 111.547 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.52 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 16.7 mt-30 -132.72 128.15 36.3 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.986 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.5 mt -109.38 137.21 47.58 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.78 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.53 113.73 26.98 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.873 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -115.64 -158.32 11.63 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.493 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.1 m -141.39 -47.36 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.475 0.178 . . . . 0.0 111.381 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.5 m -146.42 74.42 12.72 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-O 120.926 0.393 . . . . 0.0 110.964 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -83.39 18.18 1.55 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.806 2.337 . . . . 0.0 113.231 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.4 m -57.79 -32.93 68.01 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.71 0.29 . . . . 0.0 110.833 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -91.15 24.83 16.75 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.148 -0.549 . . . . 0.0 112.92 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.6 m -123.98 148.1 47.22 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.813 0.306 . . . . 0.0 110.674 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -128.97 -178.59 4.69 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.169 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.2 tt -57.77 -46.65 84.26 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -56.83 -33.76 67.07 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.719 0.295 . . . . 0.0 110.32 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.67 -30.1 49.75 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 121.001 -0.618 . . . . 0.0 111.983 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -70.8 -47.33 60.05 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.674 0.237 . . . . 0.0 111.237 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.4 -53.34 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.866 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -53.41 -33.11 52.64 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.031 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.85 -24.78 62.59 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.302 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -95.1 -42.18 8.73 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.426 ' HG3' ' H ' ' A' ' 46' ' ' THR . 7.7 pttp -92.36 -60.86 1.73 Allowed 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.426 ' H ' ' HG3' ' A' ' 45' ' ' LYS . 1.5 m -54.57 -27.29 37.85 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 122.176 -0.328 . . . . 0.0 111.244 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -82.71 -26.65 31.82 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.461 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.417 ' O ' HG12 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -135.59 -75.04 0.45 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.77 -0.195 . . . . 0.0 111.323 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.417 HG12 ' O ' ' A' ' 48' ' ' TYR . 13.0 p 40.41 89.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.396 0.678 . . . . 0.0 112.237 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -66.33 -53.7 33.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.228 179.616 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -76.65 -179.47 5.33 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.798 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.12 113.91 6.23 Favored Pre-proline 0 N--CA 1.464 0.246 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.162 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.66 -23.25 75.49 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.546 2.164 . . . . 0.0 112.5 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -90.28 5.55 46.71 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.5 pp -93.38 -21.42 19.54 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 122.379 -0.201 . . . . 0.0 111.484 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.14 -45.28 5.69 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 5.9 m -54.49 150.22 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.214 0.531 . . . . 0.0 111.66 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -66.79 -54.1 26.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.859 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.52 -43.0 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.441 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 71.4 p -87.42 11.06 15.52 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 58.55 23.09 54.02 Favored Glycine 0 C--N 1.338 0.674 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.645 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -110.17 -39.91 4.86 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.903 0.382 . . . . 0.0 110.585 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.493 HG21 ' HB3' ' A' ' 83' ' ' MET . 30.1 p -121.4 -178.05 3.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.022 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.5 mt -110.16 155.93 21.3 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.875 0.369 . . . . 0.0 111.003 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.89 148.98 82.34 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.429 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -50.3 -32.43 33.15 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.249 2.632 . . . . 0.0 113.146 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -47.84 -36.0 13.14 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 121.391 -0.433 . . . . 0.0 113.144 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.1 mt -93.11 138.0 21.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.784 0.292 . . . . 0.0 111.063 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.4 tp -102.87 106.93 17.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.93 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.7 m -84.93 133.34 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.864 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 mt -134.65 141.27 46.53 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.433 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 92' ' ' THR . 38.2 t -119.04 121.92 67.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.591 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 59.52 45.13 13.83 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.075 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.33 39.59 18.62 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.203 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 17.9 t -153.88 153.98 33.06 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.581 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -47.04 121.06 3.42 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.642 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.33 -19.03 43.68 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.684 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -77.53 -29.7 52.48 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.577 0.227 . . . . 0.0 110.838 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 43.7 t -65.24 -50.98 70.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.075 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.7 m -61.3 -36.03 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.521 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -176.78 -44.88 0.06 OUTLIER Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.773 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.41 -51.03 1.84 Allowed Glycine 0 C--N 1.335 0.51 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.213 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.493 ' HB3' HG21 ' A' ' 63' ' ' THR . 3.9 ptt? -142.5 23.74 1.95 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 120.479 0.181 . . . . 0.0 111.217 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -140.35 26.75 2.15 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -84.85 98.15 10.14 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.82 0.343 . . . . 0.0 110.945 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.9 m -61.68 141.56 17.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.584 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.63 160.19 14.52 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.185 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -158.21 31.16 0.25 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.441 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 69.6 120.62 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.89 0.376 . . . . 0.0 110.897 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 97.28 33.66 5.88 Favored Glycine 0 CA--C 1.519 0.302 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.961 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -101.86 167.44 10.07 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.94 0.4 . . . . 0.0 111.476 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 92.9 m -137.47 134.11 35.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.759 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.0 p -141.85 136.61 30.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.823 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -130.49 150.15 51.84 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.616 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -130.51 104.48 7.26 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.098 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.468 HG22 HD11 ' A' ' 96' ' ' ILE . 24.6 mt -118.99 115.4 47.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.035 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 46.6 t -81.24 140.36 34.93 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.284 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 21.3 p -132.3 -50.36 0.93 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.893 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.2 tp -78.15 99.55 6.24 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.828 0.347 . . . . 0.0 110.597 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -72.06 -60.95 1.97 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.077 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.5 -113.6 4.31 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.7 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.316 -1.269 . . . . 0.0 112.457 -179.97 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 120.515 0.198 . . . . 0.0 111.251 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.3 t -119.72 -62.67 1.46 Allowed 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.758 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -135.83 140.73 44.43 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.096 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -158.44 82.07 0.83 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.669 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -108.88 130.56 55.43 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.264 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.414 ' CD2' ' HB3' ' A' ' 26' ' ' GLN . 0.0 OUTLIER 179.35 153.44 0.43 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.071 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.482 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 33.3 mm -115.28 152.23 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.84 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.9 m -115.29 101.72 9.2 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.008 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.8 p -120.43 108.54 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-O 121.007 0.432 . . . . 0.0 111.207 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.36 156.88 44.76 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.571 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -115.05 144.93 42.85 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.859 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.0 151.89 35.34 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.672 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.37 -86.84 1.11 Allowed Glycine 0 C--N 1.336 0.538 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.44 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -143.34 27.73 2.1 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.565 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.29 5.54 21.77 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -93.1 -29.02 15.99 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.53 0.205 . . . . 0.0 111.046 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.0 mp -66.73 -15.56 63.62 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.422 ' CB ' HD12 ' A' ' 55' ' ' LEU . 3.6 pp -83.26 12.71 4.95 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -143.07 -66.5 0.37 Allowed 'General case' 0 CA--C 1.521 -0.135 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -175.78 36.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.31 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 mptt 49.7 34.92 7.95 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.865 0.364 . . . . 0.0 110.694 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -76.27 179.69 5.61 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.708 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.5 p -112.11 -74.55 0.63 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.01 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 87.9 p -135.74 156.81 48.24 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 120.777 0.322 . . . . 0.0 111.181 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.9 tp -150.13 166.56 29.43 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.688 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.482 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 1.0 OUTLIER -126.42 146.59 50.01 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.844 179.665 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.1 mt -128.73 142.57 50.96 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.09 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -102.2 111.12 23.28 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.825 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.07 -34.94 5.48 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 121.051 -0.595 . . . . 0.0 113.068 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.4 t 72.88 -63.51 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 122.646 0.378 . . . . 0.0 111.086 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.1 m -128.56 56.58 23.3 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-O 121.078 0.466 . . . . 0.0 111.154 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.56 6.54 5.08 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.895 2.397 . . . . 0.0 113.368 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.04 -46.14 68.33 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.635 0.255 . . . . 0.0 111.427 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.5 49.54 3.69 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 121.014 -0.613 . . . . 0.0 112.743 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.2 m -150.97 138.61 19.69 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.799 0.333 . . . . 0.0 111.04 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -111.33 -175.17 2.64 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.885 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.68 -42.85 89.47 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.756 -0.202 . . . . 0.0 111.1 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -55.68 -37.68 68.64 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.953 0.406 . . . . 0.0 109.948 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.75 -32.27 46.37 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.161 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 53.6 tp -62.83 -48.97 76.75 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.714 0.257 . . . . 0.0 110.591 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.16 -57.01 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.847 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -55.82 -28.15 54.84 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 120.498 0.189 . . . . 0.0 111.08 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.423 ' O ' ' HB2' ' A' ' 47' ' ' ASN . 7.1 tt -84.71 -21.86 29.97 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.848 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.2 pp -93.89 -41.08 9.81 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.72 -56.48 6.29 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.77 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.6 m -60.69 -20.33 60.78 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.554 0.216 . . . . 0.0 110.814 178.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.4 OUTLIER -67.45 -44.19 79.27 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.944 179.474 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -146.43 -62.83 0.31 Allowed 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.472 ' O ' HG12 ' A' ' 49' ' ' VAL . 13.2 p 42.91 86.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.469 0.652 . . . . 0.0 112.017 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.78 -48.17 80.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.214 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.61 -156.23 0.44 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.651 -0.249 . . . . 0.0 110.564 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.404 ' HB2' HD21 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -66.88 138.01 95.03 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-O 120.755 0.312 . . . . 0.0 111.583 -179.507 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.77 -29.9 4.16 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.562 2.174 . . . . 0.0 112.468 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.425 ' HA ' ' CG2' ' A' ' 57' ' ' VAL . 4.1 t0 -94.43 10.67 33.5 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.422 HD12 ' CB ' ' A' ' 18' ' ' LEU . 3.4 pp -77.85 -25.96 49.07 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.543 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.418 ' C ' HD21 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -97.4 -50.77 4.4 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.387 179.952 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 64' ' ' LEU . 1.3 m -60.99 149.66 7.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.209 0.528 . . . . 0.0 111.268 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -61.46 -61.3 2.63 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.299 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -171.08 -43.74 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.269 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 38.9 p -85.07 11.43 9.67 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.807 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.404 ' HA2' ' CG1' ' A' ' 57' ' ' VAL . . . 54.08 27.99 39.92 Favored Glycine 0 C--N 1.34 0.779 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.539 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -113.97 -44.66 3.13 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.983 0.42 . . . . 0.0 110.332 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.4 t -122.98 139.89 53.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.948 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 7.2 mt -66.76 154.84 39.74 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.872 0.368 . . . . 0.0 110.911 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.5 156.05 89.04 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.194 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.48 140.54 74.5 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.844 2.362 . . . . 0.0 112.37 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.61 -47.72 1.0 Allowed Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.255 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.4 mt -79.93 149.96 5.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-O 120.867 0.365 . . . . 0.0 110.984 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.3 mt -128.41 104.3 7.63 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.783 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.6 m -77.37 123.62 34.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.833 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.3 mt -124.8 141.46 52.1 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.375 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 92' ' ' THR . 36.6 t -109.34 107.0 21.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.526 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 59.35 55.44 4.23 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.899 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.0 t 57.71 49.2 12.72 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.312 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 52.4 t -162.41 143.63 10.38 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.784 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.3 122.2 9.86 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.913 0.387 . . . . 0.0 111.193 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.29 -19.98 59.37 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.901 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -71.52 -24.99 62.06 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 116.728 -0.215 . . . . 0.0 111.172 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.9 t -56.18 -32.51 34.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.017 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.6 m -105.67 -38.92 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.629 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -154.95 -56.7 0.01 OUTLIER Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.017 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 99.29 -53.16 1.04 Allowed Glycine 0 C--N 1.333 0.4 0 C-N-CA 121.125 -0.56 . . . . 0.0 112.448 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.6 23.74 3.15 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.546 0.213 . . . . 0.0 111.4 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -142.74 27.06 1.69 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.733 0.271 . . . . 0.0 111.733 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -77.74 117.38 19.08 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.77 0.319 . . . . 0.0 110.944 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.7 m -75.28 136.06 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.272 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 mp -86.48 162.19 18.21 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.294 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -146.13 33.5 1.0 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.403 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 60.42 27.34 16.94 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.396 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -169.59 40.01 0.2 Allowed Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.937 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -103.85 166.55 10.35 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.062 0.458 . . . . 0.0 111.253 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 78.9 m -127.81 137.07 52.25 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.434 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.8 p -142.22 134.21 26.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.991 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -133.39 138.81 46.45 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.316 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -110.17 105.64 14.8 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.356 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 10.9 mt -110.85 100.76 11.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.074 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -84.08 110.58 18.58 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.036 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 22.7 p -104.72 -55.64 2.31 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.983 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 11.0 tp -78.84 151.12 32.06 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.964 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -145.35 87.7 1.82 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.788 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.22 -40.14 2.57 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.795 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.177 0 CA-C-O 118.529 -1.151 . . . . 0.0 112.803 -179.978 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 tpp . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 120.777 0.322 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 63.96 -171.67 0.18 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.316 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -73.73 -40.67 63.39 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.44 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 55.66 34.47 23.34 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.954 0.407 . . . . 0.0 110.595 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.411 ' HA ' ' OD1' ' A' ' 89' ' ' ASP . 2.2 t30 -135.95 145.57 46.36 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.003 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -174.56 105.69 0.1 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.316 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 16.1 mm -90.97 157.16 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.562 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 30.3 m -124.91 93.74 3.98 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.807 0.336 . . . . 0.0 111.521 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.6 p -113.23 103.6 15.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.183 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -131.74 166.9 20.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.744 -178.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.493 ' HB2' ' HG2' ' A' ' 16' ' ' GLU . 41.6 m-85 -125.0 163.52 22.16 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.874 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 96' ' ' ILE . . . -175.17 119.51 0.19 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.053 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.67 54.89 0.76 Allowed Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.582 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.26 25.96 72.48 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.199 -0.524 . . . . 0.0 113.478 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -116.44 5.35 13.43 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 117.091 0.445 . . . . 0.0 111.675 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.493 ' HG2' ' HB2' ' A' ' 11' ' ' PHE . 64.1 mt-10 -84.17 -23.29 30.67 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.73 -4.92 21.86 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 24.7 mt -78.88 8.73 5.06 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -149.39 -63.58 0.22 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.788 0.328 . . . . 0.0 110.149 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -174.84 38.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.848 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.93 35.8 20.15 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.241 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -80.48 178.37 8.37 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.963 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 28.1 p -107.69 -74.65 0.65 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.994 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 88.0 p -132.99 160.58 36.71 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.829 0.347 . . . . 0.0 111.355 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.55 152.81 44.42 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.181 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.447 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 1.7 mt-30 -131.06 122.32 26.55 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.6 mt -94.73 136.32 35.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.338 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -117.03 115.87 26.24 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.98 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -146.49 139.81 8.32 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.446 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.0 m -65.14 -41.54 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 120.659 0.266 . . . . 0.0 111.255 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.8 t -143.79 72.99 17.02 Favored Pre-proline 0 CA--C 1.53 0.203 0 CA-C-O 120.926 0.394 . . . . 0.0 110.838 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -81.66 4.99 6.58 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.743 2.296 . . . . 0.0 113.081 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.81 166.45 8.98 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.803 0.335 . . . . 0.0 110.916 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.34 -29.38 10.93 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.52 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 58.9 m -83.37 158.84 21.99 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.61 0.243 . . . . 0.0 110.984 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -131.81 -179.55 5.46 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.896 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.4 tt -53.47 -48.36 68.94 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 111.514 0.19 . . . . 0.0 111.514 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -52.99 -36.35 60.28 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.812 0.339 . . . . 0.0 110.388 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.3 -31.05 43.33 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.137 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.84 -51.49 54.89 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.633 0.254 . . . . 0.0 110.72 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.452 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -60.7 -57.34 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.915 179.776 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -52.57 -29.33 25.05 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.319 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 30.5 tp -74.53 -27.59 60.6 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 3.5 pp -96.93 -38.61 9.75 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.16 -70.91 0.54 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.411 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.3 m -53.24 -24.32 10.95 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 111.863 0.319 . . . . 0.0 111.863 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -102.45 -23.3 13.94 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -147.84 50.17 1.05 Allowed 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.6 p -99.88 122.72 52.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.871 0.367 . . . . 0.0 110.987 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -100.79 33.05 2.91 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.888 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.439 ' HB3' HD23 ' A' ' 55' ' ' LEU . 1.7 tp10 -160.21 -161.79 0.92 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.111 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 54.5 mtt-85 -88.87 109.88 33.47 Favored Pre-proline 0 CA--C 1.529 0.172 0 CA-C-O 120.418 0.152 . . . . 0.0 110.894 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -48.41 -30.11 14.87 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.724 2.283 . . . . 0.0 112.929 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.19 -17.17 64.56 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.439 HD23 ' HB3' ' A' ' 51' ' ' GLU . 2.5 pp -80.38 -15.19 57.43 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.65 -49.15 3.2 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.712 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.9 m -57.34 148.38 5.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.078 0.466 . . . . 0.0 111.467 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -71.33 -59.72 2.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.913 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -162.96 -56.42 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.229 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.6 p -59.51 -21.2 59.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.2 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.76 21.59 49.97 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 121.149 -0.548 . . . . 0.0 111.862 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -124.45 -46.34 1.9 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.792 0.33 . . . . 0.0 110.974 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.0 t -101.91 130.91 48.52 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.701 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.7 mt -65.91 155.29 36.87 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.806 0.336 . . . . 0.0 111.123 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -53.21 143.76 32.46 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.324 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -51.57 -33.39 47.97 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.181 2.587 . . . . 0.0 112.98 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -49.49 -35.39 21.75 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.348 -0.453 . . . . 0.0 112.914 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.9 mt -82.81 114.4 23.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.83 0.315 . . . . 0.0 110.787 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.61 97.01 8.28 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.198 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.3 t -84.87 136.33 23.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.041 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.6 mt -125.62 126.68 45.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.89 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 92' ' ' THR . 38.4 t -110.23 118.76 57.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.878 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.4 m120 55.29 35.02 24.04 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.363 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.1 t 56.18 33.16 21.56 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.306 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 9.3 t -138.02 31.11 2.46 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.841 0.353 . . . . 0.0 111.01 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 69.05 145.28 0.05 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.371 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -85.08 -22.73 28.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.594 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -82.28 -33.5 29.07 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.755 -0.202 . . . . 0.0 110.993 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 39.5 t -66.16 -41.9 90.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.26 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.476 ' HB ' ' CD1' ' A' ' 85' ' ' TYR . 26.8 m -69.41 -29.13 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 168.3 -34.37 0.2 Allowed Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.339 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 109.25 -55.69 0.5 Allowed Glycine 0 C--N 1.333 0.416 0 N-CA-C 111.823 -0.511 . . . . 0.0 111.823 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.69 27.94 0.28 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.461 0.172 . . . . 0.0 111.289 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -135.42 20.55 3.38 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.476 ' CD1' ' HB ' ' A' ' 80' ' ' VAL . 34.1 t80 -68.56 112.09 5.14 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.787 0.327 . . . . 0.0 110.961 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.2 m -71.04 135.47 27.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.272 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.83 152.99 29.41 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.023 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -155.23 -59.72 0.11 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.055 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.411 ' OD1' ' HA ' ' A' ' 5' ' ' ASN . 0.4 OUTLIER -173.03 116.09 0.28 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.137 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 80.26 34.26 29.93 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.826 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -75.39 99.09 4.04 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.84 0.352 . . . . 0.0 110.358 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 16.0 m -81.77 127.84 33.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.56 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.7 p -139.02 113.96 8.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.011 0.434 . . . . 0.0 110.926 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -114.98 149.89 36.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.119 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -123.91 104.71 9.09 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.419 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 12' ' ' ALA . 29.3 mt -114.12 101.97 13.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.323 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.0 m -72.94 97.93 2.38 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.089 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.7 m -89.0 -50.92 5.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.978 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.7 tt -86.59 100.77 12.66 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.829 0.347 . . . . 0.0 110.925 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -126.0 -47.68 1.64 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.093 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 170.2 68.39 0.04 OUTLIER Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.638 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.429 -1.206 . . . . 0.0 112.605 -179.969 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 mtt . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 120.619 0.247 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.3 m 55.33 35.23 24.53 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.27 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -148.77 -58.81 0.22 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.624 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.8 m170 63.73 -174.24 0.16 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.606 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -71.48 158.41 36.3 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.972 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 25.0 p-80 -165.22 124.35 1.75 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.79 0.329 . . . . 0.0 111.515 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.447 HD13 HG23 ' A' ' 7' ' ' ILE . 33.9 mm -95.79 137.84 22.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.692 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.9 m -96.26 98.88 10.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.201 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.1 p -122.47 108.7 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-O 120.92 0.39 . . . . 0.0 110.559 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -135.2 158.91 43.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.396 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.403 ' CB ' ' HA ' ' A' ' 16' ' ' GLU . 31.0 m-85 -126.75 145.47 50.6 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.124 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -92.74 179.99 5.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.303 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.6 97.43 0.12 Allowed Glycine 0 C--N 1.335 0.504 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.6 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 135.16 -40.95 1.49 Allowed Glycine 0 C--N 1.333 0.364 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.807 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.05 -23.95 18.48 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.441 0.162 . . . . 0.0 111.418 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.403 ' HA ' ' CB ' ' A' ' 11' ' ' PHE . 6.9 pt-20 -58.43 -26.92 63.83 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 111.679 0.251 . . . . 0.0 111.679 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 mp -68.59 -8.46 41.98 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 25.3 mt -83.26 13.43 4.26 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -148.46 -59.11 0.24 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.743 0.306 . . . . 0.0 110.253 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -178.67 36.49 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.079 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.54 34.53 9.66 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.952 0.406 . . . . 0.0 110.764 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -78.84 173.25 12.7 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.021 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.2 p -107.97 -45.21 4.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.947 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 94.3 p -159.7 158.87 32.16 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.592 0.234 . . . . 0.0 111.238 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -146.95 163.6 35.63 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.232 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.24 100.8 5.32 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.855 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.0 mt -93.36 142.22 27.57 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.663 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.08 123.26 31.19 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.001 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.82 -51.19 25.72 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.604 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.4 t 69.6 -68.24 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 122.551 0.34 . . . . 0.0 111.223 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.6 p -154.04 63.78 4.43 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-O 121.309 0.576 . . . . 0.0 110.803 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.439 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 80.8 Cg_endo -87.09 26.1 0.63 Allowed 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.206 2.604 . . . . 0.0 113.193 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.5 m -53.69 -39.26 65.0 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.847 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -103.97 32.46 7.52 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 121.188 -0.529 . . . . 0.0 112.656 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.4 m -120.15 146.55 45.87 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.641 0.258 . . . . 0.0 111.075 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -136.02 -174.09 3.57 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.05 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.5 tt -56.82 -45.5 82.28 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.731 -179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -54.69 -38.63 67.22 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.03 -32.96 58.02 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.015 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.6 mt -65.61 -57.03 9.11 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.629 0.252 . . . . 0.0 110.65 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -55.27 -56.89 9.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.994 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -51.02 -29.89 13.8 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.464 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.24 -28.49 57.15 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.0 pp -94.91 -33.03 12.94 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.417 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 4.4 pttt -92.49 -61.05 1.68 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 111.595 0.221 . . . . 0.0 111.595 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.413 ' H ' ' HG3' ' A' ' 45' ' ' LYS . 1.0 OUTLIER -58.29 -20.23 41.02 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 122.126 -0.359 . . . . 0.0 111.306 179.752 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -105.68 -30.14 9.65 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -146.63 48.45 1.17 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.417 ' HB ' ' O ' ' A' ' 45' ' ' LYS . 7.5 p -80.81 -32.81 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.07 20.82 0.65 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 122.544 0.338 . . . . 0.0 111.642 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -158.73 -166.4 1.87 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.242 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.415 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 3.0 ttt180 -70.67 110.91 7.97 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-O 120.601 0.238 . . . . 0.0 110.752 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.32 -22.23 70.16 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.37 2.047 . . . . 0.0 112.347 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.19 8.23 41.03 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 52' ' ' ARG . 2.7 pp -88.85 -7.75 55.56 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 122.239 -0.288 . . . . 0.0 111.534 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.93 -47.68 2.59 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.7 m -53.58 150.35 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-O 121.275 0.56 . . . . 0.0 111.396 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -62.7 -57.15 12.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.598 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.08 -43.16 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.354 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 31.9 p -86.5 10.09 16.35 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.752 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 58.88 21.96 53.23 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.484 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -107.77 -42.05 4.83 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.901 0.382 . . . . 0.0 110.461 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.1 t -118.74 -167.78 1.43 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.097 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 10.6 mt -111.75 157.58 20.35 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.979 0.418 . . . . 0.0 111.689 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.428 ' HB2' ' HD2' ' A' ' 66' ' ' PRO . 0.5 OUTLIER -78.18 156.93 78.88 Favored Pre-proline 0 C--O 1.233 0.206 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.949 179.859 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.428 ' HD2' ' HB2' ' A' ' 65' ' ' ARG . 10.7 Cg_endo -55.22 134.33 63.21 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.637 2.225 . . . . 0.0 112.472 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 133.73 -47.99 0.97 Allowed Glycine 0 C--N 1.331 0.292 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.185 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.8 mt -86.02 137.03 21.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-O 120.678 0.275 . . . . 0.0 111.092 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -107.74 106.65 17.06 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.674 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.5 m -83.11 128.39 38.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.876 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.5 mt -132.69 136.82 46.67 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.566 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 92' ' ' THR . 38.5 t -108.95 102.86 14.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.374 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 60.36 57.41 2.88 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.764 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.2 m 57.69 49.33 12.55 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.594 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 50.3 t -163.12 137.56 6.25 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.818 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -54.02 124.99 17.16 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.823 0.345 . . . . 0.0 111.276 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.1 -23.38 35.74 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.239 -179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -70.08 -14.18 62.55 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 111.466 0.173 . . . . 0.0 111.466 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.2 t -74.05 -30.27 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 111.679 0.251 . . . . 0.0 111.679 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 18.8 m -115.73 -43.69 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -176.04 72.61 0.08 OUTLIER Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.409 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -49.93 -28.37 11.94 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 121.525 -0.369 . . . . 0.0 113.352 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.1 ptt? -132.15 29.09 4.38 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.726 0.298 . . . . 0.0 110.56 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -149.52 30.51 0.75 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.491 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -86.83 115.99 24.61 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.827 0.346 . . . . 0.0 111.281 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 29.8 m -66.23 168.61 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.341 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.439 ' HB3' ' HB2' ' A' ' 32' ' ' PRO . 0.1 OUTLIER -116.84 178.74 4.23 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.193 0.521 . . . . 0.0 111.546 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -160.96 -82.77 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.054 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -173.91 33.57 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.877 0.37 . . . . 0.0 111.455 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 178.72 37.55 0.06 OUTLIER Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.429 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -82.52 149.38 27.56 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.779 0.323 . . . . 0.0 110.965 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.442 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 61.8 m -119.43 133.18 55.83 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.401 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.3 p -141.95 127.46 17.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.907 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -128.67 145.08 51.26 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.284 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -123.29 104.59 9.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.233 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 30.0 mt -116.71 109.18 27.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.274 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.5 m -80.24 149.8 30.29 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.137 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 32.0 p -126.26 -61.84 1.19 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.014 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.8 pp -82.6 164.72 20.62 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.125 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -155.13 72.29 0.82 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.886 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 110.51 -91.92 0.65 Allowed Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.39 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.093 0 CA-C-O 118.201 -1.333 . . . . 0.0 112.912 179.873 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 mmt . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 t 69.88 165.09 0.27 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.932 0.396 . . . . 0.0 111.237 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -125.5 179.29 5.19 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.026 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -147.34 76.19 1.4 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.985 0.421 . . . . 0.0 111.72 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 72.51 133.07 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.922 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 37.3 p-80 -171.94 124.32 0.53 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.509 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 23.5 mm -99.1 146.11 9.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.847 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.413 ' HB ' ' HA ' ' A' ' 92' ' ' THR . 89.1 m -104.85 118.63 37.02 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.084 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.421 ' CG1' ' HB2' ' A' ' 25' ' ' LEU . 8.4 p -149.47 112.64 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.798 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.431 ' HB3' ' CB ' ' A' ' 24' ' ' SER . 6.2 pm0 -136.35 162.43 33.03 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.953 0.406 . . . . 0.0 111.74 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -120.8 141.75 50.23 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.164 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.32 150.76 46.93 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.387 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.32 -109.57 2.86 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.453 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -115.59 29.63 7.12 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.944 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.73 -8.11 14.19 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.984 0.392 . . . . 0.0 111.692 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -93.69 -25.32 17.51 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.573 0.225 . . . . 0.0 111.008 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.11 -7.13 47.3 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.6 pp -85.74 13.71 6.84 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -145.11 -64.11 0.34 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.922 0.391 . . . . 0.0 109.987 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -175.59 38.8 0.01 OUTLIER 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.561 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.3 mptt 51.2 40.52 26.18 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.362 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -67.23 171.98 5.22 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.918 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 62.3 p -114.09 -80.06 0.59 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.006 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.431 ' CB ' ' HB3' ' A' ' 10' ' ' GLN . 88.5 p -133.08 154.71 50.31 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.85 0.357 . . . . 0.0 111.409 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.421 ' HB2' ' CG1' ' A' ' 9' ' ' VAL . 0.4 OUTLIER -131.62 160.93 33.92 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.178 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 1.1 tt0 -131.17 120.92 23.99 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.032 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.5 mt -102.27 141.49 35.03 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.739 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -109.83 116.13 31.09 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.105 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 61.3 -102.88 0.47 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.573 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.4 m 36.25 83.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.157 0.583 . . . . 0.0 112.282 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.4 m 40.79 61.61 6.94 Favored Pre-proline 0 N--CA 1.466 0.364 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.731 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -82.39 7.79 4.92 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.969 2.446 . . . . 0.0 113.572 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.5 m -126.59 -59.23 1.3 Allowed 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.36 0.124 . . . . 0.0 110.741 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -83.58 55.38 5.02 Favored Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.831 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 89.3 m -152.64 140.8 20.39 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.826 0.346 . . . . 0.0 110.818 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 44.9 p30 -116.94 -174.95 2.68 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.967 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.3 tt -57.78 -41.76 82.74 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.004 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -51.68 -43.14 62.62 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.229 178.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.36 -31.11 61.56 Favored Glycine 0 C--N 1.334 0.472 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.549 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -70.7 -56.92 5.31 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.876 0.338 . . . . 0.0 110.955 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.407 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 0.5 OUTLIER -56.98 -56.04 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.361 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.41 ' HA ' ' CG ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -50.93 -29.85 13.24 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.733 179.785 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.414 ' HA ' ' HB2' ' A' ' 47' ' ' ASN . 0.7 OUTLIER -70.18 -34.5 73.05 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.357 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.4 pp -96.99 -25.2 15.47 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.449 0.536 . . . . 0.0 112.449 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.41 ' CG ' ' HA ' ' A' ' 42' ' ' GLN . 0.0 OUTLIER -93.02 -32.88 14.34 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.0 m -108.64 -26.04 10.57 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.414 ' HB2' ' HA ' ' A' ' 43' ' ' LEU . 2.9 m-80 -109.51 -22.38 12.02 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -178.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.69 39.82 3.16 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.4 p -98.38 143.11 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 120.85 0.357 . . . . 0.0 110.866 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.77 27.88 4.59 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.4 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -156.71 -166.98 2.25 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.52 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -57.95 111.03 2.99 Favored Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 116.935 -0.121 . . . . 0.0 110.889 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.51 -25.95 80.41 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.164 1.909 . . . . 0.0 112.209 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -90.66 7.0 41.6 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.7 pp -89.19 -15.76 32.94 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 121.161 -0.216 . . . . 0.0 111.256 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.34 -47.17 2.85 Favored 'General case' 0 C--N 1.339 0.11 0 N-CA-C 111.499 0.185 . . . . 0.0 111.499 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.4 m -58.41 147.05 7.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 121.119 0.485 . . . . 0.0 111.837 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -67.19 -57.23 7.11 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.468 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -171.59 -43.7 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.357 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 46.9 p -81.62 7.28 12.66 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.34 23.99 43.6 Favored Glycine 0 C--N 1.343 0.928 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.334 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -108.79 -39.32 5.38 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 120.753 0.311 . . . . 0.0 110.569 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 11.3 t -132.14 165.02 25.01 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.13 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.0 mt -77.55 157.76 30.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.906 0.384 . . . . 0.0 110.781 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.12 153.21 68.2 Favored Pre-proline 0 N--CA 1.465 0.292 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.254 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -49.02 -32.66 24.12 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.926 2.417 . . . . 0.0 112.591 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -51.27 -34.39 32.95 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.858 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.1 mt -97.19 148.7 5.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 116.855 0.327 . . . . 0.0 110.708 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.29 118.58 32.66 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.017 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.6 m -90.37 129.53 41.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.937 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 mt -125.49 130.43 51.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.166 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.429 HG11 ' CE1' ' A' ' 85' ' ' TYR . 26.3 t -105.0 99.48 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.465 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.1 m120 58.68 55.41 4.74 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.936 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.5 t 61.38 42.08 12.11 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.24 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 53.2 t -160.13 121.94 3.22 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.781 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -48.93 131.59 18.67 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.729 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.48 -26.27 41.69 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.973 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -72.72 -25.55 61.26 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.489 0.185 . . . . 0.0 111.119 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.11 -29.59 46.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.017 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.8 m -112.46 -39.26 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -137.41 -72.96 0.06 OUTLIER Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.858 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 119.92 -42.21 1.8 Allowed Glycine 0 C--N 1.334 0.453 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.386 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -157.42 29.35 0.29 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.743 0.306 . . . . 0.0 110.755 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -145.84 22.11 1.43 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.581 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.429 ' CE1' HG11 ' A' ' 72' ' ' VAL . 4.4 t80 -72.39 120.37 17.91 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 122.348 -0.22 . . . . 0.0 111.275 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.7 m -61.73 125.37 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.206 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.32 169.11 16.87 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.039 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -164.4 165.76 21.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.858 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -57.23 103.08 0.1 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.1 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 106.14 24.65 6.77 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 121.108 -0.568 . . . . 0.0 113.016 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.02 138.88 39.86 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.928 0.364 . . . . 0.0 110.543 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.413 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 86.1 m -113.15 115.24 27.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.117 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.8 p -125.27 111.22 26.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 121.04 0.448 . . . . 0.0 110.633 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -114.92 151.38 34.14 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.176 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -129.57 104.36 7.4 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.531 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.9 mt -106.24 100.44 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.887 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.8 106.64 7.49 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.47 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.5 p -110.24 -30.53 7.68 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.741 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 51.56 -174.72 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.119 0.568 . . . . 0.0 112.331 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.35 99.8 2.82 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.045 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -133.41 -69.61 0.08 OUTLIER Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.391 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.145 0 CA-C-O 118.507 -1.163 . . . . 0.0 112.604 179.557 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 120.742 0.306 . . . . 0.0 111.222 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.7 t -98.28 163.5 12.69 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.245 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -91.77 109.96 21.29 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.874 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -129.25 146.45 51.16 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.892 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 40.2 m-20 69.77 142.05 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.08 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 55.9 m80 63.86 176.6 0.17 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.72 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 2.0 mp -113.32 135.06 54.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-O 120.931 0.396 . . . . 0.0 111.152 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 83.5 m -88.75 96.63 10.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.983 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.8 p -117.79 113.49 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.206 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.412 ' HB3' ' CB ' ' A' ' 24' ' ' SER . 8.8 pm0 -137.08 166.87 22.69 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.931 0.396 . . . . 0.0 111.899 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -126.67 150.14 49.14 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.24 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -146.55 158.18 43.86 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.559 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 67.96 -100.48 0.64 Allowed Glycine 0 C--N 1.336 0.537 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.459 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -124.04 33.16 3.96 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.586 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.7 m -109.7 -16.23 13.97 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.449 ' HG2' ' N ' ' A' ' 17' ' ' LEU . 12.7 pm0 -81.81 -33.57 30.71 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.702 0.286 . . . . 0.0 111.143 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.449 ' N ' ' HG2' ' A' ' 16' ' ' GLU . 1.4 mp -60.98 -28.19 68.83 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.033 0.382 . . . . 0.0 112.033 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.9 pp -82.87 11.8 5.63 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -133.09 -60.01 0.87 Allowed 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 174.27 36.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.031 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.56 32.16 4.7 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.902 0.382 . . . . 0.0 110.97 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -80.16 168.55 18.96 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.106 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.3 p -101.93 -74.24 0.63 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.852 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.412 ' CB ' ' HB3' ' A' ' 10' ' ' GLN . 89.1 p -137.15 154.98 50.12 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.742 0.306 . . . . 0.0 111.198 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.8 mp -140.43 165.41 27.5 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.391 -179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.454 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 0.5 OUTLIER -131.27 119.34 21.64 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.827 179.783 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.3 mt -99.45 141.16 32.6 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.916 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.99 147.4 31.57 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.91 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.04 123.86 18.94 Favored Glycine 0 C--N 1.333 0.393 0 CA-C-N 115.958 -0.565 . . . . 0.0 113.331 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.2 t -140.26 88.65 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-O 120.791 0.329 . . . . 0.0 110.824 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.1 t 54.57 57.15 12.08 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.718 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.77 -11.02 25.62 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.621 2.214 . . . . 0.0 113.182 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.43 -57.09 13.8 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.586 0.231 . . . . 0.0 111.244 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -95.66 44.35 2.1 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.444 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 28.7 m -138.09 121.35 16.97 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.692 0.282 . . . . 0.0 111.034 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -105.26 -172.57 2.12 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.765 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.52 -35.66 65.89 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.335 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.448 ' O ' HG22 ' A' ' 41' ' ' VAL . 24.9 t-20 -54.86 -40.58 69.81 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.88 0.371 . . . . 0.0 110.087 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.15 -30.04 63.59 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.801 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.0 tt -63.37 -49.73 72.69 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.819 0.342 . . . . 0.0 110.692 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.448 HG22 ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -67.35 -52.18 44.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.728 179.767 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -54.72 -23.55 18.18 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.778 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.431 ' O ' ' HB3' ' A' ' 47' ' ' ASN . 4.6 tt -85.4 -22.95 28.14 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.878 0.371 . . . . 0.0 110.577 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -92.48 -50.21 5.74 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.949 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.451 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -89.33 -72.8 0.53 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 111.565 0.209 . . . . 0.0 111.565 -179.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.403 ' H ' ' HG3' ' A' ' 45' ' ' LYS . 5.8 m -49.46 -24.63 2.11 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.431 ' HB3' ' O ' ' A' ' 43' ' ' LEU . 10.1 t30 -106.1 -25.99 11.8 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -138.58 45.52 2.04 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.451 ' HB ' ' O ' ' A' ' 45' ' ' LYS . 10.6 p -104.42 152.41 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.168 0.508 . . . . 0.0 111.478 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.01 -40.48 1.05 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.674 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -79.94 -167.03 1.13 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.313 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.53 111.37 5.03 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.021 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.45 -25.25 80.06 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.275 1.983 . . . . 0.0 112.159 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.446 ' HA ' ' CG2' ' A' ' 57' ' ' VAL . 4.6 m-20 -92.37 8.52 38.12 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.035 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 pp -86.74 -27.4 23.67 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 122.289 -0.257 . . . . 0.0 111.068 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.96 -47.27 5.6 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.446 ' CG2' ' HA ' ' A' ' 54' ' ' ASP . 4.8 m -57.68 149.25 4.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-O 121.243 0.544 . . . . 0.0 111.598 -179.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -65.45 -56.42 12.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.739 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -173.83 -43.91 0.01 OUTLIER 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.402 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 78.0 p -87.5 12.45 12.31 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.406 ' HA2' ' CG1' ' A' ' 57' ' ' VAL . . . 58.21 22.31 49.66 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.673 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -108.86 -41.18 4.82 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.944 0.402 . . . . 0.0 110.582 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.6 p -119.87 -175.94 3.08 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.715 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.0 mt -111.07 157.06 20.41 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.857 0.361 . . . . 0.0 111.148 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.75 155.75 92.5 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.282 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.01 135.13 67.39 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.818 2.345 . . . . 0.0 112.404 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 134.4 -49.29 0.91 Allowed Glycine 0 C--N 1.331 0.284 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.299 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.0 mt -81.46 137.49 21.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-O 120.657 0.265 . . . . 0.0 111.176 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.83 103.69 13.19 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.529 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.4 m -83.25 130.41 35.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.609 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.3 mt -130.15 146.2 51.77 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.45 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 92' ' ' THR . 2.1 m -119.0 121.4 66.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.477 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 57.45 41.87 25.48 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.45 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 65.1 31.75 10.77 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.412 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 6.3 t -142.6 151.87 41.94 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.729 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -50.21 116.75 2.0 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.854 0.359 . . . . 0.0 111.535 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -84.78 -21.54 29.93 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.842 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -75.4 -27.64 59.14 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.602 0.239 . . . . 0.0 110.84 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 24.8 t -71.79 -40.84 69.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.014 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.1 m -74.3 -32.65 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.8 -46.91 0.05 OUTLIER Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.6 -0.809 . . . . 0.0 113.145 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.83 -54.25 1.66 Allowed Glycine 0 C--N 1.334 0.447 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.171 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -136.22 23.92 3.25 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.569 0.223 . . . . 0.0 111.363 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -132.61 17.08 4.35 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -77.99 120.65 23.14 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.668 0.271 . . . . 0.0 111.36 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.1 m -66.39 147.74 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.67 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.23 154.78 17.55 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.267 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -171.01 152.09 3.43 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.864 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -56.73 108.32 0.48 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.159 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 115.58 24.33 4.09 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.408 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -93.25 167.22 11.89 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.683 0.242 . . . . 0.0 110.5 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 94.9 m -141.43 111.67 6.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.817 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 14.3 p -122.78 121.25 62.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.115 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -123.83 155.87 37.21 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.447 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -132.19 104.34 6.72 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.927 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 28.5 mt -121.5 119.46 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.277 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.21 151.43 26.87 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.212 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.29 -46.68 0.08 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.672 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.55 91.42 2.3 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.753 0.311 . . . . 0.0 111.051 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -107.11 -28.03 10.23 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.488 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -152.51 -139.85 2.99 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.399 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.356 -1.247 . . . . 0.0 112.41 179.876 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 120.63 0.252 . . . . 0.0 111.44 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.7 p -108.99 152.31 25.15 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.372 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -110.66 -47.1 3.29 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.053 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 52.3 m80 69.49 166.47 0.28 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.45 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 35.0 p-10 -101.62 142.66 32.64 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.241 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -177.2 170.43 2.17 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.911 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.518 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 26.1 mm -127.75 152.83 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.794 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 19.3 m -113.66 95.29 5.26 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.775 0.322 . . . . 0.0 111.293 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.0 p -109.68 104.8 17.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.936 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -130.31 165.3 22.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.578 -179.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -117.51 161.17 20.03 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.17 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.36 155.66 39.12 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.431 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 72.38 -101.17 1.03 Allowed Glycine 0 C--N 1.335 0.51 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.26 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.72 27.35 3.52 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.684 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -95.71 -27.96 15.02 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.707 0.254 . . . . 0.0 111.505 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -58.21 -30.88 66.82 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.648 0.261 . . . . 0.0 111.282 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.9 mp -68.13 -8.56 39.41 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.989 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 60.4 mt -82.76 13.44 3.84 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -147.91 -66.16 0.25 Allowed 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -172.35 38.74 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.828 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.31 37.15 18.04 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.845 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -75.28 155.45 36.66 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.117 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 60.9 p -91.06 -69.54 0.73 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.106 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.7 p -144.59 154.4 42.81 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.95 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.6 mp -141.28 165.15 28.3 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.328 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.518 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 9.5 mt-30 -125.8 119.21 27.28 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.101 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.7 mt -99.45 142.08 31.4 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.565 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -122.65 127.96 50.01 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.623 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.18 174.25 17.33 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.819 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.5 m -103.58 -36.24 4.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.2 m -147.46 79.91 9.4 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-O 120.772 0.32 . . . . 0.0 111.367 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -67.4 -9.09 24.1 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.916 2.41 . . . . 0.0 113.113 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.49 -55.03 21.14 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.643 0.258 . . . . 0.0 111.142 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -99.03 38.68 3.0 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 121.121 -0.561 . . . . 0.0 112.327 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.8 m -121.87 146.33 47.2 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.881 0.372 . . . . 0.0 110.919 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -135.26 -173.16 3.25 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.694 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.2 tt -57.51 -41.87 81.69 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.278 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -56.19 -36.8 68.79 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.908 0.385 . . . . 0.0 110.18 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.77 -33.6 33.48 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.948 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.455 HD13 HG21 ' A' ' 7' ' ' ILE . 29.6 tp -65.41 -50.73 64.39 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.598 0.199 . . . . 0.0 110.707 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -56.91 -56.57 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.684 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -49.12 -33.22 11.43 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.345 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.34 -27.48 63.4 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.53 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -96.92 -38.42 9.82 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.429 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -81.99 -70.18 0.56 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.496 -179.52 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 m -52.41 -25.14 9.15 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -97.49 -37.29 10.03 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -142.45 58.73 1.45 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.429 ' HB ' ' O ' ' A' ' 45' ' ' LYS . 10.1 p -97.31 -34.92 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.407 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 73.32 -55.95 0.67 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 122.312 0.245 . . . . 0.0 110.644 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -91.72 -177.14 4.68 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.464 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 63.7 mtp85 -58.6 140.84 84.8 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-O 120.718 0.294 . . . . 0.0 111.501 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -81.45 -18.7 8.15 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.818 2.345 . . . . 0.0 113.03 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.72 6.83 29.42 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 52' ' ' ARG . 4.7 pp -90.62 -22.13 21.37 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.544 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.75 -47.44 4.82 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 111.566 0.21 . . . . 0.0 111.566 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.0 m -55.09 150.85 2.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 121.154 0.502 . . . . 0.0 111.489 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -65.64 -56.45 12.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.955 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -174.39 -44.68 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.183 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.9 t -83.47 9.9 10.14 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.688 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.15 23.61 47.85 Favored Glycine 0 C--N 1.34 0.763 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.812 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -110.78 -44.71 3.59 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.055 0.455 . . . . 0.0 110.484 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.2 t -115.1 168.23 10.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.088 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.4 mt -96.58 153.58 17.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.826 0.346 . . . . 0.0 111.232 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.425 ' HD3' ' N ' ' A' ' 67' ' ' GLY . 0.5 OUTLIER -57.01 155.48 15.75 Favored Pre-proline 0 N--CA 1.465 0.306 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.571 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.95 -35.97 91.66 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.142 2.562 . . . . 0.0 112.689 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.425 ' N ' ' HD3' ' A' ' 65' ' ' ARG . . . -45.79 -36.68 6.67 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-N 115.844 -0.616 . . . . 0.0 113.327 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.3 mt -102.03 138.33 26.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 117.032 0.416 . . . . 0.0 110.925 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 mt -105.75 111.13 23.68 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.1 m -80.76 125.63 39.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.208 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.8 mt -123.73 126.79 47.15 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.318 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 92' ' ' THR . 28.2 t -105.11 101.94 13.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.579 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 56.61 55.7 6.19 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.123 0.487 . . . . 0.0 110.867 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.9 m 60.87 41.42 14.47 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.499 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 53.0 t -159.74 119.36 2.92 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.657 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -47.54 126.69 10.25 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.474 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.83 -28.56 67.67 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.965 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -69.96 -25.31 63.57 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.067 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 43.9 t -58.66 -30.51 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.789 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.4 m -110.74 -37.38 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.961 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -148.52 -62.06 0.01 OUTLIER Glycine 0 C--N 1.337 0.601 0 C-N-CA 120.629 -0.796 . . . . 0.0 113.066 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 112.06 -63.34 0.28 Allowed Glycine 0 C--N 1.331 0.277 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.293 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.37 23.2 3.75 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 111.424 0.157 . . . . 0.0 111.424 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -138.02 24.3 2.8 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -70.95 118.8 14.19 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 120.75 0.309 . . . . 0.0 111.396 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.6 m -62.4 165.89 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 116.143 -0.481 . . . . 0.0 112.131 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.46 153.57 31.87 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.571 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -156.85 32.9 0.3 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.678 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 64.66 111.39 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.907 0.384 . . . . 0.0 111.267 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.67 31.63 5.69 Favored Glycine 0 CA--C 1.517 0.217 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.431 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -89.85 112.23 23.5 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.792 0.329 . . . . 0.0 110.577 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.425 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 61.8 m -81.72 130.61 35.12 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.592 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.8 p -139.5 126.73 24.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.875 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -126.75 150.75 48.93 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.194 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -120.55 105.05 10.45 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.333 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.5 mt -112.0 109.47 28.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.346 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.2 p -77.32 150.97 35.16 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.571 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.4 p -150.33 -63.78 0.2 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.133 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.2 tt -89.78 117.57 28.72 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.991 0.424 . . . . 0.0 111.043 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 24.0 p80 -124.2 179.73 4.77 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.952 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 101.9 -54.26 0.78 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.28 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.284 -1.287 . . . . 0.0 112.527 179.834 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 mmt . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.1 p -72.62 153.57 41.18 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.78 0.324 . . . . 0.0 111.656 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -115.36 -45.3 2.93 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.201 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.1 m170 -75.05 155.84 36.79 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.951 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 82.84 -26.15 0.14 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.119 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 46.2 m170 -112.13 145.3 40.04 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.64 0.257 . . . . 0.0 111.241 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 2.0 mp -103.71 138.34 28.57 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.002 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 88.5 m -86.55 93.76 9.26 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.891 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.4 p -116.6 106.48 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 120.833 0.349 . . . . 0.0 111.422 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.454 ' HB2' ' O ' ' A' ' 23' ' ' THR . 5.8 pm0 -127.12 170.93 11.85 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.976 0.417 . . . . 0.0 111.872 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.43 ' CB ' ' HA ' ' A' ' 16' ' ' GLU . 89.1 m-85 -134.83 146.74 49.58 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.899 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -167.4 113.18 0.73 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.081 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.17 45.6 0.57 Allowed Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.632 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.99 14.51 82.24 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.562 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -107.23 -25.27 11.58 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 117.523 0.662 . . . . 0.0 111.52 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.43 ' HA ' ' CB ' ' A' ' 11' ' ' PHE . 0.9 OUTLIER -60.53 -22.09 63.22 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.4 mp -68.63 -6.69 27.28 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.2 mt -85.59 12.13 9.31 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -146.98 -63.56 0.29 Allowed 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -175.94 36.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.055 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 50.79 35.36 11.93 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.09 0.471 . . . . 0.0 110.672 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -78.84 167.69 20.8 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.066 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.454 ' O ' ' HB2' ' A' ' 10' ' ' GLN . 38.1 p -100.57 -31.52 11.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.4 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 88.7 p -169.92 146.78 3.2 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.636 0.255 . . . . 0.0 111.302 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 tp -133.13 166.16 23.08 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.436 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.471 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 32.9 mt-30 -132.03 116.19 16.77 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.688 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.0 mt -95.28 139.84 31.03 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.937 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -98.39 107.13 19.52 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.613 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.01 166.78 52.11 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 121.154 -0.546 . . . . 0.0 112.967 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.0 m -132.56 -47.62 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.0 t -135.79 87.6 24.97 Favored Pre-proline 0 CA--C 1.53 0.198 0 CA-C-O 120.6 0.238 . . . . 0.0 110.851 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.74 -24.43 30.33 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.824 2.35 . . . . 0.0 113.026 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.64 -59.87 4.75 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.324 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -94.64 42.28 2.45 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.755 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 90.5 m -141.29 129.47 22.18 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.849 0.357 . . . . 0.0 111.062 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -138.85 -168.84 2.5 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.666 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.7 tt -56.69 -40.27 75.31 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.146 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.42 ' O ' HG23 ' A' ' 41' ' ' VAL . 45.7 t30 -58.02 -36.72 73.12 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.74 -32.15 59.54 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.029 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.2 mt -64.0 -49.58 71.91 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.815 0.34 . . . . 0.0 110.713 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -64.6 -53.53 41.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.009 179.793 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -56.18 -27.34 54.14 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.877 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 tp -84.56 -14.6 48.4 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 120.746 0.308 . . . . 0.0 110.914 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.83 -51.73 4.16 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.916 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.4 ' CE ' ' HB ' ' A' ' 41' ' ' VAL . 1.3 pttt -86.16 -69.52 0.66 Allowed 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.9 m -49.16 -31.54 8.52 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.594 0.235 . . . . 0.0 111.395 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -76.2 -33.85 59.28 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.452 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -130.95 -71.56 0.57 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.4 p 34.49 89.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.97 -32.02 64.93 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.038 179.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -97.13 -161.69 0.89 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.533 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.8 mmt180 -66.42 125.23 90.05 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-O 120.599 0.238 . . . . 0.0 111.207 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.53 -28.16 17.95 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.475 2.117 . . . . 0.0 112.535 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.22 7.96 43.45 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.7 pp -82.39 -12.85 57.65 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.61 -45.29 4.46 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 111.636 0.236 . . . . 0.0 111.636 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.425 ' CG1' ' HA2' ' A' ' 61' ' ' GLY . 1.4 m -59.3 149.51 6.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.163 0.506 . . . . 0.0 111.497 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -66.8 -57.99 5.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.764 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -172.44 -44.87 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.315 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.6 p -79.38 4.09 16.38 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.635 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.425 ' HA2' ' CG1' ' A' ' 57' ' ' VAL . . . 60.24 28.18 66.46 Favored Glycine 0 C--N 1.339 0.705 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.574 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.0 tp60 -121.29 -46.1 2.31 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.816 0.341 . . . . 0.0 110.604 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.7 t -114.53 140.61 48.62 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.633 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.8 mt -67.92 154.58 41.29 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.894 0.378 . . . . 0.0 111.315 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.62 158.5 87.25 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.239 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.69 131.92 45.07 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.969 2.446 . . . . 0.0 112.241 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 138.02 -48.49 0.88 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.315 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.413 HG22 ' HB3' ' A' ' 95' ' ' PHE . 5.3 mt -88.29 144.54 8.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 120.794 0.331 . . . . 0.0 111.154 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.8 mt -113.61 99.0 7.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.777 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.5 m -78.67 131.7 33.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.882 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.4 mt -130.16 127.47 39.78 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.209 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 92' ' ' THR . 39.1 t -103.72 119.14 51.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.354 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 59.5 53.29 5.19 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.968 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.9 m 53.34 35.98 21.7 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.576 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 8.2 t -150.8 153.95 36.39 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.139 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -49.23 124.18 8.62 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.681 0.277 . . . . 0.0 111.315 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.38 -20.01 66.2 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.578 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -76.01 -29.77 58.27 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.601 0.238 . . . . 0.0 110.685 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 24.4 t -70.78 -42.6 77.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.056 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.489 ' HB ' ' CD1' ' A' ' 85' ' ' TYR . 17.9 m -68.21 -28.79 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 146.02 36.65 0.06 OUTLIER Glycine 0 C--N 1.337 0.625 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.741 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 53.69 -99.35 0.05 OUTLIER Glycine 0 C--N 1.337 0.593 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.915 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.89 29.16 6.92 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.786 0.327 . . . . 0.0 110.913 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -117.66 19.89 13.68 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.939 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.489 ' CD1' ' HB ' ' A' ' 80' ' ' VAL . 15.1 t80 -81.12 120.66 25.13 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.743 0.306 . . . . 0.0 111.358 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.9 m -75.59 158.69 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.477 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.45 150.28 21.32 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.078 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -147.9 30.52 0.88 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.412 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 59.48 95.99 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.962 0.41 . . . . 0.0 111.653 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 118.75 28.92 1.97 Allowed Glycine 0 CA--C 1.52 0.376 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.694 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -78.19 166.1 23.15 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.769 0.318 . . . . 0.0 110.88 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 98.7 m -141.33 113.2 7.8 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.105 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.8 p -124.94 136.43 60.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.856 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -135.11 153.12 52.12 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.411 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.413 ' HB3' HG22 ' A' ' 68' ' ' ILE . 89.8 m-85 -125.59 104.61 8.49 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.438 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.1 mt -116.95 117.26 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.021 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.12 125.56 34.22 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.751 0.31 . . . . 0.0 111.19 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.9 p -137.58 -58.36 0.68 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.279 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 33.1 tp -67.87 155.96 38.22 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.242 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -139.87 -65.15 0.47 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.959 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -93.4 -62.39 1.1 Allowed Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.316 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.245 -1.308 . . . . 0.0 112.825 -179.766 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 120.552 0.215 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.9 t -164.39 97.94 0.8 Allowed 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.88 0.371 . . . . 0.0 110.81 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.97 105.84 4.52 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.651 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 47.92 -169.66 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.599 0.562 . . . . 0.0 112.275 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -130.57 153.02 49.31 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.972 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -167.36 169.01 12.71 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.814 0.34 . . . . 0.0 111.576 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.6 mm -132.11 136.64 56.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.224 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 89.0 m -86.44 109.23 18.91 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.892 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.0 p -129.08 112.71 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.286 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.417 ' HG2' ' HG2' ' A' ' 94' ' ' GLU . 9.0 pm0 -137.26 166.69 23.17 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.842 0.353 . . . . 0.0 111.643 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.435 ' CB ' ' HA ' ' A' ' 16' ' ' GLU . 89.4 m-85 -134.37 148.88 50.77 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.242 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -164.21 128.91 2.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.967 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.92 40.71 2.25 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.72 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.55 19.55 79.17 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 121.021 -0.609 . . . . 0.0 113.388 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.0 -12.14 14.24 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 117.279 0.539 . . . . 0.0 111.849 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.435 ' HA ' ' CB ' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -69.3 -15.5 63.36 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.701 0.259 . . . . 0.0 111.701 179.867 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 mt -69.03 -5.47 22.09 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.0 mt -81.6 13.65 2.99 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.476 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 2.6 t80 -153.57 -58.49 0.13 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.698 0.285 . . . . 0.0 110.522 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -179.27 36.37 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.136 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.92 33.9 7.2 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.889 0.376 . . . . 0.0 110.889 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -83.73 166.56 17.95 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.014 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 81.6 p -88.14 -70.66 0.62 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.825 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 83.3 p -136.73 156.05 49.03 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.717 0.294 . . . . 0.0 111.306 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.4 mp -140.44 164.57 29.77 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.442 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.23 112.03 17.67 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.523 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.8 mt -96.84 130.32 44.14 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.9 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -122.81 89.95 3.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.94 0.4 . . . . 0.0 110.81 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.78 165.83 54.37 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.759 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.7 t -92.96 -45.91 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-O 120.468 0.175 . . . . 0.0 111.309 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.3 m -131.98 72.27 79.48 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-O 120.945 0.403 . . . . 0.0 111.367 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.424 ' HB2' ' HA ' ' A' ' 88' ' ' ASN . 5.8 Cg_endo -86.19 19.11 1.45 Allowed 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.137 2.558 . . . . 0.0 113.217 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 62.5 m -59.75 -58.61 7.84 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.562 0.22 . . . . 0.0 111.063 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.58 37.22 3.54 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.489 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 54.4 m -105.02 136.77 43.89 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.922 0.391 . . . . 0.0 111.088 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -125.76 -172.35 2.58 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.744 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.3 tt -54.95 -43.59 73.54 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -57.15 -35.33 69.39 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.906 0.384 . . . . 0.0 110.124 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.22 -33.21 36.53 Favored Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.951 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 73.1 mt -63.56 -51.49 65.17 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.756 0.312 . . . . 0.0 110.624 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -57.36 -56.79 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.812 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -49.46 -34.66 17.4 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.329 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.92 -27.62 65.93 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.846 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.1 pp -96.64 -38.14 10.06 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.421 ' CA ' ' HB ' ' A' ' 49' ' ' VAL . 2.8 pttt -85.59 -62.13 1.6 Allowed 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.9 m -58.1 -21.64 47.08 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.118 -0.233 . . . . 0.0 111.61 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -98.75 -36.64 9.76 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -150.23 54.42 0.92 Allowed 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.421 ' HB ' ' CA ' ' A' ' 45' ' ' LYS . 9.4 p -80.91 -43.88 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 121.216 -0.194 . . . . 0.0 111.521 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.476 ' HG3' ' O ' ' A' ' 19' ' ' PHE . 0.6 OUTLIER 67.86 -59.06 0.43 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 122.601 0.36 . . . . 0.0 110.608 -179.126 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.22 -168.55 0.52 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.208 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.429 ' HB3' ' HB3' ' A' ' 55' ' ' LEU . 3.5 ttt180 -69.16 128.33 92.62 Favored Pre-proline 0 CA--C 1.529 0.173 0 CA-C-O 120.625 0.25 . . . . 0.0 111.471 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.72 -23.73 19.06 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.311 2.007 . . . . 0.0 112.492 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -93.08 7.38 44.42 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.429 ' HB3' ' HB3' ' A' ' 52' ' ' ARG . 3.0 pp -85.67 -21.06 28.54 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 121.117 -0.233 . . . . 0.0 111.072 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.03 -48.78 3.95 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 111.477 0.177 . . . . 0.0 111.477 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.457 ' CG1' ' HA2' ' A' ' 61' ' ' GLY . 2.8 m -62.72 144.73 14.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 121.052 0.453 . . . . 0.0 111.14 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.417 ' HA ' ' HB3' ' A' ' 65' ' ' ARG . 10.4 t70 -63.72 -60.23 3.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.596 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.8 tm0? -168.85 -44.66 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.309 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.1 p -79.55 2.71 21.21 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.534 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.457 ' HA2' ' CG1' ' A' ' 57' ' ' VAL . . . 62.16 28.41 70.64 Favored Glycine 0 C--N 1.34 0.761 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.413 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -124.05 -40.46 2.28 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.575 0.226 . . . . 0.0 111.464 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.7 t -114.09 135.8 53.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.636 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.06 132.9 46.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.869 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.417 ' HB3' ' HA ' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -58.89 155.44 31.74 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.419 -179.793 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -58.62 138.07 83.7 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.819 2.346 . . . . 0.0 112.402 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 136.85 -46.74 1.0 Allowed Glycine 0 C--N 1.332 0.336 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.195 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.4 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 5.4 mt -94.93 127.38 46.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 120.697 0.284 . . . . 0.0 111.018 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.9 mp -98.3 102.94 14.83 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.849 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.4 m -76.59 133.98 29.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.744 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.1 mt -129.15 141.98 51.01 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.487 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 92' ' ' THR . 19.6 t -113.68 111.55 36.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.586 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.0 m120 57.67 54.04 6.69 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.989 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.8 t 57.23 49.65 13.03 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.98 0.419 . . . . 0.0 111.186 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 50.6 t -162.17 146.21 12.19 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.671 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -50.83 121.71 6.34 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.46 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.99 -22.8 31.25 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.735 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -74.18 -30.58 62.3 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-O 120.555 0.217 . . . . 0.0 110.888 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 45.2 t -63.69 -40.59 89.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.127 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 26.9 m -79.48 -36.79 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.505 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -166.66 -51.55 0.03 OUTLIER Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.64 -0.791 . . . . 0.0 113.128 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 100.26 -50.97 1.05 Allowed Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.425 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.4 ptt? -144.11 25.51 1.57 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.527 0.203 . . . . 0.0 111.38 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -140.48 23.59 2.31 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -80.78 103.4 10.59 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.771 0.32 . . . . 0.0 110.774 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.6 m -72.63 145.72 11.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.836 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.12 165.39 35.79 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.012 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.424 ' HA ' ' HB2' ' A' ' 32' ' ' PRO . 9.9 t-20 -134.69 -64.78 0.66 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.084 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -146.59 132.37 18.99 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.749 0.309 . . . . 0.0 111.067 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.96 21.24 36.66 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 121.104 -0.57 . . . . 0.0 112.89 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -86.23 163.98 17.44 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.801 0.334 . . . . 0.0 111.129 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 90.8 m -138.88 130.28 27.14 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.922 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.6 p -140.54 124.07 17.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.696 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.417 ' HG2' ' HG2' ' A' ' 10' ' ' GLN . 14.0 mt-10 -126.7 137.17 53.22 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.4 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.413 ' HB2' ' CD2' ' A' ' 11' ' ' PHE . 3.9 m-85 -107.42 104.81 14.48 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.562 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 28.3 mt -109.04 104.87 17.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.148 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . 41.9 t -85.01 140.13 31.26 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.04 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 34.2 p -139.79 -55.25 0.56 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.946 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.86 81.1 8.69 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.956 0.408 . . . . 0.0 110.751 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -96.51 112.85 24.44 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.901 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 111.28 -134.51 12.19 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.321 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.468 -1.184 . . . . 0.0 112.564 179.965 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mtt . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 111.543 0.201 . . . . 0.0 111.543 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.26 81.77 8.27 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.942 0.401 . . . . 0.0 111.267 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -108.34 -39.69 5.37 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.068 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 72.99 135.42 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.151 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -73.45 129.59 38.32 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.914 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 14.0 p-80 -169.47 143.95 2.91 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.134 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 27.8 mm -117.49 152.19 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.11 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.1 m -117.15 102.33 9.21 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.05 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.7 p -128.99 112.43 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 120.788 0.328 . . . . 0.0 111.765 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.63 165.2 22.27 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.982 0.42 . . . . 0.0 111.57 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.437 ' CB ' ' HA ' ' A' ' 16' ' ' GLU . 26.0 m-85 -126.41 131.52 51.71 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.199 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.13 151.39 47.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.503 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.19 -94.97 2.03 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.688 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -137.24 28.71 2.77 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.82 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.83 -27.93 9.04 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.736 0.268 . . . . 0.0 111.61 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.437 ' HA ' ' CB ' ' A' ' 11' ' ' PHE . 0.6 OUTLIER -57.35 -30.87 65.19 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.524 0.202 . . . . 0.0 111.226 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.72 -13.86 62.65 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.857 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 32.3 mt -84.9 13.34 6.05 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -143.07 -61.92 0.42 Allowed 'General case' 0 CA--C 1.523 -0.071 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -178.81 36.37 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.103 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 50.37 31.7 5.63 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.962 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.65 173.47 12.41 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.104 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.4 p -102.46 -75.82 0.59 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.764 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 92.5 p -131.46 156.91 44.82 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.783 0.325 . . . . 0.0 111.372 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.19 159.0 43.17 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.259 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.444 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 2.6 mt-30 -129.87 129.75 44.33 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.971 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.9 mt -110.11 139.58 45.1 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.688 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -104.95 112.2 25.24 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.636 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -121.47 136.73 11.29 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.617 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.8 t -76.83 -38.83 29.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 120.554 0.216 . . . . 0.0 111.156 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.2 p -155.63 76.09 4.97 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-O 121.312 0.577 . . . . 0.0 110.931 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -78.93 4.67 6.3 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.817 2.345 . . . . 0.0 113.368 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 80.2 m -56.43 -35.38 67.77 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.691 0.281 . . . . 0.0 110.95 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -91.91 26.17 13.88 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.868 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.7 m -128.03 128.35 44.81 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.829 0.315 . . . . 0.0 110.68 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -104.28 175.76 5.38 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.029 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.2 tt -57.79 -41.93 83.1 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.682 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -54.98 -36.87 65.85 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.943 0.401 . . . . 0.0 110.377 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.13 -31.15 43.7 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.196 178.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 25.1 tp -70.08 -51.87 28.32 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.798 0.299 . . . . 0.0 110.921 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.436 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -57.46 -57.24 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.895 179.787 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -51.39 -28.81 13.64 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.609 -0.268 . . . . 0.0 111.434 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.0 tp -78.12 -27.06 48.22 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 4.6 pp -96.86 -37.15 10.35 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.463 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 0.9 OUTLIER -86.01 -69.24 0.68 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.418 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.9 m -54.66 -23.74 18.65 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -103.97 -20.51 13.85 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -148.06 48.21 1.06 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.463 ' HB ' ' O ' ' A' ' 45' ' ' LYS . 8.1 p -94.06 132.07 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 120.719 0.295 . . . . 0.0 111.222 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -115.4 32.42 6.07 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.276 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -163.17 -171.86 2.79 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.502 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.419 ' HB3' ' HB3' ' A' ' 55' ' ' LEU . 1.4 ttt180 -65.1 110.78 4.66 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.782 -0.19 . . . . 0.0 110.929 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.29 -21.65 67.72 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.345 2.03 . . . . 0.0 112.692 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -91.29 7.66 39.79 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.419 ' HB3' ' HB3' ' A' ' 52' ' ' ARG . 2.5 pp -93.56 -18.97 21.64 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.486 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.53 -48.52 4.12 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.601 0.223 . . . . 0.0 111.601 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.433 ' CG1' ' HA2' ' A' ' 61' ' ' GLY . 3.4 m -57.14 148.32 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 121.101 0.477 . . . . 0.0 111.591 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -69.57 -58.82 3.47 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.712 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -166.91 -48.95 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.517 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.3 p -77.42 6.52 6.79 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.715 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.433 ' HA2' ' CG1' ' A' ' 57' ' ' VAL . . . 57.77 27.92 59.69 Favored Glycine 0 C--N 1.339 0.707 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.637 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -122.18 -42.09 2.39 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.589 0.233 . . . . 0.0 110.943 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 49.9 p -117.21 136.24 53.2 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.426 HD11 HG13 ' A' ' 68' ' ' ILE . 6.3 mt -66.71 155.54 37.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.845 0.355 . . . . 0.0 111.142 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.53 160.14 74.06 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.47 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -51.25 -33.39 44.75 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 123.167 2.578 . . . . 0.0 112.798 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -53.43 -32.13 44.64 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.733 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.426 HG13 HD11 ' A' ' 64' ' ' LEU . 19.5 mm -83.46 151.47 3.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 120.822 0.344 . . . . 0.0 110.793 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.83 99.83 5.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.815 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.9 m -84.55 122.12 37.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.731 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.5 mt -131.3 137.55 48.86 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.174 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.3 m -109.54 118.95 57.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.784 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 24.2 m-20 64.23 -78.57 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.938 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -151.55 32.01 0.57 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.077 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 49.7 t -157.32 146.51 20.02 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.852 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.5 130.6 32.18 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.362 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.3 -23.29 57.34 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.687 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.412 ' HA ' ' CA ' ' A' ' 82' ' ' GLY . 3.2 mt-10 -74.38 -18.69 60.64 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.141 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 38.2 t -63.14 -35.74 73.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 120.661 0.267 . . . . 0.0 110.875 179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.9 m -98.88 -37.66 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.789 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -152.61 -60.19 0.01 OUTLIER Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.594 -0.812 . . . . 0.0 113.222 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.412 ' CA ' ' HA ' ' A' ' 78' ' ' GLU . . . 100.72 -51.22 1.0 Allowed Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.253 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.02 4.54 5.91 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -123.7 25.56 8.07 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -74.28 88.72 2.03 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.875 0.369 . . . . 0.0 110.81 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.4 m -61.54 139.6 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.664 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 33' ' ' THR . 7.1 mp -90.52 168.59 11.71 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.073 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 37.1 p30 -168.33 43.58 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.408 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 64.36 96.43 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.151 0.501 . . . . 0.0 110.99 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 112.96 28.25 3.45 Favored Glycine 0 CA--C 1.521 0.433 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.393 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.52 144.12 26.28 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.723 0.297 . . . . 0.0 110.715 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 88.5 m -123.25 133.95 54.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.85 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.14 130.52 18.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.996 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -123.17 155.4 37.15 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.239 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -132.41 108.08 8.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.493 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 33.6 mt -113.94 123.45 69.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.115 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.65 130.88 38.15 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.263 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 71.5 p -126.14 -50.95 1.55 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.98 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.2 tt -85.29 128.58 34.74 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.107 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -108.61 -36.22 6.24 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.193 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -130.32 169.97 21.05 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.429 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.518 -1.157 . . . . 0.0 112.571 179.897 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.42 ' O ' ' HB2' ' A' ' 2' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 120.387 0.137 . . . . 0.0 111.054 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.42 ' HB2' ' O ' ' A' ' 1' ' ' MET . 3.2 m 68.51 149.03 0.06 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.081 0.467 . . . . 0.0 111.673 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 32.5 p-10 -162.86 48.65 0.16 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.936 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.97 165.18 28.17 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.531 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -89.11 124.85 34.7 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.222 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -167.86 102.47 0.47 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.656 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.0 mp -91.27 126.06 43.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.134 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.447 ' HB ' ' CG2' ' A' ' 92' ' ' THR . 0.2 OUTLIER -85.76 96.11 9.62 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.255 179.461 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.7 p -115.72 106.0 19.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.953 0.406 . . . . 0.0 111.272 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.43 ' HB3' ' CB ' ' A' ' 24' ' ' SER . 0.0 OUTLIER -136.38 155.59 49.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.053 0.454 . . . . 0.0 111.375 179.74 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -118.89 138.66 52.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.742 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -92.03 -178.67 5.06 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.185 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.61 97.18 0.08 OUTLIER Glycine 0 C--N 1.335 0.495 0 C-N-CA 121.133 -0.556 . . . . 0.0 112.687 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 138.29 -33.28 2.25 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.733 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.04 9.04 24.25 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -83.92 -37.43 22.35 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.584 0.231 . . . . 0.0 111.426 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.0 mp -69.74 -4.6 20.51 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.7 mt -88.94 13.69 12.21 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -146.73 -61.94 0.3 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.702 0.286 . . . . 0.0 110.326 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -178.07 36.34 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.076 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.51 33.29 7.66 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.927 0.394 . . . . 0.0 110.822 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -80.19 174.47 11.56 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.715 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 79.7 p -110.66 -69.68 0.85 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.06 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.43 ' CB ' ' HB3' ' A' ' 10' ' ' GLN . 59.3 p -141.64 162.99 34.12 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.691 0.281 . . . . 0.0 111.34 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -150.98 165.33 34.05 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.258 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.12 101.02 5.85 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.675 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.4 mt -83.01 142.09 31.6 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.696 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -111.31 101.6 10.06 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.841 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -94.66 -179.12 37.9 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.823 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.9 m -137.12 -47.84 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 120.555 0.217 . . . . 0.0 111.28 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.3 m -137.58 56.41 11.57 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-O 120.755 0.312 . . . . 0.0 111.067 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.447 ' HB2' ' CB ' ' A' ' 87' ' ' LEU . 88.9 Cg_endo -82.12 8.96 4.18 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.834 2.356 . . . . 0.0 113.445 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 35.4 m -55.38 -36.48 66.42 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.612 0.244 . . . . 0.0 110.848 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -93.13 29.74 7.84 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.811 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.2 m -132.75 135.58 45.82 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.659 0.266 . . . . 0.0 110.564 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -111.83 -176.39 2.92 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.946 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.9 tt -54.32 -37.84 65.3 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.558 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.43 ' O ' HG21 ' A' ' 41' ' ' VAL . 51.5 t30 -57.77 -35.19 70.42 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.904 0.383 . . . . 0.0 110.011 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.55 -32.96 58.98 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.583 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.468 ' HG ' HD13 ' A' ' 87' ' ' LEU . 7.8 mt -64.76 -53.15 51.58 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.718 0.295 . . . . 0.0 110.527 179.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.43 HG21 ' O ' ' A' ' 38' ' ' ASN . 0.2 OUTLIER -57.48 -56.93 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.023 179.667 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -49.23 -30.8 7.58 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.654 0.264 . . . . 0.0 111.489 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.2 tp -70.76 -31.0 67.65 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 2.9 pp -97.13 -42.57 7.79 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.77 -68.46 0.68 Allowed 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -178.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.5 m -50.19 -29.68 9.86 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.422 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -77.31 -36.67 53.87 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.434 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -127.89 -68.26 0.78 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.527 ' O ' HG12 ' A' ' 49' ' ' VAL . 13.8 p 37.77 66.88 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 121.474 0.654 . . . . 0.0 111.766 -179.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.26 -30.81 62.92 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.088 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.404 ' HB3' HD23 ' A' ' 55' ' ' LEU . 0.4 OUTLIER -92.97 -164.84 1.23 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.881 179.271 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.09 135.03 91.58 Favored Pre-proline 0 N--CA 1.462 0.144 0 CA-C-O 120.64 0.257 . . . . 0.0 111.142 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -76.23 -28.45 7.22 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.369 2.046 . . . . 0.0 112.475 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -92.89 9.31 35.95 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.404 HD23 ' HB3' ' A' ' 51' ' ' GLU . 2.6 pp -82.94 -28.2 30.02 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 122.317 -0.239 . . . . 0.0 111.006 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.07 -49.19 4.38 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.445 ' CG1' ' HA2' ' A' ' 61' ' ' GLY . 6.2 m -62.42 146.8 12.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 121.101 0.477 . . . . 0.0 111.451 -179.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -67.21 -57.65 6.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.574 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -169.93 -45.03 0.02 OUTLIER 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.496 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.4 p -77.78 0.63 22.96 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.571 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.445 ' HA2' ' CG1' ' A' ' 57' ' ' VAL . . . 63.43 22.86 66.08 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.388 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -120.27 -38.32 2.93 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.749 0.309 . . . . 0.0 111.1 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.9 t -118.99 132.39 56.06 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.2 mt -67.15 153.81 42.76 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.98 0.419 . . . . 0.0 111.36 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -74.4 161.35 78.47 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.015 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -61.09 123.23 12.48 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.77 2.313 . . . . 0.0 112.188 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 154.01 -45.54 0.56 Allowed Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.4 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.6 mt -96.76 135.35 31.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 120.763 0.316 . . . . 0.0 111.068 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.3 tp -106.05 108.87 20.61 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.518 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.3 m -77.66 129.07 37.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.446 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.5 mt -126.09 128.12 46.86 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.88 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 92' ' ' THR . 4.4 m -117.31 122.4 69.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.073 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 55.24 46.31 23.97 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.52 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.3 m 61.96 30.23 18.0 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.494 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 31.1 t -153.01 130.25 11.23 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.805 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -46.44 130.41 10.91 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.899 0.381 . . . . 0.0 111.536 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.29 -21.12 59.88 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.133 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.408 ' HA ' ' CA ' ' A' ' 82' ' ' GLY . 1.7 mt-10 -73.31 -28.3 62.01 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-O 120.577 0.227 . . . . 0.0 110.918 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 43.5 t -64.93 -33.78 65.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.053 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.4 m -100.92 -37.47 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -140.01 -74.64 0.05 OUTLIER Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.096 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.408 ' CA ' ' HA ' ' A' ' 78' ' ' GLU . . . 107.81 85.11 1.72 Allowed Glycine 0 C--N 1.331 0.302 0 C-N-CA 121.155 -0.545 . . . . 0.0 112.185 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.9 mmt 58.4 23.49 10.64 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.679 0.276 . . . . 0.0 111.394 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -147.1 24.92 1.14 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.336 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -74.94 114.9 13.95 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.693 0.283 . . . . 0.0 110.95 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.7 m -65.12 140.29 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.693 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.468 HD13 ' HG ' ' A' ' 40' ' ' LEU . 2.9 mp -78.61 168.58 19.56 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.433 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -165.3 42.55 0.07 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.232 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 54.35 88.52 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.068 0.461 . . . . 0.0 111.404 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 117.94 26.64 2.71 Favored Glycine 0 CA--C 1.523 0.532 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.895 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -78.58 150.61 32.74 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-O 120.819 0.342 . . . . 0.0 110.846 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.447 ' CG2' ' HB ' ' A' ' 8' ' ' THR . 96.8 m -120.99 129.94 53.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.451 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.15 136.68 25.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.22 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -134.09 151.56 51.44 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.389 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -123.73 104.72 9.16 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.39 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 14.9 mt -115.14 116.96 54.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.11 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 68.0 m -76.17 82.37 2.98 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.911 0.386 . . . . 0.0 110.739 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -75.11 -68.74 0.52 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.244 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.3 tp -77.47 134.74 38.28 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.756 0.312 . . . . 0.0 110.824 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -92.22 -41.0 10.67 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.089 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 179.52 143.98 5.67 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.727 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.371 -1.238 . . . . 0.0 112.585 179.955 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ptp . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 120.672 0.272 . . . . 0.0 111.336 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.2 m -77.87 -51.96 9.63 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.738 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 56.95 33.89 23.99 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.252 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -88.56 179.39 6.29 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.047 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.77 105.79 17.98 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.013 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.408 ' CD2' ' HG2' ' A' ' 26' ' ' GLN . 1.1 m170 -175.36 104.68 0.08 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.981 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 25.1 mt -88.97 117.18 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-O 120.858 0.361 . . . . 0.0 111.103 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 37.6 m -82.26 112.4 19.22 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.368 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.7 105.83 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-O 120.907 0.385 . . . . 0.0 111.129 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -130.39 171.62 12.75 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.82 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.456 ' HB2' ' HB3' ' A' ' 16' ' ' GLU . 91.1 m-85 -128.87 151.36 49.71 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.18 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -148.97 130.88 15.21 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.592 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.83 -107.73 3.55 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.287 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -119.34 30.88 5.64 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 121.033 -0.604 . . . . 0.0 112.439 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -108.63 -31.29 7.82 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 111.493 0.183 . . . . 0.0 111.493 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.456 ' HB3' ' HB2' ' A' ' 11' ' ' PHE . 8.6 pm0 -63.68 -30.82 71.88 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.563 0.22 . . . . 0.0 111.206 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 mp -71.57 -7.9 50.63 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.749 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.44 ' HA ' ' HB2' ' A' ' 51' ' ' GLU . 13.3 mt -85.7 13.73 6.75 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -146.74 -61.8 0.3 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.727 0.299 . . . . 0.0 110.228 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -177.31 36.93 0.0 OUTLIER 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.051 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.3 mptt 50.93 33.71 9.27 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.904 0.383 . . . . 0.0 110.997 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -79.18 145.3 33.74 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.833 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.0 p -78.22 -68.69 0.61 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.843 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 99.4 p -137.93 164.53 28.77 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.826 0.346 . . . . 0.0 111.413 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.34 155.59 47.58 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.142 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.408 ' HG2' ' CD2' ' A' ' 6' ' ' HIS . 0.1 OUTLIER -133.36 116.93 16.67 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.028 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.2 mt -103.5 133.89 47.78 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.57 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -124.85 144.0 50.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.436 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -165.66 -172.31 32.9 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.922 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.7 m -118.01 -43.93 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 120.548 0.213 . . . . 0.0 111.443 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 18.1 t -126.56 56.33 16.75 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-O 120.976 0.417 . . . . 0.0 111.16 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -78.49 2.46 8.09 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 122.803 2.336 . . . . 0.0 113.016 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.96 170.36 4.41 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.707 0.289 . . . . 0.0 110.916 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 76.26 25.35 66.28 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.408 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 51.3 m -136.73 131.1 33.02 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 120.508 0.194 . . . . 0.0 110.591 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -108.21 -177.9 3.46 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.855 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.0 tt -56.47 -44.98 81.1 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.339 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -56.01 -37.97 69.87 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.37 -31.08 59.53 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.166 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 49.3 mt -64.87 -50.87 64.9 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.772 0.32 . . . . 0.0 110.566 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.414 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -64.78 -55.36 21.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.251 179.817 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -52.46 -22.98 5.36 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.6 tt -86.79 -26.33 24.17 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 3.4 pp -93.0 -45.37 7.96 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.243 0.461 . . . . 0.0 112.243 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.89 -55.82 6.82 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 121.014 -0.274 . . . . 0.0 111.513 -179.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 35.1 m -52.06 -28.23 16.67 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.638 0.256 . . . . 0.0 111.117 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.27 -32.96 29.36 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.124 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.88 -75.77 0.6 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.483 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 49' ' ' VAL . 7.9 p 33.52 58.03 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 121.345 0.593 . . . . 0.0 111.821 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.97 -33.5 68.93 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.189 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.44 ' HB2' ' HA ' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -90.33 172.2 8.93 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.399 179.502 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 28.5 mmm-85 -48.68 106.97 0.68 Allowed Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.61 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.11 -28.96 63.41 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.664 2.243 . . . . 0.0 112.563 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.45 9.78 32.85 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.4 pp -88.25 -28.13 21.31 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 121.148 -0.221 . . . . 0.0 111.1 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.426 HD21 HD11 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -93.77 -54.63 3.55 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.588 -179.871 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 64' ' ' LEU . 2.1 m -53.94 151.53 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 121.068 0.461 . . . . 0.0 111.612 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -65.42 -58.2 6.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.565 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.3 -45.32 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.517 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.8 p -84.09 10.73 9.36 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.617 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.427 ' HA2' ' CG1' ' A' ' 57' ' ' VAL . . . 55.28 27.91 48.36 Favored Glycine 0 C--N 1.338 0.653 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.552 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -118.25 -41.37 2.86 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.755 0.312 . . . . 0.0 110.838 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.7 t -117.97 128.67 55.02 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.979 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 8.3 mt -67.44 156.21 37.14 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.717 0.294 . . . . 0.0 110.989 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -52.44 153.81 4.97 Favored Pre-proline 0 N--CA 1.464 0.275 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.598 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.36 -38.57 73.82 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.048 2.498 . . . . 0.0 112.771 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -48.34 -36.06 16.04 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 121.167 -0.539 . . . . 0.0 112.799 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.6 mt -84.32 126.48 40.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 117.008 0.404 . . . . 0.0 110.951 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 mt -94.63 101.5 13.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.515 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.3 m -79.51 132.3 32.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.899 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.8 mt -137.22 138.77 40.49 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.386 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 92' ' ' THR . 44.0 t -119.06 119.74 61.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.656 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 28.3 m-20 61.27 54.07 3.33 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.079 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.2 m 52.82 38.44 26.63 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.492 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 21.4 t -155.43 155.05 32.87 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.523 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.18 123.91 5.97 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.665 0.269 . . . . 0.0 111.438 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.29 -23.17 63.79 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.693 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -74.86 -28.79 60.81 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.526 0.203 . . . . 0.0 110.653 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 24.1 t -73.52 -41.21 56.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.282 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.8 m -71.4 -34.19 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.663 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.9 -46.31 0.04 OUTLIER Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.74 -0.743 . . . . 0.0 113.055 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.84 73.45 1.27 Allowed Glycine 0 C--N 1.335 0.496 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.192 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER 62.2 29.71 17.51 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.586 0.231 . . . . 0.0 111.131 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -150.2 29.86 0.71 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.432 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -90.27 118.91 30.14 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.725 0.297 . . . . 0.0 110.973 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.9 m -66.8 156.25 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.813 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -89.54 161.12 16.36 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.428 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -158.4 36.84 0.24 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.253 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 47.1 t0 61.17 93.13 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.041 0.448 . . . . 0.0 110.896 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 112.52 31.34 2.6 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.588 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -70.14 166.92 18.89 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.724 0.297 . . . . 0.0 111.049 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 85.1 m -140.05 125.59 19.15 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.08 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.4 p -143.23 140.17 26.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.93 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -138.05 144.72 41.11 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.912 0.387 . . . . 0.0 111.134 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -125.15 104.85 8.74 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.719 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 96' ' ' ILE . 27.6 mt -118.83 112.63 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.22 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 74.3 m -79.98 123.32 27.71 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.394 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.94 7.84 8.67 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.944 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.21 166.86 1.47 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 27.5 t-80 -151.48 153.99 35.69 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.582 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -133.13 -89.86 0.41 Allowed Glycine 0 C--N 1.335 0.517 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.1 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.944 0 CA-C-O 118.478 -1.179 . . . . 0.0 112.632 179.785 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 120.805 0.336 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.34 136.08 12.54 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.931 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -72.19 127.78 33.63 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.268 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.08 30.25 5.27 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.679 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -122.85 135.59 54.58 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.566 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -176.91 137.93 0.25 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.982 0.42 . . . . 0.0 111.791 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 29.9 mm -111.23 153.94 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.401 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.3 m -121.19 111.32 17.26 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.664 0.268 . . . . 0.0 111.162 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.3 p -129.99 104.69 10.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-O 120.925 0.393 . . . . 0.0 111.046 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.416 ' HG2' ' HG2' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -130.74 154.94 47.44 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.804 -179.657 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -116.6 142.78 46.44 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.849 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -137.21 167.83 20.81 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.744 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 66.1 -104.74 1.09 Allowed Glycine 0 C--N 1.334 0.434 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.653 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -128.3 32.77 3.32 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.899 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.6 t -105.26 -32.26 8.7 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.865 0.332 . . . . 0.0 111.103 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -59.25 -33.35 70.93 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.32 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.7 mp -68.62 -8.84 45.67 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 68.0 mt -84.11 13.58 5.0 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -147.99 -64.42 0.26 Allowed 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -172.34 37.85 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.18 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.2 mptt 51.38 35.31 13.68 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.989 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -69.24 159.24 33.42 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.129 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 37.6 p -101.49 -71.88 0.7 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.966 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 80.3 p -141.33 162.85 34.49 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.601 0.239 . . . . 0.0 111.254 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -150.64 158.65 44.4 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.24 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.469 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 52.9 mt-30 -133.16 144.84 50.15 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.95 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.4 mt -130.8 142.03 50.37 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.972 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -77.87 110.26 12.61 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.745 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.15 125.64 27.44 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.808 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.7 m -125.75 -56.53 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 111.368 0.136 . . . . 0.0 111.368 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.457 ' N ' ' HD3' ' A' ' 32' ' ' PRO . 16.4 m -151.15 62.62 5.17 Favored Pre-proline 0 N--CA 1.467 0.389 0 CA-C-O 120.817 0.341 . . . . 0.0 111.184 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.457 ' HD3' ' N ' ' A' ' 31' ' ' VAL . 5.4 Cg_exo -74.18 -0.53 9.71 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.985 2.456 . . . . 0.0 113.219 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 93.5 m -55.51 -35.54 65.73 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.62 0.248 . . . . 0.0 111.017 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -93.6 29.49 8.39 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.891 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 25.5 m -147.7 150.55 34.53 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.749 0.309 . . . . 0.0 110.83 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.6 p30 -141.5 -171.82 3.39 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.043 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.1 tt -54.29 -42.71 70.37 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.476 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -55.68 -38.38 69.55 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.98 -32.32 60.9 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.074 178.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 24.2 mt -66.66 -54.57 21.83 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.86 0.33 . . . . 0.0 110.487 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.481 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -59.84 -58.49 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.894 179.895 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -50.26 -30.01 10.84 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.525 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.3 tt -71.43 -31.03 66.76 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 4.6 pp -97.01 -40.75 8.71 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.31 -70.79 0.6 Allowed 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.7 m -55.35 -24.62 30.3 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -96.31 -31.54 12.84 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -152.66 57.9 0.81 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.1 p -91.24 113.67 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 120.868 0.366 . . . . 0.0 110.617 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -94.8 48.74 1.21 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.769 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -177.79 -175.11 0.49 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.284 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.5 mmt-85 -62.11 110.95 3.76 Favored Pre-proline 0 N--CA 1.463 0.188 0 CA-C-O 120.502 0.191 . . . . 0.0 110.991 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.49 -24.95 79.47 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.278 1.986 . . . . 0.0 112.512 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.96 7.96 39.75 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.8 pp -89.62 -21.31 22.87 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.462 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.58 -48.62 4.47 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.402 ' CG1' ' HA2' ' A' ' 61' ' ' GLY . 2.6 m -54.89 151.25 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.063 0.459 . . . . 0.0 111.681 -179.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -69.47 -57.45 5.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.189 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -171.15 -44.6 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.418 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.9 t -82.23 7.78 12.83 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.641 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.402 ' HA2' ' CG1' ' A' ' 57' ' ' VAL . . . 59.34 24.49 59.15 Favored Glycine 0 C--N 1.342 0.885 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.702 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -115.79 -47.36 2.8 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.815 0.34 . . . . 0.0 110.371 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.468 ' HA ' ' HG3' ' A' ' 83' ' ' MET . 45.4 p -105.5 163.93 12.27 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.907 179.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.3 mt -99.06 152.82 19.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.855 0.359 . . . . 0.0 111.073 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.91 147.67 52.97 Favored Pre-proline 0 N--CA 1.467 0.379 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.352 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -49.88 -32.51 30.29 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.344 2.696 . . . . 0.0 113.326 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -45.16 -38.85 6.54 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 121.357 -0.449 . . . . 0.0 113.035 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.0 mt -100.15 135.2 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.951 0.375 . . . . 0.0 111.05 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.7 tp -100.07 101.98 13.19 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.661 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.9 m -83.37 126.12 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.185 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 mt -125.59 161.98 26.0 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.273 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.464 ' HB ' ' CE2' ' A' ' 85' ' ' TYR . 2.7 m -141.17 111.58 3.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.913 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 56.37 53.22 8.99 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.957 0.408 . . . . 0.0 110.888 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.9 m 58.33 30.3 19.36 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.502 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 49.8 t -144.19 130.72 19.98 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.223 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -45.6 128.43 8.34 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.689 0.28 . . . . 0.0 111.137 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.407 ' HA ' HG23 ' A' ' 72' ' ' VAL . . . -62.39 -21.6 65.49 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.768 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -72.52 -24.12 61.1 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.735 -0.212 . . . . 0.0 110.895 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.4 t -71.33 -47.18 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.131 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.46 HG22 HG21 ' A' ' 72' ' ' VAL . 29.8 m -69.36 -42.45 81.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.868 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 165.39 40.16 0.02 OUTLIER Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.517 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 54.3 -104.75 0.26 Allowed Glycine 0 C--N 1.336 0.582 0 C-N-CA 121.236 -0.506 . . . . 0.0 112.919 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.468 ' HG3' ' HA ' ' A' ' 63' ' ' THR . 53.8 mmm -108.89 27.06 9.86 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.682 0.277 . . . . 0.0 111.074 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -122.03 21.19 10.62 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.464 ' CE2' ' HB ' ' A' ' 72' ' ' VAL . 19.4 t80 -73.46 118.92 16.99 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.65 0.262 . . . . 0.0 111.305 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 19.7 m -78.73 159.45 4.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.525 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.7 mp -110.29 175.77 5.3 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.863 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -168.86 -62.18 0.02 OUTLIER 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.04 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -178.91 108.15 0.04 OUTLIER 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.425 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 105.51 24.17 7.21 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.978 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -79.22 143.88 34.92 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 117.02 0.41 . . . . 0.0 110.611 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.407 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 53.5 m -134.22 103.07 5.6 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.003 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.7 p -107.84 134.65 48.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.803 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.416 ' HG2' ' HG2' ' A' ' 10' ' ' GLN . 15.3 mt-10 -136.42 150.47 48.77 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.468 -179.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -124.56 104.48 8.74 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.148 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 24.3 mt -111.87 107.02 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.145 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.52 137.42 34.61 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.953 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.8 p -129.43 -54.43 1.17 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.941 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.98 125.01 28.72 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.858 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -137.44 89.91 2.46 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.853 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -154.62 -67.85 0.01 OUTLIER Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.62 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.824 -0.987 . . . . 0.0 112.895 179.96 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 120.893 0.378 . . . . 0.0 111.281 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.0 t -92.17 156.85 17.05 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.673 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 60.21 38.52 20.02 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.967 0.413 . . . . 0.0 110.832 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.412 ' O ' ' HB2' ' A' ' 5' ' ' ASN . 35.2 t60 -114.26 158.72 21.02 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.607 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 4' ' ' HIS . 5.7 m120 69.21 162.66 0.22 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.277 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.4 m170 63.83 -175.57 0.16 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.89 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.546 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 3.2 mp -129.87 145.86 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 120.741 0.305 . . . . 0.0 111.179 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.3 m -96.92 95.93 8.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.959 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.8 p -110.95 105.19 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 121.005 0.431 . . . . 0.0 110.833 179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.434 ' HB2' ' O ' ' A' ' 23' ' ' THR . 0.0 OUTLIER -130.51 175.29 9.1 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.725 -179.068 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.494 ' CG ' ' HA ' ' A' ' 16' ' ' GLU . 95.5 m-85 -118.63 161.64 19.73 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.107 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -172.8 157.93 3.82 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.369 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 66.16 45.03 89.73 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.615 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.11 33.2 82.61 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.902 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.7 -17.93 13.58 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.783 0.292 . . . . 0.0 111.613 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.494 ' HA ' ' CG ' ' A' ' 11' ' ' PHE . 2.0 pm0 -59.27 -24.94 63.66 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.7 mp -65.92 -7.7 18.18 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 58.0 mt -72.69 1.27 8.7 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.452 ' CD2' ' HB2' ' A' ' 50' ' ' LYS . 38.8 t80 -144.24 -65.97 0.35 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -172.19 40.0 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.354 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 52.58 46.83 25.97 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.77 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -75.04 -179.66 4.45 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.917 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.434 ' O ' ' HB2' ' A' ' 10' ' ' GLN . 39.9 p -113.74 -47.11 2.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.256 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.5 p -171.21 155.08 4.21 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.673 0.273 . . . . 0.0 110.978 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -141.71 166.58 24.34 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.546 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.546 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 0.8 OUTLIER -132.29 126.47 33.45 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.93 179.791 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.9 mt -103.27 141.73 35.41 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.846 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -110.16 119.75 40.28 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.534 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -106.9 151.76 16.89 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.095 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.3 m -107.46 -32.23 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.3 m -143.19 69.35 17.96 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-O 120.992 0.425 . . . . 0.0 111.2 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -75.34 -7.45 18.86 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.745 2.297 . . . . 0.0 113.454 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 74.0 m -51.43 -58.15 7.04 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.592 0.234 . . . . 0.0 111.374 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -98.48 36.39 4.03 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.519 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.5 m -123.22 119.56 30.55 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.694 0.283 . . . . 0.0 110.815 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -95.94 -176.05 3.59 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.139 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.6 tt -55.4 -40.26 71.22 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.583 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -51.85 -44.55 63.67 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.63 -32.78 67.24 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.996 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.406 ' HB2' ' CD1' ' A' ' 87' ' ' LEU . 6.3 tt -67.17 -59.2 3.64 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.562 0.22 . . . . 0.0 110.961 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -59.76 -57.77 10.14 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.143 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.288 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -48.73 -33.37 10.08 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.363 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.5 tt -71.81 -29.1 64.08 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.728 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.8 pp -95.83 -32.43 12.68 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.64 -71.07 0.59 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.477 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.9 m -51.53 -26.79 9.15 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -96.73 -36.88 10.52 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -140.62 57.26 1.58 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.5 p -95.79 -34.86 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.452 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 0.2 OUTLIER 66.25 8.46 5.61 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 111.574 0.213 . . . . 0.0 111.574 -179.307 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -144.89 -166.18 2.34 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -75.61 110.74 11.43 Favored Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 116.742 -0.208 . . . . 0.0 110.595 179.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.6 -21.64 63.35 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.315 2.01 . . . . 0.0 112.537 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.32 5.58 44.4 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pp -95.26 -26.82 15.79 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 121.166 -0.214 . . . . 0.0 111.476 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.7 -44.74 7.31 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.404 ' CG1' ' HA2' ' A' ' 61' ' ' GLY . 5.4 m -54.25 150.49 1.78 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-O 121.119 0.485 . . . . 0.0 111.699 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -63.35 -59.33 4.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.358 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -171.78 -43.92 0.02 OUTLIER 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.371 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 71.3 p -83.63 7.62 16.83 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.805 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.404 ' HA2' ' CG1' ' A' ' 57' ' ' VAL . . . 57.14 25.75 54.65 Favored Glycine 0 C--N 1.341 0.813 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.47 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.4 tm0? -115.08 -37.28 4.16 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.652 0.263 . . . . 0.0 110.977 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.9 t -127.5 142.48 51.38 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.792 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 8.1 mt -65.88 155.8 35.32 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.877 0.37 . . . . 0.0 111.205 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.26 150.37 72.26 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.075 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -52.32 -32.86 53.24 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.091 2.527 . . . . 0.0 112.819 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 99' ' ' LEU . . . -49.88 -35.97 25.75 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.874 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.4 mt -99.93 135.66 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 120.752 0.31 . . . . 0.0 110.789 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.8 mp -105.26 104.91 14.74 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.874 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.5 m -77.25 133.85 29.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.014 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.6 mt -123.98 154.56 39.64 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.551 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 25.8 t -126.53 113.47 33.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.652 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.8 m120 57.9 42.62 22.74 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.965 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.9 m 57.08 50.58 11.74 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.417 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 42.8 t -141.32 -79.38 0.26 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.485 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 177.49 132.29 0.06 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.698 0.285 . . . . 0.0 110.896 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -88.51 -24.91 22.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.562 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -80.81 -38.71 27.93 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.578 0.228 . . . . 0.0 110.842 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 61.8 t -58.58 -37.5 65.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.906 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.9 m -80.83 -32.75 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.531 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.29 -56.49 0.04 OUTLIER Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.77 -0.729 . . . . 0.0 113.13 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 110.63 -57.85 0.41 Allowed Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.253 -0.499 . . . . 0.0 112.266 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -142.92 21.72 1.95 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 111.516 0.191 . . . . 0.0 111.516 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -135.6 20.46 3.33 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -75.1 114.52 13.69 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.927 0.394 . . . . 0.0 111.302 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.8 m -71.7 153.28 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.48 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.406 ' CD1' ' HB2' ' A' ' 40' ' ' LEU . 1.2 mp -104.21 164.28 11.83 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.551 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -161.02 30.33 0.14 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.413 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 58.97 103.93 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.001 0.429 . . . . 0.0 111.604 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 116.73 35.52 1.15 Allowed Glycine 0 C--N 1.332 0.357 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.326 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.15 177.52 4.81 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.863 0.363 . . . . 0.0 111.576 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 74.2 m -140.3 132.66 28.37 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.821 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.1 p -142.46 137.06 28.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.174 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -134.2 158.47 43.6 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.993 0.425 . . . . 0.0 111.532 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -126.55 104.89 8.37 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.298 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 26.5 mt -116.08 118.5 58.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.215 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.81 155.15 39.12 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.108 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.78 -41.54 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.563 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.404 ' HA ' ' HA2' ' A' ' 67' ' ' GLY . 0.4 OUTLIER 51.49 -174.25 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.056 0.543 . . . . 0.0 111.777 -179.735 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 25.4 m170 -95.04 72.83 3.42 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.137 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -85.75 -169.05 45.53 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.106 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.197 0 CA-C-O 118.578 -1.123 . . . . 0.0 112.655 -179.591 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ttp . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 120.629 0.252 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.9 m -81.82 87.53 6.36 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.912 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -134.48 145.36 48.75 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.852 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 26.1 m170 60.38 84.06 0.13 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.827 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.459 ' HB3' ' O ' ' A' ' 89' ' ' ASP . 49.6 m-80 -109.66 165.76 11.42 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.407 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -175.74 138.64 0.38 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.277 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 29.6 mt -105.35 137.67 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.133 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -92.84 112.43 24.39 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.386 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.6 p -134.23 108.8 11.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.653 179.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -140.04 162.53 35.0 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.499 -179.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.447 ' CD2' ' HA ' ' A' ' 16' ' ' GLU . 31.3 m-85 -116.13 148.47 40.28 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.149 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -135.29 143.46 46.23 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.306 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.11 -108.54 2.65 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.138 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -117.16 25.7 8.64 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.564 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.8 m -97.64 -15.53 20.39 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.447 ' HA ' ' CD2' ' A' ' 11' ' ' PHE . 40.0 mt-10 -59.54 -32.97 70.82 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.667 0.27 . . . . 0.0 111.081 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.8 mt -72.54 -5.17 35.23 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.883 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.8 mt -83.1 14.42 3.42 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -153.76 -60.8 0.13 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.61 0.243 . . . . 0.0 110.656 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -177.4 37.49 0.0 OUTLIER 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.149 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.4 mptt 51.19 35.27 12.95 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.966 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -93.06 151.16 20.04 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.876 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.9 p -79.13 -64.29 1.22 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.926 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.8 p -143.22 163.93 31.58 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.792 0.329 . . . . 0.0 111.357 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -148.54 166.58 27.79 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.11 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -132.78 126.5 32.52 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.873 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.2 mt -114.75 141.14 48.26 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.877 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -117.51 124.0 47.66 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.612 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -118.54 133.88 10.57 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.591 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.6 t -70.15 -40.74 78.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 120.641 0.258 . . . . 0.0 111.025 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 18.0 t -134.12 67.64 73.45 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-O 120.945 0.402 . . . . 0.0 111.121 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -66.27 -16.2 50.84 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.782 2.321 . . . . 0.0 112.92 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.19 -44.24 67.78 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.669 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.06 41.05 3.06 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.029 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 58.1 m -151.41 129.9 12.17 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 120.646 0.26 . . . . 0.0 110.809 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -113.23 -175.29 2.64 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.704 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.5 tt -55.16 -35.1 64.4 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.404 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.63 -37.39 70.66 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.906 0.384 . . . . 0.0 110.135 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.97 -32.96 56.11 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.93 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 95.2 mt -65.86 -53.29 41.82 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.7 0.286 . . . . 0.0 110.58 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.444 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -56.71 -57.53 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.993 179.884 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.54 -26.65 44.41 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.431 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.9 tp -82.08 -23.81 35.57 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 4.7 pp -96.75 -38.17 10.0 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.425 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -92.37 -59.6 2.05 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -179.627 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.5 m -61.33 -21.85 64.37 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.364 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.38 -34.15 10.77 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -155.58 55.01 0.62 Allowed 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.425 ' HB ' ' O ' ' A' ' 45' ' ' LYS . 7.6 p -70.72 -33.1 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 57.79 13.48 2.07 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -158.37 -170.37 3.08 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.08 112.56 10.19 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-O 120.562 0.22 . . . . 0.0 110.838 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.85 -24.7 76.97 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.272 1.982 . . . . 0.0 112.299 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.36 6.58 42.53 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.6 pp -91.5 -29.34 17.05 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 121.236 -0.186 . . . . 0.0 111.316 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.47 -44.0 7.02 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.5 m -56.5 148.05 4.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.176 0.512 . . . . 0.0 111.696 -179.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -63.18 -55.88 21.38 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.361 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -174.22 -44.65 0.01 OUTLIER 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.481 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.7 t -89.63 15.37 9.63 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.16 23.29 32.21 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.65 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -107.77 -32.77 7.49 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.893 0.377 . . . . 0.0 110.788 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.0 t -132.66 179.48 6.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.092 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.6 mt -103.98 152.92 21.43 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.915 0.388 . . . . 0.0 111.451 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.06 154.18 82.84 Favored Pre-proline 0 N--CA 1.465 0.287 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.389 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -50.31 -32.95 35.13 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.199 2.599 . . . . 0.0 113.036 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -46.51 -37.58 8.71 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 121.392 -0.432 . . . . 0.0 112.993 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.8 mt -104.8 133.28 49.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.861 0.331 . . . . 0.0 111.054 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.0 mt -100.8 100.37 11.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.694 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.5 m -76.57 133.26 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.873 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 mt -132.13 140.62 48.86 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.391 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 92' ' ' THR . 19.5 t -115.73 117.82 56.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.493 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 56.99 49.86 13.16 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.145 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 58.81 47.36 12.75 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.951 0.405 . . . . 0.0 111.275 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 52.0 t -161.37 147.03 14.01 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.628 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -46.01 119.56 2.32 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.781 0.324 . . . . 0.0 111.357 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.2 -17.87 56.2 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.136 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.11 -34.51 49.97 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.379 0.133 . . . . 0.0 111.162 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.2 t -70.11 -45.79 74.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.053 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.9 m -60.62 -35.51 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.691 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 179.0 -35.52 0.08 OUTLIER Glycine 0 CA--C 1.524 0.599 0 C-N-CA 120.785 -0.722 . . . . 0.0 113.251 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.68 -54.13 2.67 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.225 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.52 27.51 0.91 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 120.464 0.173 . . . . 0.0 111.343 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -129.09 15.49 6.24 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -70.38 113.21 7.3 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.755 0.312 . . . . 0.0 110.943 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 26.9 m -69.4 148.21 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.473 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -96.66 157.96 15.66 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.541 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -154.16 36.16 0.43 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.194 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.459 ' O ' ' HB3' ' A' ' 5' ' ' ASN . 2.4 t0 62.96 27.31 15.89 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.963 0.411 . . . . 0.0 111.691 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -168.77 41.08 0.22 Allowed Glycine 0 C--N 1.332 0.35 0 C-N-CA 121.198 -0.525 . . . . 0.0 112.235 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -85.03 166.36 16.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.815 0.34 . . . . 0.0 111.013 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 86.1 m -141.81 127.61 19.28 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.659 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.7 p -141.8 133.63 27.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.111 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -132.96 143.18 49.29 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.327 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -113.19 104.74 12.65 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.275 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 11.0 mt -110.73 110.15 31.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.03 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 60.6 p -76.66 143.64 39.97 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.19 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.33 -50.26 0.74 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.13 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.46 77.07 1.93 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.918 0.39 . . . . 0.0 110.917 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -132.52 37.91 3.47 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.724 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -132.64 -57.81 0.08 OUTLIER Glycine 0 C--N 1.333 0.412 0 C-N-CA 121.17 -0.538 . . . . 0.0 112.097 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.416 -1.214 . . . . 0.0 112.405 179.515 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 120.704 0.288 . . . . 0.0 111.082 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 t -76.32 -47.84 22.12 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.4 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -170.17 95.55 0.26 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.625 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -67.23 157.28 34.19 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.419 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -70.3 135.48 48.95 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.89 0.376 . . . . 0.0 111.314 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 14.3 p-80 -175.17 115.02 0.15 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.172 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 33.6 mm -87.2 154.32 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.672 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.444 ' HB ' ' HA ' ' A' ' 92' ' ' THR . 48.8 m -121.14 94.12 4.24 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.653 0.263 . . . . 0.0 111.082 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.5 p -118.28 109.2 26.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-O 121.02 0.438 . . . . 0.0 111.426 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.4 pm0 -134.0 162.24 32.6 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.569 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.438 ' CB ' ' HA ' ' A' ' 16' ' ' GLU . 98.1 m-85 -122.04 151.92 40.33 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.102 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -167.23 174.38 8.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.013 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 59.66 32.03 72.8 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.916 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.1 26.91 38.92 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.224 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.6 t -108.07 -22.98 12.18 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 117.129 0.464 . . . . 0.0 111.528 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.438 ' HA ' ' CB ' ' A' ' 11' ' ' PHE . 1.9 pt-20 -57.72 -27.51 63.03 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.512 0.196 . . . . 0.0 111.339 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.1 mp -64.98 -10.66 31.12 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 71.8 mt -83.55 13.57 4.46 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -148.18 -70.83 0.22 Allowed 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -170.98 38.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.969 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.65 34.16 15.31 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.146 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -77.47 178.43 7.21 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.047 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 37.0 p -107.12 -76.89 0.6 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.895 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.6 p -136.77 164.31 28.57 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.688 0.28 . . . . 0.0 111.372 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.53 151.02 34.4 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.267 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.473 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 31.7 mt-30 -132.64 109.57 9.82 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.87 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.3 mt -97.97 141.72 30.59 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.687 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -85.72 121.07 27.86 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.699 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -91.02 157.7 25.27 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.008 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.5 m -123.6 -45.77 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.9 m -136.39 67.72 60.6 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-O 121.012 0.434 . . . . 0.0 111.457 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.447 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . 6.1 Cg_exo -77.62 0.13 10.1 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.169 2.579 . . . . 0.0 113.231 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.8 m -56.53 -58.73 6.77 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.694 0.283 . . . . 0.0 111.342 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -93.51 43.37 2.5 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.658 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.5 m -135.26 114.64 12.47 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.719 0.295 . . . . 0.0 110.646 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -100.15 -170.19 1.84 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.6 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.5 tt -55.04 -42.94 73.29 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 111.484 0.179 . . . . 0.0 111.484 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -56.78 -38.14 72.07 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.98 -34.44 47.48 Favored Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.977 178.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.43 ' HB2' ' CD1' ' A' ' 87' ' ' LEU . 23.9 tp -62.32 -52.03 65.3 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.622 0.248 . . . . 0.0 110.634 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -59.11 -57.63 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.929 179.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.07 -32.42 21.99 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.732 -0.213 . . . . 0.0 111.259 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.5 tt -70.38 -27.84 64.63 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.5 pp -97.02 -41.2 8.49 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.1 pttt -82.21 -65.19 1.04 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 m -56.67 -23.74 43.84 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -94.07 -41.13 9.7 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 111.515 0.191 . . . . 0.0 111.515 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.21 59.74 0.97 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.885 0.374 . . . . 0.0 111.902 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.1 p -78.87 -35.67 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.605 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 64.59 10.76 6.15 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.423 -179.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -154.05 -173.05 4.43 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.479 ' HB2' HD22 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -68.04 135.61 91.77 Favored Pre-proline 0 N--CA 1.464 0.275 0 CA-C-O 120.518 0.199 . . . . 0.0 110.809 179.707 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -77.39 -23.02 10.43 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.334 2.022 . . . . 0.0 112.834 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -90.69 6.92 42.02 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.479 HD22 ' HB2' ' A' ' 52' ' ' ARG . 3.7 pp -89.87 -17.71 27.55 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 120.987 -0.285 . . . . 0.0 111.312 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.12 -46.0 3.37 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.1 m -56.72 148.36 4.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 121.188 0.518 . . . . 0.0 111.692 -179.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -63.99 -53.9 42.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.496 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -177.15 -43.84 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.436 178.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.3 p -87.45 12.88 11.13 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 57.01 22.19 41.25 Favored Glycine 0 C--N 1.339 0.747 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.745 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -107.87 -35.54 6.62 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.861 0.363 . . . . 0.0 110.863 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.4 t -129.55 -178.77 4.82 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.006 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.6 mt -102.93 153.68 19.97 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.968 0.414 . . . . 0.0 111.391 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -79.78 155.0 75.85 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.135 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.24 135.21 59.39 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.867 2.378 . . . . 0.0 112.545 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.18 -48.35 0.91 Allowed Glycine 0 C--N 1.332 0.344 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.413 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.2 mt -93.39 143.08 12.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 120.83 0.348 . . . . 0.0 111.21 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -105.1 101.68 11.22 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.8 m -76.84 136.8 23.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.785 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.1 mt -131.4 146.8 52.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.317 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.433 HG12 ' CD2' ' A' ' 85' ' ' TYR . 67.7 t -128.22 133.9 66.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.325 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.2 m120 58.72 26.06 14.16 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.003 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 54.93 31.88 16.82 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.373 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.407 ' SG ' ' N ' ' A' ' 76' ' ' ASP . 16.4 p -130.04 -48.57 1.11 Allowed 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.356 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.407 ' N ' ' SG ' ' A' ' 75' ' ' CYS . 0.2 OUTLIER 172.28 140.6 0.03 OUTLIER 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.491 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -86.32 -22.58 26.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.65 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -79.19 -32.97 44.28 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.437 0.161 . . . . 0.0 110.609 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 52.7 t -60.62 -46.65 95.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.957 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 18.8 m -65.31 -23.44 33.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 147.43 -23.94 1.53 Allowed Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.766 -0.73 . . . . 0.0 113.344 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 104.04 -57.92 0.52 Allowed Glycine 0 C--N 1.338 0.692 0 C-N-CA 121.126 -0.559 . . . . 0.0 111.705 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 5.6 ptt? -152.89 26.99 0.54 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.497 0.189 . . . . 0.0 110.98 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -135.05 21.72 3.49 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.433 ' CD2' HG12 ' A' ' 72' ' ' VAL . 19.7 t80 -80.44 112.87 18.19 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.846 0.355 . . . . 0.0 110.849 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.1 m -62.72 143.64 15.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.393 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.447 ' HB3' ' HB3' ' A' ' 32' ' ' PRO . 0.6 OUTLIER -82.1 142.34 32.36 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.415 -179.783 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -130.18 43.02 3.19 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.32 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.73 27.3 8.58 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.808 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -173.44 41.2 0.15 Allowed Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.304 -0.474 . . . . 0.0 112.091 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -83.12 114.09 21.08 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.719 0.295 . . . . 0.0 111.222 -179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.444 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 28.4 m -85.01 128.62 34.71 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.56 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.0 p -140.19 133.54 34.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.126 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -129.35 161.31 30.59 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.021 0.439 . . . . 0.0 111.592 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -134.2 104.74 6.32 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.165 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 29.0 mt -114.77 112.91 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.132 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.3 140.38 38.82 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.91 0.386 . . . . 0.0 111.369 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 39.9 p -123.25 -54.07 1.8 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.217 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.43 77.86 2.38 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.054 0.454 . . . . 0.0 110.21 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 47.0 p-80 -133.01 162.79 30.76 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.053 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.08 -106.45 1.72 Allowed Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.271 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.147 0 CA-C-O 118.602 -1.11 . . . . 0.0 112.769 179.536 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 120.716 0.293 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.5 p -101.32 -35.58 9.19 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.13 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -117.54 152.8 34.35 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.057 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -100.99 100.6 11.24 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.899 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 -164.38 179.06 7.01 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.879 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 71.52 124.73 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.132 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.4 mm -88.35 111.54 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.714 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 41.8 m -81.78 102.61 10.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.343 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.9 p -119.93 104.92 16.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.467 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.413 ' HB3' ' CB ' ' A' ' 24' ' ' SER . 0.7 OUTLIER -127.28 161.8 27.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.692 -179.047 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -116.07 159.24 21.97 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.948 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -105.86 176.23 5.23 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.228 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.96 97.38 0.05 OUTLIER Glycine 0 C--N 1.336 0.583 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.53 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.67 -29.31 4.49 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.943 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.7 -27.96 15.02 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.852 0.326 . . . . 0.0 111.558 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.94 -27.87 65.71 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.585 0.231 . . . . 0.0 111.254 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 mp -67.7 -10.16 49.97 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 56.1 mt -81.13 13.3 2.87 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -149.58 -63.73 0.22 Allowed 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -174.37 37.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.114 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.49 34.81 12.94 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.003 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -72.34 -177.36 2.14 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.046 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 49.9 p -115.7 -78.17 0.58 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.919 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.413 ' CB ' ' HB3' ' A' ' 10' ' ' GLN . 83.7 p -136.12 160.24 39.25 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.933 0.397 . . . . 0.0 111.254 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.03 152.06 48.48 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.15 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -133.18 100.61 4.91 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.523 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.1 mt -97.84 139.31 33.89 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.93 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -110.43 96.75 6.4 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.796 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.62 155.89 31.14 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.366 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.9 t -66.89 -63.42 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 CA-C-O 120.636 0.255 . . . . 0.0 110.999 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.0 p -145.05 68.0 13.7 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-O 121.431 0.634 . . . . 0.0 110.845 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -79.52 7.3 4.57 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.368 2.712 . . . . 0.0 113.011 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -54.0 -38.15 64.77 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.64 0.257 . . . . 0.0 111.181 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.27 47.64 3.51 Favored Glycine 0 C--N 1.338 0.687 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.671 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 63.8 m -145.3 145.41 31.23 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.718 0.294 . . . . 0.0 110.749 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 53.2 p-10 -108.61 -173.28 2.24 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.891 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 tt -57.66 -39.28 76.69 Favored 'General case' 0 N--CA 1.46 0.071 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.032 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -54.92 -38.19 67.35 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.308 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.05 -32.22 45.12 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.103 179.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 61.7 tp -68.16 -53.08 27.68 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.652 0.226 . . . . 0.0 110.855 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -57.83 -57.4 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.854 179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.8 tm0? -50.65 -32.09 18.11 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.402 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.4 tp -71.52 -27.56 63.28 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.898 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.3 pp -96.92 -40.58 8.83 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.0 -71.69 0.5 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.4 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 22.5 m -53.04 -22.14 5.51 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.05 -31.35 10.68 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -142.25 51.6 1.48 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -178.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.2 p -100.6 120.07 49.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.873 0.368 . . . . 0.0 110.716 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -101.24 31.91 3.48 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.02 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -155.86 -174.78 5.1 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.252 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.29 110.21 3.08 Favored Pre-proline 0 CA--C 1.53 0.176 0 CA-C-N 116.803 -0.181 . . . . 0.0 111.045 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -60.33 -27.31 84.62 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.405 2.07 . . . . 0.0 112.286 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.423 ' HA ' ' CG2' ' A' ' 57' ' ' VAL . 5.8 t70 -91.38 8.04 38.11 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.994 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 pp -88.58 -26.7 21.82 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 122.306 -0.246 . . . . 0.0 111.472 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.5 -46.82 5.1 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.423 ' CG2' ' HA ' ' A' ' 54' ' ' ASP . 9.0 m -55.59 149.63 2.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 121.164 0.507 . . . . 0.0 111.7 -179.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -63.43 -52.94 59.4 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.736 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.43 -45.5 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.518 179.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.1 p -90.27 16.45 8.62 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.07 21.63 32.39 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.825 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -105.88 -35.35 7.35 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.839 0.352 . . . . 0.0 110.573 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 71.9 p -128.16 -177.07 4.0 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.983 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.4 mt -110.64 154.52 23.69 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.934 0.397 . . . . 0.0 110.997 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -71.67 152.82 93.55 Favored Pre-proline 0 C--O 1.234 0.256 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.068 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -55.77 124.48 16.38 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.764 2.31 . . . . 0.0 112.357 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 147.82 -45.02 0.76 Allowed Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.51 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.0 mt -91.52 120.11 39.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 120.7 0.286 . . . . 0.0 111.155 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.23 100.09 12.95 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.403 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.5 m -77.75 126.35 38.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.276 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.9 mt -125.4 129.67 50.35 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.874 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 92' ' ' THR . 3.6 m -112.82 114.73 47.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.016 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 11.6 m120 54.86 52.22 12.36 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.071 0.462 . . . . 0.0 110.727 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.7 m 59.23 30.1 19.78 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.58 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 46.4 t -145.38 125.31 13.54 Favored 'General case' 0 C--O 1.23 0.048 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.375 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -44.16 127.37 5.51 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.765 0.317 . . . . 0.0 111.254 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.3 -19.48 64.63 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.883 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -73.28 -26.63 61.16 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 120.577 0.227 . . . . 0.0 110.673 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 30.7 t -70.82 -44.38 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.084 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.4 m -70.39 -39.74 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.507 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.39 42.66 0.02 OUTLIER Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.804 -0.712 . . . . 0.0 113.426 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 53.07 -107.84 0.63 Allowed Glycine 0 C--N 1.334 0.455 0 C-N-CA 121.184 -0.532 . . . . 0.0 113.009 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 60.5 mmm -108.58 27.69 9.14 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.804 0.335 . . . . 0.0 111.073 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -120.29 19.22 12.17 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.828 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -68.83 117.73 10.89 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.827 0.346 . . . . 0.0 111.339 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 15.6 m -70.57 146.53 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.713 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.9 mp -94.88 161.39 14.18 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.18 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 32.8 m-20 -153.54 35.77 0.46 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.616 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 59.93 96.39 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.045 0.45 . . . . 0.0 111.21 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 112.07 36.17 1.7 Allowed Glycine 0 CA--C 1.518 0.237 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.357 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -87.3 170.33 11.52 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.784 0.326 . . . . 0.0 110.902 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 92.6 m -137.91 134.98 35.66 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.8 p -141.41 134.28 29.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.027 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -131.38 149.14 52.66 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.384 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -121.84 104.71 9.75 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.45 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.9 mt -111.89 103.84 16.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.239 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 84.0 p -82.56 132.05 35.2 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.89 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.34 -55.53 0.44 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.372 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.53 110.55 7.91 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.719 0.295 . . . . 0.0 110.839 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -88.93 122.71 32.57 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.937 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -119.64 144.89 17.75 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.515 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.093 0 CA-C-O 118.27 -1.294 . . . . 0.0 112.798 179.804 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 120.695 0.283 . . . . 0.0 111.254 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.7 p -69.02 129.4 39.82 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.936 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -108.37 116.82 32.68 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.139 -179.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 64.7 99.26 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.314 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -60.91 133.66 56.31 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.384 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -172.63 158.47 4.12 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.542 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.474 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 17.3 mm -123.66 153.73 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.86 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 49.5 m -113.12 99.23 7.68 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.914 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.7 p -121.86 115.02 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.573 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.419 ' HG2' ' HG2' ' A' ' 94' ' ' GLU . 3.8 pm0 -128.99 159.14 36.85 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.963 0.411 . . . . 0.0 111.26 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.475 ' HB3' ' N ' ' A' ' 16' ' ' GLU . 12.1 m-85 -115.73 135.12 54.34 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.25 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -142.47 144.61 33.1 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.101 0.476 . . . . 0.0 111.977 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 86.42 -91.48 1.73 Allowed Glycine 0 C--N 1.332 0.355 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.905 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -133.88 28.91 3.16 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.992 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -109.94 -31.06 7.53 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.682 0.241 . . . . 0.0 111.133 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.475 ' N ' ' HB3' ' A' ' 11' ' ' PHE . 0.7 OUTLIER -61.76 -37.08 82.96 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.26 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.461 ' N ' ' HG2' ' A' ' 16' ' ' GLU . 4.5 mt -67.93 -14.4 62.94 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.809 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.414 HD22 HD21 ' A' ' 55' ' ' LEU . 9.0 mt -83.54 13.52 4.48 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -144.28 -64.51 0.36 Allowed 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -174.64 38.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.087 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 49.57 38.79 15.62 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.058 0.456 . . . . 0.0 110.782 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -73.9 175.37 7.39 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.056 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 33.1 p -114.94 -52.25 2.7 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.013 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 94.3 p -155.39 148.83 25.02 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.669 0.271 . . . . 0.0 110.955 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.0 mt -135.72 158.01 45.44 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.931 0.396 . . . . 0.0 111.345 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.474 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 11.8 mt-30 -130.1 106.99 8.99 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.8 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.1 mt -87.68 138.41 31.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.942 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -127.92 125.12 38.98 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.787 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.99 42.44 24.8 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.929 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.8 m -127.02 -43.09 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.6 m -129.5 71.12 82.11 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-O 120.871 0.367 . . . . 0.0 111.083 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.09 -64.81 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.686 2.257 . . . . 0.0 112.458 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.3 m -151.09 -53.68 0.14 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.442 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.38 56.83 4.43 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.904 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 87.9 m -148.44 114.95 5.94 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.745 0.307 . . . . 0.0 110.731 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.7 p30 -84.43 174.05 10.38 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.975 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.424 ' CD2' ' HA ' ' A' ' 83' ' ' MET . 4.9 tt -57.84 -39.85 78.66 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.246 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -53.64 -41.24 66.56 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.933 0.397 . . . . 0.0 109.986 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.08 -31.86 63.74 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.135 178.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.3 tp -70.13 -57.13 5.29 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.525 0.202 . . . . 0.0 110.964 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -57.54 -57.51 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.203 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -49.67 -32.49 13.33 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.504 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.1 tp -75.63 -24.15 56.41 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -96.35 -37.54 10.44 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.476 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 2.9 pttt -83.95 -71.26 0.52 Allowed 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 121.162 -0.215 . . . . 0.0 111.322 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.9 m -52.25 -24.72 7.77 Favored 'General case' 0 CA--C 1.537 0.442 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -102.08 -27.2 13.06 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -142.42 50.38 1.49 Allowed 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.476 ' HB ' ' O ' ' A' ' 45' ' ' LYS . 10.4 p -96.9 139.66 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 120.684 0.278 . . . . 0.0 111.25 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.91 31.25 5.9 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.46 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -164.15 176.46 9.23 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.153 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.99 106.0 0.58 Allowed Pre-proline 0 N--CA 1.466 0.329 0 CA-C-O 120.508 0.194 . . . . 0.0 111.367 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.07 -28.47 60.47 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.44 2.093 . . . . 0.0 112.676 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.88 9.03 37.13 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.414 HD21 HD22 ' A' ' 18' ' ' LEU . 2.1 pp -83.62 -28.93 28.12 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 121.034 -0.267 . . . . 0.0 111.158 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.414 ' O ' ' HG2' ' A' ' 65' ' ' ARG . 0.2 OUTLIER -94.11 -54.46 3.57 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.765 -0.198 . . . . 0.0 111.335 179.927 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 64' ' ' LEU . 1.4 m -54.55 151.22 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.201 0.524 . . . . 0.0 111.638 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -68.02 -62.91 1.19 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.739 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -165.22 -45.36 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.404 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.1 t -78.89 3.89 15.69 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.595 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.419 ' HA2' ' CG1' ' A' ' 57' ' ' VAL . . . 61.34 22.92 61.68 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.598 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.6 tm0? -121.46 -45.47 2.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.81 0.338 . . . . 0.0 110.407 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.548 ' HA ' ' HG3' ' A' ' 83' ' ' MET . 1.8 t -102.07 123.61 46.25 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.676 178.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 7.8 mt -67.79 156.7 36.44 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.727 0.298 . . . . 0.0 110.917 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.414 ' HG2' ' O ' ' A' ' 56' ' ' LEU . 7.6 ptm180 -57.32 143.26 74.14 Favored Pre-proline 0 C--O 1.234 0.259 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.125 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -50.6 -33.28 38.63 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.091 2.527 . . . . 0.0 112.829 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -50.85 -34.7 30.25 Favored Glycine 0 CA--C 1.523 0.54 0 CA-C-N 116.037 -0.529 . . . . 0.0 113.023 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 7.2 mt -88.77 120.41 37.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-O 120.76 0.314 . . . . 0.0 111.213 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.9 mt -96.94 97.02 8.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.018 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.9 t -79.46 136.69 23.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.12 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.09 155.73 44.99 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.476 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 39.9 t -124.48 115.04 43.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.8 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 67.03 -77.15 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.2 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.9 t -153.32 33.7 0.46 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.867 0.365 . . . . 0.0 110.942 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 44.4 t -158.46 156.02 29.58 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.682 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -49.14 136.58 14.78 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.611 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.39 -23.13 35.11 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.845 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -71.59 -18.59 62.22 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.432 0.158 . . . . 0.0 111.087 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 32.6 t -72.53 -41.11 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.316 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.6 m -80.6 -29.14 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.735 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 176.61 -38.32 0.1 OUTLIER Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.035 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 99.06 -72.06 0.54 Allowed Glycine 0 C--N 1.334 0.435 0 C-N-CA 121.003 -0.618 . . . . 0.0 111.968 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.548 ' HG3' ' HA ' ' A' ' 63' ' ' THR . 2.7 mmt -129.0 25.75 5.55 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.725 0.298 . . . . 0.0 111.182 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -136.67 23.99 3.13 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.56 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -82.63 120.17 25.21 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.6 0.238 . . . . 0.0 110.738 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.2 m -69.84 134.06 30.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.426 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.5 mp -98.2 123.57 42.34 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.867 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -108.1 35.19 3.23 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.334 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 63.1 104.83 0.03 OUTLIER 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.209 0.528 . . . . 0.0 111.488 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 113.2 29.34 3.03 Favored Glycine 0 CA--C 1.519 0.322 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.503 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -101.14 152.77 20.23 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.619 0.247 . . . . 0.0 110.837 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 94.9 m -115.18 111.8 21.54 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.962 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.8 p -120.67 125.69 74.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.748 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.419 ' HG2' ' HG2' ' A' ' 10' ' ' GLN . 16.0 mt-10 -126.37 153.68 44.6 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.364 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -120.69 104.53 9.99 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.067 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 25.2 mt -106.11 99.91 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.964 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.97 140.11 29.99 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.301 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.1 p -134.99 -48.84 0.74 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.405 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.31 138.33 36.72 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.773 0.321 . . . . 0.0 111.257 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -102.51 -37.36 8.02 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.986 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -165.89 -48.61 0.02 OUTLIER Glycine 0 C--N 1.335 0.479 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.486 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.386 -1.23 . . . . 0.0 112.424 179.879 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 ptm . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 120.787 0.327 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.1 m -141.39 83.22 1.86 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.922 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -147.02 105.49 3.8 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.021 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -157.59 31.81 0.27 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.305 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -86.19 132.16 34.07 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.781 0.324 . . . . 0.0 111.145 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.3 p80 179.07 172.51 0.82 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.779 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.5 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 25.2 mm -129.62 152.2 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.611 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.7 m -115.79 122.92 46.87 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.736 0.303 . . . . 0.0 111.474 -179.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.8 p -145.89 110.1 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.201 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -135.62 160.94 36.94 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.961 0.41 . . . . 0.0 111.643 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.418 ' HB2' ' HB3' ' A' ' 16' ' ' GLU . 89.1 m-85 -117.34 147.08 42.94 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.075 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.22 145.82 31.47 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.836 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.04 -95.3 2.06 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.457 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -139.51 30.91 2.37 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.722 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.2 m -108.04 -23.91 11.8 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.418 ' HB3' ' HB2' ' A' ' 11' ' ' PHE . 1.8 pm0 -59.84 -30.65 69.09 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.621 0.248 . . . . 0.0 111.228 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.8 mp -71.26 -7.97 50.53 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.706 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 42.1 mt -87.97 13.58 10.7 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.411 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 42.0 t80 -144.95 -63.63 0.35 Allowed 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -178.22 36.17 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.077 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.74 31.59 6.11 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.965 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -80.6 134.19 35.87 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.976 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -67.76 -66.25 0.59 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.822 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 87.3 p -144.24 161.31 39.22 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.723 0.297 . . . . 0.0 111.062 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.65 148.13 36.89 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.399 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.5 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 4.7 mt-30 -132.16 117.95 18.94 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.883 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.4 mt -113.75 134.95 54.46 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.877 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -125.0 107.94 11.34 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.92 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -150.73 154.51 25.65 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.469 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.5 m -97.83 -44.63 12.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-O 120.63 0.252 . . . . 0.0 111.116 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.471 ' N ' ' CD ' ' A' ' 32' ' ' PRO . 12.1 t -90.87 -46.82 0.37 Allowed Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.624 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 31' ' ' VAL . 51.7 Cg_exo -51.97 -43.56 51.39 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.757 2.305 . . . . 0.0 112.817 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.58 -179.96 5.59 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.885 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.85 41.07 2.55 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.347 -179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.0 t -117.74 -158.14 0.7 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.255 0.222 . . . . 0.0 110.535 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -134.47 -174.24 3.51 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.869 -0.15 . . . . 0.0 110.745 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.3 tt -60.01 -44.3 94.68 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 121.285 -0.166 . . . . 0.0 111.329 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -59.48 -34.33 72.43 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.54 -33.92 46.2 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.601 178.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.0 mt -60.55 -52.17 66.31 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.735 0.302 . . . . 0.0 110.603 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -59.92 -56.66 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.975 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.43 -30.77 13.29 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.51 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.8 tp -73.11 -27.82 61.92 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.8 pp -96.97 -42.55 7.86 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.4 pttt -84.26 -68.79 0.69 Allowed 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.5 m -50.69 -28.82 9.76 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.509 0.195 . . . . 0.0 111.47 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -81.19 -34.31 32.39 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.277 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -130.8 -68.32 0.69 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 111.449 0.166 . . . . 0.0 111.449 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.499 HG13 ' O ' ' A' ' 49' ' ' VAL . 11.5 p 44.72 72.31 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 121.56 0.695 . . . . 0.0 111.491 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -52.55 -50.23 63.33 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.205 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.444 ' HB3' HD21 ' A' ' 55' ' ' LEU . 1.8 tp10 -91.44 -164.06 1.12 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.02 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.3 ttt-85 -66.2 134.39 94.77 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-O 120.675 0.274 . . . . 0.0 111.24 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.24 -25.56 8.39 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.572 2.181 . . . . 0.0 112.529 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -89.84 8.46 31.9 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.444 HD21 ' HB3' ' A' ' 51' ' ' GLU . 2.6 pp -91.41 -26.32 18.92 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 121.287 -0.165 . . . . 0.0 111.323 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.24 -45.1 6.31 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.1 m -55.3 148.52 3.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 121.258 0.551 . . . . 0.0 111.558 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -63.94 -57.0 11.09 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.532 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.76 -44.51 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.515 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 34.6 p -86.07 10.73 13.46 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.735 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 58.31 22.3 50.34 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.688 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -109.69 -34.69 6.4 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.947 0.403 . . . . 0.0 110.886 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.6 t -129.25 175.09 9.0 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.881 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 11.0 mt -93.75 158.03 15.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.043 0.449 . . . . 0.0 111.402 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.41 ' HB2' ' HD2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -83.17 165.87 38.44 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.191 -179.867 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 65' ' ' ARG . 47.2 Cg_exo -55.72 129.67 36.28 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.741 2.294 . . . . 0.0 112.428 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.49 -49.29 0.86 Allowed Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.196 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.6 mt -94.62 134.61 31.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-O 120.728 0.299 . . . . 0.0 110.859 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.3 mt -111.53 118.65 36.31 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.975 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.9 m -85.77 125.22 40.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.031 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 mt -120.96 131.55 54.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.089 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 92' ' ' THR . 1.5 m -103.99 99.31 8.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.737 179.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 59.58 51.19 6.61 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.685 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.1 t 66.02 35.35 6.42 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.506 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 47.1 t -148.69 123.9 10.18 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.559 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -47.49 114.1 0.82 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.885 0.374 . . . . 0.0 111.32 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.04 -18.99 61.27 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.842 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -73.17 -23.99 60.5 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.87 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.8 t -64.59 -35.76 75.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.813 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.9 m -95.85 -36.72 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.693 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -152.22 -66.15 0.01 OUTLIER Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.061 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 104.39 -40.29 2.51 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.664 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 5.0 ptt? -147.63 25.13 1.08 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.52 0.2 . . . . 0.0 111.318 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -148.74 25.4 0.94 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.663 0.268 . . . . 0.0 111.679 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -81.5 114.32 20.15 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.763 0.316 . . . . 0.0 110.917 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.8 m -63.6 146.1 13.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.487 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.42 168.52 11.8 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.295 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 44.4 p30 -168.45 166.14 12.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.658 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -64.45 96.16 0.16 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.931 0.396 . . . . 0.0 110.343 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 118.77 24.25 3.14 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.529 -179.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -87.41 158.38 19.01 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.751 0.31 . . . . 0.0 111.045 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 53.5 m -138.31 136.93 36.91 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.264 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.4 p -143.26 120.33 5.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.607 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -125.09 147.94 48.77 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.528 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -118.74 104.42 10.58 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.174 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.469 HD12 HG23 ' A' ' 96' ' ' ILE . 30.0 mt -116.59 112.85 41.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.243 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 27.1 t -78.37 86.99 4.41 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.237 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.5 p -63.55 -69.4 0.27 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.374 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.9 168.04 9.79 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.585 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 -126.75 76.35 1.63 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.959 0.409 . . . . 0.0 110.785 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 124.52 -109.42 1.25 Allowed Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.152 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.164 0 CA-C-O 118.779 -1.012 . . . . 0.0 112.793 -179.942 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 120.678 0.275 . . . . 0.0 111.369 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.2 p -166.98 108.26 0.65 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.054 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 43.0 m-20 -86.88 -45.45 10.83 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.845 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 64.17 175.71 0.18 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.076 0.465 . . . . 0.0 111.639 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.491 ' O ' ' HB2' ' A' ' 6' ' ' HIS . 5.3 m120 -133.56 -162.88 1.29 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.528 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.491 ' HB2' ' O ' ' A' ' 5' ' ' ASN . 12.5 m-70 72.6 123.27 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 122.702 0.401 . . . . 0.0 111.049 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 6.5 mm -81.25 145.58 8.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.185 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.2 m -102.26 107.51 18.57 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.206 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.6 p -133.07 107.69 11.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.455 178.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.438 ' HB3' ' CB ' ' A' ' 24' ' ' SER . 1.4 pm0 -136.52 164.72 27.51 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.048 0.452 . . . . 0.0 111.75 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.441 ' CD1' ' HB3' ' A' ' 15' ' ' CYS . 15.2 m-85 -112.64 149.36 32.94 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.906 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -140.68 135.51 31.7 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.028 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.22 -107.03 3.44 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.315 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -121.84 30.5 5.27 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.784 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.441 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . 7.9 m -106.06 -19.96 13.56 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.798 0.299 . . . . 0.0 111.721 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -58.34 -30.45 66.73 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.804 0.335 . . . . 0.0 110.767 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 mp -70.03 -4.46 21.03 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.873 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 91.5 mt -77.09 7.79 4.61 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -149.92 -65.11 0.21 Allowed 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -172.09 39.14 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.772 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 52.18 35.77 17.54 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.892 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -76.13 -176.9 3.71 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.023 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 72.0 p -109.96 -77.42 0.6 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.806 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.438 ' CB ' ' HB3' ' A' ' 10' ' ' GLN . 80.8 p -135.73 162.9 31.47 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.876 0.37 . . . . 0.0 111.406 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -139.08 155.51 47.87 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.779 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.422 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 35.6 mt-30 -132.15 127.78 36.66 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.143 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.5 mt -102.68 136.51 42.37 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.018 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -129.82 126.77 38.85 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.872 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 63.39 48.64 76.86 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.024 -0.607 . . . . 0.0 112.776 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.6 t -122.11 43.02 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 120.992 0.425 . . . . 0.0 110.761 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.8 t 56.29 66.25 3.57 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.272 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.15 -12.6 28.04 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.616 2.21 . . . . 0.0 113.176 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.8 m -96.98 -57.39 2.29 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.69 0.281 . . . . 0.0 111.368 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -85.97 48.62 3.99 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.667 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.461 HG21 HD23 ' A' ' 40' ' ' LEU . 89.4 m -151.23 136.7 17.77 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.919 0.36 . . . . 0.0 110.692 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -111.9 -175.11 2.61 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.887 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.7 tt -57.65 -49.47 76.34 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -57.68 -31.95 66.87 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.233 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.42 -32.22 38.98 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 111.414 -0.674 . . . . 0.0 111.414 178.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.461 HD23 HG21 ' A' ' 35' ' ' THR . 0.6 OUTLIER -63.85 -51.68 63.56 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.669 0.271 . . . . 0.0 110.463 179.345 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.434 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -56.99 -56.21 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.835 179.558 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -51.41 -29.82 17.19 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.452 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.65 -28.31 58.69 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 4.4 pp -95.89 -36.6 11.04 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.417 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 2.4 pttt -86.07 -61.39 1.76 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.2 m -58.61 -23.13 58.22 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 122.253 -0.279 . . . . 0.0 111.569 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -96.65 -39.17 9.63 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 111.412 0.152 . . . . 0.0 111.412 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -150.24 59.76 0.97 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.417 ' HB ' ' O ' ' A' ' 45' ' ' LYS . 7.5 p -78.81 -42.27 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.436 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.02 14.12 6.22 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 120.662 0.268 . . . . 0.0 111.501 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -152.34 -160.81 1.19 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.0 mmt85 -87.16 108.15 17.79 Favored Pre-proline 0 C--N 1.331 -0.225 0 N-CA-C 110.412 -0.218 . . . . 0.0 110.412 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.43 -23.21 69.5 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.148 1.898 . . . . 0.0 112.515 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.401 ' HA ' ' CG2' ' A' ' 57' ' ' VAL . 48.8 m-20 -90.43 8.09 35.47 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 pp -92.7 -20.45 20.8 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 121.19 -0.204 . . . . 0.0 111.418 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.63 -45.63 4.18 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.401 ' CG2' ' HA ' ' A' ' 54' ' ' ASP . 5.8 m -52.8 149.88 1.34 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-O 121.135 0.493 . . . . 0.0 111.864 -179.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -65.76 -61.37 2.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.555 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -168.47 -44.47 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.311 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.3 p -80.14 4.68 16.59 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.615 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.54 21.38 60.25 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.433 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -112.63 -41.06 3.9 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.769 0.319 . . . . 0.0 110.594 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 16.8 p -110.77 -167.12 1.14 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.133 179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.4 mt -114.8 154.45 28.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.828 0.347 . . . . 0.0 111.06 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.69 150.46 81.84 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.063 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.79 127.42 24.58 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.875 2.383 . . . . 0.0 112.315 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 142.58 -45.01 0.94 Allowed Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.46 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.6 mt -88.43 141.35 14.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 120.803 0.335 . . . . 0.0 111.228 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 mt -105.48 99.85 9.44 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.79 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.3 m -78.76 135.51 25.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.007 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 mt -126.57 141.2 51.94 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.013 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.9 t -123.74 118.23 53.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.737 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 56.61 31.74 19.7 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.337 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 55.2 35.76 25.54 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.873 0.368 . . . . 0.0 111.113 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 11.2 t -141.89 37.55 1.61 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.922 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 67.37 134.59 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.27 0.557 . . . . 0.0 111.388 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -84.39 -22.81 30.34 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.434 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -77.84 -32.64 52.26 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.61 0.243 . . . . 0.0 110.859 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.2 t -69.21 -42.37 81.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.246 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.447 ' HB ' ' CD1' ' A' ' 85' ' ' TYR . 14.8 m -68.23 -31.22 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.561 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 142.68 42.08 0.06 OUTLIER Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.33 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 47.35 -119.03 4.45 Favored Glycine 0 C--N 1.336 0.574 0 C-N-CA 121.281 -0.485 . . . . 0.0 112.947 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -101.5 26.3 7.43 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.69 0.281 . . . . 0.0 111.134 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -120.2 23.64 10.84 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.369 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.447 ' CD1' ' HB ' ' A' ' 80' ' ' VAL . 28.4 t80 -93.24 130.25 39.0 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.864 0.364 . . . . 0.0 111.074 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.1 m -89.46 142.52 12.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.03 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.8 mp -83.72 174.22 10.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.947 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -135.01 -67.06 0.56 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.98 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -178.52 79.4 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.817 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 6' ' ' HIS . . . 113.48 37.3 1.33 Allowed Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.821 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.91 174.19 6.45 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.774 0.321 . . . . 0.0 110.931 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 58.4 m -132.42 116.08 16.36 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.953 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.9 p -128.81 119.93 50.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.019 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.423 ' HG2' ' HG2' ' A' ' 10' ' ' GLN . 39.9 mt-10 -124.92 146.56 49.29 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.3 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -121.72 104.81 9.86 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.346 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 27.7 mt -116.68 119.52 62.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.293 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.8 t -87.46 134.23 33.63 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.094 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.56 -53.18 0.72 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.239 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.77 86.17 6.94 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.986 0.422 . . . . 0.0 110.94 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -106.3 81.43 1.61 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.826 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -169.6 157.99 30.01 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.464 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.262 -1.299 . . . . 0.0 112.573 -179.995 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.5 m-70 . . . . . 0 N--CA 1.465 0.309 0 CA-C-O 120.904 0.383 . . . . 0.0 111.522 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.532 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 8.5 mm -104.05 143.18 16.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.648 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.674 HG22 HE22 ' A' ' 10' ' ' GLN . 32.1 m -111.09 93.47 4.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.563 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.636 HG13 ' HB2' ' A' ' 25' ' ' LEU . 7.8 p -114.59 102.65 14.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.15 0.5 . . . . 0.0 110.223 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.674 HE22 HG22 ' A' ' 8' ' ' THR . 0.2 OUTLIER -128.37 175.2 8.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.96 -178.556 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.527 ' CD1' ' HB3' ' A' ' 15' ' ' CYS . 49.8 m-85 -128.39 168.65 15.28 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.112 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.878 ' HB3' HG12 ' A' ' 96' ' ' ILE . . . -155.29 136.61 14.02 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.311 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.09 -106.29 3.14 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.216 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -122.98 31.7 4.65 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.727 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.527 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . 69.3 m -106.78 -16.62 14.44 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.466 ' HG2' ' HB2' ' A' ' 11' ' ' PHE . 68.5 mt-10 -58.58 -30.98 67.6 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.523 0.201 . . . . 0.0 111.05 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.439 HD12 ' H ' ' A' ' 17' ' ' LEU . 2.8 mp -70.57 -7.8 46.73 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.51 HD21 HD11 ' A' ' 55' ' ' LEU . 13.3 mt -83.57 12.08 6.22 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.425 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 38.5 t80 -147.32 -62.37 0.28 Allowed 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -176.7 36.28 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.067 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.47 35.86 12.1 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.895 0.378 . . . . 0.0 110.663 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -90.2 146.07 24.54 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.913 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.446 ' O ' ' HB2' ' A' ' 10' ' ' GLN . 7.3 p -75.97 -32.64 59.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.098 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.9 p -170.96 157.98 5.53 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.646 0.26 . . . . 0.0 111.145 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.636 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -135.95 154.36 51.13 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.819 0.343 . . . . 0.0 111.547 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.532 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 16.7 mt-30 -132.72 128.15 36.3 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.986 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.5 mt . . . . . 0 C--O 1.235 0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.78 179.851 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.6 m . . . . . 0 C--O 1.233 0.231 0 CA-C-O 120.695 0.283 . . . . 0.0 110.674 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -128.97 -178.59 4.69 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.169 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.721 ' O ' HG22 ' A' ' 41' ' ' VAL . 5.2 tt -57.77 -46.65 84.26 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -56.83 -33.76 67.07 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.719 0.295 . . . . 0.0 110.32 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.67 -30.1 49.75 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 121.001 -0.618 . . . . 0.0 111.983 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.457 HD13 ' O ' ' A' ' 40' ' ' LEU . 1.4 tm? -70.8 -47.33 60.05 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.674 0.237 . . . . 0.0 111.237 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.721 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -62.4 -53.34 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.866 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -53.41 -33.11 52.64 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.031 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.624 HD13 ' O ' ' A' ' 43' ' ' LEU . 0.6 OUTLIER -70.85 -24.78 62.59 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.302 179.468 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.596 HD23 ' HA ' ' A' ' 41' ' ' VAL . 0.8 OUTLIER -95.1 -42.18 8.73 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.692 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.447 ' O ' HG12 ' A' ' 49' ' ' VAL . 7.7 pttp -92.36 -60.86 1.73 Allowed 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.401 ' H ' ' HG3' ' A' ' 45' ' ' LYS . 1.5 m -54.57 -27.29 37.85 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 122.176 -0.328 . . . . 0.0 111.244 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 1.6 t30 -82.71 -26.65 31.82 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.461 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -135.59 -75.04 0.45 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.77 -0.195 . . . . 0.0 111.323 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.608 ' O ' HG13 ' A' ' 49' ' ' VAL . 13.0 p 40.41 89.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.396 0.678 . . . . 0.0 112.237 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -66.33 -53.7 33.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.228 179.616 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.543 ' HB3' HD21 ' A' ' 55' ' ' LEU . 1.8 tp10 -76.65 -179.47 5.33 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.798 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.449 ' HB2' HD23 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -55.12 113.91 6.23 Favored Pre-proline 0 N--CA 1.464 0.246 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.162 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.548 ' HA ' HG21 ' A' ' 49' ' ' VAL . 18.2 Cg_endo -60.66 -23.25 75.49 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.546 2.164 . . . . 0.0 112.5 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -90.28 5.55 46.71 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.639 ' HG ' HD23 ' A' ' 56' ' ' LEU . 1.5 pp -93.38 -21.42 19.54 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 122.379 -0.201 . . . . 0.0 111.484 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.639 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -100.14 -45.28 5.69 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -179.797 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.494 HG11 ' HA2' ' A' ' 61' ' ' GLY . 5.9 m -54.49 150.22 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.214 0.531 . . . . 0.0 111.66 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -66.79 -54.1 26.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.859 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.52 -43.0 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.441 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 71.4 p -87.42 11.06 15.52 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.494 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 58.55 23.09 54.02 Favored Glycine 0 C--N 1.338 0.674 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.645 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -110.17 -39.91 4.86 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.903 0.382 . . . . 0.0 110.585 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.1 p -121.4 -178.05 3.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.022 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.468 HD13 HD13 ' A' ' 68' ' ' ILE . 6.5 mt -110.16 155.93 21.3 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.875 0.369 . . . . 0.0 111.003 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.89 148.98 82.34 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.429 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -50.3 -32.43 33.15 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.249 2.632 . . . . 0.0 113.146 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -47.84 -36.0 13.14 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 121.391 -0.433 . . . . 0.0 113.144 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.468 HD13 HD13 ' A' ' 64' ' ' LEU . 5.1 mt -93.11 138.0 21.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.784 0.292 . . . . 0.0 111.063 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.497 ' CD2' HD21 ' A' ' 71' ' ' LEU . 13.4 tp -102.87 106.93 17.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.93 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.608 HG23 ' HB3' ' A' ' 77' ' ' ALA . 12.7 m -84.93 133.34 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.864 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.497 HD21 ' CD2' ' A' ' 69' ' ' LEU . 1.9 mt -134.65 141.27 46.53 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.433 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.657 HG23 ' CB ' ' A' ' 77' ' ' ALA . 38.2 t -119.04 121.92 67.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.591 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 59.52 45.13 13.83 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.075 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.33 39.59 18.62 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.203 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 17.9 t -153.88 153.98 33.06 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.581 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.43 ' CB ' HG23 ' A' ' 79' ' ' VAL . 69.6 m-20 -47.04 121.06 3.42 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.642 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.657 ' CB ' HG23 ' A' ' 72' ' ' VAL . . . -81.33 -19.03 43.68 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.684 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -77.53 -29.7 52.48 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.577 0.227 . . . . 0.0 110.838 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.43 HG23 ' CB ' ' A' ' 76' ' ' ASP . 43.7 t -65.24 -50.98 70.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.075 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.7 m -61.3 -36.03 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.521 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -176.78 -44.88 0.06 OUTLIER Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.773 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.41 -51.03 1.84 Allowed Glycine 0 C--N 1.335 0.51 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.213 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.402 ' HA ' HD22 ' A' ' 37' ' ' LEU . 3.9 ptt? -142.5 23.74 1.95 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 120.479 0.181 . . . . 0.0 111.217 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -140.35 26.75 2.15 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.46 ' CE2' HG11 ' A' ' 72' ' ' VAL . 33.5 t80 -84.85 98.15 10.14 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.82 0.343 . . . . 0.0 110.945 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.9 m -61.68 141.56 17.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.584 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.63 160.19 14.52 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.185 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -158.21 31.16 0.25 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.441 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 69.6 120.62 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.89 0.376 . . . . 0.0 110.897 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 97.28 33.66 5.88 Favored Glycine 0 CA--C 1.519 0.302 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.961 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -101.86 167.44 10.07 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.94 0.4 . . . . 0.0 111.476 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.588 HG23 ' HB ' ' A' ' 8' ' ' THR . 92.9 m -137.47 134.11 35.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.759 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.0 p -141.85 136.61 30.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.823 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -130.49 150.15 51.84 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.616 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -130.51 104.48 7.26 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.098 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.878 HG12 ' HB3' ' A' ' 12' ' ' ALA . 24.6 mt -118.99 115.4 47.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.035 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 46.6 t -81.24 140.36 34.93 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.284 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 21.3 p . . . . . 0 C--O 1.233 0.2 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.893 179.768 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.421 ' CD2' ' HB3' ' A' ' 26' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.26 0 CA-C-O 120.778 0.323 . . . . 0.0 111.071 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 33.3 mm -115.28 152.23 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.84 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.813 HG22 ' OE1' ' A' ' 10' ' ' GLN . 24.9 m -115.29 101.72 9.2 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.008 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.534 ' O ' HG13 ' A' ' 9' ' ' VAL . 10.8 p -120.43 108.54 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-O 121.007 0.432 . . . . 0.0 111.207 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.813 ' OE1' HG22 ' A' ' 8' ' ' THR . 0.0 OUTLIER -131.36 156.88 44.76 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.571 -179.892 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.424 ' HB2' ' HB3' ' A' ' 16' ' ' GLU . 33.2 m-85 -115.05 144.93 42.85 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.859 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.0 151.89 35.34 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.672 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.37 -86.84 1.11 Allowed Glycine 0 C--N 1.336 0.538 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.44 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -143.34 27.73 2.1 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.565 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.29 5.54 21.77 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.538 ' HG2' HD12 ' A' ' 17' ' ' LEU . 1.1 pm0 -93.1 -29.02 15.99 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.53 0.205 . . . . 0.0 111.046 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.538 HD12 ' HG2' ' A' ' 16' ' ' GLU . 5.0 mp -66.73 -15.56 63.62 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.656 ' HB2' HD21 ' A' ' 55' ' ' LEU . 3.6 pp -83.26 12.71 4.95 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -143.07 -66.5 0.37 Allowed 'General case' 0 CA--C 1.521 -0.135 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -175.78 36.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.31 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 mptt 49.7 34.92 7.95 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.865 0.364 . . . . 0.0 110.694 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -76.27 179.69 5.61 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.708 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.5 p -112.11 -74.55 0.63 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.01 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 87.9 p -135.74 156.81 48.24 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 120.777 0.322 . . . . 0.0 111.181 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.9 tp -150.13 166.56 29.43 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.688 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.494 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 1.0 OUTLIER -126.42 146.59 50.01 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.844 179.665 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.1 mt . . . . . 0 C--O 1.232 0.183 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.09 -179.532 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.2 m . . . . . 0 C--O 1.233 0.223 0 CA-C-O 120.799 0.333 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -111.33 -175.17 2.64 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.885 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.623 HD22 ' HA ' ' A' ' 83' ' ' MET . 0.6 OUTLIER -58.68 -42.85 89.47 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.756 -0.202 . . . . 0.0 111.1 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.403 ' OD1' ' HA ' ' A' ' 62' ' ' GLN . 5.5 t30 -55.68 -37.68 68.64 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.953 0.406 . . . . 0.0 109.948 178.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.75 -32.27 46.37 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.161 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.526 HD22 HD11 ' A' ' 87' ' ' LEU . 53.6 tp -62.83 -48.97 76.75 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.714 0.257 . . . . 0.0 110.591 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.617 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -62.16 -57.01 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.847 179.612 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -55.82 -28.15 54.84 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 120.498 0.189 . . . . 0.0 111.08 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.411 ' O ' ' HB2' ' A' ' 47' ' ' ASN . 7.1 tt -84.71 -21.86 29.97 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.848 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.466 HD12 ' C ' ' A' ' 44' ' ' LEU . 1.2 pp -93.89 -41.08 9.81 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.418 ' HG2' ' H ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -70.72 -56.48 6.29 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.77 -179.677 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.418 ' H ' ' HG2' ' A' ' 45' ' ' LYS . 10.6 m -60.69 -20.33 60.78 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.554 0.216 . . . . 0.0 110.814 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.4 OUTLIER -67.45 -44.19 79.27 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.944 179.474 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -146.43 -62.83 0.31 Allowed 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.575 ' O ' HG13 ' A' ' 49' ' ' VAL . 13.2 p 42.91 86.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.469 0.652 . . . . 0.0 112.017 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.78 -48.17 80.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.214 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.513 ' O ' HG22 ' A' ' 49' ' ' VAL . 0.2 OUTLIER -91.61 -156.23 0.44 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.651 -0.249 . . . . 0.0 110.564 179.683 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.423 ' N ' HD23 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -66.88 138.01 95.03 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-O 120.755 0.312 . . . . 0.0 111.583 -179.507 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.527 ' HA ' HG21 ' A' ' 49' ' ' VAL . 73.7 Cg_endo -77.77 -29.9 4.16 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.562 2.174 . . . . 0.0 112.468 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.479 ' OD1' HG23 ' A' ' 57' ' ' VAL . 4.1 t0 -94.43 10.67 33.5 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.656 HD21 ' HB2' ' A' ' 18' ' ' LEU . 3.4 pp -77.85 -25.96 49.07 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.543 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.584 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -97.4 -50.77 4.4 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.387 179.952 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.534 HG11 ' HA2' ' A' ' 61' ' ' GLY . 1.3 m -60.99 149.66 7.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.209 0.528 . . . . 0.0 111.268 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -61.46 -61.3 2.63 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.299 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -171.08 -43.74 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.269 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 38.9 p -85.07 11.43 9.67 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.807 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.534 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 54.08 27.99 39.92 Favored Glycine 0 C--N 1.34 0.779 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.539 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.403 ' HA ' ' OD1' ' A' ' 38' ' ' ASN . 16.6 tt0 -113.97 -44.66 3.13 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.983 0.42 . . . . 0.0 110.332 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.4 t -122.98 139.89 53.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.948 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.509 HD22 ' HB2' ' A' ' 56' ' ' LEU . 7.2 mt -66.76 154.84 39.74 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.872 0.368 . . . . 0.0 110.911 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.5 156.05 89.04 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.194 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.48 140.54 74.5 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.844 2.362 . . . . 0.0 112.37 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.61 -47.72 1.0 Allowed Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.255 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.506 HD13 HD13 ' A' ' 64' ' ' LEU . 6.4 mt -79.93 149.96 5.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-O 120.867 0.365 . . . . 0.0 110.984 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.3 mt -128.41 104.3 7.63 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.783 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.617 HG23 ' HB3' ' A' ' 77' ' ' ALA . 30.6 m -77.37 123.62 34.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.833 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.475 HD23 ' O ' ' A' ' 70' ' ' VAL . 5.3 mt -124.8 141.46 52.1 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.375 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.739 HG23 ' HB2' ' A' ' 77' ' ' ALA . 36.6 t -109.34 107.0 21.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.526 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 59.35 55.44 4.23 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.899 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.0 t 57.71 49.2 12.72 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.312 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 52.4 t -162.41 143.63 10.38 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.784 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.3 122.2 9.86 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.913 0.387 . . . . 0.0 111.193 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.739 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -75.29 -19.98 59.37 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.901 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -71.52 -24.99 62.06 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 116.728 -0.215 . . . . 0.0 111.172 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.9 t -56.18 -32.51 34.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.017 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.6 m -105.67 -38.92 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.629 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -154.95 -56.7 0.01 OUTLIER Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.017 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 99.29 -53.16 1.04 Allowed Glycine 0 C--N 1.333 0.4 0 C-N-CA 121.125 -0.56 . . . . 0.0 112.448 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.623 ' HA ' HD22 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -136.6 23.74 3.15 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.546 0.213 . . . . 0.0 111.4 179.862 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -142.74 27.06 1.69 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.733 0.271 . . . . 0.0 111.733 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -77.74 117.38 19.08 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.77 0.319 . . . . 0.0 110.944 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.7 m -75.28 136.06 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.272 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.526 HD11 HD22 ' A' ' 40' ' ' LEU . 2.6 mp -86.48 162.19 18.21 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.294 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -146.13 33.5 1.0 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.403 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 60.42 27.34 16.94 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.396 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -169.59 40.01 0.2 Allowed Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.937 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -103.85 166.55 10.35 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.062 0.458 . . . . 0.0 111.253 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.512 HG23 ' HB ' ' A' ' 8' ' ' THR . 78.9 m -127.81 137.07 52.25 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.434 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.8 p -142.22 134.21 26.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.991 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -133.39 138.81 46.45 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.316 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -110.17 105.64 14.8 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.356 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 10.9 mt -110.85 100.76 11.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.074 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -84.08 110.58 18.58 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.036 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 22.7 p . . . . . 0 C--O 1.233 0.218 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.983 179.888 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.725 0.298 . . . . 0.0 111.316 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 16.1 mm -90.97 157.16 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.562 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.626 HG22 HE22 ' A' ' 10' ' ' GLN . 30.3 m -124.91 93.74 3.98 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.807 0.336 . . . . 0.0 111.521 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.546 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.6 p -113.23 103.6 15.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.183 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.626 HE22 HG22 ' A' ' 8' ' ' THR . 0.1 OUTLIER -131.74 166.9 20.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.744 -178.97 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.534 ' HB2' ' HG2' ' A' ' 16' ' ' GLU . 41.6 m-85 -125.0 163.52 22.16 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.874 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.412 ' O ' ' HA ' ' A' ' 96' ' ' ILE . . . -175.17 119.51 0.19 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.053 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.67 54.89 0.76 Allowed Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.582 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.26 25.96 72.48 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.199 -0.524 . . . . 0.0 113.478 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -116.44 5.35 13.43 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 117.091 0.445 . . . . 0.0 111.675 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.534 ' HG2' ' HB2' ' A' ' 11' ' ' PHE . 64.1 mt-10 -84.17 -23.29 30.67 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.73 -4.92 21.86 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.513 ' CD2' HD11 ' A' ' 55' ' ' LEU . 24.7 mt -78.88 8.73 5.06 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -149.39 -63.58 0.22 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.788 0.328 . . . . 0.0 110.149 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -174.84 38.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.848 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.93 35.8 20.15 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.241 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -80.48 178.37 8.37 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.963 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 28.1 p -107.69 -74.65 0.65 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.994 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.405 ' O ' HD12 ' A' ' 25' ' ' LEU . 88.0 p -132.99 160.58 36.71 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.829 0.347 . . . . 0.0 111.355 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.416 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -141.55 152.81 44.42 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.181 -179.935 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.458 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 1.7 mt-30 -131.06 122.32 26.55 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.6 mt . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.338 179.674 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 58.9 m . . . . . 0 CA--C 1.532 0.285 0 CA-C-O 120.61 0.243 . . . . 0.0 110.984 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -131.81 -179.55 5.46 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.896 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.657 ' O ' HG22 ' A' ' 41' ' ' VAL . 6.4 tt -53.47 -48.36 68.94 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 111.514 0.19 . . . . 0.0 111.514 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -52.99 -36.35 60.28 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.812 0.339 . . . . 0.0 110.388 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.3 -31.05 43.33 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.137 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.439 HD23 HD21 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -66.84 -51.49 54.89 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.633 0.254 . . . . 0.0 110.72 179.702 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.657 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.2 OUTLIER -60.7 -57.34 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.915 179.776 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.421 ' H ' HG23 ' A' ' 41' ' ' VAL . 0.4 OUTLIER -52.57 -29.33 25.05 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.319 179.571 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 30.5 tp -74.53 -27.59 60.6 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.547 HD12 ' N ' ' A' ' 45' ' ' LYS . 3.5 pp -96.93 -38.61 9.75 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.547 ' N ' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -84.16 -70.91 0.54 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.411 -179.793 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.3 m -53.24 -24.32 10.95 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 111.863 0.319 . . . . 0.0 111.863 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -102.45 -23.3 13.94 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -147.84 50.17 1.05 Allowed 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.607 HG22 ' H ' ' A' ' 51' ' ' GLU . 9.6 p -99.88 122.72 52.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.871 0.367 . . . . 0.0 110.987 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -100.79 33.05 2.91 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.888 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.607 ' H ' HG22 ' A' ' 49' ' ' VAL . 1.7 tp10 -160.21 -161.79 0.92 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.111 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 54.5 mtt-85 -88.87 109.88 33.47 Favored Pre-proline 0 CA--C 1.529 0.172 0 CA-C-O 120.418 0.152 . . . . 0.0 110.894 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.736 ' HA ' HD21 ' A' ' 56' ' ' LEU . 78.0 Cg_exo -48.41 -30.11 14.87 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.724 2.283 . . . . 0.0 112.929 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.19 -17.17 64.56 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.687 ' HG ' HD23 ' A' ' 56' ' ' LEU . 2.5 pp -80.38 -15.19 57.43 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.736 HD21 ' HA ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -108.65 -49.15 3.2 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.712 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.722 HG22 ' O ' ' A' ' 53' ' ' PRO . 2.9 m -57.34 148.38 5.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.078 0.466 . . . . 0.0 111.467 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -71.33 -59.72 2.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.913 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -162.96 -56.42 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.229 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.6 p -59.51 -21.2 59.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.2 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.76 21.59 49.97 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 121.149 -0.548 . . . . 0.0 111.862 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -124.45 -46.34 1.9 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.792 0.33 . . . . 0.0 110.974 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.0 t -101.91 130.91 48.52 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.701 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.519 HD22 ' HB2' ' A' ' 56' ' ' LEU . 5.7 mt -65.91 155.29 36.87 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.806 0.336 . . . . 0.0 111.123 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -53.21 143.76 32.46 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.324 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -51.57 -33.39 47.97 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.181 2.587 . . . . 0.0 112.98 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -49.49 -35.39 21.75 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.348 -0.453 . . . . 0.0 112.914 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.464 HD13 HD13 ' A' ' 64' ' ' LEU . 7.9 mt -82.81 114.4 23.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.83 0.315 . . . . 0.0 110.787 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.61 97.01 8.28 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.198 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.452 ' O ' HD23 ' A' ' 71' ' ' LEU . 19.3 t -84.87 136.33 23.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.041 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.452 HD23 ' O ' ' A' ' 70' ' ' VAL . 3.6 mt -125.62 126.68 45.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.89 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.59 HG23 ' HA ' ' A' ' 77' ' ' ALA . 38.4 t -110.23 118.76 57.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.878 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.4 m120 55.29 35.02 24.04 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.363 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.1 t 56.18 33.16 21.56 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.306 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 9.3 t -138.02 31.11 2.46 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.841 0.353 . . . . 0.0 111.01 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.669 ' HB3' HG23 ' A' ' 79' ' ' VAL . 0.4 OUTLIER 69.05 145.28 0.05 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.371 179.809 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.59 ' HA ' HG23 ' A' ' 72' ' ' VAL . . . -85.08 -22.73 28.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.594 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -82.28 -33.5 29.07 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.755 -0.202 . . . . 0.0 110.993 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.669 HG23 ' HB3' ' A' ' 76' ' ' ASP . 39.5 t -66.16 -41.9 90.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.26 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.486 ' HB ' ' CD1' ' A' ' 85' ' ' TYR . 26.8 m -69.41 -29.13 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 168.3 -34.37 0.2 Allowed Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.339 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 109.25 -55.69 0.5 Allowed Glycine 0 C--N 1.333 0.416 0 N-CA-C 111.823 -0.511 . . . . 0.0 111.823 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.538 ' HA ' HD22 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -157.69 27.94 0.28 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.461 0.172 . . . . 0.0 111.289 179.4 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -135.42 20.55 3.38 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.573 ' CD2' HG11 ' A' ' 72' ' ' VAL . 34.1 t80 -68.56 112.09 5.14 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.787 0.327 . . . . 0.0 110.961 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.2 m -71.04 135.47 27.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.272 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.439 HD21 HD23 ' A' ' 40' ' ' LEU . 0.7 OUTLIER -79.83 152.99 29.41 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.023 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -155.23 -59.72 0.11 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.055 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -173.03 116.09 0.28 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.137 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 80.26 34.26 29.93 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.826 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -75.39 99.09 4.04 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.84 0.352 . . . . 0.0 110.358 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 16.0 m -81.77 127.84 33.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.56 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.46 ' O ' HG13 ' A' ' 93' ' ' VAL . 7.7 p -139.02 113.96 8.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.011 0.434 . . . . 0.0 110.926 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -114.98 149.89 36.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.119 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -123.91 104.71 9.09 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.419 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 12' ' ' ALA . 29.3 mt -114.12 101.97 13.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.323 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.0 m -72.94 97.93 2.38 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.089 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.7 m . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.978 179.985 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 25.0 p-80 . . . . . 0 C--O 1.234 0.251 0 CA-C-O 120.79 0.329 . . . . 0.0 111.515 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 33.9 mm -95.79 137.84 22.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.692 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.698 HG22 ' OE1' ' A' ' 10' ' ' GLN . 1.9 m -96.26 98.88 10.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.201 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.537 HG13 ' HB2' ' A' ' 25' ' ' LEU . 8.1 p -122.47 108.7 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-O 120.92 0.39 . . . . 0.0 110.559 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.698 ' OE1' HG22 ' A' ' 8' ' ' THR . 1.4 pm0 -135.2 158.91 43.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.396 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.402 ' CB ' ' HA ' ' A' ' 16' ' ' GLU . 31.0 m-85 -126.75 145.47 50.6 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.124 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.548 ' HB2' HG12 ' A' ' 96' ' ' ILE . . . -92.74 179.99 5.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.303 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.6 97.43 0.12 Allowed Glycine 0 C--N 1.335 0.504 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.6 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 135.16 -40.95 1.49 Allowed Glycine 0 C--N 1.333 0.364 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.807 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.05 -23.95 18.48 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.441 0.162 . . . . 0.0 111.418 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.41 ' HG3' ' HA ' ' A' ' 21' ' ' LYS . 6.9 pt-20 -58.43 -26.92 63.83 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 111.679 0.251 . . . . 0.0 111.679 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 mp -68.59 -8.46 41.98 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.919 HD21 HD11 ' A' ' 55' ' ' LEU . 25.3 mt -83.26 13.43 4.26 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -148.46 -59.11 0.24 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.743 0.306 . . . . 0.0 110.253 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -178.67 36.49 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.079 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.41 ' HA ' ' HG3' ' A' ' 16' ' ' GLU . 0.0 OUTLIER 50.54 34.53 9.66 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.952 0.406 . . . . 0.0 110.764 -179.403 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -78.84 173.25 12.7 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.021 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.2 p -107.97 -45.21 4.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.947 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 94.3 p -159.7 158.87 32.16 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.592 0.234 . . . . 0.0 111.238 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.537 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -146.95 163.6 35.63 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.232 -179.703 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.24 100.8 5.32 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.855 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.0 mt . . . . . 0 C--O 1.233 0.191 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.663 179.952 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.4 m . . . . . 0 C--O 1.233 0.235 0 CA-C-O 120.641 0.258 . . . . 0.0 111.075 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -136.02 -174.09 3.57 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.05 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.674 ' O ' HG22 ' A' ' 41' ' ' VAL . 5.5 tt -56.82 -45.5 82.28 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.731 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -54.69 -38.63 67.22 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.03 -32.96 58.02 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.015 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.534 ' CG ' HD11 ' A' ' 87' ' ' LEU . 11.6 mt -65.61 -57.03 9.11 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.629 0.252 . . . . 0.0 110.65 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.3 OUTLIER -55.27 -56.89 9.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.994 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.414 ' H ' HG23 ' A' ' 41' ' ' VAL . 2.4 tt0 -51.02 -29.89 13.8 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.464 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.24 -28.49 57.15 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.76 HD12 ' N ' ' A' ' 45' ' ' LYS . 4.0 pp -94.91 -33.03 12.94 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.76 ' N ' HD12 ' A' ' 44' ' ' LEU . 4.4 pttt -92.49 -61.05 1.68 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 111.595 0.221 . . . . 0.0 111.595 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -58.29 -20.23 41.02 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 122.126 -0.359 . . . . 0.0 111.306 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -105.68 -30.14 9.65 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -146.63 48.45 1.17 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.435 ' HB ' ' O ' ' A' ' 45' ' ' LYS . 7.5 p -80.81 -32.81 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.07 20.82 0.65 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 122.544 0.338 . . . . 0.0 111.642 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -158.73 -166.4 1.87 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.242 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.652 ' HB3' HD23 ' A' ' 55' ' ' LEU . 3.0 ttt180 -70.67 110.91 7.97 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-O 120.601 0.238 . . . . 0.0 110.752 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.32 -22.23 70.16 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.37 2.047 . . . . 0.0 112.347 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.403 ' HA ' ' CG2' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -93.19 8.23 41.03 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.919 HD11 HD21 ' A' ' 18' ' ' LEU . 2.7 pp -88.85 -7.75 55.56 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 122.239 -0.288 . . . . 0.0 111.534 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.66 HD13 HD13 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -117.93 -47.68 2.59 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 179.782 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.5 HG11 ' HA2' ' A' ' 61' ' ' GLY . 2.7 m -53.58 150.35 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-O 121.275 0.56 . . . . 0.0 111.396 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.789 ' HB2' HG23 ' A' ' 63' ' ' THR . 25.7 t0 -62.7 -57.15 12.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.598 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.08 -43.16 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.354 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 31.9 p -86.5 10.09 16.35 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.752 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.5 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 58.88 21.96 53.23 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.484 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -107.77 -42.05 4.83 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.901 0.382 . . . . 0.0 110.461 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.789 HG23 ' HB2' ' A' ' 58' ' ' ASP . 12.1 t -118.74 -167.78 1.43 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.097 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.48 HD13 HD13 ' A' ' 68' ' ' ILE . 10.6 mt -111.75 157.58 20.35 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.979 0.418 . . . . 0.0 111.689 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.429 ' HB2' ' HD2' ' A' ' 66' ' ' PRO . 0.5 OUTLIER -78.18 156.93 78.88 Favored Pre-proline 0 C--O 1.233 0.206 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.949 179.859 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.429 ' HD2' ' HB2' ' A' ' 65' ' ' ARG . 10.7 Cg_endo -55.22 134.33 63.21 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.637 2.225 . . . . 0.0 112.472 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 133.73 -47.99 0.97 Allowed Glycine 0 C--N 1.331 0.292 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.185 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.48 HD13 HD13 ' A' ' 64' ' ' LEU . 5.8 mt -86.02 137.03 21.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-O 120.678 0.275 . . . . 0.0 111.092 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.902 HD23 HD21 ' A' ' 71' ' ' LEU . 1.0 OUTLIER -107.74 106.65 17.06 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.674 179.717 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.523 ' O ' HD23 ' A' ' 71' ' ' LEU . 16.5 m -83.11 128.39 38.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.876 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.902 HD21 HD23 ' A' ' 69' ' ' LEU . 1.5 mt -132.69 136.82 46.67 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.566 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.859 HG23 ' HB2' ' A' ' 77' ' ' ALA . 38.5 t -108.95 102.86 14.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.374 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 60.36 57.41 2.88 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.764 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.2 m 57.69 49.33 12.55 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.594 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 50.3 t -163.12 137.56 6.25 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.818 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -54.02 124.99 17.16 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.823 0.345 . . . . 0.0 111.276 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.859 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -82.1 -23.38 35.74 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.239 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -70.08 -14.18 62.55 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 111.466 0.173 . . . . 0.0 111.466 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.2 t -74.05 -30.27 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 111.679 0.251 . . . . 0.0 111.679 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.431 HG23 ' N ' ' A' ' 81' ' ' GLY . 18.8 m -115.73 -43.69 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.431 ' N ' HG23 ' A' ' 80' ' ' VAL . . . -176.04 72.61 0.08 OUTLIER Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.409 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.489 ' O ' HD13 ' A' ' 37' ' ' LEU . . . -49.93 -28.37 11.94 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 121.525 -0.369 . . . . 0.0 113.352 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.548 ' HA ' HD22 ' A' ' 37' ' ' LEU . 1.1 ptt? -132.15 29.09 4.38 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.726 0.298 . . . . 0.0 110.56 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -149.52 30.51 0.75 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.491 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.687 ' CZ ' HG11 ' A' ' 72' ' ' VAL . 1.6 t80 -86.83 115.99 24.61 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.827 0.346 . . . . 0.0 111.281 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 29.8 m -66.23 168.61 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.341 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.534 HD11 ' CG ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -116.84 178.74 4.23 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.193 0.521 . . . . 0.0 111.546 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -160.96 -82.77 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.054 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -173.91 33.57 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.877 0.37 . . . . 0.0 111.455 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 178.72 37.55 0.06 OUTLIER Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.429 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -82.52 149.38 27.56 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.779 0.323 . . . . 0.0 110.965 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.604 HG23 ' HB ' ' A' ' 8' ' ' THR . 61.8 m -119.43 133.18 55.83 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.401 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.3 p -141.95 127.46 17.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.907 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -128.67 145.08 51.26 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.284 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -123.29 104.59 9.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.233 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.548 HG12 ' HB2' ' A' ' 12' ' ' ALA . 30.0 mt -116.71 109.18 27.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.274 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.5 m -80.24 149.8 30.29 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.137 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 32.0 p . . . . . 0 C--N 1.332 -0.173 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.014 179.913 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 37.3 p-80 . . . . . 0 N--CA 1.463 0.179 0 CA-C-O 120.81 0.338 . . . . 0.0 111.509 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.557 HD13 ' H ' ' A' ' 90' ' ' GLY . 23.5 mm -99.1 146.11 9.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.847 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.449 ' HB ' ' HA ' ' A' ' 92' ' ' THR . 89.1 m -104.85 118.63 37.02 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.084 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.707 HG23 HG13 ' A' ' 93' ' ' VAL . 8.4 p -149.47 112.64 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.798 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.445 ' HB3' ' CB ' ' A' ' 24' ' ' SER . 6.2 pm0 -136.35 162.43 33.03 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.953 0.406 . . . . 0.0 111.74 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -120.8 141.75 50.23 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.164 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.32 150.76 46.93 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.387 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.32 -109.57 2.86 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.453 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -115.59 29.63 7.12 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.944 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.73 -8.11 14.19 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.984 0.392 . . . . 0.0 111.692 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -93.69 -25.32 17.51 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.573 0.225 . . . . 0.0 111.008 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.11 -7.13 47.3 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.552 ' HB3' HD11 ' A' ' 55' ' ' LEU . 3.6 pp -85.74 13.71 6.84 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -145.11 -64.11 0.34 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.922 0.391 . . . . 0.0 109.987 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -175.59 38.8 0.01 OUTLIER 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.561 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.3 mptt 51.2 40.52 26.18 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.362 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.612 ' OE1' HD21 ' A' ' 25' ' ' LEU . 29.5 pt20 -67.23 171.98 5.22 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.918 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 62.3 p -114.09 -80.06 0.59 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.006 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.445 ' CB ' ' HB3' ' A' ' 10' ' ' GLN . 88.5 p -133.08 154.71 50.31 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.85 0.357 . . . . 0.0 111.409 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.612 HD21 ' OE1' ' A' ' 22' ' ' GLN . 0.4 OUTLIER -131.62 160.93 33.92 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.178 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 1.1 tt0 -131.17 120.92 23.99 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.032 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.5 mt . . . . . 0 C--O 1.234 0.287 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.739 179.726 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 89.3 m . . . . . 0 C--O 1.235 0.303 0 CA-C-O 120.826 0.346 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 44.9 p30 -116.94 -174.95 2.68 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.967 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.836 HD22 ' HA ' ' A' ' 83' ' ' MET . 5.3 tt -57.78 -41.76 82.74 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.004 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -51.68 -43.14 62.62 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.229 178.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.36 -31.11 61.56 Favored Glycine 0 C--N 1.334 0.472 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.549 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -70.7 -56.92 5.31 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.876 0.338 . . . . 0.0 110.955 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.766 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.5 OUTLIER -56.98 -56.04 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.361 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.425 ' HA ' ' CG ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -50.93 -29.85 13.24 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.733 179.785 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.434 ' HA ' ' HB2' ' A' ' 47' ' ' ASN . 0.7 OUTLIER -70.18 -34.5 73.05 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.357 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.616 HD12 ' N ' ' A' ' 45' ' ' LYS . 4.4 pp -96.99 -25.2 15.47 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.449 0.536 . . . . 0.0 112.449 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.616 ' N ' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -93.02 -32.88 14.34 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.967 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.0 m -108.64 -26.04 10.57 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.434 ' HB2' ' HA ' ' A' ' 43' ' ' LEU . 2.9 m-80 -109.51 -22.38 12.02 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -178.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.69 39.82 3.16 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.563 HG22 ' H ' ' A' ' 51' ' ' GLU . 10.4 p -98.38 143.11 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 120.85 0.357 . . . . 0.0 110.866 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.77 27.88 4.59 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.4 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.563 ' H ' HG22 ' A' ' 49' ' ' VAL . 2.2 tp10 -156.71 -166.98 2.25 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.52 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.475 ' HB2' HD23 ' A' ' 55' ' ' LEU . 2.4 mpt_? -57.95 111.03 2.99 Favored Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 116.935 -0.121 . . . . 0.0 110.889 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.544 ' O ' HG22 ' A' ' 57' ' ' VAL . 18.9 Cg_endo -59.51 -25.95 80.41 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.164 1.909 . . . . 0.0 112.209 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.454 ' HA ' HG22 ' A' ' 57' ' ' VAL . 5.9 m-20 -90.66 7.0 41.6 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.637 ' HG ' HD23 ' A' ' 56' ' ' LEU . 1.7 pp -89.19 -15.76 32.94 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 121.161 -0.216 . . . . 0.0 111.256 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.637 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -115.34 -47.17 2.85 Favored 'General case' 0 C--N 1.339 0.11 0 N-CA-C 111.499 0.185 . . . . 0.0 111.499 179.872 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.544 HG22 ' O ' ' A' ' 53' ' ' PRO . 21.4 m -58.41 147.05 7.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 121.119 0.485 . . . . 0.0 111.837 -179.122 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -67.19 -57.23 7.11 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.468 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -171.59 -43.7 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.357 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 46.9 p -81.62 7.28 12.66 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.406 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 56.34 23.99 43.6 Favored Glycine 0 C--N 1.343 0.928 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.334 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -108.79 -39.32 5.38 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 120.753 0.311 . . . . 0.0 110.569 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 11.3 t -132.14 165.02 25.01 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.13 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.747 HD13 HD13 ' A' ' 68' ' ' ILE . 5.0 mt -77.55 157.76 30.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.906 0.384 . . . . 0.0 110.781 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.43 ' HG3' HD12 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -61.12 153.21 68.2 Favored Pre-proline 0 N--CA 1.465 0.292 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.254 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -49.02 -32.66 24.12 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.926 2.417 . . . . 0.0 112.591 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -51.27 -34.39 32.95 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.858 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.747 HD13 HD13 ' A' ' 64' ' ' LEU . 5.1 mt -97.19 148.7 5.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 116.855 0.327 . . . . 0.0 110.708 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.29 118.58 32.66 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.017 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.405 ' O ' HD23 ' A' ' 71' ' ' LEU . 16.6 m -90.37 129.53 41.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.937 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.405 HD23 ' O ' ' A' ' 70' ' ' VAL . 4.0 mt -125.49 130.43 51.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.166 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.816 HG23 ' HB2' ' A' ' 77' ' ' ALA . 26.3 t -105.0 99.48 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.465 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.1 m120 58.68 55.41 4.74 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.936 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.5 t 61.38 42.08 12.11 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.24 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 53.2 t -160.13 121.94 3.22 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.781 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.517 ' CB ' HG23 ' A' ' 79' ' ' VAL . 11.1 m-20 -48.93 131.59 18.67 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.729 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.816 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -79.48 -26.27 41.69 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.973 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -72.72 -25.55 61.26 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.489 0.185 . . . . 0.0 111.119 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.517 HG23 ' CB ' ' A' ' 76' ' ' ASP . 49.0 t -62.11 -29.59 46.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.017 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.8 m -112.46 -39.26 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -137.41 -72.96 0.06 OUTLIER Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.858 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 119.92 -42.21 1.8 Allowed Glycine 0 C--N 1.334 0.453 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.386 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.836 ' HA ' HD22 ' A' ' 37' ' ' LEU . 3.0 ptt? -157.42 29.35 0.29 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.743 0.306 . . . . 0.0 110.755 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -145.84 22.11 1.43 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.581 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.466 ' CE1' HG11 ' A' ' 72' ' ' VAL . 4.4 t80 -72.39 120.37 17.91 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 122.348 -0.22 . . . . 0.0 111.275 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.7 m -61.73 125.37 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.206 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.32 169.11 16.87 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.039 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -164.4 165.76 21.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.858 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -57.23 103.08 0.1 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.1 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.557 ' H ' HD13 ' A' ' 7' ' ' ILE . . . 106.14 24.65 6.77 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 121.108 -0.568 . . . . 0.0 113.016 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.02 138.88 39.86 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.928 0.364 . . . . 0.0 110.543 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.449 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 86.1 m -113.15 115.24 27.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.117 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.707 HG13 HG23 ' A' ' 9' ' ' VAL . 11.8 p -125.27 111.22 26.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 121.04 0.448 . . . . 0.0 110.633 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -114.92 151.38 34.14 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.176 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.548 ' HB3' HG21 ' A' ' 68' ' ' ILE . 15.7 m-85 -129.57 104.36 7.4 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.531 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.9 mt -106.24 100.44 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.887 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.8 106.64 7.49 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.47 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.5 p . . . . . 0 CA--C 1.536 0.415 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.741 -179.947 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.513 ' C ' HD12 ' A' ' 7' ' ' ILE . 55.9 m80 . . . . . 0 N--CA 1.464 0.26 0 CA-C-O 120.721 0.296 . . . . 0.0 110.72 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.513 HD12 ' C ' ' A' ' 6' ' ' HIS . 2.0 mp -113.32 135.06 54.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-O 120.931 0.396 . . . . 0.0 111.152 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.55 HG22 ' OE1' ' A' ' 10' ' ' GLN . 83.5 m -88.75 96.63 10.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.983 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.56 HG13 ' HB2' ' A' ' 25' ' ' LEU . 11.8 p -117.79 113.49 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.206 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.55 ' OE1' HG22 ' A' ' 8' ' ' THR . 8.8 pm0 -137.08 166.87 22.69 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.931 0.396 . . . . 0.0 111.899 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -126.67 150.14 49.14 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.24 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.696 ' HB3' HG12 ' A' ' 96' ' ' ILE . . . -146.55 158.18 43.86 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.559 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 67.96 -100.48 0.64 Allowed Glycine 0 C--N 1.336 0.537 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.459 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -124.04 33.16 3.96 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.586 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.7 m -109.7 -16.23 13.97 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.452 ' HG2' ' N ' ' A' ' 17' ' ' LEU . 12.7 pm0 -81.81 -33.57 30.71 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.702 0.286 . . . . 0.0 111.143 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.452 ' N ' ' HG2' ' A' ' 16' ' ' GLU . 1.4 mp -60.98 -28.19 68.83 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.033 0.382 . . . . 0.0 112.033 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.598 ' O ' HD12 ' A' ' 18' ' ' LEU . 2.9 pp -82.87 11.8 5.63 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.454 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 40.7 t80 -133.09 -60.01 0.87 Allowed 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.454 ' HB2' ' O ' ' A' ' 19' ' ' PHE . . . 174.27 36.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.031 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.56 32.16 4.7 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.902 0.382 . . . . 0.0 110.97 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -80.16 168.55 18.96 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.106 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.408 ' O ' ' HB2' ' A' ' 10' ' ' GLN . 16.3 p -101.93 -74.24 0.63 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.852 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.427 ' CB ' ' HB3' ' A' ' 10' ' ' GLN . 89.1 p -137.15 154.98 50.12 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.742 0.306 . . . . 0.0 111.198 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.56 ' HB2' HG13 ' A' ' 9' ' ' VAL . 4.8 mp -140.43 165.41 27.5 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.391 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.465 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 0.5 OUTLIER -131.27 119.34 21.64 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.827 179.783 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.3 mt . . . . . 0 C--O 1.233 0.188 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.916 -179.903 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 28.7 m . . . . . 0 N--CA 1.463 0.179 0 CA-C-O 120.692 0.282 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -105.26 -172.57 2.12 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.765 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.694 HD22 ' HA ' ' A' ' 83' ' ' MET . 1.0 OUTLIER -55.52 -35.66 65.89 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.335 -179.638 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -54.86 -40.58 69.81 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.88 0.371 . . . . 0.0 110.087 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.15 -30.04 63.59 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.801 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.627 HD21 HG11 ' A' ' 93' ' ' VAL . 10.0 tt -63.37 -49.73 72.69 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.819 0.342 . . . . 0.0 110.692 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.538 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -67.35 -52.18 44.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.728 179.767 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -54.72 -23.55 18.18 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.778 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.454 ' O ' ' HB3' ' A' ' 47' ' ' ASN . 4.6 tt -85.4 -22.95 28.14 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.878 0.371 . . . . 0.0 110.577 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.636 HD13 ' C ' ' A' ' 44' ' ' LEU . 1.2 tm? -92.48 -50.21 5.74 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.949 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.524 ' N ' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -89.33 -72.8 0.53 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 111.565 0.209 . . . . 0.0 111.565 -179.843 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.8 m -49.46 -24.63 2.11 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.454 ' HB3' ' O ' ' A' ' 43' ' ' LEU . 10.1 t30 -106.1 -25.99 11.8 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -138.58 45.52 2.04 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.461 ' HB ' ' O ' ' A' ' 45' ' ' LYS . 10.6 p -104.42 152.41 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.168 0.508 . . . . 0.0 111.478 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.01 -40.48 1.05 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.674 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -79.94 -167.03 1.13 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.313 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.406 ' HA ' ' HD2' ' A' ' 53' ' ' PRO . 0.4 OUTLIER -63.53 111.37 5.03 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.021 -179.94 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 52' ' ' ARG . 18.1 Cg_endo -60.45 -25.25 80.06 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.275 1.983 . . . . 0.0 112.159 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.461 ' HA ' ' CG2' ' A' ' 57' ' ' VAL . 4.6 m-20 -92.37 8.52 38.12 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.035 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.659 ' HG ' HD23 ' A' ' 56' ' ' LEU . 2.1 pp -86.74 -27.4 23.67 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 122.289 -0.257 . . . . 0.0 111.068 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.659 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -97.96 -47.27 5.6 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.919 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.517 HG11 ' HA2' ' A' ' 61' ' ' GLY . 4.8 m -57.68 149.25 4.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-O 121.243 0.544 . . . . 0.0 111.598 -179.07 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -65.45 -56.42 12.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.739 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -173.83 -43.91 0.01 OUTLIER 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.402 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 78.0 p -87.5 12.45 12.31 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.517 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 58.21 22.31 49.66 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.673 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -108.86 -41.18 4.82 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.944 0.402 . . . . 0.0 110.582 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.6 p -119.87 -175.94 3.08 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.715 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.0 mt -111.07 157.06 20.41 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.857 0.361 . . . . 0.0 111.148 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.75 155.75 92.5 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.282 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.01 135.13 67.39 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.818 2.345 . . . . 0.0 112.404 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 134.4 -49.29 0.91 Allowed Glycine 0 C--N 1.331 0.284 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.299 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.502 HG21 ' HB3' ' A' ' 95' ' ' PHE . 6.0 mt -81.46 137.49 21.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-O 120.657 0.265 . . . . 0.0 111.176 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.633 HD23 HD21 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -106.83 103.69 13.19 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.529 179.562 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.468 ' O ' HD23 ' A' ' 71' ' ' LEU . 15.4 m -83.25 130.41 35.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.609 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.633 HD21 HD23 ' A' ' 69' ' ' LEU . 3.3 mt -130.15 146.2 51.77 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.45 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.621 HG11 ' CD2' ' A' ' 85' ' ' TYR . 2.1 m -119.0 121.4 66.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.477 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 57.45 41.87 25.48 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.45 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 65.1 31.75 10.77 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.412 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 6.3 t -142.6 151.87 41.94 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.729 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.624 ' HB3' HG23 ' A' ' 79' ' ' VAL . 35.8 m-20 -50.21 116.75 2.0 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.854 0.359 . . . . 0.0 111.535 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.435 ' HA ' HG22 ' A' ' 72' ' ' VAL . . . -84.78 -21.54 29.93 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.842 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -75.4 -27.64 59.14 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.602 0.239 . . . . 0.0 110.84 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.624 HG23 ' HB3' ' A' ' 76' ' ' ASP . 24.8 t -71.79 -40.84 69.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.014 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.1 m -74.3 -32.65 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.8 -46.91 0.05 OUTLIER Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.6 -0.809 . . . . 0.0 113.145 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.83 -54.25 1.66 Allowed Glycine 0 C--N 1.334 0.447 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.171 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.694 ' HA ' HD22 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -136.22 23.92 3.25 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.569 0.223 . . . . 0.0 111.363 179.7 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -132.61 17.08 4.35 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.621 ' CD2' HG11 ' A' ' 72' ' ' VAL . 22.3 t80 -77.99 120.65 23.14 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.668 0.271 . . . . 0.0 111.36 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.1 m -66.39 147.74 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.67 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.23 154.78 17.55 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.267 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -171.01 152.09 3.43 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.864 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -56.73 108.32 0.48 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.159 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 115.58 24.33 4.09 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.408 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -93.25 167.22 11.89 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.683 0.242 . . . . 0.0 110.5 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 94.9 m -141.43 111.67 6.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.817 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.627 HG11 HD21 ' A' ' 40' ' ' LEU . 14.3 p -122.78 121.25 62.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.115 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -123.83 155.87 37.21 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.447 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.502 ' HB3' HG21 ' A' ' 68' ' ' ILE . 66.6 m-85 -132.19 104.34 6.72 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.927 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.696 HG12 ' HB3' ' A' ' 12' ' ' ALA . 28.5 mt -121.5 119.46 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.277 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.21 151.43 26.87 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.212 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.533 0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.672 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.465 0.28 0 CA-C-O 120.705 0.288 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.529 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 26.1 mm -127.75 152.83 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.794 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.494 HG22 ' NE2' ' A' ' 10' ' ' GLN . 19.3 m -113.66 95.29 5.26 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.775 0.322 . . . . 0.0 111.293 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.633 HG13 ' HB2' ' A' ' 25' ' ' LEU . 10.0 p -109.68 104.8 17.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.936 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.494 ' NE2' HG22 ' A' ' 8' ' ' THR . 0.4 OUTLIER -130.31 165.3 22.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.578 -179.327 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.422 ' HB2' ' HB3' ' A' ' 16' ' ' GLU . 44.5 m-85 -117.51 161.17 20.03 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.17 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.628 ' HB3' HG12 ' A' ' 96' ' ' ILE . . . -151.36 155.66 39.12 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.431 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 72.38 -101.17 1.03 Allowed Glycine 0 C--N 1.335 0.51 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.26 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.72 27.35 3.52 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.684 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.458 ' SG ' HD12 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -95.71 -27.96 15.02 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.707 0.254 . . . . 0.0 111.505 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.422 ' HB3' ' HB2' ' A' ' 11' ' ' PHE . 6.1 pt-20 -58.21 -30.88 66.82 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.648 0.261 . . . . 0.0 111.282 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.414 HD12 ' HG3' ' A' ' 16' ' ' GLU . 9.9 mp -68.13 -8.56 39.41 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.989 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.629 HD22 ' CD1' ' A' ' 55' ' ' LEU . 60.4 mt -82.76 13.44 3.84 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -147.91 -66.16 0.25 Allowed 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -172.35 38.74 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.828 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.31 37.15 18.04 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.845 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -75.28 155.45 36.66 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.117 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 60.9 p -91.06 -69.54 0.73 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.106 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.7 p -144.59 154.4 42.81 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.95 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.633 ' HB2' HG13 ' A' ' 9' ' ' VAL . 2.6 mp -141.28 165.15 28.3 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.328 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.529 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 9.5 mt-30 -125.8 119.21 27.28 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.101 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.7 mt . . . . . 0 C--O 1.233 0.205 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.565 179.82 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.8 m . . . . . 0 C--O 1.234 0.238 0 CA-C-O 120.881 0.372 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -135.26 -173.16 3.25 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.694 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.797 HD22 ' HA ' ' A' ' 83' ' ' MET . 3.2 tt -57.51 -41.87 81.69 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.278 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -56.19 -36.8 68.79 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.908 0.385 . . . . 0.0 110.18 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.77 -33.6 33.48 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.948 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.453 HD11 HG21 ' A' ' 7' ' ' ILE . 29.6 tp -65.41 -50.73 64.39 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.598 0.199 . . . . 0.0 110.707 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.78 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.3 OUTLIER -56.91 -56.57 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.684 179.568 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.409 ' H ' HG23 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -49.12 -33.22 11.43 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.345 179.578 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.34 -27.48 63.4 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.53 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.471 HD21 ' CZ ' ' A' ' 95' ' ' PHE . 1.0 OUTLIER -96.92 -38.42 9.82 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.708 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.444 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -81.99 -70.18 0.56 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.496 -179.52 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 m -52.41 -25.14 9.15 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -97.49 -37.29 10.03 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -142.45 58.73 1.45 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.444 ' HB ' ' O ' ' A' ' 45' ' ' LYS . 10.1 p -97.31 -34.92 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.407 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 73.32 -55.95 0.67 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 122.312 0.245 . . . . 0.0 110.644 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.456 ' HB3' HD21 ' A' ' 55' ' ' LEU . 2.4 tp10 -91.72 -177.14 4.68 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.463 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 63.7 mtp85 -58.6 140.84 84.8 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-O 120.718 0.294 . . . . 0.0 111.501 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.412 ' O ' HG22 ' A' ' 57' ' ' VAL . 92.7 Cg_endo -81.45 -18.7 8.15 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.818 2.345 . . . . 0.0 113.03 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.405 ' HA ' ' CG2' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -86.72 6.83 29.42 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -179.404 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.629 ' CD1' HD22 ' A' ' 18' ' ' LEU . 4.7 pp -90.62 -22.13 21.37 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.544 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.679 HD12 HD21 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -100.75 -47.44 4.82 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 111.566 0.21 . . . . 0.0 111.566 -179.874 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.506 HG11 ' HA2' ' A' ' 61' ' ' GLY . 3.0 m -55.09 150.85 2.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 121.154 0.502 . . . . 0.0 111.489 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.549 ' HB2' HG23 ' A' ' 63' ' ' THR . 18.6 t70 -65.64 -56.45 12.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.955 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -174.39 -44.68 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.183 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.9 t -83.47 9.9 10.14 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.688 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.506 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 57.15 23.61 47.85 Favored Glycine 0 C--N 1.34 0.763 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.812 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -110.78 -44.71 3.59 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.055 0.455 . . . . 0.0 110.484 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.549 HG23 ' HB2' ' A' ' 58' ' ' ASP . 10.2 t -115.1 168.23 10.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.088 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.679 HD21 HD12 ' A' ' 56' ' ' LEU . 6.4 mt -96.58 153.58 17.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.826 0.346 . . . . 0.0 111.232 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.439 ' HD3' ' N ' ' A' ' 67' ' ' GLY . 0.5 OUTLIER -57.01 155.48 15.75 Favored Pre-proline 0 N--CA 1.465 0.306 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.571 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.95 -35.97 91.66 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.142 2.562 . . . . 0.0 112.689 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.439 ' N ' ' HD3' ' A' ' 65' ' ' ARG . . . -45.79 -36.68 6.67 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-N 115.844 -0.616 . . . . 0.0 113.327 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.463 HG21 ' HB3' ' A' ' 95' ' ' PHE . 4.3 mt -102.03 138.33 26.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 117.032 0.416 . . . . 0.0 110.925 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 mt -105.75 111.13 23.68 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.474 ' C ' HD23 ' A' ' 71' ' ' LEU . 17.1 m -80.76 125.63 39.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.208 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.474 HD23 ' C ' ' A' ' 70' ' ' VAL . 3.8 mt -123.73 126.79 47.15 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.318 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.758 HG23 ' HB2' ' A' ' 77' ' ' ALA . 28.2 t -105.11 101.94 13.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.579 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 56.61 55.7 6.19 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.123 0.487 . . . . 0.0 110.867 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.9 m 60.87 41.42 14.47 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.499 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 53.0 t -159.74 119.36 2.92 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.657 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.543 ' CB ' HG23 ' A' ' 79' ' ' VAL . 1.5 m-20 -47.54 126.69 10.25 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.474 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.758 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -67.83 -28.56 67.67 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.965 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -69.96 -25.31 63.57 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.067 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.543 HG23 ' CB ' ' A' ' 76' ' ' ASP . 43.9 t -58.66 -30.51 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.789 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.4 m -110.74 -37.38 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.961 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -148.52 -62.06 0.01 OUTLIER Glycine 0 C--N 1.337 0.601 0 C-N-CA 120.629 -0.796 . . . . 0.0 113.066 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 112.06 -63.34 0.28 Allowed Glycine 0 C--N 1.331 0.277 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.293 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.797 ' HA ' HD22 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -134.37 23.2 3.75 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 111.424 0.157 . . . . 0.0 111.424 179.834 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -138.02 24.3 2.8 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.442 ' CE2' HG11 ' A' ' 72' ' ' VAL . 29.4 t80 -70.95 118.8 14.19 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 120.75 0.309 . . . . 0.0 111.396 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.6 m -62.4 165.89 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 116.143 -0.481 . . . . 0.0 112.131 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.46 153.57 31.87 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.571 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -156.85 32.9 0.3 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.678 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 64.66 111.39 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.907 0.384 . . . . 0.0 111.267 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.67 31.63 5.69 Favored Glycine 0 CA--C 1.517 0.217 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.431 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -89.85 112.23 23.5 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.792 0.329 . . . . 0.0 110.577 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 61.8 m -81.72 130.61 35.12 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.592 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.8 p -139.5 126.73 24.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.875 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -126.75 150.75 48.93 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.194 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.471 ' CZ ' HD21 ' A' ' 44' ' ' LEU . 43.2 m-85 -120.55 105.05 10.45 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.333 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.628 HG12 ' HB3' ' A' ' 12' ' ' ALA . 20.5 mt -112.0 109.47 28.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.346 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.2 p -77.32 150.97 35.16 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.571 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.463 0.216 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.133 179.653 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 46.2 m170 . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.64 0.257 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.506 ' N ' HD12 ' A' ' 7' ' ' ILE . 2.0 mp -103.71 138.34 28.57 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.002 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.417 HG22 ' OE1' ' A' ' 10' ' ' GLN . 88.5 m -86.55 93.76 9.26 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.891 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.563 ' O ' HG13 ' A' ' 9' ' ' VAL . 11.4 p -116.6 106.48 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 120.833 0.349 . . . . 0.0 111.422 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.477 ' HB2' ' O ' ' A' ' 23' ' ' THR . 5.8 pm0 -127.12 170.93 11.85 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.976 0.417 . . . . 0.0 111.872 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.421 ' CB ' ' HA ' ' A' ' 16' ' ' GLU . 89.1 m-85 -134.83 146.74 49.58 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.899 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -167.4 113.18 0.73 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.081 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.17 45.6 0.57 Allowed Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.632 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.99 14.51 82.24 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.562 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -107.23 -25.27 11.58 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 117.523 0.662 . . . . 0.0 111.52 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.421 ' HA ' ' CB ' ' A' ' 11' ' ' PHE . 0.9 OUTLIER -60.53 -22.09 63.22 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.42 HD12 ' HG2' ' A' ' 16' ' ' GLU . 6.4 mp -68.63 -6.69 27.28 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.794 HD21 HD11 ' A' ' 55' ' ' LEU . 59.2 mt -85.59 12.13 9.31 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -146.98 -63.56 0.29 Allowed 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -175.94 36.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.055 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 50.79 35.36 11.93 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.09 0.471 . . . . 0.0 110.672 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -78.84 167.69 20.8 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.066 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.477 ' O ' ' HB2' ' A' ' 10' ' ' GLN . 38.1 p -100.57 -31.52 11.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.4 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 88.7 p -169.92 146.78 3.2 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.636 0.255 . . . . 0.0 111.302 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 tp -133.13 166.16 23.08 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.436 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.485 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 32.9 mt-30 -132.03 116.19 16.77 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.688 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.494 HD22 HD23 ' A' ' 43' ' ' LEU . 14.0 mt . . . . . 0 C--O 1.232 0.132 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.937 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 90.5 m . . . . . 0 C--O 1.233 0.223 0 CA-C-O 120.849 0.357 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -138.85 -168.84 2.5 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.666 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.718 HD22 ' HA ' ' A' ' 83' ' ' MET . 1.7 tt -56.69 -40.27 75.31 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.146 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -58.02 -36.72 73.12 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.74 -32.15 59.54 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.029 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.681 HD21 HD11 ' A' ' 87' ' ' LEU . 17.2 mt -64.0 -49.58 71.91 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.815 0.34 . . . . 0.0 110.713 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.574 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -64.6 -53.53 41.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.009 179.793 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -56.18 -27.34 54.14 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.877 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.494 HD23 HD22 ' A' ' 27' ' ' LEU . 1.3 tp -84.56 -14.6 48.4 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 120.746 0.308 . . . . 0.0 110.914 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.641 HD13 ' N ' ' A' ' 45' ' ' LYS . 0.4 OUTLIER -96.83 -51.73 4.16 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.916 179.646 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.641 ' N ' HD13 ' A' ' 44' ' ' LEU . 1.3 pttt -86.16 -69.52 0.66 Allowed 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.9 m -49.16 -31.54 8.52 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.594 0.235 . . . . 0.0 111.395 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -76.2 -33.85 59.28 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.452 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -130.95 -71.56 0.57 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.602 ' O ' HG13 ' A' ' 49' ' ' VAL . 12.4 p 34.49 89.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.97 -32.02 64.93 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.038 179.074 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.409 ' O ' HG22 ' A' ' 49' ' ' VAL . 1.1 tp10 -97.13 -161.69 0.89 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.533 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.76 ' HB2' HD23 ' A' ' 55' ' ' LEU . 2.8 mmt180 -66.42 125.23 90.05 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-O 120.599 0.238 . . . . 0.0 111.207 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.41 ' HA ' HG21 ' A' ' 49' ' ' VAL . 56.8 Cg_endo -71.53 -28.16 17.95 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.475 2.117 . . . . 0.0 112.535 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.404 ' HA ' HG22 ' A' ' 57' ' ' VAL . 0.4 OUTLIER -94.22 7.96 43.45 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.752 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.794 HD11 HD21 ' A' ' 18' ' ' LEU . 1.7 pp -82.39 -12.85 57.65 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.597 ' HB2' HD22 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -105.61 -45.29 4.46 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 111.636 0.236 . . . . 0.0 111.636 179.827 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.547 HG11 ' HA2' ' A' ' 61' ' ' GLY . 1.4 m -59.3 149.51 6.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.163 0.506 . . . . 0.0 111.497 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -66.8 -57.99 5.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.764 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -172.44 -44.87 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.315 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.6 p -79.38 4.09 16.38 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.635 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.547 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 60.24 28.18 66.46 Favored Glycine 0 C--N 1.339 0.705 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.574 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -121.29 -46.1 2.31 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.816 0.341 . . . . 0.0 110.604 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.7 t -114.53 140.61 48.62 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.633 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.597 HD22 ' HB2' ' A' ' 56' ' ' LEU . 7.8 mt -67.92 154.58 41.29 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.894 0.378 . . . . 0.0 111.315 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.62 158.5 87.25 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.239 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.69 131.92 45.07 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.969 2.446 . . . . 0.0 112.241 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 138.02 -48.49 0.88 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.315 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.3 mt -88.29 144.54 8.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 120.794 0.331 . . . . 0.0 111.154 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.8 mt -113.61 99.0 7.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.777 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.81 HG23 ' HB3' ' A' ' 77' ' ' ALA . 13.5 m -78.67 131.7 33.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.882 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.453 HD23 ' O ' ' A' ' 70' ' ' VAL . 3.4 mt -130.16 127.47 39.78 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.209 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.601 HG11 ' CD2' ' A' ' 85' ' ' TYR . 39.1 t -103.72 119.14 51.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.354 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 59.5 53.29 5.19 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.968 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.9 m 53.34 35.98 21.7 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.576 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 8.2 t -150.8 153.95 36.39 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.139 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.404 ' CB ' HG23 ' A' ' 79' ' ' VAL . 4.5 m-20 -49.23 124.18 8.62 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.681 0.277 . . . . 0.0 111.315 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.81 ' HB3' HG23 ' A' ' 70' ' ' VAL . . . -65.38 -20.01 66.2 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.578 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -76.01 -29.77 58.27 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.601 0.238 . . . . 0.0 110.685 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.404 HG23 ' CB ' ' A' ' 76' ' ' ASP . 24.4 t -70.78 -42.6 77.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.056 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.5 ' HB ' ' CD1' ' A' ' 85' ' ' TYR . 17.9 m -68.21 -28.79 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 146.02 36.65 0.06 OUTLIER Glycine 0 C--N 1.337 0.625 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.741 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 53.69 -99.35 0.05 OUTLIER Glycine 0 C--N 1.337 0.593 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.915 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.718 ' HA ' HD22 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -122.89 29.16 6.92 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.786 0.327 . . . . 0.0 110.913 179.459 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -117.66 19.89 13.68 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.939 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.601 ' CD2' HG11 ' A' ' 72' ' ' VAL . 15.1 t80 -81.12 120.66 25.13 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.743 0.306 . . . . 0.0 111.358 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.9 m -75.59 158.69 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.477 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.681 HD11 HD21 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -91.45 150.28 21.32 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.078 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -147.9 30.52 0.88 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.412 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 59.48 95.99 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.962 0.41 . . . . 0.0 111.653 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 118.75 28.92 1.97 Allowed Glycine 0 CA--C 1.52 0.376 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.694 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -78.19 166.1 23.15 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.769 0.318 . . . . 0.0 110.88 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 98.7 m -141.33 113.2 7.8 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.105 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.8 p -124.94 136.43 60.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.856 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -135.11 153.12 52.12 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.411 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -125.59 104.61 8.49 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.438 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.1 mt -116.95 117.26 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.021 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.12 125.56 34.22 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.751 0.31 . . . . 0.0 111.19 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.9 p . . . . . 0 CA--C 1.531 0.242 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.279 -179.915 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.412 ' HB2' ' HG2' ' A' ' 26' ' ' GLN . 4.8 p80 . . . . . 0 N--CA 1.466 0.369 0 CA-C-O 120.814 0.34 . . . . 0.0 111.576 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.6 mm -132.11 136.64 56.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.224 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.63 HG22 ' OE1' ' A' ' 10' ' ' GLN . 89.0 m -86.44 109.23 18.91 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.892 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.546 HG13 ' HB2' ' A' ' 25' ' ' LEU . 12.0 p -129.08 112.71 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.286 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.63 ' OE1' HG22 ' A' ' 8' ' ' THR . 9.0 pm0 -137.26 166.69 23.17 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.842 0.353 . . . . 0.0 111.643 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.43 ' CD2' ' HB2' ' A' ' 95' ' ' PHE . 89.4 m-85 -134.37 148.88 50.77 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.242 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -164.21 128.91 2.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.967 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.92 40.71 2.25 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.72 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.55 19.55 79.17 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 121.021 -0.609 . . . . 0.0 113.388 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.0 -12.14 14.24 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 117.279 0.539 . . . . 0.0 111.849 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.426 ' HA ' ' CB ' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -69.3 -15.5 63.36 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.701 0.259 . . . . 0.0 111.701 179.867 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 mt -69.03 -5.47 22.09 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.921 HD21 HD11 ' A' ' 55' ' ' LEU . 53.0 mt -81.6 13.65 2.99 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.502 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 2.6 t80 -153.57 -58.49 0.13 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.698 0.285 . . . . 0.0 110.522 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -179.27 36.37 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.136 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.92 33.9 7.2 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.889 0.376 . . . . 0.0 110.889 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -83.73 166.56 17.95 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.014 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 81.6 p -88.14 -70.66 0.62 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.825 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.406 ' CB ' ' HB3' ' A' ' 10' ' ' GLN . 83.3 p -136.73 156.05 49.03 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.717 0.294 . . . . 0.0 111.306 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.546 ' HB2' HG13 ' A' ' 9' ' ' VAL . 3.4 mp -140.44 164.57 29.77 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.442 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.412 ' HG2' ' HB2' ' A' ' 6' ' ' HIS . 0.0 OUTLIER -122.23 112.03 17.67 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.523 179.743 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.8 mt . . . . . 0 C--N 1.332 -0.183 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.9 -179.882 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 54.4 m . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.922 0.391 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -125.76 -172.35 2.58 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.744 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.728 HD22 ' HA ' ' A' ' 83' ' ' MET . 5.3 tt -54.95 -43.59 73.54 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -57.15 -35.33 69.39 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.906 0.384 . . . . 0.0 110.124 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.22 -33.21 36.53 Favored Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.951 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.527 HD12 ' HA ' ' A' ' 37' ' ' LEU . 73.1 mt -63.56 -51.49 65.17 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.756 0.312 . . . . 0.0 110.624 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.694 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.3 OUTLIER -57.36 -56.79 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.812 179.641 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.408 ' H ' HG23 ' A' ' 41' ' ' VAL . 5.7 tt0 -49.46 -34.66 17.4 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.329 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.92 -27.62 65.93 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.846 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.1 pp -96.64 -38.14 10.06 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.434 ' CA ' ' HB ' ' A' ' 49' ' ' VAL . 2.8 pttt -85.59 -62.13 1.6 Allowed 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.9 m -58.1 -21.64 47.08 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.118 -0.233 . . . . 0.0 111.61 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -98.75 -36.64 9.76 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -150.23 54.42 0.92 Allowed 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.434 ' HB ' ' CA ' ' A' ' 45' ' ' LYS . 9.4 p -80.91 -43.88 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 121.216 -0.194 . . . . 0.0 111.521 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 19' ' ' PHE . 0.6 OUTLIER 67.86 -59.06 0.43 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 122.601 0.36 . . . . 0.0 110.608 -179.126 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.22 -168.55 0.52 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.208 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.445 ' HB3' ' HB3' ' A' ' 55' ' ' LEU . 3.5 ttt180 -69.16 128.33 92.62 Favored Pre-proline 0 CA--C 1.529 0.173 0 CA-C-O 120.625 0.25 . . . . 0.0 111.471 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.457 ' O ' HG22 ' A' ' 57' ' ' VAL . 58.7 Cg_endo -72.72 -23.73 19.06 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.311 2.007 . . . . 0.0 112.492 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -93.08 7.38 44.42 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.921 HD11 HD21 ' A' ' 18' ' ' LEU . 3.0 pp -85.67 -21.06 28.54 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 121.117 -0.233 . . . . 0.0 111.072 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.572 ' H ' HD23 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -103.03 -48.78 3.95 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 111.477 0.177 . . . . 0.0 111.477 179.614 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.499 HG11 ' HA2' ' A' ' 61' ' ' GLY . 2.8 m -62.72 144.73 14.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 121.052 0.453 . . . . 0.0 111.14 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.436 ' HA ' ' HB3' ' A' ' 65' ' ' ARG . 10.4 t70 -63.72 -60.23 3.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.596 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.8 tm0? -168.85 -44.66 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.309 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.1 p -79.55 2.71 21.21 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.534 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.499 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 62.16 28.41 70.64 Favored Glycine 0 C--N 1.34 0.761 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.413 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -124.05 -40.46 2.28 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.575 0.226 . . . . 0.0 111.464 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.7 t -114.09 135.8 53.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.636 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.51 HD11 ' HB2' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -70.06 132.9 46.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.869 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.436 ' HB3' ' HA ' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -58.89 155.44 31.74 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.419 -179.793 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -58.62 138.07 83.7 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.819 2.346 . . . . 0.0 112.402 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 136.85 -46.74 1.0 Allowed Glycine 0 C--N 1.332 0.336 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.195 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.422 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 5.4 mt -94.93 127.38 46.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 120.697 0.284 . . . . 0.0 111.018 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.9 mp -98.3 102.94 14.83 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.849 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.761 HG23 ' HB3' ' A' ' 77' ' ' ALA . 15.4 m -76.59 133.98 29.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.744 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.6 HD11 HD12 ' A' ' 96' ' ' ILE . 1.1 mt -129.15 141.98 51.01 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.487 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.743 HG23 ' HB2' ' A' ' 77' ' ' ALA . 19.6 t -113.68 111.55 36.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.586 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.0 m120 57.67 54.04 6.69 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.989 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.8 t 57.23 49.65 13.03 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.98 0.419 . . . . 0.0 111.186 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 50.6 t -162.17 146.21 12.19 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.671 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.653 ' HB3' HG23 ' A' ' 79' ' ' VAL . 9.5 m-20 -50.83 121.71 6.34 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.46 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.761 ' HB3' HG23 ' A' ' 70' ' ' VAL . . . -83.99 -22.8 31.25 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.735 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -74.18 -30.58 62.3 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-O 120.555 0.217 . . . . 0.0 110.888 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.653 HG23 ' HB3' ' A' ' 76' ' ' ASP . 45.2 t -63.69 -40.59 89.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.127 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 26.9 m -79.48 -36.79 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.505 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -166.66 -51.55 0.03 OUTLIER Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.64 -0.791 . . . . 0.0 113.128 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 100.26 -50.97 1.05 Allowed Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.425 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.728 ' HA ' HD22 ' A' ' 37' ' ' LEU . 2.4 ptt? -144.11 25.51 1.57 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.527 0.203 . . . . 0.0 111.38 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -140.48 23.59 2.31 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.538 ' CE1' HG11 ' A' ' 72' ' ' VAL . 38.3 t80 -80.78 103.4 10.59 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.771 0.32 . . . . 0.0 110.774 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.6 m -72.63 145.72 11.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.836 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.569 ' C ' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -153.12 165.39 35.79 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.012 -179.769 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -134.69 -64.78 0.66 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.084 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -146.59 132.37 18.99 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.749 0.309 . . . . 0.0 111.067 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.96 21.24 36.66 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 121.104 -0.57 . . . . 0.0 112.89 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -86.23 163.98 17.44 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.801 0.334 . . . . 0.0 111.129 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.425 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 90.8 m -138.88 130.28 27.14 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.922 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.6 p -140.54 124.07 17.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.696 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.414 ' HG2' ' HG2' ' A' ' 10' ' ' GLN . 14.0 mt-10 -126.7 137.17 53.22 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.4 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.43 ' HB2' ' CD2' ' A' ' 11' ' ' PHE . 3.9 m-85 -107.42 104.81 14.48 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.562 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.6 HD12 HD11 ' A' ' 71' ' ' LEU . 28.3 mt -109.04 104.87 17.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.148 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . 41.9 t -85.01 140.13 31.26 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.04 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 34.2 p . . . . . 0 C--N 1.332 -0.182 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.946 179.9 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 14.0 p-80 . . . . . 0 N--CA 1.464 0.269 0 CA-C-O 120.705 0.288 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.538 HD12 HD23 ' A' ' 87' ' ' LEU . 27.8 mm -117.49 152.19 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.11 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.485 ' HB ' HG23 ' A' ' 92' ' ' THR . 6.1 m -117.15 102.33 9.21 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.05 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.536 ' O ' HG13 ' A' ' 9' ' ' VAL . 12.7 p -128.99 112.43 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 120.788 0.328 . . . . 0.0 111.765 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -129.63 165.2 22.27 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.982 0.42 . . . . 0.0 111.57 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.432 ' CB ' ' HA ' ' A' ' 16' ' ' GLU . 26.0 m-85 -126.41 131.52 51.71 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.199 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.13 151.39 47.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.503 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.19 -94.97 2.03 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.688 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -137.24 28.71 2.77 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.82 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.83 -27.93 9.04 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.736 0.268 . . . . 0.0 111.61 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.432 ' HA ' ' CB ' ' A' ' 11' ' ' PHE . 0.6 OUTLIER -57.35 -30.87 65.19 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.524 0.202 . . . . 0.0 111.226 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.72 -13.86 62.65 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.857 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.559 HD22 HD21 ' A' ' 55' ' ' LEU . 32.3 mt -84.9 13.34 6.05 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -143.07 -61.92 0.42 Allowed 'General case' 0 CA--C 1.523 -0.071 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -178.81 36.37 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.103 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 50.37 31.7 5.63 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.962 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.65 173.47 12.41 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.104 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.4 p -102.46 -75.82 0.59 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.764 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 92.5 p -131.46 156.91 44.82 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.783 0.325 . . . . 0.0 111.372 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.505 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -137.19 159.0 43.17 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.259 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.454 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 2.6 mt-30 -129.87 129.75 44.33 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.971 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.465 HD12 HG21 ' A' ' 7' ' ' ILE . 2.9 mt . . . . . 0 C--O 1.233 0.224 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.688 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.7 m . . . . . 0 C--O 1.233 0.215 0 CA-C-O 120.695 0.283 . . . . 0.0 110.68 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -104.28 175.76 5.38 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.029 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.794 ' O ' HG22 ' A' ' 41' ' ' VAL . 5.2 tt -57.79 -41.93 83.1 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.682 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -54.98 -36.87 65.85 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.943 0.401 . . . . 0.0 110.377 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.13 -31.15 43.7 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.196 178.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 25.1 tp -70.08 -51.87 28.32 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.798 0.299 . . . . 0.0 110.921 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.794 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.4 OUTLIER -57.46 -57.24 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.895 179.787 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.44 ' H ' HG23 ' A' ' 41' ' ' VAL . 2.9 tt0 -51.39 -28.81 13.64 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.609 -0.268 . . . . 0.0 111.434 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.0 tp -78.12 -27.06 48.22 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.704 HD12 ' N ' ' A' ' 45' ' ' LYS . 4.6 pp -96.86 -37.15 10.35 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.704 ' N ' HD12 ' A' ' 44' ' ' LEU . 0.9 OUTLIER -86.01 -69.24 0.68 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.418 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.9 m -54.66 -23.74 18.65 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -103.97 -20.51 13.85 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -148.06 48.21 1.06 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.632 HG22 ' H ' ' A' ' 51' ' ' GLU . 8.1 p -94.06 132.07 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 120.719 0.295 . . . . 0.0 111.222 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -115.4 32.42 6.07 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.276 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.632 ' H ' HG22 ' A' ' 49' ' ' VAL . 1.9 tp10 -163.17 -171.86 2.79 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.502 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.599 ' HB3' HD23 ' A' ' 55' ' ' LEU . 1.4 ttt180 -65.1 110.78 4.66 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.782 -0.19 . . . . 0.0 110.929 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.418 ' O ' HG22 ' A' ' 57' ' ' VAL . 17.8 Cg_endo -60.29 -21.65 67.72 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.345 2.03 . . . . 0.0 112.692 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -91.29 7.66 39.79 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.621 ' HG ' HD23 ' A' ' 56' ' ' LEU . 2.5 pp -93.56 -18.97 21.64 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.486 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.621 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -102.53 -48.52 4.12 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.601 0.223 . . . . 0.0 111.601 179.825 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.519 HG11 ' HA2' ' A' ' 61' ' ' GLY . 3.4 m -57.14 148.32 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 121.101 0.477 . . . . 0.0 111.591 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -69.57 -58.82 3.47 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.712 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -166.91 -48.95 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.517 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.3 p -77.42 6.52 6.79 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.715 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.519 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 57.77 27.92 59.69 Favored Glycine 0 C--N 1.339 0.707 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.637 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.8 tp60 -122.18 -42.09 2.39 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.589 0.233 . . . . 0.0 110.943 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 49.9 p -117.21 136.24 53.2 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.611 HD12 HG21 ' A' ' 68' ' ' ILE . 6.3 mt -66.71 155.54 37.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.845 0.355 . . . . 0.0 111.142 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.53 160.14 74.06 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.47 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -51.25 -33.39 44.75 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 123.167 2.578 . . . . 0.0 112.798 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -53.43 -32.13 44.64 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.733 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.611 HG21 HD12 ' A' ' 64' ' ' LEU . 19.5 mm -83.46 151.47 3.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 120.822 0.344 . . . . 0.0 110.793 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.705 HD12 HD21 ' A' ' 71' ' ' LEU . 0.5 OUTLIER -127.83 99.83 5.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.815 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 70' ' ' VAL . 34.9 m -84.55 122.12 37.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.731 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.705 HD21 HD12 ' A' ' 69' ' ' LEU . 4.5 mt -131.3 137.55 48.86 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.174 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.616 HG13 ' HB2' ' A' ' 77' ' ' ALA . 3.3 m -109.54 118.95 57.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.784 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 24.2 m-20 64.23 -78.57 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.938 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -151.55 32.01 0.57 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.077 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 49.7 t -157.32 146.51 20.02 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.852 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.534 ' CB ' HG23 ' A' ' 79' ' ' VAL . 0.7 OUTLIER -52.5 130.6 32.18 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.362 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.616 ' HB2' HG13 ' A' ' 72' ' ' VAL . . . -75.3 -23.29 57.34 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.687 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.422 ' HA ' ' CA ' ' A' ' 82' ' ' GLY . 3.2 mt-10 -74.38 -18.69 60.64 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.141 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.534 HG23 ' CB ' ' A' ' 76' ' ' ASP . 38.2 t -63.14 -35.74 73.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 120.661 0.267 . . . . 0.0 110.875 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.9 m -98.88 -37.66 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.789 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -152.61 -60.19 0.01 OUTLIER Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.594 -0.812 . . . . 0.0 113.222 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.422 ' CA ' ' HA ' ' A' ' 78' ' ' GLU . . . 100.72 -51.22 1.0 Allowed Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.253 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.585 ' HA ' HD22 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -128.02 4.54 5.91 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 179.718 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -123.7 25.56 8.07 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.531 ' CE2' HG21 ' A' ' 72' ' ' VAL . 8.4 t80 -74.28 88.72 2.03 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.875 0.369 . . . . 0.0 110.81 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.4 m -61.54 139.6 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.664 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.538 HD23 HD12 ' A' ' 7' ' ' ILE . 7.1 mp -90.52 168.59 11.71 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.073 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 37.1 p30 -168.33 43.58 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.408 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 64.36 96.43 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.151 0.501 . . . . 0.0 110.99 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 112.96 28.25 3.45 Favored Glycine 0 CA--C 1.521 0.433 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.393 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.52 144.12 26.28 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.723 0.297 . . . . 0.0 110.715 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.485 HG23 ' HB ' ' A' ' 8' ' ' THR . 88.5 m -123.25 133.95 54.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.85 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.14 130.52 18.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.996 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -123.17 155.4 37.15 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.239 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -132.41 108.08 8.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.493 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 33.6 mt -113.94 123.45 69.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.115 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.65 130.88 38.15 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.263 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 71.5 p . . . . . 0 N--CA 1.465 0.288 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.98 179.7 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 . . . . . 0 N--CA 1.463 0.192 0 CA-C-O 120.715 0.293 . . . . 0.0 110.656 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.408 HG23 ' O ' ' A' ' 91' ' ' ASP . 3.0 mp -91.27 126.06 43.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.134 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.894 ' HB ' HG23 ' A' ' 92' ' ' THR . 0.2 OUTLIER -85.76 96.11 9.62 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.255 179.461 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.56 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.7 p -115.72 106.0 19.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.953 0.406 . . . . 0.0 111.272 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.822 ' OE1' HG22 ' A' ' 8' ' ' THR . 0.0 OUTLIER -136.38 155.59 49.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.053 0.454 . . . . 0.0 111.375 179.74 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -118.89 138.66 52.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.742 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.437 ' HB3' ' HA ' ' A' ' 96' ' ' ILE . . . -92.03 -178.67 5.06 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.185 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.61 97.18 0.08 OUTLIER Glycine 0 C--N 1.335 0.495 0 C-N-CA 121.133 -0.556 . . . . 0.0 112.687 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 138.29 -33.28 2.25 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.733 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.04 9.04 24.25 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -83.92 -37.43 22.35 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.584 0.231 . . . . 0.0 111.426 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.445 HD12 ' H ' ' A' ' 17' ' ' LEU . 3.0 mp -69.74 -4.6 20.51 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.506 HD22 HD21 ' A' ' 55' ' ' LEU . 4.7 mt -88.94 13.69 12.21 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -146.73 -61.94 0.3 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.702 0.286 . . . . 0.0 110.326 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -178.07 36.34 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.076 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.51 33.29 7.66 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.927 0.394 . . . . 0.0 110.822 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -80.19 174.47 11.56 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.715 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 79.7 p -110.66 -69.68 0.85 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.06 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.442 ' CB ' ' HB3' ' A' ' 10' ' ' GLN . 59.3 p -141.64 162.99 34.12 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.691 0.281 . . . . 0.0 111.34 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.465 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -150.98 165.33 34.05 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.258 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.407 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -129.12 101.02 5.85 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.675 179.778 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.4 mt . . . . . 0 C--O 1.233 0.206 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.696 -179.939 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.2 m . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.659 0.266 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -111.83 -176.39 2.92 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.946 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.653 HD22 ' HA ' ' A' ' 83' ' ' MET . 6.9 tt -54.32 -37.84 65.3 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.558 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -57.77 -35.19 70.42 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.904 0.383 . . . . 0.0 110.011 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.55 -32.96 58.98 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.583 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.503 ' HG ' HD11 ' A' ' 87' ' ' LEU . 7.8 mt -64.76 -53.15 51.58 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.718 0.295 . . . . 0.0 110.527 179.376 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.542 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.2 OUTLIER -57.48 -56.93 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.023 179.667 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -49.23 -30.8 7.58 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.654 0.264 . . . . 0.0 111.489 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.2 tp -70.76 -31.0 67.65 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 2.9 pp -97.13 -42.57 7.79 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.77 -68.46 0.68 Allowed 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -178.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.5 m -50.19 -29.68 9.86 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.422 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -77.31 -36.67 53.87 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.434 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -127.89 -68.26 0.78 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.544 ' O ' HG13 ' A' ' 49' ' ' VAL . 13.8 p 37.77 66.88 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 121.474 0.654 . . . . 0.0 111.766 -179.242 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.26 -30.81 62.92 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.088 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.97 -164.84 1.23 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.881 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.09 135.03 91.58 Favored Pre-proline 0 N--CA 1.462 0.144 0 CA-C-O 120.64 0.257 . . . . 0.0 111.142 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.491 ' O ' HG22 ' A' ' 57' ' ' VAL . 70.1 Cg_endo -76.23 -28.45 7.22 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.369 2.046 . . . . 0.0 112.475 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.405 ' HA ' ' CG2' ' A' ' 57' ' ' VAL . 11.8 m-20 -92.89 9.31 35.95 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.716 ' HG ' HD23 ' A' ' 56' ' ' LEU . 2.6 pp -82.94 -28.2 30.02 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 122.317 -0.239 . . . . 0.0 111.006 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.716 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -100.07 -49.19 4.38 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.509 HG11 ' HA2' ' A' ' 61' ' ' GLY . 6.2 m -62.42 146.8 12.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 121.101 0.477 . . . . 0.0 111.451 -179.389 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -67.21 -57.65 6.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.574 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -169.93 -45.03 0.02 OUTLIER 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.496 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.4 p -77.78 0.63 22.96 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.571 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.509 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 63.43 22.86 66.08 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.388 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -120.27 -38.32 2.93 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.749 0.309 . . . . 0.0 111.1 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.9 t -118.99 132.39 56.06 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 6.2 mt -67.15 153.81 42.76 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.98 0.419 . . . . 0.0 111.36 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -74.4 161.35 78.47 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.015 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -61.09 123.23 12.48 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.77 2.313 . . . . 0.0 112.188 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 154.01 -45.54 0.56 Allowed Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.4 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.6 mt -96.76 135.35 31.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 120.763 0.316 . . . . 0.0 111.068 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.3 tp -106.05 108.87 20.61 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.518 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.666 HG11 ' HE2' ' A' ' 83' ' ' MET . 16.3 m -77.66 129.07 37.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.446 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.501 HD23 ' O ' ' A' ' 70' ' ' VAL . 9.5 mt -126.09 128.12 46.86 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.88 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.577 HG12 ' O ' ' A' ' 92' ' ' THR . 4.4 m -117.31 122.4 69.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.073 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 55.24 46.31 23.97 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.52 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.3 m 61.96 30.23 18.0 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.494 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 31.1 t -153.01 130.25 11.23 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.805 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.633 ' HB2' HG23 ' A' ' 79' ' ' VAL . 9.2 m-20 -46.44 130.41 10.91 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.899 0.381 . . . . 0.0 111.536 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.29 -21.12 59.88 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.133 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.42 ' HA ' ' CA ' ' A' ' 82' ' ' GLY . 1.7 mt-10 -73.31 -28.3 62.01 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-O 120.577 0.227 . . . . 0.0 110.918 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.633 HG23 ' HB2' ' A' ' 76' ' ' ASP . 43.5 t -64.93 -33.78 65.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.053 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.4 m -100.92 -37.47 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -140.01 -74.64 0.05 OUTLIER Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.096 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.42 ' CA ' ' HA ' ' A' ' 78' ' ' GLU . . . 107.81 85.11 1.72 Allowed Glycine 0 C--N 1.331 0.302 0 C-N-CA 121.155 -0.545 . . . . 0.0 112.185 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.666 ' HE2' HG11 ' A' ' 70' ' ' VAL . 1.9 mmt 58.4 23.49 10.64 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.679 0.276 . . . . 0.0 111.394 -179.291 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -147.1 24.92 1.14 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.336 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -74.94 114.9 13.95 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.693 0.283 . . . . 0.0 110.95 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.7 m -65.12 140.29 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.693 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.503 HD11 ' HG ' ' A' ' 40' ' ' LEU . 2.9 mp -78.61 168.58 19.56 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.433 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -165.3 42.55 0.07 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.232 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 54.35 88.52 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.068 0.461 . . . . 0.0 111.404 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 117.94 26.64 2.71 Favored Glycine 0 CA--C 1.523 0.532 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.895 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.408 ' O ' HG23 ' A' ' 7' ' ' ILE . 2.2 t70 -78.58 150.61 32.74 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-O 120.819 0.342 . . . . 0.0 110.846 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.894 HG23 ' HB ' ' A' ' 8' ' ' THR . 96.8 m -120.99 129.94 53.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.451 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.15 136.68 25.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.22 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -134.09 151.56 51.44 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.389 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -123.73 104.72 9.16 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.39 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.437 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 14.9 mt -115.14 116.96 54.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.11 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 68.0 m -76.17 82.37 2.98 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.911 0.386 . . . . 0.0 110.739 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.53 0.177 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.244 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 . . . . . 0 N--CA 1.464 0.256 0 CA-C-O 120.434 0.159 . . . . 0.0 110.981 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.713 HD12 ' HB2' ' A' ' 27' ' ' LEU . 25.1 mt -88.97 117.18 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-O 120.858 0.361 . . . . 0.0 111.103 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.717 HG22 ' OE1' ' A' ' 10' ' ' GLN . 37.6 m -82.26 112.4 19.22 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.368 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.539 HG13 ' HB2' ' A' ' 25' ' ' LEU . 7.6 p -141.7 105.83 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-O 120.907 0.385 . . . . 0.0 111.129 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.717 ' OE1' HG22 ' A' ' 8' ' ' THR . 1.6 pm0 -130.39 171.62 12.75 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.82 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.497 ' HB2' ' HB3' ' A' ' 16' ' ' GLU . 91.1 m-85 -128.87 151.36 49.71 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.18 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.582 ' HB3' HG12 ' A' ' 96' ' ' ILE . . . -148.97 130.88 15.21 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.592 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.83 -107.73 3.55 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.287 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -119.34 30.88 5.64 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 121.033 -0.604 . . . . 0.0 112.439 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -108.63 -31.29 7.82 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 111.493 0.183 . . . . 0.0 111.493 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.497 ' HB3' ' HB2' ' A' ' 11' ' ' PHE . 8.6 pm0 -63.68 -30.82 71.88 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.563 0.22 . . . . 0.0 111.206 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 mp -71.57 -7.9 50.63 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.749 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.83 HD13 HD22 ' A' ' 56' ' ' LEU . 13.3 mt -85.7 13.73 6.75 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -146.74 -61.8 0.3 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.727 0.299 . . . . 0.0 110.228 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -177.31 36.93 0.0 OUTLIER 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.051 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.3 mptt 50.93 33.71 9.27 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.904 0.383 . . . . 0.0 110.997 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -79.18 145.3 33.74 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.833 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.0 p -78.22 -68.69 0.61 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.843 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 99.4 p -137.93 164.53 28.77 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.826 0.346 . . . . 0.0 111.413 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.539 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -139.34 155.59 47.58 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.142 179.83 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 0.1 OUTLIER -133.36 116.93 16.67 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.028 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.713 ' HB2' HD12 ' A' ' 7' ' ' ILE . 11.2 mt . . . . . 0 C--N 1.333 -0.138 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.57 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 51.3 m . . . . . 0 N--CA 1.461 0.12 0 CA-C-O 120.508 0.194 . . . . 0.0 110.591 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -108.21 -177.9 3.46 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.855 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.686 HD22 ' HA ' ' A' ' 83' ' ' MET . 7.0 tt -56.47 -44.98 81.1 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.339 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -56.01 -37.97 69.87 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.37 -31.08 59.53 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.166 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.657 HD11 ' CD1' ' A' ' 87' ' ' LEU . 49.3 mt -64.87 -50.87 64.9 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.772 0.32 . . . . 0.0 110.566 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -64.78 -55.36 21.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.251 179.817 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -52.46 -22.98 5.36 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.403 ' O ' ' HB2' ' A' ' 47' ' ' ASN . 3.6 tt -86.79 -26.33 24.17 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.534 HD12 ' N ' ' A' ' 45' ' ' LYS . 3.4 pp -93.0 -45.37 7.96 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.243 0.461 . . . . 0.0 112.243 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.534 ' N ' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -71.89 -55.82 6.82 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 121.014 -0.274 . . . . 0.0 111.513 -179.378 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 35.1 m -52.06 -28.23 16.67 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.638 0.256 . . . . 0.0 111.117 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.5 OUTLIER -82.27 -32.96 29.36 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.124 179.524 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.88 -75.77 0.6 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.483 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.598 ' O ' HG13 ' A' ' 49' ' ' VAL . 7.9 p 33.52 58.03 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 121.345 0.593 . . . . 0.0 111.821 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.97 -33.5 68.93 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.189 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.475 ' HB2' ' HA ' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -90.33 172.2 8.93 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.399 179.502 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.586 ' HB2' HD23 ' A' ' 55' ' ' LEU . 28.5 mmm-85 -48.68 106.97 0.68 Allowed Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.61 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.417 ' O ' HG22 ' A' ' 57' ' ' VAL . 50.2 Cg_exo -55.11 -28.96 63.41 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.664 2.243 . . . . 0.0 112.563 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.45 9.78 32.85 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.834 ' HG ' HD23 ' A' ' 56' ' ' LEU . 1.4 pp -88.25 -28.13 21.31 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 121.148 -0.221 . . . . 0.0 111.1 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.834 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -93.77 -54.63 3.55 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.588 -179.871 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.548 HG11 ' HA2' ' A' ' 61' ' ' GLY . 2.1 m -53.94 151.53 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 121.068 0.461 . . . . 0.0 111.612 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -65.42 -58.2 6.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.565 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.3 -45.32 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.517 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.8 p -84.09 10.73 9.36 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.617 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.548 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 55.28 27.91 48.36 Favored Glycine 0 C--N 1.338 0.653 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.552 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -118.25 -41.37 2.86 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.755 0.312 . . . . 0.0 110.838 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.7 t -117.97 128.67 55.02 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.979 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.686 HD22 ' HB2' ' A' ' 56' ' ' LEU . 8.3 mt -67.44 156.21 37.14 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.717 0.294 . . . . 0.0 110.989 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.436 ' CG ' HD12 ' A' ' 68' ' ' ILE . 0.7 OUTLIER -52.44 153.81 4.97 Favored Pre-proline 0 N--CA 1.464 0.275 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.598 -179.796 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.36 -38.57 73.82 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.048 2.498 . . . . 0.0 112.771 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -48.34 -36.06 16.04 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 121.167 -0.539 . . . . 0.0 112.799 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.505 HD13 HD13 ' A' ' 64' ' ' LEU . 6.6 mt -84.32 126.48 40.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 117.008 0.404 . . . . 0.0 110.951 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 mt -94.63 101.5 13.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.515 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.712 HG23 ' HB3' ' A' ' 77' ' ' ALA . 15.3 m -79.51 132.3 32.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.899 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.529 HD23 ' O ' ' A' ' 70' ' ' VAL . 1.8 mt -137.22 138.77 40.49 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.386 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.501 HG23 ' CB ' ' A' ' 77' ' ' ALA . 44.0 t -119.06 119.74 61.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.656 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 28.3 m-20 61.27 54.07 3.33 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.079 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.2 m 52.82 38.44 26.63 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.492 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 21.4 t -155.43 155.05 32.87 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.523 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.494 ' HB3' HG23 ' A' ' 79' ' ' VAL . 0.6 OUTLIER -47.18 123.91 5.97 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.665 0.269 . . . . 0.0 111.438 -179.84 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.712 ' HB3' HG23 ' A' ' 70' ' ' VAL . . . -69.29 -23.17 63.79 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.693 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -74.86 -28.79 60.81 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.526 0.203 . . . . 0.0 110.653 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.494 HG23 ' HB3' ' A' ' 76' ' ' ASP . 24.1 t -73.52 -41.21 56.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.282 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.414 HG21 ' HB ' ' A' ' 72' ' ' VAL . 30.8 m -71.4 -34.19 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.663 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.9 -46.31 0.04 OUTLIER Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.74 -0.743 . . . . 0.0 113.055 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.84 73.45 1.27 Allowed Glycine 0 C--N 1.335 0.496 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.192 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.686 ' HA ' HD22 ' A' ' 37' ' ' LEU . 0.7 OUTLIER 62.2 29.71 17.51 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.586 0.231 . . . . 0.0 111.131 -179.613 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -150.2 29.86 0.71 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.432 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -90.27 118.91 30.14 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.725 0.297 . . . . 0.0 110.973 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.9 m -66.8 156.25 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.813 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.657 ' CD1' HD11 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -89.54 161.12 16.36 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.428 -179.699 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -158.4 36.84 0.24 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.253 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 47.1 t0 61.17 93.13 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.041 0.448 . . . . 0.0 110.896 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 112.52 31.34 2.6 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.588 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -70.14 166.92 18.89 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.724 0.297 . . . . 0.0 111.049 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.652 HG23 ' HB ' ' A' ' 8' ' ' THR . 85.1 m -140.05 125.59 19.15 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.08 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.449 HG13 HG23 ' A' ' 9' ' ' VAL . 10.4 p -143.23 140.17 26.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.93 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -138.05 144.72 41.11 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.912 0.387 . . . . 0.0 111.134 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.502 ' HB3' HG21 ' A' ' 68' ' ' ILE . 70.1 m-85 -125.15 104.85 8.74 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.719 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.582 HG12 ' HB3' ' A' ' 12' ' ' ALA . 27.6 mt -118.83 112.63 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.22 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 74.3 m -79.98 123.32 27.71 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.394 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.541 0.61 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.944 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.339 0 CA-C-O 120.982 0.42 . . . . 0.0 111.791 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 29.9 mm -111.23 153.94 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.401 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.728 HG22 ' OE1' ' A' ' 10' ' ' GLN . 2.3 m -121.19 111.32 17.26 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.664 0.268 . . . . 0.0 111.162 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.539 ' O ' HG13 ' A' ' 9' ' ' VAL . 8.3 p -129.99 104.69 10.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-O 120.925 0.393 . . . . 0.0 111.046 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.728 ' OE1' HG22 ' A' ' 8' ' ' THR . 0.0 OUTLIER -130.74 154.94 47.44 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.804 -179.657 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.414 ' HB2' ' HB3' ' A' ' 16' ' ' GLU . 32.4 m-85 -116.6 142.78 46.44 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.849 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.474 ' HB3' HG12 ' A' ' 96' ' ' ILE . . . -137.21 167.83 20.81 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.744 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 66.1 -104.74 1.09 Allowed Glycine 0 C--N 1.334 0.434 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.653 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -128.3 32.77 3.32 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.899 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.6 t -105.26 -32.26 8.7 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.865 0.332 . . . . 0.0 111.103 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.414 ' HB3' ' HB2' ' A' ' 11' ' ' PHE . 1.3 pt-20 -59.25 -33.35 70.93 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.32 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.7 mp -68.62 -8.84 45.67 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.532 HD21 HD11 ' A' ' 55' ' ' LEU . 68.0 mt -84.11 13.58 5.0 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -147.99 -64.42 0.26 Allowed 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -172.34 37.85 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.18 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.2 mptt 51.38 35.31 13.68 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.989 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -69.24 159.24 33.42 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.129 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 37.6 p -101.49 -71.88 0.7 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.966 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.502 ' O ' HD12 ' A' ' 25' ' ' LEU . 80.3 p -141.33 162.85 34.49 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.601 0.239 . . . . 0.0 111.254 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.502 HD12 ' O ' ' A' ' 24' ' ' SER . 0.7 OUTLIER -150.64 158.65 44.4 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.24 -179.915 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.48 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 52.9 mt-30 -133.16 144.84 50.15 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.95 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.4 mt . . . . . 0 C--O 1.233 0.227 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.972 -179.792 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 25.5 m . . . . . 0 CA--C 1.531 0.249 0 CA-C-O 120.749 0.309 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.6 p30 -141.5 -171.82 3.39 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.043 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.762 ' HA ' HD12 ' A' ' 40' ' ' LEU . 7.1 tt -54.29 -42.71 70.37 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.476 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -55.68 -38.38 69.55 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.98 -32.32 60.9 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.074 178.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.799 HD11 ' CD1' ' A' ' 87' ' ' LEU . 24.2 mt -66.66 -54.57 21.83 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.86 0.33 . . . . 0.0 110.487 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.631 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.6 OUTLIER -59.84 -58.49 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.894 179.895 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.459 ' H ' HG23 ' A' ' 41' ' ' VAL . 32.0 tt0 -50.26 -30.01 10.84 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.525 179.48 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.3 tt -71.43 -31.03 66.76 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.633 HD12 ' N ' ' A' ' 45' ' ' LYS . 4.6 pp -97.01 -40.75 8.71 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.633 ' N ' HD12 ' A' ' 44' ' ' LEU . 0.7 OUTLIER -87.31 -70.79 0.6 Allowed 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.477 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.7 m -55.35 -24.62 30.3 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -96.31 -31.54 12.84 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -152.66 57.9 0.81 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 49' ' ' VAL . 7.1 p -91.24 113.67 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 120.868 0.366 . . . . 0.0 110.617 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -94.8 48.74 1.21 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.769 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -177.79 -175.11 0.49 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.284 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.682 ' HB2' HD23 ' A' ' 55' ' ' LEU . 2.5 mmt-85 -62.11 110.95 3.76 Favored Pre-proline 0 N--CA 1.463 0.188 0 CA-C-O 120.502 0.191 . . . . 0.0 110.991 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 52' ' ' ARG . 18.2 Cg_endo -60.49 -24.95 79.47 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.278 1.986 . . . . 0.0 112.512 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.96 7.96 39.75 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.75 ' HG ' HD23 ' A' ' 56' ' ' LEU . 1.8 pp -89.62 -21.31 22.87 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.462 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.75 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -100.58 -48.62 4.47 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.536 HG11 ' HA2' ' A' ' 61' ' ' GLY . 2.6 m -54.89 151.25 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.063 0.459 . . . . 0.0 111.681 -179.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -69.47 -57.45 5.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.189 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -171.15 -44.6 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.418 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.9 t -82.23 7.78 12.83 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.641 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.536 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 59.34 24.49 59.15 Favored Glycine 0 C--N 1.342 0.885 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.702 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -115.79 -47.36 2.8 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.815 0.34 . . . . 0.0 110.371 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.532 HG22 ' CG ' ' A' ' 83' ' ' MET . 45.4 p -105.5 163.93 12.27 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.907 179.164 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.628 HD22 ' HB2' ' A' ' 56' ' ' LEU . 6.3 mt -99.06 152.82 19.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.855 0.359 . . . . 0.0 111.073 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.91 147.67 52.97 Favored Pre-proline 0 N--CA 1.467 0.379 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.352 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -49.88 -32.51 30.29 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.344 2.696 . . . . 0.0 113.326 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -45.16 -38.85 6.54 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 121.357 -0.449 . . . . 0.0 113.035 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.566 HG21 ' HB3' ' A' ' 95' ' ' PHE . 4.0 mt -100.15 135.2 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.951 0.375 . . . . 0.0 111.05 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.7 tp -100.07 101.98 13.19 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.661 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.682 HG23 ' HB3' ' A' ' 77' ' ' ALA . 26.9 m -83.37 126.12 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.185 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 mt -125.59 161.98 26.0 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.273 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.586 HG11 ' CD2' ' A' ' 85' ' ' TYR . 2.7 m -141.17 111.58 3.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.913 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 56.37 53.22 8.99 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.957 0.408 . . . . 0.0 110.888 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.9 m 58.33 30.3 19.36 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.502 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 49.8 t -144.19 130.72 19.98 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.223 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -45.6 128.43 8.34 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.689 0.28 . . . . 0.0 111.137 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.682 ' HB3' HG23 ' A' ' 70' ' ' VAL . . . -62.39 -21.6 65.49 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.768 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -72.52 -24.12 61.1 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.735 -0.212 . . . . 0.0 110.895 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.4 t -71.33 -47.18 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.131 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.525 HG21 ' CG ' ' A' ' 85' ' ' TYR . 29.8 m -69.36 -42.45 81.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.868 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 165.39 40.16 0.02 OUTLIER Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.517 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 54.3 -104.75 0.26 Allowed Glycine 0 C--N 1.336 0.582 0 C-N-CA 121.236 -0.506 . . . . 0.0 112.919 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.729 ' HA ' HD22 ' A' ' 37' ' ' LEU . 53.8 mmm -108.89 27.06 9.86 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.682 0.277 . . . . 0.0 111.074 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -122.03 21.19 10.62 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.586 ' CD2' HG11 ' A' ' 72' ' ' VAL . 19.4 t80 -73.46 118.92 16.99 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.65 0.262 . . . . 0.0 111.305 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 19.7 m -78.73 159.45 4.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.525 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.799 ' CD1' HD11 ' A' ' 40' ' ' LEU . 1.7 mp -110.29 175.77 5.3 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.863 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -168.86 -62.18 0.02 OUTLIER 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.04 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -178.91 108.15 0.04 OUTLIER 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.425 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 105.51 24.17 7.21 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.978 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -79.22 143.88 34.92 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 117.02 0.41 . . . . 0.0 110.611 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 53.5 m -134.22 103.07 5.6 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.003 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.7 p -107.84 134.65 48.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.803 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.429 ' HG2' ' HG2' ' A' ' 10' ' ' GLN . 15.3 mt-10 -136.42 150.47 48.77 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.468 -179.452 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.566 ' HB3' HG21 ' A' ' 68' ' ' ILE . 88.6 m-85 -124.56 104.48 8.74 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.148 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.474 HG12 ' HB3' ' A' ' 12' ' ' ALA . 24.3 mt -111.87 107.02 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.145 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.52 137.42 34.61 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.953 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.8 p . . . . . 0 CA--C 1.53 0.199 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.941 -179.859 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.68 ' C ' HD12 ' A' ' 7' ' ' ILE . 15.4 m170 . . . . . 0 CA--C 1.533 0.31 0 CA-C-O 120.742 0.306 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.68 HD12 ' C ' ' A' ' 6' ' ' HIS . 3.2 mp -129.87 145.86 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 120.741 0.305 . . . . 0.0 111.179 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.725 HG22 ' OE1' ' A' ' 10' ' ' GLN . 24.3 m -96.92 95.93 8.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.959 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.82 HG21 HD22 ' A' ' 44' ' ' LEU . 11.8 p -110.95 105.19 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 121.005 0.431 . . . . 0.0 110.833 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.725 ' OE1' HG22 ' A' ' 8' ' ' THR . 0.0 OUTLIER -130.51 175.29 9.1 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.725 -179.068 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.502 ' CG ' ' HA ' ' A' ' 16' ' ' GLU . 95.5 m-85 -118.63 161.64 19.73 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.107 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -172.8 157.93 3.82 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.369 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 66.16 45.03 89.73 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.615 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.11 33.2 82.61 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.902 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.7 -17.93 13.58 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.783 0.292 . . . . 0.0 111.613 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.502 ' HA ' ' CG ' ' A' ' 11' ' ' PHE . 2.0 pm0 -59.27 -24.94 63.66 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.7 mp -65.92 -7.7 18.18 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.665 ' CD2' HD11 ' A' ' 55' ' ' LEU . 58.0 mt -72.69 1.27 8.7 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.458 ' CD2' ' HB2' ' A' ' 50' ' ' LYS . 38.8 t80 -144.24 -65.97 0.35 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -172.19 40.0 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.354 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 52.58 46.83 25.97 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.77 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -75.04 -179.66 4.45 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.917 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.457 ' O ' ' HB2' ' A' ' 10' ' ' GLN . 39.9 p -113.74 -47.11 2.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.256 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.5 p -171.21 155.08 4.21 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.673 0.273 . . . . 0.0 110.978 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.645 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.8 OUTLIER -141.71 166.58 24.34 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.546 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.56 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 0.8 OUTLIER -132.29 126.47 33.45 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.93 179.791 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.9 mt . . . . . 0 C--O 1.234 0.238 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.846 179.855 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.5 m . . . . . 0 C--O 1.233 0.203 0 CA-C-O 120.694 0.283 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -95.94 -176.05 3.59 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.139 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.733 ' O ' HG22 ' A' ' 41' ' ' VAL . 1.6 tt -55.4 -40.26 71.22 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.583 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -51.85 -44.55 63.67 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.63 -32.78 67.24 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.996 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.961 HD12 HD21 ' A' ' 87' ' ' LEU . 6.3 tt -67.17 -59.2 3.64 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.562 0.22 . . . . 0.0 110.961 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.733 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.6 OUTLIER -59.76 -57.77 10.14 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.143 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.288 -179.841 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.435 ' H ' HG23 ' A' ' 41' ' ' VAL . 6.4 tt0 -48.73 -33.37 10.08 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.363 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.5 tt -71.81 -29.1 64.08 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.728 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.82 HD22 HG21 ' A' ' 9' ' ' VAL . 3.8 pp -95.83 -32.43 12.68 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.754 ' N ' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -87.64 -71.07 0.59 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.477 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.9 m -51.53 -26.79 9.15 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -96.73 -36.88 10.52 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -140.62 57.26 1.58 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.5 HG13 ' H ' ' A' ' 51' ' ' GLU . 7.5 p -95.79 -34.86 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.458 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 0.2 OUTLIER 66.25 8.46 5.61 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 111.574 0.213 . . . . 0.0 111.574 -179.307 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.5 ' H ' HG13 ' A' ' 49' ' ' VAL . 1.7 tp10 -144.89 -166.18 2.34 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.507 ' CB ' HD23 ' A' ' 55' ' ' LEU . 8.9 ttm180 -75.61 110.74 11.43 Favored Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 116.742 -0.208 . . . . 0.0 110.595 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.468 ' O ' HG22 ' A' ' 57' ' ' VAL . 18.9 Cg_endo -59.6 -21.64 63.35 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.315 2.01 . . . . 0.0 112.537 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.32 5.58 44.4 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.754 ' HG ' HD23 ' A' ' 56' ' ' LEU . 1.9 pp -95.26 -26.82 15.79 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 121.166 -0.214 . . . . 0.0 111.476 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.754 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -95.7 -44.74 7.31 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -179.923 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.512 HG11 ' HA2' ' A' ' 61' ' ' GLY . 5.4 m -54.25 150.49 1.78 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-O 121.119 0.485 . . . . 0.0 111.699 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -63.35 -59.33 4.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.358 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -171.78 -43.92 0.02 OUTLIER 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.371 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 71.3 p -83.63 7.62 16.83 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.805 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.512 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 57.14 25.75 54.65 Favored Glycine 0 C--N 1.341 0.813 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.47 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.4 tm0? -115.08 -37.28 4.16 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.652 0.263 . . . . 0.0 110.977 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.9 t -127.5 142.48 51.38 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.792 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.754 HD21 HD12 ' A' ' 56' ' ' LEU . 8.1 mt -65.88 155.8 35.32 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.877 0.37 . . . . 0.0 111.205 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.26 150.37 72.26 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.075 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -52.32 -32.86 53.24 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.091 2.527 . . . . 0.0 112.819 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -49.88 -35.97 25.75 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.874 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.449 HG21 ' HB3' ' A' ' 95' ' ' PHE . 4.4 mt -99.93 135.66 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 120.752 0.31 . . . . 0.0 110.789 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.8 mp -105.26 104.91 14.74 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.874 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.905 HG23 ' HB3' ' A' ' 77' ' ' ALA . 11.5 m -77.25 133.85 29.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.014 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.6 mt -123.98 154.56 39.64 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.551 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.484 HG23 ' CA ' ' A' ' 77' ' ' ALA . 25.8 t -126.53 113.47 33.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.652 179.361 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.8 m120 57.9 42.62 22.74 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.965 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.9 m 57.08 50.58 11.74 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.417 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 42.8 t -141.32 -79.38 0.26 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.485 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 177.49 132.29 0.06 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.698 0.285 . . . . 0.0 110.896 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.905 ' HB3' HG23 ' A' ' 70' ' ' VAL . . . -88.51 -24.91 22.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.562 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -80.81 -38.71 27.93 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.578 0.228 . . . . 0.0 110.842 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 61.8 t -58.58 -37.5 65.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.906 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.9 m -80.83 -32.75 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.531 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.29 -56.49 0.04 OUTLIER Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.77 -0.729 . . . . 0.0 113.13 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 110.63 -57.85 0.41 Allowed Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.253 -0.499 . . . . 0.0 112.266 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -142.92 21.72 1.95 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 111.516 0.191 . . . . 0.0 111.516 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -135.6 20.46 3.33 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -75.1 114.52 13.69 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.927 0.394 . . . . 0.0 111.302 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.8 m -71.7 153.28 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.48 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.961 HD21 HD12 ' A' ' 40' ' ' LEU . 1.2 mp -104.21 164.28 11.83 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.551 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -161.02 30.33 0.14 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.413 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 58.97 103.93 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.001 0.429 . . . . 0.0 111.604 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 116.73 35.52 1.15 Allowed Glycine 0 C--N 1.332 0.357 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.326 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.15 177.52 4.81 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.863 0.363 . . . . 0.0 111.576 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.716 HG23 ' HB ' ' A' ' 8' ' ' THR . 74.2 m -140.3 132.66 28.37 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.821 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.625 HG11 HD21 ' A' ' 40' ' ' LEU . 7.1 p -142.46 137.06 28.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.174 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -134.2 158.47 43.6 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.993 0.425 . . . . 0.0 111.532 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.449 ' HB3' HG21 ' A' ' 68' ' ' ILE . 25.8 m-85 -126.55 104.89 8.37 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.298 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 26.5 mt -116.08 118.5 58.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.215 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.81 155.15 39.12 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.108 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.465 0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.563 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 7.7 p80 . . . . . 0 N--CA 1.466 0.344 0 CA-C-O 120.671 0.272 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.479 HG23 ' O ' ' A' ' 91' ' ' ASP . 29.6 mt -105.35 137.67 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.133 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.723 ' HB ' HG23 ' A' ' 92' ' ' THR . 0.5 OUTLIER -92.84 112.43 24.39 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.386 -179.607 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.509 HG13 ' HB2' ' A' ' 25' ' ' LEU . 7.6 p -134.23 108.8 11.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.653 179.033 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.673 ' OE1' HG22 ' A' ' 8' ' ' THR . 1.5 pm0 -140.04 162.53 35.0 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.499 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.462 ' HB2' ' HG2' ' A' ' 16' ' ' GLU . 31.3 m-85 -116.13 148.47 40.28 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.149 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -135.29 143.46 46.23 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.306 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.11 -108.54 2.65 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.138 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -117.16 25.7 8.64 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.564 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.8 m -97.64 -15.53 20.39 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.462 ' HG2' ' HB2' ' A' ' 11' ' ' PHE . 40.0 mt-10 -59.54 -32.97 70.82 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.667 0.27 . . . . 0.0 111.081 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.454 HD23 ' HG3' ' A' ' 21' ' ' LYS . 2.8 mt -72.54 -5.17 35.23 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.883 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.64 HD21 HD11 ' A' ' 55' ' ' LEU . 54.8 mt -83.1 14.42 3.42 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -153.76 -60.8 0.13 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.61 0.243 . . . . 0.0 110.656 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -177.4 37.49 0.0 OUTLIER 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.149 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.454 ' HG3' HD23 ' A' ' 17' ' ' LEU . 5.4 mptt 51.19 35.27 12.95 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.966 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -93.06 151.16 20.04 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.876 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.9 p -79.13 -64.29 1.22 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.926 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.8 p -143.22 163.93 31.58 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.792 0.329 . . . . 0.0 111.357 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.509 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.8 OUTLIER -148.54 166.58 27.79 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.11 -179.794 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -132.78 126.5 32.52 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.873 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.2 mt . . . . . 0 C--O 1.233 0.186 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.877 -179.9 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 58.1 m . . . . . 0 CA--C 1.529 0.15 0 CA-C-O 120.646 0.26 . . . . 0.0 110.809 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -113.23 -175.29 2.64 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.704 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.815 HD22 ' HA ' ' A' ' 83' ' ' MET . 4.5 tt -55.16 -35.1 64.4 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.404 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.63 -37.39 70.66 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.906 0.384 . . . . 0.0 110.135 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.97 -32.96 56.11 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.93 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.792 HD11 ' CD1' ' A' ' 87' ' ' LEU . 95.2 mt -65.86 -53.29 41.82 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.7 0.286 . . . . 0.0 110.58 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.3 OUTLIER -56.71 -57.53 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.993 179.884 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.431 ' H ' HG23 ' A' ' 41' ' ' VAL . 0.8 OUTLIER -55.54 -26.65 44.41 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.431 179.57 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.9 tp -82.08 -23.81 35.57 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.677 HD12 ' N ' ' A' ' 45' ' ' LYS . 4.7 pp -96.75 -38.17 10.0 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.677 ' N ' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -92.37 -59.6 2.05 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -179.627 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.5 m -61.33 -21.85 64.37 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.364 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.38 -34.15 10.77 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -155.58 55.01 0.62 Allowed 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.438 ' HB ' ' O ' ' A' ' 45' ' ' LYS . 7.6 p -70.72 -33.1 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 57.79 13.48 2.07 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -158.37 -170.37 3.08 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.636 ' HB2' HD23 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -67.08 112.56 10.19 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-O 120.562 0.22 . . . . 0.0 110.838 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.428 ' O ' HG22 ' A' ' 57' ' ' VAL . 18.2 Cg_endo -59.85 -24.7 76.97 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.272 1.982 . . . . 0.0 112.299 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.432 ' HA ' HG22 ' A' ' 57' ' ' VAL . 0.9 OUTLIER -90.36 6.58 42.53 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.807 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.708 ' HG ' HD23 ' A' ' 56' ' ' LEU . 1.6 pp -91.5 -29.34 17.05 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 121.236 -0.186 . . . . 0.0 111.316 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.708 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -97.47 -44.0 7.02 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.723 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.432 HG22 ' HA ' ' A' ' 54' ' ' ASP . 15.5 m -56.5 148.05 4.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.176 0.512 . . . . 0.0 111.696 -179.098 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.672 ' HB2' HG23 ' A' ' 63' ' ' THR . 12.5 t70 -63.18 -55.88 21.38 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.361 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -174.22 -44.65 0.01 OUTLIER 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.481 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.415 HG23 ' HB3' ' A' ' 62' ' ' GLN . 9.7 t -89.63 15.37 9.63 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.426 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 55.16 23.29 32.21 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.65 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.415 ' HB3' HG23 ' A' ' 60' ' ' THR . 1.0 OUTLIER -107.77 -32.77 7.49 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.893 0.377 . . . . 0.0 110.788 -179.714 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.672 HG23 ' HB2' ' A' ' 58' ' ' ASP . 6.0 t -132.66 179.48 6.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.092 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.6 mt -103.98 152.92 21.43 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.915 0.388 . . . . 0.0 111.451 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.06 154.18 82.84 Favored Pre-proline 0 N--CA 1.465 0.287 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.389 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -50.31 -32.95 35.13 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.199 2.599 . . . . 0.0 113.036 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -46.51 -37.58 8.71 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 121.392 -0.432 . . . . 0.0 112.993 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.478 HG21 ' HB3' ' A' ' 95' ' ' PHE . 3.8 mt -104.8 133.28 49.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.861 0.331 . . . . 0.0 111.054 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.0 mt -100.8 100.37 11.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.694 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.706 HG23 ' HB3' ' A' ' 77' ' ' ALA . 14.5 m -76.57 133.26 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.873 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.57 HD23 ' O ' ' A' ' 70' ' ' VAL . 2.7 mt -132.13 140.62 48.86 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.391 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.664 HG23 ' CB ' ' A' ' 77' ' ' ALA . 19.5 t -115.73 117.82 56.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.493 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 56.99 49.86 13.16 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.145 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 58.81 47.36 12.75 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.951 0.405 . . . . 0.0 111.275 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 52.0 t -161.37 147.03 14.01 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.628 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -46.01 119.56 2.32 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.781 0.324 . . . . 0.0 111.357 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.706 ' HB3' HG23 ' A' ' 70' ' ' VAL . . . -78.2 -17.87 56.2 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.136 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.11 -34.51 49.97 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.379 0.133 . . . . 0.0 111.162 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.2 t -70.11 -45.79 74.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.053 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.9 m -60.62 -35.51 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.691 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 179.0 -35.52 0.08 OUTLIER Glycine 0 CA--C 1.524 0.599 0 C-N-CA 120.785 -0.722 . . . . 0.0 113.251 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.68 -54.13 2.67 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.225 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.815 ' HA ' HD22 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -148.52 27.51 0.91 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 120.464 0.173 . . . . 0.0 111.343 179.641 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -129.09 15.49 6.24 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.476 ' CZ ' HG11 ' A' ' 72' ' ' VAL . 1.9 t80 -70.38 113.21 7.3 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.755 0.312 . . . . 0.0 110.943 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 26.9 m -69.4 148.21 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.473 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.792 ' CD1' HD11 ' A' ' 40' ' ' LEU . 1.0 OUTLIER -96.66 157.96 15.66 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.541 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -154.16 36.16 0.43 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.194 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.4 t0 62.96 27.31 15.89 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.963 0.411 . . . . 0.0 111.691 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -168.77 41.08 0.22 Allowed Glycine 0 C--N 1.332 0.35 0 C-N-CA 121.198 -0.525 . . . . 0.0 112.235 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.479 ' O ' HG23 ' A' ' 7' ' ' ILE . 4.0 t70 -85.03 166.36 16.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.815 0.34 . . . . 0.0 111.013 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.723 HG23 ' HB ' ' A' ' 8' ' ' THR . 86.1 m -141.81 127.61 19.28 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.659 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.7 p -141.8 133.63 27.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.111 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -132.96 143.18 49.29 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.327 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.478 ' HB3' HG21 ' A' ' 68' ' ' ILE . 18.2 m-85 -113.19 104.74 12.65 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.275 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 11.0 mt -110.73 110.15 31.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.03 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 60.6 p -76.66 143.64 39.97 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.19 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.532 0.269 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.13 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 14.3 p-80 . . . . . 0 C--O 1.233 0.211 0 CA-C-O 120.787 0.327 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 33.6 mm -87.2 154.32 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.672 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.607 ' CG2' HG23 ' A' ' 92' ' ' THR . 48.8 m -121.14 94.12 4.24 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.653 0.263 . . . . 0.0 111.082 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.587 HG13 ' HB2' ' A' ' 25' ' ' LEU . 11.5 p -118.28 109.2 26.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-O 121.02 0.438 . . . . 0.0 111.426 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.47 ' OE1' HG22 ' A' ' 8' ' ' THR . 8.4 pm0 -134.0 162.24 32.6 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.569 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.433 ' CB ' ' HA ' ' A' ' 16' ' ' GLU . 98.1 m-85 -122.04 151.92 40.33 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.102 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -167.23 174.38 8.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.013 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 59.66 32.03 72.8 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.916 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.1 26.91 38.92 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.224 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.6 t -108.07 -22.98 12.18 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 117.129 0.464 . . . . 0.0 111.528 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.433 ' HA ' ' CB ' ' A' ' 11' ' ' PHE . 1.9 pt-20 -57.72 -27.51 63.03 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.512 0.196 . . . . 0.0 111.339 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.1 mp -64.98 -10.66 31.12 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.556 HD22 ' CD1' ' A' ' 55' ' ' LEU . 71.8 mt -83.55 13.57 4.46 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -148.18 -70.83 0.22 Allowed 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -170.98 38.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.969 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.65 34.16 15.31 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.146 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -77.47 178.43 7.21 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.047 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 37.0 p -107.12 -76.89 0.6 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.895 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.6 p -136.77 164.31 28.57 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.688 0.28 . . . . 0.0 111.372 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.587 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -148.53 151.02 34.4 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.267 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.484 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 31.7 mt-30 -132.64 109.57 9.82 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.87 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.3 mt . . . . . 0 C--O 1.233 0.234 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.687 -179.875 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.5 m . . . . . 0 CA--C 1.529 0.172 0 CA-C-O 120.719 0.295 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -100.15 -170.19 1.84 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.6 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.666 ' O ' HG22 ' A' ' 41' ' ' VAL . 2.5 tt -55.04 -42.94 73.29 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 111.484 0.179 . . . . 0.0 111.484 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -56.78 -38.14 72.07 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.98 -34.44 47.48 Favored Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.977 178.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.996 HD13 HD21 ' A' ' 87' ' ' LEU . 23.9 tp -62.32 -52.03 65.3 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.622 0.248 . . . . 0.0 110.634 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.666 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.3 OUTLIER -59.11 -57.63 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.929 179.541 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.418 ' H ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -51.07 -32.42 21.99 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.732 -0.213 . . . . 0.0 111.259 179.576 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.466 ' O ' HD23 ' A' ' 43' ' ' LEU . 8.5 tt -70.38 -27.84 64.63 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.484 HD12 ' C ' ' A' ' 44' ' ' LEU . 1.5 pp -97.02 -41.2 8.49 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.1 pttt -82.21 -65.19 1.04 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 m -56.67 -23.74 43.84 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -94.07 -41.13 9.7 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 111.515 0.191 . . . . 0.0 111.515 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.21 59.74 0.97 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.885 0.374 . . . . 0.0 111.902 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.1 p -78.87 -35.67 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.605 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 64.59 10.76 6.15 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.423 -179.218 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -154.05 -173.05 4.43 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.681 ' HB2' HD23 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -68.04 135.61 91.77 Favored Pre-proline 0 N--CA 1.464 0.275 0 CA-C-O 120.518 0.199 . . . . 0.0 110.809 179.707 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.494 ' O ' HG22 ' A' ' 57' ' ' VAL . 73.7 Cg_endo -77.39 -23.02 10.43 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.334 2.022 . . . . 0.0 112.834 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.416 ' HA ' HG22 ' A' ' 57' ' ' VAL . 65.0 m-20 -90.69 6.92 42.02 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.681 HD23 ' HB2' ' A' ' 52' ' ' ARG . 3.7 pp -89.87 -17.71 27.55 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 120.987 -0.285 . . . . 0.0 111.312 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.526 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -111.12 -46.0 3.37 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 53' ' ' PRO . 13.1 m -56.72 148.36 4.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 121.188 0.518 . . . . 0.0 111.692 -179.188 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.685 ' HB2' HG23 ' A' ' 63' ' ' THR . 26.3 t70 -63.99 -53.9 42.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.496 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -177.15 -43.84 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.436 178.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.3 p -87.45 12.88 11.13 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.474 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 57.01 22.19 41.25 Favored Glycine 0 C--N 1.339 0.747 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.745 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -107.87 -35.54 6.62 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.861 0.363 . . . . 0.0 110.863 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.685 HG23 ' HB2' ' A' ' 58' ' ' ASP . 9.4 t -129.55 -178.77 4.82 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.006 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.6 mt -102.93 153.68 19.97 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.968 0.414 . . . . 0.0 111.391 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.408 ' HB3' ' HA ' ' A' ' 58' ' ' ASP . 0.8 OUTLIER -79.78 155.0 75.85 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.135 179.854 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.24 135.21 59.39 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.867 2.378 . . . . 0.0 112.545 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.18 -48.35 0.91 Allowed Glycine 0 C--N 1.332 0.344 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.413 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.2 mt -93.39 143.08 12.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 120.83 0.348 . . . . 0.0 111.21 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.478 HD23 HD21 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -105.1 101.68 11.22 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 179.659 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.498 HG23 ' HB3' ' A' ' 77' ' ' ALA . 10.8 m -76.84 136.8 23.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.785 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.478 HD21 HD23 ' A' ' 69' ' ' LEU . 23.1 mt -131.4 146.8 52.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.317 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.571 HG21 HG21 ' A' ' 80' ' ' VAL . 67.7 t -128.22 133.9 66.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.325 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.2 m120 58.72 26.06 14.16 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.003 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 54.93 31.88 16.82 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.373 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.407 ' SG ' ' N ' ' A' ' 76' ' ' ASP . 16.4 p -130.04 -48.57 1.11 Allowed 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.356 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.76 ' HB3' HG23 ' A' ' 79' ' ' VAL . 0.2 OUTLIER 172.28 140.6 0.03 OUTLIER 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.491 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.498 ' HB3' HG23 ' A' ' 70' ' ' VAL . . . -86.32 -22.58 26.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.65 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -79.19 -32.97 44.28 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.437 0.161 . . . . 0.0 110.609 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.76 HG23 ' HB3' ' A' ' 76' ' ' ASP . 52.7 t -60.62 -46.65 95.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.957 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.571 HG21 HG21 ' A' ' 72' ' ' VAL . 18.8 m -65.31 -23.44 33.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 147.43 -23.94 1.53 Allowed Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.766 -0.73 . . . . 0.0 113.344 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 104.04 -57.92 0.52 Allowed Glycine 0 C--N 1.338 0.692 0 C-N-CA 121.126 -0.559 . . . . 0.0 111.705 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.6 ' HA ' HD22 ' A' ' 37' ' ' LEU . 5.6 ptt? -152.89 26.99 0.54 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.497 0.189 . . . . 0.0 110.98 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -135.05 21.72 3.49 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.409 ' CD2' HG11 ' A' ' 72' ' ' VAL . 19.7 t80 -80.44 112.87 18.19 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.846 0.355 . . . . 0.0 110.849 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.1 m -62.72 143.64 15.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.393 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.996 HD21 HD13 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -82.1 142.34 32.36 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.415 -179.783 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -130.18 43.02 3.19 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.32 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.73 27.3 8.58 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.808 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -173.44 41.2 0.15 Allowed Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.304 -0.474 . . . . 0.0 112.091 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.425 ' HB2' ' HG ' ' A' ' 87' ' ' LEU . 24.8 t0 -83.12 114.09 21.08 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.719 0.295 . . . . 0.0 111.222 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.607 HG23 ' CG2' ' A' ' 8' ' ' THR . 28.4 m -85.01 128.62 34.71 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.56 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.0 p -140.19 133.54 34.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.126 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -129.35 161.31 30.59 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.021 0.439 . . . . 0.0 111.592 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -134.2 104.74 6.32 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.165 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 29.0 mt -114.77 112.91 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.132 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.3 140.38 38.82 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.91 0.386 . . . . 0.0 111.369 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 39.9 p . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.217 179.424 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 . . . . . 0 N--CA 1.468 0.46 0 CA-C-O 120.758 0.313 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.487 HG21 HD11 ' A' ' 40' ' ' LEU . 12.4 mm -88.35 111.54 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.714 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.563 HG22 ' NE2' ' A' ' 10' ' ' GLN . 41.8 m -81.78 102.61 10.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.343 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.566 HG13 ' HB2' ' A' ' 25' ' ' LEU . 7.9 p -119.93 104.92 16.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.467 179.385 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.563 ' NE2' HG22 ' A' ' 8' ' ' THR . 0.7 OUTLIER -127.28 161.8 27.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.692 -179.047 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -116.07 159.24 21.97 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.948 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.705 ' HB3' ' HA ' ' A' ' 96' ' ' ILE . . . -105.86 176.23 5.23 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.228 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.96 97.38 0.05 OUTLIER Glycine 0 C--N 1.336 0.583 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.53 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.67 -29.31 4.49 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.943 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.7 -27.96 15.02 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.852 0.326 . . . . 0.0 111.558 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.94 -27.87 65.71 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.585 0.231 . . . . 0.0 111.254 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 mp -67.7 -10.16 49.97 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.555 HD22 HD11 ' A' ' 55' ' ' LEU . 56.1 mt -81.13 13.3 2.87 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -149.58 -63.73 0.22 Allowed 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -174.37 37.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.114 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.49 34.81 12.94 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.003 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -72.34 -177.36 2.14 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.046 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 49.9 p -115.7 -78.17 0.58 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.919 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.432 ' CB ' ' HB3' ' A' ' 10' ' ' GLN . 83.7 p -136.12 160.24 39.25 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.933 0.397 . . . . 0.0 111.254 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.566 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -138.03 152.06 48.48 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.15 179.804 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -133.18 100.61 4.91 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.523 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.1 mt . . . . . 0 C--O 1.234 0.261 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.93 -179.645 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 63.8 m . . . . . 0 CA--C 1.529 0.158 0 CA-C-O 120.718 0.294 . . . . 0.0 110.749 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 53.2 p-10 -108.61 -173.28 2.24 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.891 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.786 ' O ' HG22 ' A' ' 41' ' ' VAL . 4.2 tt -57.66 -39.28 76.69 Favored 'General case' 0 N--CA 1.46 0.071 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.032 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -54.92 -38.19 67.35 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.308 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.05 -32.22 45.12 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.103 179.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.487 HD11 HG21 ' A' ' 7' ' ' ILE . 61.7 tp -68.16 -53.08 27.68 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.652 0.226 . . . . 0.0 110.855 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.786 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.5 OUTLIER -57.83 -57.4 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.854 179.788 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.456 ' H ' HG23 ' A' ' 41' ' ' VAL . 1.8 tm0? -50.65 -32.09 18.11 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.402 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.4 tp -71.52 -27.56 63.28 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.898 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.503 HD12 ' C ' ' A' ' 44' ' ' LEU . 1.3 pp -96.92 -40.58 8.83 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.408 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 0.4 OUTLIER -84.0 -71.69 0.5 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.4 -179.578 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 22.5 m -53.04 -22.14 5.51 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.05 -31.35 10.68 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -142.25 51.6 1.48 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -178.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.551 HG22 ' H ' ' A' ' 51' ' ' GLU . 12.2 p -100.6 120.07 49.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.873 0.368 . . . . 0.0 110.716 179.199 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -101.24 31.91 3.48 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.02 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.551 ' H ' HG22 ' A' ' 49' ' ' VAL . 1.9 tp10 -155.86 -174.78 5.1 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.252 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.593 ' HB2' HD23 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -62.29 110.21 3.08 Favored Pre-proline 0 CA--C 1.53 0.176 0 CA-C-N 116.803 -0.181 . . . . 0.0 111.045 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.444 ' O ' HG22 ' A' ' 57' ' ' VAL . 17.7 Cg_endo -60.33 -27.31 84.62 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.405 2.07 . . . . 0.0 112.286 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.441 ' HA ' ' CG2' ' A' ' 57' ' ' VAL . 5.8 t70 -91.38 8.04 38.11 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.994 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.687 ' HG ' HD23 ' A' ' 56' ' ' LEU . 1.2 pp -88.58 -26.7 21.82 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 122.306 -0.246 . . . . 0.0 111.472 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.687 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -100.5 -46.82 5.1 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.483 HG11 ' HA2' ' A' ' 61' ' ' GLY . 9.0 m -55.59 149.63 2.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 121.164 0.507 . . . . 0.0 111.7 -179.161 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -63.43 -52.94 59.4 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.736 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.43 -45.5 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.518 179.199 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.1 p -90.27 16.45 8.62 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.483 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 56.07 21.63 32.39 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.825 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -105.88 -35.35 7.35 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.839 0.352 . . . . 0.0 110.573 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.748 HG22 ' HG3' ' A' ' 83' ' ' MET . 71.9 p -128.16 -177.07 4.0 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.983 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.4 mt -110.64 154.52 23.69 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.934 0.397 . . . . 0.0 110.997 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -71.67 152.82 93.55 Favored Pre-proline 0 C--O 1.234 0.256 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.068 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -55.77 124.48 16.38 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.764 2.31 . . . . 0.0 112.357 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 147.82 -45.02 0.76 Allowed Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.51 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.537 HG21 ' HB3' ' A' ' 95' ' ' PHE . 5.0 mt -91.52 120.11 39.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 120.7 0.286 . . . . 0.0 111.155 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.23 100.09 12.95 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.403 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.78 HG23 ' HB3' ' A' ' 77' ' ' ALA . 29.5 m -77.75 126.35 38.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.276 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.431 HD23 ' O ' ' A' ' 70' ' ' VAL . 4.9 mt -125.4 129.67 50.35 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.874 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 92' ' ' THR . 3.6 m -112.82 114.73 47.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.016 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 11.6 m120 54.86 52.22 12.36 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.071 0.462 . . . . 0.0 110.727 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.7 m 59.23 30.1 19.78 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.58 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 46.4 t -145.38 125.31 13.54 Favored 'General case' 0 C--O 1.23 0.048 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.375 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.701 ' HB2' HG23 ' A' ' 79' ' ' VAL . 61.7 m-20 -44.16 127.37 5.51 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.765 0.317 . . . . 0.0 111.254 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.78 ' HB3' HG23 ' A' ' 70' ' ' VAL . . . -63.3 -19.48 64.63 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.883 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -73.28 -26.63 61.16 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 120.577 0.227 . . . . 0.0 110.673 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.701 HG23 ' HB2' ' A' ' 76' ' ' ASP . 30.7 t -70.82 -44.38 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.084 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.4 m -70.39 -39.74 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.507 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.39 42.66 0.02 OUTLIER Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.804 -0.712 . . . . 0.0 113.426 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 53.07 -107.84 0.63 Allowed Glycine 0 C--N 1.334 0.455 0 C-N-CA 121.184 -0.532 . . . . 0.0 113.009 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.748 ' HG3' HG22 ' A' ' 63' ' ' THR . 60.5 mmm -108.58 27.69 9.14 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.804 0.335 . . . . 0.0 111.073 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -120.29 19.22 12.17 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.828 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -68.83 117.73 10.89 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.827 0.346 . . . . 0.0 111.339 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 15.6 m -70.57 146.53 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.713 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.9 mp -94.88 161.39 14.18 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.18 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 32.8 m-20 -153.54 35.77 0.46 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.616 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 59.93 96.39 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.045 0.45 . . . . 0.0 111.21 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 112.07 36.17 1.7 Allowed Glycine 0 CA--C 1.518 0.237 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.357 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -87.3 170.33 11.52 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.784 0.326 . . . . 0.0 110.902 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.442 HG23 HE22 ' A' ' 10' ' ' GLN . 92.6 m -137.91 134.98 35.66 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.8 p -141.41 134.28 29.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.027 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -131.38 149.14 52.66 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.384 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.537 ' HB3' HG21 ' A' ' 68' ' ' ILE . 23.0 m-85 -121.84 104.71 9.75 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.45 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.705 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 17.9 mt -111.89 103.84 16.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.239 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 84.0 p -82.56 132.05 35.2 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.89 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.463 0.207 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.372 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.32 0 CA-C-O 120.742 0.306 . . . . 0.0 111.542 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.489 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 17.3 mm -123.66 153.73 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.86 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.41 ' HB ' ' HA ' ' A' ' 92' ' ' THR . 49.5 m -113.12 99.23 7.68 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.914 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.592 HG13 ' HB2' ' A' ' 25' ' ' LEU . 14.7 p -121.86 115.02 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.573 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.428 ' HG2' ' HG2' ' A' ' 94' ' ' GLU . 3.8 pm0 -128.99 159.14 36.85 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.963 0.411 . . . . 0.0 111.26 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.494 ' HB3' ' N ' ' A' ' 16' ' ' GLU . 12.1 m-85 -115.73 135.12 54.34 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.25 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -142.47 144.61 33.1 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.101 0.476 . . . . 0.0 111.977 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 86.42 -91.48 1.73 Allowed Glycine 0 C--N 1.332 0.355 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.905 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -133.88 28.91 3.16 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.992 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -109.94 -31.06 7.53 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.682 0.241 . . . . 0.0 111.133 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.494 ' N ' ' HB3' ' A' ' 11' ' ' PHE . 0.7 OUTLIER -61.76 -37.08 82.96 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.26 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.461 ' N ' ' HG2' ' A' ' 16' ' ' GLU . 4.5 mt -67.93 -14.4 62.94 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.809 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.728 HD13 HD22 ' A' ' 56' ' ' LEU . 9.0 mt -83.54 13.52 4.48 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.403 ' HA ' ' HB2' ' A' ' 50' ' ' LYS . 10.5 t80 -144.28 -64.51 0.36 Allowed 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -174.64 38.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.087 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 49.57 38.79 15.62 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.058 0.456 . . . . 0.0 110.782 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -73.9 175.37 7.39 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.056 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 33.1 p -114.94 -52.25 2.7 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.013 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 94.3 p -155.39 148.83 25.02 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.669 0.271 . . . . 0.0 110.955 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.592 ' HB2' HG13 ' A' ' 9' ' ' VAL . 5.0 mt -135.72 158.01 45.44 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.931 0.396 . . . . 0.0 111.345 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.489 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 11.8 mt-30 -130.1 106.99 8.99 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.8 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.1 mt . . . . . 0 C--N 1.331 -0.199 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.942 -179.888 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 87.9 m . . . . . 0 C--O 1.234 0.25 0 CA-C-O 120.745 0.307 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.7 p30 -84.43 174.05 10.38 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.975 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.904 HD22 ' HA ' ' A' ' 83' ' ' MET . 4.9 tt -57.84 -39.85 78.66 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.246 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -53.64 -41.24 66.56 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.933 0.397 . . . . 0.0 109.986 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.08 -31.86 63.74 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.135 178.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.3 tp -70.13 -57.13 5.29 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.525 0.202 . . . . 0.0 110.964 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.73 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.4 OUTLIER -57.54 -57.51 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.203 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.429 ' H ' HG23 ' A' ' 41' ' ' VAL . 0.7 OUTLIER -49.67 -32.49 13.33 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.504 179.773 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.1 tp -75.63 -24.15 56.41 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.409 ' C ' HD12 ' A' ' 44' ' ' LEU . 1.0 OUTLIER -96.35 -37.54 10.44 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.878 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.489 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 2.9 pttt -83.95 -71.26 0.52 Allowed 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 121.162 -0.215 . . . . 0.0 111.322 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.9 m -52.25 -24.72 7.77 Favored 'General case' 0 CA--C 1.537 0.442 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -102.08 -27.2 13.06 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -142.42 50.38 1.49 Allowed 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.623 HG22 ' H ' ' A' ' 51' ' ' GLU . 10.4 p -96.9 139.66 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 120.684 0.278 . . . . 0.0 111.25 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.403 ' HB2' ' HA ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -123.91 31.25 5.9 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.46 179.906 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.623 ' H ' HG22 ' A' ' 49' ' ' VAL . 0.7 OUTLIER -164.15 176.46 9.23 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.153 179.567 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.499 ' HB2' HD23 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -49.99 106.0 0.58 Allowed Pre-proline 0 N--CA 1.466 0.329 0 CA-C-O 120.508 0.194 . . . . 0.0 111.367 -179.814 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.07 -28.47 60.47 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.44 2.093 . . . . 0.0 112.676 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.403 ' HA ' ' CG2' ' A' ' 57' ' ' VAL . 0.3 OUTLIER -92.88 9.03 37.13 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.803 ' HG ' HD23 ' A' ' 56' ' ' LEU . 2.1 pp -83.62 -28.93 28.12 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 121.034 -0.267 . . . . 0.0 111.158 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.803 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -94.11 -54.46 3.57 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.765 -0.198 . . . . 0.0 111.335 179.927 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.553 HG11 ' HA2' ' A' ' 61' ' ' GLY . 1.4 m -54.55 151.22 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.201 0.524 . . . . 0.0 111.638 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -68.02 -62.91 1.19 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.739 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -165.22 -45.36 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.404 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.1 t -78.89 3.89 15.69 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.595 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.553 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 61.34 22.92 61.68 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.598 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.6 tm0? -121.46 -45.47 2.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.81 0.338 . . . . 0.0 110.407 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.563 ' HA ' ' HG3' ' A' ' 83' ' ' MET . 1.8 t -102.07 123.61 46.25 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.676 178.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.666 HD22 ' HB2' ' A' ' 56' ' ' LEU . 7.8 mt -67.79 156.7 36.44 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.727 0.298 . . . . 0.0 110.917 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 56' ' ' LEU . 7.6 ptm180 -57.32 143.26 74.14 Favored Pre-proline 0 C--O 1.234 0.259 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.125 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -50.6 -33.28 38.63 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.091 2.527 . . . . 0.0 112.829 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -50.85 -34.7 30.25 Favored Glycine 0 CA--C 1.523 0.54 0 CA-C-N 116.037 -0.529 . . . . 0.0 113.023 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.537 HD13 HD13 ' A' ' 64' ' ' LEU . 7.2 mt -88.77 120.41 37.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-O 120.76 0.314 . . . . 0.0 111.213 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.9 mt -96.94 97.02 8.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.018 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.9 t -79.46 136.69 23.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.12 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.09 155.73 44.99 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.476 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.564 HG23 ' CB ' ' A' ' 77' ' ' ALA . 39.9 t -124.48 115.04 43.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.8 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 67.03 -77.15 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.2 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.9 t -153.32 33.7 0.46 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.867 0.365 . . . . 0.0 110.942 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 44.4 t -158.46 156.02 29.58 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.682 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.448 ' HB2' HG23 ' A' ' 79' ' ' VAL . 51.4 m-20 -49.14 136.58 14.78 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.611 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.564 ' CB ' HG23 ' A' ' 72' ' ' VAL . . . -82.39 -23.13 35.11 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.845 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -71.59 -18.59 62.22 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.432 0.158 . . . . 0.0 111.087 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.448 HG23 ' HB2' ' A' ' 76' ' ' ASP . 32.6 t -72.53 -41.11 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.316 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.6 m -80.6 -29.14 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.735 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 176.61 -38.32 0.1 OUTLIER Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.035 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 99.06 -72.06 0.54 Allowed Glycine 0 C--N 1.334 0.435 0 C-N-CA 121.003 -0.618 . . . . 0.0 111.968 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.904 ' HA ' HD22 ' A' ' 37' ' ' LEU . 2.7 mmt -129.0 25.75 5.55 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.725 0.298 . . . . 0.0 111.182 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -136.67 23.99 3.13 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.56 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -82.63 120.17 25.21 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.6 0.238 . . . . 0.0 110.738 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.2 m -69.84 134.06 30.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.426 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.5 mp -98.2 123.57 42.34 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.867 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -108.1 35.19 3.23 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.334 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 63.1 104.83 0.03 OUTLIER 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.209 0.528 . . . . 0.0 111.488 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 113.2 29.34 3.03 Favored Glycine 0 CA--C 1.519 0.322 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.503 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -101.14 152.77 20.23 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.619 0.247 . . . . 0.0 110.837 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.41 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 94.9 m -115.18 111.8 21.54 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.962 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.8 p -120.67 125.69 74.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.748 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.428 ' HG2' ' HG2' ' A' ' 10' ' ' GLN . 16.0 mt-10 -126.37 153.68 44.6 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.364 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -120.69 104.53 9.99 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.067 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 25.2 mt -106.11 99.91 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.964 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.97 140.11 29.99 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.301 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.464 0.249 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.405 179.861 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.412 ' O ' HD13 ' A' ' 7' ' ' ILE . 2.3 p80 . . . . . 0 N--CA 1.464 0.269 0 CA-C-O 120.634 0.254 . . . . 0.0 110.779 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 25.2 mm -129.62 152.2 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.611 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.431 ' HB ' HG23 ' A' ' 92' ' ' THR . 6.7 m -115.79 122.92 46.87 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.736 0.303 . . . . 0.0 111.474 -179.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.635 HG13 ' HB2' ' A' ' 25' ' ' LEU . 9.8 p -145.89 110.1 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.201 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.404 ' HB3' ' CB ' ' A' ' 24' ' ' SER . 5.2 pm0 -135.62 160.94 36.94 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.961 0.41 . . . . 0.0 111.643 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.454 ' HB2' ' HB3' ' A' ' 16' ' ' GLU . 89.1 m-85 -117.34 147.08 42.94 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.075 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.78 ' HB3' HG12 ' A' ' 96' ' ' ILE . . . -145.22 145.82 31.47 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.836 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.04 -95.3 2.06 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.457 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -139.51 30.91 2.37 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.722 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.2 m -108.04 -23.91 11.8 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.454 ' HB3' ' HB2' ' A' ' 11' ' ' PHE . 1.8 pm0 -59.84 -30.65 69.09 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.621 0.248 . . . . 0.0 111.228 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.8 mp -71.26 -7.97 50.53 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.706 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.53 HD13 HD22 ' A' ' 56' ' ' LEU . 42.1 mt -87.97 13.58 10.7 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.425 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 42.0 t80 -144.95 -63.63 0.35 Allowed 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -178.22 36.17 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.077 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.74 31.59 6.11 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.965 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -80.6 134.19 35.87 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.976 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -67.76 -66.25 0.59 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.822 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.404 ' CB ' ' HB3' ' A' ' 10' ' ' GLN . 87.3 p -144.24 161.31 39.22 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.723 0.297 . . . . 0.0 111.062 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.635 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -142.65 148.13 36.89 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.399 -179.881 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.512 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 4.7 mt-30 -132.16 117.95 18.94 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.883 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.4 mt . . . . . 0 C--O 1.233 0.193 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.877 -179.853 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.0 t . . . . . 0 CA--C 1.536 0.406 0 N-CA-C 110.535 -0.172 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -134.47 -174.24 3.51 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.869 -0.15 . . . . 0.0 110.745 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.813 HD22 ' HA ' ' A' ' 83' ' ' MET . 3.3 tt -60.01 -44.3 94.68 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 121.285 -0.166 . . . . 0.0 111.329 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -59.48 -34.33 72.43 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.54 -33.92 46.2 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.601 178.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.658 HD13 HG11 ' A' ' 93' ' ' VAL . 14.0 mt -60.55 -52.17 66.31 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.735 0.302 . . . . 0.0 110.603 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.549 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.2 OUTLIER -59.92 -56.66 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.975 179.846 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.43 -30.77 13.29 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.51 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.8 tp -73.11 -27.82 61.92 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.437 HD12 ' C ' ' A' ' 44' ' ' LEU . 1.8 pp -96.97 -42.55 7.86 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.4 pttt -84.26 -68.79 0.69 Allowed 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.5 m -50.69 -28.82 9.76 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.509 0.195 . . . . 0.0 111.47 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -81.19 -34.31 32.39 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.277 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -130.8 -68.32 0.69 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 111.449 0.166 . . . . 0.0 111.449 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 51' ' ' GLU . 11.5 p 44.72 72.31 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 121.56 0.695 . . . . 0.0 111.491 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -52.55 -50.23 63.33 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.205 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.606 ' O ' HG22 ' A' ' 49' ' ' VAL . 1.8 tp10 -91.44 -164.06 1.12 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.02 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.452 ' CB ' HD23 ' A' ' 55' ' ' LEU . 3.3 ttt-85 -66.2 134.39 94.77 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-O 120.675 0.274 . . . . 0.0 111.24 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.582 ' HB3' HG21 ' A' ' 49' ' ' VAL . 74.1 Cg_endo -77.24 -25.56 8.39 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.572 2.181 . . . . 0.0 112.529 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.44 ' HA ' HG22 ' A' ' 57' ' ' VAL . 2.9 t70 -89.84 8.46 31.9 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.565 ' HG ' HD23 ' A' ' 56' ' ' LEU . 2.6 pp -91.41 -26.32 18.92 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 121.287 -0.165 . . . . 0.0 111.323 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.59 ' HB2' HD22 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -98.24 -45.1 6.31 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.804 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.44 HG22 ' HA ' ' A' ' 54' ' ' ASP . 11.1 m -55.3 148.52 3.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 121.258 0.551 . . . . 0.0 111.558 -179.065 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -63.94 -57.0 11.09 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.532 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.76 -44.51 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.515 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 34.6 p -86.07 10.73 13.46 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.735 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.429 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 58.31 22.3 50.34 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.688 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -109.69 -34.69 6.4 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.947 0.403 . . . . 0.0 110.886 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.6 t -129.25 175.09 9.0 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.881 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.59 HD22 ' HB2' ' A' ' 56' ' ' LEU . 11.0 mt -93.75 158.03 15.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.043 0.449 . . . . 0.0 111.402 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.437 ' HB2' ' HD2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -83.17 165.87 38.44 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.191 -179.867 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.437 ' HD2' ' HB2' ' A' ' 65' ' ' ARG . 47.2 Cg_exo -55.72 129.67 36.28 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.741 2.294 . . . . 0.0 112.428 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.49 -49.29 0.86 Allowed Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.196 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.527 HG21 ' HB3' ' A' ' 95' ' ' PHE . 4.6 mt -94.62 134.61 31.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-O 120.728 0.299 . . . . 0.0 110.859 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.3 mt -111.53 118.65 36.31 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.975 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.465 HG23 ' HB3' ' A' ' 77' ' ' ALA . 26.9 m -85.77 125.22 40.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.031 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.415 HD23 ' C ' ' A' ' 70' ' ' VAL . 1.7 mt -120.96 131.55 54.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.089 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.591 HG13 ' HB2' ' A' ' 77' ' ' ALA . 1.5 m -103.99 99.31 8.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.737 179.317 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 59.58 51.19 6.61 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.685 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.1 t 66.02 35.35 6.42 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.506 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 47.1 t -148.69 123.9 10.18 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.559 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -47.49 114.1 0.82 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.885 0.374 . . . . 0.0 111.32 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.591 ' HB2' HG13 ' A' ' 72' ' ' VAL . . . -73.04 -18.99 61.27 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.842 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.401 ' HA ' ' CA ' ' A' ' 82' ' ' GLY . 2.7 mt-10 -73.17 -23.99 60.5 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.87 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.8 t -64.59 -35.76 75.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.813 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.9 m -95.85 -36.72 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.693 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -152.22 -66.15 0.01 OUTLIER Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.061 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.401 ' CA ' ' HA ' ' A' ' 78' ' ' GLU . . . 104.39 -40.29 2.51 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.664 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.813 ' HA ' HD22 ' A' ' 37' ' ' LEU . 5.0 ptt? -147.63 25.13 1.08 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.52 0.2 . . . . 0.0 111.318 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -148.74 25.4 0.94 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.663 0.268 . . . . 0.0 111.679 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -81.5 114.32 20.15 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.763 0.316 . . . . 0.0 110.917 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.8 m -63.6 146.1 13.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.487 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.649 ' CD1' HD11 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -90.42 168.52 11.8 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.295 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 44.4 p30 -168.45 166.14 12.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.658 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -64.45 96.16 0.16 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.931 0.396 . . . . 0.0 110.343 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.417 ' H ' HD13 ' A' ' 7' ' ' ILE . . . 118.77 24.25 3.14 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.529 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -87.41 158.38 19.01 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.751 0.31 . . . . 0.0 111.045 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 53.5 m -138.31 136.93 36.91 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.264 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.658 HG11 HD13 ' A' ' 40' ' ' LEU . 3.4 p -143.26 120.33 5.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.607 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -125.09 147.94 48.77 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.528 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.527 ' HB3' HG21 ' A' ' 68' ' ' ILE . 80.6 m-85 -118.74 104.42 10.58 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.174 179.182 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.78 HG12 ' HB3' ' A' ' 12' ' ' ALA . 30.0 mt -116.59 112.85 41.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.243 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 27.1 t -78.37 86.99 4.41 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.237 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.5 p . . . . . 0 C--N 1.332 -0.182 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.374 -179.493 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.45 ' O ' ' HA2' ' A' ' 90' ' ' GLY . 12.5 m-70 . . . . . 0 N--CA 1.465 0.294 0 CA-C-O 120.814 0.34 . . . . 0.0 111.049 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.663 HD12 HD23 ' A' ' 87' ' ' LEU . 6.5 mm -81.25 145.58 8.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.185 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.601 HG22 ' OE1' ' A' ' 10' ' ' GLN . 1.2 m -102.26 107.51 18.57 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.206 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.559 HG13 ' HB2' ' A' ' 25' ' ' LEU . 7.6 p -133.07 107.69 11.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.455 178.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.601 ' OE1' HG22 ' A' ' 8' ' ' THR . 1.4 pm0 -136.52 164.72 27.51 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.048 0.452 . . . . 0.0 111.75 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.461 ' CD1' ' HB3' ' A' ' 15' ' ' CYS . 15.2 m-85 -112.64 149.36 32.94 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.906 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.925 ' HB3' HG12 ' A' ' 96' ' ' ILE . . . -140.68 135.51 31.7 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.028 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.22 -107.03 3.44 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.315 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -121.84 30.5 5.27 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.784 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.461 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . 7.9 m -106.06 -19.96 13.56 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.798 0.299 . . . . 0.0 111.721 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -58.34 -30.45 66.73 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.804 0.335 . . . . 0.0 110.767 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 mp -70.03 -4.46 21.03 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.873 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.808 ' CD2' HD11 ' A' ' 55' ' ' LEU . 91.5 mt -77.09 7.79 4.61 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.404 ' CD1' ' HB2' ' A' ' 50' ' ' LYS . 77.0 t80 -149.92 -65.11 0.21 Allowed 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -172.09 39.14 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.772 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 52.18 35.77 17.54 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.892 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -76.13 -176.9 3.71 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.023 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 72.0 p -109.96 -77.42 0.6 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.806 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.447 ' CB ' ' HB3' ' A' ' 10' ' ' GLN . 80.8 p -135.73 162.9 31.47 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.876 0.37 . . . . 0.0 111.406 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.559 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.9 OUTLIER -139.08 155.51 47.87 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.779 179.896 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 35.6 mt-30 -132.15 127.78 36.66 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.143 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.5 mt . . . . . 0 CA--C 1.53 0.18 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.018 -179.79 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 89.4 m . . . . . 0 N--CA 1.464 0.232 0 CA-C-O 120.676 0.274 . . . . 0.0 110.692 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -111.9 -175.11 2.61 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.887 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.703 HD22 ' CB ' ' A' ' 83' ' ' MET . 4.7 tt -57.65 -49.47 76.34 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.307 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -57.68 -31.95 66.87 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.233 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.42 -32.22 38.98 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 111.414 -0.674 . . . . 0.0 111.414 178.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.674 HD21 HD22 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -63.85 -51.68 63.56 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.669 0.271 . . . . 0.0 110.463 179.345 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.574 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.2 OUTLIER -56.99 -56.21 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.835 179.558 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -51.41 -29.82 17.19 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.452 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.599 HD13 ' O ' ' A' ' 43' ' ' LEU . 0.5 OUTLIER -75.65 -28.31 58.69 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.75 HD12 ' N ' ' A' ' 45' ' ' LYS . 4.4 pp -95.89 -36.6 11.04 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.535 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.75 ' N ' HD12 ' A' ' 44' ' ' LEU . 2.4 pttt -86.07 -61.39 1.76 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.2 m -58.61 -23.13 58.22 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 122.253 -0.279 . . . . 0.0 111.569 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -96.65 -39.17 9.63 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 111.412 0.152 . . . . 0.0 111.412 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -150.24 59.76 0.97 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.433 ' HB ' ' O ' ' A' ' 45' ' ' LYS . 7.5 p -78.81 -42.27 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.436 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.404 ' HB2' ' CD1' ' A' ' 19' ' ' PHE . 0.0 OUTLIER 62.02 14.12 6.22 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 120.662 0.268 . . . . 0.0 111.501 -179.684 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -152.34 -160.81 1.19 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.671 ' HB2' HD23 ' A' ' 55' ' ' LEU . 9.0 mmt85 -87.16 108.15 17.79 Favored Pre-proline 0 C--N 1.331 -0.225 0 N-CA-C 110.412 -0.218 . . . . 0.0 110.412 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.437 ' O ' HG22 ' A' ' 57' ' ' VAL . 18.5 Cg_endo -59.43 -23.21 69.5 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.148 1.898 . . . . 0.0 112.515 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.421 ' HA ' ' CG2' ' A' ' 57' ' ' VAL . 48.8 m-20 -90.43 8.09 35.47 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.808 HD11 ' CD2' ' A' ' 18' ' ' LEU . 2.1 pp -92.7 -20.45 20.8 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 121.19 -0.204 . . . . 0.0 111.418 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.651 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -106.63 -45.63 4.18 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 179.956 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.446 HG11 ' HA2' ' A' ' 61' ' ' GLY . 5.8 m -52.8 149.88 1.34 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-O 121.135 0.493 . . . . 0.0 111.864 -179.12 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -65.76 -61.37 2.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.555 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -168.47 -44.47 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.311 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.3 p -80.14 4.68 16.59 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.615 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.446 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 61.54 21.38 60.25 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.433 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -112.63 -41.06 3.9 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.769 0.319 . . . . 0.0 110.594 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.743 HG22 ' HG2' ' A' ' 83' ' ' MET . 16.8 p -110.77 -167.12 1.14 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.133 179.623 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.502 HD22 ' HB2' ' A' ' 56' ' ' LEU . 7.4 mt -114.8 154.45 28.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.828 0.347 . . . . 0.0 111.06 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.69 150.46 81.84 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.063 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.79 127.42 24.58 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.875 2.383 . . . . 0.0 112.315 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 142.58 -45.01 0.94 Allowed Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.46 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.456 HG21 ' HB3' ' A' ' 95' ' ' PHE . 5.6 mt -88.43 141.35 14.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 120.803 0.335 . . . . 0.0 111.228 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 mt -105.48 99.85 9.44 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.79 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.832 HG23 ' HB3' ' A' ' 77' ' ' ALA . 13.3 m -78.76 135.51 25.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.007 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 mt -126.57 141.2 51.94 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.013 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.719 HG11 ' CD2' ' A' ' 85' ' ' TYR . 48.9 t -123.74 118.23 53.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.737 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 56.61 31.74 19.7 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.337 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 55.2 35.76 25.54 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.873 0.368 . . . . 0.0 111.113 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 11.2 t -141.89 37.55 1.61 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.922 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.435 ' HB2' HG23 ' A' ' 79' ' ' VAL . 12.9 m-20 67.37 134.59 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.27 0.557 . . . . 0.0 111.388 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.832 ' HB3' HG23 ' A' ' 70' ' ' VAL . . . -84.39 -22.81 30.34 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.434 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -77.84 -32.64 52.26 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.61 0.243 . . . . 0.0 110.859 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.435 HG23 ' HB2' ' A' ' 76' ' ' ASP . 35.2 t -69.21 -42.37 81.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.246 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.457 ' HB ' ' CD1' ' A' ' 85' ' ' TYR . 14.8 m -68.23 -31.22 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.561 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 142.68 42.08 0.06 OUTLIER Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.33 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.422 ' O ' HD13 ' A' ' 37' ' ' LEU . . . 47.35 -119.03 4.45 Favored Glycine 0 C--N 1.336 0.574 0 C-N-CA 121.281 -0.485 . . . . 0.0 112.947 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.743 ' HG2' HG22 ' A' ' 63' ' ' THR . 0.1 OUTLIER -101.5 26.3 7.43 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.69 0.281 . . . . 0.0 111.134 179.42 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -120.2 23.64 10.84 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.369 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.719 ' CD2' HG11 ' A' ' 72' ' ' VAL . 28.4 t80 -93.24 130.25 39.0 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.864 0.364 . . . . 0.0 111.074 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.1 m -89.46 142.52 12.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.03 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.674 HD22 HD21 ' A' ' 40' ' ' LEU . 10.8 mp -83.72 174.22 10.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.947 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -135.01 -67.06 0.56 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.98 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -178.52 79.4 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.817 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.539 ' H ' HD13 ' A' ' 7' ' ' ILE . . . 113.48 37.3 1.33 Allowed Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.821 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.91 174.19 6.45 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.774 0.321 . . . . 0.0 110.931 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 58.4 m -132.42 116.08 16.36 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.953 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.468 HG13 HG23 ' A' ' 9' ' ' VAL . 12.9 p -128.81 119.93 50.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.019 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.438 ' HG2' ' HG2' ' A' ' 10' ' ' GLN . 39.9 mt-10 -124.92 146.56 49.29 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.3 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.456 ' HB3' HG21 ' A' ' 68' ' ' ILE . 20.0 m-85 -121.72 104.81 9.86 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.346 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.925 HG12 ' HB3' ' A' ' 12' ' ' ALA . 27.7 mt -116.68 119.52 62.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.293 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.8 t -87.46 134.23 33.63 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.094 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.464 0.228 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.239 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 ttm . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 120.459 0.171 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.6 t -164.65 42.42 0.08 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.889 0.376 . . . . 0.0 110.957 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -89.46 71.29 8.02 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.279 0.561 . . . . 0.0 110.578 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 64.2 m170 -107.98 96.2 6.21 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.394 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.453 ' O ' ' HB2' ' A' ' 6' ' ' HIS . 77.3 m-20 64.54 -85.23 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.949 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.453 ' HB2' ' O ' ' A' ' 5' ' ' ASN . 34.5 m-70 68.19 140.77 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.904 0.383 . . . . 0.0 111.522 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.532 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 8.5 mm -104.05 143.18 16.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.648 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.674 HG22 HE22 ' A' ' 10' ' ' GLN . 32.1 m -111.09 93.47 4.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.563 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.636 HG13 ' HB2' ' A' ' 25' ' ' LEU . 7.8 p -114.59 102.65 14.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.15 0.5 . . . . 0.0 110.223 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.674 HE22 HG22 ' A' ' 8' ' ' THR . 0.2 OUTLIER -128.37 175.2 8.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.96 -178.556 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.527 ' CD1' ' HB3' ' A' ' 15' ' ' CYS . 49.8 m-85 -128.39 168.65 15.28 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.112 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.878 ' HB3' HG12 ' A' ' 96' ' ' ILE . . . -155.29 136.61 14.02 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.311 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.09 -106.29 3.14 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.216 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -122.98 31.7 4.65 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.727 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.527 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . 69.3 m -106.78 -16.62 14.44 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.466 ' HG2' ' HB2' ' A' ' 11' ' ' PHE . 68.5 mt-10 -58.58 -30.98 67.6 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.523 0.201 . . . . 0.0 111.05 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.439 HD12 ' H ' ' A' ' 17' ' ' LEU . 2.8 mp -70.57 -7.8 46.73 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.51 HD21 HD11 ' A' ' 55' ' ' LEU . 13.3 mt -83.57 12.08 6.22 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.425 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 38.5 t80 -147.32 -62.37 0.28 Allowed 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -176.7 36.28 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.067 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.47 35.86 12.1 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.895 0.378 . . . . 0.0 110.663 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -90.2 146.07 24.54 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.913 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.446 ' O ' ' HB2' ' A' ' 10' ' ' GLN . 7.3 p -75.97 -32.64 59.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.098 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.9 p -170.96 157.98 5.53 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.646 0.26 . . . . 0.0 111.145 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.636 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -135.95 154.36 51.13 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.819 0.343 . . . . 0.0 111.547 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.532 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 16.7 mt-30 -132.72 128.15 36.3 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.986 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.5 mt -109.38 137.21 47.58 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.78 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.53 113.73 26.98 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.873 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -115.64 -158.32 11.63 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.493 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.656 HG23 HG22 ' A' ' 31' ' ' VAL . 16.1 m -141.39 -47.36 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.475 0.178 . . . . 0.0 111.381 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.656 HG22 HG23 ' A' ' 30' ' ' VAL . 10.5 m -146.42 74.42 12.72 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-O 120.926 0.393 . . . . 0.0 110.964 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -83.39 18.18 1.55 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.806 2.337 . . . . 0.0 113.231 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.4 m -57.79 -32.93 68.01 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.71 0.29 . . . . 0.0 110.833 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -91.15 24.83 16.75 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.148 -0.549 . . . . 0.0 112.92 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.6 m -123.98 148.1 47.22 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.813 0.306 . . . . 0.0 110.674 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -128.97 -178.59 4.69 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.169 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.721 ' O ' HG22 ' A' ' 41' ' ' VAL . 5.2 tt -57.77 -46.65 84.26 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -56.83 -33.76 67.07 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.719 0.295 . . . . 0.0 110.32 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.67 -30.1 49.75 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 121.001 -0.618 . . . . 0.0 111.983 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.457 HD13 ' O ' ' A' ' 40' ' ' LEU . 1.4 tm? -70.8 -47.33 60.05 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.674 0.237 . . . . 0.0 111.237 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.721 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -62.4 -53.34 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.866 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -53.41 -33.11 52.64 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.031 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.624 HD13 ' O ' ' A' ' 43' ' ' LEU . 0.6 OUTLIER -70.85 -24.78 62.59 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.302 179.468 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.596 HD23 ' HA ' ' A' ' 41' ' ' VAL . 0.8 OUTLIER -95.1 -42.18 8.73 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.692 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.447 ' O ' HG12 ' A' ' 49' ' ' VAL . 7.7 pttp -92.36 -60.86 1.73 Allowed 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.401 ' H ' ' HG3' ' A' ' 45' ' ' LYS . 1.5 m -54.57 -27.29 37.85 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 122.176 -0.328 . . . . 0.0 111.244 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 1.6 t30 -82.71 -26.65 31.82 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.461 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -135.59 -75.04 0.45 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.77 -0.195 . . . . 0.0 111.323 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.608 ' O ' HG13 ' A' ' 49' ' ' VAL . 13.0 p 40.41 89.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.396 0.678 . . . . 0.0 112.237 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -66.33 -53.7 33.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.228 179.616 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.543 ' HB3' HD21 ' A' ' 55' ' ' LEU . 1.8 tp10 -76.65 -179.47 5.33 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.798 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.449 ' HB2' HD23 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -55.12 113.91 6.23 Favored Pre-proline 0 N--CA 1.464 0.246 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.162 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.548 ' HA ' HG21 ' A' ' 49' ' ' VAL . 18.2 Cg_endo -60.66 -23.25 75.49 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.546 2.164 . . . . 0.0 112.5 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -90.28 5.55 46.71 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.639 ' HG ' HD23 ' A' ' 56' ' ' LEU . 1.5 pp -93.38 -21.42 19.54 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 122.379 -0.201 . . . . 0.0 111.484 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.639 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -100.14 -45.28 5.69 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -179.797 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.494 HG11 ' HA2' ' A' ' 61' ' ' GLY . 5.9 m -54.49 150.22 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.214 0.531 . . . . 0.0 111.66 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -66.79 -54.1 26.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.859 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.52 -43.0 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.441 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 71.4 p -87.42 11.06 15.52 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.494 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 58.55 23.09 54.02 Favored Glycine 0 C--N 1.338 0.674 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.645 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -110.17 -39.91 4.86 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.903 0.382 . . . . 0.0 110.585 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.1 p -121.4 -178.05 3.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.022 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.468 HD13 HD13 ' A' ' 68' ' ' ILE . 6.5 mt -110.16 155.93 21.3 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.875 0.369 . . . . 0.0 111.003 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.89 148.98 82.34 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.429 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -50.3 -32.43 33.15 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.249 2.632 . . . . 0.0 113.146 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -47.84 -36.0 13.14 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 121.391 -0.433 . . . . 0.0 113.144 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.468 HD13 HD13 ' A' ' 64' ' ' LEU . 5.1 mt -93.11 138.0 21.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.784 0.292 . . . . 0.0 111.063 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.497 ' CD2' HD21 ' A' ' 71' ' ' LEU . 13.4 tp -102.87 106.93 17.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.93 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.608 HG23 ' HB3' ' A' ' 77' ' ' ALA . 12.7 m -84.93 133.34 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.864 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.497 HD21 ' CD2' ' A' ' 69' ' ' LEU . 1.9 mt -134.65 141.27 46.53 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.433 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.657 HG23 ' CB ' ' A' ' 77' ' ' ALA . 38.2 t -119.04 121.92 67.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.591 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 59.52 45.13 13.83 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.075 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.33 39.59 18.62 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.203 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 17.9 t -153.88 153.98 33.06 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.581 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.43 ' CB ' HG23 ' A' ' 79' ' ' VAL . 69.6 m-20 -47.04 121.06 3.42 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.642 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.657 ' CB ' HG23 ' A' ' 72' ' ' VAL . . . -81.33 -19.03 43.68 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.684 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -77.53 -29.7 52.48 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.577 0.227 . . . . 0.0 110.838 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.43 HG23 ' CB ' ' A' ' 76' ' ' ASP . 43.7 t -65.24 -50.98 70.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.075 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.7 m -61.3 -36.03 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.521 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -176.78 -44.88 0.06 OUTLIER Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.773 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.41 -51.03 1.84 Allowed Glycine 0 C--N 1.335 0.51 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.213 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.402 ' HA ' HD22 ' A' ' 37' ' ' LEU . 3.9 ptt? -142.5 23.74 1.95 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 120.479 0.181 . . . . 0.0 111.217 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -140.35 26.75 2.15 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.46 ' CE2' HG11 ' A' ' 72' ' ' VAL . 33.5 t80 -84.85 98.15 10.14 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.82 0.343 . . . . 0.0 110.945 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.9 m -61.68 141.56 17.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.584 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.63 160.19 14.52 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.185 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -158.21 31.16 0.25 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.441 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 69.6 120.62 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.89 0.376 . . . . 0.0 110.897 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 97.28 33.66 5.88 Favored Glycine 0 CA--C 1.519 0.302 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.961 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -101.86 167.44 10.07 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.94 0.4 . . . . 0.0 111.476 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.588 HG23 ' HB ' ' A' ' 8' ' ' THR . 92.9 m -137.47 134.11 35.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.759 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.0 p -141.85 136.61 30.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.823 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -130.49 150.15 51.84 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.616 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -130.51 104.48 7.26 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.098 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.878 HG12 ' HB3' ' A' ' 12' ' ' ALA . 24.6 mt -118.99 115.4 47.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.035 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 46.6 t -81.24 140.36 34.93 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.284 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 21.3 p -132.3 -50.36 0.93 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.893 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.2 tp -78.15 99.55 6.24 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.828 0.347 . . . . 0.0 110.597 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -72.06 -60.95 1.97 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.077 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.5 -113.6 4.31 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.7 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.316 -1.269 . . . . 0.0 112.457 -179.97 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 120.515 0.198 . . . . 0.0 111.251 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.3 t -119.72 -62.67 1.46 Allowed 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.758 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -135.83 140.73 44.43 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.096 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -158.44 82.07 0.83 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.669 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -108.88 130.56 55.43 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.264 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.421 ' CD2' ' HB3' ' A' ' 26' ' ' GLN . 0.0 OUTLIER 179.35 153.44 0.43 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.071 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 33.3 mm -115.28 152.23 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.84 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.813 HG22 ' OE1' ' A' ' 10' ' ' GLN . 24.9 m -115.29 101.72 9.2 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.008 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.534 ' O ' HG13 ' A' ' 9' ' ' VAL . 10.8 p -120.43 108.54 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-O 121.007 0.432 . . . . 0.0 111.207 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.813 ' OE1' HG22 ' A' ' 8' ' ' THR . 0.0 OUTLIER -131.36 156.88 44.76 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.571 -179.892 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.424 ' HB2' ' HB3' ' A' ' 16' ' ' GLU . 33.2 m-85 -115.05 144.93 42.85 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.859 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.0 151.89 35.34 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.672 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.37 -86.84 1.11 Allowed Glycine 0 C--N 1.336 0.538 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.44 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -143.34 27.73 2.1 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.565 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.29 5.54 21.77 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.538 ' HG2' HD12 ' A' ' 17' ' ' LEU . 1.1 pm0 -93.1 -29.02 15.99 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.53 0.205 . . . . 0.0 111.046 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.538 HD12 ' HG2' ' A' ' 16' ' ' GLU . 5.0 mp -66.73 -15.56 63.62 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.656 ' HB2' HD21 ' A' ' 55' ' ' LEU . 3.6 pp -83.26 12.71 4.95 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -143.07 -66.5 0.37 Allowed 'General case' 0 CA--C 1.521 -0.135 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -175.78 36.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.31 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 mptt 49.7 34.92 7.95 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.865 0.364 . . . . 0.0 110.694 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -76.27 179.69 5.61 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.708 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.5 p -112.11 -74.55 0.63 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.01 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 87.9 p -135.74 156.81 48.24 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 120.777 0.322 . . . . 0.0 111.181 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.9 tp -150.13 166.56 29.43 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.688 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.494 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 1.0 OUTLIER -126.42 146.59 50.01 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.844 179.665 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.1 mt -128.73 142.57 50.96 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.09 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -102.2 111.12 23.28 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.825 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.07 -34.94 5.48 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 121.051 -0.595 . . . . 0.0 113.068 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.4 t 72.88 -63.51 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 122.646 0.378 . . . . 0.0 111.086 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.1 m -128.56 56.58 23.3 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-O 121.078 0.466 . . . . 0.0 111.154 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.56 6.54 5.08 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.895 2.397 . . . . 0.0 113.368 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.04 -46.14 68.33 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.635 0.255 . . . . 0.0 111.427 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.5 49.54 3.69 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 121.014 -0.613 . . . . 0.0 112.743 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.2 m -150.97 138.61 19.69 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.799 0.333 . . . . 0.0 111.04 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -111.33 -175.17 2.64 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.885 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.623 HD22 ' HA ' ' A' ' 83' ' ' MET . 0.6 OUTLIER -58.68 -42.85 89.47 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.756 -0.202 . . . . 0.0 111.1 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.403 ' OD1' ' HA ' ' A' ' 62' ' ' GLN . 5.5 t30 -55.68 -37.68 68.64 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.953 0.406 . . . . 0.0 109.948 178.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.75 -32.27 46.37 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.161 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.526 HD22 HD11 ' A' ' 87' ' ' LEU . 53.6 tp -62.83 -48.97 76.75 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.714 0.257 . . . . 0.0 110.591 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.617 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -62.16 -57.01 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.847 179.612 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -55.82 -28.15 54.84 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 120.498 0.189 . . . . 0.0 111.08 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.411 ' O ' ' HB2' ' A' ' 47' ' ' ASN . 7.1 tt -84.71 -21.86 29.97 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.848 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.466 HD12 ' C ' ' A' ' 44' ' ' LEU . 1.2 pp -93.89 -41.08 9.81 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.418 ' HG2' ' H ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -70.72 -56.48 6.29 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.77 -179.677 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.418 ' H ' ' HG2' ' A' ' 45' ' ' LYS . 10.6 m -60.69 -20.33 60.78 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.554 0.216 . . . . 0.0 110.814 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.4 OUTLIER -67.45 -44.19 79.27 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.944 179.474 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -146.43 -62.83 0.31 Allowed 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.575 ' O ' HG13 ' A' ' 49' ' ' VAL . 13.2 p 42.91 86.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.469 0.652 . . . . 0.0 112.017 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.78 -48.17 80.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.214 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.513 ' O ' HG22 ' A' ' 49' ' ' VAL . 0.2 OUTLIER -91.61 -156.23 0.44 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.651 -0.249 . . . . 0.0 110.564 179.683 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.423 ' N ' HD23 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -66.88 138.01 95.03 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-O 120.755 0.312 . . . . 0.0 111.583 -179.507 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.527 ' HA ' HG21 ' A' ' 49' ' ' VAL . 73.7 Cg_endo -77.77 -29.9 4.16 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.562 2.174 . . . . 0.0 112.468 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.479 ' OD1' HG23 ' A' ' 57' ' ' VAL . 4.1 t0 -94.43 10.67 33.5 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.656 HD21 ' HB2' ' A' ' 18' ' ' LEU . 3.4 pp -77.85 -25.96 49.07 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.543 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.584 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -97.4 -50.77 4.4 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.387 179.952 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.534 HG11 ' HA2' ' A' ' 61' ' ' GLY . 1.3 m -60.99 149.66 7.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.209 0.528 . . . . 0.0 111.268 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -61.46 -61.3 2.63 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.299 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -171.08 -43.74 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.269 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 38.9 p -85.07 11.43 9.67 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.807 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.534 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 54.08 27.99 39.92 Favored Glycine 0 C--N 1.34 0.779 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.539 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.403 ' HA ' ' OD1' ' A' ' 38' ' ' ASN . 16.6 tt0 -113.97 -44.66 3.13 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.983 0.42 . . . . 0.0 110.332 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.4 t -122.98 139.89 53.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.948 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.509 HD22 ' HB2' ' A' ' 56' ' ' LEU . 7.2 mt -66.76 154.84 39.74 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.872 0.368 . . . . 0.0 110.911 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.5 156.05 89.04 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.194 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.48 140.54 74.5 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.844 2.362 . . . . 0.0 112.37 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.61 -47.72 1.0 Allowed Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.255 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.506 HD13 HD13 ' A' ' 64' ' ' LEU . 6.4 mt -79.93 149.96 5.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-O 120.867 0.365 . . . . 0.0 110.984 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.3 mt -128.41 104.3 7.63 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.783 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.617 HG23 ' HB3' ' A' ' 77' ' ' ALA . 30.6 m -77.37 123.62 34.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.833 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.475 HD23 ' O ' ' A' ' 70' ' ' VAL . 5.3 mt -124.8 141.46 52.1 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.375 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.739 HG23 ' HB2' ' A' ' 77' ' ' ALA . 36.6 t -109.34 107.0 21.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.526 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 59.35 55.44 4.23 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.899 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.0 t 57.71 49.2 12.72 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.312 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 52.4 t -162.41 143.63 10.38 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.784 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.3 122.2 9.86 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.913 0.387 . . . . 0.0 111.193 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.739 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -75.29 -19.98 59.37 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.901 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -71.52 -24.99 62.06 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 116.728 -0.215 . . . . 0.0 111.172 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.9 t -56.18 -32.51 34.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.017 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.6 m -105.67 -38.92 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.629 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -154.95 -56.7 0.01 OUTLIER Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.017 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 99.29 -53.16 1.04 Allowed Glycine 0 C--N 1.333 0.4 0 C-N-CA 121.125 -0.56 . . . . 0.0 112.448 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.623 ' HA ' HD22 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -136.6 23.74 3.15 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.546 0.213 . . . . 0.0 111.4 179.862 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -142.74 27.06 1.69 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.733 0.271 . . . . 0.0 111.733 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -77.74 117.38 19.08 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.77 0.319 . . . . 0.0 110.944 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.7 m -75.28 136.06 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.272 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.526 HD11 HD22 ' A' ' 40' ' ' LEU . 2.6 mp -86.48 162.19 18.21 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.294 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -146.13 33.5 1.0 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.403 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 60.42 27.34 16.94 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.396 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -169.59 40.01 0.2 Allowed Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.937 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -103.85 166.55 10.35 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.062 0.458 . . . . 0.0 111.253 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.512 HG23 ' HB ' ' A' ' 8' ' ' THR . 78.9 m -127.81 137.07 52.25 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.434 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.8 p -142.22 134.21 26.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.991 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -133.39 138.81 46.45 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.316 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -110.17 105.64 14.8 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.356 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 10.9 mt -110.85 100.76 11.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.074 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -84.08 110.58 18.58 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.036 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 22.7 p -104.72 -55.64 2.31 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.983 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 11.0 tp -78.84 151.12 32.06 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.964 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -145.35 87.7 1.82 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.788 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.22 -40.14 2.57 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.795 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.177 0 CA-C-O 118.529 -1.151 . . . . 0.0 112.803 -179.978 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 tpp . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 120.777 0.322 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 63.96 -171.67 0.18 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.316 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -73.73 -40.67 63.39 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.44 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 55.66 34.47 23.34 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.954 0.407 . . . . 0.0 110.595 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.42 ' HA ' ' OD1' ' A' ' 89' ' ' ASP . 2.2 t30 -135.95 145.57 46.36 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.003 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -174.56 105.69 0.1 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.316 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 16.1 mm -90.97 157.16 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.562 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.626 HG22 HE22 ' A' ' 10' ' ' GLN . 30.3 m -124.91 93.74 3.98 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.807 0.336 . . . . 0.0 111.521 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.546 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.6 p -113.23 103.6 15.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.183 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.626 HE22 HG22 ' A' ' 8' ' ' THR . 0.1 OUTLIER -131.74 166.9 20.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.744 -178.97 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.534 ' HB2' ' HG2' ' A' ' 16' ' ' GLU . 41.6 m-85 -125.0 163.52 22.16 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.874 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.412 ' O ' ' HA ' ' A' ' 96' ' ' ILE . . . -175.17 119.51 0.19 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.053 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.67 54.89 0.76 Allowed Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.582 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.26 25.96 72.48 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.199 -0.524 . . . . 0.0 113.478 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -116.44 5.35 13.43 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 117.091 0.445 . . . . 0.0 111.675 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.534 ' HG2' ' HB2' ' A' ' 11' ' ' PHE . 64.1 mt-10 -84.17 -23.29 30.67 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.73 -4.92 21.86 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.513 ' CD2' HD11 ' A' ' 55' ' ' LEU . 24.7 mt -78.88 8.73 5.06 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -149.39 -63.58 0.22 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.788 0.328 . . . . 0.0 110.149 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -174.84 38.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.848 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.93 35.8 20.15 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.241 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -80.48 178.37 8.37 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.963 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 28.1 p -107.69 -74.65 0.65 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.994 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.405 ' O ' HD12 ' A' ' 25' ' ' LEU . 88.0 p -132.99 160.58 36.71 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.829 0.347 . . . . 0.0 111.355 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.416 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -141.55 152.81 44.42 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.181 -179.935 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.458 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 1.7 mt-30 -131.06 122.32 26.55 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.6 mt -94.73 136.32 35.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.338 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -117.03 115.87 26.24 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.98 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -146.49 139.81 8.32 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.446 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.0 m -65.14 -41.54 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 120.659 0.266 . . . . 0.0 111.255 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.8 t -143.79 72.99 17.02 Favored Pre-proline 0 CA--C 1.53 0.203 0 CA-C-O 120.926 0.394 . . . . 0.0 110.838 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -81.66 4.99 6.58 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.743 2.296 . . . . 0.0 113.081 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.81 166.45 8.98 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.803 0.335 . . . . 0.0 110.916 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.34 -29.38 10.93 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.52 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 58.9 m -83.37 158.84 21.99 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.61 0.243 . . . . 0.0 110.984 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -131.81 -179.55 5.46 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.896 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.657 ' O ' HG22 ' A' ' 41' ' ' VAL . 6.4 tt -53.47 -48.36 68.94 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 111.514 0.19 . . . . 0.0 111.514 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -52.99 -36.35 60.28 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.812 0.339 . . . . 0.0 110.388 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.3 -31.05 43.33 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.137 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.439 HD23 HD21 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -66.84 -51.49 54.89 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.633 0.254 . . . . 0.0 110.72 179.702 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.657 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.2 OUTLIER -60.7 -57.34 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.915 179.776 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.421 ' H ' HG23 ' A' ' 41' ' ' VAL . 0.4 OUTLIER -52.57 -29.33 25.05 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.319 179.571 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 30.5 tp -74.53 -27.59 60.6 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.547 HD12 ' N ' ' A' ' 45' ' ' LYS . 3.5 pp -96.93 -38.61 9.75 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.547 ' N ' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -84.16 -70.91 0.54 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.411 -179.793 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.3 m -53.24 -24.32 10.95 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 111.863 0.319 . . . . 0.0 111.863 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -102.45 -23.3 13.94 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -147.84 50.17 1.05 Allowed 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.607 HG22 ' H ' ' A' ' 51' ' ' GLU . 9.6 p -99.88 122.72 52.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.871 0.367 . . . . 0.0 110.987 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -100.79 33.05 2.91 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.888 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.607 ' H ' HG22 ' A' ' 49' ' ' VAL . 1.7 tp10 -160.21 -161.79 0.92 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.111 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 54.5 mtt-85 -88.87 109.88 33.47 Favored Pre-proline 0 CA--C 1.529 0.172 0 CA-C-O 120.418 0.152 . . . . 0.0 110.894 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.736 ' HA ' HD21 ' A' ' 56' ' ' LEU . 78.0 Cg_exo -48.41 -30.11 14.87 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.724 2.283 . . . . 0.0 112.929 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.19 -17.17 64.56 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.687 ' HG ' HD23 ' A' ' 56' ' ' LEU . 2.5 pp -80.38 -15.19 57.43 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.736 HD21 ' HA ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -108.65 -49.15 3.2 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.712 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.722 HG22 ' O ' ' A' ' 53' ' ' PRO . 2.9 m -57.34 148.38 5.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.078 0.466 . . . . 0.0 111.467 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -71.33 -59.72 2.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.913 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -162.96 -56.42 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.229 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.6 p -59.51 -21.2 59.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.2 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.76 21.59 49.97 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 121.149 -0.548 . . . . 0.0 111.862 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -124.45 -46.34 1.9 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.792 0.33 . . . . 0.0 110.974 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.0 t -101.91 130.91 48.52 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.701 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.519 HD22 ' HB2' ' A' ' 56' ' ' LEU . 5.7 mt -65.91 155.29 36.87 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.806 0.336 . . . . 0.0 111.123 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -53.21 143.76 32.46 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.324 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -51.57 -33.39 47.97 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.181 2.587 . . . . 0.0 112.98 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -49.49 -35.39 21.75 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.348 -0.453 . . . . 0.0 112.914 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.464 HD13 HD13 ' A' ' 64' ' ' LEU . 7.9 mt -82.81 114.4 23.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.83 0.315 . . . . 0.0 110.787 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.61 97.01 8.28 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.198 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.452 ' O ' HD23 ' A' ' 71' ' ' LEU . 19.3 t -84.87 136.33 23.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.041 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.452 HD23 ' O ' ' A' ' 70' ' ' VAL . 3.6 mt -125.62 126.68 45.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.89 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.59 HG23 ' HA ' ' A' ' 77' ' ' ALA . 38.4 t -110.23 118.76 57.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.878 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.4 m120 55.29 35.02 24.04 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.363 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.1 t 56.18 33.16 21.56 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.306 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 9.3 t -138.02 31.11 2.46 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.841 0.353 . . . . 0.0 111.01 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.669 ' HB3' HG23 ' A' ' 79' ' ' VAL . 0.4 OUTLIER 69.05 145.28 0.05 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.371 179.809 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.59 ' HA ' HG23 ' A' ' 72' ' ' VAL . . . -85.08 -22.73 28.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.594 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -82.28 -33.5 29.07 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.755 -0.202 . . . . 0.0 110.993 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.669 HG23 ' HB3' ' A' ' 76' ' ' ASP . 39.5 t -66.16 -41.9 90.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.26 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.486 ' HB ' ' CD1' ' A' ' 85' ' ' TYR . 26.8 m -69.41 -29.13 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 168.3 -34.37 0.2 Allowed Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.339 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 109.25 -55.69 0.5 Allowed Glycine 0 C--N 1.333 0.416 0 N-CA-C 111.823 -0.511 . . . . 0.0 111.823 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.538 ' HA ' HD22 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -157.69 27.94 0.28 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.461 0.172 . . . . 0.0 111.289 179.4 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -135.42 20.55 3.38 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.573 ' CD2' HG11 ' A' ' 72' ' ' VAL . 34.1 t80 -68.56 112.09 5.14 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.787 0.327 . . . . 0.0 110.961 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.2 m -71.04 135.47 27.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.272 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.439 HD21 HD23 ' A' ' 40' ' ' LEU . 0.7 OUTLIER -79.83 152.99 29.41 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.023 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -155.23 -59.72 0.11 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.055 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.42 ' OD1' ' HA ' ' A' ' 5' ' ' ASN . 0.4 OUTLIER -173.03 116.09 0.28 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.137 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 80.26 34.26 29.93 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.826 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -75.39 99.09 4.04 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.84 0.352 . . . . 0.0 110.358 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 16.0 m -81.77 127.84 33.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.56 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.46 ' O ' HG13 ' A' ' 93' ' ' VAL . 7.7 p -139.02 113.96 8.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.011 0.434 . . . . 0.0 110.926 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -114.98 149.89 36.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.119 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -123.91 104.71 9.09 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.419 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 12' ' ' ALA . 29.3 mt -114.12 101.97 13.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.323 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.0 m -72.94 97.93 2.38 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.089 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.7 m -89.0 -50.92 5.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.978 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.7 tt -86.59 100.77 12.66 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.829 0.347 . . . . 0.0 110.925 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -126.0 -47.68 1.64 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.093 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 170.2 68.39 0.04 OUTLIER Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.638 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.429 -1.206 . . . . 0.0 112.605 -179.969 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 mtt . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 120.619 0.247 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.3 m 55.33 35.23 24.53 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.27 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -148.77 -58.81 0.22 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.624 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.8 m170 63.73 -174.24 0.16 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.606 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 30.7 m-20 -71.48 158.41 36.3 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.972 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 25.0 p-80 -165.22 124.35 1.75 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.79 0.329 . . . . 0.0 111.515 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 33.9 mm -95.79 137.84 22.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.692 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.698 HG22 ' OE1' ' A' ' 10' ' ' GLN . 1.9 m -96.26 98.88 10.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.201 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.537 HG13 ' HB2' ' A' ' 25' ' ' LEU . 8.1 p -122.47 108.7 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-O 120.92 0.39 . . . . 0.0 110.559 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.698 ' OE1' HG22 ' A' ' 8' ' ' THR . 1.4 pm0 -135.2 158.91 43.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.396 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.402 ' CB ' ' HA ' ' A' ' 16' ' ' GLU . 31.0 m-85 -126.75 145.47 50.6 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.124 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.548 ' HB2' HG12 ' A' ' 96' ' ' ILE . . . -92.74 179.99 5.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.303 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.6 97.43 0.12 Allowed Glycine 0 C--N 1.335 0.504 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.6 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 135.16 -40.95 1.49 Allowed Glycine 0 C--N 1.333 0.364 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.807 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.05 -23.95 18.48 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.441 0.162 . . . . 0.0 111.418 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.41 ' HG3' ' HA ' ' A' ' 21' ' ' LYS . 6.9 pt-20 -58.43 -26.92 63.83 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 111.679 0.251 . . . . 0.0 111.679 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 mp -68.59 -8.46 41.98 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.919 HD21 HD11 ' A' ' 55' ' ' LEU . 25.3 mt -83.26 13.43 4.26 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -148.46 -59.11 0.24 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.743 0.306 . . . . 0.0 110.253 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -178.67 36.49 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.079 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.41 ' HA ' ' HG3' ' A' ' 16' ' ' GLU . 0.0 OUTLIER 50.54 34.53 9.66 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.952 0.406 . . . . 0.0 110.764 -179.403 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -78.84 173.25 12.7 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.021 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.2 p -107.97 -45.21 4.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.947 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 94.3 p -159.7 158.87 32.16 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.592 0.234 . . . . 0.0 111.238 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.537 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -146.95 163.6 35.63 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.232 -179.703 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.24 100.8 5.32 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.855 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.0 mt -93.36 142.22 27.57 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.663 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.08 123.26 31.19 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.001 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.82 -51.19 25.72 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.604 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.4 t 69.6 -68.24 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 122.551 0.34 . . . . 0.0 111.223 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.495 ' O ' HG13 ' A' ' 31' ' ' VAL . 9.6 p -154.04 63.78 4.43 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-O 121.309 0.576 . . . . 0.0 110.803 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.478 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 80.8 Cg_endo -87.09 26.1 0.63 Allowed 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.206 2.604 . . . . 0.0 113.193 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.5 m -53.69 -39.26 65.0 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.847 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -103.97 32.46 7.52 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 121.188 -0.529 . . . . 0.0 112.656 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.4 m -120.15 146.55 45.87 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.641 0.258 . . . . 0.0 111.075 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -136.02 -174.09 3.57 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.05 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.674 ' O ' HG22 ' A' ' 41' ' ' VAL . 5.5 tt -56.82 -45.5 82.28 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.731 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -54.69 -38.63 67.22 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.03 -32.96 58.02 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.015 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.534 ' CG ' HD11 ' A' ' 87' ' ' LEU . 11.6 mt -65.61 -57.03 9.11 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.629 0.252 . . . . 0.0 110.65 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.3 OUTLIER -55.27 -56.89 9.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.994 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.414 ' H ' HG23 ' A' ' 41' ' ' VAL . 2.4 tt0 -51.02 -29.89 13.8 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.464 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.24 -28.49 57.15 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.76 HD12 ' N ' ' A' ' 45' ' ' LYS . 4.0 pp -94.91 -33.03 12.94 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.76 ' N ' HD12 ' A' ' 44' ' ' LEU . 4.4 pttt -92.49 -61.05 1.68 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 111.595 0.221 . . . . 0.0 111.595 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -58.29 -20.23 41.02 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 122.126 -0.359 . . . . 0.0 111.306 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -105.68 -30.14 9.65 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -146.63 48.45 1.17 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.435 ' HB ' ' O ' ' A' ' 45' ' ' LYS . 7.5 p -80.81 -32.81 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.07 20.82 0.65 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 122.544 0.338 . . . . 0.0 111.642 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -158.73 -166.4 1.87 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.242 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.652 ' HB3' HD23 ' A' ' 55' ' ' LEU . 3.0 ttt180 -70.67 110.91 7.97 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-O 120.601 0.238 . . . . 0.0 110.752 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.32 -22.23 70.16 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.37 2.047 . . . . 0.0 112.347 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.403 ' HA ' ' CG2' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -93.19 8.23 41.03 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.919 HD11 HD21 ' A' ' 18' ' ' LEU . 2.7 pp -88.85 -7.75 55.56 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 122.239 -0.288 . . . . 0.0 111.534 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.66 HD13 HD13 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -117.93 -47.68 2.59 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 179.782 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.5 HG11 ' HA2' ' A' ' 61' ' ' GLY . 2.7 m -53.58 150.35 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-O 121.275 0.56 . . . . 0.0 111.396 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.789 ' HB2' HG23 ' A' ' 63' ' ' THR . 25.7 t0 -62.7 -57.15 12.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.598 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.08 -43.16 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.354 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 31.9 p -86.5 10.09 16.35 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.752 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.5 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 58.88 21.96 53.23 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.484 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -107.77 -42.05 4.83 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.901 0.382 . . . . 0.0 110.461 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.789 HG23 ' HB2' ' A' ' 58' ' ' ASP . 12.1 t -118.74 -167.78 1.43 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.097 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.48 HD13 HD13 ' A' ' 68' ' ' ILE . 10.6 mt -111.75 157.58 20.35 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.979 0.418 . . . . 0.0 111.689 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.429 ' HB2' ' HD2' ' A' ' 66' ' ' PRO . 0.5 OUTLIER -78.18 156.93 78.88 Favored Pre-proline 0 C--O 1.233 0.206 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.949 179.859 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.429 ' HD2' ' HB2' ' A' ' 65' ' ' ARG . 10.7 Cg_endo -55.22 134.33 63.21 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.637 2.225 . . . . 0.0 112.472 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 133.73 -47.99 0.97 Allowed Glycine 0 C--N 1.331 0.292 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.185 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.48 HD13 HD13 ' A' ' 64' ' ' LEU . 5.8 mt -86.02 137.03 21.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-O 120.678 0.275 . . . . 0.0 111.092 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.902 HD23 HD21 ' A' ' 71' ' ' LEU . 1.0 OUTLIER -107.74 106.65 17.06 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.674 179.717 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.523 ' O ' HD23 ' A' ' 71' ' ' LEU . 16.5 m -83.11 128.39 38.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.876 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.902 HD21 HD23 ' A' ' 69' ' ' LEU . 1.5 mt -132.69 136.82 46.67 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.566 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.859 HG23 ' HB2' ' A' ' 77' ' ' ALA . 38.5 t -108.95 102.86 14.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.374 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 60.36 57.41 2.88 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.764 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.2 m 57.69 49.33 12.55 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.594 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 50.3 t -163.12 137.56 6.25 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.818 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -54.02 124.99 17.16 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.823 0.345 . . . . 0.0 111.276 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.859 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -82.1 -23.38 35.74 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.239 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -70.08 -14.18 62.55 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 111.466 0.173 . . . . 0.0 111.466 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.2 t -74.05 -30.27 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 111.679 0.251 . . . . 0.0 111.679 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.431 HG23 ' N ' ' A' ' 81' ' ' GLY . 18.8 m -115.73 -43.69 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.431 ' N ' HG23 ' A' ' 80' ' ' VAL . . . -176.04 72.61 0.08 OUTLIER Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.409 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.489 ' O ' HD13 ' A' ' 37' ' ' LEU . . . -49.93 -28.37 11.94 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 121.525 -0.369 . . . . 0.0 113.352 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.548 ' HA ' HD22 ' A' ' 37' ' ' LEU . 1.1 ptt? -132.15 29.09 4.38 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.726 0.298 . . . . 0.0 110.56 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -149.52 30.51 0.75 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.491 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.687 ' CZ ' HG11 ' A' ' 72' ' ' VAL . 1.6 t80 -86.83 115.99 24.61 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.827 0.346 . . . . 0.0 111.281 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 29.8 m -66.23 168.61 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.341 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.534 HD11 ' CG ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -116.84 178.74 4.23 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.193 0.521 . . . . 0.0 111.546 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -160.96 -82.77 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.054 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -173.91 33.57 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.877 0.37 . . . . 0.0 111.455 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 178.72 37.55 0.06 OUTLIER Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.429 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -82.52 149.38 27.56 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.779 0.323 . . . . 0.0 110.965 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.604 HG23 ' HB ' ' A' ' 8' ' ' THR . 61.8 m -119.43 133.18 55.83 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.401 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.3 p -141.95 127.46 17.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.907 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -128.67 145.08 51.26 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.284 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -123.29 104.59 9.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.233 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.548 HG12 ' HB2' ' A' ' 12' ' ' ALA . 30.0 mt -116.71 109.18 27.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.274 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.5 m -80.24 149.8 30.29 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.137 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 32.0 p -126.26 -61.84 1.19 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.014 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.8 pp -82.6 164.72 20.62 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.125 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -155.13 72.29 0.82 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.886 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 110.51 -91.92 0.65 Allowed Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.39 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.093 0 CA-C-O 118.201 -1.333 . . . . 0.0 112.912 179.873 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 mmt . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 t 69.88 165.09 0.27 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.932 0.396 . . . . 0.0 111.237 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -125.5 179.29 5.19 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.026 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -147.34 76.19 1.4 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.985 0.421 . . . . 0.0 111.72 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 72.51 133.07 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.922 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 37.3 p-80 -171.94 124.32 0.53 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.509 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.557 HD13 ' H ' ' A' ' 90' ' ' GLY . 23.5 mm -99.1 146.11 9.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.847 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.449 ' HB ' ' HA ' ' A' ' 92' ' ' THR . 89.1 m -104.85 118.63 37.02 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.084 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.707 HG23 HG13 ' A' ' 93' ' ' VAL . 8.4 p -149.47 112.64 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.798 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.445 ' HB3' ' CB ' ' A' ' 24' ' ' SER . 6.2 pm0 -136.35 162.43 33.03 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.953 0.406 . . . . 0.0 111.74 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -120.8 141.75 50.23 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.164 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.32 150.76 46.93 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.387 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.32 -109.57 2.86 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.453 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -115.59 29.63 7.12 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.944 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.73 -8.11 14.19 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.984 0.392 . . . . 0.0 111.692 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -93.69 -25.32 17.51 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.573 0.225 . . . . 0.0 111.008 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.11 -7.13 47.3 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.552 ' HB3' HD11 ' A' ' 55' ' ' LEU . 3.6 pp -85.74 13.71 6.84 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -145.11 -64.11 0.34 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.922 0.391 . . . . 0.0 109.987 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -175.59 38.8 0.01 OUTLIER 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.561 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.3 mptt 51.2 40.52 26.18 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.362 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.612 ' OE1' HD21 ' A' ' 25' ' ' LEU . 29.5 pt20 -67.23 171.98 5.22 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.918 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 62.3 p -114.09 -80.06 0.59 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.006 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.445 ' CB ' ' HB3' ' A' ' 10' ' ' GLN . 88.5 p -133.08 154.71 50.31 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.85 0.357 . . . . 0.0 111.409 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.612 HD21 ' OE1' ' A' ' 22' ' ' GLN . 0.4 OUTLIER -131.62 160.93 33.92 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.178 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 1.1 tt0 -131.17 120.92 23.99 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.032 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.5 mt -102.27 141.49 35.03 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.739 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -109.83 116.13 31.09 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.105 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 61.3 -102.88 0.47 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.573 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.4 m 36.25 83.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.157 0.583 . . . . 0.0 112.282 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.4 m 40.79 61.61 6.94 Favored Pre-proline 0 N--CA 1.466 0.364 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.731 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -82.39 7.79 4.92 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.969 2.446 . . . . 0.0 113.572 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.5 m -126.59 -59.23 1.3 Allowed 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.36 0.124 . . . . 0.0 110.741 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -83.58 55.38 5.02 Favored Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.831 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 89.3 m -152.64 140.8 20.39 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.826 0.346 . . . . 0.0 110.818 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 44.9 p30 -116.94 -174.95 2.68 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.967 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.836 HD22 ' HA ' ' A' ' 83' ' ' MET . 5.3 tt -57.78 -41.76 82.74 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.004 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -51.68 -43.14 62.62 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.229 178.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.36 -31.11 61.56 Favored Glycine 0 C--N 1.334 0.472 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.549 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -70.7 -56.92 5.31 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.876 0.338 . . . . 0.0 110.955 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.766 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.5 OUTLIER -56.98 -56.04 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.361 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.425 ' HA ' ' CG ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -50.93 -29.85 13.24 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.733 179.785 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.434 ' HA ' ' HB2' ' A' ' 47' ' ' ASN . 0.7 OUTLIER -70.18 -34.5 73.05 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.357 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.616 HD12 ' N ' ' A' ' 45' ' ' LYS . 4.4 pp -96.99 -25.2 15.47 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.449 0.536 . . . . 0.0 112.449 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.616 ' N ' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -93.02 -32.88 14.34 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.967 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.0 m -108.64 -26.04 10.57 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.434 ' HB2' ' HA ' ' A' ' 43' ' ' LEU . 2.9 m-80 -109.51 -22.38 12.02 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -178.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.69 39.82 3.16 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.563 HG22 ' H ' ' A' ' 51' ' ' GLU . 10.4 p -98.38 143.11 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 120.85 0.357 . . . . 0.0 110.866 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.77 27.88 4.59 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.4 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.563 ' H ' HG22 ' A' ' 49' ' ' VAL . 2.2 tp10 -156.71 -166.98 2.25 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.52 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.475 ' HB2' HD23 ' A' ' 55' ' ' LEU . 2.4 mpt_? -57.95 111.03 2.99 Favored Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 116.935 -0.121 . . . . 0.0 110.889 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.544 ' O ' HG22 ' A' ' 57' ' ' VAL . 18.9 Cg_endo -59.51 -25.95 80.41 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.164 1.909 . . . . 0.0 112.209 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.454 ' HA ' HG22 ' A' ' 57' ' ' VAL . 5.9 m-20 -90.66 7.0 41.6 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.637 ' HG ' HD23 ' A' ' 56' ' ' LEU . 1.7 pp -89.19 -15.76 32.94 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 121.161 -0.216 . . . . 0.0 111.256 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.637 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -115.34 -47.17 2.85 Favored 'General case' 0 C--N 1.339 0.11 0 N-CA-C 111.499 0.185 . . . . 0.0 111.499 179.872 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.544 HG22 ' O ' ' A' ' 53' ' ' PRO . 21.4 m -58.41 147.05 7.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 121.119 0.485 . . . . 0.0 111.837 -179.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -67.19 -57.23 7.11 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.468 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -171.59 -43.7 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.357 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 46.9 p -81.62 7.28 12.66 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.406 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 56.34 23.99 43.6 Favored Glycine 0 C--N 1.343 0.928 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.334 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -108.79 -39.32 5.38 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 120.753 0.311 . . . . 0.0 110.569 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 11.3 t -132.14 165.02 25.01 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.13 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.747 HD13 HD13 ' A' ' 68' ' ' ILE . 5.0 mt -77.55 157.76 30.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.906 0.384 . . . . 0.0 110.781 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.43 ' HG3' HD12 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -61.12 153.21 68.2 Favored Pre-proline 0 N--CA 1.465 0.292 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.254 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -49.02 -32.66 24.12 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.926 2.417 . . . . 0.0 112.591 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -51.27 -34.39 32.95 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.858 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.747 HD13 HD13 ' A' ' 64' ' ' LEU . 5.1 mt -97.19 148.7 5.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 116.855 0.327 . . . . 0.0 110.708 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.29 118.58 32.66 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.017 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.405 ' O ' HD23 ' A' ' 71' ' ' LEU . 16.6 m -90.37 129.53 41.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.937 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.405 HD23 ' O ' ' A' ' 70' ' ' VAL . 4.0 mt -125.49 130.43 51.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.166 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.816 HG23 ' HB2' ' A' ' 77' ' ' ALA . 26.3 t -105.0 99.48 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.465 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.1 m120 58.68 55.41 4.74 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.936 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.5 t 61.38 42.08 12.11 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.24 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 53.2 t -160.13 121.94 3.22 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.781 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.517 ' CB ' HG23 ' A' ' 79' ' ' VAL . 11.1 m-20 -48.93 131.59 18.67 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.729 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.816 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -79.48 -26.27 41.69 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.973 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -72.72 -25.55 61.26 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.489 0.185 . . . . 0.0 111.119 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.517 HG23 ' CB ' ' A' ' 76' ' ' ASP . 49.0 t -62.11 -29.59 46.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.017 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.8 m -112.46 -39.26 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -137.41 -72.96 0.06 OUTLIER Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.858 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 119.92 -42.21 1.8 Allowed Glycine 0 C--N 1.334 0.453 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.386 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.836 ' HA ' HD22 ' A' ' 37' ' ' LEU . 3.0 ptt? -157.42 29.35 0.29 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.743 0.306 . . . . 0.0 110.755 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -145.84 22.11 1.43 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.581 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.466 ' CE1' HG11 ' A' ' 72' ' ' VAL . 4.4 t80 -72.39 120.37 17.91 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 122.348 -0.22 . . . . 0.0 111.275 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.7 m -61.73 125.37 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.206 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.32 169.11 16.87 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.039 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -164.4 165.76 21.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.858 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -57.23 103.08 0.1 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.1 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.557 ' H ' HD13 ' A' ' 7' ' ' ILE . . . 106.14 24.65 6.77 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 121.108 -0.568 . . . . 0.0 113.016 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.02 138.88 39.86 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.928 0.364 . . . . 0.0 110.543 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.449 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 86.1 m -113.15 115.24 27.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.117 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.707 HG13 HG23 ' A' ' 9' ' ' VAL . 11.8 p -125.27 111.22 26.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 121.04 0.448 . . . . 0.0 110.633 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -114.92 151.38 34.14 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.176 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.548 ' HB3' HG21 ' A' ' 68' ' ' ILE . 15.7 m-85 -129.57 104.36 7.4 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.531 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.9 mt -106.24 100.44 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.887 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.8 106.64 7.49 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.47 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.5 p -110.24 -30.53 7.68 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.741 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 51.56 -174.72 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.119 0.568 . . . . 0.0 112.331 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.35 99.8 2.82 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.045 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -133.41 -69.61 0.08 OUTLIER Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.391 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.145 0 CA-C-O 118.507 -1.163 . . . . 0.0 112.604 179.557 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 120.742 0.306 . . . . 0.0 111.222 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.7 t -98.28 163.5 12.69 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.245 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -91.77 109.96 21.29 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.874 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -129.25 146.45 51.16 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.892 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 40.2 m-20 69.77 142.05 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.08 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.513 ' C ' HD12 ' A' ' 7' ' ' ILE . 55.9 m80 63.86 176.6 0.17 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.72 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.513 HD12 ' C ' ' A' ' 6' ' ' HIS . 2.0 mp -113.32 135.06 54.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-O 120.931 0.396 . . . . 0.0 111.152 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.55 HG22 ' OE1' ' A' ' 10' ' ' GLN . 83.5 m -88.75 96.63 10.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.983 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.56 HG13 ' HB2' ' A' ' 25' ' ' LEU . 11.8 p -117.79 113.49 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.206 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.55 ' OE1' HG22 ' A' ' 8' ' ' THR . 8.8 pm0 -137.08 166.87 22.69 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.931 0.396 . . . . 0.0 111.899 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -126.67 150.14 49.14 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.24 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.696 ' HB3' HG12 ' A' ' 96' ' ' ILE . . . -146.55 158.18 43.86 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.559 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 67.96 -100.48 0.64 Allowed Glycine 0 C--N 1.336 0.537 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.459 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -124.04 33.16 3.96 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.586 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.7 m -109.7 -16.23 13.97 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.452 ' HG2' ' N ' ' A' ' 17' ' ' LEU . 12.7 pm0 -81.81 -33.57 30.71 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.702 0.286 . . . . 0.0 111.143 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.452 ' N ' ' HG2' ' A' ' 16' ' ' GLU . 1.4 mp -60.98 -28.19 68.83 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.033 0.382 . . . . 0.0 112.033 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.598 ' O ' HD12 ' A' ' 18' ' ' LEU . 2.9 pp -82.87 11.8 5.63 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.454 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 40.7 t80 -133.09 -60.01 0.87 Allowed 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.454 ' HB2' ' O ' ' A' ' 19' ' ' PHE . . . 174.27 36.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.031 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.56 32.16 4.7 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.902 0.382 . . . . 0.0 110.97 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -80.16 168.55 18.96 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.106 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.408 ' O ' ' HB2' ' A' ' 10' ' ' GLN . 16.3 p -101.93 -74.24 0.63 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.852 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.427 ' CB ' ' HB3' ' A' ' 10' ' ' GLN . 89.1 p -137.15 154.98 50.12 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.742 0.306 . . . . 0.0 111.198 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.56 ' HB2' HG13 ' A' ' 9' ' ' VAL . 4.8 mp -140.43 165.41 27.5 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.391 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.465 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 0.5 OUTLIER -131.27 119.34 21.64 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.827 179.783 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.3 mt -99.45 141.16 32.6 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.916 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.99 147.4 31.57 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.91 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.04 123.86 18.94 Favored Glycine 0 C--N 1.333 0.393 0 CA-C-N 115.958 -0.565 . . . . 0.0 113.331 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.2 t -140.26 88.65 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-O 120.791 0.329 . . . . 0.0 110.824 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.1 t 54.57 57.15 12.08 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.718 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.77 -11.02 25.62 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.621 2.214 . . . . 0.0 113.182 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.43 -57.09 13.8 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.586 0.231 . . . . 0.0 111.244 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -95.66 44.35 2.1 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.444 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 28.7 m -138.09 121.35 16.97 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.692 0.282 . . . . 0.0 111.034 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -105.26 -172.57 2.12 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.765 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.694 HD22 ' HA ' ' A' ' 83' ' ' MET . 1.0 OUTLIER -55.52 -35.66 65.89 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.335 -179.638 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -54.86 -40.58 69.81 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.88 0.371 . . . . 0.0 110.087 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.15 -30.04 63.59 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.801 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.627 HD21 HG11 ' A' ' 93' ' ' VAL . 10.0 tt -63.37 -49.73 72.69 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.819 0.342 . . . . 0.0 110.692 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.538 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -67.35 -52.18 44.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.728 179.767 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -54.72 -23.55 18.18 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.778 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.454 ' O ' ' HB3' ' A' ' 47' ' ' ASN . 4.6 tt -85.4 -22.95 28.14 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.878 0.371 . . . . 0.0 110.577 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.636 HD13 ' C ' ' A' ' 44' ' ' LEU . 1.2 tm? -92.48 -50.21 5.74 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.949 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.524 ' N ' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -89.33 -72.8 0.53 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 111.565 0.209 . . . . 0.0 111.565 -179.843 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.8 m -49.46 -24.63 2.11 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.454 ' HB3' ' O ' ' A' ' 43' ' ' LEU . 10.1 t30 -106.1 -25.99 11.8 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -138.58 45.52 2.04 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.461 ' HB ' ' O ' ' A' ' 45' ' ' LYS . 10.6 p -104.42 152.41 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.168 0.508 . . . . 0.0 111.478 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.01 -40.48 1.05 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.674 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -79.94 -167.03 1.13 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.313 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.406 ' HA ' ' HD2' ' A' ' 53' ' ' PRO . 0.4 OUTLIER -63.53 111.37 5.03 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.021 -179.94 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 52' ' ' ARG . 18.1 Cg_endo -60.45 -25.25 80.06 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.275 1.983 . . . . 0.0 112.159 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.461 ' HA ' ' CG2' ' A' ' 57' ' ' VAL . 4.6 m-20 -92.37 8.52 38.12 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.035 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.659 ' HG ' HD23 ' A' ' 56' ' ' LEU . 2.1 pp -86.74 -27.4 23.67 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 122.289 -0.257 . . . . 0.0 111.068 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.659 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -97.96 -47.27 5.6 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.919 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.517 HG11 ' HA2' ' A' ' 61' ' ' GLY . 4.8 m -57.68 149.25 4.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-O 121.243 0.544 . . . . 0.0 111.598 -179.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -65.45 -56.42 12.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.739 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -173.83 -43.91 0.01 OUTLIER 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.402 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 78.0 p -87.5 12.45 12.31 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.517 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 58.21 22.31 49.66 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.673 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -108.86 -41.18 4.82 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.944 0.402 . . . . 0.0 110.582 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.6 p -119.87 -175.94 3.08 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.715 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.0 mt -111.07 157.06 20.41 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.857 0.361 . . . . 0.0 111.148 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.75 155.75 92.5 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.282 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.01 135.13 67.39 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.818 2.345 . . . . 0.0 112.404 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 134.4 -49.29 0.91 Allowed Glycine 0 C--N 1.331 0.284 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.299 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.502 HG21 ' HB3' ' A' ' 95' ' ' PHE . 6.0 mt -81.46 137.49 21.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-O 120.657 0.265 . . . . 0.0 111.176 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.633 HD23 HD21 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -106.83 103.69 13.19 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.529 179.562 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.468 ' O ' HD23 ' A' ' 71' ' ' LEU . 15.4 m -83.25 130.41 35.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.609 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.633 HD21 HD23 ' A' ' 69' ' ' LEU . 3.3 mt -130.15 146.2 51.77 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.45 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.621 HG11 ' CD2' ' A' ' 85' ' ' TYR . 2.1 m -119.0 121.4 66.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.477 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 57.45 41.87 25.48 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.45 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 65.1 31.75 10.77 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.412 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 6.3 t -142.6 151.87 41.94 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.729 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.624 ' HB3' HG23 ' A' ' 79' ' ' VAL . 35.8 m-20 -50.21 116.75 2.0 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.854 0.359 . . . . 0.0 111.535 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.435 ' HA ' HG22 ' A' ' 72' ' ' VAL . . . -84.78 -21.54 29.93 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.842 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -75.4 -27.64 59.14 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.602 0.239 . . . . 0.0 110.84 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.624 HG23 ' HB3' ' A' ' 76' ' ' ASP . 24.8 t -71.79 -40.84 69.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.014 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.1 m -74.3 -32.65 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.8 -46.91 0.05 OUTLIER Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.6 -0.809 . . . . 0.0 113.145 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.83 -54.25 1.66 Allowed Glycine 0 C--N 1.334 0.447 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.171 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.694 ' HA ' HD22 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -136.22 23.92 3.25 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.569 0.223 . . . . 0.0 111.363 179.7 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -132.61 17.08 4.35 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.621 ' CD2' HG11 ' A' ' 72' ' ' VAL . 22.3 t80 -77.99 120.65 23.14 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.668 0.271 . . . . 0.0 111.36 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.1 m -66.39 147.74 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.67 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.23 154.78 17.55 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.267 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -171.01 152.09 3.43 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.864 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -56.73 108.32 0.48 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.159 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 115.58 24.33 4.09 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.408 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -93.25 167.22 11.89 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.683 0.242 . . . . 0.0 110.5 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 94.9 m -141.43 111.67 6.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.817 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.627 HG11 HD21 ' A' ' 40' ' ' LEU . 14.3 p -122.78 121.25 62.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.115 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -123.83 155.87 37.21 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.447 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.502 ' HB3' HG21 ' A' ' 68' ' ' ILE . 66.6 m-85 -132.19 104.34 6.72 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.927 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.696 HG12 ' HB3' ' A' ' 12' ' ' ALA . 28.5 mt -121.5 119.46 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.277 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.21 151.43 26.87 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.212 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.29 -46.68 0.08 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.672 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.55 91.42 2.3 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.753 0.311 . . . . 0.0 111.051 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -107.11 -28.03 10.23 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.488 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -152.51 -139.85 2.99 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.399 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.356 -1.247 . . . . 0.0 112.41 179.876 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 120.63 0.252 . . . . 0.0 111.44 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.7 p -108.99 152.31 25.15 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.372 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -110.66 -47.1 3.29 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.053 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 69.49 166.47 0.28 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.45 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 35.0 p-10 -101.62 142.66 32.64 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.241 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -177.2 170.43 2.17 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.911 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.529 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 26.1 mm -127.75 152.83 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.794 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.494 HG22 ' NE2' ' A' ' 10' ' ' GLN . 19.3 m -113.66 95.29 5.26 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.775 0.322 . . . . 0.0 111.293 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.633 HG13 ' HB2' ' A' ' 25' ' ' LEU . 10.0 p -109.68 104.8 17.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.936 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.494 ' NE2' HG22 ' A' ' 8' ' ' THR . 0.4 OUTLIER -130.31 165.3 22.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.578 -179.327 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.422 ' HB2' ' HB3' ' A' ' 16' ' ' GLU . 44.5 m-85 -117.51 161.17 20.03 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.17 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.628 ' HB3' HG12 ' A' ' 96' ' ' ILE . . . -151.36 155.66 39.12 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.431 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 72.38 -101.17 1.03 Allowed Glycine 0 C--N 1.335 0.51 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.26 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.72 27.35 3.52 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.684 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.458 ' SG ' HD12 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -95.71 -27.96 15.02 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.707 0.254 . . . . 0.0 111.505 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.422 ' HB3' ' HB2' ' A' ' 11' ' ' PHE . 6.1 pt-20 -58.21 -30.88 66.82 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.648 0.261 . . . . 0.0 111.282 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.414 HD12 ' HG3' ' A' ' 16' ' ' GLU . 9.9 mp -68.13 -8.56 39.41 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.989 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.629 HD22 ' CD1' ' A' ' 55' ' ' LEU . 60.4 mt -82.76 13.44 3.84 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -147.91 -66.16 0.25 Allowed 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -172.35 38.74 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.828 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.31 37.15 18.04 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.845 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -75.28 155.45 36.66 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.117 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 60.9 p -91.06 -69.54 0.73 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.106 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.7 p -144.59 154.4 42.81 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.95 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.633 ' HB2' HG13 ' A' ' 9' ' ' VAL . 2.6 mp -141.28 165.15 28.3 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.328 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.529 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 9.5 mt-30 -125.8 119.21 27.28 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.101 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.7 mt -99.45 142.08 31.4 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.565 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -122.65 127.96 50.01 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.623 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.18 174.25 17.33 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.819 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.692 HG23 HG22 ' A' ' 31' ' ' VAL . 10.5 m -103.58 -36.24 4.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.692 HG22 HG23 ' A' ' 30' ' ' VAL . 3.2 m -147.46 79.91 9.4 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-O 120.772 0.32 . . . . 0.0 111.367 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -67.4 -9.09 24.1 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.916 2.41 . . . . 0.0 113.113 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.49 -55.03 21.14 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.643 0.258 . . . . 0.0 111.142 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -99.03 38.68 3.0 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 121.121 -0.561 . . . . 0.0 112.327 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.8 m -121.87 146.33 47.2 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.881 0.372 . . . . 0.0 110.919 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -135.26 -173.16 3.25 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.694 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.797 HD22 ' HA ' ' A' ' 83' ' ' MET . 3.2 tt -57.51 -41.87 81.69 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.278 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -56.19 -36.8 68.79 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.908 0.385 . . . . 0.0 110.18 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.77 -33.6 33.48 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.948 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.453 HD11 HG21 ' A' ' 7' ' ' ILE . 29.6 tp -65.41 -50.73 64.39 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.598 0.199 . . . . 0.0 110.707 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.78 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.3 OUTLIER -56.91 -56.57 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.684 179.568 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.409 ' H ' HG23 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -49.12 -33.22 11.43 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.345 179.578 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.34 -27.48 63.4 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.53 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.471 HD21 ' CZ ' ' A' ' 95' ' ' PHE . 1.0 OUTLIER -96.92 -38.42 9.82 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.708 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.444 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -81.99 -70.18 0.56 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.496 -179.52 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 m -52.41 -25.14 9.15 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -97.49 -37.29 10.03 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -142.45 58.73 1.45 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.444 ' HB ' ' O ' ' A' ' 45' ' ' LYS . 10.1 p -97.31 -34.92 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.407 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 73.32 -55.95 0.67 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 122.312 0.245 . . . . 0.0 110.644 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.456 ' HB3' HD21 ' A' ' 55' ' ' LEU . 2.4 tp10 -91.72 -177.14 4.68 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.463 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 63.7 mtp85 -58.6 140.84 84.8 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-O 120.718 0.294 . . . . 0.0 111.501 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.412 ' O ' HG22 ' A' ' 57' ' ' VAL . 92.7 Cg_endo -81.45 -18.7 8.15 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.818 2.345 . . . . 0.0 113.03 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.405 ' HA ' ' CG2' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -86.72 6.83 29.42 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -179.404 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.629 ' CD1' HD22 ' A' ' 18' ' ' LEU . 4.7 pp -90.62 -22.13 21.37 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.544 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.679 HD12 HD21 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -100.75 -47.44 4.82 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 111.566 0.21 . . . . 0.0 111.566 -179.874 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.506 HG11 ' HA2' ' A' ' 61' ' ' GLY . 3.0 m -55.09 150.85 2.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 121.154 0.502 . . . . 0.0 111.489 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.549 ' HB2' HG23 ' A' ' 63' ' ' THR . 18.6 t70 -65.64 -56.45 12.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.955 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -174.39 -44.68 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.183 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.9 t -83.47 9.9 10.14 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.688 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.506 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 57.15 23.61 47.85 Favored Glycine 0 C--N 1.34 0.763 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.812 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -110.78 -44.71 3.59 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.055 0.455 . . . . 0.0 110.484 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.549 HG23 ' HB2' ' A' ' 58' ' ' ASP . 10.2 t -115.1 168.23 10.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.088 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.679 HD21 HD12 ' A' ' 56' ' ' LEU . 6.4 mt -96.58 153.58 17.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.826 0.346 . . . . 0.0 111.232 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.439 ' HD3' ' N ' ' A' ' 67' ' ' GLY . 0.5 OUTLIER -57.01 155.48 15.75 Favored Pre-proline 0 N--CA 1.465 0.306 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.571 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.95 -35.97 91.66 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.142 2.562 . . . . 0.0 112.689 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.439 ' N ' ' HD3' ' A' ' 65' ' ' ARG . . . -45.79 -36.68 6.67 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-N 115.844 -0.616 . . . . 0.0 113.327 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.463 HG21 ' HB3' ' A' ' 95' ' ' PHE . 4.3 mt -102.03 138.33 26.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 117.032 0.416 . . . . 0.0 110.925 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 mt -105.75 111.13 23.68 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.474 ' C ' HD23 ' A' ' 71' ' ' LEU . 17.1 m -80.76 125.63 39.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.208 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.474 HD23 ' C ' ' A' ' 70' ' ' VAL . 3.8 mt -123.73 126.79 47.15 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.318 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.758 HG23 ' HB2' ' A' ' 77' ' ' ALA . 28.2 t -105.11 101.94 13.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.579 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 56.61 55.7 6.19 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.123 0.487 . . . . 0.0 110.867 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.9 m 60.87 41.42 14.47 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.499 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 53.0 t -159.74 119.36 2.92 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.657 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.543 ' CB ' HG23 ' A' ' 79' ' ' VAL . 1.5 m-20 -47.54 126.69 10.25 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.474 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.758 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -67.83 -28.56 67.67 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.965 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -69.96 -25.31 63.57 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.067 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.543 HG23 ' CB ' ' A' ' 76' ' ' ASP . 43.9 t -58.66 -30.51 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.789 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.4 m -110.74 -37.38 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.961 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -148.52 -62.06 0.01 OUTLIER Glycine 0 C--N 1.337 0.601 0 C-N-CA 120.629 -0.796 . . . . 0.0 113.066 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 112.06 -63.34 0.28 Allowed Glycine 0 C--N 1.331 0.277 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.293 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.797 ' HA ' HD22 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -134.37 23.2 3.75 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 111.424 0.157 . . . . 0.0 111.424 179.834 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -138.02 24.3 2.8 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.442 ' CE2' HG11 ' A' ' 72' ' ' VAL . 29.4 t80 -70.95 118.8 14.19 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 120.75 0.309 . . . . 0.0 111.396 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.6 m -62.4 165.89 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 116.143 -0.481 . . . . 0.0 112.131 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.46 153.57 31.87 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.571 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -156.85 32.9 0.3 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.678 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 64.66 111.39 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.907 0.384 . . . . 0.0 111.267 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.67 31.63 5.69 Favored Glycine 0 CA--C 1.517 0.217 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.431 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -89.85 112.23 23.5 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.792 0.329 . . . . 0.0 110.577 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 61.8 m -81.72 130.61 35.12 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.592 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.8 p -139.5 126.73 24.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.875 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -126.75 150.75 48.93 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.194 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.471 ' CZ ' HD21 ' A' ' 44' ' ' LEU . 43.2 m-85 -120.55 105.05 10.45 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.333 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.628 HG12 ' HB3' ' A' ' 12' ' ' ALA . 20.5 mt -112.0 109.47 28.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.346 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.2 p -77.32 150.97 35.16 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.571 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.4 p -150.33 -63.78 0.2 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.133 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.2 tt -89.78 117.57 28.72 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.991 0.424 . . . . 0.0 111.043 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 24.0 p80 -124.2 179.73 4.77 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.952 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 101.9 -54.26 0.78 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.28 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.284 -1.287 . . . . 0.0 112.527 179.834 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 mmt . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.1 p -72.62 153.57 41.18 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.78 0.324 . . . . 0.0 111.656 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -115.36 -45.3 2.93 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.201 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.1 m170 -75.05 155.84 36.79 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.951 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 82.84 -26.15 0.14 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.119 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 46.2 m170 -112.13 145.3 40.04 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.64 0.257 . . . . 0.0 111.241 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.506 ' N ' HD12 ' A' ' 7' ' ' ILE . 2.0 mp -103.71 138.34 28.57 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.002 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.417 HG22 ' OE1' ' A' ' 10' ' ' GLN . 88.5 m -86.55 93.76 9.26 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.891 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.563 ' O ' HG13 ' A' ' 9' ' ' VAL . 11.4 p -116.6 106.48 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 120.833 0.349 . . . . 0.0 111.422 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.477 ' HB2' ' O ' ' A' ' 23' ' ' THR . 5.8 pm0 -127.12 170.93 11.85 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.976 0.417 . . . . 0.0 111.872 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.421 ' CB ' ' HA ' ' A' ' 16' ' ' GLU . 89.1 m-85 -134.83 146.74 49.58 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.899 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -167.4 113.18 0.73 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.081 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.17 45.6 0.57 Allowed Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.632 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.99 14.51 82.24 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.562 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -107.23 -25.27 11.58 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 117.523 0.662 . . . . 0.0 111.52 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.421 ' HA ' ' CB ' ' A' ' 11' ' ' PHE . 0.9 OUTLIER -60.53 -22.09 63.22 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.42 HD12 ' HG2' ' A' ' 16' ' ' GLU . 6.4 mp -68.63 -6.69 27.28 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.794 HD21 HD11 ' A' ' 55' ' ' LEU . 59.2 mt -85.59 12.13 9.31 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -146.98 -63.56 0.29 Allowed 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -175.94 36.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.055 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 50.79 35.36 11.93 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.09 0.471 . . . . 0.0 110.672 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -78.84 167.69 20.8 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.066 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.477 ' O ' ' HB2' ' A' ' 10' ' ' GLN . 38.1 p -100.57 -31.52 11.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.4 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 88.7 p -169.92 146.78 3.2 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.636 0.255 . . . . 0.0 111.302 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 tp -133.13 166.16 23.08 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.436 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.485 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 32.9 mt-30 -132.03 116.19 16.77 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.688 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.494 HD22 HD23 ' A' ' 43' ' ' LEU . 14.0 mt -95.28 139.84 31.03 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.937 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -98.39 107.13 19.52 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.613 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.01 166.78 52.11 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 121.154 -0.546 . . . . 0.0 112.967 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.0 m -132.56 -47.62 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.0 t -135.79 87.6 24.97 Favored Pre-proline 0 CA--C 1.53 0.198 0 CA-C-O 120.6 0.238 . . . . 0.0 110.851 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.74 -24.43 30.33 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.824 2.35 . . . . 0.0 113.026 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.64 -59.87 4.75 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.324 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -94.64 42.28 2.45 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.755 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 90.5 m -141.29 129.47 22.18 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.849 0.357 . . . . 0.0 111.062 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -138.85 -168.84 2.5 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.666 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.718 HD22 ' HA ' ' A' ' 83' ' ' MET . 1.7 tt -56.69 -40.27 75.31 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.146 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -58.02 -36.72 73.12 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.74 -32.15 59.54 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.029 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.681 HD21 HD11 ' A' ' 87' ' ' LEU . 17.2 mt -64.0 -49.58 71.91 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.815 0.34 . . . . 0.0 110.713 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.574 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -64.6 -53.53 41.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.009 179.793 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -56.18 -27.34 54.14 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.877 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.494 HD23 HD22 ' A' ' 27' ' ' LEU . 1.3 tp -84.56 -14.6 48.4 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 120.746 0.308 . . . . 0.0 110.914 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.641 HD13 ' N ' ' A' ' 45' ' ' LYS . 0.4 OUTLIER -96.83 -51.73 4.16 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.916 179.646 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.641 ' N ' HD13 ' A' ' 44' ' ' LEU . 1.3 pttt -86.16 -69.52 0.66 Allowed 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.9 m -49.16 -31.54 8.52 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.594 0.235 . . . . 0.0 111.395 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -76.2 -33.85 59.28 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.452 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -130.95 -71.56 0.57 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.602 ' O ' HG13 ' A' ' 49' ' ' VAL . 12.4 p 34.49 89.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.97 -32.02 64.93 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.038 179.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.409 ' O ' HG22 ' A' ' 49' ' ' VAL . 1.1 tp10 -97.13 -161.69 0.89 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.533 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.76 ' HB2' HD23 ' A' ' 55' ' ' LEU . 2.8 mmt180 -66.42 125.23 90.05 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-O 120.599 0.238 . . . . 0.0 111.207 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.41 ' HA ' HG21 ' A' ' 49' ' ' VAL . 56.8 Cg_endo -71.53 -28.16 17.95 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.475 2.117 . . . . 0.0 112.535 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.404 ' HA ' HG22 ' A' ' 57' ' ' VAL . 0.4 OUTLIER -94.22 7.96 43.45 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.752 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.794 HD11 HD21 ' A' ' 18' ' ' LEU . 1.7 pp -82.39 -12.85 57.65 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.597 ' HB2' HD22 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -105.61 -45.29 4.46 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 111.636 0.236 . . . . 0.0 111.636 179.827 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.547 HG11 ' HA2' ' A' ' 61' ' ' GLY . 1.4 m -59.3 149.51 6.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.163 0.506 . . . . 0.0 111.497 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -66.8 -57.99 5.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.764 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -172.44 -44.87 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.315 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.6 p -79.38 4.09 16.38 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.635 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.547 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 60.24 28.18 66.46 Favored Glycine 0 C--N 1.339 0.705 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.574 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -121.29 -46.1 2.31 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.816 0.341 . . . . 0.0 110.604 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.7 t -114.53 140.61 48.62 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.633 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.597 HD22 ' HB2' ' A' ' 56' ' ' LEU . 7.8 mt -67.92 154.58 41.29 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.894 0.378 . . . . 0.0 111.315 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.62 158.5 87.25 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.239 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.69 131.92 45.07 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.969 2.446 . . . . 0.0 112.241 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 138.02 -48.49 0.88 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.315 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.3 mt -88.29 144.54 8.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 120.794 0.331 . . . . 0.0 111.154 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.8 mt -113.61 99.0 7.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.777 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.81 HG23 ' HB3' ' A' ' 77' ' ' ALA . 13.5 m -78.67 131.7 33.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.882 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.453 HD23 ' O ' ' A' ' 70' ' ' VAL . 3.4 mt -130.16 127.47 39.78 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.209 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.601 HG11 ' CD2' ' A' ' 85' ' ' TYR . 39.1 t -103.72 119.14 51.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.354 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 59.5 53.29 5.19 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.968 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.9 m 53.34 35.98 21.7 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.576 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 8.2 t -150.8 153.95 36.39 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.139 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.404 ' CB ' HG23 ' A' ' 79' ' ' VAL . 4.5 m-20 -49.23 124.18 8.62 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.681 0.277 . . . . 0.0 111.315 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.81 ' HB3' HG23 ' A' ' 70' ' ' VAL . . . -65.38 -20.01 66.2 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.578 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -76.01 -29.77 58.27 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.601 0.238 . . . . 0.0 110.685 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.404 HG23 ' CB ' ' A' ' 76' ' ' ASP . 24.4 t -70.78 -42.6 77.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.056 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.5 ' HB ' ' CD1' ' A' ' 85' ' ' TYR . 17.9 m -68.21 -28.79 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 146.02 36.65 0.06 OUTLIER Glycine 0 C--N 1.337 0.625 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.741 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 53.69 -99.35 0.05 OUTLIER Glycine 0 C--N 1.337 0.593 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.915 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.718 ' HA ' HD22 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -122.89 29.16 6.92 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.786 0.327 . . . . 0.0 110.913 179.459 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -117.66 19.89 13.68 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.939 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.601 ' CD2' HG11 ' A' ' 72' ' ' VAL . 15.1 t80 -81.12 120.66 25.13 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.743 0.306 . . . . 0.0 111.358 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.9 m -75.59 158.69 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.477 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.681 HD11 HD21 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -91.45 150.28 21.32 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.078 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -147.9 30.52 0.88 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.412 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 59.48 95.99 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.962 0.41 . . . . 0.0 111.653 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 118.75 28.92 1.97 Allowed Glycine 0 CA--C 1.52 0.376 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.694 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -78.19 166.1 23.15 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.769 0.318 . . . . 0.0 110.88 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 98.7 m -141.33 113.2 7.8 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.105 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.8 p -124.94 136.43 60.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.856 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -135.11 153.12 52.12 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.411 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -125.59 104.61 8.49 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.438 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.1 mt -116.95 117.26 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.021 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.12 125.56 34.22 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.751 0.31 . . . . 0.0 111.19 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.9 p -137.58 -58.36 0.68 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.279 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 33.1 tp -67.87 155.96 38.22 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.242 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -139.87 -65.15 0.47 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.959 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -93.4 -62.39 1.1 Allowed Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.316 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.245 -1.308 . . . . 0.0 112.825 -179.766 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 120.552 0.215 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.9 t -164.39 97.94 0.8 Allowed 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.88 0.371 . . . . 0.0 110.81 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.97 105.84 4.52 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.651 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 47.92 -169.66 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.599 0.562 . . . . 0.0 112.275 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -130.57 153.02 49.31 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.972 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.412 ' HB2' ' HG2' ' A' ' 26' ' ' GLN . 4.8 p80 -167.36 169.01 12.71 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.814 0.34 . . . . 0.0 111.576 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.6 mm -132.11 136.64 56.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.224 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.63 HG22 ' OE1' ' A' ' 10' ' ' GLN . 89.0 m -86.44 109.23 18.91 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.892 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.546 HG13 ' HB2' ' A' ' 25' ' ' LEU . 12.0 p -129.08 112.71 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.286 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.63 ' OE1' HG22 ' A' ' 8' ' ' THR . 9.0 pm0 -137.26 166.69 23.17 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.842 0.353 . . . . 0.0 111.643 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.43 ' CD2' ' HB2' ' A' ' 95' ' ' PHE . 89.4 m-85 -134.37 148.88 50.77 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.242 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -164.21 128.91 2.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.967 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.92 40.71 2.25 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.72 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.55 19.55 79.17 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 121.021 -0.609 . . . . 0.0 113.388 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.0 -12.14 14.24 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 117.279 0.539 . . . . 0.0 111.849 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.426 ' HA ' ' CB ' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -69.3 -15.5 63.36 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.701 0.259 . . . . 0.0 111.701 179.867 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 mt -69.03 -5.47 22.09 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.921 HD21 HD11 ' A' ' 55' ' ' LEU . 53.0 mt -81.6 13.65 2.99 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.502 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 2.6 t80 -153.57 -58.49 0.13 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.698 0.285 . . . . 0.0 110.522 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -179.27 36.37 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.136 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.92 33.9 7.2 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.889 0.376 . . . . 0.0 110.889 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -83.73 166.56 17.95 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.014 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 81.6 p -88.14 -70.66 0.62 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.825 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.406 ' CB ' ' HB3' ' A' ' 10' ' ' GLN . 83.3 p -136.73 156.05 49.03 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.717 0.294 . . . . 0.0 111.306 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.546 ' HB2' HG13 ' A' ' 9' ' ' VAL . 3.4 mp -140.44 164.57 29.77 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.442 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.412 ' HG2' ' HB2' ' A' ' 6' ' ' HIS . 0.0 OUTLIER -122.23 112.03 17.67 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.523 179.743 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.8 mt -96.84 130.32 44.14 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.9 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -122.81 89.95 3.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.94 0.4 . . . . 0.0 110.81 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.78 165.83 54.37 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.759 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.7 t -92.96 -45.91 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-O 120.468 0.175 . . . . 0.0 111.309 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.3 m -131.98 72.27 79.48 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-O 120.945 0.403 . . . . 0.0 111.367 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.445 ' HB2' ' HA ' ' A' ' 88' ' ' ASN . 5.8 Cg_endo -86.19 19.11 1.45 Allowed 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.137 2.558 . . . . 0.0 113.217 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 62.5 m -59.75 -58.61 7.84 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.562 0.22 . . . . 0.0 111.063 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.58 37.22 3.54 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.489 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 54.4 m -105.02 136.77 43.89 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.922 0.391 . . . . 0.0 111.088 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -125.76 -172.35 2.58 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.744 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.728 HD22 ' HA ' ' A' ' 83' ' ' MET . 5.3 tt -54.95 -43.59 73.54 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -57.15 -35.33 69.39 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.906 0.384 . . . . 0.0 110.124 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.22 -33.21 36.53 Favored Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.951 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.527 HD12 ' HA ' ' A' ' 37' ' ' LEU . 73.1 mt -63.56 -51.49 65.17 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.756 0.312 . . . . 0.0 110.624 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.694 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.3 OUTLIER -57.36 -56.79 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.812 179.641 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.408 ' H ' HG23 ' A' ' 41' ' ' VAL . 5.7 tt0 -49.46 -34.66 17.4 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.329 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.92 -27.62 65.93 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.846 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.1 pp -96.64 -38.14 10.06 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.434 ' CA ' ' HB ' ' A' ' 49' ' ' VAL . 2.8 pttt -85.59 -62.13 1.6 Allowed 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.9 m -58.1 -21.64 47.08 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.118 -0.233 . . . . 0.0 111.61 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -98.75 -36.64 9.76 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -150.23 54.42 0.92 Allowed 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.434 ' HB ' ' CA ' ' A' ' 45' ' ' LYS . 9.4 p -80.91 -43.88 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 121.216 -0.194 . . . . 0.0 111.521 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 19' ' ' PHE . 0.6 OUTLIER 67.86 -59.06 0.43 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 122.601 0.36 . . . . 0.0 110.608 -179.126 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.22 -168.55 0.52 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.208 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.445 ' HB3' ' HB3' ' A' ' 55' ' ' LEU . 3.5 ttt180 -69.16 128.33 92.62 Favored Pre-proline 0 CA--C 1.529 0.173 0 CA-C-O 120.625 0.25 . . . . 0.0 111.471 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.457 ' O ' HG22 ' A' ' 57' ' ' VAL . 58.7 Cg_endo -72.72 -23.73 19.06 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.311 2.007 . . . . 0.0 112.492 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -93.08 7.38 44.42 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.921 HD11 HD21 ' A' ' 18' ' ' LEU . 3.0 pp -85.67 -21.06 28.54 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 121.117 -0.233 . . . . 0.0 111.072 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.572 ' H ' HD23 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -103.03 -48.78 3.95 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 111.477 0.177 . . . . 0.0 111.477 179.614 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.499 HG11 ' HA2' ' A' ' 61' ' ' GLY . 2.8 m -62.72 144.73 14.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 121.052 0.453 . . . . 0.0 111.14 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.436 ' HA ' ' HB3' ' A' ' 65' ' ' ARG . 10.4 t70 -63.72 -60.23 3.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.596 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.8 tm0? -168.85 -44.66 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.309 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.1 p -79.55 2.71 21.21 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.534 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.499 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 62.16 28.41 70.64 Favored Glycine 0 C--N 1.34 0.761 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.413 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -124.05 -40.46 2.28 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.575 0.226 . . . . 0.0 111.464 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.7 t -114.09 135.8 53.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.636 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.51 HD11 ' HB2' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -70.06 132.9 46.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.869 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.436 ' HB3' ' HA ' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -58.89 155.44 31.74 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.419 -179.793 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -58.62 138.07 83.7 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.819 2.346 . . . . 0.0 112.402 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 136.85 -46.74 1.0 Allowed Glycine 0 C--N 1.332 0.336 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.195 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.422 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 5.4 mt -94.93 127.38 46.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 120.697 0.284 . . . . 0.0 111.018 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.9 mp -98.3 102.94 14.83 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.849 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.761 HG23 ' HB3' ' A' ' 77' ' ' ALA . 15.4 m -76.59 133.98 29.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.744 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.6 HD11 HD12 ' A' ' 96' ' ' ILE . 1.1 mt -129.15 141.98 51.01 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.487 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.743 HG23 ' HB2' ' A' ' 77' ' ' ALA . 19.6 t -113.68 111.55 36.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.586 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.0 m120 57.67 54.04 6.69 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.989 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.8 t 57.23 49.65 13.03 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.98 0.419 . . . . 0.0 111.186 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 50.6 t -162.17 146.21 12.19 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.671 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.653 ' HB3' HG23 ' A' ' 79' ' ' VAL . 9.5 m-20 -50.83 121.71 6.34 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.46 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.761 ' HB3' HG23 ' A' ' 70' ' ' VAL . . . -83.99 -22.8 31.25 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.735 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -74.18 -30.58 62.3 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-O 120.555 0.217 . . . . 0.0 110.888 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.653 HG23 ' HB3' ' A' ' 76' ' ' ASP . 45.2 t -63.69 -40.59 89.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.127 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 26.9 m -79.48 -36.79 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.505 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -166.66 -51.55 0.03 OUTLIER Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.64 -0.791 . . . . 0.0 113.128 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 100.26 -50.97 1.05 Allowed Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.425 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.728 ' HA ' HD22 ' A' ' 37' ' ' LEU . 2.4 ptt? -144.11 25.51 1.57 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.527 0.203 . . . . 0.0 111.38 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -140.48 23.59 2.31 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.538 ' CE1' HG11 ' A' ' 72' ' ' VAL . 38.3 t80 -80.78 103.4 10.59 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.771 0.32 . . . . 0.0 110.774 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.6 m -72.63 145.72 11.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.836 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.569 ' C ' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -153.12 165.39 35.79 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.012 -179.769 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.445 ' HA ' ' HB2' ' A' ' 32' ' ' PRO . 9.9 t-20 -134.69 -64.78 0.66 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.084 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -146.59 132.37 18.99 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.749 0.309 . . . . 0.0 111.067 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.96 21.24 36.66 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 121.104 -0.57 . . . . 0.0 112.89 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -86.23 163.98 17.44 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.801 0.334 . . . . 0.0 111.129 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.425 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 90.8 m -138.88 130.28 27.14 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.922 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.6 p -140.54 124.07 17.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.696 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.414 ' HG2' ' HG2' ' A' ' 10' ' ' GLN . 14.0 mt-10 -126.7 137.17 53.22 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.4 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.43 ' HB2' ' CD2' ' A' ' 11' ' ' PHE . 3.9 m-85 -107.42 104.81 14.48 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.562 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.6 HD12 HD11 ' A' ' 71' ' ' LEU . 28.3 mt -109.04 104.87 17.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.148 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . 41.9 t -85.01 140.13 31.26 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.04 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 34.2 p -139.79 -55.25 0.56 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.946 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.86 81.1 8.69 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.956 0.408 . . . . 0.0 110.751 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -96.51 112.85 24.44 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.901 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 111.28 -134.51 12.19 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.321 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.468 -1.184 . . . . 0.0 112.564 179.965 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mtt . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 111.543 0.201 . . . . 0.0 111.543 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.26 81.77 8.27 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.942 0.401 . . . . 0.0 111.267 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -108.34 -39.69 5.37 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.068 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 72.99 135.42 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.151 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -73.45 129.59 38.32 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.914 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 14.0 p-80 -169.47 143.95 2.91 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.134 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.538 HD12 HD23 ' A' ' 87' ' ' LEU . 27.8 mm -117.49 152.19 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.11 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.485 ' HB ' HG23 ' A' ' 92' ' ' THR . 6.1 m -117.15 102.33 9.21 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.05 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.536 ' O ' HG13 ' A' ' 9' ' ' VAL . 12.7 p -128.99 112.43 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 120.788 0.328 . . . . 0.0 111.765 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -129.63 165.2 22.27 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.982 0.42 . . . . 0.0 111.57 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.432 ' CB ' ' HA ' ' A' ' 16' ' ' GLU . 26.0 m-85 -126.41 131.52 51.71 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.199 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.13 151.39 47.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.503 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.19 -94.97 2.03 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.688 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -137.24 28.71 2.77 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.82 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.83 -27.93 9.04 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.736 0.268 . . . . 0.0 111.61 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.432 ' HA ' ' CB ' ' A' ' 11' ' ' PHE . 0.6 OUTLIER -57.35 -30.87 65.19 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.524 0.202 . . . . 0.0 111.226 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.72 -13.86 62.65 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.857 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.559 HD22 HD21 ' A' ' 55' ' ' LEU . 32.3 mt -84.9 13.34 6.05 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -143.07 -61.92 0.42 Allowed 'General case' 0 CA--C 1.523 -0.071 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -178.81 36.37 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.103 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 50.37 31.7 5.63 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.962 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.65 173.47 12.41 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.104 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.4 p -102.46 -75.82 0.59 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.764 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 92.5 p -131.46 156.91 44.82 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.783 0.325 . . . . 0.0 111.372 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.505 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -137.19 159.0 43.17 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.259 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.454 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 2.6 mt-30 -129.87 129.75 44.33 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.971 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.465 HD12 HG21 ' A' ' 7' ' ' ILE . 2.9 mt -110.11 139.58 45.1 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.688 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -104.95 112.2 25.24 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.636 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -121.47 136.73 11.29 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.617 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.8 t -76.83 -38.83 29.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 120.554 0.216 . . . . 0.0 111.156 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.533 ' O ' HG13 ' A' ' 31' ' ' VAL . 7.2 p -155.63 76.09 4.97 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-O 121.312 0.577 . . . . 0.0 110.931 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -78.93 4.67 6.3 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.817 2.345 . . . . 0.0 113.368 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 80.2 m -56.43 -35.38 67.77 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.691 0.281 . . . . 0.0 110.95 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -91.91 26.17 13.88 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.868 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.7 m -128.03 128.35 44.81 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.829 0.315 . . . . 0.0 110.68 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -104.28 175.76 5.38 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.029 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.794 ' O ' HG22 ' A' ' 41' ' ' VAL . 5.2 tt -57.79 -41.93 83.1 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.682 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -54.98 -36.87 65.85 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.943 0.401 . . . . 0.0 110.377 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.13 -31.15 43.7 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.196 178.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 25.1 tp -70.08 -51.87 28.32 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.798 0.299 . . . . 0.0 110.921 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.794 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.4 OUTLIER -57.46 -57.24 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.895 179.787 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.44 ' H ' HG23 ' A' ' 41' ' ' VAL . 2.9 tt0 -51.39 -28.81 13.64 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.609 -0.268 . . . . 0.0 111.434 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.0 tp -78.12 -27.06 48.22 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.704 HD12 ' N ' ' A' ' 45' ' ' LYS . 4.6 pp -96.86 -37.15 10.35 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.704 ' N ' HD12 ' A' ' 44' ' ' LEU . 0.9 OUTLIER -86.01 -69.24 0.68 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.418 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.9 m -54.66 -23.74 18.65 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -103.97 -20.51 13.85 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -148.06 48.21 1.06 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.632 HG22 ' H ' ' A' ' 51' ' ' GLU . 8.1 p -94.06 132.07 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 120.719 0.295 . . . . 0.0 111.222 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -115.4 32.42 6.07 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.276 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.632 ' H ' HG22 ' A' ' 49' ' ' VAL . 1.9 tp10 -163.17 -171.86 2.79 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.502 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.599 ' HB3' HD23 ' A' ' 55' ' ' LEU . 1.4 ttt180 -65.1 110.78 4.66 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.782 -0.19 . . . . 0.0 110.929 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.418 ' O ' HG22 ' A' ' 57' ' ' VAL . 17.8 Cg_endo -60.29 -21.65 67.72 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.345 2.03 . . . . 0.0 112.692 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -91.29 7.66 39.79 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.621 ' HG ' HD23 ' A' ' 56' ' ' LEU . 2.5 pp -93.56 -18.97 21.64 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.486 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.621 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -102.53 -48.52 4.12 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.601 0.223 . . . . 0.0 111.601 179.825 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.519 HG11 ' HA2' ' A' ' 61' ' ' GLY . 3.4 m -57.14 148.32 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 121.101 0.477 . . . . 0.0 111.591 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -69.57 -58.82 3.47 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.712 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -166.91 -48.95 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.517 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.3 p -77.42 6.52 6.79 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.715 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.519 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 57.77 27.92 59.69 Favored Glycine 0 C--N 1.339 0.707 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.637 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.8 tp60 -122.18 -42.09 2.39 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.589 0.233 . . . . 0.0 110.943 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 49.9 p -117.21 136.24 53.2 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.611 HD12 HG21 ' A' ' 68' ' ' ILE . 6.3 mt -66.71 155.54 37.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.845 0.355 . . . . 0.0 111.142 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.53 160.14 74.06 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.47 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -51.25 -33.39 44.75 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 123.167 2.578 . . . . 0.0 112.798 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -53.43 -32.13 44.64 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.733 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.611 HG21 HD12 ' A' ' 64' ' ' LEU . 19.5 mm -83.46 151.47 3.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 120.822 0.344 . . . . 0.0 110.793 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.705 HD12 HD21 ' A' ' 71' ' ' LEU . 0.5 OUTLIER -127.83 99.83 5.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.815 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 70' ' ' VAL . 34.9 m -84.55 122.12 37.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.731 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.705 HD21 HD12 ' A' ' 69' ' ' LEU . 4.5 mt -131.3 137.55 48.86 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.174 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.616 HG13 ' HB2' ' A' ' 77' ' ' ALA . 3.3 m -109.54 118.95 57.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.784 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 24.2 m-20 64.23 -78.57 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.938 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -151.55 32.01 0.57 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.077 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 49.7 t -157.32 146.51 20.02 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.852 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.534 ' CB ' HG23 ' A' ' 79' ' ' VAL . 0.7 OUTLIER -52.5 130.6 32.18 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.362 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.616 ' HB2' HG13 ' A' ' 72' ' ' VAL . . . -75.3 -23.29 57.34 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.687 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.422 ' HA ' ' CA ' ' A' ' 82' ' ' GLY . 3.2 mt-10 -74.38 -18.69 60.64 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.141 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.534 HG23 ' CB ' ' A' ' 76' ' ' ASP . 38.2 t -63.14 -35.74 73.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 120.661 0.267 . . . . 0.0 110.875 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.9 m -98.88 -37.66 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.789 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -152.61 -60.19 0.01 OUTLIER Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.594 -0.812 . . . . 0.0 113.222 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.422 ' CA ' ' HA ' ' A' ' 78' ' ' GLU . . . 100.72 -51.22 1.0 Allowed Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.253 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.585 ' HA ' HD22 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -128.02 4.54 5.91 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 179.718 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -123.7 25.56 8.07 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.531 ' CE2' HG21 ' A' ' 72' ' ' VAL . 8.4 t80 -74.28 88.72 2.03 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.875 0.369 . . . . 0.0 110.81 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.4 m -61.54 139.6 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.664 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.538 HD23 HD12 ' A' ' 7' ' ' ILE . 7.1 mp -90.52 168.59 11.71 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.073 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 37.1 p30 -168.33 43.58 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.408 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 64.36 96.43 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.151 0.501 . . . . 0.0 110.99 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 112.96 28.25 3.45 Favored Glycine 0 CA--C 1.521 0.433 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.393 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.52 144.12 26.28 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.723 0.297 . . . . 0.0 110.715 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.485 HG23 ' HB ' ' A' ' 8' ' ' THR . 88.5 m -123.25 133.95 54.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.85 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.14 130.52 18.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.996 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -123.17 155.4 37.15 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.239 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -132.41 108.08 8.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.493 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 33.6 mt -113.94 123.45 69.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.115 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.65 130.88 38.15 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.263 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 71.5 p -126.14 -50.95 1.55 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.98 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.2 tt -85.29 128.58 34.74 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.107 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -108.61 -36.22 6.24 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.193 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -130.32 169.97 21.05 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.429 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.518 -1.157 . . . . 0.0 112.571 179.897 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.425 ' O ' ' HB2' ' A' ' 2' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 120.387 0.137 . . . . 0.0 111.054 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 1' ' ' MET . 3.2 m 68.51 149.03 0.06 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.081 0.467 . . . . 0.0 111.673 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 32.5 p-10 -162.86 48.65 0.16 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.936 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.97 165.18 28.17 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.531 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -89.11 124.85 34.7 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.222 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -167.86 102.47 0.47 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.656 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.408 HG23 ' O ' ' A' ' 91' ' ' ASP . 3.0 mp -91.27 126.06 43.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.134 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.894 ' HB ' HG23 ' A' ' 92' ' ' THR . 0.2 OUTLIER -85.76 96.11 9.62 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.255 179.461 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.56 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.7 p -115.72 106.0 19.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.953 0.406 . . . . 0.0 111.272 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.822 ' OE1' HG22 ' A' ' 8' ' ' THR . 0.0 OUTLIER -136.38 155.59 49.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.053 0.454 . . . . 0.0 111.375 179.74 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -118.89 138.66 52.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.742 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.437 ' HB3' ' HA ' ' A' ' 96' ' ' ILE . . . -92.03 -178.67 5.06 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.185 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.61 97.18 0.08 OUTLIER Glycine 0 C--N 1.335 0.495 0 C-N-CA 121.133 -0.556 . . . . 0.0 112.687 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 138.29 -33.28 2.25 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.733 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.04 9.04 24.25 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -83.92 -37.43 22.35 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.584 0.231 . . . . 0.0 111.426 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.445 HD12 ' H ' ' A' ' 17' ' ' LEU . 3.0 mp -69.74 -4.6 20.51 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.506 HD22 HD21 ' A' ' 55' ' ' LEU . 4.7 mt -88.94 13.69 12.21 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -146.73 -61.94 0.3 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.702 0.286 . . . . 0.0 110.326 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -178.07 36.34 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.076 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.51 33.29 7.66 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.927 0.394 . . . . 0.0 110.822 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -80.19 174.47 11.56 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.715 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 79.7 p -110.66 -69.68 0.85 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.06 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.442 ' CB ' ' HB3' ' A' ' 10' ' ' GLN . 59.3 p -141.64 162.99 34.12 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.691 0.281 . . . . 0.0 111.34 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.465 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -150.98 165.33 34.05 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.258 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.407 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -129.12 101.02 5.85 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.675 179.778 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.4 mt -83.01 142.09 31.6 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.696 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -111.31 101.6 10.06 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.841 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -94.66 -179.12 37.9 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.823 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.54 HG23 HG22 ' A' ' 31' ' ' VAL . 14.9 m -137.12 -47.84 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 120.555 0.217 . . . . 0.0 111.28 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.54 HG22 HG23 ' A' ' 30' ' ' VAL . 20.3 m -137.58 56.41 11.57 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-O 120.755 0.312 . . . . 0.0 111.067 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.459 ' HB2' ' CB ' ' A' ' 87' ' ' LEU . 88.9 Cg_endo -82.12 8.96 4.18 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.834 2.356 . . . . 0.0 113.445 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 35.4 m -55.38 -36.48 66.42 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.612 0.244 . . . . 0.0 110.848 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -93.13 29.74 7.84 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.811 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.2 m -132.75 135.58 45.82 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.659 0.266 . . . . 0.0 110.564 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -111.83 -176.39 2.92 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.946 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.653 HD22 ' HA ' ' A' ' 83' ' ' MET . 6.9 tt -54.32 -37.84 65.3 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.558 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -57.77 -35.19 70.42 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.904 0.383 . . . . 0.0 110.011 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.55 -32.96 58.98 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.583 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.503 ' HG ' HD11 ' A' ' 87' ' ' LEU . 7.8 mt -64.76 -53.15 51.58 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.718 0.295 . . . . 0.0 110.527 179.376 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.542 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.2 OUTLIER -57.48 -56.93 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.023 179.667 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -49.23 -30.8 7.58 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.654 0.264 . . . . 0.0 111.489 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.2 tp -70.76 -31.0 67.65 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 2.9 pp -97.13 -42.57 7.79 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.77 -68.46 0.68 Allowed 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -178.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.5 m -50.19 -29.68 9.86 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.422 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -77.31 -36.67 53.87 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.434 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -127.89 -68.26 0.78 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.544 ' O ' HG13 ' A' ' 49' ' ' VAL . 13.8 p 37.77 66.88 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 121.474 0.654 . . . . 0.0 111.766 -179.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.26 -30.81 62.92 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.088 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.97 -164.84 1.23 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.881 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.09 135.03 91.58 Favored Pre-proline 0 N--CA 1.462 0.144 0 CA-C-O 120.64 0.257 . . . . 0.0 111.142 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.491 ' O ' HG22 ' A' ' 57' ' ' VAL . 70.1 Cg_endo -76.23 -28.45 7.22 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.369 2.046 . . . . 0.0 112.475 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.405 ' HA ' ' CG2' ' A' ' 57' ' ' VAL . 11.8 m-20 -92.89 9.31 35.95 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.716 ' HG ' HD23 ' A' ' 56' ' ' LEU . 2.6 pp -82.94 -28.2 30.02 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 122.317 -0.239 . . . . 0.0 111.006 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.716 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -100.07 -49.19 4.38 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.509 HG11 ' HA2' ' A' ' 61' ' ' GLY . 6.2 m -62.42 146.8 12.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 121.101 0.477 . . . . 0.0 111.451 -179.389 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -67.21 -57.65 6.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.574 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -169.93 -45.03 0.02 OUTLIER 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.496 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.4 p -77.78 0.63 22.96 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.571 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.509 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 63.43 22.86 66.08 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.388 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -120.27 -38.32 2.93 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.749 0.309 . . . . 0.0 111.1 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.9 t -118.99 132.39 56.06 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 6.2 mt -67.15 153.81 42.76 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.98 0.419 . . . . 0.0 111.36 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -74.4 161.35 78.47 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.015 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -61.09 123.23 12.48 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.77 2.313 . . . . 0.0 112.188 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 154.01 -45.54 0.56 Allowed Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.4 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.6 mt -96.76 135.35 31.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 120.763 0.316 . . . . 0.0 111.068 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.3 tp -106.05 108.87 20.61 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.518 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.666 HG11 ' HE2' ' A' ' 83' ' ' MET . 16.3 m -77.66 129.07 37.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.446 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.501 HD23 ' O ' ' A' ' 70' ' ' VAL . 9.5 mt -126.09 128.12 46.86 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.88 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.577 HG12 ' O ' ' A' ' 92' ' ' THR . 4.4 m -117.31 122.4 69.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.073 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 55.24 46.31 23.97 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.52 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.3 m 61.96 30.23 18.0 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.494 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 31.1 t -153.01 130.25 11.23 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.805 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.633 ' HB2' HG23 ' A' ' 79' ' ' VAL . 9.2 m-20 -46.44 130.41 10.91 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.899 0.381 . . . . 0.0 111.536 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.29 -21.12 59.88 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.133 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.42 ' HA ' ' CA ' ' A' ' 82' ' ' GLY . 1.7 mt-10 -73.31 -28.3 62.01 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-O 120.577 0.227 . . . . 0.0 110.918 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.633 HG23 ' HB2' ' A' ' 76' ' ' ASP . 43.5 t -64.93 -33.78 65.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.053 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.4 m -100.92 -37.47 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -140.01 -74.64 0.05 OUTLIER Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.096 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.42 ' CA ' ' HA ' ' A' ' 78' ' ' GLU . . . 107.81 85.11 1.72 Allowed Glycine 0 C--N 1.331 0.302 0 C-N-CA 121.155 -0.545 . . . . 0.0 112.185 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.666 ' HE2' HG11 ' A' ' 70' ' ' VAL . 1.9 mmt 58.4 23.49 10.64 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.679 0.276 . . . . 0.0 111.394 -179.291 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -147.1 24.92 1.14 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.336 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -74.94 114.9 13.95 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.693 0.283 . . . . 0.0 110.95 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.7 m -65.12 140.29 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.693 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.503 HD11 ' HG ' ' A' ' 40' ' ' LEU . 2.9 mp -78.61 168.58 19.56 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.433 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -165.3 42.55 0.07 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.232 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 54.35 88.52 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.068 0.461 . . . . 0.0 111.404 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 117.94 26.64 2.71 Favored Glycine 0 CA--C 1.523 0.532 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.895 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.408 ' O ' HG23 ' A' ' 7' ' ' ILE . 2.2 t70 -78.58 150.61 32.74 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-O 120.819 0.342 . . . . 0.0 110.846 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.894 HG23 ' HB ' ' A' ' 8' ' ' THR . 96.8 m -120.99 129.94 53.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.451 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.15 136.68 25.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.22 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -134.09 151.56 51.44 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.389 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -123.73 104.72 9.16 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.39 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.437 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 14.9 mt -115.14 116.96 54.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.11 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 68.0 m -76.17 82.37 2.98 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.911 0.386 . . . . 0.0 110.739 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -75.11 -68.74 0.52 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.244 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.3 tp -77.47 134.74 38.28 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.756 0.312 . . . . 0.0 110.824 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -92.22 -41.0 10.67 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.089 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 179.52 143.98 5.67 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.727 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.371 -1.238 . . . . 0.0 112.585 179.955 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ptp . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 120.672 0.272 . . . . 0.0 111.336 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.2 m -77.87 -51.96 9.63 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.738 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 56.95 33.89 23.99 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.252 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -88.56 179.39 6.29 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.047 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.77 105.79 17.98 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.013 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -175.36 104.68 0.08 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.981 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.713 HD12 ' HB2' ' A' ' 27' ' ' LEU . 25.1 mt -88.97 117.18 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-O 120.858 0.361 . . . . 0.0 111.103 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.717 HG22 ' OE1' ' A' ' 10' ' ' GLN . 37.6 m -82.26 112.4 19.22 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.368 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.539 HG13 ' HB2' ' A' ' 25' ' ' LEU . 7.6 p -141.7 105.83 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-O 120.907 0.385 . . . . 0.0 111.129 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.717 ' OE1' HG22 ' A' ' 8' ' ' THR . 1.6 pm0 -130.39 171.62 12.75 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.82 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.497 ' HB2' ' HB3' ' A' ' 16' ' ' GLU . 91.1 m-85 -128.87 151.36 49.71 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.18 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.582 ' HB3' HG12 ' A' ' 96' ' ' ILE . . . -148.97 130.88 15.21 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.592 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.83 -107.73 3.55 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.287 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -119.34 30.88 5.64 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 121.033 -0.604 . . . . 0.0 112.439 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -108.63 -31.29 7.82 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 111.493 0.183 . . . . 0.0 111.493 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.497 ' HB3' ' HB2' ' A' ' 11' ' ' PHE . 8.6 pm0 -63.68 -30.82 71.88 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.563 0.22 . . . . 0.0 111.206 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 mp -71.57 -7.9 50.63 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.749 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.83 HD13 HD22 ' A' ' 56' ' ' LEU . 13.3 mt -85.7 13.73 6.75 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -146.74 -61.8 0.3 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.727 0.299 . . . . 0.0 110.228 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -177.31 36.93 0.0 OUTLIER 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.051 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.3 mptt 50.93 33.71 9.27 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.904 0.383 . . . . 0.0 110.997 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -79.18 145.3 33.74 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.833 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.0 p -78.22 -68.69 0.61 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.843 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 99.4 p -137.93 164.53 28.77 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.826 0.346 . . . . 0.0 111.413 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.539 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -139.34 155.59 47.58 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.142 179.83 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 0.1 OUTLIER -133.36 116.93 16.67 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.028 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.713 ' HB2' HD12 ' A' ' 7' ' ' ILE . 11.2 mt -103.5 133.89 47.78 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.57 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -124.85 144.0 50.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.436 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -165.66 -172.31 32.9 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.922 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.7 m -118.01 -43.93 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 120.548 0.213 . . . . 0.0 111.443 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 18.1 t -126.56 56.33 16.75 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-O 120.976 0.417 . . . . 0.0 111.16 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -78.49 2.46 8.09 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 122.803 2.336 . . . . 0.0 113.016 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.96 170.36 4.41 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.707 0.289 . . . . 0.0 110.916 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 76.26 25.35 66.28 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.408 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 51.3 m -136.73 131.1 33.02 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 120.508 0.194 . . . . 0.0 110.591 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -108.21 -177.9 3.46 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.855 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.686 HD22 ' HA ' ' A' ' 83' ' ' MET . 7.0 tt -56.47 -44.98 81.1 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.339 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -56.01 -37.97 69.87 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.37 -31.08 59.53 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.166 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.657 HD11 ' CD1' ' A' ' 87' ' ' LEU . 49.3 mt -64.87 -50.87 64.9 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.772 0.32 . . . . 0.0 110.566 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -64.78 -55.36 21.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.251 179.817 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -52.46 -22.98 5.36 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.403 ' O ' ' HB2' ' A' ' 47' ' ' ASN . 3.6 tt -86.79 -26.33 24.17 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.534 HD12 ' N ' ' A' ' 45' ' ' LYS . 3.4 pp -93.0 -45.37 7.96 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.243 0.461 . . . . 0.0 112.243 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.534 ' N ' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -71.89 -55.82 6.82 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 121.014 -0.274 . . . . 0.0 111.513 -179.378 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 35.1 m -52.06 -28.23 16.67 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.638 0.256 . . . . 0.0 111.117 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.5 OUTLIER -82.27 -32.96 29.36 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.124 179.524 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.88 -75.77 0.6 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.483 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.598 ' O ' HG13 ' A' ' 49' ' ' VAL . 7.9 p 33.52 58.03 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 121.345 0.593 . . . . 0.0 111.821 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.97 -33.5 68.93 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.189 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.475 ' HB2' ' HA ' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -90.33 172.2 8.93 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.399 179.502 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.586 ' HB2' HD23 ' A' ' 55' ' ' LEU . 28.5 mmm-85 -48.68 106.97 0.68 Allowed Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.61 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.417 ' O ' HG22 ' A' ' 57' ' ' VAL . 50.2 Cg_exo -55.11 -28.96 63.41 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.664 2.243 . . . . 0.0 112.563 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.45 9.78 32.85 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.834 ' HG ' HD23 ' A' ' 56' ' ' LEU . 1.4 pp -88.25 -28.13 21.31 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 121.148 -0.221 . . . . 0.0 111.1 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.834 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -93.77 -54.63 3.55 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.588 -179.871 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.548 HG11 ' HA2' ' A' ' 61' ' ' GLY . 2.1 m -53.94 151.53 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 121.068 0.461 . . . . 0.0 111.612 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -65.42 -58.2 6.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.565 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.3 -45.32 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.517 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.8 p -84.09 10.73 9.36 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.617 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.548 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 55.28 27.91 48.36 Favored Glycine 0 C--N 1.338 0.653 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.552 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -118.25 -41.37 2.86 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.755 0.312 . . . . 0.0 110.838 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.7 t -117.97 128.67 55.02 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.979 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.686 HD22 ' HB2' ' A' ' 56' ' ' LEU . 8.3 mt -67.44 156.21 37.14 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.717 0.294 . . . . 0.0 110.989 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.436 ' CG ' HD12 ' A' ' 68' ' ' ILE . 0.7 OUTLIER -52.44 153.81 4.97 Favored Pre-proline 0 N--CA 1.464 0.275 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.598 -179.796 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.36 -38.57 73.82 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.048 2.498 . . . . 0.0 112.771 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.428 ' HA3' ' HB3' ' A' ' 99' ' ' LEU . . . -48.34 -36.06 16.04 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 121.167 -0.539 . . . . 0.0 112.799 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.505 HD13 HD13 ' A' ' 64' ' ' LEU . 6.6 mt -84.32 126.48 40.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 117.008 0.404 . . . . 0.0 110.951 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 mt -94.63 101.5 13.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.515 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.712 HG23 ' HB3' ' A' ' 77' ' ' ALA . 15.3 m -79.51 132.3 32.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.899 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.529 HD23 ' O ' ' A' ' 70' ' ' VAL . 1.8 mt -137.22 138.77 40.49 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.386 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.501 HG23 ' CB ' ' A' ' 77' ' ' ALA . 44.0 t -119.06 119.74 61.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.656 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 28.3 m-20 61.27 54.07 3.33 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.079 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.2 m 52.82 38.44 26.63 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.492 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 21.4 t -155.43 155.05 32.87 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.523 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.494 ' HB3' HG23 ' A' ' 79' ' ' VAL . 0.6 OUTLIER -47.18 123.91 5.97 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.665 0.269 . . . . 0.0 111.438 -179.84 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.712 ' HB3' HG23 ' A' ' 70' ' ' VAL . . . -69.29 -23.17 63.79 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.693 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -74.86 -28.79 60.81 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.526 0.203 . . . . 0.0 110.653 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.494 HG23 ' HB3' ' A' ' 76' ' ' ASP . 24.1 t -73.52 -41.21 56.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.282 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.414 HG21 ' HB ' ' A' ' 72' ' ' VAL . 30.8 m -71.4 -34.19 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.663 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.9 -46.31 0.04 OUTLIER Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.74 -0.743 . . . . 0.0 113.055 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.84 73.45 1.27 Allowed Glycine 0 C--N 1.335 0.496 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.192 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.686 ' HA ' HD22 ' A' ' 37' ' ' LEU . 0.7 OUTLIER 62.2 29.71 17.51 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.586 0.231 . . . . 0.0 111.131 -179.613 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -150.2 29.86 0.71 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.432 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -90.27 118.91 30.14 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.725 0.297 . . . . 0.0 110.973 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.9 m -66.8 156.25 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.813 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.657 ' CD1' HD11 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -89.54 161.12 16.36 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.428 -179.699 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -158.4 36.84 0.24 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.253 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 47.1 t0 61.17 93.13 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.041 0.448 . . . . 0.0 110.896 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 112.52 31.34 2.6 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.588 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -70.14 166.92 18.89 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.724 0.297 . . . . 0.0 111.049 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.652 HG23 ' HB ' ' A' ' 8' ' ' THR . 85.1 m -140.05 125.59 19.15 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.08 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.449 HG13 HG23 ' A' ' 9' ' ' VAL . 10.4 p -143.23 140.17 26.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.93 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -138.05 144.72 41.11 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.912 0.387 . . . . 0.0 111.134 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.502 ' HB3' HG21 ' A' ' 68' ' ' ILE . 70.1 m-85 -125.15 104.85 8.74 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.719 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.582 HG12 ' HB3' ' A' ' 12' ' ' ALA . 27.6 mt -118.83 112.63 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.22 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 74.3 m -79.98 123.32 27.71 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.394 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.94 7.84 8.67 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.944 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.601 HD22 ' C ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -58.21 166.86 1.47 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.914 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.465 ' N ' HD22 ' A' ' 99' ' ' LEU . 27.5 t-80 -151.48 153.99 35.69 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.582 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -133.13 -89.86 0.41 Allowed Glycine 0 C--N 1.335 0.517 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.1 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.944 0 CA-C-O 118.478 -1.179 . . . . 0.0 112.632 179.785 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 120.805 0.336 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.34 136.08 12.54 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.931 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -72.19 127.78 33.63 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.268 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.08 30.25 5.27 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.679 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -122.85 135.59 54.58 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.566 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -176.91 137.93 0.25 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.982 0.42 . . . . 0.0 111.791 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 29.9 mm -111.23 153.94 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.401 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.728 HG22 ' OE1' ' A' ' 10' ' ' GLN . 2.3 m -121.19 111.32 17.26 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.664 0.268 . . . . 0.0 111.162 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.539 ' O ' HG13 ' A' ' 9' ' ' VAL . 8.3 p -129.99 104.69 10.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-O 120.925 0.393 . . . . 0.0 111.046 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.728 ' OE1' HG22 ' A' ' 8' ' ' THR . 0.0 OUTLIER -130.74 154.94 47.44 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.804 -179.657 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.414 ' HB2' ' HB3' ' A' ' 16' ' ' GLU . 32.4 m-85 -116.6 142.78 46.44 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.849 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.474 ' HB3' HG12 ' A' ' 96' ' ' ILE . . . -137.21 167.83 20.81 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.744 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 66.1 -104.74 1.09 Allowed Glycine 0 C--N 1.334 0.434 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.653 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -128.3 32.77 3.32 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.899 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.6 t -105.26 -32.26 8.7 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.865 0.332 . . . . 0.0 111.103 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.414 ' HB3' ' HB2' ' A' ' 11' ' ' PHE . 1.3 pt-20 -59.25 -33.35 70.93 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.32 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.7 mp -68.62 -8.84 45.67 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.532 HD21 HD11 ' A' ' 55' ' ' LEU . 68.0 mt -84.11 13.58 5.0 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -147.99 -64.42 0.26 Allowed 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -172.34 37.85 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.18 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.2 mptt 51.38 35.31 13.68 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.989 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -69.24 159.24 33.42 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.129 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 37.6 p -101.49 -71.88 0.7 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.966 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.502 ' O ' HD12 ' A' ' 25' ' ' LEU . 80.3 p -141.33 162.85 34.49 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.601 0.239 . . . . 0.0 111.254 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.502 HD12 ' O ' ' A' ' 24' ' ' SER . 0.7 OUTLIER -150.64 158.65 44.4 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.24 -179.915 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.48 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 52.9 mt-30 -133.16 144.84 50.15 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.95 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.4 mt -130.8 142.03 50.37 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.972 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -77.87 110.26 12.61 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.745 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.15 125.64 27.44 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.808 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.479 HG23 ' H ' ' A' ' 31' ' ' VAL . 3.7 m -125.75 -56.53 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 111.368 0.136 . . . . 0.0 111.368 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.479 ' H ' HG23 ' A' ' 30' ' ' VAL . 16.4 m -151.15 62.62 5.17 Favored Pre-proline 0 N--CA 1.467 0.389 0 CA-C-O 120.817 0.341 . . . . 0.0 111.184 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.459 ' HD3' ' N ' ' A' ' 31' ' ' VAL . 5.4 Cg_exo -74.18 -0.53 9.71 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.985 2.456 . . . . 0.0 113.219 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 93.5 m -55.51 -35.54 65.73 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.62 0.248 . . . . 0.0 111.017 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -93.6 29.49 8.39 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.891 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 25.5 m -147.7 150.55 34.53 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.749 0.309 . . . . 0.0 110.83 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.6 p30 -141.5 -171.82 3.39 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.043 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.762 ' HA ' HD12 ' A' ' 40' ' ' LEU . 7.1 tt -54.29 -42.71 70.37 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.476 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -55.68 -38.38 69.55 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.98 -32.32 60.9 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.074 178.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.799 HD11 ' CD1' ' A' ' 87' ' ' LEU . 24.2 mt -66.66 -54.57 21.83 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.86 0.33 . . . . 0.0 110.487 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.631 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.6 OUTLIER -59.84 -58.49 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.894 179.895 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.459 ' H ' HG23 ' A' ' 41' ' ' VAL . 32.0 tt0 -50.26 -30.01 10.84 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.525 179.48 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.3 tt -71.43 -31.03 66.76 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.633 HD12 ' N ' ' A' ' 45' ' ' LYS . 4.6 pp -97.01 -40.75 8.71 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.633 ' N ' HD12 ' A' ' 44' ' ' LEU . 0.7 OUTLIER -87.31 -70.79 0.6 Allowed 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.477 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.7 m -55.35 -24.62 30.3 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -96.31 -31.54 12.84 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -152.66 57.9 0.81 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 49' ' ' VAL . 7.1 p -91.24 113.67 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 120.868 0.366 . . . . 0.0 110.617 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -94.8 48.74 1.21 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.769 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -177.79 -175.11 0.49 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.284 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.682 ' HB2' HD23 ' A' ' 55' ' ' LEU . 2.5 mmt-85 -62.11 110.95 3.76 Favored Pre-proline 0 N--CA 1.463 0.188 0 CA-C-O 120.502 0.191 . . . . 0.0 110.991 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 52' ' ' ARG . 18.2 Cg_endo -60.49 -24.95 79.47 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.278 1.986 . . . . 0.0 112.512 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.96 7.96 39.75 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.75 ' HG ' HD23 ' A' ' 56' ' ' LEU . 1.8 pp -89.62 -21.31 22.87 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.462 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.75 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -100.58 -48.62 4.47 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.536 HG11 ' HA2' ' A' ' 61' ' ' GLY . 2.6 m -54.89 151.25 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.063 0.459 . . . . 0.0 111.681 -179.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -69.47 -57.45 5.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.189 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -171.15 -44.6 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.418 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.9 t -82.23 7.78 12.83 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.641 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.536 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 59.34 24.49 59.15 Favored Glycine 0 C--N 1.342 0.885 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.702 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -115.79 -47.36 2.8 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.815 0.34 . . . . 0.0 110.371 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.532 HG22 ' CG ' ' A' ' 83' ' ' MET . 45.4 p -105.5 163.93 12.27 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.907 179.164 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.628 HD22 ' HB2' ' A' ' 56' ' ' LEU . 6.3 mt -99.06 152.82 19.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.855 0.359 . . . . 0.0 111.073 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.91 147.67 52.97 Favored Pre-proline 0 N--CA 1.467 0.379 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.352 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -49.88 -32.51 30.29 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.344 2.696 . . . . 0.0 113.326 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -45.16 -38.85 6.54 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 121.357 -0.449 . . . . 0.0 113.035 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.566 HG21 ' HB3' ' A' ' 95' ' ' PHE . 4.0 mt -100.15 135.2 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.951 0.375 . . . . 0.0 111.05 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.7 tp -100.07 101.98 13.19 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.661 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.682 HG23 ' HB3' ' A' ' 77' ' ' ALA . 26.9 m -83.37 126.12 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.185 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 mt -125.59 161.98 26.0 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.273 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.586 HG11 ' CD2' ' A' ' 85' ' ' TYR . 2.7 m -141.17 111.58 3.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.913 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 56.37 53.22 8.99 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.957 0.408 . . . . 0.0 110.888 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.9 m 58.33 30.3 19.36 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.502 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 49.8 t -144.19 130.72 19.98 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.223 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -45.6 128.43 8.34 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.689 0.28 . . . . 0.0 111.137 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.682 ' HB3' HG23 ' A' ' 70' ' ' VAL . . . -62.39 -21.6 65.49 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.768 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -72.52 -24.12 61.1 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.735 -0.212 . . . . 0.0 110.895 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.4 t -71.33 -47.18 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.131 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.525 HG21 ' CG ' ' A' ' 85' ' ' TYR . 29.8 m -69.36 -42.45 81.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.868 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 165.39 40.16 0.02 OUTLIER Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.517 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 54.3 -104.75 0.26 Allowed Glycine 0 C--N 1.336 0.582 0 C-N-CA 121.236 -0.506 . . . . 0.0 112.919 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.729 ' HA ' HD22 ' A' ' 37' ' ' LEU . 53.8 mmm -108.89 27.06 9.86 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.682 0.277 . . . . 0.0 111.074 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -122.03 21.19 10.62 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.586 ' CD2' HG11 ' A' ' 72' ' ' VAL . 19.4 t80 -73.46 118.92 16.99 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.65 0.262 . . . . 0.0 111.305 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 19.7 m -78.73 159.45 4.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.525 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.799 ' CD1' HD11 ' A' ' 40' ' ' LEU . 1.7 mp -110.29 175.77 5.3 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.863 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -168.86 -62.18 0.02 OUTLIER 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.04 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -178.91 108.15 0.04 OUTLIER 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.425 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 105.51 24.17 7.21 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.978 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -79.22 143.88 34.92 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 117.02 0.41 . . . . 0.0 110.611 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 53.5 m -134.22 103.07 5.6 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.003 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.7 p -107.84 134.65 48.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.803 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.429 ' HG2' ' HG2' ' A' ' 10' ' ' GLN . 15.3 mt-10 -136.42 150.47 48.77 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.468 -179.452 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.566 ' HB3' HG21 ' A' ' 68' ' ' ILE . 88.6 m-85 -124.56 104.48 8.74 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.148 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.474 HG12 ' HB3' ' A' ' 12' ' ' ALA . 24.3 mt -111.87 107.02 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.145 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.52 137.42 34.61 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.953 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.8 p -129.43 -54.43 1.17 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.941 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.98 125.01 28.72 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.858 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -137.44 89.91 2.46 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.853 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -154.62 -67.85 0.01 OUTLIER Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.62 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.824 -0.987 . . . . 0.0 112.895 179.96 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 120.893 0.378 . . . . 0.0 111.281 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.0 t -92.17 156.85 17.05 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.673 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 60.21 38.52 20.02 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.967 0.413 . . . . 0.0 110.832 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.423 ' O ' ' HB2' ' A' ' 5' ' ' ASN . 35.2 t60 -114.26 158.72 21.02 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.607 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 4' ' ' HIS . 5.7 m120 69.21 162.66 0.22 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.277 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.68 ' C ' HD12 ' A' ' 7' ' ' ILE . 1.3 m-70 63.83 -175.57 0.16 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.89 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.68 HD12 ' C ' ' A' ' 6' ' ' HIS . 3.2 mp -129.87 145.86 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 120.741 0.305 . . . . 0.0 111.179 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.725 HG22 ' OE1' ' A' ' 10' ' ' GLN . 24.3 m -96.92 95.93 8.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.959 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.82 HG21 HD22 ' A' ' 44' ' ' LEU . 11.8 p -110.95 105.19 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 121.005 0.431 . . . . 0.0 110.833 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.725 ' OE1' HG22 ' A' ' 8' ' ' THR . 0.0 OUTLIER -130.51 175.29 9.1 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.725 -179.068 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.502 ' CG ' ' HA ' ' A' ' 16' ' ' GLU . 95.5 m-85 -118.63 161.64 19.73 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.107 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -172.8 157.93 3.82 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.369 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 66.16 45.03 89.73 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.615 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.11 33.2 82.61 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.902 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.7 -17.93 13.58 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.783 0.292 . . . . 0.0 111.613 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.502 ' HA ' ' CG ' ' A' ' 11' ' ' PHE . 2.0 pm0 -59.27 -24.94 63.66 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.7 mp -65.92 -7.7 18.18 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.665 ' CD2' HD11 ' A' ' 55' ' ' LEU . 58.0 mt -72.69 1.27 8.7 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.458 ' CD2' ' HB2' ' A' ' 50' ' ' LYS . 38.8 t80 -144.24 -65.97 0.35 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -172.19 40.0 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.354 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 52.58 46.83 25.97 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.77 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -75.04 -179.66 4.45 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.917 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.457 ' O ' ' HB2' ' A' ' 10' ' ' GLN . 39.9 p -113.74 -47.11 2.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.256 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.5 p -171.21 155.08 4.21 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.673 0.273 . . . . 0.0 110.978 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.645 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.8 OUTLIER -141.71 166.58 24.34 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.546 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.56 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 0.8 OUTLIER -132.29 126.47 33.45 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.93 179.791 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.9 mt -103.27 141.73 35.41 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.846 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -110.16 119.75 40.28 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.534 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -106.9 151.76 16.89 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.095 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.482 HG23 HG22 ' A' ' 31' ' ' VAL . 8.3 m -107.46 -32.23 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.482 HG22 HG23 ' A' ' 30' ' ' VAL . 14.3 m -143.19 69.35 17.96 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-O 120.992 0.425 . . . . 0.0 111.2 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -75.34 -7.45 18.86 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.745 2.297 . . . . 0.0 113.454 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 74.0 m -51.43 -58.15 7.04 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.592 0.234 . . . . 0.0 111.374 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -98.48 36.39 4.03 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.519 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.5 m -123.22 119.56 30.55 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.694 0.283 . . . . 0.0 110.815 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -95.94 -176.05 3.59 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.139 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.733 ' O ' HG22 ' A' ' 41' ' ' VAL . 1.6 tt -55.4 -40.26 71.22 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.583 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -51.85 -44.55 63.67 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.63 -32.78 67.24 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.996 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.961 HD12 HD21 ' A' ' 87' ' ' LEU . 6.3 tt -67.17 -59.2 3.64 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.562 0.22 . . . . 0.0 110.961 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.733 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.6 OUTLIER -59.76 -57.77 10.14 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.143 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.288 -179.841 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.435 ' H ' HG23 ' A' ' 41' ' ' VAL . 6.4 tt0 -48.73 -33.37 10.08 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.363 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.5 tt -71.81 -29.1 64.08 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.728 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.82 HD22 HG21 ' A' ' 9' ' ' VAL . 3.8 pp -95.83 -32.43 12.68 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.754 ' N ' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -87.64 -71.07 0.59 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.477 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.9 m -51.53 -26.79 9.15 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -96.73 -36.88 10.52 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -140.62 57.26 1.58 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.5 HG13 ' H ' ' A' ' 51' ' ' GLU . 7.5 p -95.79 -34.86 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.458 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 0.2 OUTLIER 66.25 8.46 5.61 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 111.574 0.213 . . . . 0.0 111.574 -179.307 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.5 ' H ' HG13 ' A' ' 49' ' ' VAL . 1.7 tp10 -144.89 -166.18 2.34 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.507 ' CB ' HD23 ' A' ' 55' ' ' LEU . 8.9 ttm180 -75.61 110.74 11.43 Favored Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 116.742 -0.208 . . . . 0.0 110.595 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.468 ' O ' HG22 ' A' ' 57' ' ' VAL . 18.9 Cg_endo -59.6 -21.64 63.35 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.315 2.01 . . . . 0.0 112.537 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.32 5.58 44.4 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.754 ' HG ' HD23 ' A' ' 56' ' ' LEU . 1.9 pp -95.26 -26.82 15.79 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 121.166 -0.214 . . . . 0.0 111.476 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.754 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -95.7 -44.74 7.31 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -179.923 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.512 HG11 ' HA2' ' A' ' 61' ' ' GLY . 5.4 m -54.25 150.49 1.78 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-O 121.119 0.485 . . . . 0.0 111.699 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -63.35 -59.33 4.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.358 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -171.78 -43.92 0.02 OUTLIER 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.371 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 71.3 p -83.63 7.62 16.83 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.805 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.512 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 57.14 25.75 54.65 Favored Glycine 0 C--N 1.341 0.813 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.47 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.4 tm0? -115.08 -37.28 4.16 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.652 0.263 . . . . 0.0 110.977 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.9 t -127.5 142.48 51.38 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.792 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.754 HD21 HD12 ' A' ' 56' ' ' LEU . 8.1 mt -65.88 155.8 35.32 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.877 0.37 . . . . 0.0 111.205 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.26 150.37 72.26 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.075 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -52.32 -32.86 53.24 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.091 2.527 . . . . 0.0 112.819 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 99' ' ' LEU . . . -49.88 -35.97 25.75 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.874 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.449 HG21 ' HB3' ' A' ' 95' ' ' PHE . 4.4 mt -99.93 135.66 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 120.752 0.31 . . . . 0.0 110.789 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.8 mp -105.26 104.91 14.74 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.874 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.905 HG23 ' HB3' ' A' ' 77' ' ' ALA . 11.5 m -77.25 133.85 29.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.014 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.6 mt -123.98 154.56 39.64 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.551 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.484 HG23 ' CA ' ' A' ' 77' ' ' ALA . 25.8 t -126.53 113.47 33.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.652 179.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.8 m120 57.9 42.62 22.74 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.965 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.9 m 57.08 50.58 11.74 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.417 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 42.8 t -141.32 -79.38 0.26 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.485 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 177.49 132.29 0.06 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.698 0.285 . . . . 0.0 110.896 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.905 ' HB3' HG23 ' A' ' 70' ' ' VAL . . . -88.51 -24.91 22.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.562 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -80.81 -38.71 27.93 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.578 0.228 . . . . 0.0 110.842 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 61.8 t -58.58 -37.5 65.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.906 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.9 m -80.83 -32.75 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.531 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.29 -56.49 0.04 OUTLIER Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.77 -0.729 . . . . 0.0 113.13 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 110.63 -57.85 0.41 Allowed Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.253 -0.499 . . . . 0.0 112.266 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -142.92 21.72 1.95 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 111.516 0.191 . . . . 0.0 111.516 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -135.6 20.46 3.33 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -75.1 114.52 13.69 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.927 0.394 . . . . 0.0 111.302 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.8 m -71.7 153.28 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.48 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.961 HD21 HD12 ' A' ' 40' ' ' LEU . 1.2 mp -104.21 164.28 11.83 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.551 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -161.02 30.33 0.14 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.413 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 58.97 103.93 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.001 0.429 . . . . 0.0 111.604 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 116.73 35.52 1.15 Allowed Glycine 0 C--N 1.332 0.357 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.326 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.15 177.52 4.81 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.863 0.363 . . . . 0.0 111.576 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.716 HG23 ' HB ' ' A' ' 8' ' ' THR . 74.2 m -140.3 132.66 28.37 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.821 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.625 HG11 HD21 ' A' ' 40' ' ' LEU . 7.1 p -142.46 137.06 28.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.174 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -134.2 158.47 43.6 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.993 0.425 . . . . 0.0 111.532 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.449 ' HB3' HG21 ' A' ' 68' ' ' ILE . 25.8 m-85 -126.55 104.89 8.37 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.298 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 26.5 mt -116.08 118.5 58.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.215 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.81 155.15 39.12 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.108 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.78 -41.54 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.563 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.414 ' HA ' ' HA2' ' A' ' 67' ' ' GLY . 0.4 OUTLIER 51.49 -174.25 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.056 0.543 . . . . 0.0 111.777 -179.735 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 25.4 m170 -95.04 72.83 3.42 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.137 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -85.75 -169.05 45.53 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.106 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.197 0 CA-C-O 118.578 -1.123 . . . . 0.0 112.655 -179.591 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ttp . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 120.629 0.252 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.9 m -81.82 87.53 6.36 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.912 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -134.48 145.36 48.75 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.852 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 26.1 m170 60.38 84.06 0.13 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.827 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.456 ' HB3' ' O ' ' A' ' 89' ' ' ASP . 49.6 m-80 -109.66 165.76 11.42 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.407 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -175.74 138.64 0.38 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.277 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.479 HG23 ' O ' ' A' ' 91' ' ' ASP . 29.6 mt -105.35 137.67 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.133 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.723 ' HB ' HG23 ' A' ' 92' ' ' THR . 0.5 OUTLIER -92.84 112.43 24.39 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.386 -179.607 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.509 HG13 ' HB2' ' A' ' 25' ' ' LEU . 7.6 p -134.23 108.8 11.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.653 179.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.673 ' OE1' HG22 ' A' ' 8' ' ' THR . 1.5 pm0 -140.04 162.53 35.0 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.499 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.462 ' HB2' ' HG2' ' A' ' 16' ' ' GLU . 31.3 m-85 -116.13 148.47 40.28 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.149 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -135.29 143.46 46.23 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.306 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.11 -108.54 2.65 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.138 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -117.16 25.7 8.64 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.564 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.8 m -97.64 -15.53 20.39 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.462 ' HG2' ' HB2' ' A' ' 11' ' ' PHE . 40.0 mt-10 -59.54 -32.97 70.82 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.667 0.27 . . . . 0.0 111.081 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.454 HD23 ' HG3' ' A' ' 21' ' ' LYS . 2.8 mt -72.54 -5.17 35.23 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.883 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.64 HD21 HD11 ' A' ' 55' ' ' LEU . 54.8 mt -83.1 14.42 3.42 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -153.76 -60.8 0.13 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.61 0.243 . . . . 0.0 110.656 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -177.4 37.49 0.0 OUTLIER 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.149 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.454 ' HG3' HD23 ' A' ' 17' ' ' LEU . 5.4 mptt 51.19 35.27 12.95 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.966 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -93.06 151.16 20.04 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.876 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.9 p -79.13 -64.29 1.22 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.926 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.8 p -143.22 163.93 31.58 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.792 0.329 . . . . 0.0 111.357 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.509 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.8 OUTLIER -148.54 166.58 27.79 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.11 -179.794 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -132.78 126.5 32.52 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.873 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.2 mt -114.75 141.14 48.26 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.877 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -117.51 124.0 47.66 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.612 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -118.54 133.88 10.57 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.591 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.6 t -70.15 -40.74 78.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 120.641 0.258 . . . . 0.0 111.025 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 18.0 t -134.12 67.64 73.45 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-O 120.945 0.402 . . . . 0.0 111.121 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.818 ' HB3' HD23 ' A' ' 87' ' ' LEU . 19.9 Cg_exo -66.27 -16.2 50.84 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.782 2.321 . . . . 0.0 112.92 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.19 -44.24 67.78 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.669 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.06 41.05 3.06 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.029 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 58.1 m -151.41 129.9 12.17 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 120.646 0.26 . . . . 0.0 110.809 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -113.23 -175.29 2.64 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.704 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.815 HD22 ' HA ' ' A' ' 83' ' ' MET . 4.5 tt -55.16 -35.1 64.4 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.404 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.63 -37.39 70.66 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.906 0.384 . . . . 0.0 110.135 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.97 -32.96 56.11 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.93 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.792 HD11 ' CD1' ' A' ' 87' ' ' LEU . 95.2 mt -65.86 -53.29 41.82 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.7 0.286 . . . . 0.0 110.58 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.3 OUTLIER -56.71 -57.53 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.993 179.884 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.431 ' H ' HG23 ' A' ' 41' ' ' VAL . 0.8 OUTLIER -55.54 -26.65 44.41 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.431 179.57 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.9 tp -82.08 -23.81 35.57 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.677 HD12 ' N ' ' A' ' 45' ' ' LYS . 4.7 pp -96.75 -38.17 10.0 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.677 ' N ' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -92.37 -59.6 2.05 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -179.627 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.5 m -61.33 -21.85 64.37 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.364 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.38 -34.15 10.77 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -155.58 55.01 0.62 Allowed 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.438 ' HB ' ' O ' ' A' ' 45' ' ' LYS . 7.6 p -70.72 -33.1 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 57.79 13.48 2.07 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -158.37 -170.37 3.08 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.636 ' HB2' HD23 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -67.08 112.56 10.19 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-O 120.562 0.22 . . . . 0.0 110.838 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.428 ' O ' HG22 ' A' ' 57' ' ' VAL . 18.2 Cg_endo -59.85 -24.7 76.97 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.272 1.982 . . . . 0.0 112.299 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.432 ' HA ' HG22 ' A' ' 57' ' ' VAL . 0.9 OUTLIER -90.36 6.58 42.53 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.807 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.708 ' HG ' HD23 ' A' ' 56' ' ' LEU . 1.6 pp -91.5 -29.34 17.05 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 121.236 -0.186 . . . . 0.0 111.316 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.708 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -97.47 -44.0 7.02 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.723 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.432 HG22 ' HA ' ' A' ' 54' ' ' ASP . 15.5 m -56.5 148.05 4.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.176 0.512 . . . . 0.0 111.696 -179.098 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.672 ' HB2' HG23 ' A' ' 63' ' ' THR . 12.5 t70 -63.18 -55.88 21.38 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.361 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -174.22 -44.65 0.01 OUTLIER 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.481 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.415 HG23 ' HB3' ' A' ' 62' ' ' GLN . 9.7 t -89.63 15.37 9.63 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.426 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 55.16 23.29 32.21 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.65 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.415 ' HB3' HG23 ' A' ' 60' ' ' THR . 1.0 OUTLIER -107.77 -32.77 7.49 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.893 0.377 . . . . 0.0 110.788 -179.714 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.672 HG23 ' HB2' ' A' ' 58' ' ' ASP . 6.0 t -132.66 179.48 6.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.092 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.6 mt -103.98 152.92 21.43 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.915 0.388 . . . . 0.0 111.451 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.06 154.18 82.84 Favored Pre-proline 0 N--CA 1.465 0.287 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.389 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -50.31 -32.95 35.13 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.199 2.599 . . . . 0.0 113.036 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -46.51 -37.58 8.71 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 121.392 -0.432 . . . . 0.0 112.993 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.478 HG21 ' HB3' ' A' ' 95' ' ' PHE . 3.8 mt -104.8 133.28 49.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.861 0.331 . . . . 0.0 111.054 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.0 mt -100.8 100.37 11.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.694 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.706 HG23 ' HB3' ' A' ' 77' ' ' ALA . 14.5 m -76.57 133.26 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.873 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.57 HD23 ' O ' ' A' ' 70' ' ' VAL . 2.7 mt -132.13 140.62 48.86 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.391 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.664 HG23 ' CB ' ' A' ' 77' ' ' ALA . 19.5 t -115.73 117.82 56.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.493 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 56.99 49.86 13.16 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.145 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 58.81 47.36 12.75 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.951 0.405 . . . . 0.0 111.275 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 52.0 t -161.37 147.03 14.01 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.628 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -46.01 119.56 2.32 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.781 0.324 . . . . 0.0 111.357 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.706 ' HB3' HG23 ' A' ' 70' ' ' VAL . . . -78.2 -17.87 56.2 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.136 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.11 -34.51 49.97 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.379 0.133 . . . . 0.0 111.162 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.2 t -70.11 -45.79 74.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.053 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.9 m -60.62 -35.51 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.691 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 179.0 -35.52 0.08 OUTLIER Glycine 0 CA--C 1.524 0.599 0 C-N-CA 120.785 -0.722 . . . . 0.0 113.251 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.68 -54.13 2.67 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.225 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.815 ' HA ' HD22 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -148.52 27.51 0.91 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 120.464 0.173 . . . . 0.0 111.343 179.641 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -129.09 15.49 6.24 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.476 ' CZ ' HG11 ' A' ' 72' ' ' VAL . 1.9 t80 -70.38 113.21 7.3 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.755 0.312 . . . . 0.0 110.943 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 26.9 m -69.4 148.21 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.473 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.818 HD23 ' HB3' ' A' ' 32' ' ' PRO . 1.0 OUTLIER -96.66 157.96 15.66 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.541 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -154.16 36.16 0.43 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.194 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.456 ' O ' ' HB3' ' A' ' 5' ' ' ASN . 2.4 t0 62.96 27.31 15.89 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.963 0.411 . . . . 0.0 111.691 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -168.77 41.08 0.22 Allowed Glycine 0 C--N 1.332 0.35 0 C-N-CA 121.198 -0.525 . . . . 0.0 112.235 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.479 ' O ' HG23 ' A' ' 7' ' ' ILE . 4.0 t70 -85.03 166.36 16.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.815 0.34 . . . . 0.0 111.013 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.723 HG23 ' HB ' ' A' ' 8' ' ' THR . 86.1 m -141.81 127.61 19.28 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.659 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.7 p -141.8 133.63 27.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.111 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -132.96 143.18 49.29 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.327 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.478 ' HB3' HG21 ' A' ' 68' ' ' ILE . 18.2 m-85 -113.19 104.74 12.65 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.275 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 11.0 mt -110.73 110.15 31.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.03 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 60.6 p -76.66 143.64 39.97 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.19 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.33 -50.26 0.74 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.13 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.46 77.07 1.93 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.918 0.39 . . . . 0.0 110.917 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -132.52 37.91 3.47 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.724 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -132.64 -57.81 0.08 OUTLIER Glycine 0 C--N 1.333 0.412 0 C-N-CA 121.17 -0.538 . . . . 0.0 112.097 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.416 -1.214 . . . . 0.0 112.405 179.515 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 120.704 0.288 . . . . 0.0 111.082 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 t -76.32 -47.84 22.12 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.4 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -170.17 95.55 0.26 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.625 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -67.23 157.28 34.19 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.419 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -70.3 135.48 48.95 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.89 0.376 . . . . 0.0 111.314 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 14.3 p-80 -175.17 115.02 0.15 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.172 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 33.6 mm -87.2 154.32 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.672 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.607 ' CG2' HG23 ' A' ' 92' ' ' THR . 48.8 m -121.14 94.12 4.24 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.653 0.263 . . . . 0.0 111.082 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.587 HG13 ' HB2' ' A' ' 25' ' ' LEU . 11.5 p -118.28 109.2 26.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-O 121.02 0.438 . . . . 0.0 111.426 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.47 ' OE1' HG22 ' A' ' 8' ' ' THR . 8.4 pm0 -134.0 162.24 32.6 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.569 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.433 ' CB ' ' HA ' ' A' ' 16' ' ' GLU . 98.1 m-85 -122.04 151.92 40.33 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.102 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -167.23 174.38 8.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.013 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 59.66 32.03 72.8 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.916 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.1 26.91 38.92 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.224 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.6 t -108.07 -22.98 12.18 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 117.129 0.464 . . . . 0.0 111.528 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.433 ' HA ' ' CB ' ' A' ' 11' ' ' PHE . 1.9 pt-20 -57.72 -27.51 63.03 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.512 0.196 . . . . 0.0 111.339 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.1 mp -64.98 -10.66 31.12 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.556 HD22 ' CD1' ' A' ' 55' ' ' LEU . 71.8 mt -83.55 13.57 4.46 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -148.18 -70.83 0.22 Allowed 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -170.98 38.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.969 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.65 34.16 15.31 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.146 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -77.47 178.43 7.21 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.047 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 37.0 p -107.12 -76.89 0.6 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.895 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.6 p -136.77 164.31 28.57 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.688 0.28 . . . . 0.0 111.372 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.587 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -148.53 151.02 34.4 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.267 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.484 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 31.7 mt-30 -132.64 109.57 9.82 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.87 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.3 mt -97.97 141.72 30.59 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.687 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -85.72 121.07 27.86 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.699 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -91.02 157.7 25.27 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.008 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.552 HG23 HG22 ' A' ' 31' ' ' VAL . 15.5 m -123.6 -45.77 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.552 HG22 HG23 ' A' ' 30' ' ' VAL . 15.9 m -136.39 67.72 60.6 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-O 121.012 0.434 . . . . 0.0 111.457 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.48 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . 6.1 Cg_exo -77.62 0.13 10.1 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.169 2.579 . . . . 0.0 113.231 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.8 m -56.53 -58.73 6.77 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.694 0.283 . . . . 0.0 111.342 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -93.51 43.37 2.5 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.658 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.5 m -135.26 114.64 12.47 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.719 0.295 . . . . 0.0 110.646 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -100.15 -170.19 1.84 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.6 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.666 ' O ' HG22 ' A' ' 41' ' ' VAL . 2.5 tt -55.04 -42.94 73.29 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 111.484 0.179 . . . . 0.0 111.484 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -56.78 -38.14 72.07 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.98 -34.44 47.48 Favored Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.977 178.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.996 HD13 HD21 ' A' ' 87' ' ' LEU . 23.9 tp -62.32 -52.03 65.3 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.622 0.248 . . . . 0.0 110.634 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.666 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.3 OUTLIER -59.11 -57.63 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.929 179.541 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.418 ' H ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -51.07 -32.42 21.99 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.732 -0.213 . . . . 0.0 111.259 179.576 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.466 ' O ' HD23 ' A' ' 43' ' ' LEU . 8.5 tt -70.38 -27.84 64.63 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.484 HD12 ' C ' ' A' ' 44' ' ' LEU . 1.5 pp -97.02 -41.2 8.49 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.1 pttt -82.21 -65.19 1.04 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 m -56.67 -23.74 43.84 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -94.07 -41.13 9.7 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 111.515 0.191 . . . . 0.0 111.515 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.21 59.74 0.97 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.885 0.374 . . . . 0.0 111.902 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.1 p -78.87 -35.67 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.605 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 64.59 10.76 6.15 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.423 -179.218 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -154.05 -173.05 4.43 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.681 ' HB2' HD23 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -68.04 135.61 91.77 Favored Pre-proline 0 N--CA 1.464 0.275 0 CA-C-O 120.518 0.199 . . . . 0.0 110.809 179.707 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.494 ' O ' HG22 ' A' ' 57' ' ' VAL . 73.7 Cg_endo -77.39 -23.02 10.43 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.334 2.022 . . . . 0.0 112.834 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.416 ' HA ' HG22 ' A' ' 57' ' ' VAL . 65.0 m-20 -90.69 6.92 42.02 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.681 HD23 ' HB2' ' A' ' 52' ' ' ARG . 3.7 pp -89.87 -17.71 27.55 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 120.987 -0.285 . . . . 0.0 111.312 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.526 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -111.12 -46.0 3.37 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 53' ' ' PRO . 13.1 m -56.72 148.36 4.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 121.188 0.518 . . . . 0.0 111.692 -179.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.685 ' HB2' HG23 ' A' ' 63' ' ' THR . 26.3 t70 -63.99 -53.9 42.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.496 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -177.15 -43.84 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.436 178.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.3 p -87.45 12.88 11.13 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.474 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 57.01 22.19 41.25 Favored Glycine 0 C--N 1.339 0.747 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.745 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -107.87 -35.54 6.62 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.861 0.363 . . . . 0.0 110.863 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.685 HG23 ' HB2' ' A' ' 58' ' ' ASP . 9.4 t -129.55 -178.77 4.82 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.006 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.6 mt -102.93 153.68 19.97 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.968 0.414 . . . . 0.0 111.391 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.408 ' HB3' ' HA ' ' A' ' 58' ' ' ASP . 0.8 OUTLIER -79.78 155.0 75.85 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.135 179.854 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.24 135.21 59.39 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.867 2.378 . . . . 0.0 112.545 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.18 -48.35 0.91 Allowed Glycine 0 C--N 1.332 0.344 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.413 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.2 mt -93.39 143.08 12.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 120.83 0.348 . . . . 0.0 111.21 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.478 HD23 HD21 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -105.1 101.68 11.22 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 179.659 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.498 HG23 ' HB3' ' A' ' 77' ' ' ALA . 10.8 m -76.84 136.8 23.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.785 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.478 HD21 HD23 ' A' ' 69' ' ' LEU . 23.1 mt -131.4 146.8 52.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.317 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.571 HG21 HG21 ' A' ' 80' ' ' VAL . 67.7 t -128.22 133.9 66.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.325 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.2 m120 58.72 26.06 14.16 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.003 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 54.93 31.88 16.82 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.373 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.407 ' SG ' ' N ' ' A' ' 76' ' ' ASP . 16.4 p -130.04 -48.57 1.11 Allowed 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.356 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.76 ' HB3' HG23 ' A' ' 79' ' ' VAL . 0.2 OUTLIER 172.28 140.6 0.03 OUTLIER 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.491 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.498 ' HB3' HG23 ' A' ' 70' ' ' VAL . . . -86.32 -22.58 26.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.65 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -79.19 -32.97 44.28 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.437 0.161 . . . . 0.0 110.609 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.76 HG23 ' HB3' ' A' ' 76' ' ' ASP . 52.7 t -60.62 -46.65 95.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.957 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.571 HG21 HG21 ' A' ' 72' ' ' VAL . 18.8 m -65.31 -23.44 33.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 147.43 -23.94 1.53 Allowed Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.766 -0.73 . . . . 0.0 113.344 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 104.04 -57.92 0.52 Allowed Glycine 0 C--N 1.338 0.692 0 C-N-CA 121.126 -0.559 . . . . 0.0 111.705 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.6 ' HA ' HD22 ' A' ' 37' ' ' LEU . 5.6 ptt? -152.89 26.99 0.54 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.497 0.189 . . . . 0.0 110.98 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -135.05 21.72 3.49 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.409 ' CD2' HG11 ' A' ' 72' ' ' VAL . 19.7 t80 -80.44 112.87 18.19 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.846 0.355 . . . . 0.0 110.849 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.1 m -62.72 143.64 15.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.393 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.996 HD21 HD13 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -82.1 142.34 32.36 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.415 -179.783 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -130.18 43.02 3.19 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.32 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.73 27.3 8.58 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.808 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -173.44 41.2 0.15 Allowed Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.304 -0.474 . . . . 0.0 112.091 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.425 ' HB2' ' HG ' ' A' ' 87' ' ' LEU . 24.8 t0 -83.12 114.09 21.08 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.719 0.295 . . . . 0.0 111.222 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.607 HG23 ' CG2' ' A' ' 8' ' ' THR . 28.4 m -85.01 128.62 34.71 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.56 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.0 p -140.19 133.54 34.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.126 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -129.35 161.31 30.59 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.021 0.439 . . . . 0.0 111.592 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -134.2 104.74 6.32 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.165 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 29.0 mt -114.77 112.91 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.132 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.3 140.38 38.82 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.91 0.386 . . . . 0.0 111.369 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 39.9 p -123.25 -54.07 1.8 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.217 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.43 77.86 2.38 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.054 0.454 . . . . 0.0 110.21 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 47.0 p-80 -133.01 162.79 30.76 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.053 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.08 -106.45 1.72 Allowed Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.271 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.147 0 CA-C-O 118.602 -1.11 . . . . 0.0 112.769 179.536 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 120.716 0.293 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.5 p -101.32 -35.58 9.19 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.13 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -117.54 152.8 34.35 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.057 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -100.99 100.6 11.24 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.899 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 -164.38 179.06 7.01 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.879 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 71.52 124.73 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.132 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.487 HG21 HD11 ' A' ' 40' ' ' LEU . 12.4 mm -88.35 111.54 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.714 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.563 HG22 ' NE2' ' A' ' 10' ' ' GLN . 41.8 m -81.78 102.61 10.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.343 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.566 HG13 ' HB2' ' A' ' 25' ' ' LEU . 7.9 p -119.93 104.92 16.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.467 179.385 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.563 ' NE2' HG22 ' A' ' 8' ' ' THR . 0.7 OUTLIER -127.28 161.8 27.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.692 -179.047 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -116.07 159.24 21.97 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.948 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.705 ' HB3' ' HA ' ' A' ' 96' ' ' ILE . . . -105.86 176.23 5.23 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.228 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.96 97.38 0.05 OUTLIER Glycine 0 C--N 1.336 0.583 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.53 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.67 -29.31 4.49 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.943 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.7 -27.96 15.02 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.852 0.326 . . . . 0.0 111.558 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.94 -27.87 65.71 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.585 0.231 . . . . 0.0 111.254 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 mp -67.7 -10.16 49.97 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.555 HD22 HD11 ' A' ' 55' ' ' LEU . 56.1 mt -81.13 13.3 2.87 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -149.58 -63.73 0.22 Allowed 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -174.37 37.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.114 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.49 34.81 12.94 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.003 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -72.34 -177.36 2.14 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.046 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 49.9 p -115.7 -78.17 0.58 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.919 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.432 ' CB ' ' HB3' ' A' ' 10' ' ' GLN . 83.7 p -136.12 160.24 39.25 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.933 0.397 . . . . 0.0 111.254 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.566 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -138.03 152.06 48.48 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.15 179.804 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -133.18 100.61 4.91 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.523 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.1 mt -97.84 139.31 33.89 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.93 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -110.43 96.75 6.4 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.796 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.62 155.89 31.14 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.366 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.9 t -66.89 -63.42 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 CA-C-O 120.636 0.255 . . . . 0.0 110.999 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.503 ' O ' HG13 ' A' ' 31' ' ' VAL . 9.0 p -145.05 68.0 13.7 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-O 121.431 0.634 . . . . 0.0 110.845 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -79.52 7.3 4.57 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.368 2.712 . . . . 0.0 113.011 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -54.0 -38.15 64.77 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.64 0.257 . . . . 0.0 111.181 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.27 47.64 3.51 Favored Glycine 0 C--N 1.338 0.687 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.671 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 63.8 m -145.3 145.41 31.23 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.718 0.294 . . . . 0.0 110.749 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 53.2 p-10 -108.61 -173.28 2.24 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.891 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.786 ' O ' HG22 ' A' ' 41' ' ' VAL . 4.2 tt -57.66 -39.28 76.69 Favored 'General case' 0 N--CA 1.46 0.071 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.032 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -54.92 -38.19 67.35 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.308 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.05 -32.22 45.12 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.103 179.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.487 HD11 HG21 ' A' ' 7' ' ' ILE . 61.7 tp -68.16 -53.08 27.68 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.652 0.226 . . . . 0.0 110.855 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.786 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.5 OUTLIER -57.83 -57.4 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.854 179.788 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.456 ' H ' HG23 ' A' ' 41' ' ' VAL . 1.8 tm0? -50.65 -32.09 18.11 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.402 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.4 tp -71.52 -27.56 63.28 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.898 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.503 HD12 ' C ' ' A' ' 44' ' ' LEU . 1.3 pp -96.92 -40.58 8.83 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.408 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 0.4 OUTLIER -84.0 -71.69 0.5 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.4 -179.578 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 22.5 m -53.04 -22.14 5.51 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.05 -31.35 10.68 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -142.25 51.6 1.48 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -178.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.551 HG22 ' H ' ' A' ' 51' ' ' GLU . 12.2 p -100.6 120.07 49.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.873 0.368 . . . . 0.0 110.716 179.199 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -101.24 31.91 3.48 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.02 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.551 ' H ' HG22 ' A' ' 49' ' ' VAL . 1.9 tp10 -155.86 -174.78 5.1 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.252 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.593 ' HB2' HD23 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -62.29 110.21 3.08 Favored Pre-proline 0 CA--C 1.53 0.176 0 CA-C-N 116.803 -0.181 . . . . 0.0 111.045 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.444 ' O ' HG22 ' A' ' 57' ' ' VAL . 17.7 Cg_endo -60.33 -27.31 84.62 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.405 2.07 . . . . 0.0 112.286 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.441 ' HA ' ' CG2' ' A' ' 57' ' ' VAL . 5.8 t70 -91.38 8.04 38.11 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.994 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.687 ' HG ' HD23 ' A' ' 56' ' ' LEU . 1.2 pp -88.58 -26.7 21.82 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 122.306 -0.246 . . . . 0.0 111.472 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.687 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -100.5 -46.82 5.1 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.483 HG11 ' HA2' ' A' ' 61' ' ' GLY . 9.0 m -55.59 149.63 2.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 121.164 0.507 . . . . 0.0 111.7 -179.161 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -63.43 -52.94 59.4 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.736 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.43 -45.5 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.518 179.199 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.1 p -90.27 16.45 8.62 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.483 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 56.07 21.63 32.39 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.825 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -105.88 -35.35 7.35 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.839 0.352 . . . . 0.0 110.573 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.748 HG22 ' HG3' ' A' ' 83' ' ' MET . 71.9 p -128.16 -177.07 4.0 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.983 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.4 mt -110.64 154.52 23.69 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.934 0.397 . . . . 0.0 110.997 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -71.67 152.82 93.55 Favored Pre-proline 0 C--O 1.234 0.256 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.068 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -55.77 124.48 16.38 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.764 2.31 . . . . 0.0 112.357 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 147.82 -45.02 0.76 Allowed Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.51 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.537 HG21 ' HB3' ' A' ' 95' ' ' PHE . 5.0 mt -91.52 120.11 39.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 120.7 0.286 . . . . 0.0 111.155 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.23 100.09 12.95 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.403 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.78 HG23 ' HB3' ' A' ' 77' ' ' ALA . 29.5 m -77.75 126.35 38.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.276 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.431 HD23 ' O ' ' A' ' 70' ' ' VAL . 4.9 mt -125.4 129.67 50.35 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.874 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 92' ' ' THR . 3.6 m -112.82 114.73 47.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.016 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 11.6 m120 54.86 52.22 12.36 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.071 0.462 . . . . 0.0 110.727 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.7 m 59.23 30.1 19.78 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.58 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 46.4 t -145.38 125.31 13.54 Favored 'General case' 0 C--O 1.23 0.048 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.375 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.701 ' HB2' HG23 ' A' ' 79' ' ' VAL . 61.7 m-20 -44.16 127.37 5.51 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.765 0.317 . . . . 0.0 111.254 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.78 ' HB3' HG23 ' A' ' 70' ' ' VAL . . . -63.3 -19.48 64.63 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.883 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -73.28 -26.63 61.16 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 120.577 0.227 . . . . 0.0 110.673 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.701 HG23 ' HB2' ' A' ' 76' ' ' ASP . 30.7 t -70.82 -44.38 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.084 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.4 m -70.39 -39.74 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.507 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.39 42.66 0.02 OUTLIER Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.804 -0.712 . . . . 0.0 113.426 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 53.07 -107.84 0.63 Allowed Glycine 0 C--N 1.334 0.455 0 C-N-CA 121.184 -0.532 . . . . 0.0 113.009 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.748 ' HG3' HG22 ' A' ' 63' ' ' THR . 60.5 mmm -108.58 27.69 9.14 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.804 0.335 . . . . 0.0 111.073 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -120.29 19.22 12.17 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.828 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -68.83 117.73 10.89 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.827 0.346 . . . . 0.0 111.339 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 15.6 m -70.57 146.53 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.713 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.9 mp -94.88 161.39 14.18 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.18 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 32.8 m-20 -153.54 35.77 0.46 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.616 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 59.93 96.39 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.045 0.45 . . . . 0.0 111.21 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 112.07 36.17 1.7 Allowed Glycine 0 CA--C 1.518 0.237 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.357 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -87.3 170.33 11.52 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.784 0.326 . . . . 0.0 110.902 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.442 HG23 HE22 ' A' ' 10' ' ' GLN . 92.6 m -137.91 134.98 35.66 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.8 p -141.41 134.28 29.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.027 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -131.38 149.14 52.66 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.384 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.537 ' HB3' HG21 ' A' ' 68' ' ' ILE . 23.0 m-85 -121.84 104.71 9.75 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.45 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.705 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 17.9 mt -111.89 103.84 16.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.239 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 84.0 p -82.56 132.05 35.2 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.89 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.34 -55.53 0.44 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.372 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -73.53 110.55 7.91 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.719 0.295 . . . . 0.0 110.839 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -88.93 122.71 32.57 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.937 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -119.64 144.89 17.75 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.515 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.093 0 CA-C-O 118.27 -1.294 . . . . 0.0 112.798 179.804 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 120.695 0.283 . . . . 0.0 111.254 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.7 p -69.02 129.4 39.82 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.936 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -108.37 116.82 32.68 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.139 -179.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 64.7 99.26 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.314 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -60.91 133.66 56.31 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.384 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -172.63 158.47 4.12 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.542 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.489 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 17.3 mm -123.66 153.73 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.86 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.41 ' HB ' ' HA ' ' A' ' 92' ' ' THR . 49.5 m -113.12 99.23 7.68 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.914 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.592 HG13 ' HB2' ' A' ' 25' ' ' LEU . 14.7 p -121.86 115.02 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.573 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.428 ' HG2' ' HG2' ' A' ' 94' ' ' GLU . 3.8 pm0 -128.99 159.14 36.85 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.963 0.411 . . . . 0.0 111.26 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.494 ' HB3' ' N ' ' A' ' 16' ' ' GLU . 12.1 m-85 -115.73 135.12 54.34 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.25 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -142.47 144.61 33.1 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.101 0.476 . . . . 0.0 111.977 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 86.42 -91.48 1.73 Allowed Glycine 0 C--N 1.332 0.355 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.905 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -133.88 28.91 3.16 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.992 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -109.94 -31.06 7.53 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.682 0.241 . . . . 0.0 111.133 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.494 ' N ' ' HB3' ' A' ' 11' ' ' PHE . 0.7 OUTLIER -61.76 -37.08 82.96 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.26 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.461 ' N ' ' HG2' ' A' ' 16' ' ' GLU . 4.5 mt -67.93 -14.4 62.94 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.809 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.728 HD13 HD22 ' A' ' 56' ' ' LEU . 9.0 mt -83.54 13.52 4.48 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.403 ' HA ' ' HB2' ' A' ' 50' ' ' LYS . 10.5 t80 -144.28 -64.51 0.36 Allowed 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -174.64 38.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.087 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 49.57 38.79 15.62 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.058 0.456 . . . . 0.0 110.782 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -73.9 175.37 7.39 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.056 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 33.1 p -114.94 -52.25 2.7 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.013 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 94.3 p -155.39 148.83 25.02 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.669 0.271 . . . . 0.0 110.955 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.592 ' HB2' HG13 ' A' ' 9' ' ' VAL . 5.0 mt -135.72 158.01 45.44 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.931 0.396 . . . . 0.0 111.345 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.489 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 11.8 mt-30 -130.1 106.99 8.99 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.8 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.1 mt -87.68 138.41 31.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.942 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -127.92 125.12 38.98 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.787 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.99 42.44 24.8 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.929 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.8 m -127.02 -43.09 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.974 HG12 HG21 ' A' ' 35' ' ' THR . 30.6 m -129.5 71.12 82.11 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-O 120.871 0.367 . . . . 0.0 111.083 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.09 -64.81 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.686 2.257 . . . . 0.0 112.458 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.3 m -151.09 -53.68 0.14 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.442 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.38 56.83 4.43 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.904 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.974 HG21 HG12 ' A' ' 31' ' ' VAL . 87.9 m -148.44 114.95 5.94 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.745 0.307 . . . . 0.0 110.731 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.7 p30 -84.43 174.05 10.38 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.975 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.904 HD22 ' HA ' ' A' ' 83' ' ' MET . 4.9 tt -57.84 -39.85 78.66 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.246 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -53.64 -41.24 66.56 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.933 0.397 . . . . 0.0 109.986 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.08 -31.86 63.74 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.135 178.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.3 tp -70.13 -57.13 5.29 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.525 0.202 . . . . 0.0 110.964 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.73 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.4 OUTLIER -57.54 -57.51 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.203 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.429 ' H ' HG23 ' A' ' 41' ' ' VAL . 0.7 OUTLIER -49.67 -32.49 13.33 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.504 179.773 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.1 tp -75.63 -24.15 56.41 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.409 ' C ' HD12 ' A' ' 44' ' ' LEU . 1.0 OUTLIER -96.35 -37.54 10.44 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.878 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.489 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 2.9 pttt -83.95 -71.26 0.52 Allowed 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 121.162 -0.215 . . . . 0.0 111.322 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.9 m -52.25 -24.72 7.77 Favored 'General case' 0 CA--C 1.537 0.442 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -102.08 -27.2 13.06 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -142.42 50.38 1.49 Allowed 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.623 HG22 ' H ' ' A' ' 51' ' ' GLU . 10.4 p -96.9 139.66 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 120.684 0.278 . . . . 0.0 111.25 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.403 ' HB2' ' HA ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -123.91 31.25 5.9 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.46 179.906 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.623 ' H ' HG22 ' A' ' 49' ' ' VAL . 0.7 OUTLIER -164.15 176.46 9.23 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.153 179.567 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.499 ' HB2' HD23 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -49.99 106.0 0.58 Allowed Pre-proline 0 N--CA 1.466 0.329 0 CA-C-O 120.508 0.194 . . . . 0.0 111.367 -179.814 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.07 -28.47 60.47 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.44 2.093 . . . . 0.0 112.676 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.403 ' HA ' ' CG2' ' A' ' 57' ' ' VAL . 0.3 OUTLIER -92.88 9.03 37.13 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.803 ' HG ' HD23 ' A' ' 56' ' ' LEU . 2.1 pp -83.62 -28.93 28.12 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 121.034 -0.267 . . . . 0.0 111.158 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.803 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -94.11 -54.46 3.57 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.765 -0.198 . . . . 0.0 111.335 179.927 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.553 HG11 ' HA2' ' A' ' 61' ' ' GLY . 1.4 m -54.55 151.22 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.201 0.524 . . . . 0.0 111.638 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -68.02 -62.91 1.19 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.739 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -165.22 -45.36 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.404 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.1 t -78.89 3.89 15.69 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.595 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.553 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 61.34 22.92 61.68 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.598 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.6 tm0? -121.46 -45.47 2.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.81 0.338 . . . . 0.0 110.407 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.563 ' HA ' ' HG3' ' A' ' 83' ' ' MET . 1.8 t -102.07 123.61 46.25 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.676 178.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.666 HD22 ' HB2' ' A' ' 56' ' ' LEU . 7.8 mt -67.79 156.7 36.44 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.727 0.298 . . . . 0.0 110.917 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 56' ' ' LEU . 7.6 ptm180 -57.32 143.26 74.14 Favored Pre-proline 0 C--O 1.234 0.259 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.125 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -50.6 -33.28 38.63 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.091 2.527 . . . . 0.0 112.829 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -50.85 -34.7 30.25 Favored Glycine 0 CA--C 1.523 0.54 0 CA-C-N 116.037 -0.529 . . . . 0.0 113.023 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.537 HD13 HD13 ' A' ' 64' ' ' LEU . 7.2 mt -88.77 120.41 37.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-O 120.76 0.314 . . . . 0.0 111.213 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.9 mt -96.94 97.02 8.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.018 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.9 t -79.46 136.69 23.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.12 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.09 155.73 44.99 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.476 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.564 HG23 ' CB ' ' A' ' 77' ' ' ALA . 39.9 t -124.48 115.04 43.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.8 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 67.03 -77.15 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.2 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.9 t -153.32 33.7 0.46 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.867 0.365 . . . . 0.0 110.942 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 44.4 t -158.46 156.02 29.58 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.682 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.448 ' HB2' HG23 ' A' ' 79' ' ' VAL . 51.4 m-20 -49.14 136.58 14.78 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.611 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.564 ' CB ' HG23 ' A' ' 72' ' ' VAL . . . -82.39 -23.13 35.11 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.845 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -71.59 -18.59 62.22 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.432 0.158 . . . . 0.0 111.087 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.448 HG23 ' HB2' ' A' ' 76' ' ' ASP . 32.6 t -72.53 -41.11 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.316 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.6 m -80.6 -29.14 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.735 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 176.61 -38.32 0.1 OUTLIER Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.035 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 99.06 -72.06 0.54 Allowed Glycine 0 C--N 1.334 0.435 0 C-N-CA 121.003 -0.618 . . . . 0.0 111.968 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.904 ' HA ' HD22 ' A' ' 37' ' ' LEU . 2.7 mmt -129.0 25.75 5.55 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.725 0.298 . . . . 0.0 111.182 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -136.67 23.99 3.13 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.56 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -82.63 120.17 25.21 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.6 0.238 . . . . 0.0 110.738 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.2 m -69.84 134.06 30.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.426 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.605 HD22 HG21 ' A' ' 31' ' ' VAL . 6.5 mp -98.2 123.57 42.34 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.867 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -108.1 35.19 3.23 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.334 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 63.1 104.83 0.03 OUTLIER 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.209 0.528 . . . . 0.0 111.488 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 113.2 29.34 3.03 Favored Glycine 0 CA--C 1.519 0.322 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.503 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -101.14 152.77 20.23 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.619 0.247 . . . . 0.0 110.837 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.41 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 94.9 m -115.18 111.8 21.54 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.962 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.8 p -120.67 125.69 74.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.748 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.428 ' HG2' ' HG2' ' A' ' 10' ' ' GLN . 16.0 mt-10 -126.37 153.68 44.6 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.364 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -120.69 104.53 9.99 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.067 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 25.2 mt -106.11 99.91 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.964 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.97 140.11 29.99 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.301 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.1 p -134.99 -48.84 0.74 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.405 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.31 138.33 36.72 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.773 0.321 . . . . 0.0 111.257 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -102.51 -37.36 8.02 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.986 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -165.89 -48.61 0.02 OUTLIER Glycine 0 C--N 1.335 0.479 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.486 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.386 -1.23 . . . . 0.0 112.424 179.879 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 ptm . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 120.787 0.327 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.1 m -141.39 83.22 1.86 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.922 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -147.02 105.49 3.8 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.021 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -157.59 31.81 0.27 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.305 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -86.19 132.16 34.07 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.781 0.324 . . . . 0.0 111.145 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.412 ' O ' HD13 ' A' ' 7' ' ' ILE . 2.3 p80 179.07 172.51 0.82 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.779 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 25.2 mm -129.62 152.2 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.611 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.431 ' HB ' HG23 ' A' ' 92' ' ' THR . 6.7 m -115.79 122.92 46.87 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.736 0.303 . . . . 0.0 111.474 -179.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.635 HG13 ' HB2' ' A' ' 25' ' ' LEU . 9.8 p -145.89 110.1 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.201 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.404 ' HB3' ' CB ' ' A' ' 24' ' ' SER . 5.2 pm0 -135.62 160.94 36.94 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.961 0.41 . . . . 0.0 111.643 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.454 ' HB2' ' HB3' ' A' ' 16' ' ' GLU . 89.1 m-85 -117.34 147.08 42.94 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.075 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.78 ' HB3' HG12 ' A' ' 96' ' ' ILE . . . -145.22 145.82 31.47 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.836 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.04 -95.3 2.06 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.457 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -139.51 30.91 2.37 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.722 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.2 m -108.04 -23.91 11.8 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.454 ' HB3' ' HB2' ' A' ' 11' ' ' PHE . 1.8 pm0 -59.84 -30.65 69.09 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.621 0.248 . . . . 0.0 111.228 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.8 mp -71.26 -7.97 50.53 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.706 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.53 HD13 HD22 ' A' ' 56' ' ' LEU . 42.1 mt -87.97 13.58 10.7 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.425 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 42.0 t80 -144.95 -63.63 0.35 Allowed 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -178.22 36.17 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.077 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.74 31.59 6.11 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.965 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -80.6 134.19 35.87 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.976 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -67.76 -66.25 0.59 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.822 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.404 ' CB ' ' HB3' ' A' ' 10' ' ' GLN . 87.3 p -144.24 161.31 39.22 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.723 0.297 . . . . 0.0 111.062 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.635 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -142.65 148.13 36.89 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.399 -179.881 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.512 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 4.7 mt-30 -132.16 117.95 18.94 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.883 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.4 mt -113.75 134.95 54.46 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.877 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -125.0 107.94 11.34 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.92 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -150.73 154.51 25.65 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.469 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.688 HG23 HG23 ' A' ' 31' ' ' VAL . 35.5 m -97.83 -44.63 12.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-O 120.63 0.252 . . . . 0.0 111.116 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.688 HG23 HG23 ' A' ' 30' ' ' VAL . 12.1 t -90.87 -46.82 0.37 Allowed Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.624 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 31' ' ' VAL . 51.7 Cg_exo -51.97 -43.56 51.39 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.757 2.305 . . . . 0.0 112.817 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.462 HG22 ' H ' ' A' ' 34' ' ' GLY . 0.2 OUTLIER -76.58 -179.96 5.59 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.885 -179.796 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.462 ' H ' HG22 ' A' ' 33' ' ' THR . . . 101.85 41.07 2.55 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.347 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.0 t -117.74 -158.14 0.7 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.255 0.222 . . . . 0.0 110.535 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -134.47 -174.24 3.51 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.869 -0.15 . . . . 0.0 110.745 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.813 HD22 ' HA ' ' A' ' 83' ' ' MET . 3.3 tt -60.01 -44.3 94.68 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 121.285 -0.166 . . . . 0.0 111.329 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -59.48 -34.33 72.43 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.54 -33.92 46.2 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.601 178.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.658 HD13 HG11 ' A' ' 93' ' ' VAL . 14.0 mt -60.55 -52.17 66.31 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.735 0.302 . . . . 0.0 110.603 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.549 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.2 OUTLIER -59.92 -56.66 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.975 179.846 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.43 -30.77 13.29 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.51 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.8 tp -73.11 -27.82 61.92 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.437 HD12 ' C ' ' A' ' 44' ' ' LEU . 1.8 pp -96.97 -42.55 7.86 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.4 pttt -84.26 -68.79 0.69 Allowed 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.5 m -50.69 -28.82 9.76 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.509 0.195 . . . . 0.0 111.47 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -81.19 -34.31 32.39 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.277 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -130.8 -68.32 0.69 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 111.449 0.166 . . . . 0.0 111.449 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 51' ' ' GLU . 11.5 p 44.72 72.31 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 121.56 0.695 . . . . 0.0 111.491 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -52.55 -50.23 63.33 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.205 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.606 ' O ' HG22 ' A' ' 49' ' ' VAL . 1.8 tp10 -91.44 -164.06 1.12 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.02 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.452 ' CB ' HD23 ' A' ' 55' ' ' LEU . 3.3 ttt-85 -66.2 134.39 94.77 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-O 120.675 0.274 . . . . 0.0 111.24 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.582 ' HB3' HG21 ' A' ' 49' ' ' VAL . 74.1 Cg_endo -77.24 -25.56 8.39 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.572 2.181 . . . . 0.0 112.529 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.44 ' HA ' HG22 ' A' ' 57' ' ' VAL . 2.9 t70 -89.84 8.46 31.9 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.565 ' HG ' HD23 ' A' ' 56' ' ' LEU . 2.6 pp -91.41 -26.32 18.92 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 121.287 -0.165 . . . . 0.0 111.323 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.59 ' HB2' HD22 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -98.24 -45.1 6.31 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.804 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.44 HG22 ' HA ' ' A' ' 54' ' ' ASP . 11.1 m -55.3 148.52 3.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 121.258 0.551 . . . . 0.0 111.558 -179.065 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -63.94 -57.0 11.09 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.532 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.76 -44.51 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.515 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 34.6 p -86.07 10.73 13.46 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.735 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.429 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 58.31 22.3 50.34 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.688 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -109.69 -34.69 6.4 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.947 0.403 . . . . 0.0 110.886 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.6 t -129.25 175.09 9.0 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.881 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.59 HD22 ' HB2' ' A' ' 56' ' ' LEU . 11.0 mt -93.75 158.03 15.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.043 0.449 . . . . 0.0 111.402 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.437 ' HB2' ' HD2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -83.17 165.87 38.44 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.191 -179.867 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.437 ' HD2' ' HB2' ' A' ' 65' ' ' ARG . 47.2 Cg_exo -55.72 129.67 36.28 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.741 2.294 . . . . 0.0 112.428 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.49 -49.29 0.86 Allowed Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.196 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.527 HG21 ' HB3' ' A' ' 95' ' ' PHE . 4.6 mt -94.62 134.61 31.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-O 120.728 0.299 . . . . 0.0 110.859 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.3 mt -111.53 118.65 36.31 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.975 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.465 HG23 ' HB3' ' A' ' 77' ' ' ALA . 26.9 m -85.77 125.22 40.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.031 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.415 HD23 ' C ' ' A' ' 70' ' ' VAL . 1.7 mt -120.96 131.55 54.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.089 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.591 HG13 ' HB2' ' A' ' 77' ' ' ALA . 1.5 m -103.99 99.31 8.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.737 179.317 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 59.58 51.19 6.61 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.685 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.1 t 66.02 35.35 6.42 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.506 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 47.1 t -148.69 123.9 10.18 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.559 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -47.49 114.1 0.82 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.885 0.374 . . . . 0.0 111.32 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.591 ' HB2' HG13 ' A' ' 72' ' ' VAL . . . -73.04 -18.99 61.27 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.842 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.401 ' HA ' ' CA ' ' A' ' 82' ' ' GLY . 2.7 mt-10 -73.17 -23.99 60.5 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.87 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.8 t -64.59 -35.76 75.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.813 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.9 m -95.85 -36.72 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.693 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -152.22 -66.15 0.01 OUTLIER Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.061 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.401 ' CA ' ' HA ' ' A' ' 78' ' ' GLU . . . 104.39 -40.29 2.51 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.664 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.813 ' HA ' HD22 ' A' ' 37' ' ' LEU . 5.0 ptt? -147.63 25.13 1.08 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.52 0.2 . . . . 0.0 111.318 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -148.74 25.4 0.94 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.663 0.268 . . . . 0.0 111.679 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -81.5 114.32 20.15 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.763 0.316 . . . . 0.0 110.917 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.8 m -63.6 146.1 13.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.487 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.649 ' CD1' HD11 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -90.42 168.52 11.8 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.295 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 44.4 p30 -168.45 166.14 12.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.658 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -64.45 96.16 0.16 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.931 0.396 . . . . 0.0 110.343 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.417 ' H ' HD13 ' A' ' 7' ' ' ILE . . . 118.77 24.25 3.14 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.529 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -87.41 158.38 19.01 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.751 0.31 . . . . 0.0 111.045 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 53.5 m -138.31 136.93 36.91 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.264 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.658 HG11 HD13 ' A' ' 40' ' ' LEU . 3.4 p -143.26 120.33 5.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.607 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -125.09 147.94 48.77 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.528 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.527 ' HB3' HG21 ' A' ' 68' ' ' ILE . 80.6 m-85 -118.74 104.42 10.58 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.174 179.182 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.78 HG12 ' HB3' ' A' ' 12' ' ' ALA . 30.0 mt -116.59 112.85 41.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.243 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 27.1 t -78.37 86.99 4.41 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.237 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.5 p -63.55 -69.4 0.27 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.374 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.9 168.04 9.79 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.585 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 -126.75 76.35 1.63 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.959 0.409 . . . . 0.0 110.785 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 124.52 -109.42 1.25 Allowed Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.152 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.164 0 CA-C-O 118.779 -1.012 . . . . 0.0 112.793 -179.942 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 120.678 0.275 . . . . 0.0 111.369 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.2 p -166.98 108.26 0.65 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.054 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 43.0 m-20 -86.88 -45.45 10.83 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.845 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 64.17 175.71 0.18 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.076 0.465 . . . . 0.0 111.639 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.5 ' O ' ' HB2' ' A' ' 6' ' ' HIS . 5.3 m120 -133.56 -162.88 1.29 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.528 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.5 ' HB2' ' O ' ' A' ' 5' ' ' ASN . 12.5 m-70 72.6 123.27 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 122.702 0.401 . . . . 0.0 111.049 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.663 HD12 HD23 ' A' ' 87' ' ' LEU . 6.5 mm -81.25 145.58 8.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.185 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.601 HG22 ' OE1' ' A' ' 10' ' ' GLN . 1.2 m -102.26 107.51 18.57 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.206 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.559 HG13 ' HB2' ' A' ' 25' ' ' LEU . 7.6 p -133.07 107.69 11.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.455 178.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.601 ' OE1' HG22 ' A' ' 8' ' ' THR . 1.4 pm0 -136.52 164.72 27.51 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.048 0.452 . . . . 0.0 111.75 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.461 ' CD1' ' HB3' ' A' ' 15' ' ' CYS . 15.2 m-85 -112.64 149.36 32.94 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.906 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.925 ' HB3' HG12 ' A' ' 96' ' ' ILE . . . -140.68 135.51 31.7 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.028 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.22 -107.03 3.44 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.315 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -121.84 30.5 5.27 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.784 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.461 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . 7.9 m -106.06 -19.96 13.56 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.798 0.299 . . . . 0.0 111.721 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -58.34 -30.45 66.73 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.804 0.335 . . . . 0.0 110.767 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 mp -70.03 -4.46 21.03 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.873 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.808 ' CD2' HD11 ' A' ' 55' ' ' LEU . 91.5 mt -77.09 7.79 4.61 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.404 ' CD1' ' HB2' ' A' ' 50' ' ' LYS . 77.0 t80 -149.92 -65.11 0.21 Allowed 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -172.09 39.14 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.772 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 52.18 35.77 17.54 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.892 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -76.13 -176.9 3.71 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.023 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 72.0 p -109.96 -77.42 0.6 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.806 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.447 ' CB ' ' HB3' ' A' ' 10' ' ' GLN . 80.8 p -135.73 162.9 31.47 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.876 0.37 . . . . 0.0 111.406 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.559 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.9 OUTLIER -139.08 155.51 47.87 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.779 179.896 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 35.6 mt-30 -132.15 127.78 36.66 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.143 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.5 mt -102.68 136.51 42.37 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.018 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -129.82 126.77 38.85 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.872 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 63.39 48.64 76.86 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.024 -0.607 . . . . 0.0 112.776 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.415 ' O ' HG12 ' A' ' 30' ' ' VAL . 10.6 t -122.11 43.02 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 120.992 0.425 . . . . 0.0 110.761 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.8 t 56.29 66.25 3.57 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.272 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.15 -12.6 28.04 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.616 2.21 . . . . 0.0 113.176 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.8 m -96.98 -57.39 2.29 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.69 0.281 . . . . 0.0 111.368 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -85.97 48.62 3.99 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.667 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 89.4 m -151.23 136.7 17.77 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.919 0.36 . . . . 0.0 110.692 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -111.9 -175.11 2.61 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.887 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.703 HD22 ' CB ' ' A' ' 83' ' ' MET . 4.7 tt -57.65 -49.47 76.34 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.307 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -57.68 -31.95 66.87 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.233 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.42 -32.22 38.98 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 111.414 -0.674 . . . . 0.0 111.414 178.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.674 HD21 HD22 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -63.85 -51.68 63.56 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.669 0.271 . . . . 0.0 110.463 179.345 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.574 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.2 OUTLIER -56.99 -56.21 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.835 179.558 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -51.41 -29.82 17.19 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.452 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.599 HD13 ' O ' ' A' ' 43' ' ' LEU . 0.5 OUTLIER -75.65 -28.31 58.69 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.75 HD12 ' N ' ' A' ' 45' ' ' LYS . 4.4 pp -95.89 -36.6 11.04 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.75 ' N ' HD12 ' A' ' 44' ' ' LEU . 2.4 pttt -86.07 -61.39 1.76 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.2 m -58.61 -23.13 58.22 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 122.253 -0.279 . . . . 0.0 111.569 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -96.65 -39.17 9.63 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 111.412 0.152 . . . . 0.0 111.412 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -150.24 59.76 0.97 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.433 ' HB ' ' O ' ' A' ' 45' ' ' LYS . 7.5 p -78.81 -42.27 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.436 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.404 ' HB2' ' CD1' ' A' ' 19' ' ' PHE . 0.0 OUTLIER 62.02 14.12 6.22 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 120.662 0.268 . . . . 0.0 111.501 -179.684 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -152.34 -160.81 1.19 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.671 ' HB2' HD23 ' A' ' 55' ' ' LEU . 9.0 mmt85 -87.16 108.15 17.79 Favored Pre-proline 0 C--N 1.331 -0.225 0 N-CA-C 110.412 -0.218 . . . . 0.0 110.412 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.437 ' O ' HG22 ' A' ' 57' ' ' VAL . 18.5 Cg_endo -59.43 -23.21 69.5 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.148 1.898 . . . . 0.0 112.515 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.421 ' HA ' ' CG2' ' A' ' 57' ' ' VAL . 48.8 m-20 -90.43 8.09 35.47 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.808 HD11 ' CD2' ' A' ' 18' ' ' LEU . 2.1 pp -92.7 -20.45 20.8 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 121.19 -0.204 . . . . 0.0 111.418 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.651 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -106.63 -45.63 4.18 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 179.956 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.446 HG11 ' HA2' ' A' ' 61' ' ' GLY . 5.8 m -52.8 149.88 1.34 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-O 121.135 0.493 . . . . 0.0 111.864 -179.12 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -65.76 -61.37 2.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.555 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -168.47 -44.47 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.311 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.3 p -80.14 4.68 16.59 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.615 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.446 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 61.54 21.38 60.25 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.433 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -112.63 -41.06 3.9 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.769 0.319 . . . . 0.0 110.594 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.743 HG22 ' HG2' ' A' ' 83' ' ' MET . 16.8 p -110.77 -167.12 1.14 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.133 179.623 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.502 HD22 ' HB2' ' A' ' 56' ' ' LEU . 7.4 mt -114.8 154.45 28.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.828 0.347 . . . . 0.0 111.06 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.69 150.46 81.84 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.063 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.79 127.42 24.58 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.875 2.383 . . . . 0.0 112.315 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 142.58 -45.01 0.94 Allowed Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.46 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.456 HG21 ' HB3' ' A' ' 95' ' ' PHE . 5.6 mt -88.43 141.35 14.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 120.803 0.335 . . . . 0.0 111.228 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 mt -105.48 99.85 9.44 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.79 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.832 HG23 ' HB3' ' A' ' 77' ' ' ALA . 13.3 m -78.76 135.51 25.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.007 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 mt -126.57 141.2 51.94 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.013 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.719 HG11 ' CD2' ' A' ' 85' ' ' TYR . 48.9 t -123.74 118.23 53.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.737 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 56.61 31.74 19.7 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.337 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 55.2 35.76 25.54 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.873 0.368 . . . . 0.0 111.113 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 11.2 t -141.89 37.55 1.61 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.922 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.435 ' HB2' HG23 ' A' ' 79' ' ' VAL . 12.9 m-20 67.37 134.59 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.27 0.557 . . . . 0.0 111.388 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.832 ' HB3' HG23 ' A' ' 70' ' ' VAL . . . -84.39 -22.81 30.34 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.434 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -77.84 -32.64 52.26 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.61 0.243 . . . . 0.0 110.859 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.435 HG23 ' HB2' ' A' ' 76' ' ' ASP . 35.2 t -69.21 -42.37 81.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.246 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.457 ' HB ' ' CD1' ' A' ' 85' ' ' TYR . 14.8 m -68.23 -31.22 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.561 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 142.68 42.08 0.06 OUTLIER Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.33 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.422 ' O ' HD13 ' A' ' 37' ' ' LEU . . . 47.35 -119.03 4.45 Favored Glycine 0 C--N 1.336 0.574 0 C-N-CA 121.281 -0.485 . . . . 0.0 112.947 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.743 ' HG2' HG22 ' A' ' 63' ' ' THR . 0.1 OUTLIER -101.5 26.3 7.43 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.69 0.281 . . . . 0.0 111.134 179.42 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -120.2 23.64 10.84 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.369 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.719 ' CD2' HG11 ' A' ' 72' ' ' VAL . 28.4 t80 -93.24 130.25 39.0 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.864 0.364 . . . . 0.0 111.074 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.1 m -89.46 142.52 12.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.03 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.674 HD22 HD21 ' A' ' 40' ' ' LEU . 10.8 mp -83.72 174.22 10.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.947 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -135.01 -67.06 0.56 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.98 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -178.52 79.4 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.817 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.539 ' H ' HD13 ' A' ' 7' ' ' ILE . . . 113.48 37.3 1.33 Allowed Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.821 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.91 174.19 6.45 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.774 0.321 . . . . 0.0 110.931 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 58.4 m -132.42 116.08 16.36 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.953 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.468 HG13 HG23 ' A' ' 9' ' ' VAL . 12.9 p -128.81 119.93 50.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.019 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.438 ' HG2' ' HG2' ' A' ' 10' ' ' GLN . 39.9 mt-10 -124.92 146.56 49.29 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.3 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.456 ' HB3' HG21 ' A' ' 68' ' ' ILE . 20.0 m-85 -121.72 104.81 9.86 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.346 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.925 HG12 ' HB3' ' A' ' 12' ' ' ALA . 27.7 mt -116.68 119.52 62.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.293 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.8 t -87.46 134.23 33.63 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.094 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.56 -53.18 0.72 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.239 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.77 86.17 6.94 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.986 0.422 . . . . 0.0 110.94 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -106.3 81.43 1.61 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.826 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -169.6 157.99 30.01 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.464 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.262 -1.299 . . . . 0.0 112.573 -179.995 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.5 m-70 . . . . . 0 N--CA 1.465 0.309 0 CA-C-O 120.904 0.383 . . . . 0.0 111.522 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.532 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 8.5 mm -104.05 143.18 16.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.648 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.674 HG22 HE22 ' A' ' 10' ' ' GLN . 32.1 m -111.09 93.47 4.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.563 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.636 HG13 ' HB2' ' A' ' 25' ' ' LEU . 7.8 p -114.59 102.65 14.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.15 0.5 . . . . 0.0 110.223 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.674 HE22 HG22 ' A' ' 8' ' ' THR . 0.2 OUTLIER -128.37 175.2 8.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.96 -178.556 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.527 ' CD1' ' HB3' ' A' ' 15' ' ' CYS . 49.8 m-85 -128.39 168.65 15.28 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.112 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.878 ' HB3' HG12 ' A' ' 96' ' ' ILE . . . -155.29 136.61 14.02 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.311 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.09 -106.29 3.14 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.216 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -122.98 31.7 4.65 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.727 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.527 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . 69.3 m -106.78 -16.62 14.44 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.466 ' HG2' ' HB2' ' A' ' 11' ' ' PHE . 68.5 mt-10 -58.58 -30.98 67.6 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.523 0.201 . . . . 0.0 111.05 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.439 HD12 ' H ' ' A' ' 17' ' ' LEU . 2.8 mp -70.57 -7.8 46.73 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.51 HD21 HD11 ' A' ' 55' ' ' LEU . 13.3 mt -83.57 12.08 6.22 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.425 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 38.5 t80 -147.32 -62.37 0.28 Allowed 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -176.7 36.28 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.067 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.47 35.86 12.1 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.895 0.378 . . . . 0.0 110.663 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -90.2 146.07 24.54 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.913 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.446 ' O ' ' HB2' ' A' ' 10' ' ' GLN . 7.3 p -75.97 -32.64 59.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.098 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.9 p -170.96 157.98 5.53 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.646 0.26 . . . . 0.0 111.145 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.636 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -135.95 154.36 51.13 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.819 0.343 . . . . 0.0 111.547 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.532 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 16.7 mt-30 -132.72 128.15 36.3 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.986 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.5 mt . . . . . 0 C--O 1.235 0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.78 179.851 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.6 m . . . . . 0 C--O 1.233 0.231 0 CA-C-O 120.695 0.283 . . . . 0.0 110.674 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -128.97 -178.59 4.69 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.169 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.721 ' O ' HG22 ' A' ' 41' ' ' VAL . 5.2 tt -57.77 -46.65 84.26 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -56.83 -33.76 67.07 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.719 0.295 . . . . 0.0 110.32 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.67 -30.1 49.75 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 121.001 -0.618 . . . . 0.0 111.983 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.457 HD13 ' O ' ' A' ' 40' ' ' LEU . 1.4 tm? -70.8 -47.33 60.05 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.674 0.237 . . . . 0.0 111.237 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.721 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -62.4 -53.34 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.866 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -53.41 -33.11 52.64 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.031 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.624 HD13 ' O ' ' A' ' 43' ' ' LEU . 0.6 OUTLIER -70.85 -24.78 62.59 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.302 179.468 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.596 HD23 ' HA ' ' A' ' 41' ' ' VAL . 0.8 OUTLIER -95.1 -42.18 8.73 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.692 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.447 ' O ' HG12 ' A' ' 49' ' ' VAL . 7.7 pttp -92.36 -60.86 1.73 Allowed 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.401 ' H ' ' HG3' ' A' ' 45' ' ' LYS . 1.5 m -54.57 -27.29 37.85 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 122.176 -0.328 . . . . 0.0 111.244 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 1.6 t30 -82.71 -26.65 31.82 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.461 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -135.59 -75.04 0.45 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.77 -0.195 . . . . 0.0 111.323 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.608 ' O ' HG13 ' A' ' 49' ' ' VAL . 13.0 p 40.41 89.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.396 0.678 . . . . 0.0 112.237 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -66.33 -53.7 33.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.228 179.616 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.543 ' HB3' HD21 ' A' ' 55' ' ' LEU . 1.8 tp10 -76.65 -179.47 5.33 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.798 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.449 ' HB2' HD23 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -55.12 113.91 6.23 Favored Pre-proline 0 N--CA 1.464 0.246 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.162 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.548 ' HA ' HG21 ' A' ' 49' ' ' VAL . 18.2 Cg_endo -60.66 -23.25 75.49 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.546 2.164 . . . . 0.0 112.5 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -90.28 5.55 46.71 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.639 ' HG ' HD23 ' A' ' 56' ' ' LEU . 1.5 pp -93.38 -21.42 19.54 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 122.379 -0.201 . . . . 0.0 111.484 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.639 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -100.14 -45.28 5.69 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -179.797 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.494 HG11 ' HA2' ' A' ' 61' ' ' GLY . 5.9 m -54.49 150.22 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.214 0.531 . . . . 0.0 111.66 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -66.79 -54.1 26.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.859 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.52 -43.0 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.441 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 71.4 p -87.42 11.06 15.52 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.494 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 58.55 23.09 54.02 Favored Glycine 0 C--N 1.338 0.674 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.645 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -110.17 -39.91 4.86 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.903 0.382 . . . . 0.0 110.585 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.1 p -121.4 -178.05 3.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.022 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.468 HD13 HD13 ' A' ' 68' ' ' ILE . 6.5 mt -110.16 155.93 21.3 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.875 0.369 . . . . 0.0 111.003 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.89 148.98 82.34 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.429 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -50.3 -32.43 33.15 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.249 2.632 . . . . 0.0 113.146 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -47.84 -36.0 13.14 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 121.391 -0.433 . . . . 0.0 113.144 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.468 HD13 HD13 ' A' ' 64' ' ' LEU . 5.1 mt -93.11 138.0 21.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.784 0.292 . . . . 0.0 111.063 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.497 ' CD2' HD21 ' A' ' 71' ' ' LEU . 13.4 tp -102.87 106.93 17.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.93 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.608 HG23 ' HB3' ' A' ' 77' ' ' ALA . 12.7 m -84.93 133.34 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.864 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.497 HD21 ' CD2' ' A' ' 69' ' ' LEU . 1.9 mt -134.65 141.27 46.53 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.433 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.657 HG23 ' CB ' ' A' ' 77' ' ' ALA . 38.2 t -119.04 121.92 67.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.591 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 59.52 45.13 13.83 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.075 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.33 39.59 18.62 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.203 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 17.9 t -153.88 153.98 33.06 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.581 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.43 ' CB ' HG23 ' A' ' 79' ' ' VAL . 69.6 m-20 -47.04 121.06 3.42 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.642 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.657 ' CB ' HG23 ' A' ' 72' ' ' VAL . . . -81.33 -19.03 43.68 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.684 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -77.53 -29.7 52.48 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.577 0.227 . . . . 0.0 110.838 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.43 HG23 ' CB ' ' A' ' 76' ' ' ASP . 43.7 t -65.24 -50.98 70.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.075 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.7 m -61.3 -36.03 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.521 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -176.78 -44.88 0.06 OUTLIER Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.773 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.41 -51.03 1.84 Allowed Glycine 0 C--N 1.335 0.51 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.213 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.402 ' HA ' HD22 ' A' ' 37' ' ' LEU . 3.9 ptt? -142.5 23.74 1.95 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 120.479 0.181 . . . . 0.0 111.217 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -140.35 26.75 2.15 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.46 ' CE2' HG11 ' A' ' 72' ' ' VAL . 33.5 t80 -84.85 98.15 10.14 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.82 0.343 . . . . 0.0 110.945 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.9 m -61.68 141.56 17.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.584 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.63 160.19 14.52 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.185 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -158.21 31.16 0.25 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.441 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 69.6 120.62 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.89 0.376 . . . . 0.0 110.897 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 97.28 33.66 5.88 Favored Glycine 0 CA--C 1.519 0.302 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.961 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -101.86 167.44 10.07 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.94 0.4 . . . . 0.0 111.476 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.588 HG23 ' HB ' ' A' ' 8' ' ' THR . 92.9 m -137.47 134.11 35.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.759 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.0 p -141.85 136.61 30.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.823 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -130.49 150.15 51.84 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.616 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -130.51 104.48 7.26 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.098 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.878 HG12 ' HB3' ' A' ' 12' ' ' ALA . 24.6 mt -118.99 115.4 47.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.035 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 46.6 t -81.24 140.36 34.93 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.284 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 21.3 p . . . . . 0 C--O 1.233 0.2 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.893 179.768 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.421 ' CD2' ' HB3' ' A' ' 26' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.26 0 CA-C-O 120.778 0.323 . . . . 0.0 111.071 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 33.3 mm -115.28 152.23 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.84 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.813 HG22 ' OE1' ' A' ' 10' ' ' GLN . 24.9 m -115.29 101.72 9.2 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.008 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.534 ' O ' HG13 ' A' ' 9' ' ' VAL . 10.8 p -120.43 108.54 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-O 121.007 0.432 . . . . 0.0 111.207 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.813 ' OE1' HG22 ' A' ' 8' ' ' THR . 0.0 OUTLIER -131.36 156.88 44.76 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.571 -179.892 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.424 ' HB2' ' HB3' ' A' ' 16' ' ' GLU . 33.2 m-85 -115.05 144.93 42.85 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.859 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.0 151.89 35.34 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.672 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.37 -86.84 1.11 Allowed Glycine 0 C--N 1.336 0.538 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.44 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -143.34 27.73 2.1 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.565 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.29 5.54 21.77 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.538 ' HG2' HD12 ' A' ' 17' ' ' LEU . 1.1 pm0 -93.1 -29.02 15.99 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.53 0.205 . . . . 0.0 111.046 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.538 HD12 ' HG2' ' A' ' 16' ' ' GLU . 5.0 mp -66.73 -15.56 63.62 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.656 ' HB2' HD21 ' A' ' 55' ' ' LEU . 3.6 pp -83.26 12.71 4.95 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -143.07 -66.5 0.37 Allowed 'General case' 0 CA--C 1.521 -0.135 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -175.78 36.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.31 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 mptt 49.7 34.92 7.95 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.865 0.364 . . . . 0.0 110.694 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -76.27 179.69 5.61 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.708 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.5 p -112.11 -74.55 0.63 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.01 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 87.9 p -135.74 156.81 48.24 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 120.777 0.322 . . . . 0.0 111.181 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.9 tp -150.13 166.56 29.43 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.688 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.494 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 1.0 OUTLIER -126.42 146.59 50.01 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.844 179.665 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.1 mt . . . . . 0 C--O 1.232 0.183 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.09 -179.532 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.2 m . . . . . 0 C--O 1.233 0.223 0 CA-C-O 120.799 0.333 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -111.33 -175.17 2.64 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.885 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.623 HD22 ' HA ' ' A' ' 83' ' ' MET . 0.6 OUTLIER -58.68 -42.85 89.47 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.756 -0.202 . . . . 0.0 111.1 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.403 ' OD1' ' HA ' ' A' ' 62' ' ' GLN . 5.5 t30 -55.68 -37.68 68.64 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.953 0.406 . . . . 0.0 109.948 178.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.75 -32.27 46.37 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.161 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.526 HD22 HD11 ' A' ' 87' ' ' LEU . 53.6 tp -62.83 -48.97 76.75 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.714 0.257 . . . . 0.0 110.591 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.617 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -62.16 -57.01 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.847 179.612 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -55.82 -28.15 54.84 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 120.498 0.189 . . . . 0.0 111.08 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.411 ' O ' ' HB2' ' A' ' 47' ' ' ASN . 7.1 tt -84.71 -21.86 29.97 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.848 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.466 HD12 ' C ' ' A' ' 44' ' ' LEU . 1.2 pp -93.89 -41.08 9.81 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.418 ' HG2' ' H ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -70.72 -56.48 6.29 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.77 -179.677 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.418 ' H ' ' HG2' ' A' ' 45' ' ' LYS . 10.6 m -60.69 -20.33 60.78 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.554 0.216 . . . . 0.0 110.814 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.4 OUTLIER -67.45 -44.19 79.27 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.944 179.474 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -146.43 -62.83 0.31 Allowed 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.575 ' O ' HG13 ' A' ' 49' ' ' VAL . 13.2 p 42.91 86.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.469 0.652 . . . . 0.0 112.017 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.78 -48.17 80.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.214 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.513 ' O ' HG22 ' A' ' 49' ' ' VAL . 0.2 OUTLIER -91.61 -156.23 0.44 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.651 -0.249 . . . . 0.0 110.564 179.683 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.423 ' N ' HD23 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -66.88 138.01 95.03 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-O 120.755 0.312 . . . . 0.0 111.583 -179.507 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.527 ' HA ' HG21 ' A' ' 49' ' ' VAL . 73.7 Cg_endo -77.77 -29.9 4.16 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.562 2.174 . . . . 0.0 112.468 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.479 ' OD1' HG23 ' A' ' 57' ' ' VAL . 4.1 t0 -94.43 10.67 33.5 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.656 HD21 ' HB2' ' A' ' 18' ' ' LEU . 3.4 pp -77.85 -25.96 49.07 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.543 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.584 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -97.4 -50.77 4.4 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.387 179.952 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.534 HG11 ' HA2' ' A' ' 61' ' ' GLY . 1.3 m -60.99 149.66 7.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.209 0.528 . . . . 0.0 111.268 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -61.46 -61.3 2.63 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.299 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -171.08 -43.74 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.269 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 38.9 p -85.07 11.43 9.67 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.807 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.534 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 54.08 27.99 39.92 Favored Glycine 0 C--N 1.34 0.779 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.539 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.403 ' HA ' ' OD1' ' A' ' 38' ' ' ASN . 16.6 tt0 -113.97 -44.66 3.13 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.983 0.42 . . . . 0.0 110.332 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.4 t -122.98 139.89 53.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.948 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.509 HD22 ' HB2' ' A' ' 56' ' ' LEU . 7.2 mt -66.76 154.84 39.74 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.872 0.368 . . . . 0.0 110.911 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.5 156.05 89.04 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.194 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.48 140.54 74.5 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.844 2.362 . . . . 0.0 112.37 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.61 -47.72 1.0 Allowed Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.255 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.506 HD13 HD13 ' A' ' 64' ' ' LEU . 6.4 mt -79.93 149.96 5.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-O 120.867 0.365 . . . . 0.0 110.984 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.3 mt -128.41 104.3 7.63 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.783 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.617 HG23 ' HB3' ' A' ' 77' ' ' ALA . 30.6 m -77.37 123.62 34.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.833 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.475 HD23 ' O ' ' A' ' 70' ' ' VAL . 5.3 mt -124.8 141.46 52.1 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.375 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.739 HG23 ' HB2' ' A' ' 77' ' ' ALA . 36.6 t -109.34 107.0 21.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.526 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 59.35 55.44 4.23 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.899 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.0 t 57.71 49.2 12.72 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.312 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 52.4 t -162.41 143.63 10.38 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.784 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.3 122.2 9.86 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.913 0.387 . . . . 0.0 111.193 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.739 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -75.29 -19.98 59.37 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.901 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -71.52 -24.99 62.06 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 116.728 -0.215 . . . . 0.0 111.172 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.9 t -56.18 -32.51 34.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.017 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.6 m -105.67 -38.92 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.629 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -154.95 -56.7 0.01 OUTLIER Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.017 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 99.29 -53.16 1.04 Allowed Glycine 0 C--N 1.333 0.4 0 C-N-CA 121.125 -0.56 . . . . 0.0 112.448 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.623 ' HA ' HD22 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -136.6 23.74 3.15 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.546 0.213 . . . . 0.0 111.4 179.862 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -142.74 27.06 1.69 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.733 0.271 . . . . 0.0 111.733 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -77.74 117.38 19.08 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.77 0.319 . . . . 0.0 110.944 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.7 m -75.28 136.06 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.272 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.526 HD11 HD22 ' A' ' 40' ' ' LEU . 2.6 mp -86.48 162.19 18.21 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.294 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -146.13 33.5 1.0 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.403 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 60.42 27.34 16.94 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.396 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -169.59 40.01 0.2 Allowed Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.937 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -103.85 166.55 10.35 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.062 0.458 . . . . 0.0 111.253 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.512 HG23 ' HB ' ' A' ' 8' ' ' THR . 78.9 m -127.81 137.07 52.25 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.434 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.8 p -142.22 134.21 26.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.991 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -133.39 138.81 46.45 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.316 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -110.17 105.64 14.8 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.356 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 10.9 mt -110.85 100.76 11.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.074 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -84.08 110.58 18.58 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.036 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 22.7 p . . . . . 0 C--O 1.233 0.218 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.983 179.888 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.725 0.298 . . . . 0.0 111.316 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 16.1 mm -90.97 157.16 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.562 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.626 HG22 HE22 ' A' ' 10' ' ' GLN . 30.3 m -124.91 93.74 3.98 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.807 0.336 . . . . 0.0 111.521 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.546 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.6 p -113.23 103.6 15.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.183 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.626 HE22 HG22 ' A' ' 8' ' ' THR . 0.1 OUTLIER -131.74 166.9 20.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.744 -178.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.534 ' HB2' ' HG2' ' A' ' 16' ' ' GLU . 41.6 m-85 -125.0 163.52 22.16 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.874 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.412 ' O ' ' HA ' ' A' ' 96' ' ' ILE . . . -175.17 119.51 0.19 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.053 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.67 54.89 0.76 Allowed Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.582 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.26 25.96 72.48 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.199 -0.524 . . . . 0.0 113.478 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -116.44 5.35 13.43 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 117.091 0.445 . . . . 0.0 111.675 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.534 ' HG2' ' HB2' ' A' ' 11' ' ' PHE . 64.1 mt-10 -84.17 -23.29 30.67 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.73 -4.92 21.86 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.513 ' CD2' HD11 ' A' ' 55' ' ' LEU . 24.7 mt -78.88 8.73 5.06 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -149.39 -63.58 0.22 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.788 0.328 . . . . 0.0 110.149 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -174.84 38.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.848 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.93 35.8 20.15 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.241 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -80.48 178.37 8.37 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.963 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 28.1 p -107.69 -74.65 0.65 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.994 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.405 ' O ' HD12 ' A' ' 25' ' ' LEU . 88.0 p -132.99 160.58 36.71 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.829 0.347 . . . . 0.0 111.355 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.416 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -141.55 152.81 44.42 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.181 -179.935 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.458 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 1.7 mt-30 -131.06 122.32 26.55 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.6 mt . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.338 179.674 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 58.9 m . . . . . 0 CA--C 1.532 0.285 0 CA-C-O 120.61 0.243 . . . . 0.0 110.984 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -131.81 -179.55 5.46 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.896 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.657 ' O ' HG22 ' A' ' 41' ' ' VAL . 6.4 tt -53.47 -48.36 68.94 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 111.514 0.19 . . . . 0.0 111.514 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -52.99 -36.35 60.28 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.812 0.339 . . . . 0.0 110.388 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.3 -31.05 43.33 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.137 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.439 HD23 HD21 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -66.84 -51.49 54.89 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.633 0.254 . . . . 0.0 110.72 179.702 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.657 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.2 OUTLIER -60.7 -57.34 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.915 179.776 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.421 ' H ' HG23 ' A' ' 41' ' ' VAL . 0.4 OUTLIER -52.57 -29.33 25.05 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.319 179.571 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 30.5 tp -74.53 -27.59 60.6 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.547 HD12 ' N ' ' A' ' 45' ' ' LYS . 3.5 pp -96.93 -38.61 9.75 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.547 ' N ' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -84.16 -70.91 0.54 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.411 -179.793 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.3 m -53.24 -24.32 10.95 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 111.863 0.319 . . . . 0.0 111.863 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -102.45 -23.3 13.94 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -147.84 50.17 1.05 Allowed 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.607 HG22 ' H ' ' A' ' 51' ' ' GLU . 9.6 p -99.88 122.72 52.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.871 0.367 . . . . 0.0 110.987 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -100.79 33.05 2.91 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.888 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.607 ' H ' HG22 ' A' ' 49' ' ' VAL . 1.7 tp10 -160.21 -161.79 0.92 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.111 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 54.5 mtt-85 -88.87 109.88 33.47 Favored Pre-proline 0 CA--C 1.529 0.172 0 CA-C-O 120.418 0.152 . . . . 0.0 110.894 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.736 ' HA ' HD21 ' A' ' 56' ' ' LEU . 78.0 Cg_exo -48.41 -30.11 14.87 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.724 2.283 . . . . 0.0 112.929 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.19 -17.17 64.56 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.687 ' HG ' HD23 ' A' ' 56' ' ' LEU . 2.5 pp -80.38 -15.19 57.43 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.736 HD21 ' HA ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -108.65 -49.15 3.2 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.712 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.722 HG22 ' O ' ' A' ' 53' ' ' PRO . 2.9 m -57.34 148.38 5.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.078 0.466 . . . . 0.0 111.467 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -71.33 -59.72 2.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.913 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -162.96 -56.42 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.229 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.6 p -59.51 -21.2 59.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.2 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.76 21.59 49.97 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 121.149 -0.548 . . . . 0.0 111.862 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -124.45 -46.34 1.9 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.792 0.33 . . . . 0.0 110.974 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.0 t -101.91 130.91 48.52 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.701 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.519 HD22 ' HB2' ' A' ' 56' ' ' LEU . 5.7 mt -65.91 155.29 36.87 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.806 0.336 . . . . 0.0 111.123 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -53.21 143.76 32.46 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.324 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -51.57 -33.39 47.97 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.181 2.587 . . . . 0.0 112.98 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -49.49 -35.39 21.75 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.348 -0.453 . . . . 0.0 112.914 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.464 HD13 HD13 ' A' ' 64' ' ' LEU . 7.9 mt -82.81 114.4 23.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.83 0.315 . . . . 0.0 110.787 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.61 97.01 8.28 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.198 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.452 ' O ' HD23 ' A' ' 71' ' ' LEU . 19.3 t -84.87 136.33 23.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.041 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.452 HD23 ' O ' ' A' ' 70' ' ' VAL . 3.6 mt -125.62 126.68 45.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.89 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.59 HG23 ' HA ' ' A' ' 77' ' ' ALA . 38.4 t -110.23 118.76 57.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.878 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.4 m120 55.29 35.02 24.04 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.363 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.1 t 56.18 33.16 21.56 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.306 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 9.3 t -138.02 31.11 2.46 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.841 0.353 . . . . 0.0 111.01 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.669 ' HB3' HG23 ' A' ' 79' ' ' VAL . 0.4 OUTLIER 69.05 145.28 0.05 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.371 179.809 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.59 ' HA ' HG23 ' A' ' 72' ' ' VAL . . . -85.08 -22.73 28.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.594 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -82.28 -33.5 29.07 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.755 -0.202 . . . . 0.0 110.993 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.669 HG23 ' HB3' ' A' ' 76' ' ' ASP . 39.5 t -66.16 -41.9 90.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.26 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.486 ' HB ' ' CD1' ' A' ' 85' ' ' TYR . 26.8 m -69.41 -29.13 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 168.3 -34.37 0.2 Allowed Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.339 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 109.25 -55.69 0.5 Allowed Glycine 0 C--N 1.333 0.416 0 N-CA-C 111.823 -0.511 . . . . 0.0 111.823 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.538 ' HA ' HD22 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -157.69 27.94 0.28 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.461 0.172 . . . . 0.0 111.289 179.4 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -135.42 20.55 3.38 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.573 ' CD2' HG11 ' A' ' 72' ' ' VAL . 34.1 t80 -68.56 112.09 5.14 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.787 0.327 . . . . 0.0 110.961 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.2 m -71.04 135.47 27.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.272 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.439 HD21 HD23 ' A' ' 40' ' ' LEU . 0.7 OUTLIER -79.83 152.99 29.41 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.023 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -155.23 -59.72 0.11 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.055 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -173.03 116.09 0.28 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.137 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 80.26 34.26 29.93 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.826 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -75.39 99.09 4.04 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.84 0.352 . . . . 0.0 110.358 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 16.0 m -81.77 127.84 33.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.56 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.46 ' O ' HG13 ' A' ' 93' ' ' VAL . 7.7 p -139.02 113.96 8.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.011 0.434 . . . . 0.0 110.926 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -114.98 149.89 36.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.119 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -123.91 104.71 9.09 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.419 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 12' ' ' ALA . 29.3 mt -114.12 101.97 13.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.323 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.0 m -72.94 97.93 2.38 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.089 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.7 m . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.978 179.985 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 25.0 p-80 . . . . . 0 C--O 1.234 0.251 0 CA-C-O 120.79 0.329 . . . . 0.0 111.515 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 33.9 mm -95.79 137.84 22.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.692 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.698 HG22 ' OE1' ' A' ' 10' ' ' GLN . 1.9 m -96.26 98.88 10.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.201 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.537 HG13 ' HB2' ' A' ' 25' ' ' LEU . 8.1 p -122.47 108.7 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-O 120.92 0.39 . . . . 0.0 110.559 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.698 ' OE1' HG22 ' A' ' 8' ' ' THR . 1.4 pm0 -135.2 158.91 43.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.396 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.402 ' CB ' ' HA ' ' A' ' 16' ' ' GLU . 31.0 m-85 -126.75 145.47 50.6 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.124 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.548 ' HB2' HG12 ' A' ' 96' ' ' ILE . . . -92.74 179.99 5.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.303 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.6 97.43 0.12 Allowed Glycine 0 C--N 1.335 0.504 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.6 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 135.16 -40.95 1.49 Allowed Glycine 0 C--N 1.333 0.364 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.807 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.05 -23.95 18.48 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.441 0.162 . . . . 0.0 111.418 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.41 ' HG3' ' HA ' ' A' ' 21' ' ' LYS . 6.9 pt-20 -58.43 -26.92 63.83 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 111.679 0.251 . . . . 0.0 111.679 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 mp -68.59 -8.46 41.98 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.919 HD21 HD11 ' A' ' 55' ' ' LEU . 25.3 mt -83.26 13.43 4.26 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -148.46 -59.11 0.24 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.743 0.306 . . . . 0.0 110.253 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -178.67 36.49 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.079 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.41 ' HA ' ' HG3' ' A' ' 16' ' ' GLU . 0.0 OUTLIER 50.54 34.53 9.66 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.952 0.406 . . . . 0.0 110.764 -179.403 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -78.84 173.25 12.7 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.021 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.2 p -107.97 -45.21 4.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.947 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 94.3 p -159.7 158.87 32.16 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.592 0.234 . . . . 0.0 111.238 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.537 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -146.95 163.6 35.63 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.232 -179.703 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.24 100.8 5.32 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.855 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.0 mt . . . . . 0 C--O 1.233 0.191 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.663 179.952 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.4 m . . . . . 0 C--O 1.233 0.235 0 CA-C-O 120.641 0.258 . . . . 0.0 111.075 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -136.02 -174.09 3.57 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.05 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.674 ' O ' HG22 ' A' ' 41' ' ' VAL . 5.5 tt -56.82 -45.5 82.28 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.731 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -54.69 -38.63 67.22 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.03 -32.96 58.02 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.015 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.534 ' CG ' HD11 ' A' ' 87' ' ' LEU . 11.6 mt -65.61 -57.03 9.11 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.629 0.252 . . . . 0.0 110.65 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.3 OUTLIER -55.27 -56.89 9.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.994 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.414 ' H ' HG23 ' A' ' 41' ' ' VAL . 2.4 tt0 -51.02 -29.89 13.8 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.464 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.24 -28.49 57.15 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.76 HD12 ' N ' ' A' ' 45' ' ' LYS . 4.0 pp -94.91 -33.03 12.94 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.76 ' N ' HD12 ' A' ' 44' ' ' LEU . 4.4 pttt -92.49 -61.05 1.68 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 111.595 0.221 . . . . 0.0 111.595 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -58.29 -20.23 41.02 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 122.126 -0.359 . . . . 0.0 111.306 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -105.68 -30.14 9.65 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -146.63 48.45 1.17 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.435 ' HB ' ' O ' ' A' ' 45' ' ' LYS . 7.5 p -80.81 -32.81 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.07 20.82 0.65 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 122.544 0.338 . . . . 0.0 111.642 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -158.73 -166.4 1.87 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.242 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.652 ' HB3' HD23 ' A' ' 55' ' ' LEU . 3.0 ttt180 -70.67 110.91 7.97 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-O 120.601 0.238 . . . . 0.0 110.752 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.32 -22.23 70.16 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.37 2.047 . . . . 0.0 112.347 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.403 ' HA ' ' CG2' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -93.19 8.23 41.03 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.919 HD11 HD21 ' A' ' 18' ' ' LEU . 2.7 pp -88.85 -7.75 55.56 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 122.239 -0.288 . . . . 0.0 111.534 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.66 HD13 HD13 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -117.93 -47.68 2.59 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 179.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.5 HG11 ' HA2' ' A' ' 61' ' ' GLY . 2.7 m -53.58 150.35 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-O 121.275 0.56 . . . . 0.0 111.396 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.789 ' HB2' HG23 ' A' ' 63' ' ' THR . 25.7 t0 -62.7 -57.15 12.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.598 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.08 -43.16 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.354 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 31.9 p -86.5 10.09 16.35 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.752 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.5 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 58.88 21.96 53.23 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.484 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -107.77 -42.05 4.83 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.901 0.382 . . . . 0.0 110.461 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.789 HG23 ' HB2' ' A' ' 58' ' ' ASP . 12.1 t -118.74 -167.78 1.43 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.097 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.48 HD13 HD13 ' A' ' 68' ' ' ILE . 10.6 mt -111.75 157.58 20.35 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.979 0.418 . . . . 0.0 111.689 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.429 ' HB2' ' HD2' ' A' ' 66' ' ' PRO . 0.5 OUTLIER -78.18 156.93 78.88 Favored Pre-proline 0 C--O 1.233 0.206 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.949 179.859 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.429 ' HD2' ' HB2' ' A' ' 65' ' ' ARG . 10.7 Cg_endo -55.22 134.33 63.21 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.637 2.225 . . . . 0.0 112.472 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 133.73 -47.99 0.97 Allowed Glycine 0 C--N 1.331 0.292 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.185 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.48 HD13 HD13 ' A' ' 64' ' ' LEU . 5.8 mt -86.02 137.03 21.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-O 120.678 0.275 . . . . 0.0 111.092 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.902 HD23 HD21 ' A' ' 71' ' ' LEU . 1.0 OUTLIER -107.74 106.65 17.06 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.674 179.717 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.523 ' O ' HD23 ' A' ' 71' ' ' LEU . 16.5 m -83.11 128.39 38.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.876 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.902 HD21 HD23 ' A' ' 69' ' ' LEU . 1.5 mt -132.69 136.82 46.67 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.566 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.859 HG23 ' HB2' ' A' ' 77' ' ' ALA . 38.5 t -108.95 102.86 14.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.374 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 60.36 57.41 2.88 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.764 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.2 m 57.69 49.33 12.55 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.594 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 50.3 t -163.12 137.56 6.25 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.818 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -54.02 124.99 17.16 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.823 0.345 . . . . 0.0 111.276 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.859 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -82.1 -23.38 35.74 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.239 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -70.08 -14.18 62.55 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 111.466 0.173 . . . . 0.0 111.466 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.2 t -74.05 -30.27 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 111.679 0.251 . . . . 0.0 111.679 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.431 HG23 ' N ' ' A' ' 81' ' ' GLY . 18.8 m -115.73 -43.69 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.431 ' N ' HG23 ' A' ' 80' ' ' VAL . . . -176.04 72.61 0.08 OUTLIER Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.409 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.489 ' O ' HD13 ' A' ' 37' ' ' LEU . . . -49.93 -28.37 11.94 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 121.525 -0.369 . . . . 0.0 113.352 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.548 ' HA ' HD22 ' A' ' 37' ' ' LEU . 1.1 ptt? -132.15 29.09 4.38 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.726 0.298 . . . . 0.0 110.56 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -149.52 30.51 0.75 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.491 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.687 ' CZ ' HG11 ' A' ' 72' ' ' VAL . 1.6 t80 -86.83 115.99 24.61 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.827 0.346 . . . . 0.0 111.281 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 29.8 m -66.23 168.61 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.341 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.534 HD11 ' CG ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -116.84 178.74 4.23 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.193 0.521 . . . . 0.0 111.546 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -160.96 -82.77 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.054 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -173.91 33.57 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.877 0.37 . . . . 0.0 111.455 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 178.72 37.55 0.06 OUTLIER Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.429 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -82.52 149.38 27.56 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.779 0.323 . . . . 0.0 110.965 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.604 HG23 ' HB ' ' A' ' 8' ' ' THR . 61.8 m -119.43 133.18 55.83 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.401 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.3 p -141.95 127.46 17.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.907 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -128.67 145.08 51.26 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.284 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -123.29 104.59 9.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.233 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.548 HG12 ' HB2' ' A' ' 12' ' ' ALA . 30.0 mt -116.71 109.18 27.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.274 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.5 m -80.24 149.8 30.29 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.137 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 32.0 p . . . . . 0 C--N 1.332 -0.173 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.014 179.913 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 37.3 p-80 . . . . . 0 N--CA 1.463 0.179 0 CA-C-O 120.81 0.338 . . . . 0.0 111.509 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.557 HD13 ' H ' ' A' ' 90' ' ' GLY . 23.5 mm -99.1 146.11 9.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.847 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.449 ' HB ' ' HA ' ' A' ' 92' ' ' THR . 89.1 m -104.85 118.63 37.02 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.084 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.707 HG23 HG13 ' A' ' 93' ' ' VAL . 8.4 p -149.47 112.64 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.798 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.445 ' HB3' ' CB ' ' A' ' 24' ' ' SER . 6.2 pm0 -136.35 162.43 33.03 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.953 0.406 . . . . 0.0 111.74 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -120.8 141.75 50.23 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.164 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.32 150.76 46.93 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.387 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.32 -109.57 2.86 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.453 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -115.59 29.63 7.12 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.944 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.73 -8.11 14.19 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.984 0.392 . . . . 0.0 111.692 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -93.69 -25.32 17.51 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.573 0.225 . . . . 0.0 111.008 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.11 -7.13 47.3 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.552 ' HB3' HD11 ' A' ' 55' ' ' LEU . 3.6 pp -85.74 13.71 6.84 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -145.11 -64.11 0.34 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.922 0.391 . . . . 0.0 109.987 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -175.59 38.8 0.01 OUTLIER 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.561 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.3 mptt 51.2 40.52 26.18 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.362 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.612 ' OE1' HD21 ' A' ' 25' ' ' LEU . 29.5 pt20 -67.23 171.98 5.22 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.918 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 62.3 p -114.09 -80.06 0.59 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.006 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.445 ' CB ' ' HB3' ' A' ' 10' ' ' GLN . 88.5 p -133.08 154.71 50.31 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.85 0.357 . . . . 0.0 111.409 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.612 HD21 ' OE1' ' A' ' 22' ' ' GLN . 0.4 OUTLIER -131.62 160.93 33.92 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.178 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 1.1 tt0 -131.17 120.92 23.99 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.032 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.5 mt . . . . . 0 C--O 1.234 0.287 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.739 179.726 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 89.3 m . . . . . 0 C--O 1.235 0.303 0 CA-C-O 120.826 0.346 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 44.9 p30 -116.94 -174.95 2.68 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.967 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.836 HD22 ' HA ' ' A' ' 83' ' ' MET . 5.3 tt -57.78 -41.76 82.74 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.004 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -51.68 -43.14 62.62 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.229 178.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.36 -31.11 61.56 Favored Glycine 0 C--N 1.334 0.472 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.549 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -70.7 -56.92 5.31 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.876 0.338 . . . . 0.0 110.955 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.766 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.5 OUTLIER -56.98 -56.04 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.361 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.425 ' HA ' ' CG ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -50.93 -29.85 13.24 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.733 179.785 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.434 ' HA ' ' HB2' ' A' ' 47' ' ' ASN . 0.7 OUTLIER -70.18 -34.5 73.05 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.357 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.616 HD12 ' N ' ' A' ' 45' ' ' LYS . 4.4 pp -96.99 -25.2 15.47 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.449 0.536 . . . . 0.0 112.449 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.616 ' N ' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -93.02 -32.88 14.34 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.0 m -108.64 -26.04 10.57 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.434 ' HB2' ' HA ' ' A' ' 43' ' ' LEU . 2.9 m-80 -109.51 -22.38 12.02 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -178.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.69 39.82 3.16 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.563 HG22 ' H ' ' A' ' 51' ' ' GLU . 10.4 p -98.38 143.11 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 120.85 0.357 . . . . 0.0 110.866 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.77 27.88 4.59 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.4 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.563 ' H ' HG22 ' A' ' 49' ' ' VAL . 2.2 tp10 -156.71 -166.98 2.25 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.52 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.475 ' HB2' HD23 ' A' ' 55' ' ' LEU . 2.4 mpt_? -57.95 111.03 2.99 Favored Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 116.935 -0.121 . . . . 0.0 110.889 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.544 ' O ' HG22 ' A' ' 57' ' ' VAL . 18.9 Cg_endo -59.51 -25.95 80.41 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.164 1.909 . . . . 0.0 112.209 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.454 ' HA ' HG22 ' A' ' 57' ' ' VAL . 5.9 m-20 -90.66 7.0 41.6 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.637 ' HG ' HD23 ' A' ' 56' ' ' LEU . 1.7 pp -89.19 -15.76 32.94 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 121.161 -0.216 . . . . 0.0 111.256 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.637 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -115.34 -47.17 2.85 Favored 'General case' 0 C--N 1.339 0.11 0 N-CA-C 111.499 0.185 . . . . 0.0 111.499 179.872 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.544 HG22 ' O ' ' A' ' 53' ' ' PRO . 21.4 m -58.41 147.05 7.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 121.119 0.485 . . . . 0.0 111.837 -179.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -67.19 -57.23 7.11 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.468 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -171.59 -43.7 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.357 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 46.9 p -81.62 7.28 12.66 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.406 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 56.34 23.99 43.6 Favored Glycine 0 C--N 1.343 0.928 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.334 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -108.79 -39.32 5.38 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 120.753 0.311 . . . . 0.0 110.569 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 11.3 t -132.14 165.02 25.01 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.13 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.747 HD13 HD13 ' A' ' 68' ' ' ILE . 5.0 mt -77.55 157.76 30.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.906 0.384 . . . . 0.0 110.781 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.43 ' HG3' HD12 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -61.12 153.21 68.2 Favored Pre-proline 0 N--CA 1.465 0.292 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.254 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -49.02 -32.66 24.12 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.926 2.417 . . . . 0.0 112.591 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -51.27 -34.39 32.95 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.858 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.747 HD13 HD13 ' A' ' 64' ' ' LEU . 5.1 mt -97.19 148.7 5.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 116.855 0.327 . . . . 0.0 110.708 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.29 118.58 32.66 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.017 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.405 ' O ' HD23 ' A' ' 71' ' ' LEU . 16.6 m -90.37 129.53 41.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.937 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.405 HD23 ' O ' ' A' ' 70' ' ' VAL . 4.0 mt -125.49 130.43 51.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.166 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.816 HG23 ' HB2' ' A' ' 77' ' ' ALA . 26.3 t -105.0 99.48 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.465 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.1 m120 58.68 55.41 4.74 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.936 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.5 t 61.38 42.08 12.11 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.24 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 53.2 t -160.13 121.94 3.22 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.781 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.517 ' CB ' HG23 ' A' ' 79' ' ' VAL . 11.1 m-20 -48.93 131.59 18.67 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.729 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.816 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -79.48 -26.27 41.69 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.973 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -72.72 -25.55 61.26 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.489 0.185 . . . . 0.0 111.119 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.517 HG23 ' CB ' ' A' ' 76' ' ' ASP . 49.0 t -62.11 -29.59 46.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.017 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.8 m -112.46 -39.26 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -137.41 -72.96 0.06 OUTLIER Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.858 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 119.92 -42.21 1.8 Allowed Glycine 0 C--N 1.334 0.453 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.386 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.836 ' HA ' HD22 ' A' ' 37' ' ' LEU . 3.0 ptt? -157.42 29.35 0.29 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.743 0.306 . . . . 0.0 110.755 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -145.84 22.11 1.43 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.581 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.466 ' CE1' HG11 ' A' ' 72' ' ' VAL . 4.4 t80 -72.39 120.37 17.91 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 122.348 -0.22 . . . . 0.0 111.275 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.7 m -61.73 125.37 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.206 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.32 169.11 16.87 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.039 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -164.4 165.76 21.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.858 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -57.23 103.08 0.1 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.1 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.557 ' H ' HD13 ' A' ' 7' ' ' ILE . . . 106.14 24.65 6.77 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 121.108 -0.568 . . . . 0.0 113.016 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.02 138.88 39.86 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.928 0.364 . . . . 0.0 110.543 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.449 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 86.1 m -113.15 115.24 27.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.117 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.707 HG13 HG23 ' A' ' 9' ' ' VAL . 11.8 p -125.27 111.22 26.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 121.04 0.448 . . . . 0.0 110.633 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -114.92 151.38 34.14 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.176 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.548 ' HB3' HG21 ' A' ' 68' ' ' ILE . 15.7 m-85 -129.57 104.36 7.4 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.531 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.9 mt -106.24 100.44 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.887 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.8 106.64 7.49 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.47 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.5 p . . . . . 0 CA--C 1.536 0.415 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.741 -179.947 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.513 ' C ' HD12 ' A' ' 7' ' ' ILE . 55.9 m80 . . . . . 0 N--CA 1.464 0.26 0 CA-C-O 120.721 0.296 . . . . 0.0 110.72 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.513 HD12 ' C ' ' A' ' 6' ' ' HIS . 2.0 mp -113.32 135.06 54.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-O 120.931 0.396 . . . . 0.0 111.152 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.55 HG22 ' OE1' ' A' ' 10' ' ' GLN . 83.5 m -88.75 96.63 10.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.983 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.56 HG13 ' HB2' ' A' ' 25' ' ' LEU . 11.8 p -117.79 113.49 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.206 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.55 ' OE1' HG22 ' A' ' 8' ' ' THR . 8.8 pm0 -137.08 166.87 22.69 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.931 0.396 . . . . 0.0 111.899 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -126.67 150.14 49.14 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.24 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.696 ' HB3' HG12 ' A' ' 96' ' ' ILE . . . -146.55 158.18 43.86 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.559 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 67.96 -100.48 0.64 Allowed Glycine 0 C--N 1.336 0.537 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.459 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -124.04 33.16 3.96 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.586 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.7 m -109.7 -16.23 13.97 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.452 ' HG2' ' N ' ' A' ' 17' ' ' LEU . 12.7 pm0 -81.81 -33.57 30.71 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.702 0.286 . . . . 0.0 111.143 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.452 ' N ' ' HG2' ' A' ' 16' ' ' GLU . 1.4 mp -60.98 -28.19 68.83 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.033 0.382 . . . . 0.0 112.033 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.598 ' O ' HD12 ' A' ' 18' ' ' LEU . 2.9 pp -82.87 11.8 5.63 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.454 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 40.7 t80 -133.09 -60.01 0.87 Allowed 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.454 ' HB2' ' O ' ' A' ' 19' ' ' PHE . . . 174.27 36.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.031 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.56 32.16 4.7 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.902 0.382 . . . . 0.0 110.97 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -80.16 168.55 18.96 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.106 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.408 ' O ' ' HB2' ' A' ' 10' ' ' GLN . 16.3 p -101.93 -74.24 0.63 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.852 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.427 ' CB ' ' HB3' ' A' ' 10' ' ' GLN . 89.1 p -137.15 154.98 50.12 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.742 0.306 . . . . 0.0 111.198 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.56 ' HB2' HG13 ' A' ' 9' ' ' VAL . 4.8 mp -140.43 165.41 27.5 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.391 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.465 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 0.5 OUTLIER -131.27 119.34 21.64 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.827 179.783 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.3 mt . . . . . 0 C--O 1.233 0.188 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.916 -179.903 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 28.7 m . . . . . 0 N--CA 1.463 0.179 0 CA-C-O 120.692 0.282 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -105.26 -172.57 2.12 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.765 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.694 HD22 ' HA ' ' A' ' 83' ' ' MET . 1.0 OUTLIER -55.52 -35.66 65.89 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.335 -179.638 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -54.86 -40.58 69.81 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.88 0.371 . . . . 0.0 110.087 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.15 -30.04 63.59 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.801 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.627 HD21 HG11 ' A' ' 93' ' ' VAL . 10.0 tt -63.37 -49.73 72.69 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.819 0.342 . . . . 0.0 110.692 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.538 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -67.35 -52.18 44.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.728 179.767 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -54.72 -23.55 18.18 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.778 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.454 ' O ' ' HB3' ' A' ' 47' ' ' ASN . 4.6 tt -85.4 -22.95 28.14 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.878 0.371 . . . . 0.0 110.577 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.636 HD13 ' C ' ' A' ' 44' ' ' LEU . 1.2 tm? -92.48 -50.21 5.74 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.949 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.524 ' N ' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -89.33 -72.8 0.53 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 111.565 0.209 . . . . 0.0 111.565 -179.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.8 m -49.46 -24.63 2.11 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.454 ' HB3' ' O ' ' A' ' 43' ' ' LEU . 10.1 t30 -106.1 -25.99 11.8 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -138.58 45.52 2.04 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.461 ' HB ' ' O ' ' A' ' 45' ' ' LYS . 10.6 p -104.42 152.41 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.168 0.508 . . . . 0.0 111.478 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.01 -40.48 1.05 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.674 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -79.94 -167.03 1.13 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.313 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.406 ' HA ' ' HD2' ' A' ' 53' ' ' PRO . 0.4 OUTLIER -63.53 111.37 5.03 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.021 -179.94 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 52' ' ' ARG . 18.1 Cg_endo -60.45 -25.25 80.06 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.275 1.983 . . . . 0.0 112.159 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.461 ' HA ' ' CG2' ' A' ' 57' ' ' VAL . 4.6 m-20 -92.37 8.52 38.12 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.035 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.659 ' HG ' HD23 ' A' ' 56' ' ' LEU . 2.1 pp -86.74 -27.4 23.67 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 122.289 -0.257 . . . . 0.0 111.068 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.659 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -97.96 -47.27 5.6 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.517 HG11 ' HA2' ' A' ' 61' ' ' GLY . 4.8 m -57.68 149.25 4.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-O 121.243 0.544 . . . . 0.0 111.598 -179.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -65.45 -56.42 12.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.739 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -173.83 -43.91 0.01 OUTLIER 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.402 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 78.0 p -87.5 12.45 12.31 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.517 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 58.21 22.31 49.66 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.673 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -108.86 -41.18 4.82 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.944 0.402 . . . . 0.0 110.582 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.6 p -119.87 -175.94 3.08 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.715 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.0 mt -111.07 157.06 20.41 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.857 0.361 . . . . 0.0 111.148 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.75 155.75 92.5 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.282 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.01 135.13 67.39 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.818 2.345 . . . . 0.0 112.404 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 134.4 -49.29 0.91 Allowed Glycine 0 C--N 1.331 0.284 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.299 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.502 HG21 ' HB3' ' A' ' 95' ' ' PHE . 6.0 mt -81.46 137.49 21.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-O 120.657 0.265 . . . . 0.0 111.176 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.633 HD23 HD21 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -106.83 103.69 13.19 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.529 179.562 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.468 ' O ' HD23 ' A' ' 71' ' ' LEU . 15.4 m -83.25 130.41 35.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.609 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.633 HD21 HD23 ' A' ' 69' ' ' LEU . 3.3 mt -130.15 146.2 51.77 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.45 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.621 HG11 ' CD2' ' A' ' 85' ' ' TYR . 2.1 m -119.0 121.4 66.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.477 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 57.45 41.87 25.48 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.45 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 65.1 31.75 10.77 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.412 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 6.3 t -142.6 151.87 41.94 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.729 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.624 ' HB3' HG23 ' A' ' 79' ' ' VAL . 35.8 m-20 -50.21 116.75 2.0 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.854 0.359 . . . . 0.0 111.535 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.435 ' HA ' HG22 ' A' ' 72' ' ' VAL . . . -84.78 -21.54 29.93 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.842 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -75.4 -27.64 59.14 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.602 0.239 . . . . 0.0 110.84 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.624 HG23 ' HB3' ' A' ' 76' ' ' ASP . 24.8 t -71.79 -40.84 69.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.014 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.1 m -74.3 -32.65 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.8 -46.91 0.05 OUTLIER Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.6 -0.809 . . . . 0.0 113.145 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.83 -54.25 1.66 Allowed Glycine 0 C--N 1.334 0.447 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.171 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.694 ' HA ' HD22 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -136.22 23.92 3.25 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.569 0.223 . . . . 0.0 111.363 179.7 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -132.61 17.08 4.35 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.621 ' CD2' HG11 ' A' ' 72' ' ' VAL . 22.3 t80 -77.99 120.65 23.14 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.668 0.271 . . . . 0.0 111.36 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.1 m -66.39 147.74 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.67 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.23 154.78 17.55 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.267 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -171.01 152.09 3.43 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.864 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -56.73 108.32 0.48 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.159 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 115.58 24.33 4.09 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.408 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -93.25 167.22 11.89 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.683 0.242 . . . . 0.0 110.5 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 94.9 m -141.43 111.67 6.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.817 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.627 HG11 HD21 ' A' ' 40' ' ' LEU . 14.3 p -122.78 121.25 62.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.115 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -123.83 155.87 37.21 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.447 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.502 ' HB3' HG21 ' A' ' 68' ' ' ILE . 66.6 m-85 -132.19 104.34 6.72 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.927 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.696 HG12 ' HB3' ' A' ' 12' ' ' ALA . 28.5 mt -121.5 119.46 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.277 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.21 151.43 26.87 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.212 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.533 0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.672 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.465 0.28 0 CA-C-O 120.705 0.288 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.529 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 26.1 mm -127.75 152.83 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.794 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.494 HG22 ' NE2' ' A' ' 10' ' ' GLN . 19.3 m -113.66 95.29 5.26 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.775 0.322 . . . . 0.0 111.293 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.633 HG13 ' HB2' ' A' ' 25' ' ' LEU . 10.0 p -109.68 104.8 17.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.936 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.494 ' NE2' HG22 ' A' ' 8' ' ' THR . 0.4 OUTLIER -130.31 165.3 22.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.578 -179.327 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.422 ' HB2' ' HB3' ' A' ' 16' ' ' GLU . 44.5 m-85 -117.51 161.17 20.03 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.17 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.628 ' HB3' HG12 ' A' ' 96' ' ' ILE . . . -151.36 155.66 39.12 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.431 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 72.38 -101.17 1.03 Allowed Glycine 0 C--N 1.335 0.51 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.26 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.72 27.35 3.52 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.684 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.458 ' SG ' HD12 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -95.71 -27.96 15.02 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.707 0.254 . . . . 0.0 111.505 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.422 ' HB3' ' HB2' ' A' ' 11' ' ' PHE . 6.1 pt-20 -58.21 -30.88 66.82 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.648 0.261 . . . . 0.0 111.282 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.414 HD12 ' HG3' ' A' ' 16' ' ' GLU . 9.9 mp -68.13 -8.56 39.41 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.989 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.629 HD22 ' CD1' ' A' ' 55' ' ' LEU . 60.4 mt -82.76 13.44 3.84 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -147.91 -66.16 0.25 Allowed 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -172.35 38.74 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.828 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.31 37.15 18.04 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.845 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -75.28 155.45 36.66 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.117 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 60.9 p -91.06 -69.54 0.73 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.106 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.7 p -144.59 154.4 42.81 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.95 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.633 ' HB2' HG13 ' A' ' 9' ' ' VAL . 2.6 mp -141.28 165.15 28.3 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.328 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.529 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 9.5 mt-30 -125.8 119.21 27.28 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.101 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.7 mt . . . . . 0 C--O 1.233 0.205 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.565 179.82 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.8 m . . . . . 0 C--O 1.234 0.238 0 CA-C-O 120.881 0.372 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -135.26 -173.16 3.25 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.694 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.797 HD22 ' HA ' ' A' ' 83' ' ' MET . 3.2 tt -57.51 -41.87 81.69 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.278 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -56.19 -36.8 68.79 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.908 0.385 . . . . 0.0 110.18 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.77 -33.6 33.48 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.948 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.453 HD11 HG21 ' A' ' 7' ' ' ILE . 29.6 tp -65.41 -50.73 64.39 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.598 0.199 . . . . 0.0 110.707 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.78 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.3 OUTLIER -56.91 -56.57 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.684 179.568 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.409 ' H ' HG23 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -49.12 -33.22 11.43 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.345 179.578 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.34 -27.48 63.4 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.53 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.471 HD21 ' CZ ' ' A' ' 95' ' ' PHE . 1.0 OUTLIER -96.92 -38.42 9.82 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.708 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.444 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -81.99 -70.18 0.56 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.496 -179.52 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 m -52.41 -25.14 9.15 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -97.49 -37.29 10.03 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -142.45 58.73 1.45 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.444 ' HB ' ' O ' ' A' ' 45' ' ' LYS . 10.1 p -97.31 -34.92 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.407 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 73.32 -55.95 0.67 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 122.312 0.245 . . . . 0.0 110.644 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.456 ' HB3' HD21 ' A' ' 55' ' ' LEU . 2.4 tp10 -91.72 -177.14 4.68 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.463 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 63.7 mtp85 -58.6 140.84 84.8 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-O 120.718 0.294 . . . . 0.0 111.501 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.412 ' O ' HG22 ' A' ' 57' ' ' VAL . 92.7 Cg_endo -81.45 -18.7 8.15 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.818 2.345 . . . . 0.0 113.03 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.405 ' HA ' ' CG2' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -86.72 6.83 29.42 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -179.404 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.629 ' CD1' HD22 ' A' ' 18' ' ' LEU . 4.7 pp -90.62 -22.13 21.37 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.544 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.679 HD12 HD21 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -100.75 -47.44 4.82 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 111.566 0.21 . . . . 0.0 111.566 -179.874 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.506 HG11 ' HA2' ' A' ' 61' ' ' GLY . 3.0 m -55.09 150.85 2.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 121.154 0.502 . . . . 0.0 111.489 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.549 ' HB2' HG23 ' A' ' 63' ' ' THR . 18.6 t70 -65.64 -56.45 12.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.955 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -174.39 -44.68 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.183 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.9 t -83.47 9.9 10.14 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.688 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.506 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 57.15 23.61 47.85 Favored Glycine 0 C--N 1.34 0.763 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.812 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -110.78 -44.71 3.59 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.055 0.455 . . . . 0.0 110.484 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.549 HG23 ' HB2' ' A' ' 58' ' ' ASP . 10.2 t -115.1 168.23 10.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.088 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.679 HD21 HD12 ' A' ' 56' ' ' LEU . 6.4 mt -96.58 153.58 17.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.826 0.346 . . . . 0.0 111.232 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.439 ' HD3' ' N ' ' A' ' 67' ' ' GLY . 0.5 OUTLIER -57.01 155.48 15.75 Favored Pre-proline 0 N--CA 1.465 0.306 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.571 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.95 -35.97 91.66 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.142 2.562 . . . . 0.0 112.689 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.439 ' N ' ' HD3' ' A' ' 65' ' ' ARG . . . -45.79 -36.68 6.67 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-N 115.844 -0.616 . . . . 0.0 113.327 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.463 HG21 ' HB3' ' A' ' 95' ' ' PHE . 4.3 mt -102.03 138.33 26.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 117.032 0.416 . . . . 0.0 110.925 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 mt -105.75 111.13 23.68 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.474 ' C ' HD23 ' A' ' 71' ' ' LEU . 17.1 m -80.76 125.63 39.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.208 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.474 HD23 ' C ' ' A' ' 70' ' ' VAL . 3.8 mt -123.73 126.79 47.15 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.318 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.758 HG23 ' HB2' ' A' ' 77' ' ' ALA . 28.2 t -105.11 101.94 13.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.579 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 56.61 55.7 6.19 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.123 0.487 . . . . 0.0 110.867 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.9 m 60.87 41.42 14.47 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.499 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 53.0 t -159.74 119.36 2.92 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.657 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.543 ' CB ' HG23 ' A' ' 79' ' ' VAL . 1.5 m-20 -47.54 126.69 10.25 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.474 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.758 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -67.83 -28.56 67.67 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.965 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -69.96 -25.31 63.57 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.067 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.543 HG23 ' CB ' ' A' ' 76' ' ' ASP . 43.9 t -58.66 -30.51 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.789 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.4 m -110.74 -37.38 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.961 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -148.52 -62.06 0.01 OUTLIER Glycine 0 C--N 1.337 0.601 0 C-N-CA 120.629 -0.796 . . . . 0.0 113.066 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 112.06 -63.34 0.28 Allowed Glycine 0 C--N 1.331 0.277 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.293 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.797 ' HA ' HD22 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -134.37 23.2 3.75 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 111.424 0.157 . . . . 0.0 111.424 179.834 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -138.02 24.3 2.8 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.442 ' CE2' HG11 ' A' ' 72' ' ' VAL . 29.4 t80 -70.95 118.8 14.19 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 120.75 0.309 . . . . 0.0 111.396 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.6 m -62.4 165.89 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 116.143 -0.481 . . . . 0.0 112.131 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.46 153.57 31.87 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.571 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -156.85 32.9 0.3 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.678 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 64.66 111.39 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.907 0.384 . . . . 0.0 111.267 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.67 31.63 5.69 Favored Glycine 0 CA--C 1.517 0.217 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.431 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -89.85 112.23 23.5 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.792 0.329 . . . . 0.0 110.577 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 61.8 m -81.72 130.61 35.12 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.592 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.8 p -139.5 126.73 24.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.875 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -126.75 150.75 48.93 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.194 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.471 ' CZ ' HD21 ' A' ' 44' ' ' LEU . 43.2 m-85 -120.55 105.05 10.45 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.333 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.628 HG12 ' HB3' ' A' ' 12' ' ' ALA . 20.5 mt -112.0 109.47 28.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.346 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.2 p -77.32 150.97 35.16 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.571 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.463 0.216 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.133 179.653 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 46.2 m170 . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.64 0.257 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.506 ' N ' HD12 ' A' ' 7' ' ' ILE . 2.0 mp -103.71 138.34 28.57 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.002 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.417 HG22 ' OE1' ' A' ' 10' ' ' GLN . 88.5 m -86.55 93.76 9.26 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.891 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.563 ' O ' HG13 ' A' ' 9' ' ' VAL . 11.4 p -116.6 106.48 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 120.833 0.349 . . . . 0.0 111.422 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.477 ' HB2' ' O ' ' A' ' 23' ' ' THR . 5.8 pm0 -127.12 170.93 11.85 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.976 0.417 . . . . 0.0 111.872 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.421 ' CB ' ' HA ' ' A' ' 16' ' ' GLU . 89.1 m-85 -134.83 146.74 49.58 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.899 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -167.4 113.18 0.73 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.081 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.17 45.6 0.57 Allowed Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.632 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.99 14.51 82.24 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.562 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -107.23 -25.27 11.58 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 117.523 0.662 . . . . 0.0 111.52 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.421 ' HA ' ' CB ' ' A' ' 11' ' ' PHE . 0.9 OUTLIER -60.53 -22.09 63.22 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.42 HD12 ' HG2' ' A' ' 16' ' ' GLU . 6.4 mp -68.63 -6.69 27.28 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.794 HD21 HD11 ' A' ' 55' ' ' LEU . 59.2 mt -85.59 12.13 9.31 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -146.98 -63.56 0.29 Allowed 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -175.94 36.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.055 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 50.79 35.36 11.93 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.09 0.471 . . . . 0.0 110.672 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -78.84 167.69 20.8 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.066 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.477 ' O ' ' HB2' ' A' ' 10' ' ' GLN . 38.1 p -100.57 -31.52 11.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.4 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 88.7 p -169.92 146.78 3.2 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.636 0.255 . . . . 0.0 111.302 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 tp -133.13 166.16 23.08 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.436 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.485 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 32.9 mt-30 -132.03 116.19 16.77 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.688 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.494 HD22 HD23 ' A' ' 43' ' ' LEU . 14.0 mt . . . . . 0 C--O 1.232 0.132 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.937 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 90.5 m . . . . . 0 C--O 1.233 0.223 0 CA-C-O 120.849 0.357 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -138.85 -168.84 2.5 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.666 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.718 HD22 ' HA ' ' A' ' 83' ' ' MET . 1.7 tt -56.69 -40.27 75.31 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.146 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -58.02 -36.72 73.12 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.74 -32.15 59.54 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.029 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.681 HD21 HD11 ' A' ' 87' ' ' LEU . 17.2 mt -64.0 -49.58 71.91 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.815 0.34 . . . . 0.0 110.713 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.574 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -64.6 -53.53 41.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.009 179.793 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -56.18 -27.34 54.14 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.877 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.494 HD23 HD22 ' A' ' 27' ' ' LEU . 1.3 tp -84.56 -14.6 48.4 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 120.746 0.308 . . . . 0.0 110.914 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.641 HD13 ' N ' ' A' ' 45' ' ' LYS . 0.4 OUTLIER -96.83 -51.73 4.16 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.916 179.646 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.641 ' N ' HD13 ' A' ' 44' ' ' LEU . 1.3 pttt -86.16 -69.52 0.66 Allowed 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.9 m -49.16 -31.54 8.52 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.594 0.235 . . . . 0.0 111.395 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -76.2 -33.85 59.28 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.452 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -130.95 -71.56 0.57 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.602 ' O ' HG13 ' A' ' 49' ' ' VAL . 12.4 p 34.49 89.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.97 -32.02 64.93 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.038 179.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.409 ' O ' HG22 ' A' ' 49' ' ' VAL . 1.1 tp10 -97.13 -161.69 0.89 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.533 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.76 ' HB2' HD23 ' A' ' 55' ' ' LEU . 2.8 mmt180 -66.42 125.23 90.05 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-O 120.599 0.238 . . . . 0.0 111.207 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.41 ' HA ' HG21 ' A' ' 49' ' ' VAL . 56.8 Cg_endo -71.53 -28.16 17.95 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.475 2.117 . . . . 0.0 112.535 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.404 ' HA ' HG22 ' A' ' 57' ' ' VAL . 0.4 OUTLIER -94.22 7.96 43.45 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.752 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.794 HD11 HD21 ' A' ' 18' ' ' LEU . 1.7 pp -82.39 -12.85 57.65 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.597 ' HB2' HD22 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -105.61 -45.29 4.46 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 111.636 0.236 . . . . 0.0 111.636 179.827 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.547 HG11 ' HA2' ' A' ' 61' ' ' GLY . 1.4 m -59.3 149.51 6.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.163 0.506 . . . . 0.0 111.497 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -66.8 -57.99 5.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.764 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -172.44 -44.87 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.315 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.6 p -79.38 4.09 16.38 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.635 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.547 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 60.24 28.18 66.46 Favored Glycine 0 C--N 1.339 0.705 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.574 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.0 tp60 -121.29 -46.1 2.31 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.816 0.341 . . . . 0.0 110.604 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.7 t -114.53 140.61 48.62 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.633 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.597 HD22 ' HB2' ' A' ' 56' ' ' LEU . 7.8 mt -67.92 154.58 41.29 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.894 0.378 . . . . 0.0 111.315 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.62 158.5 87.25 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.239 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.69 131.92 45.07 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.969 2.446 . . . . 0.0 112.241 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 138.02 -48.49 0.88 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.315 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.3 mt -88.29 144.54 8.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 120.794 0.331 . . . . 0.0 111.154 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.8 mt -113.61 99.0 7.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.777 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.81 HG23 ' HB3' ' A' ' 77' ' ' ALA . 13.5 m -78.67 131.7 33.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.882 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.453 HD23 ' O ' ' A' ' 70' ' ' VAL . 3.4 mt -130.16 127.47 39.78 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.209 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.601 HG11 ' CD2' ' A' ' 85' ' ' TYR . 39.1 t -103.72 119.14 51.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.354 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 59.5 53.29 5.19 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.968 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.9 m 53.34 35.98 21.7 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.576 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 8.2 t -150.8 153.95 36.39 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.139 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.404 ' CB ' HG23 ' A' ' 79' ' ' VAL . 4.5 m-20 -49.23 124.18 8.62 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.681 0.277 . . . . 0.0 111.315 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.81 ' HB3' HG23 ' A' ' 70' ' ' VAL . . . -65.38 -20.01 66.2 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.578 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -76.01 -29.77 58.27 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.601 0.238 . . . . 0.0 110.685 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.404 HG23 ' CB ' ' A' ' 76' ' ' ASP . 24.4 t -70.78 -42.6 77.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.056 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.5 ' HB ' ' CD1' ' A' ' 85' ' ' TYR . 17.9 m -68.21 -28.79 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 146.02 36.65 0.06 OUTLIER Glycine 0 C--N 1.337 0.625 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.741 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 53.69 -99.35 0.05 OUTLIER Glycine 0 C--N 1.337 0.593 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.915 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.718 ' HA ' HD22 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -122.89 29.16 6.92 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.786 0.327 . . . . 0.0 110.913 179.459 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -117.66 19.89 13.68 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.939 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.601 ' CD2' HG11 ' A' ' 72' ' ' VAL . 15.1 t80 -81.12 120.66 25.13 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.743 0.306 . . . . 0.0 111.358 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.9 m -75.59 158.69 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.477 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.681 HD11 HD21 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -91.45 150.28 21.32 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.078 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -147.9 30.52 0.88 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.412 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 59.48 95.99 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.962 0.41 . . . . 0.0 111.653 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 118.75 28.92 1.97 Allowed Glycine 0 CA--C 1.52 0.376 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.694 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -78.19 166.1 23.15 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.769 0.318 . . . . 0.0 110.88 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 98.7 m -141.33 113.2 7.8 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.105 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.8 p -124.94 136.43 60.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.856 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -135.11 153.12 52.12 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.411 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -125.59 104.61 8.49 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.438 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.1 mt -116.95 117.26 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.021 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.12 125.56 34.22 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.751 0.31 . . . . 0.0 111.19 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.9 p . . . . . 0 CA--C 1.531 0.242 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.279 -179.915 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.412 ' HB2' ' HG2' ' A' ' 26' ' ' GLN . 4.8 p80 . . . . . 0 N--CA 1.466 0.369 0 CA-C-O 120.814 0.34 . . . . 0.0 111.576 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.6 mm -132.11 136.64 56.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.224 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.63 HG22 ' OE1' ' A' ' 10' ' ' GLN . 89.0 m -86.44 109.23 18.91 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.892 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.546 HG13 ' HB2' ' A' ' 25' ' ' LEU . 12.0 p -129.08 112.71 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.286 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.63 ' OE1' HG22 ' A' ' 8' ' ' THR . 9.0 pm0 -137.26 166.69 23.17 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.842 0.353 . . . . 0.0 111.643 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.43 ' CD2' ' HB2' ' A' ' 95' ' ' PHE . 89.4 m-85 -134.37 148.88 50.77 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.242 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -164.21 128.91 2.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.967 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.92 40.71 2.25 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.72 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.55 19.55 79.17 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 121.021 -0.609 . . . . 0.0 113.388 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.0 -12.14 14.24 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 117.279 0.539 . . . . 0.0 111.849 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.426 ' HA ' ' CB ' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -69.3 -15.5 63.36 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.701 0.259 . . . . 0.0 111.701 179.867 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 mt -69.03 -5.47 22.09 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.921 HD21 HD11 ' A' ' 55' ' ' LEU . 53.0 mt -81.6 13.65 2.99 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.502 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 2.6 t80 -153.57 -58.49 0.13 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.698 0.285 . . . . 0.0 110.522 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -179.27 36.37 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.136 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.92 33.9 7.2 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.889 0.376 . . . . 0.0 110.889 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -83.73 166.56 17.95 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.014 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 81.6 p -88.14 -70.66 0.62 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.825 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.406 ' CB ' ' HB3' ' A' ' 10' ' ' GLN . 83.3 p -136.73 156.05 49.03 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.717 0.294 . . . . 0.0 111.306 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.546 ' HB2' HG13 ' A' ' 9' ' ' VAL . 3.4 mp -140.44 164.57 29.77 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.442 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.412 ' HG2' ' HB2' ' A' ' 6' ' ' HIS . 0.0 OUTLIER -122.23 112.03 17.67 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.523 179.743 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.8 mt . . . . . 0 C--N 1.332 -0.183 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.9 -179.882 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 54.4 m . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.922 0.391 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -125.76 -172.35 2.58 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.744 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.728 HD22 ' HA ' ' A' ' 83' ' ' MET . 5.3 tt -54.95 -43.59 73.54 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -57.15 -35.33 69.39 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.906 0.384 . . . . 0.0 110.124 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.22 -33.21 36.53 Favored Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.951 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.527 HD12 ' HA ' ' A' ' 37' ' ' LEU . 73.1 mt -63.56 -51.49 65.17 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.756 0.312 . . . . 0.0 110.624 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.694 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.3 OUTLIER -57.36 -56.79 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.812 179.641 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.408 ' H ' HG23 ' A' ' 41' ' ' VAL . 5.7 tt0 -49.46 -34.66 17.4 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.329 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.92 -27.62 65.93 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.846 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.1 pp -96.64 -38.14 10.06 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.434 ' CA ' ' HB ' ' A' ' 49' ' ' VAL . 2.8 pttt -85.59 -62.13 1.6 Allowed 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.9 m -58.1 -21.64 47.08 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.118 -0.233 . . . . 0.0 111.61 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -98.75 -36.64 9.76 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -150.23 54.42 0.92 Allowed 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.434 ' HB ' ' CA ' ' A' ' 45' ' ' LYS . 9.4 p -80.91 -43.88 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 121.216 -0.194 . . . . 0.0 111.521 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 19' ' ' PHE . 0.6 OUTLIER 67.86 -59.06 0.43 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 122.601 0.36 . . . . 0.0 110.608 -179.126 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.22 -168.55 0.52 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.208 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.445 ' HB3' ' HB3' ' A' ' 55' ' ' LEU . 3.5 ttt180 -69.16 128.33 92.62 Favored Pre-proline 0 CA--C 1.529 0.173 0 CA-C-O 120.625 0.25 . . . . 0.0 111.471 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.457 ' O ' HG22 ' A' ' 57' ' ' VAL . 58.7 Cg_endo -72.72 -23.73 19.06 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.311 2.007 . . . . 0.0 112.492 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -93.08 7.38 44.42 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.921 HD11 HD21 ' A' ' 18' ' ' LEU . 3.0 pp -85.67 -21.06 28.54 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 121.117 -0.233 . . . . 0.0 111.072 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.572 ' H ' HD23 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -103.03 -48.78 3.95 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 111.477 0.177 . . . . 0.0 111.477 179.614 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.499 HG11 ' HA2' ' A' ' 61' ' ' GLY . 2.8 m -62.72 144.73 14.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 121.052 0.453 . . . . 0.0 111.14 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.436 ' HA ' ' HB3' ' A' ' 65' ' ' ARG . 10.4 t70 -63.72 -60.23 3.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.596 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.8 tm0? -168.85 -44.66 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.309 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.1 p -79.55 2.71 21.21 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.534 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.499 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 62.16 28.41 70.64 Favored Glycine 0 C--N 1.34 0.761 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.413 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -124.05 -40.46 2.28 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.575 0.226 . . . . 0.0 111.464 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.7 t -114.09 135.8 53.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.636 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.51 HD11 ' HB2' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -70.06 132.9 46.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.869 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.436 ' HB3' ' HA ' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -58.89 155.44 31.74 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.419 -179.793 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -58.62 138.07 83.7 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.819 2.346 . . . . 0.0 112.402 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 136.85 -46.74 1.0 Allowed Glycine 0 C--N 1.332 0.336 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.195 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.422 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 5.4 mt -94.93 127.38 46.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 120.697 0.284 . . . . 0.0 111.018 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.9 mp -98.3 102.94 14.83 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.849 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.761 HG23 ' HB3' ' A' ' 77' ' ' ALA . 15.4 m -76.59 133.98 29.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.744 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.6 HD11 HD12 ' A' ' 96' ' ' ILE . 1.1 mt -129.15 141.98 51.01 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.487 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.743 HG23 ' HB2' ' A' ' 77' ' ' ALA . 19.6 t -113.68 111.55 36.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.586 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.0 m120 57.67 54.04 6.69 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.989 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.8 t 57.23 49.65 13.03 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.98 0.419 . . . . 0.0 111.186 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 50.6 t -162.17 146.21 12.19 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.671 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.653 ' HB3' HG23 ' A' ' 79' ' ' VAL . 9.5 m-20 -50.83 121.71 6.34 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.46 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.761 ' HB3' HG23 ' A' ' 70' ' ' VAL . . . -83.99 -22.8 31.25 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.735 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -74.18 -30.58 62.3 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-O 120.555 0.217 . . . . 0.0 110.888 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.653 HG23 ' HB3' ' A' ' 76' ' ' ASP . 45.2 t -63.69 -40.59 89.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.127 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 26.9 m -79.48 -36.79 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.505 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -166.66 -51.55 0.03 OUTLIER Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.64 -0.791 . . . . 0.0 113.128 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 100.26 -50.97 1.05 Allowed Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.425 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.728 ' HA ' HD22 ' A' ' 37' ' ' LEU . 2.4 ptt? -144.11 25.51 1.57 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.527 0.203 . . . . 0.0 111.38 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -140.48 23.59 2.31 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.538 ' CE1' HG11 ' A' ' 72' ' ' VAL . 38.3 t80 -80.78 103.4 10.59 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.771 0.32 . . . . 0.0 110.774 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.6 m -72.63 145.72 11.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.836 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.569 ' C ' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -153.12 165.39 35.79 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.012 -179.769 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -134.69 -64.78 0.66 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.084 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -146.59 132.37 18.99 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.749 0.309 . . . . 0.0 111.067 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.96 21.24 36.66 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 121.104 -0.57 . . . . 0.0 112.89 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -86.23 163.98 17.44 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.801 0.334 . . . . 0.0 111.129 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.425 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 90.8 m -138.88 130.28 27.14 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.922 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.6 p -140.54 124.07 17.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.696 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.414 ' HG2' ' HG2' ' A' ' 10' ' ' GLN . 14.0 mt-10 -126.7 137.17 53.22 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.4 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.43 ' HB2' ' CD2' ' A' ' 11' ' ' PHE . 3.9 m-85 -107.42 104.81 14.48 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.562 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.6 HD12 HD11 ' A' ' 71' ' ' LEU . 28.3 mt -109.04 104.87 17.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.148 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . 41.9 t -85.01 140.13 31.26 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.04 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 34.2 p . . . . . 0 C--N 1.332 -0.182 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.946 179.9 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 14.0 p-80 . . . . . 0 N--CA 1.464 0.269 0 CA-C-O 120.705 0.288 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.538 HD12 HD23 ' A' ' 87' ' ' LEU . 27.8 mm -117.49 152.19 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.11 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.485 ' HB ' HG23 ' A' ' 92' ' ' THR . 6.1 m -117.15 102.33 9.21 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.05 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.536 ' O ' HG13 ' A' ' 9' ' ' VAL . 12.7 p -128.99 112.43 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 120.788 0.328 . . . . 0.0 111.765 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.63 165.2 22.27 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.982 0.42 . . . . 0.0 111.57 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.432 ' CB ' ' HA ' ' A' ' 16' ' ' GLU . 26.0 m-85 -126.41 131.52 51.71 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.199 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.13 151.39 47.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.503 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.19 -94.97 2.03 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.688 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -137.24 28.71 2.77 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.82 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.83 -27.93 9.04 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.736 0.268 . . . . 0.0 111.61 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.432 ' HA ' ' CB ' ' A' ' 11' ' ' PHE . 0.6 OUTLIER -57.35 -30.87 65.19 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.524 0.202 . . . . 0.0 111.226 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.72 -13.86 62.65 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.857 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.559 HD22 HD21 ' A' ' 55' ' ' LEU . 32.3 mt -84.9 13.34 6.05 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -143.07 -61.92 0.42 Allowed 'General case' 0 CA--C 1.523 -0.071 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -178.81 36.37 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.103 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 50.37 31.7 5.63 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.962 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.65 173.47 12.41 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.104 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.4 p -102.46 -75.82 0.59 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.764 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 92.5 p -131.46 156.91 44.82 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.783 0.325 . . . . 0.0 111.372 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.505 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -137.19 159.0 43.17 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.259 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.454 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 2.6 mt-30 -129.87 129.75 44.33 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.971 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.465 HD12 HG21 ' A' ' 7' ' ' ILE . 2.9 mt . . . . . 0 C--O 1.233 0.224 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.688 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.7 m . . . . . 0 C--O 1.233 0.215 0 CA-C-O 120.695 0.283 . . . . 0.0 110.68 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -104.28 175.76 5.38 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.029 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.794 ' O ' HG22 ' A' ' 41' ' ' VAL . 5.2 tt -57.79 -41.93 83.1 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.682 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -54.98 -36.87 65.85 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.943 0.401 . . . . 0.0 110.377 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.13 -31.15 43.7 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.196 178.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 25.1 tp -70.08 -51.87 28.32 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.798 0.299 . . . . 0.0 110.921 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.794 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.4 OUTLIER -57.46 -57.24 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.895 179.787 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.44 ' H ' HG23 ' A' ' 41' ' ' VAL . 2.9 tt0 -51.39 -28.81 13.64 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.609 -0.268 . . . . 0.0 111.434 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.0 tp -78.12 -27.06 48.22 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.704 HD12 ' N ' ' A' ' 45' ' ' LYS . 4.6 pp -96.86 -37.15 10.35 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.704 ' N ' HD12 ' A' ' 44' ' ' LEU . 0.9 OUTLIER -86.01 -69.24 0.68 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.418 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.9 m -54.66 -23.74 18.65 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -103.97 -20.51 13.85 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -148.06 48.21 1.06 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.632 HG22 ' H ' ' A' ' 51' ' ' GLU . 8.1 p -94.06 132.07 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 120.719 0.295 . . . . 0.0 111.222 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -115.4 32.42 6.07 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.276 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.632 ' H ' HG22 ' A' ' 49' ' ' VAL . 1.9 tp10 -163.17 -171.86 2.79 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.502 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.599 ' HB3' HD23 ' A' ' 55' ' ' LEU . 1.4 ttt180 -65.1 110.78 4.66 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.782 -0.19 . . . . 0.0 110.929 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.418 ' O ' HG22 ' A' ' 57' ' ' VAL . 17.8 Cg_endo -60.29 -21.65 67.72 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.345 2.03 . . . . 0.0 112.692 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -91.29 7.66 39.79 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.621 ' HG ' HD23 ' A' ' 56' ' ' LEU . 2.5 pp -93.56 -18.97 21.64 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.486 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.621 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -102.53 -48.52 4.12 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.601 0.223 . . . . 0.0 111.601 179.825 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.519 HG11 ' HA2' ' A' ' 61' ' ' GLY . 3.4 m -57.14 148.32 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 121.101 0.477 . . . . 0.0 111.591 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -69.57 -58.82 3.47 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.712 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -166.91 -48.95 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.517 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.3 p -77.42 6.52 6.79 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.715 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.519 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 57.77 27.92 59.69 Favored Glycine 0 C--N 1.339 0.707 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.637 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -122.18 -42.09 2.39 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.589 0.233 . . . . 0.0 110.943 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 49.9 p -117.21 136.24 53.2 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.611 HD12 HG21 ' A' ' 68' ' ' ILE . 6.3 mt -66.71 155.54 37.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.845 0.355 . . . . 0.0 111.142 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.53 160.14 74.06 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.47 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -51.25 -33.39 44.75 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 123.167 2.578 . . . . 0.0 112.798 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -53.43 -32.13 44.64 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.733 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.611 HG21 HD12 ' A' ' 64' ' ' LEU . 19.5 mm -83.46 151.47 3.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 120.822 0.344 . . . . 0.0 110.793 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.705 HD12 HD21 ' A' ' 71' ' ' LEU . 0.5 OUTLIER -127.83 99.83 5.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.815 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 70' ' ' VAL . 34.9 m -84.55 122.12 37.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.731 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.705 HD21 HD12 ' A' ' 69' ' ' LEU . 4.5 mt -131.3 137.55 48.86 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.174 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.616 HG13 ' HB2' ' A' ' 77' ' ' ALA . 3.3 m -109.54 118.95 57.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.784 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 24.2 m-20 64.23 -78.57 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.938 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -151.55 32.01 0.57 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.077 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 49.7 t -157.32 146.51 20.02 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.852 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.534 ' CB ' HG23 ' A' ' 79' ' ' VAL . 0.7 OUTLIER -52.5 130.6 32.18 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.362 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.616 ' HB2' HG13 ' A' ' 72' ' ' VAL . . . -75.3 -23.29 57.34 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.687 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.422 ' HA ' ' CA ' ' A' ' 82' ' ' GLY . 3.2 mt-10 -74.38 -18.69 60.64 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.141 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.534 HG23 ' CB ' ' A' ' 76' ' ' ASP . 38.2 t -63.14 -35.74 73.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 120.661 0.267 . . . . 0.0 110.875 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.9 m -98.88 -37.66 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.789 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -152.61 -60.19 0.01 OUTLIER Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.594 -0.812 . . . . 0.0 113.222 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.422 ' CA ' ' HA ' ' A' ' 78' ' ' GLU . . . 100.72 -51.22 1.0 Allowed Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.253 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.585 ' HA ' HD22 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -128.02 4.54 5.91 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 179.718 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -123.7 25.56 8.07 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.531 ' CE2' HG21 ' A' ' 72' ' ' VAL . 8.4 t80 -74.28 88.72 2.03 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.875 0.369 . . . . 0.0 110.81 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.4 m -61.54 139.6 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.664 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.538 HD23 HD12 ' A' ' 7' ' ' ILE . 7.1 mp -90.52 168.59 11.71 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.073 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 37.1 p30 -168.33 43.58 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.408 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 64.36 96.43 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.151 0.501 . . . . 0.0 110.99 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 112.96 28.25 3.45 Favored Glycine 0 CA--C 1.521 0.433 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.393 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.52 144.12 26.28 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.723 0.297 . . . . 0.0 110.715 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.485 HG23 ' HB ' ' A' ' 8' ' ' THR . 88.5 m -123.25 133.95 54.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.85 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.14 130.52 18.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.996 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -123.17 155.4 37.15 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.239 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -132.41 108.08 8.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.493 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 33.6 mt -113.94 123.45 69.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.115 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.65 130.88 38.15 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.263 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 71.5 p . . . . . 0 N--CA 1.465 0.288 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.98 179.7 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 . . . . . 0 N--CA 1.463 0.192 0 CA-C-O 120.715 0.293 . . . . 0.0 110.656 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.408 HG23 ' O ' ' A' ' 91' ' ' ASP . 3.0 mp -91.27 126.06 43.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.134 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.894 ' HB ' HG23 ' A' ' 92' ' ' THR . 0.2 OUTLIER -85.76 96.11 9.62 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.255 179.461 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.56 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.7 p -115.72 106.0 19.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.953 0.406 . . . . 0.0 111.272 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.822 ' OE1' HG22 ' A' ' 8' ' ' THR . 0.0 OUTLIER -136.38 155.59 49.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.053 0.454 . . . . 0.0 111.375 179.74 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -118.89 138.66 52.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.742 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.437 ' HB3' ' HA ' ' A' ' 96' ' ' ILE . . . -92.03 -178.67 5.06 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.185 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.61 97.18 0.08 OUTLIER Glycine 0 C--N 1.335 0.495 0 C-N-CA 121.133 -0.556 . . . . 0.0 112.687 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 138.29 -33.28 2.25 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.733 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.04 9.04 24.25 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -83.92 -37.43 22.35 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.584 0.231 . . . . 0.0 111.426 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.445 HD12 ' H ' ' A' ' 17' ' ' LEU . 3.0 mp -69.74 -4.6 20.51 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.506 HD22 HD21 ' A' ' 55' ' ' LEU . 4.7 mt -88.94 13.69 12.21 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -146.73 -61.94 0.3 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.702 0.286 . . . . 0.0 110.326 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -178.07 36.34 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.076 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.51 33.29 7.66 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.927 0.394 . . . . 0.0 110.822 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -80.19 174.47 11.56 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.715 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 79.7 p -110.66 -69.68 0.85 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.06 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.442 ' CB ' ' HB3' ' A' ' 10' ' ' GLN . 59.3 p -141.64 162.99 34.12 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.691 0.281 . . . . 0.0 111.34 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.465 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -150.98 165.33 34.05 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.258 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.407 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -129.12 101.02 5.85 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.675 179.778 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.4 mt . . . . . 0 C--O 1.233 0.206 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.696 -179.939 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.2 m . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.659 0.266 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -111.83 -176.39 2.92 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.946 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.653 HD22 ' HA ' ' A' ' 83' ' ' MET . 6.9 tt -54.32 -37.84 65.3 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.558 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -57.77 -35.19 70.42 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.904 0.383 . . . . 0.0 110.011 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.55 -32.96 58.98 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.583 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.503 ' HG ' HD11 ' A' ' 87' ' ' LEU . 7.8 mt -64.76 -53.15 51.58 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.718 0.295 . . . . 0.0 110.527 179.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.542 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.2 OUTLIER -57.48 -56.93 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.023 179.667 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -49.23 -30.8 7.58 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.654 0.264 . . . . 0.0 111.489 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.2 tp -70.76 -31.0 67.65 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 2.9 pp -97.13 -42.57 7.79 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.77 -68.46 0.68 Allowed 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -178.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.5 m -50.19 -29.68 9.86 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.422 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -77.31 -36.67 53.87 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.434 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -127.89 -68.26 0.78 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.544 ' O ' HG13 ' A' ' 49' ' ' VAL . 13.8 p 37.77 66.88 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 121.474 0.654 . . . . 0.0 111.766 -179.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.26 -30.81 62.92 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.088 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.97 -164.84 1.23 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.881 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.09 135.03 91.58 Favored Pre-proline 0 N--CA 1.462 0.144 0 CA-C-O 120.64 0.257 . . . . 0.0 111.142 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.491 ' O ' HG22 ' A' ' 57' ' ' VAL . 70.1 Cg_endo -76.23 -28.45 7.22 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.369 2.046 . . . . 0.0 112.475 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.405 ' HA ' ' CG2' ' A' ' 57' ' ' VAL . 11.8 m-20 -92.89 9.31 35.95 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.716 ' HG ' HD23 ' A' ' 56' ' ' LEU . 2.6 pp -82.94 -28.2 30.02 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 122.317 -0.239 . . . . 0.0 111.006 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.716 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -100.07 -49.19 4.38 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.509 HG11 ' HA2' ' A' ' 61' ' ' GLY . 6.2 m -62.42 146.8 12.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 121.101 0.477 . . . . 0.0 111.451 -179.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -67.21 -57.65 6.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.574 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -169.93 -45.03 0.02 OUTLIER 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.496 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.4 p -77.78 0.63 22.96 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.571 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.509 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 63.43 22.86 66.08 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.388 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -120.27 -38.32 2.93 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.749 0.309 . . . . 0.0 111.1 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.9 t -118.99 132.39 56.06 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 6.2 mt -67.15 153.81 42.76 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.98 0.419 . . . . 0.0 111.36 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -74.4 161.35 78.47 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.015 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -61.09 123.23 12.48 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.77 2.313 . . . . 0.0 112.188 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 154.01 -45.54 0.56 Allowed Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.4 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.6 mt -96.76 135.35 31.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 120.763 0.316 . . . . 0.0 111.068 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.3 tp -106.05 108.87 20.61 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.518 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.666 HG11 ' HE2' ' A' ' 83' ' ' MET . 16.3 m -77.66 129.07 37.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.446 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.501 HD23 ' O ' ' A' ' 70' ' ' VAL . 9.5 mt -126.09 128.12 46.86 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.88 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.577 HG12 ' O ' ' A' ' 92' ' ' THR . 4.4 m -117.31 122.4 69.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.073 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 55.24 46.31 23.97 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.52 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.3 m 61.96 30.23 18.0 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.494 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 31.1 t -153.01 130.25 11.23 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.805 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.633 ' HB2' HG23 ' A' ' 79' ' ' VAL . 9.2 m-20 -46.44 130.41 10.91 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.899 0.381 . . . . 0.0 111.536 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.29 -21.12 59.88 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.133 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.42 ' HA ' ' CA ' ' A' ' 82' ' ' GLY . 1.7 mt-10 -73.31 -28.3 62.01 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-O 120.577 0.227 . . . . 0.0 110.918 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.633 HG23 ' HB2' ' A' ' 76' ' ' ASP . 43.5 t -64.93 -33.78 65.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.053 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.4 m -100.92 -37.47 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -140.01 -74.64 0.05 OUTLIER Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.096 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.42 ' CA ' ' HA ' ' A' ' 78' ' ' GLU . . . 107.81 85.11 1.72 Allowed Glycine 0 C--N 1.331 0.302 0 C-N-CA 121.155 -0.545 . . . . 0.0 112.185 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.666 ' HE2' HG11 ' A' ' 70' ' ' VAL . 1.9 mmt 58.4 23.49 10.64 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.679 0.276 . . . . 0.0 111.394 -179.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -147.1 24.92 1.14 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.336 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -74.94 114.9 13.95 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.693 0.283 . . . . 0.0 110.95 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.7 m -65.12 140.29 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.693 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.503 HD11 ' HG ' ' A' ' 40' ' ' LEU . 2.9 mp -78.61 168.58 19.56 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.433 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -165.3 42.55 0.07 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.232 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 54.35 88.52 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.068 0.461 . . . . 0.0 111.404 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 117.94 26.64 2.71 Favored Glycine 0 CA--C 1.523 0.532 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.895 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.408 ' O ' HG23 ' A' ' 7' ' ' ILE . 2.2 t70 -78.58 150.61 32.74 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-O 120.819 0.342 . . . . 0.0 110.846 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.894 HG23 ' HB ' ' A' ' 8' ' ' THR . 96.8 m -120.99 129.94 53.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.451 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.15 136.68 25.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.22 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -134.09 151.56 51.44 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.389 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -123.73 104.72 9.16 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.39 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.437 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 14.9 mt -115.14 116.96 54.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.11 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 68.0 m -76.17 82.37 2.98 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.911 0.386 . . . . 0.0 110.739 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.53 0.177 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.244 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.409 ' CD2' ' HG2' ' A' ' 26' ' ' GLN . 1.1 m170 . . . . . 0 N--CA 1.464 0.256 0 CA-C-O 120.434 0.159 . . . . 0.0 110.981 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.713 HD12 ' HB2' ' A' ' 27' ' ' LEU . 25.1 mt -88.97 117.18 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-O 120.858 0.361 . . . . 0.0 111.103 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.717 HG22 ' OE1' ' A' ' 10' ' ' GLN . 37.6 m -82.26 112.4 19.22 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.368 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.539 HG13 ' HB2' ' A' ' 25' ' ' LEU . 7.6 p -141.7 105.83 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-O 120.907 0.385 . . . . 0.0 111.129 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.717 ' OE1' HG22 ' A' ' 8' ' ' THR . 1.6 pm0 -130.39 171.62 12.75 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.82 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.497 ' HB2' ' HB3' ' A' ' 16' ' ' GLU . 91.1 m-85 -128.87 151.36 49.71 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.18 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.582 ' HB3' HG12 ' A' ' 96' ' ' ILE . . . -148.97 130.88 15.21 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.592 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.83 -107.73 3.55 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.287 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -119.34 30.88 5.64 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 121.033 -0.604 . . . . 0.0 112.439 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -108.63 -31.29 7.82 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 111.493 0.183 . . . . 0.0 111.493 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.497 ' HB3' ' HB2' ' A' ' 11' ' ' PHE . 8.6 pm0 -63.68 -30.82 71.88 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.563 0.22 . . . . 0.0 111.206 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 mp -71.57 -7.9 50.63 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.749 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.83 HD13 HD22 ' A' ' 56' ' ' LEU . 13.3 mt -85.7 13.73 6.75 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -146.74 -61.8 0.3 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.727 0.299 . . . . 0.0 110.228 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -177.31 36.93 0.0 OUTLIER 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.051 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.3 mptt 50.93 33.71 9.27 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.904 0.383 . . . . 0.0 110.997 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -79.18 145.3 33.74 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.833 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.0 p -78.22 -68.69 0.61 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.843 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 99.4 p -137.93 164.53 28.77 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.826 0.346 . . . . 0.0 111.413 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.539 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -139.34 155.59 47.58 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.142 179.83 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.409 ' HG2' ' CD2' ' A' ' 6' ' ' HIS . 0.1 OUTLIER -133.36 116.93 16.67 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.028 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.713 ' HB2' HD12 ' A' ' 7' ' ' ILE . 11.2 mt . . . . . 0 C--N 1.333 -0.138 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.57 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 51.3 m . . . . . 0 N--CA 1.461 0.12 0 CA-C-O 120.508 0.194 . . . . 0.0 110.591 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -108.21 -177.9 3.46 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.855 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.686 HD22 ' HA ' ' A' ' 83' ' ' MET . 7.0 tt -56.47 -44.98 81.1 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.339 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -56.01 -37.97 69.87 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.37 -31.08 59.53 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.166 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.657 HD11 ' CD1' ' A' ' 87' ' ' LEU . 49.3 mt -64.87 -50.87 64.9 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.772 0.32 . . . . 0.0 110.566 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -64.78 -55.36 21.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.251 179.817 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -52.46 -22.98 5.36 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.403 ' O ' ' HB2' ' A' ' 47' ' ' ASN . 3.6 tt -86.79 -26.33 24.17 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.534 HD12 ' N ' ' A' ' 45' ' ' LYS . 3.4 pp -93.0 -45.37 7.96 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.243 0.461 . . . . 0.0 112.243 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.534 ' N ' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -71.89 -55.82 6.82 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 121.014 -0.274 . . . . 0.0 111.513 -179.378 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 35.1 m -52.06 -28.23 16.67 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.638 0.256 . . . . 0.0 111.117 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.5 OUTLIER -82.27 -32.96 29.36 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.124 179.524 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.88 -75.77 0.6 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.483 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.598 ' O ' HG13 ' A' ' 49' ' ' VAL . 7.9 p 33.52 58.03 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 121.345 0.593 . . . . 0.0 111.821 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.97 -33.5 68.93 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.189 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.475 ' HB2' ' HA ' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -90.33 172.2 8.93 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.399 179.502 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.586 ' HB2' HD23 ' A' ' 55' ' ' LEU . 28.5 mmm-85 -48.68 106.97 0.68 Allowed Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.61 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.417 ' O ' HG22 ' A' ' 57' ' ' VAL . 50.2 Cg_exo -55.11 -28.96 63.41 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.664 2.243 . . . . 0.0 112.563 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.45 9.78 32.85 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.834 ' HG ' HD23 ' A' ' 56' ' ' LEU . 1.4 pp -88.25 -28.13 21.31 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 121.148 -0.221 . . . . 0.0 111.1 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.834 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -93.77 -54.63 3.55 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.588 -179.871 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.548 HG11 ' HA2' ' A' ' 61' ' ' GLY . 2.1 m -53.94 151.53 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 121.068 0.461 . . . . 0.0 111.612 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -65.42 -58.2 6.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.565 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.3 -45.32 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.517 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.8 p -84.09 10.73 9.36 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.617 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.548 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 55.28 27.91 48.36 Favored Glycine 0 C--N 1.338 0.653 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.552 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -118.25 -41.37 2.86 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.755 0.312 . . . . 0.0 110.838 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.7 t -117.97 128.67 55.02 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.979 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.686 HD22 ' HB2' ' A' ' 56' ' ' LEU . 8.3 mt -67.44 156.21 37.14 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.717 0.294 . . . . 0.0 110.989 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.436 ' CG ' HD12 ' A' ' 68' ' ' ILE . 0.7 OUTLIER -52.44 153.81 4.97 Favored Pre-proline 0 N--CA 1.464 0.275 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.598 -179.796 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.36 -38.57 73.82 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.048 2.498 . . . . 0.0 112.771 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -48.34 -36.06 16.04 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 121.167 -0.539 . . . . 0.0 112.799 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.505 HD13 HD13 ' A' ' 64' ' ' LEU . 6.6 mt -84.32 126.48 40.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 117.008 0.404 . . . . 0.0 110.951 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 mt -94.63 101.5 13.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.515 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.712 HG23 ' HB3' ' A' ' 77' ' ' ALA . 15.3 m -79.51 132.3 32.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.899 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.529 HD23 ' O ' ' A' ' 70' ' ' VAL . 1.8 mt -137.22 138.77 40.49 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.386 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.501 HG23 ' CB ' ' A' ' 77' ' ' ALA . 44.0 t -119.06 119.74 61.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.656 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 28.3 m-20 61.27 54.07 3.33 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.079 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.2 m 52.82 38.44 26.63 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.492 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 21.4 t -155.43 155.05 32.87 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.523 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.494 ' HB3' HG23 ' A' ' 79' ' ' VAL . 0.6 OUTLIER -47.18 123.91 5.97 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.665 0.269 . . . . 0.0 111.438 -179.84 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.712 ' HB3' HG23 ' A' ' 70' ' ' VAL . . . -69.29 -23.17 63.79 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.693 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -74.86 -28.79 60.81 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.526 0.203 . . . . 0.0 110.653 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.494 HG23 ' HB3' ' A' ' 76' ' ' ASP . 24.1 t -73.52 -41.21 56.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.282 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.414 HG21 ' HB ' ' A' ' 72' ' ' VAL . 30.8 m -71.4 -34.19 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.663 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.9 -46.31 0.04 OUTLIER Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.74 -0.743 . . . . 0.0 113.055 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.84 73.45 1.27 Allowed Glycine 0 C--N 1.335 0.496 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.192 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.686 ' HA ' HD22 ' A' ' 37' ' ' LEU . 0.7 OUTLIER 62.2 29.71 17.51 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.586 0.231 . . . . 0.0 111.131 -179.613 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -150.2 29.86 0.71 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.432 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -90.27 118.91 30.14 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.725 0.297 . . . . 0.0 110.973 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.9 m -66.8 156.25 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.813 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.657 ' CD1' HD11 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -89.54 161.12 16.36 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.428 -179.699 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -158.4 36.84 0.24 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.253 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 47.1 t0 61.17 93.13 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.041 0.448 . . . . 0.0 110.896 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 112.52 31.34 2.6 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.588 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -70.14 166.92 18.89 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.724 0.297 . . . . 0.0 111.049 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.652 HG23 ' HB ' ' A' ' 8' ' ' THR . 85.1 m -140.05 125.59 19.15 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.08 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.449 HG13 HG23 ' A' ' 9' ' ' VAL . 10.4 p -143.23 140.17 26.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.93 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -138.05 144.72 41.11 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.912 0.387 . . . . 0.0 111.134 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.502 ' HB3' HG21 ' A' ' 68' ' ' ILE . 70.1 m-85 -125.15 104.85 8.74 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.719 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.582 HG12 ' HB3' ' A' ' 12' ' ' ALA . 27.6 mt -118.83 112.63 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.22 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 74.3 m -79.98 123.32 27.71 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.394 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.541 0.61 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.944 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.466 0.339 0 CA-C-O 120.982 0.42 . . . . 0.0 111.791 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 29.9 mm -111.23 153.94 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.401 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.728 HG22 ' OE1' ' A' ' 10' ' ' GLN . 2.3 m -121.19 111.32 17.26 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.664 0.268 . . . . 0.0 111.162 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.539 ' O ' HG13 ' A' ' 9' ' ' VAL . 8.3 p -129.99 104.69 10.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-O 120.925 0.393 . . . . 0.0 111.046 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.728 ' OE1' HG22 ' A' ' 8' ' ' THR . 0.0 OUTLIER -130.74 154.94 47.44 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.804 -179.657 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.414 ' HB2' ' HB3' ' A' ' 16' ' ' GLU . 32.4 m-85 -116.6 142.78 46.44 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.849 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.474 ' HB3' HG12 ' A' ' 96' ' ' ILE . . . -137.21 167.83 20.81 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.744 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 66.1 -104.74 1.09 Allowed Glycine 0 C--N 1.334 0.434 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.653 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -128.3 32.77 3.32 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.899 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.6 t -105.26 -32.26 8.7 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.865 0.332 . . . . 0.0 111.103 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.414 ' HB3' ' HB2' ' A' ' 11' ' ' PHE . 1.3 pt-20 -59.25 -33.35 70.93 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.32 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.7 mp -68.62 -8.84 45.67 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.532 HD21 HD11 ' A' ' 55' ' ' LEU . 68.0 mt -84.11 13.58 5.0 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -147.99 -64.42 0.26 Allowed 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -172.34 37.85 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.18 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.2 mptt 51.38 35.31 13.68 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.989 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -69.24 159.24 33.42 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.129 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 37.6 p -101.49 -71.88 0.7 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.966 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.502 ' O ' HD12 ' A' ' 25' ' ' LEU . 80.3 p -141.33 162.85 34.49 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.601 0.239 . . . . 0.0 111.254 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.502 HD12 ' O ' ' A' ' 24' ' ' SER . 0.7 OUTLIER -150.64 158.65 44.4 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.24 -179.915 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.48 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 52.9 mt-30 -133.16 144.84 50.15 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.95 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.4 mt . . . . . 0 C--O 1.233 0.227 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.972 -179.792 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 25.5 m . . . . . 0 CA--C 1.531 0.249 0 CA-C-O 120.749 0.309 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.6 p30 -141.5 -171.82 3.39 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.043 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.762 ' HA ' HD12 ' A' ' 40' ' ' LEU . 7.1 tt -54.29 -42.71 70.37 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.476 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -55.68 -38.38 69.55 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.98 -32.32 60.9 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.074 178.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.799 HD11 ' CD1' ' A' ' 87' ' ' LEU . 24.2 mt -66.66 -54.57 21.83 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.86 0.33 . . . . 0.0 110.487 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.631 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.6 OUTLIER -59.84 -58.49 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.894 179.895 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.459 ' H ' HG23 ' A' ' 41' ' ' VAL . 32.0 tt0 -50.26 -30.01 10.84 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.525 179.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.3 tt -71.43 -31.03 66.76 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.633 HD12 ' N ' ' A' ' 45' ' ' LYS . 4.6 pp -97.01 -40.75 8.71 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.633 ' N ' HD12 ' A' ' 44' ' ' LEU . 0.7 OUTLIER -87.31 -70.79 0.6 Allowed 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.477 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.7 m -55.35 -24.62 30.3 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -96.31 -31.54 12.84 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -152.66 57.9 0.81 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 49' ' ' VAL . 7.1 p -91.24 113.67 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 120.868 0.366 . . . . 0.0 110.617 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -94.8 48.74 1.21 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.769 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -177.79 -175.11 0.49 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.284 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.682 ' HB2' HD23 ' A' ' 55' ' ' LEU . 2.5 mmt-85 -62.11 110.95 3.76 Favored Pre-proline 0 N--CA 1.463 0.188 0 CA-C-O 120.502 0.191 . . . . 0.0 110.991 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 52' ' ' ARG . 18.2 Cg_endo -60.49 -24.95 79.47 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.278 1.986 . . . . 0.0 112.512 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.96 7.96 39.75 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.75 ' HG ' HD23 ' A' ' 56' ' ' LEU . 1.8 pp -89.62 -21.31 22.87 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.462 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.75 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -100.58 -48.62 4.47 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.536 HG11 ' HA2' ' A' ' 61' ' ' GLY . 2.6 m -54.89 151.25 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.063 0.459 . . . . 0.0 111.681 -179.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -69.47 -57.45 5.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.189 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -171.15 -44.6 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.418 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.9 t -82.23 7.78 12.83 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.641 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.536 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 59.34 24.49 59.15 Favored Glycine 0 C--N 1.342 0.885 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.702 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -115.79 -47.36 2.8 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.815 0.34 . . . . 0.0 110.371 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.532 HG22 ' CG ' ' A' ' 83' ' ' MET . 45.4 p -105.5 163.93 12.27 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.907 179.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.628 HD22 ' HB2' ' A' ' 56' ' ' LEU . 6.3 mt -99.06 152.82 19.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.855 0.359 . . . . 0.0 111.073 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.91 147.67 52.97 Favored Pre-proline 0 N--CA 1.467 0.379 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.352 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -49.88 -32.51 30.29 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.344 2.696 . . . . 0.0 113.326 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -45.16 -38.85 6.54 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 121.357 -0.449 . . . . 0.0 113.035 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.566 HG21 ' HB3' ' A' ' 95' ' ' PHE . 4.0 mt -100.15 135.2 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.951 0.375 . . . . 0.0 111.05 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.7 tp -100.07 101.98 13.19 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.661 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.682 HG23 ' HB3' ' A' ' 77' ' ' ALA . 26.9 m -83.37 126.12 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.185 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 mt -125.59 161.98 26.0 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.273 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.586 HG11 ' CD2' ' A' ' 85' ' ' TYR . 2.7 m -141.17 111.58 3.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.913 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 56.37 53.22 8.99 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.957 0.408 . . . . 0.0 110.888 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.9 m 58.33 30.3 19.36 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.502 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 49.8 t -144.19 130.72 19.98 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.223 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -45.6 128.43 8.34 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.689 0.28 . . . . 0.0 111.137 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.682 ' HB3' HG23 ' A' ' 70' ' ' VAL . . . -62.39 -21.6 65.49 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.768 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -72.52 -24.12 61.1 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.735 -0.212 . . . . 0.0 110.895 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.4 t -71.33 -47.18 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.131 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.525 HG21 ' CG ' ' A' ' 85' ' ' TYR . 29.8 m -69.36 -42.45 81.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.868 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 165.39 40.16 0.02 OUTLIER Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.517 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 54.3 -104.75 0.26 Allowed Glycine 0 C--N 1.336 0.582 0 C-N-CA 121.236 -0.506 . . . . 0.0 112.919 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.729 ' HA ' HD22 ' A' ' 37' ' ' LEU . 53.8 mmm -108.89 27.06 9.86 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.682 0.277 . . . . 0.0 111.074 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -122.03 21.19 10.62 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.586 ' CD2' HG11 ' A' ' 72' ' ' VAL . 19.4 t80 -73.46 118.92 16.99 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.65 0.262 . . . . 0.0 111.305 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 19.7 m -78.73 159.45 4.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.525 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.799 ' CD1' HD11 ' A' ' 40' ' ' LEU . 1.7 mp -110.29 175.77 5.3 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.863 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -168.86 -62.18 0.02 OUTLIER 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.04 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -178.91 108.15 0.04 OUTLIER 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.425 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 105.51 24.17 7.21 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.978 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -79.22 143.88 34.92 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 117.02 0.41 . . . . 0.0 110.611 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 53.5 m -134.22 103.07 5.6 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.003 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.7 p -107.84 134.65 48.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.803 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.429 ' HG2' ' HG2' ' A' ' 10' ' ' GLN . 15.3 mt-10 -136.42 150.47 48.77 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.468 -179.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.566 ' HB3' HG21 ' A' ' 68' ' ' ILE . 88.6 m-85 -124.56 104.48 8.74 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.148 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.474 HG12 ' HB3' ' A' ' 12' ' ' ALA . 24.3 mt -111.87 107.02 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.145 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.52 137.42 34.61 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.953 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.8 p . . . . . 0 CA--C 1.53 0.199 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.941 -179.859 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.68 ' C ' HD12 ' A' ' 7' ' ' ILE . 15.4 m170 . . . . . 0 CA--C 1.533 0.31 0 CA-C-O 120.742 0.306 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.68 HD12 ' C ' ' A' ' 6' ' ' HIS . 3.2 mp -129.87 145.86 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 120.741 0.305 . . . . 0.0 111.179 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.725 HG22 ' OE1' ' A' ' 10' ' ' GLN . 24.3 m -96.92 95.93 8.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.959 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.82 HG21 HD22 ' A' ' 44' ' ' LEU . 11.8 p -110.95 105.19 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 121.005 0.431 . . . . 0.0 110.833 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.725 ' OE1' HG22 ' A' ' 8' ' ' THR . 0.0 OUTLIER -130.51 175.29 9.1 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.725 -179.068 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.502 ' CG ' ' HA ' ' A' ' 16' ' ' GLU . 95.5 m-85 -118.63 161.64 19.73 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.107 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -172.8 157.93 3.82 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.369 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 66.16 45.03 89.73 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.615 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.11 33.2 82.61 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.902 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.7 -17.93 13.58 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.783 0.292 . . . . 0.0 111.613 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.502 ' HA ' ' CG ' ' A' ' 11' ' ' PHE . 2.0 pm0 -59.27 -24.94 63.66 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.7 mp -65.92 -7.7 18.18 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.665 ' CD2' HD11 ' A' ' 55' ' ' LEU . 58.0 mt -72.69 1.27 8.7 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.458 ' CD2' ' HB2' ' A' ' 50' ' ' LYS . 38.8 t80 -144.24 -65.97 0.35 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -172.19 40.0 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.354 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 52.58 46.83 25.97 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.77 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -75.04 -179.66 4.45 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.917 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.457 ' O ' ' HB2' ' A' ' 10' ' ' GLN . 39.9 p -113.74 -47.11 2.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.256 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.5 p -171.21 155.08 4.21 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.673 0.273 . . . . 0.0 110.978 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.645 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.8 OUTLIER -141.71 166.58 24.34 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.546 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.56 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 0.8 OUTLIER -132.29 126.47 33.45 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.93 179.791 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.9 mt . . . . . 0 C--O 1.234 0.238 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.846 179.855 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.5 m . . . . . 0 C--O 1.233 0.203 0 CA-C-O 120.694 0.283 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -95.94 -176.05 3.59 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.139 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.733 ' O ' HG22 ' A' ' 41' ' ' VAL . 1.6 tt -55.4 -40.26 71.22 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.583 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -51.85 -44.55 63.67 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.63 -32.78 67.24 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.996 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.961 HD12 HD21 ' A' ' 87' ' ' LEU . 6.3 tt -67.17 -59.2 3.64 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.562 0.22 . . . . 0.0 110.961 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.733 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.6 OUTLIER -59.76 -57.77 10.14 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.143 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.288 -179.841 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.435 ' H ' HG23 ' A' ' 41' ' ' VAL . 6.4 tt0 -48.73 -33.37 10.08 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.363 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.5 tt -71.81 -29.1 64.08 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.728 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.82 HD22 HG21 ' A' ' 9' ' ' VAL . 3.8 pp -95.83 -32.43 12.68 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.754 ' N ' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -87.64 -71.07 0.59 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.477 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.9 m -51.53 -26.79 9.15 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -96.73 -36.88 10.52 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -140.62 57.26 1.58 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.5 HG13 ' H ' ' A' ' 51' ' ' GLU . 7.5 p -95.79 -34.86 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.458 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 0.2 OUTLIER 66.25 8.46 5.61 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 111.574 0.213 . . . . 0.0 111.574 -179.307 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.5 ' H ' HG13 ' A' ' 49' ' ' VAL . 1.7 tp10 -144.89 -166.18 2.34 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.507 ' CB ' HD23 ' A' ' 55' ' ' LEU . 8.9 ttm180 -75.61 110.74 11.43 Favored Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 116.742 -0.208 . . . . 0.0 110.595 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.468 ' O ' HG22 ' A' ' 57' ' ' VAL . 18.9 Cg_endo -59.6 -21.64 63.35 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.315 2.01 . . . . 0.0 112.537 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.32 5.58 44.4 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.754 ' HG ' HD23 ' A' ' 56' ' ' LEU . 1.9 pp -95.26 -26.82 15.79 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 121.166 -0.214 . . . . 0.0 111.476 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.754 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -95.7 -44.74 7.31 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -179.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.512 HG11 ' HA2' ' A' ' 61' ' ' GLY . 5.4 m -54.25 150.49 1.78 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-O 121.119 0.485 . . . . 0.0 111.699 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -63.35 -59.33 4.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.358 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -171.78 -43.92 0.02 OUTLIER 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.371 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 71.3 p -83.63 7.62 16.83 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.805 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.512 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 57.14 25.75 54.65 Favored Glycine 0 C--N 1.341 0.813 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.47 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.4 tm0? -115.08 -37.28 4.16 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.652 0.263 . . . . 0.0 110.977 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.9 t -127.5 142.48 51.38 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.792 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.754 HD21 HD12 ' A' ' 56' ' ' LEU . 8.1 mt -65.88 155.8 35.32 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.877 0.37 . . . . 0.0 111.205 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.26 150.37 72.26 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.075 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -52.32 -32.86 53.24 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.091 2.527 . . . . 0.0 112.819 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -49.88 -35.97 25.75 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.874 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.449 HG21 ' HB3' ' A' ' 95' ' ' PHE . 4.4 mt -99.93 135.66 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 120.752 0.31 . . . . 0.0 110.789 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.8 mp -105.26 104.91 14.74 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.874 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.905 HG23 ' HB3' ' A' ' 77' ' ' ALA . 11.5 m -77.25 133.85 29.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.014 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.6 mt -123.98 154.56 39.64 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.551 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.484 HG23 ' CA ' ' A' ' 77' ' ' ALA . 25.8 t -126.53 113.47 33.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.652 179.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.8 m120 57.9 42.62 22.74 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.965 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.9 m 57.08 50.58 11.74 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.417 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 42.8 t -141.32 -79.38 0.26 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.485 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 177.49 132.29 0.06 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.698 0.285 . . . . 0.0 110.896 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.905 ' HB3' HG23 ' A' ' 70' ' ' VAL . . . -88.51 -24.91 22.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.562 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -80.81 -38.71 27.93 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.578 0.228 . . . . 0.0 110.842 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 61.8 t -58.58 -37.5 65.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.906 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.9 m -80.83 -32.75 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.531 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.29 -56.49 0.04 OUTLIER Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.77 -0.729 . . . . 0.0 113.13 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 110.63 -57.85 0.41 Allowed Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.253 -0.499 . . . . 0.0 112.266 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -142.92 21.72 1.95 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 111.516 0.191 . . . . 0.0 111.516 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -135.6 20.46 3.33 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -75.1 114.52 13.69 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.927 0.394 . . . . 0.0 111.302 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.8 m -71.7 153.28 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.48 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.961 HD21 HD12 ' A' ' 40' ' ' LEU . 1.2 mp -104.21 164.28 11.83 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.551 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -161.02 30.33 0.14 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.413 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 58.97 103.93 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.001 0.429 . . . . 0.0 111.604 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 116.73 35.52 1.15 Allowed Glycine 0 C--N 1.332 0.357 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.326 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.15 177.52 4.81 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.863 0.363 . . . . 0.0 111.576 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.716 HG23 ' HB ' ' A' ' 8' ' ' THR . 74.2 m -140.3 132.66 28.37 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.821 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.625 HG11 HD21 ' A' ' 40' ' ' LEU . 7.1 p -142.46 137.06 28.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.174 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -134.2 158.47 43.6 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.993 0.425 . . . . 0.0 111.532 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.449 ' HB3' HG21 ' A' ' 68' ' ' ILE . 25.8 m-85 -126.55 104.89 8.37 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.298 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 26.5 mt -116.08 118.5 58.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.215 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.81 155.15 39.12 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.108 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.465 0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.563 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 7.7 p80 . . . . . 0 N--CA 1.466 0.344 0 CA-C-O 120.671 0.272 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.479 HG23 ' O ' ' A' ' 91' ' ' ASP . 29.6 mt -105.35 137.67 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.133 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.723 ' HB ' HG23 ' A' ' 92' ' ' THR . 0.5 OUTLIER -92.84 112.43 24.39 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.386 -179.607 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.509 HG13 ' HB2' ' A' ' 25' ' ' LEU . 7.6 p -134.23 108.8 11.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.653 179.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.673 ' OE1' HG22 ' A' ' 8' ' ' THR . 1.5 pm0 -140.04 162.53 35.0 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.499 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.462 ' HB2' ' HG2' ' A' ' 16' ' ' GLU . 31.3 m-85 -116.13 148.47 40.28 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.149 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -135.29 143.46 46.23 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.306 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.11 -108.54 2.65 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.138 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -117.16 25.7 8.64 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.564 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.8 m -97.64 -15.53 20.39 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.462 ' HG2' ' HB2' ' A' ' 11' ' ' PHE . 40.0 mt-10 -59.54 -32.97 70.82 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.667 0.27 . . . . 0.0 111.081 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.454 HD23 ' HG3' ' A' ' 21' ' ' LYS . 2.8 mt -72.54 -5.17 35.23 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.883 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.64 HD21 HD11 ' A' ' 55' ' ' LEU . 54.8 mt -83.1 14.42 3.42 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -153.76 -60.8 0.13 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.61 0.243 . . . . 0.0 110.656 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -177.4 37.49 0.0 OUTLIER 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.149 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.454 ' HG3' HD23 ' A' ' 17' ' ' LEU . 5.4 mptt 51.19 35.27 12.95 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.966 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -93.06 151.16 20.04 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.876 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.9 p -79.13 -64.29 1.22 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.926 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.8 p -143.22 163.93 31.58 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.792 0.329 . . . . 0.0 111.357 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.509 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.8 OUTLIER -148.54 166.58 27.79 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.11 -179.794 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -132.78 126.5 32.52 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.873 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.2 mt . . . . . 0 C--O 1.233 0.186 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.877 -179.9 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 58.1 m . . . . . 0 CA--C 1.529 0.15 0 CA-C-O 120.646 0.26 . . . . 0.0 110.809 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -113.23 -175.29 2.64 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.704 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.815 HD22 ' HA ' ' A' ' 83' ' ' MET . 4.5 tt -55.16 -35.1 64.4 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.404 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.63 -37.39 70.66 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.906 0.384 . . . . 0.0 110.135 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.97 -32.96 56.11 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.93 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.792 HD11 ' CD1' ' A' ' 87' ' ' LEU . 95.2 mt -65.86 -53.29 41.82 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.7 0.286 . . . . 0.0 110.58 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.3 OUTLIER -56.71 -57.53 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.993 179.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.431 ' H ' HG23 ' A' ' 41' ' ' VAL . 0.8 OUTLIER -55.54 -26.65 44.41 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.431 179.57 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.9 tp -82.08 -23.81 35.57 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.677 HD12 ' N ' ' A' ' 45' ' ' LYS . 4.7 pp -96.75 -38.17 10.0 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.677 ' N ' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -92.37 -59.6 2.05 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -179.627 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.5 m -61.33 -21.85 64.37 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.364 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.38 -34.15 10.77 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -155.58 55.01 0.62 Allowed 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.438 ' HB ' ' O ' ' A' ' 45' ' ' LYS . 7.6 p -70.72 -33.1 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 57.79 13.48 2.07 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -158.37 -170.37 3.08 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.636 ' HB2' HD23 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -67.08 112.56 10.19 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-O 120.562 0.22 . . . . 0.0 110.838 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.428 ' O ' HG22 ' A' ' 57' ' ' VAL . 18.2 Cg_endo -59.85 -24.7 76.97 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.272 1.982 . . . . 0.0 112.299 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.432 ' HA ' HG22 ' A' ' 57' ' ' VAL . 0.9 OUTLIER -90.36 6.58 42.53 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.807 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.708 ' HG ' HD23 ' A' ' 56' ' ' LEU . 1.6 pp -91.5 -29.34 17.05 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 121.236 -0.186 . . . . 0.0 111.316 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.708 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -97.47 -44.0 7.02 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.723 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.432 HG22 ' HA ' ' A' ' 54' ' ' ASP . 15.5 m -56.5 148.05 4.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.176 0.512 . . . . 0.0 111.696 -179.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.672 ' HB2' HG23 ' A' ' 63' ' ' THR . 12.5 t70 -63.18 -55.88 21.38 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.361 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -174.22 -44.65 0.01 OUTLIER 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.481 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.415 HG23 ' HB3' ' A' ' 62' ' ' GLN . 9.7 t -89.63 15.37 9.63 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.426 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 55.16 23.29 32.21 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.65 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.415 ' HB3' HG23 ' A' ' 60' ' ' THR . 1.0 OUTLIER -107.77 -32.77 7.49 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.893 0.377 . . . . 0.0 110.788 -179.714 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.672 HG23 ' HB2' ' A' ' 58' ' ' ASP . 6.0 t -132.66 179.48 6.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.092 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.6 mt -103.98 152.92 21.43 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.915 0.388 . . . . 0.0 111.451 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.06 154.18 82.84 Favored Pre-proline 0 N--CA 1.465 0.287 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.389 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -50.31 -32.95 35.13 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.199 2.599 . . . . 0.0 113.036 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -46.51 -37.58 8.71 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 121.392 -0.432 . . . . 0.0 112.993 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.478 HG21 ' HB3' ' A' ' 95' ' ' PHE . 3.8 mt -104.8 133.28 49.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.861 0.331 . . . . 0.0 111.054 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.0 mt -100.8 100.37 11.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.694 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.706 HG23 ' HB3' ' A' ' 77' ' ' ALA . 14.5 m -76.57 133.26 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.873 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.57 HD23 ' O ' ' A' ' 70' ' ' VAL . 2.7 mt -132.13 140.62 48.86 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.391 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.664 HG23 ' CB ' ' A' ' 77' ' ' ALA . 19.5 t -115.73 117.82 56.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.493 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 56.99 49.86 13.16 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.145 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 58.81 47.36 12.75 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.951 0.405 . . . . 0.0 111.275 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 52.0 t -161.37 147.03 14.01 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.628 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -46.01 119.56 2.32 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.781 0.324 . . . . 0.0 111.357 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.706 ' HB3' HG23 ' A' ' 70' ' ' VAL . . . -78.2 -17.87 56.2 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.136 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.11 -34.51 49.97 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.379 0.133 . . . . 0.0 111.162 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.2 t -70.11 -45.79 74.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.053 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.9 m -60.62 -35.51 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.691 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 179.0 -35.52 0.08 OUTLIER Glycine 0 CA--C 1.524 0.599 0 C-N-CA 120.785 -0.722 . . . . 0.0 113.251 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.68 -54.13 2.67 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.225 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.815 ' HA ' HD22 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -148.52 27.51 0.91 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 120.464 0.173 . . . . 0.0 111.343 179.641 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -129.09 15.49 6.24 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.476 ' CZ ' HG11 ' A' ' 72' ' ' VAL . 1.9 t80 -70.38 113.21 7.3 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.755 0.312 . . . . 0.0 110.943 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 26.9 m -69.4 148.21 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.473 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.792 ' CD1' HD11 ' A' ' 40' ' ' LEU . 1.0 OUTLIER -96.66 157.96 15.66 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.541 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -154.16 36.16 0.43 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.194 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.4 t0 62.96 27.31 15.89 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.963 0.411 . . . . 0.0 111.691 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -168.77 41.08 0.22 Allowed Glycine 0 C--N 1.332 0.35 0 C-N-CA 121.198 -0.525 . . . . 0.0 112.235 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.479 ' O ' HG23 ' A' ' 7' ' ' ILE . 4.0 t70 -85.03 166.36 16.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.815 0.34 . . . . 0.0 111.013 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.723 HG23 ' HB ' ' A' ' 8' ' ' THR . 86.1 m -141.81 127.61 19.28 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.659 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.7 p -141.8 133.63 27.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.111 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -132.96 143.18 49.29 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.327 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.478 ' HB3' HG21 ' A' ' 68' ' ' ILE . 18.2 m-85 -113.19 104.74 12.65 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.275 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 11.0 mt -110.73 110.15 31.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.03 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 60.6 p -76.66 143.64 39.97 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.19 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.532 0.269 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.13 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 14.3 p-80 . . . . . 0 C--O 1.233 0.211 0 CA-C-O 120.787 0.327 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 33.6 mm -87.2 154.32 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.672 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.607 ' CG2' HG23 ' A' ' 92' ' ' THR . 48.8 m -121.14 94.12 4.24 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.653 0.263 . . . . 0.0 111.082 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.587 HG13 ' HB2' ' A' ' 25' ' ' LEU . 11.5 p -118.28 109.2 26.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-O 121.02 0.438 . . . . 0.0 111.426 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.47 ' OE1' HG22 ' A' ' 8' ' ' THR . 8.4 pm0 -134.0 162.24 32.6 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.569 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.433 ' CB ' ' HA ' ' A' ' 16' ' ' GLU . 98.1 m-85 -122.04 151.92 40.33 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.102 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -167.23 174.38 8.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.013 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 59.66 32.03 72.8 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.916 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.1 26.91 38.92 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.224 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.6 t -108.07 -22.98 12.18 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 117.129 0.464 . . . . 0.0 111.528 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.433 ' HA ' ' CB ' ' A' ' 11' ' ' PHE . 1.9 pt-20 -57.72 -27.51 63.03 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.512 0.196 . . . . 0.0 111.339 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.1 mp -64.98 -10.66 31.12 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.556 HD22 ' CD1' ' A' ' 55' ' ' LEU . 71.8 mt -83.55 13.57 4.46 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -148.18 -70.83 0.22 Allowed 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -170.98 38.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.969 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.65 34.16 15.31 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.146 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -77.47 178.43 7.21 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.047 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 37.0 p -107.12 -76.89 0.6 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.895 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.6 p -136.77 164.31 28.57 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.688 0.28 . . . . 0.0 111.372 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.587 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -148.53 151.02 34.4 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.267 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.484 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 31.7 mt-30 -132.64 109.57 9.82 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.87 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.3 mt . . . . . 0 C--O 1.233 0.234 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.687 -179.875 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.5 m . . . . . 0 CA--C 1.529 0.172 0 CA-C-O 120.719 0.295 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -100.15 -170.19 1.84 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.6 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.666 ' O ' HG22 ' A' ' 41' ' ' VAL . 2.5 tt -55.04 -42.94 73.29 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 111.484 0.179 . . . . 0.0 111.484 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -56.78 -38.14 72.07 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.98 -34.44 47.48 Favored Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.977 178.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.996 HD13 HD21 ' A' ' 87' ' ' LEU . 23.9 tp -62.32 -52.03 65.3 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.622 0.248 . . . . 0.0 110.634 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.666 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.3 OUTLIER -59.11 -57.63 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.929 179.541 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.418 ' H ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -51.07 -32.42 21.99 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.732 -0.213 . . . . 0.0 111.259 179.576 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.466 ' O ' HD23 ' A' ' 43' ' ' LEU . 8.5 tt -70.38 -27.84 64.63 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.484 HD12 ' C ' ' A' ' 44' ' ' LEU . 1.5 pp -97.02 -41.2 8.49 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.1 pttt -82.21 -65.19 1.04 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 m -56.67 -23.74 43.84 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -94.07 -41.13 9.7 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 111.515 0.191 . . . . 0.0 111.515 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.21 59.74 0.97 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.885 0.374 . . . . 0.0 111.902 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.1 p -78.87 -35.67 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.605 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 64.59 10.76 6.15 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.423 -179.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -154.05 -173.05 4.43 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.681 ' HB2' HD23 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -68.04 135.61 91.77 Favored Pre-proline 0 N--CA 1.464 0.275 0 CA-C-O 120.518 0.199 . . . . 0.0 110.809 179.707 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.494 ' O ' HG22 ' A' ' 57' ' ' VAL . 73.7 Cg_endo -77.39 -23.02 10.43 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.334 2.022 . . . . 0.0 112.834 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.416 ' HA ' HG22 ' A' ' 57' ' ' VAL . 65.0 m-20 -90.69 6.92 42.02 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.681 HD23 ' HB2' ' A' ' 52' ' ' ARG . 3.7 pp -89.87 -17.71 27.55 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 120.987 -0.285 . . . . 0.0 111.312 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.526 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -111.12 -46.0 3.37 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 53' ' ' PRO . 13.1 m -56.72 148.36 4.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 121.188 0.518 . . . . 0.0 111.692 -179.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.685 ' HB2' HG23 ' A' ' 63' ' ' THR . 26.3 t70 -63.99 -53.9 42.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.496 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -177.15 -43.84 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.436 178.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.3 p -87.45 12.88 11.13 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.474 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 57.01 22.19 41.25 Favored Glycine 0 C--N 1.339 0.747 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.745 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -107.87 -35.54 6.62 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.861 0.363 . . . . 0.0 110.863 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.685 HG23 ' HB2' ' A' ' 58' ' ' ASP . 9.4 t -129.55 -178.77 4.82 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.006 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.6 mt -102.93 153.68 19.97 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.968 0.414 . . . . 0.0 111.391 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.408 ' HB3' ' HA ' ' A' ' 58' ' ' ASP . 0.8 OUTLIER -79.78 155.0 75.85 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.135 179.854 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.24 135.21 59.39 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.867 2.378 . . . . 0.0 112.545 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.18 -48.35 0.91 Allowed Glycine 0 C--N 1.332 0.344 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.413 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.2 mt -93.39 143.08 12.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 120.83 0.348 . . . . 0.0 111.21 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.478 HD23 HD21 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -105.1 101.68 11.22 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 179.659 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.498 HG23 ' HB3' ' A' ' 77' ' ' ALA . 10.8 m -76.84 136.8 23.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.785 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.478 HD21 HD23 ' A' ' 69' ' ' LEU . 23.1 mt -131.4 146.8 52.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.317 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.571 HG21 HG21 ' A' ' 80' ' ' VAL . 67.7 t -128.22 133.9 66.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.325 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.2 m120 58.72 26.06 14.16 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.003 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 54.93 31.88 16.82 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.373 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.407 ' SG ' ' N ' ' A' ' 76' ' ' ASP . 16.4 p -130.04 -48.57 1.11 Allowed 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.356 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.76 ' HB3' HG23 ' A' ' 79' ' ' VAL . 0.2 OUTLIER 172.28 140.6 0.03 OUTLIER 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.491 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.498 ' HB3' HG23 ' A' ' 70' ' ' VAL . . . -86.32 -22.58 26.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.65 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -79.19 -32.97 44.28 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.437 0.161 . . . . 0.0 110.609 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.76 HG23 ' HB3' ' A' ' 76' ' ' ASP . 52.7 t -60.62 -46.65 95.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.957 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.571 HG21 HG21 ' A' ' 72' ' ' VAL . 18.8 m -65.31 -23.44 33.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 147.43 -23.94 1.53 Allowed Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.766 -0.73 . . . . 0.0 113.344 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 104.04 -57.92 0.52 Allowed Glycine 0 C--N 1.338 0.692 0 C-N-CA 121.126 -0.559 . . . . 0.0 111.705 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.6 ' HA ' HD22 ' A' ' 37' ' ' LEU . 5.6 ptt? -152.89 26.99 0.54 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.497 0.189 . . . . 0.0 110.98 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -135.05 21.72 3.49 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.409 ' CD2' HG11 ' A' ' 72' ' ' VAL . 19.7 t80 -80.44 112.87 18.19 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.846 0.355 . . . . 0.0 110.849 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.1 m -62.72 143.64 15.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.393 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.996 HD21 HD13 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -82.1 142.34 32.36 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.415 -179.783 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -130.18 43.02 3.19 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.32 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.73 27.3 8.58 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.808 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -173.44 41.2 0.15 Allowed Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.304 -0.474 . . . . 0.0 112.091 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.425 ' HB2' ' HG ' ' A' ' 87' ' ' LEU . 24.8 t0 -83.12 114.09 21.08 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.719 0.295 . . . . 0.0 111.222 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.607 HG23 ' CG2' ' A' ' 8' ' ' THR . 28.4 m -85.01 128.62 34.71 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.56 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.0 p -140.19 133.54 34.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.126 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -129.35 161.31 30.59 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.021 0.439 . . . . 0.0 111.592 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -134.2 104.74 6.32 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.165 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 29.0 mt -114.77 112.91 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.132 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.3 140.38 38.82 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.91 0.386 . . . . 0.0 111.369 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 39.9 p . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.217 179.424 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 . . . . . 0 N--CA 1.468 0.46 0 CA-C-O 120.758 0.313 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.487 HG21 HD11 ' A' ' 40' ' ' LEU . 12.4 mm -88.35 111.54 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.714 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.563 HG22 ' NE2' ' A' ' 10' ' ' GLN . 41.8 m -81.78 102.61 10.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.343 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.566 HG13 ' HB2' ' A' ' 25' ' ' LEU . 7.9 p -119.93 104.92 16.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.467 179.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.563 ' NE2' HG22 ' A' ' 8' ' ' THR . 0.7 OUTLIER -127.28 161.8 27.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.692 -179.047 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -116.07 159.24 21.97 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.948 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.705 ' HB3' ' HA ' ' A' ' 96' ' ' ILE . . . -105.86 176.23 5.23 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.228 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.96 97.38 0.05 OUTLIER Glycine 0 C--N 1.336 0.583 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.53 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.67 -29.31 4.49 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.943 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.7 -27.96 15.02 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.852 0.326 . . . . 0.0 111.558 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.94 -27.87 65.71 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.585 0.231 . . . . 0.0 111.254 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 mp -67.7 -10.16 49.97 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.555 HD22 HD11 ' A' ' 55' ' ' LEU . 56.1 mt -81.13 13.3 2.87 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -149.58 -63.73 0.22 Allowed 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -174.37 37.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.114 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.49 34.81 12.94 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.003 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -72.34 -177.36 2.14 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.046 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 49.9 p -115.7 -78.17 0.58 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.919 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.432 ' CB ' ' HB3' ' A' ' 10' ' ' GLN . 83.7 p -136.12 160.24 39.25 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.933 0.397 . . . . 0.0 111.254 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.566 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -138.03 152.06 48.48 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.15 179.804 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -133.18 100.61 4.91 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.523 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.1 mt . . . . . 0 C--O 1.234 0.261 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.93 -179.645 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 63.8 m . . . . . 0 CA--C 1.529 0.158 0 CA-C-O 120.718 0.294 . . . . 0.0 110.749 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 53.2 p-10 -108.61 -173.28 2.24 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.891 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.786 ' O ' HG22 ' A' ' 41' ' ' VAL . 4.2 tt -57.66 -39.28 76.69 Favored 'General case' 0 N--CA 1.46 0.071 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.032 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -54.92 -38.19 67.35 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.308 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.05 -32.22 45.12 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.103 179.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.487 HD11 HG21 ' A' ' 7' ' ' ILE . 61.7 tp -68.16 -53.08 27.68 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.652 0.226 . . . . 0.0 110.855 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.786 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.5 OUTLIER -57.83 -57.4 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.854 179.788 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.456 ' H ' HG23 ' A' ' 41' ' ' VAL . 1.8 tm0? -50.65 -32.09 18.11 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.402 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.4 tp -71.52 -27.56 63.28 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.898 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.503 HD12 ' C ' ' A' ' 44' ' ' LEU . 1.3 pp -96.92 -40.58 8.83 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.408 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 0.4 OUTLIER -84.0 -71.69 0.5 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.4 -179.578 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 22.5 m -53.04 -22.14 5.51 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.05 -31.35 10.68 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -142.25 51.6 1.48 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -178.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.551 HG22 ' H ' ' A' ' 51' ' ' GLU . 12.2 p -100.6 120.07 49.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.873 0.368 . . . . 0.0 110.716 179.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -101.24 31.91 3.48 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.02 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.551 ' H ' HG22 ' A' ' 49' ' ' VAL . 1.9 tp10 -155.86 -174.78 5.1 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.252 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.593 ' HB2' HD23 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -62.29 110.21 3.08 Favored Pre-proline 0 CA--C 1.53 0.176 0 CA-C-N 116.803 -0.181 . . . . 0.0 111.045 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.444 ' O ' HG22 ' A' ' 57' ' ' VAL . 17.7 Cg_endo -60.33 -27.31 84.62 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.405 2.07 . . . . 0.0 112.286 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.441 ' HA ' ' CG2' ' A' ' 57' ' ' VAL . 5.8 t70 -91.38 8.04 38.11 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.994 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.687 ' HG ' HD23 ' A' ' 56' ' ' LEU . 1.2 pp -88.58 -26.7 21.82 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 122.306 -0.246 . . . . 0.0 111.472 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.687 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -100.5 -46.82 5.1 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.483 HG11 ' HA2' ' A' ' 61' ' ' GLY . 9.0 m -55.59 149.63 2.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 121.164 0.507 . . . . 0.0 111.7 -179.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -63.43 -52.94 59.4 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.736 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.43 -45.5 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.518 179.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.1 p -90.27 16.45 8.62 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.483 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 56.07 21.63 32.39 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.825 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -105.88 -35.35 7.35 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.839 0.352 . . . . 0.0 110.573 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.748 HG22 ' HG3' ' A' ' 83' ' ' MET . 71.9 p -128.16 -177.07 4.0 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.983 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.4 mt -110.64 154.52 23.69 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.934 0.397 . . . . 0.0 110.997 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -71.67 152.82 93.55 Favored Pre-proline 0 C--O 1.234 0.256 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.068 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -55.77 124.48 16.38 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.764 2.31 . . . . 0.0 112.357 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 147.82 -45.02 0.76 Allowed Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.51 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.537 HG21 ' HB3' ' A' ' 95' ' ' PHE . 5.0 mt -91.52 120.11 39.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 120.7 0.286 . . . . 0.0 111.155 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.23 100.09 12.95 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.403 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.78 HG23 ' HB3' ' A' ' 77' ' ' ALA . 29.5 m -77.75 126.35 38.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.276 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.431 HD23 ' O ' ' A' ' 70' ' ' VAL . 4.9 mt -125.4 129.67 50.35 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.874 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 92' ' ' THR . 3.6 m -112.82 114.73 47.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.016 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 11.6 m120 54.86 52.22 12.36 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.071 0.462 . . . . 0.0 110.727 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.7 m 59.23 30.1 19.78 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.58 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 46.4 t -145.38 125.31 13.54 Favored 'General case' 0 C--O 1.23 0.048 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.375 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.701 ' HB2' HG23 ' A' ' 79' ' ' VAL . 61.7 m-20 -44.16 127.37 5.51 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.765 0.317 . . . . 0.0 111.254 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.78 ' HB3' HG23 ' A' ' 70' ' ' VAL . . . -63.3 -19.48 64.63 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.883 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -73.28 -26.63 61.16 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 120.577 0.227 . . . . 0.0 110.673 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.701 HG23 ' HB2' ' A' ' 76' ' ' ASP . 30.7 t -70.82 -44.38 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.084 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.4 m -70.39 -39.74 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.507 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.39 42.66 0.02 OUTLIER Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.804 -0.712 . . . . 0.0 113.426 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 53.07 -107.84 0.63 Allowed Glycine 0 C--N 1.334 0.455 0 C-N-CA 121.184 -0.532 . . . . 0.0 113.009 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.748 ' HG3' HG22 ' A' ' 63' ' ' THR . 60.5 mmm -108.58 27.69 9.14 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.804 0.335 . . . . 0.0 111.073 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -120.29 19.22 12.17 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.828 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -68.83 117.73 10.89 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.827 0.346 . . . . 0.0 111.339 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 15.6 m -70.57 146.53 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.713 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.9 mp -94.88 161.39 14.18 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.18 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 32.8 m-20 -153.54 35.77 0.46 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.616 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 59.93 96.39 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.045 0.45 . . . . 0.0 111.21 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 112.07 36.17 1.7 Allowed Glycine 0 CA--C 1.518 0.237 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.357 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -87.3 170.33 11.52 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.784 0.326 . . . . 0.0 110.902 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.442 HG23 HE22 ' A' ' 10' ' ' GLN . 92.6 m -137.91 134.98 35.66 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.8 p -141.41 134.28 29.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.027 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -131.38 149.14 52.66 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.384 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.537 ' HB3' HG21 ' A' ' 68' ' ' ILE . 23.0 m-85 -121.84 104.71 9.75 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.45 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.705 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 17.9 mt -111.89 103.84 16.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.239 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 84.0 p -82.56 132.05 35.2 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.89 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.463 0.207 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.372 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.32 0 CA-C-O 120.742 0.306 . . . . 0.0 111.542 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.489 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 17.3 mm -123.66 153.73 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.86 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.41 ' HB ' ' HA ' ' A' ' 92' ' ' THR . 49.5 m -113.12 99.23 7.68 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.914 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.592 HG13 ' HB2' ' A' ' 25' ' ' LEU . 14.7 p -121.86 115.02 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.573 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.428 ' HG2' ' HG2' ' A' ' 94' ' ' GLU . 3.8 pm0 -128.99 159.14 36.85 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.963 0.411 . . . . 0.0 111.26 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.494 ' HB3' ' N ' ' A' ' 16' ' ' GLU . 12.1 m-85 -115.73 135.12 54.34 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.25 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -142.47 144.61 33.1 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.101 0.476 . . . . 0.0 111.977 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 86.42 -91.48 1.73 Allowed Glycine 0 C--N 1.332 0.355 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.905 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -133.88 28.91 3.16 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.992 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -109.94 -31.06 7.53 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.682 0.241 . . . . 0.0 111.133 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.494 ' N ' ' HB3' ' A' ' 11' ' ' PHE . 0.7 OUTLIER -61.76 -37.08 82.96 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.26 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.461 ' N ' ' HG2' ' A' ' 16' ' ' GLU . 4.5 mt -67.93 -14.4 62.94 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.809 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.728 HD13 HD22 ' A' ' 56' ' ' LEU . 9.0 mt -83.54 13.52 4.48 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.403 ' HA ' ' HB2' ' A' ' 50' ' ' LYS . 10.5 t80 -144.28 -64.51 0.36 Allowed 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -174.64 38.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.087 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 49.57 38.79 15.62 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.058 0.456 . . . . 0.0 110.782 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -73.9 175.37 7.39 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.056 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 33.1 p -114.94 -52.25 2.7 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.013 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 94.3 p -155.39 148.83 25.02 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.669 0.271 . . . . 0.0 110.955 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.592 ' HB2' HG13 ' A' ' 9' ' ' VAL . 5.0 mt -135.72 158.01 45.44 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.931 0.396 . . . . 0.0 111.345 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.489 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 11.8 mt-30 -130.1 106.99 8.99 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.8 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.1 mt . . . . . 0 C--N 1.331 -0.199 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.942 -179.888 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 87.9 m . . . . . 0 C--O 1.234 0.25 0 CA-C-O 120.745 0.307 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.7 p30 -84.43 174.05 10.38 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.975 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.904 HD22 ' HA ' ' A' ' 83' ' ' MET . 4.9 tt -57.84 -39.85 78.66 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.246 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -53.64 -41.24 66.56 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.933 0.397 . . . . 0.0 109.986 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.08 -31.86 63.74 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.135 178.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.3 tp -70.13 -57.13 5.29 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.525 0.202 . . . . 0.0 110.964 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.73 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.4 OUTLIER -57.54 -57.51 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.203 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.429 ' H ' HG23 ' A' ' 41' ' ' VAL . 0.7 OUTLIER -49.67 -32.49 13.33 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.504 179.773 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.1 tp -75.63 -24.15 56.41 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.409 ' C ' HD12 ' A' ' 44' ' ' LEU . 1.0 OUTLIER -96.35 -37.54 10.44 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.878 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.489 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 2.9 pttt -83.95 -71.26 0.52 Allowed 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 121.162 -0.215 . . . . 0.0 111.322 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.9 m -52.25 -24.72 7.77 Favored 'General case' 0 CA--C 1.537 0.442 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -102.08 -27.2 13.06 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -142.42 50.38 1.49 Allowed 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.623 HG22 ' H ' ' A' ' 51' ' ' GLU . 10.4 p -96.9 139.66 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 120.684 0.278 . . . . 0.0 111.25 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.403 ' HB2' ' HA ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -123.91 31.25 5.9 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.46 179.906 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.623 ' H ' HG22 ' A' ' 49' ' ' VAL . 0.7 OUTLIER -164.15 176.46 9.23 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.153 179.567 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.499 ' HB2' HD23 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -49.99 106.0 0.58 Allowed Pre-proline 0 N--CA 1.466 0.329 0 CA-C-O 120.508 0.194 . . . . 0.0 111.367 -179.814 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.07 -28.47 60.47 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.44 2.093 . . . . 0.0 112.676 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.403 ' HA ' ' CG2' ' A' ' 57' ' ' VAL . 0.3 OUTLIER -92.88 9.03 37.13 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.803 ' HG ' HD23 ' A' ' 56' ' ' LEU . 2.1 pp -83.62 -28.93 28.12 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 121.034 -0.267 . . . . 0.0 111.158 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.803 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -94.11 -54.46 3.57 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.765 -0.198 . . . . 0.0 111.335 179.927 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.553 HG11 ' HA2' ' A' ' 61' ' ' GLY . 1.4 m -54.55 151.22 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.201 0.524 . . . . 0.0 111.638 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -68.02 -62.91 1.19 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.739 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -165.22 -45.36 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.404 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.1 t -78.89 3.89 15.69 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.595 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.553 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 61.34 22.92 61.68 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.598 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.6 tm0? -121.46 -45.47 2.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.81 0.338 . . . . 0.0 110.407 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.563 ' HA ' ' HG3' ' A' ' 83' ' ' MET . 1.8 t -102.07 123.61 46.25 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.676 178.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.666 HD22 ' HB2' ' A' ' 56' ' ' LEU . 7.8 mt -67.79 156.7 36.44 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.727 0.298 . . . . 0.0 110.917 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 56' ' ' LEU . 7.6 ptm180 -57.32 143.26 74.14 Favored Pre-proline 0 C--O 1.234 0.259 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.125 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -50.6 -33.28 38.63 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.091 2.527 . . . . 0.0 112.829 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -50.85 -34.7 30.25 Favored Glycine 0 CA--C 1.523 0.54 0 CA-C-N 116.037 -0.529 . . . . 0.0 113.023 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.537 HD13 HD13 ' A' ' 64' ' ' LEU . 7.2 mt -88.77 120.41 37.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-O 120.76 0.314 . . . . 0.0 111.213 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.9 mt -96.94 97.02 8.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.018 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.9 t -79.46 136.69 23.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.12 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.09 155.73 44.99 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.476 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.564 HG23 ' CB ' ' A' ' 77' ' ' ALA . 39.9 t -124.48 115.04 43.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.8 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 67.03 -77.15 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.2 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.9 t -153.32 33.7 0.46 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.867 0.365 . . . . 0.0 110.942 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 44.4 t -158.46 156.02 29.58 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.682 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.448 ' HB2' HG23 ' A' ' 79' ' ' VAL . 51.4 m-20 -49.14 136.58 14.78 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.611 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.564 ' CB ' HG23 ' A' ' 72' ' ' VAL . . . -82.39 -23.13 35.11 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.845 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -71.59 -18.59 62.22 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.432 0.158 . . . . 0.0 111.087 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.448 HG23 ' HB2' ' A' ' 76' ' ' ASP . 32.6 t -72.53 -41.11 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.316 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.6 m -80.6 -29.14 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.735 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 176.61 -38.32 0.1 OUTLIER Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.035 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 99.06 -72.06 0.54 Allowed Glycine 0 C--N 1.334 0.435 0 C-N-CA 121.003 -0.618 . . . . 0.0 111.968 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.904 ' HA ' HD22 ' A' ' 37' ' ' LEU . 2.7 mmt -129.0 25.75 5.55 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.725 0.298 . . . . 0.0 111.182 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -136.67 23.99 3.13 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.56 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -82.63 120.17 25.21 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.6 0.238 . . . . 0.0 110.738 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.2 m -69.84 134.06 30.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.426 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.5 mp -98.2 123.57 42.34 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.867 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -108.1 35.19 3.23 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.334 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 63.1 104.83 0.03 OUTLIER 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.209 0.528 . . . . 0.0 111.488 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 113.2 29.34 3.03 Favored Glycine 0 CA--C 1.519 0.322 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.503 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -101.14 152.77 20.23 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.619 0.247 . . . . 0.0 110.837 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.41 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 94.9 m -115.18 111.8 21.54 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.962 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.8 p -120.67 125.69 74.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.748 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.428 ' HG2' ' HG2' ' A' ' 10' ' ' GLN . 16.0 mt-10 -126.37 153.68 44.6 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.364 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -120.69 104.53 9.99 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.067 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 25.2 mt -106.11 99.91 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.964 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.97 140.11 29.99 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.301 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.464 0.249 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.405 179.861 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.412 ' O ' HD13 ' A' ' 7' ' ' ILE . 2.3 p80 . . . . . 0 N--CA 1.464 0.269 0 CA-C-O 120.634 0.254 . . . . 0.0 110.779 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 25.2 mm -129.62 152.2 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.611 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.431 ' HB ' HG23 ' A' ' 92' ' ' THR . 6.7 m -115.79 122.92 46.87 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.736 0.303 . . . . 0.0 111.474 -179.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.635 HG13 ' HB2' ' A' ' 25' ' ' LEU . 9.8 p -145.89 110.1 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.201 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.404 ' HB3' ' CB ' ' A' ' 24' ' ' SER . 5.2 pm0 -135.62 160.94 36.94 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.961 0.41 . . . . 0.0 111.643 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.454 ' HB2' ' HB3' ' A' ' 16' ' ' GLU . 89.1 m-85 -117.34 147.08 42.94 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.075 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.78 ' HB3' HG12 ' A' ' 96' ' ' ILE . . . -145.22 145.82 31.47 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.836 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.04 -95.3 2.06 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.457 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -139.51 30.91 2.37 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.722 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.2 m -108.04 -23.91 11.8 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.454 ' HB3' ' HB2' ' A' ' 11' ' ' PHE . 1.8 pm0 -59.84 -30.65 69.09 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.621 0.248 . . . . 0.0 111.228 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.8 mp -71.26 -7.97 50.53 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.706 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.53 HD13 HD22 ' A' ' 56' ' ' LEU . 42.1 mt -87.97 13.58 10.7 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.425 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 42.0 t80 -144.95 -63.63 0.35 Allowed 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -178.22 36.17 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.077 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.74 31.59 6.11 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.965 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -80.6 134.19 35.87 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.976 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -67.76 -66.25 0.59 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.822 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.404 ' CB ' ' HB3' ' A' ' 10' ' ' GLN . 87.3 p -144.24 161.31 39.22 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.723 0.297 . . . . 0.0 111.062 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.635 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -142.65 148.13 36.89 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.399 -179.881 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.512 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 4.7 mt-30 -132.16 117.95 18.94 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.883 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.4 mt . . . . . 0 C--O 1.233 0.193 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.877 -179.853 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.0 t . . . . . 0 CA--C 1.536 0.406 0 N-CA-C 110.535 -0.172 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -134.47 -174.24 3.51 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.869 -0.15 . . . . 0.0 110.745 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.813 HD22 ' HA ' ' A' ' 83' ' ' MET . 3.3 tt -60.01 -44.3 94.68 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 121.285 -0.166 . . . . 0.0 111.329 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -59.48 -34.33 72.43 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.54 -33.92 46.2 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.601 178.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.658 HD13 HG11 ' A' ' 93' ' ' VAL . 14.0 mt -60.55 -52.17 66.31 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.735 0.302 . . . . 0.0 110.603 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.549 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.2 OUTLIER -59.92 -56.66 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.975 179.846 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.43 -30.77 13.29 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.51 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.8 tp -73.11 -27.82 61.92 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.437 HD12 ' C ' ' A' ' 44' ' ' LEU . 1.8 pp -96.97 -42.55 7.86 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.4 pttt -84.26 -68.79 0.69 Allowed 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.5 m -50.69 -28.82 9.76 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.509 0.195 . . . . 0.0 111.47 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -81.19 -34.31 32.39 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.277 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -130.8 -68.32 0.69 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 111.449 0.166 . . . . 0.0 111.449 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 51' ' ' GLU . 11.5 p 44.72 72.31 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 121.56 0.695 . . . . 0.0 111.491 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -52.55 -50.23 63.33 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.205 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.606 ' O ' HG22 ' A' ' 49' ' ' VAL . 1.8 tp10 -91.44 -164.06 1.12 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.02 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.452 ' CB ' HD23 ' A' ' 55' ' ' LEU . 3.3 ttt-85 -66.2 134.39 94.77 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-O 120.675 0.274 . . . . 0.0 111.24 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.582 ' HB3' HG21 ' A' ' 49' ' ' VAL . 74.1 Cg_endo -77.24 -25.56 8.39 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.572 2.181 . . . . 0.0 112.529 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.44 ' HA ' HG22 ' A' ' 57' ' ' VAL . 2.9 t70 -89.84 8.46 31.9 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.565 ' HG ' HD23 ' A' ' 56' ' ' LEU . 2.6 pp -91.41 -26.32 18.92 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 121.287 -0.165 . . . . 0.0 111.323 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.59 ' HB2' HD22 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -98.24 -45.1 6.31 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.804 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.44 HG22 ' HA ' ' A' ' 54' ' ' ASP . 11.1 m -55.3 148.52 3.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 121.258 0.551 . . . . 0.0 111.558 -179.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -63.94 -57.0 11.09 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.532 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.76 -44.51 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.515 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 34.6 p -86.07 10.73 13.46 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.735 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.429 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 58.31 22.3 50.34 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.688 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -109.69 -34.69 6.4 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.947 0.403 . . . . 0.0 110.886 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.6 t -129.25 175.09 9.0 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.881 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.59 HD22 ' HB2' ' A' ' 56' ' ' LEU . 11.0 mt -93.75 158.03 15.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.043 0.449 . . . . 0.0 111.402 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.437 ' HB2' ' HD2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -83.17 165.87 38.44 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.191 -179.867 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.437 ' HD2' ' HB2' ' A' ' 65' ' ' ARG . 47.2 Cg_exo -55.72 129.67 36.28 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.741 2.294 . . . . 0.0 112.428 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.49 -49.29 0.86 Allowed Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.196 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.527 HG21 ' HB3' ' A' ' 95' ' ' PHE . 4.6 mt -94.62 134.61 31.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-O 120.728 0.299 . . . . 0.0 110.859 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.3 mt -111.53 118.65 36.31 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.975 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.465 HG23 ' HB3' ' A' ' 77' ' ' ALA . 26.9 m -85.77 125.22 40.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.031 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.415 HD23 ' C ' ' A' ' 70' ' ' VAL . 1.7 mt -120.96 131.55 54.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.089 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.591 HG13 ' HB2' ' A' ' 77' ' ' ALA . 1.5 m -103.99 99.31 8.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.737 179.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 59.58 51.19 6.61 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.685 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.1 t 66.02 35.35 6.42 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.506 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 47.1 t -148.69 123.9 10.18 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.559 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -47.49 114.1 0.82 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.885 0.374 . . . . 0.0 111.32 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.591 ' HB2' HG13 ' A' ' 72' ' ' VAL . . . -73.04 -18.99 61.27 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.842 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.401 ' HA ' ' CA ' ' A' ' 82' ' ' GLY . 2.7 mt-10 -73.17 -23.99 60.5 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.87 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.8 t -64.59 -35.76 75.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.813 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.9 m -95.85 -36.72 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.693 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -152.22 -66.15 0.01 OUTLIER Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.061 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.401 ' CA ' ' HA ' ' A' ' 78' ' ' GLU . . . 104.39 -40.29 2.51 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.664 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.813 ' HA ' HD22 ' A' ' 37' ' ' LEU . 5.0 ptt? -147.63 25.13 1.08 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.52 0.2 . . . . 0.0 111.318 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -148.74 25.4 0.94 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.663 0.268 . . . . 0.0 111.679 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -81.5 114.32 20.15 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.763 0.316 . . . . 0.0 110.917 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.8 m -63.6 146.1 13.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.487 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.649 ' CD1' HD11 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -90.42 168.52 11.8 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.295 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 44.4 p30 -168.45 166.14 12.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.658 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -64.45 96.16 0.16 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.931 0.396 . . . . 0.0 110.343 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.417 ' H ' HD13 ' A' ' 7' ' ' ILE . . . 118.77 24.25 3.14 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.529 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -87.41 158.38 19.01 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.751 0.31 . . . . 0.0 111.045 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 53.5 m -138.31 136.93 36.91 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.264 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.658 HG11 HD13 ' A' ' 40' ' ' LEU . 3.4 p -143.26 120.33 5.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.607 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -125.09 147.94 48.77 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.528 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.527 ' HB3' HG21 ' A' ' 68' ' ' ILE . 80.6 m-85 -118.74 104.42 10.58 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.174 179.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.78 HG12 ' HB3' ' A' ' 12' ' ' ALA . 30.0 mt -116.59 112.85 41.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.243 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 27.1 t -78.37 86.99 4.41 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.237 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.5 p . . . . . 0 C--N 1.332 -0.182 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.374 -179.493 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.45 ' O ' ' HA2' ' A' ' 90' ' ' GLY . 12.5 m-70 . . . . . 0 N--CA 1.465 0.294 0 CA-C-O 120.814 0.34 . . . . 0.0 111.049 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.663 HD12 HD23 ' A' ' 87' ' ' LEU . 6.5 mm -81.25 145.58 8.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.185 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.601 HG22 ' OE1' ' A' ' 10' ' ' GLN . 1.2 m -102.26 107.51 18.57 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.206 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.559 HG13 ' HB2' ' A' ' 25' ' ' LEU . 7.6 p -133.07 107.69 11.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.455 178.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.601 ' OE1' HG22 ' A' ' 8' ' ' THR . 1.4 pm0 -136.52 164.72 27.51 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.048 0.452 . . . . 0.0 111.75 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.461 ' CD1' ' HB3' ' A' ' 15' ' ' CYS . 15.2 m-85 -112.64 149.36 32.94 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.906 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.925 ' HB3' HG12 ' A' ' 96' ' ' ILE . . . -140.68 135.51 31.7 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.028 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.22 -107.03 3.44 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.315 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -121.84 30.5 5.27 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.784 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.461 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . 7.9 m -106.06 -19.96 13.56 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.798 0.299 . . . . 0.0 111.721 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -58.34 -30.45 66.73 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.804 0.335 . . . . 0.0 110.767 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 mp -70.03 -4.46 21.03 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.873 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.808 ' CD2' HD11 ' A' ' 55' ' ' LEU . 91.5 mt -77.09 7.79 4.61 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.404 ' CD1' ' HB2' ' A' ' 50' ' ' LYS . 77.0 t80 -149.92 -65.11 0.21 Allowed 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -172.09 39.14 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.772 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 52.18 35.77 17.54 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.892 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -76.13 -176.9 3.71 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.023 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 72.0 p -109.96 -77.42 0.6 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.806 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.447 ' CB ' ' HB3' ' A' ' 10' ' ' GLN . 80.8 p -135.73 162.9 31.47 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.876 0.37 . . . . 0.0 111.406 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.559 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.9 OUTLIER -139.08 155.51 47.87 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.779 179.896 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 35.6 mt-30 -132.15 127.78 36.66 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.143 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.5 mt . . . . . 0 CA--C 1.53 0.18 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.018 -179.79 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 89.4 m . . . . . 0 N--CA 1.464 0.232 0 CA-C-O 120.676 0.274 . . . . 0.0 110.692 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -111.9 -175.11 2.61 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.887 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.703 HD22 ' CB ' ' A' ' 83' ' ' MET . 4.7 tt -57.65 -49.47 76.34 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -57.68 -31.95 66.87 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.233 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.42 -32.22 38.98 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 111.414 -0.674 . . . . 0.0 111.414 178.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.674 HD21 HD22 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -63.85 -51.68 63.56 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.669 0.271 . . . . 0.0 110.463 179.345 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.574 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.2 OUTLIER -56.99 -56.21 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.835 179.558 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -51.41 -29.82 17.19 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.452 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.599 HD13 ' O ' ' A' ' 43' ' ' LEU . 0.5 OUTLIER -75.65 -28.31 58.69 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.75 HD12 ' N ' ' A' ' 45' ' ' LYS . 4.4 pp -95.89 -36.6 11.04 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.75 ' N ' HD12 ' A' ' 44' ' ' LEU . 2.4 pttt -86.07 -61.39 1.76 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.2 m -58.61 -23.13 58.22 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 122.253 -0.279 . . . . 0.0 111.569 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -96.65 -39.17 9.63 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 111.412 0.152 . . . . 0.0 111.412 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -150.24 59.76 0.97 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.433 ' HB ' ' O ' ' A' ' 45' ' ' LYS . 7.5 p -78.81 -42.27 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.436 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.404 ' HB2' ' CD1' ' A' ' 19' ' ' PHE . 0.0 OUTLIER 62.02 14.12 6.22 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 120.662 0.268 . . . . 0.0 111.501 -179.684 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -152.34 -160.81 1.19 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.671 ' HB2' HD23 ' A' ' 55' ' ' LEU . 9.0 mmt85 -87.16 108.15 17.79 Favored Pre-proline 0 C--N 1.331 -0.225 0 N-CA-C 110.412 -0.218 . . . . 0.0 110.412 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.437 ' O ' HG22 ' A' ' 57' ' ' VAL . 18.5 Cg_endo -59.43 -23.21 69.5 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.148 1.898 . . . . 0.0 112.515 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.421 ' HA ' ' CG2' ' A' ' 57' ' ' VAL . 48.8 m-20 -90.43 8.09 35.47 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.808 HD11 ' CD2' ' A' ' 18' ' ' LEU . 2.1 pp -92.7 -20.45 20.8 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 121.19 -0.204 . . . . 0.0 111.418 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.651 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -106.63 -45.63 4.18 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 179.956 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.446 HG11 ' HA2' ' A' ' 61' ' ' GLY . 5.8 m -52.8 149.88 1.34 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-O 121.135 0.493 . . . . 0.0 111.864 -179.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -65.76 -61.37 2.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.555 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -168.47 -44.47 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.311 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.3 p -80.14 4.68 16.59 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.615 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.446 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 61.54 21.38 60.25 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.433 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -112.63 -41.06 3.9 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.769 0.319 . . . . 0.0 110.594 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.743 HG22 ' HG2' ' A' ' 83' ' ' MET . 16.8 p -110.77 -167.12 1.14 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.133 179.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.502 HD22 ' HB2' ' A' ' 56' ' ' LEU . 7.4 mt -114.8 154.45 28.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.828 0.347 . . . . 0.0 111.06 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.69 150.46 81.84 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.063 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.79 127.42 24.58 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.875 2.383 . . . . 0.0 112.315 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 142.58 -45.01 0.94 Allowed Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.46 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.456 HG21 ' HB3' ' A' ' 95' ' ' PHE . 5.6 mt -88.43 141.35 14.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 120.803 0.335 . . . . 0.0 111.228 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 mt -105.48 99.85 9.44 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.79 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.832 HG23 ' HB3' ' A' ' 77' ' ' ALA . 13.3 m -78.76 135.51 25.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.007 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 mt -126.57 141.2 51.94 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.013 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.719 HG11 ' CD2' ' A' ' 85' ' ' TYR . 48.9 t -123.74 118.23 53.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.737 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 56.61 31.74 19.7 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.337 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 55.2 35.76 25.54 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.873 0.368 . . . . 0.0 111.113 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 11.2 t -141.89 37.55 1.61 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.922 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.435 ' HB2' HG23 ' A' ' 79' ' ' VAL . 12.9 m-20 67.37 134.59 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.27 0.557 . . . . 0.0 111.388 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.832 ' HB3' HG23 ' A' ' 70' ' ' VAL . . . -84.39 -22.81 30.34 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.434 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -77.84 -32.64 52.26 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.61 0.243 . . . . 0.0 110.859 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.435 HG23 ' HB2' ' A' ' 76' ' ' ASP . 35.2 t -69.21 -42.37 81.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.246 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.457 ' HB ' ' CD1' ' A' ' 85' ' ' TYR . 14.8 m -68.23 -31.22 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.561 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 142.68 42.08 0.06 OUTLIER Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.33 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.422 ' O ' HD13 ' A' ' 37' ' ' LEU . . . 47.35 -119.03 4.45 Favored Glycine 0 C--N 1.336 0.574 0 C-N-CA 121.281 -0.485 . . . . 0.0 112.947 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.743 ' HG2' HG22 ' A' ' 63' ' ' THR . 0.1 OUTLIER -101.5 26.3 7.43 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.69 0.281 . . . . 0.0 111.134 179.42 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -120.2 23.64 10.84 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.369 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.719 ' CD2' HG11 ' A' ' 72' ' ' VAL . 28.4 t80 -93.24 130.25 39.0 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.864 0.364 . . . . 0.0 111.074 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.1 m -89.46 142.52 12.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.03 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.674 HD22 HD21 ' A' ' 40' ' ' LEU . 10.8 mp -83.72 174.22 10.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.947 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -135.01 -67.06 0.56 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.98 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -178.52 79.4 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.817 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.539 ' H ' HD13 ' A' ' 7' ' ' ILE . . . 113.48 37.3 1.33 Allowed Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.821 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.91 174.19 6.45 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.774 0.321 . . . . 0.0 110.931 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 58.4 m -132.42 116.08 16.36 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.953 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.468 HG13 HG23 ' A' ' 9' ' ' VAL . 12.9 p -128.81 119.93 50.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.019 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.438 ' HG2' ' HG2' ' A' ' 10' ' ' GLN . 39.9 mt-10 -124.92 146.56 49.29 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.3 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.456 ' HB3' HG21 ' A' ' 68' ' ' ILE . 20.0 m-85 -121.72 104.81 9.86 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.346 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.925 HG12 ' HB3' ' A' ' 12' ' ' ALA . 27.7 mt -116.68 119.52 62.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.293 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.8 t -87.46 134.23 33.63 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.094 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.464 0.228 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.239 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 ttm . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 120.459 0.171 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.6 t -164.65 42.42 0.08 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.889 0.376 . . . . 0.0 110.957 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -89.46 71.29 8.02 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 121.279 0.561 . . . . 0.0 110.578 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 64.2 m170 -107.98 96.2 6.21 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.394 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.453 ' O ' ' HB2' ' A' ' 6' ' ' HIS . 77.3 m-20 64.54 -85.23 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.949 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.453 ' HB2' ' O ' ' A' ' 5' ' ' ASN . 34.5 m-70 68.19 140.77 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.904 0.383 . . . . 0.0 111.522 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.532 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 8.5 mm -104.05 143.18 16.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.648 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.674 HG22 HE22 ' A' ' 10' ' ' GLN . 32.1 m -111.09 93.47 4.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.563 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.636 HG13 ' HB2' ' A' ' 25' ' ' LEU . 7.8 p -114.59 102.65 14.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 121.15 0.5 . . . . 0.0 110.223 178.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.674 HE22 HG22 ' A' ' 8' ' ' THR . 0.2 OUTLIER -128.37 175.2 8.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.96 -178.556 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.527 ' CD1' ' HB3' ' A' ' 15' ' ' CYS . 49.8 m-85 -128.39 168.65 15.28 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.112 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.878 ' HB3' HG12 ' A' ' 96' ' ' ILE . . . -155.29 136.61 14.02 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.311 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.09 -106.29 3.14 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.216 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -122.98 31.7 4.65 Favored Glycine 0 CA--C 1.521 0.464 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.727 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.527 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . 69.3 m -106.78 -16.62 14.44 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.466 ' HG2' ' HB2' ' A' ' 11' ' ' PHE . 68.5 mt-10 -58.58 -30.98 67.6 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.523 0.201 . . . . 0.0 111.05 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.439 HD12 ' H ' ' A' ' 17' ' ' LEU . 2.8 mp -70.57 -7.8 46.73 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.51 HD21 HD11 ' A' ' 55' ' ' LEU . 13.3 mt -83.57 12.08 6.22 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.425 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 38.5 t80 -147.32 -62.37 0.28 Allowed 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -176.7 36.28 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.067 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.47 35.86 12.1 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.895 0.378 . . . . 0.0 110.663 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -90.2 146.07 24.54 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.913 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.446 ' O ' ' HB2' ' A' ' 10' ' ' GLN . 7.3 p -75.97 -32.64 59.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.098 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.9 p -170.96 157.98 5.53 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.646 0.26 . . . . 0.0 111.145 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.636 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -135.95 154.36 51.13 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.819 0.343 . . . . 0.0 111.547 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.532 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 16.7 mt-30 -132.72 128.15 36.3 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.986 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.5 mt -109.38 137.21 47.58 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.78 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.53 113.73 26.98 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.873 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -115.64 -158.32 11.63 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.493 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.656 HG23 HG22 ' A' ' 31' ' ' VAL . 16.1 m -141.39 -47.36 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.475 0.178 . . . . 0.0 111.381 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.656 HG22 HG23 ' A' ' 30' ' ' VAL . 10.5 m -146.42 74.42 12.72 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-O 120.926 0.393 . . . . 0.0 110.964 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -83.39 18.18 1.55 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.806 2.337 . . . . 0.0 113.231 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.4 m -57.79 -32.93 68.01 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.71 0.29 . . . . 0.0 110.833 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -91.15 24.83 16.75 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.148 -0.549 . . . . 0.0 112.92 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.6 m -123.98 148.1 47.22 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.813 0.306 . . . . 0.0 110.674 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -128.97 -178.59 4.69 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.169 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.721 ' O ' HG22 ' A' ' 41' ' ' VAL . 5.2 tt -57.77 -46.65 84.26 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -56.83 -33.76 67.07 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.719 0.295 . . . . 0.0 110.32 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.67 -30.1 49.75 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 121.001 -0.618 . . . . 0.0 111.983 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.457 HD13 ' O ' ' A' ' 40' ' ' LEU . 1.4 tm? -70.8 -47.33 60.05 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.674 0.237 . . . . 0.0 111.237 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.721 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -62.4 -53.34 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.866 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -53.41 -33.11 52.64 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.031 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.624 HD13 ' O ' ' A' ' 43' ' ' LEU . 0.6 OUTLIER -70.85 -24.78 62.59 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.302 179.468 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.596 HD23 ' HA ' ' A' ' 41' ' ' VAL . 0.8 OUTLIER -95.1 -42.18 8.73 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.692 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.447 ' O ' HG12 ' A' ' 49' ' ' VAL . 7.7 pttp -92.36 -60.86 1.73 Allowed 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.401 ' H ' ' HG3' ' A' ' 45' ' ' LYS . 1.5 m -54.57 -27.29 37.85 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 122.176 -0.328 . . . . 0.0 111.244 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 1.6 t30 -82.71 -26.65 31.82 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.461 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -135.59 -75.04 0.45 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.77 -0.195 . . . . 0.0 111.323 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.608 ' O ' HG13 ' A' ' 49' ' ' VAL . 13.0 p 40.41 89.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.396 0.678 . . . . 0.0 112.237 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -66.33 -53.7 33.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.228 179.616 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.543 ' HB3' HD21 ' A' ' 55' ' ' LEU . 1.8 tp10 -76.65 -179.47 5.33 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.798 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.449 ' HB2' HD23 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -55.12 113.91 6.23 Favored Pre-proline 0 N--CA 1.464 0.246 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.162 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.548 ' HA ' HG21 ' A' ' 49' ' ' VAL . 18.2 Cg_endo -60.66 -23.25 75.49 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.546 2.164 . . . . 0.0 112.5 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -90.28 5.55 46.71 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.639 ' HG ' HD23 ' A' ' 56' ' ' LEU . 1.5 pp -93.38 -21.42 19.54 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 122.379 -0.201 . . . . 0.0 111.484 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.639 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -100.14 -45.28 5.69 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -179.797 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.494 HG11 ' HA2' ' A' ' 61' ' ' GLY . 5.9 m -54.49 150.22 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.214 0.531 . . . . 0.0 111.66 -179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -66.79 -54.1 26.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.859 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.52 -43.0 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.441 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 71.4 p -87.42 11.06 15.52 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.494 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 58.55 23.09 54.02 Favored Glycine 0 C--N 1.338 0.674 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.645 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -110.17 -39.91 4.86 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.903 0.382 . . . . 0.0 110.585 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.1 p -121.4 -178.05 3.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.022 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.468 HD13 HD13 ' A' ' 68' ' ' ILE . 6.5 mt -110.16 155.93 21.3 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.875 0.369 . . . . 0.0 111.003 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.89 148.98 82.34 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.429 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -50.3 -32.43 33.15 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.249 2.632 . . . . 0.0 113.146 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -47.84 -36.0 13.14 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 121.391 -0.433 . . . . 0.0 113.144 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.468 HD13 HD13 ' A' ' 64' ' ' LEU . 5.1 mt -93.11 138.0 21.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.784 0.292 . . . . 0.0 111.063 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.497 ' CD2' HD21 ' A' ' 71' ' ' LEU . 13.4 tp -102.87 106.93 17.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.93 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.608 HG23 ' HB3' ' A' ' 77' ' ' ALA . 12.7 m -84.93 133.34 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.864 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.497 HD21 ' CD2' ' A' ' 69' ' ' LEU . 1.9 mt -134.65 141.27 46.53 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.433 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.657 HG23 ' CB ' ' A' ' 77' ' ' ALA . 38.2 t -119.04 121.92 67.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.591 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 59.52 45.13 13.83 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.075 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.33 39.59 18.62 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.203 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 17.9 t -153.88 153.98 33.06 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.581 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.43 ' CB ' HG23 ' A' ' 79' ' ' VAL . 69.6 m-20 -47.04 121.06 3.42 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.642 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.657 ' CB ' HG23 ' A' ' 72' ' ' VAL . . . -81.33 -19.03 43.68 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.684 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -77.53 -29.7 52.48 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.577 0.227 . . . . 0.0 110.838 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.43 HG23 ' CB ' ' A' ' 76' ' ' ASP . 43.7 t -65.24 -50.98 70.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.075 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.7 m -61.3 -36.03 70.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.521 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -176.78 -44.88 0.06 OUTLIER Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.773 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.41 -51.03 1.84 Allowed Glycine 0 C--N 1.335 0.51 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.213 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.402 ' HA ' HD22 ' A' ' 37' ' ' LEU . 3.9 ptt? -142.5 23.74 1.95 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 120.479 0.181 . . . . 0.0 111.217 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -140.35 26.75 2.15 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.46 ' CE2' HG11 ' A' ' 72' ' ' VAL . 33.5 t80 -84.85 98.15 10.14 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.82 0.343 . . . . 0.0 110.945 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.9 m -61.68 141.56 17.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.584 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.63 160.19 14.52 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.185 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -158.21 31.16 0.25 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.441 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 69.6 120.62 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.89 0.376 . . . . 0.0 110.897 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 97.28 33.66 5.88 Favored Glycine 0 CA--C 1.519 0.302 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.961 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -101.86 167.44 10.07 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.94 0.4 . . . . 0.0 111.476 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.588 HG23 ' HB ' ' A' ' 8' ' ' THR . 92.9 m -137.47 134.11 35.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.759 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.0 p -141.85 136.61 30.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.823 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -130.49 150.15 51.84 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.616 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -130.51 104.48 7.26 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.098 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.878 HG12 ' HB3' ' A' ' 12' ' ' ALA . 24.6 mt -118.99 115.4 47.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.035 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 46.6 t -81.24 140.36 34.93 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.284 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 21.3 p -132.3 -50.36 0.93 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.893 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.2 tp -78.15 99.55 6.24 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.828 0.347 . . . . 0.0 110.597 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -72.06 -60.95 1.97 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.077 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 73.5 -113.6 4.31 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.7 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.316 -1.269 . . . . 0.0 112.457 -179.97 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 120.515 0.198 . . . . 0.0 111.251 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.3 t -119.72 -62.67 1.46 Allowed 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.758 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -135.83 140.73 44.43 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.096 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -158.44 82.07 0.83 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.669 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -108.88 130.56 55.43 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.264 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.421 ' CD2' ' HB3' ' A' ' 26' ' ' GLN . 0.0 OUTLIER 179.35 153.44 0.43 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.071 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 33.3 mm -115.28 152.23 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.84 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.813 HG22 ' OE1' ' A' ' 10' ' ' GLN . 24.9 m -115.29 101.72 9.2 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.008 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.534 ' O ' HG13 ' A' ' 9' ' ' VAL . 10.8 p -120.43 108.54 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-O 121.007 0.432 . . . . 0.0 111.207 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.813 ' OE1' HG22 ' A' ' 8' ' ' THR . 0.0 OUTLIER -131.36 156.88 44.76 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.571 -179.892 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.424 ' HB2' ' HB3' ' A' ' 16' ' ' GLU . 33.2 m-85 -115.05 144.93 42.85 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.859 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.0 151.89 35.34 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.672 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.37 -86.84 1.11 Allowed Glycine 0 C--N 1.336 0.538 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.44 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -143.34 27.73 2.1 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.565 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.29 5.54 21.77 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.538 ' HG2' HD12 ' A' ' 17' ' ' LEU . 1.1 pm0 -93.1 -29.02 15.99 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.53 0.205 . . . . 0.0 111.046 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.538 HD12 ' HG2' ' A' ' 16' ' ' GLU . 5.0 mp -66.73 -15.56 63.62 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.656 ' HB2' HD21 ' A' ' 55' ' ' LEU . 3.6 pp -83.26 12.71 4.95 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -143.07 -66.5 0.37 Allowed 'General case' 0 CA--C 1.521 -0.135 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -175.78 36.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.31 179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 mptt 49.7 34.92 7.95 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.865 0.364 . . . . 0.0 110.694 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -76.27 179.69 5.61 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.708 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 67.5 p -112.11 -74.55 0.63 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.01 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 87.9 p -135.74 156.81 48.24 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 120.777 0.322 . . . . 0.0 111.181 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.9 tp -150.13 166.56 29.43 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.688 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.494 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 1.0 OUTLIER -126.42 146.59 50.01 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.844 179.665 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.1 mt -128.73 142.57 50.96 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.09 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -102.2 111.12 23.28 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.825 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.07 -34.94 5.48 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 121.051 -0.595 . . . . 0.0 113.068 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.4 t 72.88 -63.51 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 122.646 0.378 . . . . 0.0 111.086 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.1 m -128.56 56.58 23.3 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-O 121.078 0.466 . . . . 0.0 111.154 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.56 6.54 5.08 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.895 2.397 . . . . 0.0 113.368 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.04 -46.14 68.33 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.635 0.255 . . . . 0.0 111.427 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.5 49.54 3.69 Favored Glycine 0 C--N 1.336 0.544 0 C-N-CA 121.014 -0.613 . . . . 0.0 112.743 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.2 m -150.97 138.61 19.69 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.799 0.333 . . . . 0.0 111.04 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -111.33 -175.17 2.64 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.885 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.623 HD22 ' HA ' ' A' ' 83' ' ' MET . 0.6 OUTLIER -58.68 -42.85 89.47 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.756 -0.202 . . . . 0.0 111.1 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.403 ' OD1' ' HA ' ' A' ' 62' ' ' GLN . 5.5 t30 -55.68 -37.68 68.64 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.953 0.406 . . . . 0.0 109.948 178.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.75 -32.27 46.37 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.161 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.526 HD22 HD11 ' A' ' 87' ' ' LEU . 53.6 tp -62.83 -48.97 76.75 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.714 0.257 . . . . 0.0 110.591 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.617 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -62.16 -57.01 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.847 179.612 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -55.82 -28.15 54.84 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 120.498 0.189 . . . . 0.0 111.08 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.411 ' O ' ' HB2' ' A' ' 47' ' ' ASN . 7.1 tt -84.71 -21.86 29.97 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.848 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.466 HD12 ' C ' ' A' ' 44' ' ' LEU . 1.2 pp -93.89 -41.08 9.81 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.418 ' HG2' ' H ' ' A' ' 46' ' ' THR . 0.1 OUTLIER -70.72 -56.48 6.29 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.77 -179.677 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.418 ' H ' ' HG2' ' A' ' 45' ' ' LYS . 10.6 m -60.69 -20.33 60.78 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.554 0.216 . . . . 0.0 110.814 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.4 OUTLIER -67.45 -44.19 79.27 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.944 179.474 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -146.43 -62.83 0.31 Allowed 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.575 ' O ' HG13 ' A' ' 49' ' ' VAL . 13.2 p 42.91 86.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.469 0.652 . . . . 0.0 112.017 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.78 -48.17 80.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.214 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.513 ' O ' HG22 ' A' ' 49' ' ' VAL . 0.2 OUTLIER -91.61 -156.23 0.44 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.651 -0.249 . . . . 0.0 110.564 179.683 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.423 ' N ' HD23 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -66.88 138.01 95.03 Favored Pre-proline 0 CA--C 1.531 0.221 0 CA-C-O 120.755 0.312 . . . . 0.0 111.583 -179.507 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.527 ' HA ' HG21 ' A' ' 49' ' ' VAL . 73.7 Cg_endo -77.77 -29.9 4.16 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.562 2.174 . . . . 0.0 112.468 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.479 ' OD1' HG23 ' A' ' 57' ' ' VAL . 4.1 t0 -94.43 10.67 33.5 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.656 HD21 ' HB2' ' A' ' 18' ' ' LEU . 3.4 pp -77.85 -25.96 49.07 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.543 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.584 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -97.4 -50.77 4.4 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.387 179.952 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.534 HG11 ' HA2' ' A' ' 61' ' ' GLY . 1.3 m -60.99 149.66 7.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.209 0.528 . . . . 0.0 111.268 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -61.46 -61.3 2.63 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.299 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -171.08 -43.74 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.269 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 38.9 p -85.07 11.43 9.67 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.807 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.534 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 54.08 27.99 39.92 Favored Glycine 0 C--N 1.34 0.779 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.539 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.403 ' HA ' ' OD1' ' A' ' 38' ' ' ASN . 16.6 tt0 -113.97 -44.66 3.13 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.983 0.42 . . . . 0.0 110.332 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.4 t -122.98 139.89 53.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.948 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.509 HD22 ' HB2' ' A' ' 56' ' ' LEU . 7.2 mt -66.76 154.84 39.74 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.872 0.368 . . . . 0.0 110.911 -179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.5 156.05 89.04 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.194 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.48 140.54 74.5 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.844 2.362 . . . . 0.0 112.37 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.61 -47.72 1.0 Allowed Glycine 0 C--N 1.331 0.252 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.255 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.506 HD13 HD13 ' A' ' 64' ' ' LEU . 6.4 mt -79.93 149.96 5.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-O 120.867 0.365 . . . . 0.0 110.984 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.3 mt -128.41 104.3 7.63 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.783 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.617 HG23 ' HB3' ' A' ' 77' ' ' ALA . 30.6 m -77.37 123.62 34.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.833 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.475 HD23 ' O ' ' A' ' 70' ' ' VAL . 5.3 mt -124.8 141.46 52.1 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.375 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.739 HG23 ' HB2' ' A' ' 77' ' ' ALA . 36.6 t -109.34 107.0 21.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.526 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 59.35 55.44 4.23 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.899 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 12.0 t 57.71 49.2 12.72 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.312 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 52.4 t -162.41 143.63 10.38 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.784 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.3 122.2 9.86 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.913 0.387 . . . . 0.0 111.193 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.739 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -75.29 -19.98 59.37 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.901 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -71.52 -24.99 62.06 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 116.728 -0.215 . . . . 0.0 111.172 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.9 t -56.18 -32.51 34.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.017 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.6 m -105.67 -38.92 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.629 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -154.95 -56.7 0.01 OUTLIER Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.017 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 99.29 -53.16 1.04 Allowed Glycine 0 C--N 1.333 0.4 0 C-N-CA 121.125 -0.56 . . . . 0.0 112.448 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.623 ' HA ' HD22 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -136.6 23.74 3.15 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.546 0.213 . . . . 0.0 111.4 179.862 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -142.74 27.06 1.69 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.733 0.271 . . . . 0.0 111.733 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -77.74 117.38 19.08 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.77 0.319 . . . . 0.0 110.944 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 14.7 m -75.28 136.06 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.272 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.526 HD11 HD22 ' A' ' 40' ' ' LEU . 2.6 mp -86.48 162.19 18.21 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.294 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -146.13 33.5 1.0 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.403 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 60.42 27.34 16.94 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.396 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -169.59 40.01 0.2 Allowed Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.937 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -103.85 166.55 10.35 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.062 0.458 . . . . 0.0 111.253 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.512 HG23 ' HB ' ' A' ' 8' ' ' THR . 78.9 m -127.81 137.07 52.25 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.434 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.8 p -142.22 134.21 26.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.991 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -133.39 138.81 46.45 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.316 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -110.17 105.64 14.8 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.356 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 10.9 mt -110.85 100.76 11.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.074 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -84.08 110.58 18.58 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.036 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 22.7 p -104.72 -55.64 2.31 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.983 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 11.0 tp -78.84 151.12 32.06 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.964 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -145.35 87.7 1.82 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.788 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.22 -40.14 2.57 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.795 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.177 0 CA-C-O 118.529 -1.151 . . . . 0.0 112.803 -179.978 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 tpp . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 120.777 0.322 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 63.96 -171.67 0.18 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.316 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -73.73 -40.67 63.39 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.44 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.9 t-160 55.66 34.47 23.34 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.954 0.407 . . . . 0.0 110.595 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.42 ' HA ' ' OD1' ' A' ' 89' ' ' ASP . 2.2 t30 -135.95 145.57 46.36 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.003 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -174.56 105.69 0.1 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.316 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 16.1 mm -90.97 157.16 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.562 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.626 HG22 HE22 ' A' ' 10' ' ' GLN . 30.3 m -124.91 93.74 3.98 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.807 0.336 . . . . 0.0 111.521 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.546 ' O ' HG13 ' A' ' 9' ' ' VAL . 7.6 p -113.23 103.6 15.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.183 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.626 HE22 HG22 ' A' ' 8' ' ' THR . 0.1 OUTLIER -131.74 166.9 20.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.744 -178.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.534 ' HB2' ' HG2' ' A' ' 16' ' ' GLU . 41.6 m-85 -125.0 163.52 22.16 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.874 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.412 ' O ' ' HA ' ' A' ' 96' ' ' ILE . . . -175.17 119.51 0.19 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.053 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.67 54.89 0.76 Allowed Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.582 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.26 25.96 72.48 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.199 -0.524 . . . . 0.0 113.478 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -116.44 5.35 13.43 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 117.091 0.445 . . . . 0.0 111.675 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.534 ' HG2' ' HB2' ' A' ' 11' ' ' PHE . 64.1 mt-10 -84.17 -23.29 30.67 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.73 -4.92 21.86 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.513 ' CD2' HD11 ' A' ' 55' ' ' LEU . 24.7 mt -78.88 8.73 5.06 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -149.39 -63.58 0.22 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.788 0.328 . . . . 0.0 110.149 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -174.84 38.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.848 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.93 35.8 20.15 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.241 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -80.48 178.37 8.37 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.963 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 28.1 p -107.69 -74.65 0.65 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.994 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.405 ' O ' HD12 ' A' ' 25' ' ' LEU . 88.0 p -132.99 160.58 36.71 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.829 0.347 . . . . 0.0 111.355 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.416 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -141.55 152.81 44.42 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.181 -179.935 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.458 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 1.7 mt-30 -131.06 122.32 26.55 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.6 mt -94.73 136.32 35.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.338 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -117.03 115.87 26.24 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.98 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -146.49 139.81 8.32 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.446 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.0 m -65.14 -41.54 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 120.659 0.266 . . . . 0.0 111.255 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.8 t -143.79 72.99 17.02 Favored Pre-proline 0 CA--C 1.53 0.203 0 CA-C-O 120.926 0.394 . . . . 0.0 110.838 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -81.66 4.99 6.58 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.743 2.296 . . . . 0.0 113.081 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.81 166.45 8.98 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.803 0.335 . . . . 0.0 110.916 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.34 -29.38 10.93 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.52 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 58.9 m -83.37 158.84 21.99 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.61 0.243 . . . . 0.0 110.984 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -131.81 -179.55 5.46 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.896 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.657 ' O ' HG22 ' A' ' 41' ' ' VAL . 6.4 tt -53.47 -48.36 68.94 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 111.514 0.19 . . . . 0.0 111.514 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -52.99 -36.35 60.28 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.812 0.339 . . . . 0.0 110.388 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.3 -31.05 43.33 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.137 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.439 HD23 HD21 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -66.84 -51.49 54.89 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.633 0.254 . . . . 0.0 110.72 179.702 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.657 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.2 OUTLIER -60.7 -57.34 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.915 179.776 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.421 ' H ' HG23 ' A' ' 41' ' ' VAL . 0.4 OUTLIER -52.57 -29.33 25.05 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.319 179.571 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 30.5 tp -74.53 -27.59 60.6 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.547 HD12 ' N ' ' A' ' 45' ' ' LYS . 3.5 pp -96.93 -38.61 9.75 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.547 ' N ' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -84.16 -70.91 0.54 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.859 -0.336 . . . . 0.0 111.411 -179.793 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.3 m -53.24 -24.32 10.95 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 111.863 0.319 . . . . 0.0 111.863 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -102.45 -23.3 13.94 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -147.84 50.17 1.05 Allowed 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.607 HG22 ' H ' ' A' ' 51' ' ' GLU . 9.6 p -99.88 122.72 52.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.871 0.367 . . . . 0.0 110.987 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.4 mttt -100.79 33.05 2.91 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.888 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.607 ' H ' HG22 ' A' ' 49' ' ' VAL . 1.7 tp10 -160.21 -161.79 0.92 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.111 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 54.5 mtt-85 -88.87 109.88 33.47 Favored Pre-proline 0 CA--C 1.529 0.172 0 CA-C-O 120.418 0.152 . . . . 0.0 110.894 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.736 ' HA ' HD21 ' A' ' 56' ' ' LEU . 78.0 Cg_exo -48.41 -30.11 14.87 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.724 2.283 . . . . 0.0 112.929 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.19 -17.17 64.56 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.687 ' HG ' HD23 ' A' ' 56' ' ' LEU . 2.5 pp -80.38 -15.19 57.43 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.736 HD21 ' HA ' ' A' ' 53' ' ' PRO . 0.2 OUTLIER -108.65 -49.15 3.2 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.712 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.722 HG22 ' O ' ' A' ' 53' ' ' PRO . 2.9 m -57.34 148.38 5.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-O 121.078 0.466 . . . . 0.0 111.467 -179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -71.33 -59.72 2.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.913 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -162.96 -56.42 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.229 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.6 p -59.51 -21.2 59.83 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.2 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.76 21.59 49.97 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 121.149 -0.548 . . . . 0.0 111.862 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -124.45 -46.34 1.9 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.792 0.33 . . . . 0.0 110.974 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.0 t -101.91 130.91 48.52 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.701 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.519 HD22 ' HB2' ' A' ' 56' ' ' LEU . 5.7 mt -65.91 155.29 36.87 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.806 0.336 . . . . 0.0 111.123 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -53.21 143.76 32.46 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.324 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -51.57 -33.39 47.97 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.181 2.587 . . . . 0.0 112.98 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -49.49 -35.39 21.75 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.348 -0.453 . . . . 0.0 112.914 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.464 HD13 HD13 ' A' ' 64' ' ' LEU . 7.9 mt -82.81 114.4 23.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.83 0.315 . . . . 0.0 110.787 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.61 97.01 8.28 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.198 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.452 ' O ' HD23 ' A' ' 71' ' ' LEU . 19.3 t -84.87 136.33 23.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.041 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.452 HD23 ' O ' ' A' ' 70' ' ' VAL . 3.6 mt -125.62 126.68 45.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.89 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.59 HG23 ' HA ' ' A' ' 77' ' ' ALA . 38.4 t -110.23 118.76 57.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.878 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.4 m120 55.29 35.02 24.04 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.363 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.1 t 56.18 33.16 21.56 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.306 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 9.3 t -138.02 31.11 2.46 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.841 0.353 . . . . 0.0 111.01 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.669 ' HB3' HG23 ' A' ' 79' ' ' VAL . 0.4 OUTLIER 69.05 145.28 0.05 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.371 179.809 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.59 ' HA ' HG23 ' A' ' 72' ' ' VAL . . . -85.08 -22.73 28.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.594 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -82.28 -33.5 29.07 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.755 -0.202 . . . . 0.0 110.993 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.669 HG23 ' HB3' ' A' ' 76' ' ' ASP . 39.5 t -66.16 -41.9 90.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.26 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.486 ' HB ' ' CD1' ' A' ' 85' ' ' TYR . 26.8 m -69.41 -29.13 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 168.3 -34.37 0.2 Allowed Glycine 0 CA--C 1.523 0.55 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.339 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 109.25 -55.69 0.5 Allowed Glycine 0 C--N 1.333 0.416 0 N-CA-C 111.823 -0.511 . . . . 0.0 111.823 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.538 ' HA ' HD22 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -157.69 27.94 0.28 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.461 0.172 . . . . 0.0 111.289 179.4 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -135.42 20.55 3.38 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.573 ' CD2' HG11 ' A' ' 72' ' ' VAL . 34.1 t80 -68.56 112.09 5.14 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.787 0.327 . . . . 0.0 110.961 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.2 m -71.04 135.47 27.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.272 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.439 HD21 HD23 ' A' ' 40' ' ' LEU . 0.7 OUTLIER -79.83 152.99 29.41 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.023 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -155.23 -59.72 0.11 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.055 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.42 ' OD1' ' HA ' ' A' ' 5' ' ' ASN . 0.4 OUTLIER -173.03 116.09 0.28 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.137 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 80.26 34.26 29.93 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.826 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -75.39 99.09 4.04 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.84 0.352 . . . . 0.0 110.358 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 16.0 m -81.77 127.84 33.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.56 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.46 ' O ' HG13 ' A' ' 93' ' ' VAL . 7.7 p -139.02 113.96 8.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.011 0.434 . . . . 0.0 110.926 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -114.98 149.89 36.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.119 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -123.91 104.71 9.09 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.419 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 12' ' ' ALA . 29.3 mt -114.12 101.97 13.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.323 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.0 m -72.94 97.93 2.38 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.089 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.7 m -89.0 -50.92 5.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.978 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.7 tt -86.59 100.77 12.66 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.829 0.347 . . . . 0.0 110.925 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -126.0 -47.68 1.64 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.093 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 170.2 68.39 0.04 OUTLIER Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.638 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.429 -1.206 . . . . 0.0 112.605 -179.969 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 mtt . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 120.619 0.247 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.3 m 55.33 35.23 24.53 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.27 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -148.77 -58.81 0.22 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.624 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.8 m170 63.73 -174.24 0.16 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.606 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -71.48 158.41 36.3 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.972 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 25.0 p-80 -165.22 124.35 1.75 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.79 0.329 . . . . 0.0 111.515 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 33.9 mm -95.79 137.84 22.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.692 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.698 HG22 ' OE1' ' A' ' 10' ' ' GLN . 1.9 m -96.26 98.88 10.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.201 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.537 HG13 ' HB2' ' A' ' 25' ' ' LEU . 8.1 p -122.47 108.7 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-O 120.92 0.39 . . . . 0.0 110.559 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.698 ' OE1' HG22 ' A' ' 8' ' ' THR . 1.4 pm0 -135.2 158.91 43.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.396 -179.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.402 ' CB ' ' HA ' ' A' ' 16' ' ' GLU . 31.0 m-85 -126.75 145.47 50.6 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.124 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.548 ' HB2' HG12 ' A' ' 96' ' ' ILE . . . -92.74 179.99 5.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.303 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.6 97.43 0.12 Allowed Glycine 0 C--N 1.335 0.504 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.6 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 135.16 -40.95 1.49 Allowed Glycine 0 C--N 1.333 0.364 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.807 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.05 -23.95 18.48 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.441 0.162 . . . . 0.0 111.418 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.41 ' HG3' ' HA ' ' A' ' 21' ' ' LYS . 6.9 pt-20 -58.43 -26.92 63.83 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 111.679 0.251 . . . . 0.0 111.679 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 mp -68.59 -8.46 41.98 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.919 HD21 HD11 ' A' ' 55' ' ' LEU . 25.3 mt -83.26 13.43 4.26 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -148.46 -59.11 0.24 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.743 0.306 . . . . 0.0 110.253 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -178.67 36.49 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.079 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.41 ' HA ' ' HG3' ' A' ' 16' ' ' GLU . 0.0 OUTLIER 50.54 34.53 9.66 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.952 0.406 . . . . 0.0 110.764 -179.403 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -78.84 173.25 12.7 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.021 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.2 p -107.97 -45.21 4.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.947 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 94.3 p -159.7 158.87 32.16 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.592 0.234 . . . . 0.0 111.238 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.537 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -146.95 163.6 35.63 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.232 -179.703 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.24 100.8 5.32 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.855 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.0 mt -93.36 142.22 27.57 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.663 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.08 123.26 31.19 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.001 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -69.82 -51.19 25.72 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.604 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.4 t 69.6 -68.24 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 122.551 0.34 . . . . 0.0 111.223 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.495 ' O ' HG13 ' A' ' 31' ' ' VAL . 9.6 p -154.04 63.78 4.43 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-O 121.309 0.576 . . . . 0.0 110.803 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.478 ' HB2' ' HB3' ' A' ' 87' ' ' LEU . 80.8 Cg_endo -87.09 26.1 0.63 Allowed 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.206 2.604 . . . . 0.0 113.193 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.5 m -53.69 -39.26 65.0 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.847 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -103.97 32.46 7.52 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 121.188 -0.529 . . . . 0.0 112.656 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 27.4 m -120.15 146.55 45.87 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.641 0.258 . . . . 0.0 111.075 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -136.02 -174.09 3.57 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.05 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.674 ' O ' HG22 ' A' ' 41' ' ' VAL . 5.5 tt -56.82 -45.5 82.28 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.731 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -54.69 -38.63 67.22 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.03 -32.96 58.02 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.015 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.534 ' CG ' HD11 ' A' ' 87' ' ' LEU . 11.6 mt -65.61 -57.03 9.11 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.629 0.252 . . . . 0.0 110.65 179.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.3 OUTLIER -55.27 -56.89 9.16 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.994 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.414 ' H ' HG23 ' A' ' 41' ' ' VAL . 2.4 tt0 -51.02 -29.89 13.8 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.594 -0.276 . . . . 0.0 111.464 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.24 -28.49 57.15 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.76 HD12 ' N ' ' A' ' 45' ' ' LYS . 4.0 pp -94.91 -33.03 12.94 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.76 ' N ' HD12 ' A' ' 44' ' ' LEU . 4.4 pttt -92.49 -61.05 1.68 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 111.595 0.221 . . . . 0.0 111.595 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -58.29 -20.23 41.02 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 122.126 -0.359 . . . . 0.0 111.306 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -105.68 -30.14 9.65 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -146.63 48.45 1.17 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -179.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.435 ' HB ' ' O ' ' A' ' 45' ' ' LYS . 7.5 p -80.81 -32.81 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.07 20.82 0.65 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 122.544 0.338 . . . . 0.0 111.642 -179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -158.73 -166.4 1.87 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.242 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.652 ' HB3' HD23 ' A' ' 55' ' ' LEU . 3.0 ttt180 -70.67 110.91 7.97 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-O 120.601 0.238 . . . . 0.0 110.752 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.32 -22.23 70.16 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.37 2.047 . . . . 0.0 112.347 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.403 ' HA ' ' CG2' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -93.19 8.23 41.03 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.919 HD11 HD21 ' A' ' 18' ' ' LEU . 2.7 pp -88.85 -7.75 55.56 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 122.239 -0.288 . . . . 0.0 111.534 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.66 HD13 HD13 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -117.93 -47.68 2.59 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 179.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.5 HG11 ' HA2' ' A' ' 61' ' ' GLY . 2.7 m -53.58 150.35 1.54 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-O 121.275 0.56 . . . . 0.0 111.396 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.789 ' HB2' HG23 ' A' ' 63' ' ' THR . 25.7 t0 -62.7 -57.15 12.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.598 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.08 -43.16 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.354 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 31.9 p -86.5 10.09 16.35 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.752 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.5 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 58.88 21.96 53.23 Favored Glycine 0 C--N 1.338 0.693 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.484 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -107.77 -42.05 4.83 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.901 0.382 . . . . 0.0 110.461 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.789 HG23 ' HB2' ' A' ' 58' ' ' ASP . 12.1 t -118.74 -167.78 1.43 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.097 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.48 HD13 HD13 ' A' ' 68' ' ' ILE . 10.6 mt -111.75 157.58 20.35 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.979 0.418 . . . . 0.0 111.689 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.429 ' HB2' ' HD2' ' A' ' 66' ' ' PRO . 0.5 OUTLIER -78.18 156.93 78.88 Favored Pre-proline 0 C--O 1.233 0.206 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.949 179.859 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.429 ' HD2' ' HB2' ' A' ' 65' ' ' ARG . 10.7 Cg_endo -55.22 134.33 63.21 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.637 2.225 . . . . 0.0 112.472 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 133.73 -47.99 0.97 Allowed Glycine 0 C--N 1.331 0.292 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.185 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.48 HD13 HD13 ' A' ' 64' ' ' LEU . 5.8 mt -86.02 137.03 21.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-O 120.678 0.275 . . . . 0.0 111.092 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.902 HD23 HD21 ' A' ' 71' ' ' LEU . 1.0 OUTLIER -107.74 106.65 17.06 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.674 179.717 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.523 ' O ' HD23 ' A' ' 71' ' ' LEU . 16.5 m -83.11 128.39 38.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.876 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.902 HD21 HD23 ' A' ' 69' ' ' LEU . 1.5 mt -132.69 136.82 46.67 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.566 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.859 HG23 ' HB2' ' A' ' 77' ' ' ALA . 38.5 t -108.95 102.86 14.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.374 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 60.36 57.41 2.88 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.764 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.2 m 57.69 49.33 12.55 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.594 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 50.3 t -163.12 137.56 6.25 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.818 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -54.02 124.99 17.16 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.823 0.345 . . . . 0.0 111.276 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.859 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -82.1 -23.38 35.74 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.239 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -70.08 -14.18 62.55 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 111.466 0.173 . . . . 0.0 111.466 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.2 t -74.05 -30.27 27.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 111.679 0.251 . . . . 0.0 111.679 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.431 HG23 ' N ' ' A' ' 81' ' ' GLY . 18.8 m -115.73 -43.69 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.431 ' N ' HG23 ' A' ' 80' ' ' VAL . . . -176.04 72.61 0.08 OUTLIER Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.409 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.489 ' O ' HD13 ' A' ' 37' ' ' LEU . . . -49.93 -28.37 11.94 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 121.525 -0.369 . . . . 0.0 113.352 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.548 ' HA ' HD22 ' A' ' 37' ' ' LEU . 1.1 ptt? -132.15 29.09 4.38 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.726 0.298 . . . . 0.0 110.56 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -149.52 30.51 0.75 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.491 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.687 ' CZ ' HG11 ' A' ' 72' ' ' VAL . 1.6 t80 -86.83 115.99 24.61 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.827 0.346 . . . . 0.0 111.281 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 29.8 m -66.23 168.61 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.341 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.534 HD11 ' CG ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -116.84 178.74 4.23 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.193 0.521 . . . . 0.0 111.546 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -160.96 -82.77 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.054 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -173.91 33.57 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.877 0.37 . . . . 0.0 111.455 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 178.72 37.55 0.06 OUTLIER Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.429 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -82.52 149.38 27.56 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.779 0.323 . . . . 0.0 110.965 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.604 HG23 ' HB ' ' A' ' 8' ' ' THR . 61.8 m -119.43 133.18 55.83 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.401 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.3 p -141.95 127.46 17.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.907 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -128.67 145.08 51.26 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.284 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -123.29 104.59 9.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.233 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.548 HG12 ' HB2' ' A' ' 12' ' ' ALA . 30.0 mt -116.71 109.18 27.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.274 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.5 m -80.24 149.8 30.29 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.137 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 32.0 p -126.26 -61.84 1.19 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.014 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.8 pp -82.6 164.72 20.62 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.125 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -155.13 72.29 0.82 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.886 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 110.51 -91.92 0.65 Allowed Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.39 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.093 0 CA-C-O 118.201 -1.333 . . . . 0.0 112.912 179.873 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 mmt . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 t 69.88 165.09 0.27 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.932 0.396 . . . . 0.0 111.237 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -125.5 179.29 5.19 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.026 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -147.34 76.19 1.4 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.985 0.421 . . . . 0.0 111.72 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 72.51 133.07 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.922 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 37.3 p-80 -171.94 124.32 0.53 Allowed 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.509 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.557 HD13 ' H ' ' A' ' 90' ' ' GLY . 23.5 mm -99.1 146.11 9.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.847 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.449 ' HB ' ' HA ' ' A' ' 92' ' ' THR . 89.1 m -104.85 118.63 37.02 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.084 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.707 HG23 HG13 ' A' ' 93' ' ' VAL . 8.4 p -149.47 112.64 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.798 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.445 ' HB3' ' CB ' ' A' ' 24' ' ' SER . 6.2 pm0 -136.35 162.43 33.03 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.953 0.406 . . . . 0.0 111.74 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -120.8 141.75 50.23 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.164 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.32 150.76 46.93 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.387 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.32 -109.57 2.86 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.453 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -115.59 29.63 7.12 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.944 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.73 -8.11 14.19 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.984 0.392 . . . . 0.0 111.692 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -93.69 -25.32 17.51 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.573 0.225 . . . . 0.0 111.008 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.11 -7.13 47.3 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.552 ' HB3' HD11 ' A' ' 55' ' ' LEU . 3.6 pp -85.74 13.71 6.84 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -145.11 -64.11 0.34 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.922 0.391 . . . . 0.0 109.987 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -175.59 38.8 0.01 OUTLIER 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.561 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.3 mptt 51.2 40.52 26.18 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.362 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.612 ' OE1' HD21 ' A' ' 25' ' ' LEU . 29.5 pt20 -67.23 171.98 5.22 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.918 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 62.3 p -114.09 -80.06 0.59 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.006 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.445 ' CB ' ' HB3' ' A' ' 10' ' ' GLN . 88.5 p -133.08 154.71 50.31 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.85 0.357 . . . . 0.0 111.409 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.612 HD21 ' OE1' ' A' ' 22' ' ' GLN . 0.4 OUTLIER -131.62 160.93 33.92 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.178 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 1.1 tt0 -131.17 120.92 23.99 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.032 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.5 mt -102.27 141.49 35.03 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.739 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -109.83 116.13 31.09 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.105 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 61.3 -102.88 0.47 Allowed Glycine 0 C--N 1.334 0.443 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.573 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.4 m 36.25 83.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 123.157 0.583 . . . . 0.0 112.282 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.4 m 40.79 61.61 6.94 Favored Pre-proline 0 N--CA 1.466 0.364 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.731 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -82.39 7.79 4.92 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.969 2.446 . . . . 0.0 113.572 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.5 m -126.59 -59.23 1.3 Allowed 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.36 0.124 . . . . 0.0 110.741 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -83.58 55.38 5.02 Favored Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.831 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 89.3 m -152.64 140.8 20.39 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.826 0.346 . . . . 0.0 110.818 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 44.9 p30 -116.94 -174.95 2.68 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.967 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.836 HD22 ' HA ' ' A' ' 83' ' ' MET . 5.3 tt -57.78 -41.76 82.74 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.004 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -51.68 -43.14 62.62 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.229 178.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.36 -31.11 61.56 Favored Glycine 0 C--N 1.334 0.472 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.549 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -70.7 -56.92 5.31 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.876 0.338 . . . . 0.0 110.955 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.766 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.5 OUTLIER -56.98 -56.04 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.361 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.425 ' HA ' ' CG ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -50.93 -29.85 13.24 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.733 179.785 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.434 ' HA ' ' HB2' ' A' ' 47' ' ' ASN . 0.7 OUTLIER -70.18 -34.5 73.05 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.357 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.616 HD12 ' N ' ' A' ' 45' ' ' LYS . 4.4 pp -96.99 -25.2 15.47 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.449 0.536 . . . . 0.0 112.449 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.616 ' N ' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -93.02 -32.88 14.34 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.0 m -108.64 -26.04 10.57 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.434 ' HB2' ' HA ' ' A' ' 43' ' ' LEU . 2.9 m-80 -109.51 -22.38 12.02 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -178.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.69 39.82 3.16 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.563 HG22 ' H ' ' A' ' 51' ' ' GLU . 10.4 p -98.38 143.11 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 120.85 0.357 . . . . 0.0 110.866 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.77 27.88 4.59 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.4 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.563 ' H ' HG22 ' A' ' 49' ' ' VAL . 2.2 tp10 -156.71 -166.98 2.25 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.52 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.475 ' HB2' HD23 ' A' ' 55' ' ' LEU . 2.4 mpt_? -57.95 111.03 2.99 Favored Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 116.935 -0.121 . . . . 0.0 110.889 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.544 ' O ' HG22 ' A' ' 57' ' ' VAL . 18.9 Cg_endo -59.51 -25.95 80.41 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.164 1.909 . . . . 0.0 112.209 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.454 ' HA ' HG22 ' A' ' 57' ' ' VAL . 5.9 m-20 -90.66 7.0 41.6 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.637 ' HG ' HD23 ' A' ' 56' ' ' LEU . 1.7 pp -89.19 -15.76 32.94 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 121.161 -0.216 . . . . 0.0 111.256 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.637 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -115.34 -47.17 2.85 Favored 'General case' 0 C--N 1.339 0.11 0 N-CA-C 111.499 0.185 . . . . 0.0 111.499 179.872 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.544 HG22 ' O ' ' A' ' 53' ' ' PRO . 21.4 m -58.41 147.05 7.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-O 121.119 0.485 . . . . 0.0 111.837 -179.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -67.19 -57.23 7.11 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.468 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -171.59 -43.7 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.357 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 46.9 p -81.62 7.28 12.66 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.406 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 56.34 23.99 43.6 Favored Glycine 0 C--N 1.343 0.928 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.334 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -108.79 -39.32 5.38 Favored 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 120.753 0.311 . . . . 0.0 110.569 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 11.3 t -132.14 165.02 25.01 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.13 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.747 HD13 HD13 ' A' ' 68' ' ' ILE . 5.0 mt -77.55 157.76 30.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.906 0.384 . . . . 0.0 110.781 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.43 ' HG3' HD12 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -61.12 153.21 68.2 Favored Pre-proline 0 N--CA 1.465 0.292 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.254 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -49.02 -32.66 24.12 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.926 2.417 . . . . 0.0 112.591 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -51.27 -34.39 32.95 Favored Glycine 0 C--N 1.335 0.499 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.858 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.747 HD13 HD13 ' A' ' 64' ' ' LEU . 5.1 mt -97.19 148.7 5.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 116.855 0.327 . . . . 0.0 110.708 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.29 118.58 32.66 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.017 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.405 ' O ' HD23 ' A' ' 71' ' ' LEU . 16.6 m -90.37 129.53 41.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.937 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.405 HD23 ' O ' ' A' ' 70' ' ' VAL . 4.0 mt -125.49 130.43 51.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.166 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.816 HG23 ' HB2' ' A' ' 77' ' ' ALA . 26.3 t -105.0 99.48 8.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.465 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.1 m120 58.68 55.41 4.74 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.936 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.5 t 61.38 42.08 12.11 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.24 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 53.2 t -160.13 121.94 3.22 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.781 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.517 ' CB ' HG23 ' A' ' 79' ' ' VAL . 11.1 m-20 -48.93 131.59 18.67 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.729 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.816 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -79.48 -26.27 41.69 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.973 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -72.72 -25.55 61.26 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.489 0.185 . . . . 0.0 111.119 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.517 HG23 ' CB ' ' A' ' 76' ' ' ASP . 49.0 t -62.11 -29.59 46.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.017 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.8 m -112.46 -39.26 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -137.41 -72.96 0.06 OUTLIER Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.858 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 119.92 -42.21 1.8 Allowed Glycine 0 C--N 1.334 0.453 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.386 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.836 ' HA ' HD22 ' A' ' 37' ' ' LEU . 3.0 ptt? -157.42 29.35 0.29 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.743 0.306 . . . . 0.0 110.755 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -145.84 22.11 1.43 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.581 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.466 ' CE1' HG11 ' A' ' 72' ' ' VAL . 4.4 t80 -72.39 120.37 17.91 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 122.348 -0.22 . . . . 0.0 111.275 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.7 m -61.73 125.37 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.206 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.32 169.11 16.87 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.039 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -164.4 165.76 21.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.858 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 58.4 t0 -57.23 103.08 0.1 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.1 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.557 ' H ' HD13 ' A' ' 7' ' ' ILE . . . 106.14 24.65 6.77 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 121.108 -0.568 . . . . 0.0 113.016 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.02 138.88 39.86 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.928 0.364 . . . . 0.0 110.543 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.449 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 86.1 m -113.15 115.24 27.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.117 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.707 HG13 HG23 ' A' ' 9' ' ' VAL . 11.8 p -125.27 111.22 26.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 121.04 0.448 . . . . 0.0 110.633 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -114.92 151.38 34.14 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.176 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.548 ' HB3' HG21 ' A' ' 68' ' ' ILE . 15.7 m-85 -129.57 104.36 7.4 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.531 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.9 mt -106.24 100.44 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.887 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -75.8 106.64 7.49 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.47 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.5 p -110.24 -30.53 7.68 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.741 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 51.56 -174.72 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.119 0.568 . . . . 0.0 112.331 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.35 99.8 2.82 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.045 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -133.41 -69.61 0.08 OUTLIER Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.391 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.145 0 CA-C-O 118.507 -1.163 . . . . 0.0 112.604 179.557 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 120.742 0.306 . . . . 0.0 111.222 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.7 t -98.28 163.5 12.69 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.245 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -91.77 109.96 21.29 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.874 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -129.25 146.45 51.16 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.892 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 40.2 m-20 69.77 142.05 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.08 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.513 ' C ' HD12 ' A' ' 7' ' ' ILE . 55.9 m80 63.86 176.6 0.17 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.72 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.513 HD12 ' C ' ' A' ' 6' ' ' HIS . 2.0 mp -113.32 135.06 54.04 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-O 120.931 0.396 . . . . 0.0 111.152 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.55 HG22 ' OE1' ' A' ' 10' ' ' GLN . 83.5 m -88.75 96.63 10.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.983 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.56 HG13 ' HB2' ' A' ' 25' ' ' LEU . 11.8 p -117.79 113.49 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.206 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.55 ' OE1' HG22 ' A' ' 8' ' ' THR . 8.8 pm0 -137.08 166.87 22.69 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.931 0.396 . . . . 0.0 111.899 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -126.67 150.14 49.14 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.24 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.696 ' HB3' HG12 ' A' ' 96' ' ' ILE . . . -146.55 158.18 43.86 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.559 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 67.96 -100.48 0.64 Allowed Glycine 0 C--N 1.336 0.537 0 C-N-CA 121.203 -0.522 . . . . 0.0 112.459 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -124.04 33.16 3.96 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.586 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.7 m -109.7 -16.23 13.97 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.452 ' HG2' ' N ' ' A' ' 17' ' ' LEU . 12.7 pm0 -81.81 -33.57 30.71 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.702 0.286 . . . . 0.0 111.143 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.452 ' N ' ' HG2' ' A' ' 16' ' ' GLU . 1.4 mp -60.98 -28.19 68.83 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.033 0.382 . . . . 0.0 112.033 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.598 ' O ' HD12 ' A' ' 18' ' ' LEU . 2.9 pp -82.87 11.8 5.63 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.454 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 40.7 t80 -133.09 -60.01 0.87 Allowed 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.454 ' HB2' ' O ' ' A' ' 19' ' ' PHE . . . 174.27 36.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.031 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.56 32.16 4.7 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.902 0.382 . . . . 0.0 110.97 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 19.4 mm-40 -80.16 168.55 18.96 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.106 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.408 ' O ' ' HB2' ' A' ' 10' ' ' GLN . 16.3 p -101.93 -74.24 0.63 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.852 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.427 ' CB ' ' HB3' ' A' ' 10' ' ' GLN . 89.1 p -137.15 154.98 50.12 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.742 0.306 . . . . 0.0 111.198 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.56 ' HB2' HG13 ' A' ' 9' ' ' VAL . 4.8 mp -140.43 165.41 27.5 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.391 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.465 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 0.5 OUTLIER -131.27 119.34 21.64 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.827 179.783 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.3 mt -99.45 141.16 32.6 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.916 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.99 147.4 31.57 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.91 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.04 123.86 18.94 Favored Glycine 0 C--N 1.333 0.393 0 CA-C-N 115.958 -0.565 . . . . 0.0 113.331 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.2 t -140.26 88.65 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-O 120.791 0.329 . . . . 0.0 110.824 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.1 t 54.57 57.15 12.08 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.718 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.77 -11.02 25.62 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.621 2.214 . . . . 0.0 113.182 179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.43 -57.09 13.8 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.586 0.231 . . . . 0.0 111.244 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -95.66 44.35 2.1 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.444 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 28.7 m -138.09 121.35 16.97 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.692 0.282 . . . . 0.0 111.034 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.0 p-10 -105.26 -172.57 2.12 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.765 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.694 HD22 ' HA ' ' A' ' 83' ' ' MET . 1.0 OUTLIER -55.52 -35.66 65.89 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.335 -179.638 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -54.86 -40.58 69.81 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.88 0.371 . . . . 0.0 110.087 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.15 -30.04 63.59 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.801 178.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.627 HD21 HG11 ' A' ' 93' ' ' VAL . 10.0 tt -63.37 -49.73 72.69 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.819 0.342 . . . . 0.0 110.692 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.538 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -67.35 -52.18 44.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.728 179.767 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -54.72 -23.55 18.18 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.778 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.454 ' O ' ' HB3' ' A' ' 47' ' ' ASN . 4.6 tt -85.4 -22.95 28.14 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.878 0.371 . . . . 0.0 110.577 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.636 HD13 ' C ' ' A' ' 44' ' ' LEU . 1.2 tm? -92.48 -50.21 5.74 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.949 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.524 ' N ' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -89.33 -72.8 0.53 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 111.565 0.209 . . . . 0.0 111.565 -179.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.8 m -49.46 -24.63 2.11 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.454 ' HB3' ' O ' ' A' ' 43' ' ' LEU . 10.1 t30 -106.1 -25.99 11.8 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -138.58 45.52 2.04 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.461 ' HB ' ' O ' ' A' ' 45' ' ' LYS . 10.6 p -104.42 152.41 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 121.168 0.508 . . . . 0.0 111.478 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.01 -40.48 1.05 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.674 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -79.94 -167.03 1.13 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.313 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.406 ' HA ' ' HD2' ' A' ' 53' ' ' PRO . 0.4 OUTLIER -63.53 111.37 5.03 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.021 -179.94 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 52' ' ' ARG . 18.1 Cg_endo -60.45 -25.25 80.06 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.275 1.983 . . . . 0.0 112.159 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.461 ' HA ' ' CG2' ' A' ' 57' ' ' VAL . 4.6 m-20 -92.37 8.52 38.12 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.035 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.659 ' HG ' HD23 ' A' ' 56' ' ' LEU . 2.1 pp -86.74 -27.4 23.67 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 122.289 -0.257 . . . . 0.0 111.068 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.659 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -97.96 -47.27 5.6 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.517 HG11 ' HA2' ' A' ' 61' ' ' GLY . 4.8 m -57.68 149.25 4.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-O 121.243 0.544 . . . . 0.0 111.598 -179.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -65.45 -56.42 12.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.739 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -173.83 -43.91 0.01 OUTLIER 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.402 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 78.0 p -87.5 12.45 12.31 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.517 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 58.21 22.31 49.66 Favored Glycine 0 C--N 1.338 0.677 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.673 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -108.86 -41.18 4.82 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.944 0.402 . . . . 0.0 110.582 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.6 p -119.87 -175.94 3.08 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.715 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 7.0 mt -111.07 157.06 20.41 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.857 0.361 . . . . 0.0 111.148 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.75 155.75 92.5 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.282 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.01 135.13 67.39 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.818 2.345 . . . . 0.0 112.404 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 134.4 -49.29 0.91 Allowed Glycine 0 C--N 1.331 0.284 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.299 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.502 HG21 ' HB3' ' A' ' 95' ' ' PHE . 6.0 mt -81.46 137.49 21.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-O 120.657 0.265 . . . . 0.0 111.176 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.633 HD23 HD21 ' A' ' 71' ' ' LEU . 0.1 OUTLIER -106.83 103.69 13.19 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.529 179.562 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.468 ' O ' HD23 ' A' ' 71' ' ' LEU . 15.4 m -83.25 130.41 35.8 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.609 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.633 HD21 HD23 ' A' ' 69' ' ' LEU . 3.3 mt -130.15 146.2 51.77 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.45 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.621 HG11 ' CD2' ' A' ' 85' ' ' TYR . 2.1 m -119.0 121.4 66.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.477 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 57.45 41.87 25.48 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.45 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 65.1 31.75 10.77 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.412 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 6.3 t -142.6 151.87 41.94 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.729 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.624 ' HB3' HG23 ' A' ' 79' ' ' VAL . 35.8 m-20 -50.21 116.75 2.0 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.854 0.359 . . . . 0.0 111.535 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.435 ' HA ' HG22 ' A' ' 72' ' ' VAL . . . -84.78 -21.54 29.93 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.842 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -75.4 -27.64 59.14 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.602 0.239 . . . . 0.0 110.84 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.624 HG23 ' HB3' ' A' ' 76' ' ' ASP . 24.8 t -71.79 -40.84 69.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.014 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.1 m -74.3 -32.65 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -173.8 -46.91 0.05 OUTLIER Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.6 -0.809 . . . . 0.0 113.145 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.83 -54.25 1.66 Allowed Glycine 0 C--N 1.334 0.447 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.171 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.694 ' HA ' HD22 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -136.22 23.92 3.25 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.569 0.223 . . . . 0.0 111.363 179.7 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -132.61 17.08 4.35 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.621 ' CD2' HG11 ' A' ' 72' ' ' VAL . 22.3 t80 -77.99 120.65 23.14 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.668 0.271 . . . . 0.0 111.36 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.1 m -66.39 147.74 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.67 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.23 154.78 17.55 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.267 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -171.01 152.09 3.43 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.864 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -56.73 108.32 0.48 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.159 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 115.58 24.33 4.09 Favored Glycine 0 CA--C 1.525 0.658 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.408 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -93.25 167.22 11.89 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.683 0.242 . . . . 0.0 110.5 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 94.9 m -141.43 111.67 6.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.817 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.627 HG11 HD21 ' A' ' 40' ' ' LEU . 14.3 p -122.78 121.25 62.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.115 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -123.83 155.87 37.21 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.447 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.502 ' HB3' HG21 ' A' ' 68' ' ' ILE . 66.6 m-85 -132.19 104.34 6.72 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.927 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.696 HG12 ' HB3' ' A' ' 12' ' ' ALA . 28.5 mt -121.5 119.46 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.277 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.21 151.43 26.87 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.212 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.29 -46.68 0.08 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.672 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.55 91.42 2.3 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.753 0.311 . . . . 0.0 111.051 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -107.11 -28.03 10.23 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.488 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -152.51 -139.85 2.99 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.399 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.356 -1.247 . . . . 0.0 112.41 179.876 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 120.63 0.252 . . . . 0.0 111.44 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.7 p -108.99 152.31 25.15 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.372 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -110.66 -47.1 3.29 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.053 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 52.3 m80 69.49 166.47 0.28 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.45 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 35.0 p-10 -101.62 142.66 32.64 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.241 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -177.2 170.43 2.17 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.911 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.529 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 26.1 mm -127.75 152.83 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.794 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.494 HG22 ' NE2' ' A' ' 10' ' ' GLN . 19.3 m -113.66 95.29 5.26 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.775 0.322 . . . . 0.0 111.293 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.633 HG13 ' HB2' ' A' ' 25' ' ' LEU . 10.0 p -109.68 104.8 17.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.936 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.494 ' NE2' HG22 ' A' ' 8' ' ' THR . 0.4 OUTLIER -130.31 165.3 22.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.578 -179.327 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.422 ' HB2' ' HB3' ' A' ' 16' ' ' GLU . 44.5 m-85 -117.51 161.17 20.03 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.17 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.628 ' HB3' HG12 ' A' ' 96' ' ' ILE . . . -151.36 155.66 39.12 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.431 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 72.38 -101.17 1.03 Allowed Glycine 0 C--N 1.335 0.51 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.26 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -132.72 27.35 3.52 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.684 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.458 ' SG ' HD12 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -95.71 -27.96 15.02 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.707 0.254 . . . . 0.0 111.505 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.422 ' HB3' ' HB2' ' A' ' 11' ' ' PHE . 6.1 pt-20 -58.21 -30.88 66.82 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.648 0.261 . . . . 0.0 111.282 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.414 HD12 ' HG3' ' A' ' 16' ' ' GLU . 9.9 mp -68.13 -8.56 39.41 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.989 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.629 HD22 ' CD1' ' A' ' 55' ' ' LEU . 60.4 mt -82.76 13.44 3.84 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -147.91 -66.16 0.25 Allowed 'General case' 0 CA--C 1.521 -0.172 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -172.35 38.74 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.828 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.31 37.15 18.04 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.845 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -75.28 155.45 36.66 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.117 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 60.9 p -91.06 -69.54 0.73 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.106 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.7 p -144.59 154.4 42.81 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.95 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.633 ' HB2' HG13 ' A' ' 9' ' ' VAL . 2.6 mp -141.28 165.15 28.3 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.328 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.529 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 9.5 mt-30 -125.8 119.21 27.28 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.101 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.7 mt -99.45 142.08 31.4 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.565 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -122.65 127.96 50.01 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.623 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -110.18 174.25 17.33 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.819 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.692 HG23 HG22 ' A' ' 31' ' ' VAL . 10.5 m -103.58 -36.24 4.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.692 HG22 HG23 ' A' ' 30' ' ' VAL . 3.2 m -147.46 79.91 9.4 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-O 120.772 0.32 . . . . 0.0 111.367 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -67.4 -9.09 24.1 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.916 2.41 . . . . 0.0 113.113 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.49 -55.03 21.14 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.643 0.258 . . . . 0.0 111.142 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -99.03 38.68 3.0 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 121.121 -0.561 . . . . 0.0 112.327 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 8.8 m -121.87 146.33 47.2 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.881 0.372 . . . . 0.0 110.919 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -135.26 -173.16 3.25 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.694 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.797 HD22 ' HA ' ' A' ' 83' ' ' MET . 3.2 tt -57.51 -41.87 81.69 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.66 -0.245 . . . . 0.0 111.278 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -56.19 -36.8 68.79 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.908 0.385 . . . . 0.0 110.18 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.77 -33.6 33.48 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.948 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.453 HD11 HG21 ' A' ' 7' ' ' ILE . 29.6 tp -65.41 -50.73 64.39 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.598 0.199 . . . . 0.0 110.707 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.78 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.3 OUTLIER -56.91 -56.57 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.684 179.568 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.409 ' H ' HG23 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -49.12 -33.22 11.43 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.345 179.578 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.34 -27.48 63.4 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.53 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.471 HD21 ' CZ ' ' A' ' 95' ' ' PHE . 1.0 OUTLIER -96.92 -38.42 9.82 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.708 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.444 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 0.2 OUTLIER -81.99 -70.18 0.56 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.496 -179.52 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 m -52.41 -25.14 9.15 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -97.49 -37.29 10.03 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -142.45 58.73 1.45 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.444 ' HB ' ' O ' ' A' ' 45' ' ' LYS . 10.1 p -97.31 -34.92 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.407 179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 73.32 -55.95 0.67 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 122.312 0.245 . . . . 0.0 110.644 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.456 ' HB3' HD21 ' A' ' 55' ' ' LEU . 2.4 tp10 -91.72 -177.14 4.68 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.463 ' O ' ' HG ' ' A' ' 55' ' ' LEU . 63.7 mtp85 -58.6 140.84 84.8 Favored Pre-proline 0 CA--C 1.53 0.201 0 CA-C-O 120.718 0.294 . . . . 0.0 111.501 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.412 ' O ' HG22 ' A' ' 57' ' ' VAL . 92.7 Cg_endo -81.45 -18.7 8.15 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.818 2.345 . . . . 0.0 113.03 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.405 ' HA ' ' CG2' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -86.72 6.83 29.42 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -179.404 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.629 ' CD1' HD22 ' A' ' 18' ' ' LEU . 4.7 pp -90.62 -22.13 21.37 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.544 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.679 HD12 HD21 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -100.75 -47.44 4.82 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 111.566 0.21 . . . . 0.0 111.566 -179.874 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.506 HG11 ' HA2' ' A' ' 61' ' ' GLY . 3.0 m -55.09 150.85 2.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 121.154 0.502 . . . . 0.0 111.489 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.549 ' HB2' HG23 ' A' ' 63' ' ' THR . 18.6 t70 -65.64 -56.45 12.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.955 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -174.39 -44.68 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.183 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.9 t -83.47 9.9 10.14 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.688 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.506 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 57.15 23.61 47.85 Favored Glycine 0 C--N 1.34 0.763 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.812 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -110.78 -44.71 3.59 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.055 0.455 . . . . 0.0 110.484 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.549 HG23 ' HB2' ' A' ' 58' ' ' ASP . 10.2 t -115.1 168.23 10.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.088 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.679 HD21 HD12 ' A' ' 56' ' ' LEU . 6.4 mt -96.58 153.58 17.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.826 0.346 . . . . 0.0 111.232 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.439 ' HD3' ' N ' ' A' ' 67' ' ' GLY . 0.5 OUTLIER -57.01 155.48 15.75 Favored Pre-proline 0 N--CA 1.465 0.306 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.571 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.95 -35.97 91.66 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.142 2.562 . . . . 0.0 112.689 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.439 ' N ' ' HD3' ' A' ' 65' ' ' ARG . . . -45.79 -36.68 6.67 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-N 115.844 -0.616 . . . . 0.0 113.327 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.463 HG21 ' HB3' ' A' ' 95' ' ' PHE . 4.3 mt -102.03 138.33 26.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-N 117.032 0.416 . . . . 0.0 110.925 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 mt -105.75 111.13 23.68 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.837 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.474 ' C ' HD23 ' A' ' 71' ' ' LEU . 17.1 m -80.76 125.63 39.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.208 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.474 HD23 ' C ' ' A' ' 70' ' ' VAL . 3.8 mt -123.73 126.79 47.15 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.318 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.758 HG23 ' HB2' ' A' ' 77' ' ' ALA . 28.2 t -105.11 101.94 13.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.579 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 56.61 55.7 6.19 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.123 0.487 . . . . 0.0 110.867 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.9 m 60.87 41.42 14.47 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.499 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 53.0 t -159.74 119.36 2.92 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.657 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.543 ' CB ' HG23 ' A' ' 79' ' ' VAL . 1.5 m-20 -47.54 126.69 10.25 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.474 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.758 ' HB2' HG23 ' A' ' 72' ' ' VAL . . . -67.83 -28.56 67.67 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.965 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -69.96 -25.31 63.57 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 116.738 -0.21 . . . . 0.0 111.067 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.543 HG23 ' CB ' ' A' ' 76' ' ' ASP . 43.9 t -58.66 -30.51 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.789 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.4 m -110.74 -37.38 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.961 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -148.52 -62.06 0.01 OUTLIER Glycine 0 C--N 1.337 0.601 0 C-N-CA 120.629 -0.796 . . . . 0.0 113.066 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 112.06 -63.34 0.28 Allowed Glycine 0 C--N 1.331 0.277 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.293 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.797 ' HA ' HD22 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -134.37 23.2 3.75 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 111.424 0.157 . . . . 0.0 111.424 179.834 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -138.02 24.3 2.8 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.442 ' CE2' HG11 ' A' ' 72' ' ' VAL . 29.4 t80 -70.95 118.8 14.19 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 120.75 0.309 . . . . 0.0 111.396 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.6 m -62.4 165.89 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 116.143 -0.481 . . . . 0.0 112.131 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.46 153.57 31.87 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.571 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -156.85 32.9 0.3 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.678 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 64.66 111.39 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.907 0.384 . . . . 0.0 111.267 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 100.67 31.63 5.69 Favored Glycine 0 CA--C 1.517 0.217 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.431 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -89.85 112.23 23.5 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.792 0.329 . . . . 0.0 110.577 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 61.8 m -81.72 130.61 35.12 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.592 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.8 p -139.5 126.73 24.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.875 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -126.75 150.75 48.93 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.194 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.471 ' CZ ' HD21 ' A' ' 44' ' ' LEU . 43.2 m-85 -120.55 105.05 10.45 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.333 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.628 HG12 ' HB3' ' A' ' 12' ' ' ALA . 20.5 mt -112.0 109.47 28.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.346 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.2 p -77.32 150.97 35.16 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.571 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.4 p -150.33 -63.78 0.2 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.133 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 6.2 tt -89.78 117.57 28.72 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.991 0.424 . . . . 0.0 111.043 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 24.0 p80 -124.2 179.73 4.77 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.952 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 101.9 -54.26 0.78 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.28 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.284 -1.287 . . . . 0.0 112.527 179.834 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 mmt . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.1 p -72.62 153.57 41.18 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.78 0.324 . . . . 0.0 111.656 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -115.36 -45.3 2.93 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.201 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.1 m170 -75.05 155.84 36.79 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.951 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 82.84 -26.15 0.14 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.119 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 46.2 m170 -112.13 145.3 40.04 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.64 0.257 . . . . 0.0 111.241 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.506 ' N ' HD12 ' A' ' 7' ' ' ILE . 2.0 mp -103.71 138.34 28.57 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.002 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.417 HG22 ' OE1' ' A' ' 10' ' ' GLN . 88.5 m -86.55 93.76 9.26 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.891 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.563 ' O ' HG13 ' A' ' 9' ' ' VAL . 11.4 p -116.6 106.48 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 120.833 0.349 . . . . 0.0 111.422 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.477 ' HB2' ' O ' ' A' ' 23' ' ' THR . 5.8 pm0 -127.12 170.93 11.85 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.976 0.417 . . . . 0.0 111.872 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.421 ' CB ' ' HA ' ' A' ' 16' ' ' GLU . 89.1 m-85 -134.83 146.74 49.58 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.899 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -167.4 113.18 0.73 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.081 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.17 45.6 0.57 Allowed Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.632 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.99 14.51 82.24 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.562 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -107.23 -25.27 11.58 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 117.523 0.662 . . . . 0.0 111.52 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.421 ' HA ' ' CB ' ' A' ' 11' ' ' PHE . 0.9 OUTLIER -60.53 -22.09 63.22 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.42 HD12 ' HG2' ' A' ' 16' ' ' GLU . 6.4 mp -68.63 -6.69 27.28 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.794 HD21 HD11 ' A' ' 55' ' ' LEU . 59.2 mt -85.59 12.13 9.31 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 112.087 0.402 . . . . 0.0 112.087 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -146.98 -63.56 0.29 Allowed 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -175.94 36.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.055 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 50.79 35.36 11.93 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.09 0.471 . . . . 0.0 110.672 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -78.84 167.69 20.8 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.066 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.477 ' O ' ' HB2' ' A' ' 10' ' ' GLN . 38.1 p -100.57 -31.52 11.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.4 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 88.7 p -169.92 146.78 3.2 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.636 0.255 . . . . 0.0 111.302 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 tp -133.13 166.16 23.08 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.436 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.485 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 32.9 mt-30 -132.03 116.19 16.77 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.688 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.494 HD22 HD23 ' A' ' 43' ' ' LEU . 14.0 mt -95.28 139.84 31.03 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.937 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -98.39 107.13 19.52 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.613 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.01 166.78 52.11 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 121.154 -0.546 . . . . 0.0 112.967 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.0 m -132.56 -47.62 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.0 t -135.79 87.6 24.97 Favored Pre-proline 0 CA--C 1.53 0.198 0 CA-C-O 120.6 0.238 . . . . 0.0 110.851 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.74 -24.43 30.33 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.824 2.35 . . . . 0.0 113.026 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.64 -59.87 4.75 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.324 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -94.64 42.28 2.45 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.755 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 90.5 m -141.29 129.47 22.18 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.849 0.357 . . . . 0.0 111.062 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -138.85 -168.84 2.5 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.666 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.718 HD22 ' HA ' ' A' ' 83' ' ' MET . 1.7 tt -56.69 -40.27 75.31 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.146 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -58.02 -36.72 73.12 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.74 -32.15 59.54 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.029 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.681 HD21 HD11 ' A' ' 87' ' ' LEU . 17.2 mt -64.0 -49.58 71.91 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.815 0.34 . . . . 0.0 110.713 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.574 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.0 OUTLIER -64.6 -53.53 41.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.009 179.793 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -56.18 -27.34 54.14 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.877 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.494 HD23 HD22 ' A' ' 27' ' ' LEU . 1.3 tp -84.56 -14.6 48.4 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 120.746 0.308 . . . . 0.0 110.914 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.641 HD13 ' N ' ' A' ' 45' ' ' LYS . 0.4 OUTLIER -96.83 -51.73 4.16 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.916 179.646 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.641 ' N ' HD13 ' A' ' 44' ' ' LEU . 1.3 pttt -86.16 -69.52 0.66 Allowed 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.9 m -49.16 -31.54 8.52 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.594 0.235 . . . . 0.0 111.395 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -76.2 -33.85 59.28 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.452 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -130.95 -71.56 0.57 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.602 ' O ' HG13 ' A' ' 49' ' ' VAL . 12.4 p 34.49 89.04 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.97 -32.02 64.93 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.038 179.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.409 ' O ' HG22 ' A' ' 49' ' ' VAL . 1.1 tp10 -97.13 -161.69 0.89 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.533 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.76 ' HB2' HD23 ' A' ' 55' ' ' LEU . 2.8 mmt180 -66.42 125.23 90.05 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-O 120.599 0.238 . . . . 0.0 111.207 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.41 ' HA ' HG21 ' A' ' 49' ' ' VAL . 56.8 Cg_endo -71.53 -28.16 17.95 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.475 2.117 . . . . 0.0 112.535 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.404 ' HA ' HG22 ' A' ' 57' ' ' VAL . 0.4 OUTLIER -94.22 7.96 43.45 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -179.752 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.794 HD11 HD21 ' A' ' 18' ' ' LEU . 1.7 pp -82.39 -12.85 57.65 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.597 ' HB2' HD22 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -105.61 -45.29 4.46 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 111.636 0.236 . . . . 0.0 111.636 179.827 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.547 HG11 ' HA2' ' A' ' 61' ' ' GLY . 1.4 m -59.3 149.51 6.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.163 0.506 . . . . 0.0 111.497 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -66.8 -57.99 5.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.764 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -172.44 -44.87 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.315 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.6 p -79.38 4.09 16.38 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.635 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.547 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 60.24 28.18 66.46 Favored Glycine 0 C--N 1.339 0.705 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.574 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.0 tp60 -121.29 -46.1 2.31 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.816 0.341 . . . . 0.0 110.604 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.7 t -114.53 140.61 48.62 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.633 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.597 HD22 ' HB2' ' A' ' 56' ' ' LEU . 7.8 mt -67.92 154.58 41.29 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.894 0.378 . . . . 0.0 111.315 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.62 158.5 87.25 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.239 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.69 131.92 45.07 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.969 2.446 . . . . 0.0 112.241 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 138.02 -48.49 0.88 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.315 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.3 mt -88.29 144.54 8.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 120.794 0.331 . . . . 0.0 111.154 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.8 mt -113.61 99.0 7.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.777 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.81 HG23 ' HB3' ' A' ' 77' ' ' ALA . 13.5 m -78.67 131.7 33.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.882 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.453 HD23 ' O ' ' A' ' 70' ' ' VAL . 3.4 mt -130.16 127.47 39.78 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.209 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.601 HG11 ' CD2' ' A' ' 85' ' ' TYR . 39.1 t -103.72 119.14 51.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.354 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 59.5 53.29 5.19 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.968 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 40.9 m 53.34 35.98 21.7 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.576 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 8.2 t -150.8 153.95 36.39 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.139 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.404 ' CB ' HG23 ' A' ' 79' ' ' VAL . 4.5 m-20 -49.23 124.18 8.62 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.681 0.277 . . . . 0.0 111.315 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.81 ' HB3' HG23 ' A' ' 70' ' ' VAL . . . -65.38 -20.01 66.2 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.578 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -76.01 -29.77 58.27 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.601 0.238 . . . . 0.0 110.685 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.404 HG23 ' CB ' ' A' ' 76' ' ' ASP . 24.4 t -70.78 -42.6 77.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.056 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.5 ' HB ' ' CD1' ' A' ' 85' ' ' TYR . 17.9 m -68.21 -28.79 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 146.02 36.65 0.06 OUTLIER Glycine 0 C--N 1.337 0.625 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.741 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 53.69 -99.35 0.05 OUTLIER Glycine 0 C--N 1.337 0.593 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.915 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.718 ' HA ' HD22 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -122.89 29.16 6.92 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.786 0.327 . . . . 0.0 110.913 179.459 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -117.66 19.89 13.68 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.939 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.601 ' CD2' HG11 ' A' ' 72' ' ' VAL . 15.1 t80 -81.12 120.66 25.13 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.743 0.306 . . . . 0.0 111.358 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.9 m -75.59 158.69 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.477 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.681 HD11 HD21 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -91.45 150.28 21.32 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.078 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -147.9 30.52 0.88 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.412 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 59.48 95.99 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.962 0.41 . . . . 0.0 111.653 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 118.75 28.92 1.97 Allowed Glycine 0 CA--C 1.52 0.376 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.694 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -78.19 166.1 23.15 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.769 0.318 . . . . 0.0 110.88 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 98.7 m -141.33 113.2 7.8 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.105 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.8 p -124.94 136.43 60.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.856 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -135.11 153.12 52.12 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.411 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -125.59 104.61 8.49 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.438 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.1 mt -116.95 117.26 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.021 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.12 125.56 34.22 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.751 0.31 . . . . 0.0 111.19 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.9 p -137.58 -58.36 0.68 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.279 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 33.1 tp -67.87 155.96 38.22 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.242 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -139.87 -65.15 0.47 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.959 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -93.4 -62.39 1.1 Allowed Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.316 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.245 -1.308 . . . . 0.0 112.825 -179.766 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 120.552 0.215 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.9 t -164.39 97.94 0.8 Allowed 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.88 0.371 . . . . 0.0 110.81 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.97 105.84 4.52 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.651 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 47.92 -169.66 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.599 0.562 . . . . 0.0 112.275 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -130.57 153.02 49.31 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.972 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.412 ' HB2' ' HG2' ' A' ' 26' ' ' GLN . 4.8 p80 -167.36 169.01 12.71 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.814 0.34 . . . . 0.0 111.576 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 20.6 mm -132.11 136.64 56.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.224 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.63 HG22 ' OE1' ' A' ' 10' ' ' GLN . 89.0 m -86.44 109.23 18.91 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.892 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.546 HG13 ' HB2' ' A' ' 25' ' ' LEU . 12.0 p -129.08 112.71 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.286 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.63 ' OE1' HG22 ' A' ' 8' ' ' THR . 9.0 pm0 -137.26 166.69 23.17 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.842 0.353 . . . . 0.0 111.643 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.43 ' CD2' ' HB2' ' A' ' 95' ' ' PHE . 89.4 m-85 -134.37 148.88 50.77 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.242 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -164.21 128.91 2.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.967 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.92 40.71 2.25 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.72 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.55 19.55 79.17 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 121.021 -0.609 . . . . 0.0 113.388 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.0 -12.14 14.24 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 117.279 0.539 . . . . 0.0 111.849 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.426 ' HA ' ' CB ' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -69.3 -15.5 63.36 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.701 0.259 . . . . 0.0 111.701 179.867 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 mt -69.03 -5.47 22.09 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.921 HD21 HD11 ' A' ' 55' ' ' LEU . 53.0 mt -81.6 13.65 2.99 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.502 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 2.6 t80 -153.57 -58.49 0.13 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.698 0.285 . . . . 0.0 110.522 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -179.27 36.37 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.136 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.92 33.9 7.2 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.889 0.376 . . . . 0.0 110.889 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -83.73 166.56 17.95 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.014 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 81.6 p -88.14 -70.66 0.62 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.825 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.406 ' CB ' ' HB3' ' A' ' 10' ' ' GLN . 83.3 p -136.73 156.05 49.03 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.717 0.294 . . . . 0.0 111.306 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.546 ' HB2' HG13 ' A' ' 9' ' ' VAL . 3.4 mp -140.44 164.57 29.77 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.442 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.412 ' HG2' ' HB2' ' A' ' 6' ' ' HIS . 0.0 OUTLIER -122.23 112.03 17.67 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.523 179.743 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.8 mt -96.84 130.32 44.14 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.9 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -122.81 89.95 3.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.94 0.4 . . . . 0.0 110.81 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.78 165.83 54.37 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.759 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 19.7 t -92.96 -45.91 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-O 120.468 0.175 . . . . 0.0 111.309 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.3 m -131.98 72.27 79.48 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-O 120.945 0.403 . . . . 0.0 111.367 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.445 ' HB2' ' HA ' ' A' ' 88' ' ' ASN . 5.8 Cg_endo -86.19 19.11 1.45 Allowed 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.137 2.558 . . . . 0.0 113.217 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 62.5 m -59.75 -58.61 7.84 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.562 0.22 . . . . 0.0 111.063 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -97.58 37.22 3.54 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.489 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 54.4 m -105.02 136.77 43.89 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.922 0.391 . . . . 0.0 111.088 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -125.76 -172.35 2.58 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.744 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.728 HD22 ' HA ' ' A' ' 83' ' ' MET . 5.3 tt -54.95 -43.59 73.54 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -57.15 -35.33 69.39 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.906 0.384 . . . . 0.0 110.124 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.22 -33.21 36.53 Favored Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.951 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.527 HD12 ' HA ' ' A' ' 37' ' ' LEU . 73.1 mt -63.56 -51.49 65.17 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.756 0.312 . . . . 0.0 110.624 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.694 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.3 OUTLIER -57.36 -56.79 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.812 179.641 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.408 ' H ' HG23 ' A' ' 41' ' ' VAL . 5.7 tt0 -49.46 -34.66 17.4 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.329 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.92 -27.62 65.93 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.846 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.1 pp -96.64 -38.14 10.06 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.434 ' CA ' ' HB ' ' A' ' 49' ' ' VAL . 2.8 pttt -85.59 -62.13 1.6 Allowed 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.9 m -58.1 -21.64 47.08 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 121.118 -0.233 . . . . 0.0 111.61 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -98.75 -36.64 9.76 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -150.23 54.42 0.92 Allowed 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.434 ' HB ' ' CA ' ' A' ' 45' ' ' LYS . 9.4 p -80.91 -43.88 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 121.216 -0.194 . . . . 0.0 111.521 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 19' ' ' PHE . 0.6 OUTLIER 67.86 -59.06 0.43 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 122.601 0.36 . . . . 0.0 110.608 -179.126 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.22 -168.55 0.52 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.208 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.445 ' HB3' ' HB3' ' A' ' 55' ' ' LEU . 3.5 ttt180 -69.16 128.33 92.62 Favored Pre-proline 0 CA--C 1.529 0.173 0 CA-C-O 120.625 0.25 . . . . 0.0 111.471 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.457 ' O ' HG22 ' A' ' 57' ' ' VAL . 58.7 Cg_endo -72.72 -23.73 19.06 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.311 2.007 . . . . 0.0 112.492 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -93.08 7.38 44.42 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.921 HD11 HD21 ' A' ' 18' ' ' LEU . 3.0 pp -85.67 -21.06 28.54 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 121.117 -0.233 . . . . 0.0 111.072 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.572 ' H ' HD23 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -103.03 -48.78 3.95 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 111.477 0.177 . . . . 0.0 111.477 179.614 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.499 HG11 ' HA2' ' A' ' 61' ' ' GLY . 2.8 m -62.72 144.73 14.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 121.052 0.453 . . . . 0.0 111.14 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.436 ' HA ' ' HB3' ' A' ' 65' ' ' ARG . 10.4 t70 -63.72 -60.23 3.57 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.596 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.8 tm0? -168.85 -44.66 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.309 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 81.1 p -79.55 2.71 21.21 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.534 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.499 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 62.16 28.41 70.64 Favored Glycine 0 C--N 1.34 0.761 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.413 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -124.05 -40.46 2.28 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.575 0.226 . . . . 0.0 111.464 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.7 t -114.09 135.8 53.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.636 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.51 HD11 ' HB2' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -70.06 132.9 46.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.869 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.436 ' HB3' ' HA ' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -58.89 155.44 31.74 Favored Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.419 -179.793 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -58.62 138.07 83.7 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.819 2.346 . . . . 0.0 112.402 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 136.85 -46.74 1.0 Allowed Glycine 0 C--N 1.332 0.336 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.195 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.422 ' HA ' ' HA ' ' A' ' 97' ' ' SER . 5.4 mt -94.93 127.38 46.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 120.697 0.284 . . . . 0.0 111.018 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.9 mp -98.3 102.94 14.83 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.849 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.761 HG23 ' HB3' ' A' ' 77' ' ' ALA . 15.4 m -76.59 133.98 29.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.744 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.6 HD11 HD12 ' A' ' 96' ' ' ILE . 1.1 mt -129.15 141.98 51.01 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.487 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.743 HG23 ' HB2' ' A' ' 77' ' ' ALA . 19.6 t -113.68 111.55 36.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.586 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.0 m120 57.67 54.04 6.69 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.989 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 22.8 t 57.23 49.65 13.03 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.98 0.419 . . . . 0.0 111.186 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 50.6 t -162.17 146.21 12.19 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.671 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.653 ' HB3' HG23 ' A' ' 79' ' ' VAL . 9.5 m-20 -50.83 121.71 6.34 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.46 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.761 ' HB3' HG23 ' A' ' 70' ' ' VAL . . . -83.99 -22.8 31.25 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.735 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -74.18 -30.58 62.3 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-O 120.555 0.217 . . . . 0.0 110.888 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.653 HG23 ' HB3' ' A' ' 76' ' ' ASP . 45.2 t -63.69 -40.59 89.62 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.127 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 26.9 m -79.48 -36.79 18.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.505 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -166.66 -51.55 0.03 OUTLIER Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.64 -0.791 . . . . 0.0 113.128 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 100.26 -50.97 1.05 Allowed Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.425 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.728 ' HA ' HD22 ' A' ' 37' ' ' LEU . 2.4 ptt? -144.11 25.51 1.57 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.527 0.203 . . . . 0.0 111.38 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -140.48 23.59 2.31 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.538 ' CE1' HG11 ' A' ' 72' ' ' VAL . 38.3 t80 -80.78 103.4 10.59 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.771 0.32 . . . . 0.0 110.774 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.6 m -72.63 145.72 11.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.836 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.569 ' C ' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -153.12 165.39 35.79 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.012 -179.769 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.445 ' HA ' ' HB2' ' A' ' 32' ' ' PRO . 9.9 t-20 -134.69 -64.78 0.66 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.084 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -146.59 132.37 18.99 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.749 0.309 . . . . 0.0 111.067 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.96 21.24 36.66 Favored Glycine 0 CA--C 1.521 0.413 0 C-N-CA 121.104 -0.57 . . . . 0.0 112.89 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -86.23 163.98 17.44 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 120.801 0.334 . . . . 0.0 111.129 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.425 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 90.8 m -138.88 130.28 27.14 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.922 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.6 p -140.54 124.07 17.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.696 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.414 ' HG2' ' HG2' ' A' ' 10' ' ' GLN . 14.0 mt-10 -126.7 137.17 53.22 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.4 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.43 ' HB2' ' CD2' ' A' ' 11' ' ' PHE . 3.9 m-85 -107.42 104.81 14.48 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.562 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.6 HD12 HD11 ' A' ' 71' ' ' LEU . 28.3 mt -109.04 104.87 17.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.148 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 68' ' ' ILE . 41.9 t -85.01 140.13 31.26 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.04 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 34.2 p -139.79 -55.25 0.56 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.946 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.86 81.1 8.69 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.956 0.408 . . . . 0.0 110.751 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -96.51 112.85 24.44 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.901 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 111.28 -134.51 12.19 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.321 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.468 -1.184 . . . . 0.0 112.564 179.965 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mtt . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 111.543 0.201 . . . . 0.0 111.543 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.26 81.77 8.27 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.942 0.401 . . . . 0.0 111.267 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -108.34 -39.69 5.37 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.068 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 72.99 135.42 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.151 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -73.45 129.59 38.32 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.914 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 14.0 p-80 -169.47 143.95 2.91 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.134 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.538 HD12 HD23 ' A' ' 87' ' ' LEU . 27.8 mm -117.49 152.19 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.11 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.485 ' HB ' HG23 ' A' ' 92' ' ' THR . 6.1 m -117.15 102.33 9.21 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.05 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.536 ' O ' HG13 ' A' ' 9' ' ' VAL . 12.7 p -128.99 112.43 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-O 120.788 0.328 . . . . 0.0 111.765 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.63 165.2 22.27 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.982 0.42 . . . . 0.0 111.57 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.432 ' CB ' ' HA ' ' A' ' 16' ' ' GLU . 26.0 m-85 -126.41 131.52 51.71 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.199 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -138.13 151.39 47.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.503 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.19 -94.97 2.03 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.149 -0.548 . . . . 0.0 112.688 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -137.24 28.71 2.77 Favored Glycine 0 CA--C 1.523 0.57 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.82 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.83 -27.93 9.04 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.736 0.268 . . . . 0.0 111.61 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.432 ' HA ' ' CB ' ' A' ' 11' ' ' PHE . 0.6 OUTLIER -57.35 -30.87 65.19 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.524 0.202 . . . . 0.0 111.226 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.72 -13.86 62.65 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.857 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.559 HD22 HD21 ' A' ' 55' ' ' LEU . 32.3 mt -84.9 13.34 6.05 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -143.07 -61.92 0.42 Allowed 'General case' 0 CA--C 1.523 -0.071 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -178.81 36.37 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.103 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 50.37 31.7 5.63 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.962 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.65 173.47 12.41 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.104 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.4 p -102.46 -75.82 0.59 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.764 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 92.5 p -131.46 156.91 44.82 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.783 0.325 . . . . 0.0 111.372 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.505 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -137.19 159.0 43.17 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.259 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.454 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 2.6 mt-30 -129.87 129.75 44.33 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.971 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.465 HD12 HG21 ' A' ' 7' ' ' ILE . 2.9 mt -110.11 139.58 45.1 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.688 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -104.95 112.2 25.24 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.636 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -121.47 136.73 11.29 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.617 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.8 t -76.83 -38.83 29.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 120.554 0.216 . . . . 0.0 111.156 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.533 ' O ' HG13 ' A' ' 31' ' ' VAL . 7.2 p -155.63 76.09 4.97 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-O 121.312 0.577 . . . . 0.0 110.931 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -78.93 4.67 6.3 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.817 2.345 . . . . 0.0 113.368 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 87' ' ' LEU . 80.2 m -56.43 -35.38 67.77 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.691 0.281 . . . . 0.0 110.95 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -91.91 26.17 13.88 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.868 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.7 m -128.03 128.35 44.81 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.829 0.315 . . . . 0.0 110.68 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -104.28 175.76 5.38 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.029 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.794 ' O ' HG22 ' A' ' 41' ' ' VAL . 5.2 tt -57.79 -41.93 83.1 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.682 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -54.98 -36.87 65.85 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.943 0.401 . . . . 0.0 110.377 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.13 -31.15 43.7 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.196 178.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 25.1 tp -70.08 -51.87 28.32 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.798 0.299 . . . . 0.0 110.921 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.794 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.4 OUTLIER -57.46 -57.24 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.895 179.787 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.44 ' H ' HG23 ' A' ' 41' ' ' VAL . 2.9 tt0 -51.39 -28.81 13.64 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.609 -0.268 . . . . 0.0 111.434 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.0 tp -78.12 -27.06 48.22 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.704 HD12 ' N ' ' A' ' 45' ' ' LYS . 4.6 pp -96.86 -37.15 10.35 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.704 ' N ' HD12 ' A' ' 44' ' ' LEU . 0.9 OUTLIER -86.01 -69.24 0.68 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.418 -179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.9 m -54.66 -23.74 18.65 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -103.97 -20.51 13.85 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -148.06 48.21 1.06 Allowed 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.632 HG22 ' H ' ' A' ' 51' ' ' GLU . 8.1 p -94.06 132.07 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 120.719 0.295 . . . . 0.0 111.222 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -115.4 32.42 6.07 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.276 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.632 ' H ' HG22 ' A' ' 49' ' ' VAL . 1.9 tp10 -163.17 -171.86 2.79 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.502 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.599 ' HB3' HD23 ' A' ' 55' ' ' LEU . 1.4 ttt180 -65.1 110.78 4.66 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.782 -0.19 . . . . 0.0 110.929 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.418 ' O ' HG22 ' A' ' 57' ' ' VAL . 17.8 Cg_endo -60.29 -21.65 67.72 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.345 2.03 . . . . 0.0 112.692 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -91.29 7.66 39.79 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.621 ' HG ' HD23 ' A' ' 56' ' ' LEU . 2.5 pp -93.56 -18.97 21.64 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.486 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.621 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -102.53 -48.52 4.12 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 111.601 0.223 . . . . 0.0 111.601 179.825 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.519 HG11 ' HA2' ' A' ' 61' ' ' GLY . 3.4 m -57.14 148.32 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 121.101 0.477 . . . . 0.0 111.591 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -69.57 -58.82 3.47 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.712 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -166.91 -48.95 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.517 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.3 p -77.42 6.52 6.79 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.715 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.519 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 57.77 27.92 59.69 Favored Glycine 0 C--N 1.339 0.707 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.637 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -122.18 -42.09 2.39 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.589 0.233 . . . . 0.0 110.943 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 49.9 p -117.21 136.24 53.2 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.611 HD12 HG21 ' A' ' 68' ' ' ILE . 6.3 mt -66.71 155.54 37.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.845 0.355 . . . . 0.0 111.142 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.53 160.14 74.06 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.47 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -51.25 -33.39 44.75 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 123.167 2.578 . . . . 0.0 112.798 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -53.43 -32.13 44.64 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.733 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.611 HG21 HD12 ' A' ' 64' ' ' LEU . 19.5 mm -83.46 151.47 3.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 120.822 0.344 . . . . 0.0 110.793 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.705 HD12 HD21 ' A' ' 71' ' ' LEU . 0.5 OUTLIER -127.83 99.83 5.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.815 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 70' ' ' VAL . 34.9 m -84.55 122.12 37.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.731 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.705 HD21 HD12 ' A' ' 69' ' ' LEU . 4.5 mt -131.3 137.55 48.86 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.174 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.616 HG13 ' HB2' ' A' ' 77' ' ' ALA . 3.3 m -109.54 118.95 57.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.784 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 24.2 m-20 64.23 -78.57 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.938 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -151.55 32.01 0.57 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.077 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 49.7 t -157.32 146.51 20.02 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.852 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.534 ' CB ' HG23 ' A' ' 79' ' ' VAL . 0.7 OUTLIER -52.5 130.6 32.18 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.362 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.616 ' HB2' HG13 ' A' ' 72' ' ' VAL . . . -75.3 -23.29 57.34 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.687 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.422 ' HA ' ' CA ' ' A' ' 82' ' ' GLY . 3.2 mt-10 -74.38 -18.69 60.64 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.141 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.534 HG23 ' CB ' ' A' ' 76' ' ' ASP . 38.2 t -63.14 -35.74 73.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 120.661 0.267 . . . . 0.0 110.875 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.9 m -98.88 -37.66 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.789 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -152.61 -60.19 0.01 OUTLIER Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.594 -0.812 . . . . 0.0 113.222 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.422 ' CA ' ' HA ' ' A' ' 78' ' ' GLU . . . 100.72 -51.22 1.0 Allowed Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.253 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.585 ' HA ' HD22 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -128.02 4.54 5.91 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 179.718 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -123.7 25.56 8.07 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.531 ' CE2' HG21 ' A' ' 72' ' ' VAL . 8.4 t80 -74.28 88.72 2.03 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.875 0.369 . . . . 0.0 110.81 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.4 m -61.54 139.6 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.664 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.538 HD23 HD12 ' A' ' 7' ' ' ILE . 7.1 mp -90.52 168.59 11.71 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.073 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 37.1 p30 -168.33 43.58 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.408 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 64.36 96.43 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.151 0.501 . . . . 0.0 110.99 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 112.96 28.25 3.45 Favored Glycine 0 CA--C 1.521 0.433 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.393 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.52 144.12 26.28 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.723 0.297 . . . . 0.0 110.715 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.485 HG23 ' HB ' ' A' ' 8' ' ' THR . 88.5 m -123.25 133.95 54.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.85 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.14 130.52 18.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.996 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -123.17 155.4 37.15 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.239 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -132.41 108.08 8.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.493 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 33.6 mt -113.94 123.45 69.61 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.115 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -92.65 130.88 38.15 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.263 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 71.5 p -126.14 -50.95 1.55 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.98 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 8.2 tt -85.29 128.58 34.74 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.107 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -108.61 -36.22 6.24 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.193 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -130.32 169.97 21.05 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.429 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.518 -1.157 . . . . 0.0 112.571 179.897 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.425 ' O ' ' HB2' ' A' ' 2' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 120.387 0.137 . . . . 0.0 111.054 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 1' ' ' MET . 3.2 m 68.51 149.03 0.06 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.081 0.467 . . . . 0.0 111.673 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 32.5 p-10 -162.86 48.65 0.16 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.936 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.97 165.18 28.17 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.531 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -89.11 124.85 34.7 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.222 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -167.86 102.47 0.47 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.656 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.408 HG23 ' O ' ' A' ' 91' ' ' ASP . 3.0 mp -91.27 126.06 43.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.134 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.894 ' HB ' HG23 ' A' ' 92' ' ' THR . 0.2 OUTLIER -85.76 96.11 9.62 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.255 179.461 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.56 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.7 p -115.72 106.0 19.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.953 0.406 . . . . 0.0 111.272 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.822 ' OE1' HG22 ' A' ' 8' ' ' THR . 0.0 OUTLIER -136.38 155.59 49.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.053 0.454 . . . . 0.0 111.375 179.74 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -118.89 138.66 52.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.742 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.437 ' HB3' ' HA ' ' A' ' 96' ' ' ILE . . . -92.03 -178.67 5.06 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.185 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.61 97.18 0.08 OUTLIER Glycine 0 C--N 1.335 0.495 0 C-N-CA 121.133 -0.556 . . . . 0.0 112.687 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 138.29 -33.28 2.25 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.733 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.04 9.04 24.25 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -83.92 -37.43 22.35 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.584 0.231 . . . . 0.0 111.426 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.445 HD12 ' H ' ' A' ' 17' ' ' LEU . 3.0 mp -69.74 -4.6 20.51 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.506 HD22 HD21 ' A' ' 55' ' ' LEU . 4.7 mt -88.94 13.69 12.21 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -146.73 -61.94 0.3 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.702 0.286 . . . . 0.0 110.326 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -178.07 36.34 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.076 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.51 33.29 7.66 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.927 0.394 . . . . 0.0 110.822 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.7 mm-40 -80.19 174.47 11.56 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.715 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 79.7 p -110.66 -69.68 0.85 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.06 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.442 ' CB ' ' HB3' ' A' ' 10' ' ' GLN . 59.3 p -141.64 162.99 34.12 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.691 0.281 . . . . 0.0 111.34 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.465 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -150.98 165.33 34.05 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.258 179.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.407 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -129.12 101.02 5.85 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.675 179.778 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.4 mt -83.01 142.09 31.6 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.696 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -111.31 101.6 10.06 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.841 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -94.66 -179.12 37.9 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.823 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.54 HG23 HG22 ' A' ' 31' ' ' VAL . 14.9 m -137.12 -47.84 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 120.555 0.217 . . . . 0.0 111.28 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.54 HG22 HG23 ' A' ' 30' ' ' VAL . 20.3 m -137.58 56.41 11.57 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-O 120.755 0.312 . . . . 0.0 111.067 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.459 ' HB2' ' CB ' ' A' ' 87' ' ' LEU . 88.9 Cg_endo -82.12 8.96 4.18 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.834 2.356 . . . . 0.0 113.445 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 35.4 m -55.38 -36.48 66.42 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.612 0.244 . . . . 0.0 110.848 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -93.13 29.74 7.84 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.811 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.2 m -132.75 135.58 45.82 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.659 0.266 . . . . 0.0 110.564 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -111.83 -176.39 2.92 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.946 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.653 HD22 ' HA ' ' A' ' 83' ' ' MET . 6.9 tt -54.32 -37.84 65.3 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.558 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -57.77 -35.19 70.42 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.904 0.383 . . . . 0.0 110.011 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -73.55 -32.96 58.98 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.583 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.503 ' HG ' HD11 ' A' ' 87' ' ' LEU . 7.8 mt -64.76 -53.15 51.58 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.718 0.295 . . . . 0.0 110.527 179.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.542 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.2 OUTLIER -57.48 -56.93 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.023 179.667 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -49.23 -30.8 7.58 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.654 0.264 . . . . 0.0 111.489 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.2 tp -70.76 -31.0 67.65 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 41' ' ' VAL . 2.9 pp -97.13 -42.57 7.79 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.77 -68.46 0.68 Allowed 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -178.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.5 m -50.19 -29.68 9.86 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.422 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -77.31 -36.67 53.87 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.434 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -127.89 -68.26 0.78 Allowed 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.544 ' O ' HG13 ' A' ' 49' ' ' VAL . 13.8 p 37.77 66.88 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 121.474 0.654 . . . . 0.0 111.766 -179.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.26 -30.81 62.92 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.088 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.97 -164.84 1.23 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.881 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.09 135.03 91.58 Favored Pre-proline 0 N--CA 1.462 0.144 0 CA-C-O 120.64 0.257 . . . . 0.0 111.142 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.491 ' O ' HG22 ' A' ' 57' ' ' VAL . 70.1 Cg_endo -76.23 -28.45 7.22 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.369 2.046 . . . . 0.0 112.475 179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.405 ' HA ' ' CG2' ' A' ' 57' ' ' VAL . 11.8 m-20 -92.89 9.31 35.95 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.716 ' HG ' HD23 ' A' ' 56' ' ' LEU . 2.6 pp -82.94 -28.2 30.02 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 122.317 -0.239 . . . . 0.0 111.006 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.716 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -100.07 -49.19 4.38 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.509 HG11 ' HA2' ' A' ' 61' ' ' GLY . 6.2 m -62.42 146.8 12.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-O 121.101 0.477 . . . . 0.0 111.451 -179.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -67.21 -57.65 6.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.574 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -169.93 -45.03 0.02 OUTLIER 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.496 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 82.4 p -77.78 0.63 22.96 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.571 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.509 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 63.43 22.86 66.08 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.388 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -120.27 -38.32 2.93 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.749 0.309 . . . . 0.0 111.1 -179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.9 t -118.99 132.39 56.06 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . 6.2 mt -67.15 153.81 42.76 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.98 0.419 . . . . 0.0 111.36 -179.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -74.4 161.35 78.47 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.015 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -61.09 123.23 12.48 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.77 2.313 . . . . 0.0 112.188 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 154.01 -45.54 0.56 Allowed Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.4 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 4.6 mt -96.76 135.35 31.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 120.763 0.316 . . . . 0.0 111.068 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.3 tp -106.05 108.87 20.61 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.518 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.666 HG11 ' HE2' ' A' ' 83' ' ' MET . 16.3 m -77.66 129.07 37.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.446 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.501 HD23 ' O ' ' A' ' 70' ' ' VAL . 9.5 mt -126.09 128.12 46.86 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.88 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.577 HG12 ' O ' ' A' ' 92' ' ' THR . 4.4 m -117.31 122.4 69.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.143 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.073 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 55.24 46.31 23.97 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.52 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.3 m 61.96 30.23 18.0 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.494 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 31.1 t -153.01 130.25 11.23 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.805 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.633 ' HB2' HG23 ' A' ' 79' ' ' VAL . 9.2 m-20 -46.44 130.41 10.91 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.899 0.381 . . . . 0.0 111.536 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.29 -21.12 59.88 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.133 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.42 ' HA ' ' CA ' ' A' ' 82' ' ' GLY . 1.7 mt-10 -73.31 -28.3 62.01 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-O 120.577 0.227 . . . . 0.0 110.918 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.633 HG23 ' HB2' ' A' ' 76' ' ' ASP . 43.5 t -64.93 -33.78 65.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.053 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.4 m -100.92 -37.47 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -140.01 -74.64 0.05 OUTLIER Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.773 -0.727 . . . . 0.0 113.096 -179.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.42 ' CA ' ' HA ' ' A' ' 78' ' ' GLU . . . 107.81 85.11 1.72 Allowed Glycine 0 C--N 1.331 0.302 0 C-N-CA 121.155 -0.545 . . . . 0.0 112.185 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.666 ' HE2' HG11 ' A' ' 70' ' ' VAL . 1.9 mmt 58.4 23.49 10.64 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.679 0.276 . . . . 0.0 111.394 -179.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -147.1 24.92 1.14 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.336 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -74.94 114.9 13.95 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.693 0.283 . . . . 0.0 110.95 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.7 m -65.12 140.29 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.693 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.503 HD11 ' HG ' ' A' ' 40' ' ' LEU . 2.9 mp -78.61 168.58 19.56 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.433 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -165.3 42.55 0.07 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.232 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 54.35 88.52 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.068 0.461 . . . . 0.0 111.404 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 117.94 26.64 2.71 Favored Glycine 0 CA--C 1.523 0.532 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.895 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.408 ' O ' HG23 ' A' ' 7' ' ' ILE . 2.2 t70 -78.58 150.61 32.74 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-O 120.819 0.342 . . . . 0.0 110.846 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.894 HG23 ' HB ' ' A' ' 8' ' ' THR . 96.8 m -120.99 129.94 53.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.451 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.15 136.68 25.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.22 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -134.09 151.56 51.44 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.389 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -123.73 104.72 9.16 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.39 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.437 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 14.9 mt -115.14 116.96 54.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.11 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 68.0 m -76.17 82.37 2.98 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.911 0.386 . . . . 0.0 110.739 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -75.11 -68.74 0.52 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.244 -179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.3 tp -77.47 134.74 38.28 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.756 0.312 . . . . 0.0 110.824 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -92.22 -41.0 10.67 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.089 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 179.52 143.98 5.67 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.727 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.371 -1.238 . . . . 0.0 112.585 179.955 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ptp . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 120.672 0.272 . . . . 0.0 111.336 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.2 m -77.87 -51.96 9.63 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.738 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 56.95 33.89 23.99 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.252 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -88.56 179.39 6.29 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.047 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.77 105.79 17.98 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.013 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.409 ' CD2' ' HG2' ' A' ' 26' ' ' GLN . 1.1 m170 -175.36 104.68 0.08 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.981 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.713 HD12 ' HB2' ' A' ' 27' ' ' LEU . 25.1 mt -88.97 117.18 31.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 CA-C-O 120.858 0.361 . . . . 0.0 111.103 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.717 HG22 ' OE1' ' A' ' 10' ' ' GLN . 37.6 m -82.26 112.4 19.22 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.368 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.539 HG13 ' HB2' ' A' ' 25' ' ' LEU . 7.6 p -141.7 105.83 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-O 120.907 0.385 . . . . 0.0 111.129 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.717 ' OE1' HG22 ' A' ' 8' ' ' THR . 1.6 pm0 -130.39 171.62 12.75 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.82 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.497 ' HB2' ' HB3' ' A' ' 16' ' ' GLU . 91.1 m-85 -128.87 151.36 49.71 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.18 -179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.582 ' HB3' HG12 ' A' ' 96' ' ' ILE . . . -148.97 130.88 15.21 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.592 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.83 -107.73 3.55 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.287 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -119.34 30.88 5.64 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 121.033 -0.604 . . . . 0.0 112.439 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -108.63 -31.29 7.82 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 111.493 0.183 . . . . 0.0 111.493 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.497 ' HB3' ' HB2' ' A' ' 11' ' ' PHE . 8.6 pm0 -63.68 -30.82 71.88 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 120.563 0.22 . . . . 0.0 111.206 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 mp -71.57 -7.9 50.63 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.749 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.83 HD13 HD22 ' A' ' 56' ' ' LEU . 13.3 mt -85.7 13.73 6.75 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -146.74 -61.8 0.3 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.727 0.299 . . . . 0.0 110.228 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -177.31 36.93 0.0 OUTLIER 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.051 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.3 mptt 50.93 33.71 9.27 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.904 0.383 . . . . 0.0 110.997 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -79.18 145.3 33.74 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.833 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 40.0 p -78.22 -68.69 0.61 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.843 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 99.4 p -137.93 164.53 28.77 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.826 0.346 . . . . 0.0 111.413 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.539 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.2 OUTLIER -139.34 155.59 47.58 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.142 179.83 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.409 ' HG2' ' CD2' ' A' ' 6' ' ' HIS . 0.1 OUTLIER -133.36 116.93 16.67 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.028 179.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.713 ' HB2' HD12 ' A' ' 7' ' ' ILE . 11.2 mt -103.5 133.89 47.78 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.57 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -124.85 144.0 50.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.436 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -165.66 -172.31 32.9 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.922 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.7 m -118.01 -43.93 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-O 120.548 0.213 . . . . 0.0 111.443 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 18.1 t -126.56 56.33 16.75 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-O 120.976 0.417 . . . . 0.0 111.16 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -78.49 2.46 8.09 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 122.803 2.336 . . . . 0.0 113.016 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.96 170.36 4.41 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.707 0.289 . . . . 0.0 110.916 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 76.26 25.35 66.28 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.408 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 51.3 m -136.73 131.1 33.02 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 120.508 0.194 . . . . 0.0 110.591 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -108.21 -177.9 3.46 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.855 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.686 HD22 ' HA ' ' A' ' 83' ' ' MET . 7.0 tt -56.47 -44.98 81.1 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.339 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -56.01 -37.97 69.87 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.37 -31.08 59.53 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.166 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.657 HD11 ' CD1' ' A' ' 87' ' ' LEU . 49.3 mt -64.87 -50.87 64.9 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.772 0.32 . . . . 0.0 110.566 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.1 OUTLIER -64.78 -55.36 21.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.251 179.817 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -52.46 -22.98 5.36 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.403 ' O ' ' HB2' ' A' ' 47' ' ' ASN . 3.6 tt -86.79 -26.33 24.17 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.534 HD12 ' N ' ' A' ' 45' ' ' LYS . 3.4 pp -93.0 -45.37 7.96 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.243 0.461 . . . . 0.0 112.243 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.534 ' N ' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -71.89 -55.82 6.82 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 121.014 -0.274 . . . . 0.0 111.513 -179.378 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 35.1 m -52.06 -28.23 16.67 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.638 0.256 . . . . 0.0 111.117 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 43' ' ' LEU . 0.5 OUTLIER -82.27 -32.96 29.36 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.124 179.524 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -123.88 -75.77 0.6 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.483 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.598 ' O ' HG13 ' A' ' 49' ' ' VAL . 7.9 p 33.52 58.03 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-O 121.345 0.593 . . . . 0.0 111.821 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.97 -33.5 68.93 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.189 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.475 ' HB2' ' HA ' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -90.33 172.2 8.93 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.399 179.502 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.586 ' HB2' HD23 ' A' ' 55' ' ' LEU . 28.5 mmm-85 -48.68 106.97 0.68 Allowed Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.61 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.417 ' O ' HG22 ' A' ' 57' ' ' VAL . 50.2 Cg_exo -55.11 -28.96 63.41 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.664 2.243 . . . . 0.0 112.563 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -92.45 9.78 32.85 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.834 ' HG ' HD23 ' A' ' 56' ' ' LEU . 1.4 pp -88.25 -28.13 21.31 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 121.148 -0.221 . . . . 0.0 111.1 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.834 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -93.77 -54.63 3.55 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.588 -179.871 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.548 HG11 ' HA2' ' A' ' 61' ' ' GLY . 2.1 m -53.94 151.53 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 121.068 0.461 . . . . 0.0 111.612 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -65.42 -58.2 6.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.565 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.3 -45.32 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.517 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.8 p -84.09 10.73 9.36 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.617 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.548 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 55.28 27.91 48.36 Favored Glycine 0 C--N 1.338 0.653 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.552 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -118.25 -41.37 2.86 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.755 0.312 . . . . 0.0 110.838 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.7 t -117.97 128.67 55.02 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.979 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.686 HD22 ' HB2' ' A' ' 56' ' ' LEU . 8.3 mt -67.44 156.21 37.14 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.717 0.294 . . . . 0.0 110.989 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.436 ' CG ' HD12 ' A' ' 68' ' ' ILE . 0.7 OUTLIER -52.44 153.81 4.97 Favored Pre-proline 0 N--CA 1.464 0.275 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.598 -179.796 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.36 -38.57 73.82 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.048 2.498 . . . . 0.0 112.771 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.428 ' HA3' ' HB3' ' A' ' 99' ' ' LEU . . . -48.34 -36.06 16.04 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 121.167 -0.539 . . . . 0.0 112.799 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.505 HD13 HD13 ' A' ' 64' ' ' LEU . 6.6 mt -84.32 126.48 40.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 117.008 0.404 . . . . 0.0 110.951 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 mt -94.63 101.5 13.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.515 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.712 HG23 ' HB3' ' A' ' 77' ' ' ALA . 15.3 m -79.51 132.3 32.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.899 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.529 HD23 ' O ' ' A' ' 70' ' ' VAL . 1.8 mt -137.22 138.77 40.49 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.386 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.501 HG23 ' CB ' ' A' ' 77' ' ' ALA . 44.0 t -119.06 119.74 61.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.154 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.656 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 28.3 m-20 61.27 54.07 3.33 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.079 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.2 m 52.82 38.44 26.63 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.492 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 21.4 t -155.43 155.05 32.87 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.523 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.494 ' HB3' HG23 ' A' ' 79' ' ' VAL . 0.6 OUTLIER -47.18 123.91 5.97 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.665 0.269 . . . . 0.0 111.438 -179.84 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.712 ' HB3' HG23 ' A' ' 70' ' ' VAL . . . -69.29 -23.17 63.79 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.693 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -74.86 -28.79 60.81 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.526 0.203 . . . . 0.0 110.653 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.494 HG23 ' HB3' ' A' ' 76' ' ' ASP . 24.1 t -73.52 -41.21 56.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.282 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.414 HG21 ' HB ' ' A' ' 72' ' ' VAL . 30.8 m -71.4 -34.19 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.663 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -170.9 -46.31 0.04 OUTLIER Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.74 -0.743 . . . . 0.0 113.055 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 90.84 73.45 1.27 Allowed Glycine 0 C--N 1.335 0.496 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.192 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.686 ' HA ' HD22 ' A' ' 37' ' ' LEU . 0.7 OUTLIER 62.2 29.71 17.51 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.586 0.231 . . . . 0.0 111.131 -179.613 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -150.2 29.86 0.71 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.432 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -90.27 118.91 30.14 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.725 0.297 . . . . 0.0 110.973 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.9 m -66.8 156.25 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.813 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.657 ' CD1' HD11 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -89.54 161.12 16.36 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.428 -179.699 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -158.4 36.84 0.24 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.253 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 47.1 t0 61.17 93.13 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.041 0.448 . . . . 0.0 110.896 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 112.52 31.34 2.6 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.588 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -70.14 166.92 18.89 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.724 0.297 . . . . 0.0 111.049 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.652 HG23 ' HB ' ' A' ' 8' ' ' THR . 85.1 m -140.05 125.59 19.15 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.08 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.449 HG13 HG23 ' A' ' 9' ' ' VAL . 10.4 p -143.23 140.17 26.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.93 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -138.05 144.72 41.11 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.912 0.387 . . . . 0.0 111.134 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.502 ' HB3' HG21 ' A' ' 68' ' ' ILE . 70.1 m-85 -125.15 104.85 8.74 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.719 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.582 HG12 ' HB3' ' A' ' 12' ' ' ALA . 27.6 mt -118.83 112.63 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.22 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 74.3 m -79.98 123.32 27.71 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.394 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.94 7.84 8.67 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.944 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.601 HD22 ' C ' ' A' ' 99' ' ' LEU . 0.0 OUTLIER -58.21 166.86 1.47 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.914 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.465 ' N ' HD22 ' A' ' 99' ' ' LEU . 27.5 t-80 -151.48 153.99 35.69 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.582 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -133.13 -89.86 0.41 Allowed Glycine 0 C--N 1.335 0.517 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.1 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.944 0 CA-C-O 118.478 -1.179 . . . . 0.0 112.632 179.785 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 120.805 0.336 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.34 136.08 12.54 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.931 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 -72.19 127.78 33.63 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.268 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.08 30.25 5.27 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.679 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -122.85 135.59 54.58 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.566 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -176.91 137.93 0.25 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.982 0.42 . . . . 0.0 111.791 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 29.9 mm -111.23 153.94 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.401 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.728 HG22 ' OE1' ' A' ' 10' ' ' GLN . 2.3 m -121.19 111.32 17.26 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.664 0.268 . . . . 0.0 111.162 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.539 ' O ' HG13 ' A' ' 9' ' ' VAL . 8.3 p -129.99 104.69 10.75 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-O 120.925 0.393 . . . . 0.0 111.046 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.728 ' OE1' HG22 ' A' ' 8' ' ' THR . 0.0 OUTLIER -130.74 154.94 47.44 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.804 -179.657 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.414 ' HB2' ' HB3' ' A' ' 16' ' ' GLU . 32.4 m-85 -116.6 142.78 46.44 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.849 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.474 ' HB3' HG12 ' A' ' 96' ' ' ILE . . . -137.21 167.83 20.81 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.744 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 66.1 -104.74 1.09 Allowed Glycine 0 C--N 1.334 0.434 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.653 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -128.3 32.77 3.32 Favored Glycine 0 CA--C 1.521 0.43 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.899 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 3.6 t -105.26 -32.26 8.7 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.865 0.332 . . . . 0.0 111.103 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.414 ' HB3' ' HB2' ' A' ' 11' ' ' PHE . 1.3 pt-20 -59.25 -33.35 70.93 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.32 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.7 mp -68.62 -8.84 45.67 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.532 HD21 HD11 ' A' ' 55' ' ' LEU . 68.0 mt -84.11 13.58 5.0 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -147.99 -64.42 0.26 Allowed 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -172.34 37.85 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.18 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.2 mptt 51.38 35.31 13.68 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.989 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -69.24 159.24 33.42 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.129 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 37.6 p -101.49 -71.88 0.7 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.966 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.502 ' O ' HD12 ' A' ' 25' ' ' LEU . 80.3 p -141.33 162.85 34.49 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.601 0.239 . . . . 0.0 111.254 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.502 HD12 ' O ' ' A' ' 24' ' ' SER . 0.7 OUTLIER -150.64 158.65 44.4 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.24 -179.915 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.48 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 52.9 mt-30 -133.16 144.84 50.15 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.95 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.4 mt -130.8 142.03 50.37 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.972 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -77.87 110.26 12.61 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.745 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.15 125.64 27.44 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.808 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.479 HG23 ' H ' ' A' ' 31' ' ' VAL . 3.7 m -125.75 -56.53 1.94 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 111.368 0.136 . . . . 0.0 111.368 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.479 ' H ' HG23 ' A' ' 30' ' ' VAL . 16.4 m -151.15 62.62 5.17 Favored Pre-proline 0 N--CA 1.467 0.389 0 CA-C-O 120.817 0.341 . . . . 0.0 111.184 179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.459 ' HD3' ' N ' ' A' ' 31' ' ' VAL . 5.4 Cg_exo -74.18 -0.53 9.71 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.985 2.456 . . . . 0.0 113.219 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 93.5 m -55.51 -35.54 65.73 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.62 0.248 . . . . 0.0 111.017 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -93.6 29.49 8.39 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.891 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 25.5 m -147.7 150.55 34.53 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.749 0.309 . . . . 0.0 110.83 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.6 p30 -141.5 -171.82 3.39 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.043 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.762 ' HA ' HD12 ' A' ' 40' ' ' LEU . 7.1 tt -54.29 -42.71 70.37 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.476 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -55.68 -38.38 69.55 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.98 -32.32 60.9 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.074 178.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.799 HD11 ' CD1' ' A' ' 87' ' ' LEU . 24.2 mt -66.66 -54.57 21.83 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.86 0.33 . . . . 0.0 110.487 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.631 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.6 OUTLIER -59.84 -58.49 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.894 179.895 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.459 ' H ' HG23 ' A' ' 41' ' ' VAL . 32.0 tt0 -50.26 -30.01 10.84 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.525 179.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.3 tt -71.43 -31.03 66.76 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.633 HD12 ' N ' ' A' ' 45' ' ' LYS . 4.6 pp -97.01 -40.75 8.71 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.633 ' N ' HD12 ' A' ' 44' ' ' LEU . 0.7 OUTLIER -87.31 -70.79 0.6 Allowed 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.477 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.7 m -55.35 -24.62 30.3 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -96.31 -31.54 12.84 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -152.66 57.9 0.81 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 49' ' ' VAL . 7.1 p -91.24 113.67 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 120.868 0.366 . . . . 0.0 110.617 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -94.8 48.74 1.21 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.769 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -177.79 -175.11 0.49 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.284 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.682 ' HB2' HD23 ' A' ' 55' ' ' LEU . 2.5 mmt-85 -62.11 110.95 3.76 Favored Pre-proline 0 N--CA 1.463 0.188 0 CA-C-O 120.502 0.191 . . . . 0.0 110.991 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 52' ' ' ARG . 18.2 Cg_endo -60.49 -24.95 79.47 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.278 1.986 . . . . 0.0 112.512 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.96 7.96 39.75 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.75 ' HG ' HD23 ' A' ' 56' ' ' LEU . 1.8 pp -89.62 -21.31 22.87 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.462 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.75 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -100.58 -48.62 4.47 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.536 HG11 ' HA2' ' A' ' 61' ' ' GLY . 2.6 m -54.89 151.25 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.063 0.459 . . . . 0.0 111.681 -179.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -69.47 -57.45 5.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.189 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -171.15 -44.6 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.418 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.9 t -82.23 7.78 12.83 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.641 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.536 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 59.34 24.49 59.15 Favored Glycine 0 C--N 1.342 0.885 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.702 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -115.79 -47.36 2.8 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.815 0.34 . . . . 0.0 110.371 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.532 HG22 ' CG ' ' A' ' 83' ' ' MET . 45.4 p -105.5 163.93 12.27 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.907 179.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.628 HD22 ' HB2' ' A' ' 56' ' ' LEU . 6.3 mt -99.06 152.82 19.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.855 0.359 . . . . 0.0 111.073 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.91 147.67 52.97 Favored Pre-proline 0 N--CA 1.467 0.379 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.352 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -49.88 -32.51 30.29 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.344 2.696 . . . . 0.0 113.326 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -45.16 -38.85 6.54 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 121.357 -0.449 . . . . 0.0 113.035 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.566 HG21 ' HB3' ' A' ' 95' ' ' PHE . 4.0 mt -100.15 135.2 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.951 0.375 . . . . 0.0 111.05 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.7 tp -100.07 101.98 13.19 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.661 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.682 HG23 ' HB3' ' A' ' 77' ' ' ALA . 26.9 m -83.37 126.12 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.185 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 mt -125.59 161.98 26.0 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.273 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.586 HG11 ' CD2' ' A' ' 85' ' ' TYR . 2.7 m -141.17 111.58 3.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.913 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 56.37 53.22 8.99 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.957 0.408 . . . . 0.0 110.888 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.9 m 58.33 30.3 19.36 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.502 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 49.8 t -144.19 130.72 19.98 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.223 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -45.6 128.43 8.34 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.689 0.28 . . . . 0.0 111.137 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.682 ' HB3' HG23 ' A' ' 70' ' ' VAL . . . -62.39 -21.6 65.49 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.768 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -72.52 -24.12 61.1 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.735 -0.212 . . . . 0.0 110.895 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 21.4 t -71.33 -47.18 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.131 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.525 HG21 ' CG ' ' A' ' 85' ' ' TYR . 29.8 m -69.36 -42.45 81.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.868 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 165.39 40.16 0.02 OUTLIER Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.666 -0.778 . . . . 0.0 113.517 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 54.3 -104.75 0.26 Allowed Glycine 0 C--N 1.336 0.582 0 C-N-CA 121.236 -0.506 . . . . 0.0 112.919 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.729 ' HA ' HD22 ' A' ' 37' ' ' LEU . 53.8 mmm -108.89 27.06 9.86 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 120.682 0.277 . . . . 0.0 111.074 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -122.03 21.19 10.62 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.586 ' CD2' HG11 ' A' ' 72' ' ' VAL . 19.4 t80 -73.46 118.92 16.99 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.65 0.262 . . . . 0.0 111.305 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 19.7 m -78.73 159.45 4.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.525 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.799 ' CD1' HD11 ' A' ' 40' ' ' LEU . 1.7 mp -110.29 175.77 5.3 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.863 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -168.86 -62.18 0.02 OUTLIER 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.04 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -178.91 108.15 0.04 OUTLIER 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.425 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 105.51 24.17 7.21 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.978 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -79.22 143.88 34.92 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 117.02 0.41 . . . . 0.0 110.611 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 53.5 m -134.22 103.07 5.6 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.003 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.7 p -107.84 134.65 48.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.803 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.429 ' HG2' ' HG2' ' A' ' 10' ' ' GLN . 15.3 mt-10 -136.42 150.47 48.77 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.468 -179.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.566 ' HB3' HG21 ' A' ' 68' ' ' ILE . 88.6 m-85 -124.56 104.48 8.74 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.148 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.474 HG12 ' HB3' ' A' ' 12' ' ' ALA . 24.3 mt -111.87 107.02 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.145 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.52 137.42 34.61 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.953 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.8 p -129.43 -54.43 1.17 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.941 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.98 125.01 28.72 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.858 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -137.44 89.91 2.46 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.853 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -154.62 -67.85 0.01 OUTLIER Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.62 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.824 -0.987 . . . . 0.0 112.895 179.96 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 120.893 0.378 . . . . 0.0 111.281 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.0 t -92.17 156.85 17.05 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.673 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 60.21 38.52 20.02 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.967 0.413 . . . . 0.0 110.832 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.423 ' O ' ' HB2' ' A' ' 5' ' ' ASN . 35.2 t60 -114.26 158.72 21.02 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.607 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 4' ' ' HIS . 5.7 m120 69.21 162.66 0.22 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.277 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.68 ' C ' HD12 ' A' ' 7' ' ' ILE . 15.4 m170 63.83 -175.57 0.16 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.89 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.68 HD12 ' C ' ' A' ' 6' ' ' HIS . 3.2 mp -129.87 145.86 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 120.741 0.305 . . . . 0.0 111.179 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.725 HG22 ' OE1' ' A' ' 10' ' ' GLN . 24.3 m -96.92 95.93 8.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.959 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.82 HG21 HD22 ' A' ' 44' ' ' LEU . 11.8 p -110.95 105.19 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 121.005 0.431 . . . . 0.0 110.833 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.725 ' OE1' HG22 ' A' ' 8' ' ' THR . 0.0 OUTLIER -130.51 175.29 9.1 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.725 -179.068 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.502 ' CG ' ' HA ' ' A' ' 16' ' ' GLU . 95.5 m-85 -118.63 161.64 19.73 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.107 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -172.8 157.93 3.82 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.369 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 66.16 45.03 89.73 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.615 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.11 33.2 82.61 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.902 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.7 -17.93 13.58 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.783 0.292 . . . . 0.0 111.613 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.502 ' HA ' ' CG ' ' A' ' 11' ' ' PHE . 2.0 pm0 -59.27 -24.94 63.66 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.7 mp -65.92 -7.7 18.18 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.665 ' CD2' HD11 ' A' ' 55' ' ' LEU . 58.0 mt -72.69 1.27 8.7 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.458 ' CD2' ' HB2' ' A' ' 50' ' ' LYS . 38.8 t80 -144.24 -65.97 0.35 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -172.19 40.0 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.354 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 52.58 46.83 25.97 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.77 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -75.04 -179.66 4.45 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.917 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.457 ' O ' ' HB2' ' A' ' 10' ' ' GLN . 39.9 p -113.74 -47.11 2.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.256 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.5 p -171.21 155.08 4.21 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.673 0.273 . . . . 0.0 110.978 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.645 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.8 OUTLIER -141.71 166.58 24.34 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.546 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.56 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 0.8 OUTLIER -132.29 126.47 33.45 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.93 179.791 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.9 mt -103.27 141.73 35.41 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.846 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -110.16 119.75 40.28 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.534 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -106.9 151.76 16.89 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.964 -0.636 . . . . 0.0 113.095 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.482 HG23 HG22 ' A' ' 31' ' ' VAL . 8.3 m -107.46 -32.23 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.482 HG22 HG23 ' A' ' 30' ' ' VAL . 14.3 m -143.19 69.35 17.96 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-O 120.992 0.425 . . . . 0.0 111.2 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -75.34 -7.45 18.86 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.745 2.297 . . . . 0.0 113.454 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 74.0 m -51.43 -58.15 7.04 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.592 0.234 . . . . 0.0 111.374 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -98.48 36.39 4.03 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.519 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.5 m -123.22 119.56 30.55 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.694 0.283 . . . . 0.0 110.815 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -95.94 -176.05 3.59 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.139 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.733 ' O ' HG22 ' A' ' 41' ' ' VAL . 1.6 tt -55.4 -40.26 71.22 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.583 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -51.85 -44.55 63.67 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -70.63 -32.78 67.24 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.996 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.961 HD12 HD21 ' A' ' 87' ' ' LEU . 6.3 tt -67.17 -59.2 3.64 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.562 0.22 . . . . 0.0 110.961 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.733 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.6 OUTLIER -59.76 -57.77 10.14 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.143 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.288 -179.841 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.435 ' H ' HG23 ' A' ' 41' ' ' VAL . 6.4 tt0 -48.73 -33.37 10.08 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.734 -0.212 . . . . 0.0 111.363 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.5 tt -71.81 -29.1 64.08 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.728 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.82 HD22 HG21 ' A' ' 9' ' ' VAL . 3.8 pp -95.83 -32.43 12.68 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.754 ' N ' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -87.64 -71.07 0.59 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.477 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.9 m -51.53 -26.79 9.15 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -96.73 -36.88 10.52 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -140.62 57.26 1.58 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.5 HG13 ' H ' ' A' ' 51' ' ' GLU . 7.5 p -95.79 -34.86 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.458 ' HB2' ' CD2' ' A' ' 19' ' ' PHE . 0.2 OUTLIER 66.25 8.46 5.61 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 111.574 0.213 . . . . 0.0 111.574 -179.307 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.5 ' H ' HG13 ' A' ' 49' ' ' VAL . 1.7 tp10 -144.89 -166.18 2.34 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.507 ' CB ' HD23 ' A' ' 55' ' ' LEU . 8.9 ttm180 -75.61 110.74 11.43 Favored Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 116.742 -0.208 . . . . 0.0 110.595 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.468 ' O ' HG22 ' A' ' 57' ' ' VAL . 18.9 Cg_endo -59.6 -21.64 63.35 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.315 2.01 . . . . 0.0 112.537 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.32 5.58 44.4 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.754 ' HG ' HD23 ' A' ' 56' ' ' LEU . 1.9 pp -95.26 -26.82 15.79 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 121.166 -0.214 . . . . 0.0 111.476 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.754 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -95.7 -44.74 7.31 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 111.806 0.299 . . . . 0.0 111.806 -179.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.512 HG11 ' HA2' ' A' ' 61' ' ' GLY . 5.4 m -54.25 150.49 1.78 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-O 121.119 0.485 . . . . 0.0 111.699 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -63.35 -59.33 4.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.358 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -171.78 -43.92 0.02 OUTLIER 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.371 179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 71.3 p -83.63 7.62 16.83 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.805 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.512 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 57.14 25.75 54.65 Favored Glycine 0 C--N 1.341 0.813 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.47 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.4 tm0? -115.08 -37.28 4.16 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.652 0.263 . . . . 0.0 110.977 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.9 t -127.5 142.48 51.38 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.792 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.754 HD21 HD12 ' A' ' 56' ' ' LEU . 8.1 mt -65.88 155.8 35.32 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.877 0.37 . . . . 0.0 111.205 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.26 150.37 72.26 Favored Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.075 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -52.32 -32.86 53.24 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.091 2.527 . . . . 0.0 112.819 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 99' ' ' LEU . . . -49.88 -35.97 25.75 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.874 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.449 HG21 ' HB3' ' A' ' 95' ' ' PHE . 4.4 mt -99.93 135.66 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 120.752 0.31 . . . . 0.0 110.789 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.8 mp -105.26 104.91 14.74 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.874 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.905 HG23 ' HB3' ' A' ' 77' ' ' ALA . 11.5 m -77.25 133.85 29.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.014 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.6 mt -123.98 154.56 39.64 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.551 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.484 HG23 ' CA ' ' A' ' 77' ' ' ALA . 25.8 t -126.53 113.47 33.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.652 179.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.8 m120 57.9 42.62 22.74 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.965 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.9 m 57.08 50.58 11.74 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.417 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 42.8 t -141.32 -79.38 0.26 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.485 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 177.49 132.29 0.06 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.698 0.285 . . . . 0.0 110.896 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.905 ' HB3' HG23 ' A' ' 70' ' ' VAL . . . -88.51 -24.91 22.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.562 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -80.81 -38.71 27.93 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.578 0.228 . . . . 0.0 110.842 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 61.8 t -58.58 -37.5 65.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.906 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.9 m -80.83 -32.75 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.531 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.29 -56.49 0.04 OUTLIER Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.77 -0.729 . . . . 0.0 113.13 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 110.63 -57.85 0.41 Allowed Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.253 -0.499 . . . . 0.0 112.266 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -142.92 21.72 1.95 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 111.516 0.191 . . . . 0.0 111.516 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -135.6 20.46 3.33 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.111 0.412 . . . . 0.0 112.111 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -75.1 114.52 13.69 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.927 0.394 . . . . 0.0 111.302 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.8 m -71.7 153.28 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.48 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.961 HD21 HD12 ' A' ' 40' ' ' LEU . 1.2 mp -104.21 164.28 11.83 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.551 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -161.02 30.33 0.14 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.413 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 58.97 103.93 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.001 0.429 . . . . 0.0 111.604 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 116.73 35.52 1.15 Allowed Glycine 0 C--N 1.332 0.357 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.326 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.15 177.52 4.81 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.863 0.363 . . . . 0.0 111.576 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.716 HG23 ' HB ' ' A' ' 8' ' ' THR . 74.2 m -140.3 132.66 28.37 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.821 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.625 HG11 HD21 ' A' ' 40' ' ' LEU . 7.1 p -142.46 137.06 28.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.174 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -134.2 158.47 43.6 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.993 0.425 . . . . 0.0 111.532 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.449 ' HB3' HG21 ' A' ' 68' ' ' ILE . 25.8 m-85 -126.55 104.89 8.37 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.298 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 26.5 mt -116.08 118.5 58.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.215 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.81 155.15 39.12 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.108 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.78 -41.54 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.563 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.414 ' HA ' ' HA2' ' A' ' 67' ' ' GLY . 0.4 OUTLIER 51.49 -174.25 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.056 0.543 . . . . 0.0 111.777 -179.735 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 25.4 m170 -95.04 72.83 3.42 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.137 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -85.75 -169.05 45.53 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.106 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.197 0 CA-C-O 118.578 -1.123 . . . . 0.0 112.655 -179.591 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ttp . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 120.629 0.252 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.9 m -81.82 87.53 6.36 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.912 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -134.48 145.36 48.75 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.852 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 26.1 m170 60.38 84.06 0.13 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.827 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.456 ' HB3' ' O ' ' A' ' 89' ' ' ASP . 49.6 m-80 -109.66 165.76 11.42 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.407 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -175.74 138.64 0.38 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.277 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.479 HG23 ' O ' ' A' ' 91' ' ' ASP . 29.6 mt -105.35 137.67 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.133 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.723 ' HB ' HG23 ' A' ' 92' ' ' THR . 0.5 OUTLIER -92.84 112.43 24.39 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.386 -179.607 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.509 HG13 ' HB2' ' A' ' 25' ' ' LEU . 7.6 p -134.23 108.8 11.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.653 179.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.673 ' OE1' HG22 ' A' ' 8' ' ' THR . 1.5 pm0 -140.04 162.53 35.0 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.499 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.462 ' HB2' ' HG2' ' A' ' 16' ' ' GLU . 31.3 m-85 -116.13 148.47 40.28 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.149 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -135.29 143.46 46.23 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.306 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.11 -108.54 2.65 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.997 -0.621 . . . . 0.0 112.138 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -117.16 25.7 8.64 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.564 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.8 m -97.64 -15.53 20.39 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.462 ' HG2' ' HB2' ' A' ' 11' ' ' PHE . 40.0 mt-10 -59.54 -32.97 70.82 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.667 0.27 . . . . 0.0 111.081 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.454 HD23 ' HG3' ' A' ' 21' ' ' LYS . 2.8 mt -72.54 -5.17 35.23 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.883 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.64 HD21 HD11 ' A' ' 55' ' ' LEU . 54.8 mt -83.1 14.42 3.42 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -153.76 -60.8 0.13 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.61 0.243 . . . . 0.0 110.656 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -177.4 37.49 0.0 OUTLIER 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.149 179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.454 ' HG3' HD23 ' A' ' 17' ' ' LEU . 5.4 mptt 51.19 35.27 12.95 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.966 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -93.06 151.16 20.04 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.876 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.9 p -79.13 -64.29 1.22 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.926 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.8 p -143.22 163.93 31.58 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.792 0.329 . . . . 0.0 111.357 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.509 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.8 OUTLIER -148.54 166.58 27.79 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.11 -179.794 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -132.78 126.5 32.52 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.873 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.2 mt -114.75 141.14 48.26 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.877 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -117.51 124.0 47.66 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.612 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -118.54 133.88 10.57 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.591 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.6 t -70.15 -40.74 78.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 120.641 0.258 . . . . 0.0 111.025 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 18.0 t -134.12 67.64 73.45 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-O 120.945 0.402 . . . . 0.0 111.121 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.818 ' HB3' HD23 ' A' ' 87' ' ' LEU . 19.9 Cg_exo -66.27 -16.2 50.84 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.782 2.321 . . . . 0.0 112.92 179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.19 -44.24 67.78 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.669 -179.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.06 41.05 3.06 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 121.015 -0.612 . . . . 0.0 113.029 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 58.1 m -151.41 129.9 12.17 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 120.646 0.26 . . . . 0.0 110.809 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -113.23 -175.29 2.64 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.704 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.815 HD22 ' HA ' ' A' ' 83' ' ' MET . 4.5 tt -55.16 -35.1 64.4 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.404 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -56.63 -37.39 70.66 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.906 0.384 . . . . 0.0 110.135 179.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.97 -32.96 56.11 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.93 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.792 HD11 ' CD1' ' A' ' 87' ' ' LEU . 95.2 mt -65.86 -53.29 41.82 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.7 0.286 . . . . 0.0 110.58 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.3 OUTLIER -56.71 -57.53 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.993 179.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.431 ' H ' HG23 ' A' ' 41' ' ' VAL . 0.8 OUTLIER -55.54 -26.65 44.41 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.431 179.57 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.9 tp -82.08 -23.81 35.57 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.677 HD12 ' N ' ' A' ' 45' ' ' LYS . 4.7 pp -96.75 -38.17 10.0 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.677 ' N ' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -92.37 -59.6 2.05 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -179.627 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.5 m -61.33 -21.85 64.37 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.364 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.38 -34.15 10.77 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -155.58 55.01 0.62 Allowed 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.438 ' HB ' ' O ' ' A' ' 45' ' ' LYS . 7.6 p -70.72 -33.1 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 57.79 13.48 2.07 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -158.37 -170.37 3.08 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.636 ' HB2' HD23 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -67.08 112.56 10.19 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-O 120.562 0.22 . . . . 0.0 110.838 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.428 ' O ' HG22 ' A' ' 57' ' ' VAL . 18.2 Cg_endo -59.85 -24.7 76.97 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.272 1.982 . . . . 0.0 112.299 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.432 ' HA ' HG22 ' A' ' 57' ' ' VAL . 0.9 OUTLIER -90.36 6.58 42.53 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.807 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.708 ' HG ' HD23 ' A' ' 56' ' ' LEU . 1.6 pp -91.5 -29.34 17.05 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 121.236 -0.186 . . . . 0.0 111.316 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.708 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -97.47 -44.0 7.02 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.723 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.432 HG22 ' HA ' ' A' ' 54' ' ' ASP . 15.5 m -56.5 148.05 4.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.176 0.512 . . . . 0.0 111.696 -179.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.672 ' HB2' HG23 ' A' ' 63' ' ' THR . 12.5 t70 -63.18 -55.88 21.38 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.361 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -174.22 -44.65 0.01 OUTLIER 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.481 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.415 HG23 ' HB3' ' A' ' 62' ' ' GLN . 9.7 t -89.63 15.37 9.63 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.426 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 55.16 23.29 32.21 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.65 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.415 ' HB3' HG23 ' A' ' 60' ' ' THR . 1.0 OUTLIER -107.77 -32.77 7.49 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.893 0.377 . . . . 0.0 110.788 -179.714 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.672 HG23 ' HB2' ' A' ' 58' ' ' ASP . 6.0 t -132.66 179.48 6.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.092 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.6 mt -103.98 152.92 21.43 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.915 0.388 . . . . 0.0 111.451 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.06 154.18 82.84 Favored Pre-proline 0 N--CA 1.465 0.287 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.389 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -50.31 -32.95 35.13 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.199 2.599 . . . . 0.0 113.036 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -46.51 -37.58 8.71 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 121.392 -0.432 . . . . 0.0 112.993 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.478 HG21 ' HB3' ' A' ' 95' ' ' PHE . 3.8 mt -104.8 133.28 49.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.861 0.331 . . . . 0.0 111.054 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.0 mt -100.8 100.37 11.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.694 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.706 HG23 ' HB3' ' A' ' 77' ' ' ALA . 14.5 m -76.57 133.26 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.873 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.57 HD23 ' O ' ' A' ' 70' ' ' VAL . 2.7 mt -132.13 140.62 48.86 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.391 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.664 HG23 ' CB ' ' A' ' 77' ' ' ALA . 19.5 t -115.73 117.82 56.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.493 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 56.99 49.86 13.16 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.145 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 58.81 47.36 12.75 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.951 0.405 . . . . 0.0 111.275 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 52.0 t -161.37 147.03 14.01 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.628 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -46.01 119.56 2.32 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.781 0.324 . . . . 0.0 111.357 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.706 ' HB3' HG23 ' A' ' 70' ' ' VAL . . . -78.2 -17.87 56.2 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.136 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.11 -34.51 49.97 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.379 0.133 . . . . 0.0 111.162 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 28.2 t -70.11 -45.79 74.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.053 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.9 m -60.62 -35.51 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.691 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 179.0 -35.52 0.08 OUTLIER Glycine 0 CA--C 1.524 0.599 0 C-N-CA 120.785 -0.722 . . . . 0.0 113.251 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.68 -54.13 2.67 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 121.079 -0.581 . . . . 0.0 112.225 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.815 ' HA ' HD22 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -148.52 27.51 0.91 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 120.464 0.173 . . . . 0.0 111.343 179.641 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -129.09 15.49 6.24 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.476 ' CZ ' HG11 ' A' ' 72' ' ' VAL . 1.9 t80 -70.38 113.21 7.3 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.755 0.312 . . . . 0.0 110.943 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 26.9 m -69.4 148.21 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.473 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.818 HD23 ' HB3' ' A' ' 32' ' ' PRO . 1.0 OUTLIER -96.66 157.96 15.66 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.541 -179.875 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -154.16 36.16 0.43 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.194 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.456 ' O ' ' HB3' ' A' ' 5' ' ' ASN . 2.4 t0 62.96 27.31 15.89 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.963 0.411 . . . . 0.0 111.691 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -168.77 41.08 0.22 Allowed Glycine 0 C--N 1.332 0.35 0 C-N-CA 121.198 -0.525 . . . . 0.0 112.235 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.479 ' O ' HG23 ' A' ' 7' ' ' ILE . 4.0 t70 -85.03 166.36 16.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.815 0.34 . . . . 0.0 111.013 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.723 HG23 ' HB ' ' A' ' 8' ' ' THR . 86.1 m -141.81 127.61 19.28 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.659 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.7 p -141.8 133.63 27.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.111 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -132.96 143.18 49.29 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.327 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.478 ' HB3' HG21 ' A' ' 68' ' ' ILE . 18.2 m-85 -113.19 104.74 12.65 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.275 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 11.0 mt -110.73 110.15 31.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.03 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 60.6 p -76.66 143.64 39.97 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.19 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.33 -50.26 0.74 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.13 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.46 77.07 1.93 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.918 0.39 . . . . 0.0 110.917 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -132.52 37.91 3.47 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.724 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -132.64 -57.81 0.08 OUTLIER Glycine 0 C--N 1.333 0.412 0 C-N-CA 121.17 -0.538 . . . . 0.0 112.097 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.416 -1.214 . . . . 0.0 112.405 179.515 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 120.704 0.288 . . . . 0.0 111.082 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 t -76.32 -47.84 22.12 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.4 179.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -170.17 95.55 0.26 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.625 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -67.23 157.28 34.19 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.419 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -70.3 135.48 48.95 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.89 0.376 . . . . 0.0 111.314 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 14.3 p-80 -175.17 115.02 0.15 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.172 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 33.6 mm -87.2 154.32 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.672 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.607 ' CG2' HG23 ' A' ' 92' ' ' THR . 48.8 m -121.14 94.12 4.24 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.653 0.263 . . . . 0.0 111.082 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.587 HG13 ' HB2' ' A' ' 25' ' ' LEU . 11.5 p -118.28 109.2 26.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-O 121.02 0.438 . . . . 0.0 111.426 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.47 ' OE1' HG22 ' A' ' 8' ' ' THR . 8.4 pm0 -134.0 162.24 32.6 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.569 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.433 ' CB ' ' HA ' ' A' ' 16' ' ' GLU . 98.1 m-85 -122.04 151.92 40.33 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.102 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -167.23 174.38 8.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.013 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 59.66 32.03 72.8 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.916 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.1 26.91 38.92 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.224 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.6 t -108.07 -22.98 12.18 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 117.129 0.464 . . . . 0.0 111.528 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.433 ' HA ' ' CB ' ' A' ' 11' ' ' PHE . 1.9 pt-20 -57.72 -27.51 63.03 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.512 0.196 . . . . 0.0 111.339 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.1 mp -64.98 -10.66 31.12 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.556 HD22 ' CD1' ' A' ' 55' ' ' LEU . 71.8 mt -83.55 13.57 4.46 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -148.18 -70.83 0.22 Allowed 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -170.98 38.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.969 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.65 34.16 15.31 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.146 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.1 mm100 -77.47 178.43 7.21 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.047 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 37.0 p -107.12 -76.89 0.6 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.895 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.6 p -136.77 164.31 28.57 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.688 0.28 . . . . 0.0 111.372 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.587 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.3 OUTLIER -148.53 151.02 34.4 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.267 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.484 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 31.7 mt-30 -132.64 109.57 9.82 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.87 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.3 mt -97.97 141.72 30.59 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.687 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -85.72 121.07 27.86 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.699 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -91.02 157.7 25.27 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.777 -0.725 . . . . 0.0 113.008 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.552 HG23 HG22 ' A' ' 31' ' ' VAL . 15.5 m -123.6 -45.77 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.552 HG22 HG23 ' A' ' 30' ' ' VAL . 15.9 m -136.39 67.72 60.6 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-O 121.012 0.434 . . . . 0.0 111.457 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.48 ' HB3' ' HB3' ' A' ' 87' ' ' LEU . 6.1 Cg_exo -77.62 0.13 10.1 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.169 2.579 . . . . 0.0 113.231 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.8 m -56.53 -58.73 6.77 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.694 0.283 . . . . 0.0 111.342 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -93.51 43.37 2.5 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.658 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.5 m -135.26 114.64 12.47 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.719 0.295 . . . . 0.0 110.646 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -100.15 -170.19 1.84 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.6 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.666 ' O ' HG22 ' A' ' 41' ' ' VAL . 2.5 tt -55.04 -42.94 73.29 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 111.484 0.179 . . . . 0.0 111.484 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -56.78 -38.14 72.07 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.98 -34.44 47.48 Favored Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.977 178.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.996 HD13 HD21 ' A' ' 87' ' ' LEU . 23.9 tp -62.32 -52.03 65.3 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.622 0.248 . . . . 0.0 110.634 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.666 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.3 OUTLIER -59.11 -57.63 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.929 179.541 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.418 ' H ' HG23 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -51.07 -32.42 21.99 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.732 -0.213 . . . . 0.0 111.259 179.576 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.466 ' O ' HD23 ' A' ' 43' ' ' LEU . 8.5 tt -70.38 -27.84 64.63 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.484 HD12 ' C ' ' A' ' 44' ' ' LEU . 1.5 pp -97.02 -41.2 8.49 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.1 pttt -82.21 -65.19 1.04 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.3 m -56.67 -23.74 43.84 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 111.779 0.289 . . . . 0.0 111.779 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -94.07 -41.13 9.7 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 111.515 0.191 . . . . 0.0 111.515 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.21 59.74 0.97 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.885 0.374 . . . . 0.0 111.902 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.1 p -78.87 -35.67 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.605 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 64.59 10.76 6.15 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.423 -179.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -154.05 -173.05 4.43 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.681 ' HB2' HD23 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -68.04 135.61 91.77 Favored Pre-proline 0 N--CA 1.464 0.275 0 CA-C-O 120.518 0.199 . . . . 0.0 110.809 179.707 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.494 ' O ' HG22 ' A' ' 57' ' ' VAL . 73.7 Cg_endo -77.39 -23.02 10.43 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.334 2.022 . . . . 0.0 112.834 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.416 ' HA ' HG22 ' A' ' 57' ' ' VAL . 65.0 m-20 -90.69 6.92 42.02 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.681 HD23 ' HB2' ' A' ' 52' ' ' ARG . 3.7 pp -89.87 -17.71 27.55 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 120.987 -0.285 . . . . 0.0 111.312 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.526 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -111.12 -46.0 3.37 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 53' ' ' PRO . 13.1 m -56.72 148.36 4.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 121.188 0.518 . . . . 0.0 111.692 -179.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.685 ' HB2' HG23 ' A' ' 63' ' ' THR . 26.3 t70 -63.99 -53.9 42.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.496 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -177.15 -43.84 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.436 178.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 5.3 p -87.45 12.88 11.13 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.474 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 57.01 22.19 41.25 Favored Glycine 0 C--N 1.339 0.747 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.745 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.8 tt0 -107.87 -35.54 6.62 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.861 0.363 . . . . 0.0 110.863 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.685 HG23 ' HB2' ' A' ' 58' ' ' ASP . 9.4 t -129.55 -178.77 4.82 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.006 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.6 mt -102.93 153.68 19.97 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.968 0.414 . . . . 0.0 111.391 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.408 ' HB3' ' HA ' ' A' ' 58' ' ' ASP . 0.8 OUTLIER -79.78 155.0 75.85 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.135 179.854 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.24 135.21 59.39 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.867 2.378 . . . . 0.0 112.545 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.18 -48.35 0.91 Allowed Glycine 0 C--N 1.332 0.344 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.413 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 5.2 mt -93.39 143.08 12.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-O 120.83 0.348 . . . . 0.0 111.21 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.478 HD23 HD21 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -105.1 101.68 11.22 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 179.659 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.498 HG23 ' HB3' ' A' ' 77' ' ' ALA . 10.8 m -76.84 136.8 23.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.785 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.478 HD21 HD23 ' A' ' 69' ' ' LEU . 23.1 mt -131.4 146.8 52.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.317 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.571 HG21 HG21 ' A' ' 80' ' ' VAL . 67.7 t -128.22 133.9 66.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.325 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.2 m120 58.72 26.06 14.16 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.003 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 54.93 31.88 16.82 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.373 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.407 ' SG ' ' N ' ' A' ' 76' ' ' ASP . 16.4 p -130.04 -48.57 1.11 Allowed 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.356 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.76 ' HB3' HG23 ' A' ' 79' ' ' VAL . 0.2 OUTLIER 172.28 140.6 0.03 OUTLIER 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.491 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.498 ' HB3' HG23 ' A' ' 70' ' ' VAL . . . -86.32 -22.58 26.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.65 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -79.19 -32.97 44.28 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 120.437 0.161 . . . . 0.0 110.609 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.76 HG23 ' HB3' ' A' ' 76' ' ' ASP . 52.7 t -60.62 -46.65 95.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.957 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.571 HG21 HG21 ' A' ' 72' ' ' VAL . 18.8 m -65.31 -23.44 33.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 147.43 -23.94 1.53 Allowed Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.766 -0.73 . . . . 0.0 113.344 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 104.04 -57.92 0.52 Allowed Glycine 0 C--N 1.338 0.692 0 C-N-CA 121.126 -0.559 . . . . 0.0 111.705 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.6 ' HA ' HD22 ' A' ' 37' ' ' LEU . 5.6 ptt? -152.89 26.99 0.54 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.497 0.189 . . . . 0.0 110.98 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -135.05 21.72 3.49 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.409 ' CD2' HG11 ' A' ' 72' ' ' VAL . 19.7 t80 -80.44 112.87 18.19 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.846 0.355 . . . . 0.0 110.849 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.1 m -62.72 143.64 15.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.393 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.996 HD21 HD13 ' A' ' 40' ' ' LEU . 0.6 OUTLIER -82.1 142.34 32.36 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.415 -179.783 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -130.18 43.02 3.19 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.32 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 54.73 27.3 8.58 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.808 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -173.44 41.2 0.15 Allowed Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.304 -0.474 . . . . 0.0 112.091 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.425 ' HB2' ' HG ' ' A' ' 87' ' ' LEU . 24.8 t0 -83.12 114.09 21.08 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.719 0.295 . . . . 0.0 111.222 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.607 HG23 ' CG2' ' A' ' 8' ' ' THR . 28.4 m -85.01 128.62 34.71 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.56 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.0 p -140.19 133.54 34.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.126 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -129.35 161.31 30.59 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.021 0.439 . . . . 0.0 111.592 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -134.2 104.74 6.32 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.165 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 29.0 mt -114.77 112.91 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.132 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.3 140.38 38.82 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.91 0.386 . . . . 0.0 111.369 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 39.9 p -123.25 -54.07 1.8 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.217 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.43 77.86 2.38 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.054 0.454 . . . . 0.0 110.21 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 47.0 p-80 -133.01 162.79 30.76 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.053 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.08 -106.45 1.72 Allowed Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.271 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.147 0 CA-C-O 118.602 -1.11 . . . . 0.0 112.769 179.536 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 120.716 0.293 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.5 p -101.32 -35.58 9.19 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.13 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -117.54 152.8 34.35 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.057 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -100.99 100.6 11.24 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.899 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 -164.38 179.06 7.01 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.879 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 71.52 124.73 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.132 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.487 HG21 HD11 ' A' ' 40' ' ' LEU . 12.4 mm -88.35 111.54 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.714 179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.563 HG22 ' NE2' ' A' ' 10' ' ' GLN . 41.8 m -81.78 102.61 10.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.343 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.566 HG13 ' HB2' ' A' ' 25' ' ' LEU . 7.9 p -119.93 104.92 16.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.467 179.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.563 ' NE2' HG22 ' A' ' 8' ' ' THR . 0.7 OUTLIER -127.28 161.8 27.74 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.692 -179.047 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -116.07 159.24 21.97 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.948 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.705 ' HB3' ' HA ' ' A' ' 96' ' ' ILE . . . -105.86 176.23 5.23 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.228 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.96 97.38 0.05 OUTLIER Glycine 0 C--N 1.336 0.583 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.53 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 126.67 -29.31 4.49 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.943 -179.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.7 -27.96 15.02 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.852 0.326 . . . . 0.0 111.558 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.94 -27.87 65.71 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.585 0.231 . . . . 0.0 111.254 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 mp -67.7 -10.16 49.97 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.555 HD22 HD11 ' A' ' 55' ' ' LEU . 56.1 mt -81.13 13.3 2.87 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -149.58 -63.73 0.22 Allowed 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -174.37 37.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.114 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.49 34.81 12.94 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.003 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -72.34 -177.36 2.14 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.046 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 49.9 p -115.7 -78.17 0.58 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.919 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.432 ' CB ' ' HB3' ' A' ' 10' ' ' GLN . 83.7 p -136.12 160.24 39.25 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.933 0.397 . . . . 0.0 111.254 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.566 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -138.03 152.06 48.48 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.15 179.804 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -133.18 100.61 4.91 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.523 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 15.1 mt -97.84 139.31 33.89 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.93 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -110.43 96.75 6.4 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.796 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -84.62 155.89 31.14 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.366 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.9 t -66.89 -63.42 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 CA-C-O 120.636 0.255 . . . . 0.0 110.999 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.503 ' O ' HG13 ' A' ' 31' ' ' VAL . 9.0 p -145.05 68.0 13.7 Favored Pre-proline 0 CA--C 1.536 0.433 0 CA-C-O 121.431 0.634 . . . . 0.0 110.845 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -79.52 7.3 4.57 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.368 2.712 . . . . 0.0 113.011 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -54.0 -38.15 64.77 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.64 0.257 . . . . 0.0 111.181 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.27 47.64 3.51 Favored Glycine 0 C--N 1.338 0.687 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.671 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 63.8 m -145.3 145.41 31.23 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 120.718 0.294 . . . . 0.0 110.749 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 53.2 p-10 -108.61 -173.28 2.24 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.891 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.786 ' O ' HG22 ' A' ' 41' ' ' VAL . 4.2 tt -57.66 -39.28 76.69 Favored 'General case' 0 N--CA 1.46 0.071 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.032 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -54.92 -38.19 67.35 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.308 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -78.05 -32.22 45.12 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.103 179.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.487 HD11 HG21 ' A' ' 7' ' ' ILE . 61.7 tp -68.16 -53.08 27.68 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.652 0.226 . . . . 0.0 110.855 179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.786 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.5 OUTLIER -57.83 -57.4 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.854 179.788 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.456 ' H ' HG23 ' A' ' 41' ' ' VAL . 1.8 tm0? -50.65 -32.09 18.11 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.402 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.4 tp -71.52 -27.56 63.28 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.898 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.503 HD12 ' C ' ' A' ' 44' ' ' LEU . 1.3 pp -96.92 -40.58 8.83 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.408 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 0.4 OUTLIER -84.0 -71.69 0.5 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.4 -179.578 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 22.5 m -53.04 -22.14 5.51 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.05 -31.35 10.68 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -142.25 51.6 1.48 Allowed 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -178.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.551 HG22 ' H ' ' A' ' 51' ' ' GLU . 12.2 p -100.6 120.07 49.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.873 0.368 . . . . 0.0 110.716 179.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.0 mttt -101.24 31.91 3.48 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.02 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.551 ' H ' HG22 ' A' ' 49' ' ' VAL . 1.9 tp10 -155.86 -174.78 5.1 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.252 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.593 ' HB2' HD23 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -62.29 110.21 3.08 Favored Pre-proline 0 CA--C 1.53 0.176 0 CA-C-N 116.803 -0.181 . . . . 0.0 111.045 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.444 ' O ' HG22 ' A' ' 57' ' ' VAL . 17.7 Cg_endo -60.33 -27.31 84.62 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.405 2.07 . . . . 0.0 112.286 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.441 ' HA ' ' CG2' ' A' ' 57' ' ' VAL . 5.8 t70 -91.38 8.04 38.11 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.994 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.687 ' HG ' HD23 ' A' ' 56' ' ' LEU . 1.2 pp -88.58 -26.7 21.82 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 122.306 -0.246 . . . . 0.0 111.472 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.687 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -100.5 -46.82 5.1 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -179.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.483 HG11 ' HA2' ' A' ' 61' ' ' GLY . 9.0 m -55.59 149.63 2.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-O 121.164 0.507 . . . . 0.0 111.7 -179.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -63.43 -52.94 59.4 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.736 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.43 -45.5 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.518 179.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.1 p -90.27 16.45 8.62 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.483 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 56.07 21.63 32.39 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.825 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -105.88 -35.35 7.35 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.839 0.352 . . . . 0.0 110.573 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.748 HG22 ' HG3' ' A' ' 83' ' ' MET . 71.9 p -128.16 -177.07 4.0 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.983 179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.4 mt -110.64 154.52 23.69 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.934 0.397 . . . . 0.0 110.997 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -71.67 152.82 93.55 Favored Pre-proline 0 C--O 1.234 0.256 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.068 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -55.77 124.48 16.38 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.764 2.31 . . . . 0.0 112.357 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 147.82 -45.02 0.76 Allowed Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.51 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.537 HG21 ' HB3' ' A' ' 95' ' ' PHE . 5.0 mt -91.52 120.11 39.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 120.7 0.286 . . . . 0.0 111.155 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.23 100.09 12.95 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.403 179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.78 HG23 ' HB3' ' A' ' 77' ' ' ALA . 29.5 m -77.75 126.35 38.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.276 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.431 HD23 ' O ' ' A' ' 70' ' ' VAL . 4.9 mt -125.4 129.67 50.35 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.874 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 92' ' ' THR . 3.6 m -112.82 114.73 47.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.016 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 11.6 m120 54.86 52.22 12.36 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.071 0.462 . . . . 0.0 110.727 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.7 m 59.23 30.1 19.78 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.58 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 46.4 t -145.38 125.31 13.54 Favored 'General case' 0 C--O 1.23 0.048 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.375 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.701 ' HB2' HG23 ' A' ' 79' ' ' VAL . 61.7 m-20 -44.16 127.37 5.51 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.765 0.317 . . . . 0.0 111.254 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.78 ' HB3' HG23 ' A' ' 70' ' ' VAL . . . -63.3 -19.48 64.63 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.883 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -73.28 -26.63 61.16 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 120.577 0.227 . . . . 0.0 110.673 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.701 HG23 ' HB2' ' A' ' 76' ' ' ASP . 30.7 t -70.82 -44.38 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.084 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.4 m -70.39 -39.74 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.507 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.39 42.66 0.02 OUTLIER Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.804 -0.712 . . . . 0.0 113.426 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 53.07 -107.84 0.63 Allowed Glycine 0 C--N 1.334 0.455 0 C-N-CA 121.184 -0.532 . . . . 0.0 113.009 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.748 ' HG3' HG22 ' A' ' 63' ' ' THR . 60.5 mmm -108.58 27.69 9.14 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.804 0.335 . . . . 0.0 111.073 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -120.29 19.22 12.17 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.828 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -68.83 117.73 10.89 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.827 0.346 . . . . 0.0 111.339 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 15.6 m -70.57 146.53 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.713 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 1.9 mp -94.88 161.39 14.18 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.18 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 32.8 m-20 -153.54 35.77 0.46 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.616 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 59.93 96.39 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.045 0.45 . . . . 0.0 111.21 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 112.07 36.17 1.7 Allowed Glycine 0 CA--C 1.518 0.237 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.357 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -87.3 170.33 11.52 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.784 0.326 . . . . 0.0 110.902 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.442 HG23 HE22 ' A' ' 10' ' ' GLN . 92.6 m -137.91 134.98 35.66 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.8 p -141.41 134.28 29.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.027 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -131.38 149.14 52.66 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.384 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.537 ' HB3' HG21 ' A' ' 68' ' ' ILE . 23.0 m-85 -121.84 104.71 9.75 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.45 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.705 ' HA ' ' HB3' ' A' ' 12' ' ' ALA . 17.9 mt -111.89 103.84 16.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.239 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 84.0 p -82.56 132.05 35.2 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.89 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.34 -55.53 0.44 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.372 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 99' ' ' LEU . 0.2 OUTLIER -73.53 110.55 7.91 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.719 0.295 . . . . 0.0 110.839 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -88.93 122.71 32.57 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.937 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -119.64 144.89 17.75 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.515 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.093 0 CA-C-O 118.27 -1.294 . . . . 0.0 112.798 179.804 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 120.695 0.283 . . . . 0.0 111.254 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.7 p -69.02 129.4 39.82 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.936 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -108.37 116.82 32.68 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.139 -179.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 66.7 m-70 64.7 99.26 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.314 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -60.91 133.66 56.31 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.384 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -172.63 158.47 4.12 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.542 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.489 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 17.3 mm -123.66 153.73 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.86 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.41 ' HB ' ' HA ' ' A' ' 92' ' ' THR . 49.5 m -113.12 99.23 7.68 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.914 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.592 HG13 ' HB2' ' A' ' 25' ' ' LEU . 14.7 p -121.86 115.02 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.573 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.428 ' HG2' ' HG2' ' A' ' 94' ' ' GLU . 3.8 pm0 -128.99 159.14 36.85 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.963 0.411 . . . . 0.0 111.26 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.494 ' HB3' ' N ' ' A' ' 16' ' ' GLU . 12.1 m-85 -115.73 135.12 54.34 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.25 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -142.47 144.61 33.1 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.101 0.476 . . . . 0.0 111.977 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 86.42 -91.48 1.73 Allowed Glycine 0 C--N 1.332 0.355 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.905 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -133.88 28.91 3.16 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.992 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -109.94 -31.06 7.53 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.682 0.241 . . . . 0.0 111.133 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.494 ' N ' ' HB3' ' A' ' 11' ' ' PHE . 0.7 OUTLIER -61.76 -37.08 82.96 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.26 -179.845 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.461 ' N ' ' HG2' ' A' ' 16' ' ' GLU . 4.5 mt -67.93 -14.4 62.94 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.809 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.728 HD13 HD22 ' A' ' 56' ' ' LEU . 9.0 mt -83.54 13.52 4.48 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.403 ' HA ' ' HB2' ' A' ' 50' ' ' LYS . 10.5 t80 -144.28 -64.51 0.36 Allowed 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -174.64 38.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.087 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 49.57 38.79 15.62 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.058 0.456 . . . . 0.0 110.782 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -73.9 175.37 7.39 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.056 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 33.1 p -114.94 -52.25 2.7 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.013 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 94.3 p -155.39 148.83 25.02 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.669 0.271 . . . . 0.0 110.955 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.592 ' HB2' HG13 ' A' ' 9' ' ' VAL . 5.0 mt -135.72 158.01 45.44 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.931 0.396 . . . . 0.0 111.345 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.489 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 11.8 mt-30 -130.1 106.99 8.99 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.8 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.1 mt -87.68 138.41 31.49 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.942 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -127.92 125.12 38.98 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.787 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.99 42.44 24.8 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.929 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.8 m -127.02 -43.09 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.974 HG12 HG21 ' A' ' 35' ' ' THR . 30.6 m -129.5 71.12 82.11 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-O 120.871 0.367 . . . . 0.0 111.083 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.09 -64.81 0.12 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.686 2.257 . . . . 0.0 112.458 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.3 m -151.09 -53.68 0.14 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.442 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.38 56.83 4.43 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.904 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.974 HG21 HG12 ' A' ' 31' ' ' VAL . 87.9 m -148.44 114.95 5.94 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.745 0.307 . . . . 0.0 110.731 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 43.7 p30 -84.43 174.05 10.38 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.975 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.904 HD22 ' HA ' ' A' ' 83' ' ' MET . 4.9 tt -57.84 -39.85 78.66 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.246 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -53.64 -41.24 66.56 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.933 0.397 . . . . 0.0 109.986 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.08 -31.86 63.74 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.135 178.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.3 tp -70.13 -57.13 5.29 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.525 0.202 . . . . 0.0 110.964 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.73 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.4 OUTLIER -57.54 -57.51 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.203 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.429 ' H ' HG23 ' A' ' 41' ' ' VAL . 0.7 OUTLIER -49.67 -32.49 13.33 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.504 179.773 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.1 tp -75.63 -24.15 56.41 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.409 ' C ' HD12 ' A' ' 44' ' ' LEU . 1.0 OUTLIER -96.35 -37.54 10.44 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.878 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.489 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 2.9 pttt -83.95 -71.26 0.52 Allowed 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 121.162 -0.215 . . . . 0.0 111.322 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.9 m -52.25 -24.72 7.77 Favored 'General case' 0 CA--C 1.537 0.442 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -102.08 -27.2 13.06 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -142.42 50.38 1.49 Allowed 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.623 HG22 ' H ' ' A' ' 51' ' ' GLU . 10.4 p -96.9 139.66 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 120.684 0.278 . . . . 0.0 111.25 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.403 ' HB2' ' HA ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -123.91 31.25 5.9 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.46 179.906 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.623 ' H ' HG22 ' A' ' 49' ' ' VAL . 0.7 OUTLIER -164.15 176.46 9.23 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.153 179.567 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.499 ' HB2' HD23 ' A' ' 55' ' ' LEU . 0.1 OUTLIER -49.99 106.0 0.58 Allowed Pre-proline 0 N--CA 1.466 0.329 0 CA-C-O 120.508 0.194 . . . . 0.0 111.367 -179.814 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.07 -28.47 60.47 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.44 2.093 . . . . 0.0 112.676 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.403 ' HA ' ' CG2' ' A' ' 57' ' ' VAL . 0.3 OUTLIER -92.88 9.03 37.13 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.803 ' HG ' HD23 ' A' ' 56' ' ' LEU . 2.1 pp -83.62 -28.93 28.12 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 121.034 -0.267 . . . . 0.0 111.158 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.803 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -94.11 -54.46 3.57 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.765 -0.198 . . . . 0.0 111.335 179.927 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.553 HG11 ' HA2' ' A' ' 61' ' ' GLY . 1.4 m -54.55 151.22 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.201 0.524 . . . . 0.0 111.638 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -68.02 -62.91 1.19 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.739 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -165.22 -45.36 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.404 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.1 t -78.89 3.89 15.69 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.595 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.553 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 61.34 22.92 61.68 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.598 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.6 tm0? -121.46 -45.47 2.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.81 0.338 . . . . 0.0 110.407 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.563 ' HA ' ' HG3' ' A' ' 83' ' ' MET . 1.8 t -102.07 123.61 46.25 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.676 178.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.666 HD22 ' HB2' ' A' ' 56' ' ' LEU . 7.8 mt -67.79 156.7 36.44 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.727 0.298 . . . . 0.0 110.917 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 56' ' ' LEU . 7.6 ptm180 -57.32 143.26 74.14 Favored Pre-proline 0 C--O 1.234 0.259 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.125 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -50.6 -33.28 38.63 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.091 2.527 . . . . 0.0 112.829 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -50.85 -34.7 30.25 Favored Glycine 0 CA--C 1.523 0.54 0 CA-C-N 116.037 -0.529 . . . . 0.0 113.023 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.537 HD13 HD13 ' A' ' 64' ' ' LEU . 7.2 mt -88.77 120.41 37.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-O 120.76 0.314 . . . . 0.0 111.213 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.9 mt -96.94 97.02 8.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.018 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.9 t -79.46 136.69 23.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.12 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.09 155.73 44.99 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.476 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.564 HG23 ' CB ' ' A' ' 77' ' ' ALA . 39.9 t -124.48 115.04 43.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.8 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 67.03 -77.15 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.2 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.9 t -153.32 33.7 0.46 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.867 0.365 . . . . 0.0 110.942 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 44.4 t -158.46 156.02 29.58 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.682 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.448 ' HB2' HG23 ' A' ' 79' ' ' VAL . 51.4 m-20 -49.14 136.58 14.78 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.611 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.564 ' CB ' HG23 ' A' ' 72' ' ' VAL . . . -82.39 -23.13 35.11 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.845 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -71.59 -18.59 62.22 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.432 0.158 . . . . 0.0 111.087 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.448 HG23 ' HB2' ' A' ' 76' ' ' ASP . 32.6 t -72.53 -41.11 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.316 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.6 m -80.6 -29.14 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.735 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 176.61 -38.32 0.1 OUTLIER Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.035 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 99.06 -72.06 0.54 Allowed Glycine 0 C--N 1.334 0.435 0 C-N-CA 121.003 -0.618 . . . . 0.0 111.968 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.904 ' HA ' HD22 ' A' ' 37' ' ' LEU . 2.7 mmt -129.0 25.75 5.55 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.725 0.298 . . . . 0.0 111.182 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -136.67 23.99 3.13 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.56 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -82.63 120.17 25.21 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 120.6 0.238 . . . . 0.0 110.738 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.2 m -69.84 134.06 30.78 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.426 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.605 HD22 HG21 ' A' ' 31' ' ' VAL . 6.5 mp -98.2 123.57 42.34 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.867 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -108.1 35.19 3.23 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.334 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 63.1 104.83 0.03 OUTLIER 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.209 0.528 . . . . 0.0 111.488 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 113.2 29.34 3.03 Favored Glycine 0 CA--C 1.519 0.322 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.503 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -101.14 152.77 20.23 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.619 0.247 . . . . 0.0 110.837 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.41 ' HA ' ' HB ' ' A' ' 8' ' ' THR . 94.9 m -115.18 111.8 21.54 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.962 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.8 p -120.67 125.69 74.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.748 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.428 ' HG2' ' HG2' ' A' ' 10' ' ' GLN . 16.0 mt-10 -126.37 153.68 44.6 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.364 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -120.69 104.53 9.99 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.067 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 25.2 mt -106.11 99.91 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.964 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.97 140.11 29.99 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.301 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.1 p -134.99 -48.84 0.74 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.405 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.31 138.33 36.72 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.773 0.321 . . . . 0.0 111.257 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -102.51 -37.36 8.02 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.986 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -165.89 -48.61 0.02 OUTLIER Glycine 0 C--N 1.335 0.479 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.486 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.386 -1.23 . . . . 0.0 112.424 179.879 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 ptm . . . . . 0 N--CA 1.489 1.478 0 CA-C-O 120.787 0.327 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.1 m -141.39 83.22 1.86 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.922 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -147.02 105.49 3.8 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.021 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -157.59 31.81 0.27 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.305 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -86.19 132.16 34.07 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.781 0.324 . . . . 0.0 111.145 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.412 ' O ' HD13 ' A' ' 7' ' ' ILE . 2.3 p80 179.07 172.51 0.82 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.779 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 26' ' ' GLN . 25.2 mm -129.62 152.2 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.611 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.431 ' HB ' HG23 ' A' ' 92' ' ' THR . 6.7 m -115.79 122.92 46.87 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.736 0.303 . . . . 0.0 111.474 -179.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.635 HG13 ' HB2' ' A' ' 25' ' ' LEU . 9.8 p -145.89 110.1 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.201 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.404 ' HB3' ' CB ' ' A' ' 24' ' ' SER . 5.2 pm0 -135.62 160.94 36.94 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.961 0.41 . . . . 0.0 111.643 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.454 ' HB2' ' HB3' ' A' ' 16' ' ' GLU . 89.1 m-85 -117.34 147.08 42.94 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.075 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.78 ' HB3' HG12 ' A' ' 96' ' ' ILE . . . -145.22 145.82 31.47 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.836 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.04 -95.3 2.06 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.457 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -139.51 30.91 2.37 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.722 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.2 m -108.04 -23.91 11.8 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 111.71 0.263 . . . . 0.0 111.71 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.454 ' HB3' ' HB2' ' A' ' 11' ' ' PHE . 1.8 pm0 -59.84 -30.65 69.09 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.621 0.248 . . . . 0.0 111.228 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.8 mp -71.26 -7.97 50.53 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.706 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.53 HD13 HD22 ' A' ' 56' ' ' LEU . 42.1 mt -87.97 13.58 10.7 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.425 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 42.0 t80 -144.95 -63.63 0.35 Allowed 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -178.22 36.17 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.077 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.74 31.59 6.11 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.965 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -80.6 134.19 35.87 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.976 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -67.76 -66.25 0.59 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.822 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.404 ' CB ' ' HB3' ' A' ' 10' ' ' GLN . 87.3 p -144.24 161.31 39.22 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.723 0.297 . . . . 0.0 111.062 179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.635 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -142.65 148.13 36.89 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.399 -179.881 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.512 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 4.7 mt-30 -132.16 117.95 18.94 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.883 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.4 mt -113.75 134.95 54.46 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.877 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -125.0 107.94 11.34 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.92 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -150.73 154.51 25.65 Favored Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.469 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.688 HG23 HG23 ' A' ' 31' ' ' VAL . 35.5 m -97.83 -44.63 12.42 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-O 120.63 0.252 . . . . 0.0 111.116 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.688 HG23 HG23 ' A' ' 30' ' ' VAL . 12.1 t -90.87 -46.82 0.37 Allowed Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.624 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 31' ' ' VAL . 51.7 Cg_exo -51.97 -43.56 51.39 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.757 2.305 . . . . 0.0 112.817 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.462 HG22 ' H ' ' A' ' 34' ' ' GLY . 0.2 OUTLIER -76.58 -179.96 5.59 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.885 -179.796 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.462 ' H ' HG22 ' A' ' 33' ' ' THR . . . 101.85 41.07 2.55 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.347 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.0 t -117.74 -158.14 0.7 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.255 0.222 . . . . 0.0 110.535 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -134.47 -174.24 3.51 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.869 -0.15 . . . . 0.0 110.745 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.813 HD22 ' HA ' ' A' ' 83' ' ' MET . 3.3 tt -60.01 -44.3 94.68 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 121.285 -0.166 . . . . 0.0 111.329 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -59.48 -34.33 72.43 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.54 -33.92 46.2 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.601 178.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.658 HD13 HG11 ' A' ' 93' ' ' VAL . 14.0 mt -60.55 -52.17 66.31 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 120.735 0.302 . . . . 0.0 110.603 179.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.549 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.2 OUTLIER -59.92 -56.66 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.975 179.846 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.43 -30.77 13.29 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.51 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.8 tp -73.11 -27.82 61.92 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.437 HD12 ' C ' ' A' ' 44' ' ' LEU . 1.8 pp -96.97 -42.55 7.86 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.4 pttt -84.26 -68.79 0.69 Allowed 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.5 m -50.69 -28.82 9.76 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.509 0.195 . . . . 0.0 111.47 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -81.19 -34.31 32.39 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.277 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -130.8 -68.32 0.69 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 111.449 0.166 . . . . 0.0 111.449 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 51' ' ' GLU . 11.5 p 44.72 72.31 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 121.56 0.695 . . . . 0.0 111.491 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -52.55 -50.23 63.33 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.205 179.956 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.606 ' O ' HG22 ' A' ' 49' ' ' VAL . 1.8 tp10 -91.44 -164.06 1.12 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.02 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.452 ' CB ' HD23 ' A' ' 55' ' ' LEU . 3.3 ttt-85 -66.2 134.39 94.77 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-O 120.675 0.274 . . . . 0.0 111.24 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.582 ' HB3' HG21 ' A' ' 49' ' ' VAL . 74.1 Cg_endo -77.24 -25.56 8.39 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.572 2.181 . . . . 0.0 112.529 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.44 ' HA ' HG22 ' A' ' 57' ' ' VAL . 2.9 t70 -89.84 8.46 31.9 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.565 ' HG ' HD23 ' A' ' 56' ' ' LEU . 2.6 pp -91.41 -26.32 18.92 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 121.287 -0.165 . . . . 0.0 111.323 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.59 ' HB2' HD22 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -98.24 -45.1 6.31 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.804 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.44 HG22 ' HA ' ' A' ' 54' ' ' ASP . 11.1 m -55.3 148.52 3.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 121.258 0.551 . . . . 0.0 111.558 -179.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -63.94 -57.0 11.09 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.532 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.76 -44.51 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.515 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 34.6 p -86.07 10.73 13.46 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.735 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.429 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 58.31 22.3 50.34 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.688 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -109.69 -34.69 6.4 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.947 0.403 . . . . 0.0 110.886 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.6 t -129.25 175.09 9.0 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.881 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.59 HD22 ' HB2' ' A' ' 56' ' ' LEU . 11.0 mt -93.75 158.03 15.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.043 0.449 . . . . 0.0 111.402 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.437 ' HB2' ' HD2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -83.17 165.87 38.44 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.191 -179.867 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.437 ' HD2' ' HB2' ' A' ' 65' ' ' ARG . 47.2 Cg_exo -55.72 129.67 36.28 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.741 2.294 . . . . 0.0 112.428 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.49 -49.29 0.86 Allowed Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.196 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.527 HG21 ' HB3' ' A' ' 95' ' ' PHE . 4.6 mt -94.62 134.61 31.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-O 120.728 0.299 . . . . 0.0 110.859 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.3 mt -111.53 118.65 36.31 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.975 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.465 HG23 ' HB3' ' A' ' 77' ' ' ALA . 26.9 m -85.77 125.22 40.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.031 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.415 HD23 ' C ' ' A' ' 70' ' ' VAL . 1.7 mt -120.96 131.55 54.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.089 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.591 HG13 ' HB2' ' A' ' 77' ' ' ALA . 1.5 m -103.99 99.31 8.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.737 179.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 59.58 51.19 6.61 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.685 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.1 t 66.02 35.35 6.42 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.506 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 47.1 t -148.69 123.9 10.18 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.559 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -47.49 114.1 0.82 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.885 0.374 . . . . 0.0 111.32 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.591 ' HB2' HG13 ' A' ' 72' ' ' VAL . . . -73.04 -18.99 61.27 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.842 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.401 ' HA ' ' CA ' ' A' ' 82' ' ' GLY . 2.7 mt-10 -73.17 -23.99 60.5 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.87 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.8 t -64.59 -35.76 75.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.813 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 15.9 m -95.85 -36.72 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.693 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -152.22 -66.15 0.01 OUTLIER Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.061 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.401 ' CA ' ' HA ' ' A' ' 78' ' ' GLU . . . 104.39 -40.29 2.51 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.664 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.813 ' HA ' HD22 ' A' ' 37' ' ' LEU . 5.0 ptt? -147.63 25.13 1.08 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.52 0.2 . . . . 0.0 111.318 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -148.74 25.4 0.94 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.663 0.268 . . . . 0.0 111.679 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -81.5 114.32 20.15 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.763 0.316 . . . . 0.0 110.917 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.8 m -63.6 146.1 13.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.487 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.649 ' CD1' HD11 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -90.42 168.52 11.8 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.295 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 44.4 p30 -168.45 166.14 12.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.658 179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -64.45 96.16 0.16 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.931 0.396 . . . . 0.0 110.343 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.417 ' H ' HD13 ' A' ' 7' ' ' ILE . . . 118.77 24.25 3.14 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.529 -179.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -87.41 158.38 19.01 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.751 0.31 . . . . 0.0 111.045 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.45 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 53.5 m -138.31 136.93 36.91 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.264 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.658 HG11 HD13 ' A' ' 40' ' ' LEU . 3.4 p -143.26 120.33 5.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.607 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -125.09 147.94 48.77 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.528 -179.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.527 ' HB3' HG21 ' A' ' 68' ' ' ILE . 80.6 m-85 -118.74 104.42 10.58 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.174 179.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.78 HG12 ' HB3' ' A' ' 12' ' ' ALA . 30.0 mt -116.59 112.85 41.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.243 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 27.1 t -78.37 86.99 4.41 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.237 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.5 p -63.55 -69.4 0.27 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.374 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.9 168.04 9.79 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.585 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 -126.75 76.35 1.63 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.959 0.409 . . . . 0.0 110.785 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 124.52 -109.42 1.25 Allowed Glycine 0 C--N 1.332 0.31 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.152 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.164 0 CA-C-O 118.779 -1.012 . . . . 0.0 112.793 -179.942 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 120.678 0.275 . . . . 0.0 111.369 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.2 p -166.98 108.26 0.65 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.054 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 43.0 m-20 -86.88 -45.45 10.83 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.845 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 64.17 175.71 0.18 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 121.076 0.465 . . . . 0.0 111.639 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.5 ' O ' ' HB2' ' A' ' 6' ' ' HIS . 5.3 m120 -133.56 -162.88 1.29 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.528 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.5 ' HB2' ' O ' ' A' ' 5' ' ' ASN . 12.5 m-70 72.6 123.27 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 122.702 0.401 . . . . 0.0 111.049 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.663 HD12 HD23 ' A' ' 87' ' ' LEU . 6.5 mm -81.25 145.58 8.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.185 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.601 HG22 ' OE1' ' A' ' 10' ' ' GLN . 1.2 m -102.26 107.51 18.57 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.206 -179.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.559 HG13 ' HB2' ' A' ' 25' ' ' LEU . 7.6 p -133.07 107.69 11.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.455 178.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.601 ' OE1' HG22 ' A' ' 8' ' ' THR . 1.4 pm0 -136.52 164.72 27.51 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.048 0.452 . . . . 0.0 111.75 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.461 ' CD1' ' HB3' ' A' ' 15' ' ' CYS . 15.2 m-85 -112.64 149.36 32.94 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.906 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.925 ' HB3' HG12 ' A' ' 96' ' ' ILE . . . -140.68 135.51 31.7 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.028 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.22 -107.03 3.44 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.315 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -121.84 30.5 5.27 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.784 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.461 ' HB3' ' CD1' ' A' ' 11' ' ' PHE . 7.9 m -106.06 -19.96 13.56 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.798 0.299 . . . . 0.0 111.721 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -58.34 -30.45 66.73 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.804 0.335 . . . . 0.0 110.767 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 mp -70.03 -4.46 21.03 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.873 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.808 ' CD2' HD11 ' A' ' 55' ' ' LEU . 91.5 mt -77.09 7.79 4.61 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.404 ' CD1' ' HB2' ' A' ' 50' ' ' LYS . 77.0 t80 -149.92 -65.11 0.21 Allowed 'General case' 0 N--CA 1.463 0.188 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -172.09 39.14 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.772 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 52.18 35.77 17.54 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.892 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -76.13 -176.9 3.71 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.023 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 72.0 p -109.96 -77.42 0.6 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.806 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.447 ' CB ' ' HB3' ' A' ' 10' ' ' GLN . 80.8 p -135.73 162.9 31.47 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.876 0.37 . . . . 0.0 111.406 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.559 ' HB2' HG13 ' A' ' 9' ' ' VAL . 0.9 OUTLIER -139.08 155.51 47.87 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.779 179.896 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 7' ' ' ILE . 35.6 mt-30 -132.15 127.78 36.66 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.143 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.5 mt -102.68 136.51 42.37 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.018 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -129.82 126.77 38.85 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.872 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 63.39 48.64 76.86 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.024 -0.607 . . . . 0.0 112.776 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.415 ' O ' HG12 ' A' ' 30' ' ' VAL . 10.6 t -122.11 43.02 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 120.992 0.425 . . . . 0.0 110.761 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.8 t 56.29 66.25 3.57 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.272 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -72.15 -12.6 28.04 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.616 2.21 . . . . 0.0 113.176 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.8 m -96.98 -57.39 2.29 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.69 0.281 . . . . 0.0 111.368 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -85.97 48.62 3.99 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 120.982 -0.628 . . . . 0.0 113.667 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 89.4 m -151.23 136.7 17.77 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.919 0.36 . . . . 0.0 110.692 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -111.9 -175.11 2.61 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.887 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.703 HD22 ' CB ' ' A' ' 83' ' ' MET . 4.7 tt -57.65 -49.47 76.34 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -57.68 -31.95 66.87 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.233 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -79.42 -32.22 38.98 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 111.414 -0.674 . . . . 0.0 111.414 178.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.674 HD21 HD22 ' A' ' 87' ' ' LEU . 0.6 OUTLIER -63.85 -51.68 63.56 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.669 0.271 . . . . 0.0 110.463 179.345 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.574 HG22 ' O ' ' A' ' 37' ' ' LEU . 0.2 OUTLIER -56.99 -56.21 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.835 179.558 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -51.41 -29.82 17.19 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.452 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.599 HD13 ' O ' ' A' ' 43' ' ' LEU . 0.5 OUTLIER -75.65 -28.31 58.69 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.75 HD12 ' N ' ' A' ' 45' ' ' LYS . 4.4 pp -95.89 -36.6 11.04 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.75 ' N ' HD12 ' A' ' 44' ' ' LEU . 2.4 pttt -86.07 -61.39 1.76 Allowed 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.2 m -58.61 -23.13 58.22 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 122.253 -0.279 . . . . 0.0 111.569 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -96.65 -39.17 9.63 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 111.412 0.152 . . . . 0.0 111.412 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -150.24 59.76 0.97 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.433 ' HB ' ' O ' ' A' ' 45' ' ' LYS . 7.5 p -78.81 -42.27 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 C-N-CA 121.107 -0.237 . . . . 0.0 111.436 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.404 ' HB2' ' CD1' ' A' ' 19' ' ' PHE . 0.0 OUTLIER 62.02 14.12 6.22 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 120.662 0.268 . . . . 0.0 111.501 -179.684 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -152.34 -160.81 1.19 Allowed 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.671 ' HB2' HD23 ' A' ' 55' ' ' LEU . 9.0 mmt85 -87.16 108.15 17.79 Favored Pre-proline 0 C--N 1.331 -0.225 0 N-CA-C 110.412 -0.218 . . . . 0.0 110.412 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.437 ' O ' HG22 ' A' ' 57' ' ' VAL . 18.5 Cg_endo -59.43 -23.21 69.5 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.148 1.898 . . . . 0.0 112.515 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.421 ' HA ' ' CG2' ' A' ' 57' ' ' VAL . 48.8 m-20 -90.43 8.09 35.47 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.808 HD11 ' CD2' ' A' ' 18' ' ' LEU . 2.1 pp -92.7 -20.45 20.8 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 121.19 -0.204 . . . . 0.0 111.418 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.651 HD23 ' HG ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -106.63 -45.63 4.18 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 179.956 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.446 HG11 ' HA2' ' A' ' 61' ' ' GLY . 5.8 m -52.8 149.88 1.34 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-O 121.135 0.493 . . . . 0.0 111.864 -179.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -65.76 -61.37 2.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.555 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -168.47 -44.47 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.311 179.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.3 p -80.14 4.68 16.59 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.615 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.446 ' HA2' HG11 ' A' ' 57' ' ' VAL . . . 61.54 21.38 60.25 Favored Glycine 0 C--N 1.339 0.709 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.433 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.3 tp60 -112.63 -41.06 3.9 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.769 0.319 . . . . 0.0 110.594 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.743 HG22 ' HG2' ' A' ' 83' ' ' MET . 16.8 p -110.77 -167.12 1.14 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.133 179.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.502 HD22 ' HB2' ' A' ' 56' ' ' LEU . 7.4 mt -114.8 154.45 28.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.828 0.347 . . . . 0.0 111.06 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.69 150.46 81.84 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.063 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.79 127.42 24.58 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.875 2.383 . . . . 0.0 112.315 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 142.58 -45.01 0.94 Allowed Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.46 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.456 HG21 ' HB3' ' A' ' 95' ' ' PHE . 5.6 mt -88.43 141.35 14.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 120.803 0.335 . . . . 0.0 111.228 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.1 mt -105.48 99.85 9.44 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.79 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.832 HG23 ' HB3' ' A' ' 77' ' ' ALA . 13.3 m -78.76 135.51 25.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.007 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 mt -126.57 141.2 51.94 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.013 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.719 HG11 ' CD2' ' A' ' 85' ' ' TYR . 48.9 t -123.74 118.23 53.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.737 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 56.61 31.74 19.7 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.337 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 55.2 35.76 25.54 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.873 0.368 . . . . 0.0 111.113 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 11.2 t -141.89 37.55 1.61 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.922 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.435 ' HB2' HG23 ' A' ' 79' ' ' VAL . 12.9 m-20 67.37 134.59 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.27 0.557 . . . . 0.0 111.388 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.832 ' HB3' HG23 ' A' ' 70' ' ' VAL . . . -84.39 -22.81 30.34 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.434 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -77.84 -32.64 52.26 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.61 0.243 . . . . 0.0 110.859 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.435 HG23 ' HB2' ' A' ' 76' ' ' ASP . 35.2 t -69.21 -42.37 81.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.246 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.457 ' HB ' ' CD1' ' A' ' 85' ' ' TYR . 14.8 m -68.23 -31.22 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.561 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 142.68 42.08 0.06 OUTLIER Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.33 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.422 ' O ' HD13 ' A' ' 37' ' ' LEU . . . 47.35 -119.03 4.45 Favored Glycine 0 C--N 1.336 0.574 0 C-N-CA 121.281 -0.485 . . . . 0.0 112.947 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.743 ' HG2' HG22 ' A' ' 63' ' ' THR . 0.1 OUTLIER -101.5 26.3 7.43 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.69 0.281 . . . . 0.0 111.134 179.42 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -120.2 23.64 10.84 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.369 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.719 ' CD2' HG11 ' A' ' 72' ' ' VAL . 28.4 t80 -93.24 130.25 39.0 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.864 0.364 . . . . 0.0 111.074 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.1 m -89.46 142.52 12.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.03 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.674 HD22 HD21 ' A' ' 40' ' ' LEU . 10.8 mp -83.72 174.22 10.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.947 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -135.01 -67.06 0.56 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.98 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -178.52 79.4 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.817 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.539 ' H ' HD13 ' A' ' 7' ' ' ILE . . . 113.48 37.3 1.33 Allowed Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.821 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.91 174.19 6.45 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.774 0.321 . . . . 0.0 110.931 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 58.4 m -132.42 116.08 16.36 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.953 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.468 HG13 HG23 ' A' ' 9' ' ' VAL . 12.9 p -128.81 119.93 50.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.019 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.438 ' HG2' ' HG2' ' A' ' 10' ' ' GLN . 39.9 mt-10 -124.92 146.56 49.29 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.3 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.456 ' HB3' HG21 ' A' ' 68' ' ' ILE . 20.0 m-85 -121.72 104.81 9.86 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.346 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.925 HG12 ' HB3' ' A' ' 12' ' ' ALA . 27.7 mt -116.68 119.52 62.21 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.293 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.8 t -87.46 134.23 33.63 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.094 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.56 -53.18 0.72 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.239 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -82.77 86.17 6.94 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.986 0.422 . . . . 0.0 110.94 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -106.3 81.43 1.61 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.826 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -169.6 157.99 30.01 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.464 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.262 -1.299 . . . . 0.0 112.573 -179.995 . . . . . . . . 0 0 . 1 stop_ save_